(lp1
(dp2
S'cdsr_refcode'
p3
VSTD-Dimson-1986_x0023_
p4
sS'pmc_id'
p5
S'PMC1778127'
p6
sS'cdsr_filename'
p7
VCD002112 v. 6.0 Desmopressin for nocturnal enuresis in children.rm5
p8
sS'pm_filename'
p9
V3539030.xml
p10
sa(dp11
g3
VSTD-Aladjem-1982
p12
sg5
S'PMC1627511'
p13
sg7
g8
sg9
V7039520.xml
p14
sa(dp15
g3
VSTD-Fjellestad-1987_x0023_
p16
sg5
S'PMC1779260'
p17
sg7
g8
sg9
V3307643.xml
p18
sa(dp19
g3
VSTD-Wille-1986
p20
sg5
S'PMC1777552'
p21
sg7
g8
sg9
V3513716.xml
p22
sa(dp23
g3
VSTD-Dearlove-1983
p24
sg5
S'PMC1548276'
p25
sg7
VCD003019 v. 7.0 Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in child.rm5
p26
sg9
V6407644.xml
p27
sa(dp28
g3
VSTD-Kass-1989
p29
sg5
S'PMC1298559'
p30
sg7
VCD003167 v. 5.0 Medical interventions for primary open angle glaucoma and ocular hypertension.rm5
p31
sg9
V2562546.xml
p32
sa(dp33
g3
VSTD-Geyer-1988
p34
sg5
S'PMC1041616'
p35
sg7
g31
sg9
V3067745.xml
p36
sa(dp37
g3
VSTD-Watson-2001
p38
sg5
S'PMC1724066'
p39
sg7
g31
sg9
V11466256.xml
p40
sa(dp41
g3
VSTD-Small-2000
p42
sg5
S'PMC27510'
p43
sg7
VCD000560 v. 11.0 Psychological debriefing for preventing post traumatic stress disorder (PTSD).rm5
p44
sg9
V11053173.xml
p45
sa(dp46
g3
VSTD-Hobbs-1996
p47
sg5
S'PMC2352974'
p48
sg7
g44
sg9
V8973231.xml
p49
sa(dp50
g3
VSTD-Mozambique-1986
p51
sg5
S'PMC2491050'
p52
sg7
VCD000016 v. 10.0 Amodiaquine for treating malaria.rm5
p53
sg9
V3293827.xml
p54
sa(dp55
g3
VSTD-China-1986
p56
sg5
S'PMC2491139'
p57
sg7
g53
sg9
V3048759.xml
p58
sa(dp59
g3
VSTD-Cameroon_x002d_H_x00e9_v_x00e9_cam2001
p60
sg5
S'PMC2567565'
p61
sg7
g53
sg9
V12163917.xml
p62
sa(dp63
g3
VSTD-Lammers-1986a
p64
sg5
S'PMC1401187'
p65
sg7
VCD002992 v. 11.0 Cardioselective beta-blockers for reversible airway disease.rm5
p66
sg9
V2878680.xml
p67
sa(dp68
g3
VSTD-Benson-1978
p69
sg5
S'PMC1429350'
p70
sg7
g66
sg9
V26371.xml
p71
sa(dp72
g3
VSTD-Skinner-1975b
p73
sg5
S'PMC1402628'
p74
sg7
g66
sg9
V786353.xml
p75
sa(dp76
g3
VSTD-Chen-2011
p77
sg5
S'PMC3167410'
p78
sg7
VCD008987 v. 2.0 Surgical interventions for treating radial head fractures in adults.rm5
p79
sg9
V20680272.xml
p80
sa(dp81
g3
VSTD-Ruan-2009
p82
sg5
S'PMC2899229'
p83
sg7
g79
sg9
V17938924.xml
p84
sa(dp85
g3
VSTD-Fugere-1983
p86
sg5
S'PMC1875263'
p87
sg7
VCD007482 v. 3.0 Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.rm5
p88
sg9
V6344970.xml
p89
sa(dp90
g3
VSTD-Hansudewechakul--2012
p91
sg5
S'PMC3494174'
p92
sg7
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p93
sg9
V23078768.xml
p94
sa(dp95
g3
VSTD-Humphreys-2010
p96
sg5
S'PMC2924332'
p97
sg7
g93
sg9
V20687955.xml
p98
sa(dp99
g3
VSTD-Fatti-2010
p100
sg5
S'PMC2943483'
p101
sg7
g93
sg9
V20877631.xml
p102
sa(dp103
g3
VSTD-Jaffar-2009
p104
sg5
S'PMC2806484'
p105
sg7
g93
sg9
V19939445.xml
p106
sa(dp107
g3
VSTD-Odafe-2012
p108
sg5
S'PMC3521762'
p109
sg7
g93
sg9
V23272094.xml
p110
sa(dp111
g3
VSTD-Vickers-2004
p112
sg5
S'PMC381326'
p113
sg7
VCD001218 v. 8.0 Acupuncture for migraine prophylaxis.rm5
p114
sg9
V15023828.xml
p115
sa(dp116
g3
VSTD-DeLuca-2002
p117
sg5
S'PMC3580954'
p118
sg7
VCD004149 v. 4.0 Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic c.rm5
p119
sg9
V23426574.xml
p120
sa(dp121
g3
VSTD-Abrams-1958
p122
sg5
S'PMC3699438'
p123
sg7
VCD000284 v. 13.5 Chlorpromazine versus placebo for schizophrenia.rm5
p124
sg9
V23776198.xml
p125
sa(dp126
g3
VSTD-Chouinard-1990
p127
sg5
S'PMC1449877'
p128
sg7
g124
sg9
V16699603.xml
p129
sa(dp130
g3
VSTD-Payne-1960
p131
sg5
S'PMC3577661'
p132
sg7
g124
sg9
V23388243.xml
p133
sa(dp134
g3
VSTD-Shepherd-1956
p135
sg5
S'PMC497211'
p136
sg7
g124
sg9
V13357965.xml
p137
sa(dp138
g3
VSTD-Harbarth-1999
p139
sg5
S'PMC89288'
p140
sg7
VCD006216 v. 5.0 Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.rm5
p141
sg9
V10348762.xml
p142
sa(dp143
g3
VSTD-Trivedi-2003
p144
sg5
S'PMC150177'
p145
sg7
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p146
sg9
V12609940.xml
p147
sa(dp148
g3
VSTD-Lannin-2007
p149
sg5
S'PMC1832184'
p150
sg7
g146
sg9
V17355644.xml
p151
sa(dp152
g3
VSTD-McMurdo-1997
p153
sg5
S'PMC2126045'
p154
sg7
g146
sg9
V9055716.xml
p155
sa(dp156
g3
VSTD-Spink-2011
p157
sg5
S'PMC3116775'
p158
sg7
g146
sg9
V21680622.xml
p159
sa(dp160
g3
VSTD-Robertson-2001a
p161
sg5
S'PMC30094'
p162
sg7
g146
sg9
V11264206.xml
p163
sa(dp164
g3
VSTD-Carpenter-1990
p165
sg5
S'PMC1662856'
p166
sg7
g146
sg9
V2354297.xml
p167
sa(dp168
g3
VSTD-Campbell-2005
p169
sg5
S'PMC1246082'
p170
sg7
g146
sg9
V16183652.xml
p171
sa(dp172
g3
VSTD-Harwood-2005
p173
sg5
S'PMC1772474'
p174
sg7
g146
sg9
V15615747.xml
p175
sa(dp176
g3
VSTD-Van-Rossum-1993
p177
sg5
S'PMC1678489'
p178
sg7
g146
sg9
V8343668.xml
p179
sa(dp180
g3
VSTD-Van-Haastregt-2000
p181
sg5
S'PMC27508'
p182
sg7
g146
sg9
V11039967.xml
p183
sa(dp184
g3
VSTD-Wagner-1994
p185
sg5
S'PMC1615188'
p186
sg7
g146
sg9
V7977921.xml
p187
sa(dp188
g3
VSTD-Carter-2002
p189
sg5
S'PMC134175'
p190
sg7
g146
sg9
V12403738.xml
p191
sa(dp192
g3
VSTD-Campbell-1997
p193
sg5
S'PMC2127698'
p194
sg7
g146
sg9
V9366737.xml
p195
sa(dp196
g3
VSTD-Haran-2010
p197
sg5
S'PMC2876235'
p198
sg7
g146
sg9
V20501583.xml
p199
sa(dp200
g3
VSTD-Conroy-2010
p201
sg5
S'PMC2956530'
p202
sg7
g146
sg9
V20823124.xml
p203
sa(dp204
g3
VSTD-Dangour-2011
p205
sg5
S'PMC3079648'
p206
sg7
g146
sg9
V21526229.xml
p207
sa(dp208
g3
VSTD-Vetter-1992
p209
sg5
S'PMC1882829'
p210
sg7
g146
sg9
V1392755.xml
p211
sa(dp212
g3
VSTD-Logan-2010
p213
sg5
S'PMC2868162'
p214
sg7
g146
sg9
V20460331.xml
p215
sa(dp216
g3
VSTD-Porthouse-2005
p217
sg5
S'PMC557150'
p218
sg7
g146
sg9
V15860827.xml
p219
sa(dp220
g3
VSTD-Hogan-2001
p221
sg5
S'PMC81411'
p222
sg7
g146
sg9
V11563205.xml
p223
sa(dp224
g3
VSTD-Steinberg-2000
p225
sg5
S'PMC1731645'
p226
sg7
g146
sg9
V10746118.xml
p227
sa(dp228
g3
VSTD-Weber-2008
p229
sg5
S'PMC2359523'
p230
sg7
g146
sg9
V18373136.xml
p231
sa(dp232
g3
VSTD-Liu_x002d_Ambrose-2004
p233
sg5
S'PMC3344816'
p234
sg7
g146
sg9
V15086643.xml
p235
sa(dp236
g3
VSTD-Batch-1980
p237
sg5
S'PMC1713320'
p238
sg7
VCD001732 v. 7.0 Injection sclerotherapy for varicose veins.rm5
p239
sg9
V7427301.xml
p240
sa(dp241
g3
VSTD-Scurr-1985
p242
sg5
S'PMC2498276'
p243
sg7
g239
sg9
V3883876.xml
p244
sa(dp245
g3
VSTD-Shouler-1989
p246
sg5
S'PMC2499037'
p247
sg7
g239
sg9
V2690721.xml
p248
sa(dp249
g3
VSTD-Asilian-2003
p250
sg5
S'PMC2572463'
p251
sg7
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p252
sg9
V12856053.xml
p253
sa(dp254
g3
VSTD-Nilforoushzadeh-2007
p255
sg5
S'PMC1891315'
p256
sg7
g252
sg9
V17466071.xml
p257
sa(dp258
g3
VSTD-Nilforoushzadeh-2004
p259
sg5
S'PMC2553342'
p260
sg7
g252
sg9
V18830058.xml
p261
sa(dp262
g3
VSTD-Dybul-2001
p263
sg5
S'PMC65000'
p264
sg7
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p265
sg9
V11734634.xml
p266
sa(dp267
g3
VSTD-Papasavvas-2004
p268
sg5
S'PMC539050'
p269
sg7
g265
sg9
V15630469.xml
p270
sa(dp271
g3
VSTD-Hance-2001
p272
sg5
S'PMC114364'
p273
sg7
g265
sg9
V11413308.xml
p274
sa(dp275
g3
VSTD-Ortiz-2001
p276
sg5
S'PMC60863'
p277
sg7
g265
sg9
V11687611.xml
p278
sa(dp279
g3
VSTD-Oxenius-2002a
p280
sg5
S'PMC129766'
p281
sg7
g265
sg9
V12370434.xml
p282
sa(dp283
g3
VSTD-Oxenius-2002
p284
sg5
S'PMC136545'
p285
sg7
g265
sg9
V12239291.xml
p286
sa(dp287
g3
VSTD-Imbasciati-1985
p288
sg5
S'PMC1417455'
p289
sg7
VCD001537 v. 7.0 Interventions for minimal change disease in adults with nephrotic syndrome.rm5
p290
sg9
V3933645.xml
p291
sa(dp292
g3
VSTD-Coggins-1985
p293
sg5
S'PMC2279687'
p294
sg7
g290
sg9
V3915841.xml
p295
sa(dp296
g3
VSTD-Perkins-1956
p297
sg5
S'PMC1324697'
p298
sg7
VCD002218 v. 8.0 Antibiotics versus control for toxoplasma retinochoroiditis.rm5
p299
sg9
V13374225.xml
p300
sa(dp301
g3
VSTD-B_x00f8_-1999
p302
sg5
S'PMC27740'
p303
sg7
VCD002114 v. 10.0 Weighted vaginal cones for urinary incontinence.rm5
p304
sg9
V10024253.xml
p305
sa(dp306
g3
VSTD-Chisholm-2001
p307
sg5
S'PMC1718812'
p308
sg7
VCD006484 v. 4.0 Influenza vaccination in children being treated with chemotherapy for cancer.rm5
p309
sg9
V11369567.xml
p310
sa(dp311
g3
VSTD-Lyon-1998
p312
sg5
S'PMC1720741'
p313
sg7
VCD004338 v. 7.0 Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.rm5
p314
sg9
V9536833.xml
p315
sa(dp316
g3
VSTD-Murphy-2008
p317
sg5
S'PMC3767995'
p318
sg7
VCD006517 v. 5.2 Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.rm5
p319
sg9
V22692090.xml
p320
sa(dp321
g3
VSTD-Warley-1965
p322
sg5
S'PMC1845333'
p323
sg7
VCD003489 v. 5.2 Malaria chemoprophylaxis in sickle cell disease.rm5
p324
sg9
V14305376.xml
p325
sa(dp326
g3
VSTD-ter-Riet-1995
p327
sg5
S'PMC2549431'
p328
sg7
VCD001275 v. 12.0 Therapeutic ultrasound for pressure ulcers.rm5
p329
sg9
V7728058.xml
p330
sa(dp331
g3
VSTD-Norway
p332
sg5
S'PMC1678377'
p333
sg7
VCD007058 v. 3.0 Ultrasound for fetal assessment in early pregnancy.rm5
p334
sg9
V7688253.xml
p335
sa(dp336
g3
VSTD-Taitz-1986
p337
sg5
S'PMC1777784'
p338
sg7
VCD002240 v. 6.0 Behavioural and cognitive interventions with or without other treatments for the management of faeca.rm5
p339
sg9
V3717993.xml
p340
sa(dp341
g3
VSTD-Nolan-1998
p342
sg5
S'PMC1717674'
p343
sg7
g339
sg9
V9797593.xml
p344
sa(dp345
g3
VSTD-van-der-Plas-1996a
p346
sg5
S'PMC1511777'
p347
sg7
g339
sg9
V8957948.xml
p348
sa(dp349
g3
VSTD-Hager-1996
p350
sg5
S'PMC2364471'
p351
sg7
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p352
sg9
V18476075.xml
p353
sa(dp354
g3
VSTD-Gilboa_x002d_Schechtman-2010
p355
sg5
S'PMC2945239'
p356
sg7
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p357
sg9
V20855048.xml
p358
sa(dp359
g3
VSTD-Catani-2009
p360
sg5
S'PMC2685130'
p361
sg7
g357
sg9
V19439099.xml
p362
sa(dp363
g3
VSTD-Krasnik-1990
p364
sg5
S'PMC1663335'
p365
sg7
VCD002215 v. 4.0 Capitation salary fee-for-service and mixed systems of payment effects on the behaviour of primar.rm5
p366
sg9
V2390552.xml
p367
sa(dp368
g3
VSTD-Hutchison-1996
p369
sg5
S'PMC1487544'
p370
sg7
g366
sg9
V8603321.xml
p371
sa(dp372
g3
VSTD-Bredin-1999
p373
sg5
S'PMC27809'
p374
sg7
VCD004282 v. 7.0 Non-invasive interventions for improving well-being and quality of life in patients with lung cancer.rm5
p375
sg9
V10102851.xml
p376
sa(dp377
g3
VSTD-Wilkie-2010
p378
sg5
S'PMC3644582'
p379
sg7
g375
sg9
V20164474.xml
p380
sa(dp381
g3
VSTD-Moore-2002
p382
sg5
S'PMC133453'
p383
sg7
g375
sg9
V12433764.xml
p384
sa(dp385
g3
VSTD-Allen-2008
p386
sg5
S'PMC2664509'
p387
sg7
VCD007617 v. 4.0 Interventions for supporting informal caregivers of patients in the terminal phase of a disease.rm5
p388
sg9
V18788966.xml
p389
sa(dp390
g3
VSTD-Addington_x002d_Hall-1992
p391
sg5
S'PMC1883850'
p392
sg7
g388
sg9
V1483075.xml
p393
sa(dp394
g3
VSTD-Radwan-2008
p395
sg5
S'PMC2551723'
p396
sg7
VCD003525 v. 7.0 Surgery for lateral elbow pain.rm5
p397
sg9
V17551726.xml
p398
sa(dp399
g3
VSTD-ERC-1960
p400
sg5
S'PMC1007132'
p401
sg7
VCD000520 v. 7.0 Injectable gold for rheumatoid arthritis.rm5
p402
sg9
V13856636.xml
p403
sa(dp404
g3
VSTD-Paschalidis-2006
p405
sg5
S'PMC1860748'
p406
sg7
VCD004981 v. 4.0 Treatment for femoral pseudoaneurysms.rm5
p407
sg9
V16415194.xml
p408
sa(dp409
g3
VSTD-Connett-1994a
p410
sg5
S'PMC1029734'
p411
sg7
VCD002178 v. 6.0 Early emergency department treatment of acute asthma with systemic corticosteroids.rm5
p412
sg9
V8135557.xml
p413
sa(dp414
g3
VSTD-Connett-1994b
p415
sg5
S'PMC1029734'
p416
sg7
g412
sg9
V8135557.xml
p417
sa(dp418
g3
VSTD-Druss-2010
p419
sg5
S'PMC3775666'
p420
sg7
VCD008567 v. 5.0 General physical health advice for people with serious mental illness.rm5
p421
sg9
V20008945.xml
p422
sa(dp423
g3
VSTD-Mosforth-1958
p424
sg5
S'PMC2026410'
p425
sg7
VCD006283 v. 4.0 Physical therapy for Bell's palsy (idiopathic facial paralysis).rm5
p426
sg9
V13572865.xml
p427
sa(dp428
g3
VSTD-Qu-2005
p429
sg5
S'PMC3770119'
p430
sg7
g426
sg9
V24027359.xml
p431
sa(dp432
g3
VSTD-Marigold-2005
p433
sg5
S'PMC3226796'
p434
sg7
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p435
sg9
V15743283.xml
p436
sa(dp437
g3
VSTD-Haran-2010
p438
sg5
S'PMC2876235'
p439
sg7
g435
sg9
V20501583.xml
p440
sa(dp441
g3
VSTD-Walsh-1993
p442
sg5
S'PMC187962'
p443
sg7
VCD003340 v. 7.0 Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.rm5
p444
sg9
V8328783.xml
p445
sa(dp446
g3
VSTD-Parras-1995
p447
sg5
S'PMC162505'
p448
sg7
g444
sg9
V7695302.xml
p449
sa(dp450
g3
VSTD-Harbarth-1999
p451
sg5
S'PMC89288'
p452
sg7
g444
sg9
V10348762.xml
p453
sa(dp454
g3
VSTD-Elliott-2005
p455
sg5
S'PMC1352364'
p456
sg7
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p457
sg9
V16371154.xml
p458
sa(dp459
g3
VSTD-Davies-2000
p460
sg5
S'PMC27532'
p461
sg7
VCD003573 v. 8.6 Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.rm5
p462
sg9
V11082090.xml
p463
sa(dp464
g3
VSTD-Ojoo-2002
p465
sg5
S'PMC1746235'
p466
sg7
g462
sg9
V11828049.xml
p467
sa(dp468
g3
VSTD-Cotton-2000
p469
sg5
S'PMC1745631'
p470
sg7
g462
sg9
V11050257.xml
p471
sa(dp472
g3
VSTD-Skwarska-2000
p473
sg5
S'PMC1745644'
p474
sg7
g462
sg9
V11050258.xml
p475
sa(dp476
g3
VSTD-Gleeson-1983
p477
sg5
S'PMC1875644'
p478
sg7
VCD001751 v. 6.2 Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.rm5
p479
sg9
V6351994.xml
p480
sa(dp481
g3
VSTD-Changulani-2007
p482
sg5
S'PMC2267584'
p483
sg7
VCD005959 v. 3.0 Dynamic compression plating versus locked intramedullary nailing for humeral shaft fractures in adul.rm5
p484
sg9
V16900354.xml
p485
sa(dp486
g3
VSTD-Bergmann-1995
p487
sg5
S'PMC2549556'
p488
sg7
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p489
sg9
V7767151.xml
p490
sa(dp491
g3
VSTD-Selby-1989
p492
sg5
S'PMC2247066'
p493
sg7
g489
sg9
V2539180.xml
p494
sa(dp495
g3
VSTD-Anderson-1984
p496
sg5
S'PMC1976928'
p497
sg7
g489
sg9
V6378236.xml
p498
sa(dp499
g3
VSTD-Bubley-1989
p500
sg5
S'PMC284246'
p501
sg7
g489
sg9
V2669626.xml
p502
sa(dp503
g3
VSTD-Barile_x002d_Fabris-2005
p504
sg5
S'PMC1755456'
p505
sg7
VCD002265 v. 9.0 Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lup.rm5
p506
sg9
V15769918.xml
p507
sa(dp508
g3
VSTD-Foshee-1998
p509
sg5
S'PMC1508378'
p510
sg7
VCD004534 v. 5.2 Educational and skills-based interventions for preventing relationship and dating violence in adoles.rm5
p511
sg9
V9584032.xml
p512
sa(dp513
g3
VSTD-Davis-1997
p514
sg5
S'PMC3184292'
p515
sg7
g511
sg9
V21734267.xml
p516
sa(dp517
g3
VSTD-Trinder-2006
p518
sg5
S'PMC1471967'
p519
sg7
VCD003518 v. 8.0 Expectant care versus surgical treatment for miscarriage.rm5
p520
sg9
V16707509.xml
p521
sa(dp522
g3
VSTD-Noyes-1998
p523
sg5
S'PMC1784814'
p524
sg7
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p525
sg9
V9894177.xml
p526
sa(dp527
g3
VSTD-Jamtvedt-2008
p528
sg5
S'PMC2518288'
p529
sg7
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p530
sg9
V18710487.xml
p531
sa(dp532
g3
VSTD-Clarke-1998
p533
sg5
S'PMC1756722'
p534
sg7
g530
sg9
V9764257.xml
p535
sa(dp536
g3
VSTD-Finsen-2006
p537
sg5
S'PMC1459867'
p538
sg7
g530
sg9
V16646970.xml
p539
sa(dp540
g3
VSTD-Cockayne-2005
p541
sg5
S'PMC1280926'
p542
sg7
g530
sg9
V16250910.xml
p543
sa(dp544
g3
VSTD-Sallis-1984
p545
sg5
S'PMC1651776'
p546
sg7
g530
sg9
V6465406.xml
p547
sa(dp548
g3
VSTD-Campbell-1990
p549
sg5
S'PMC1060602'
p550
sg7
g530
sg9
V2348155.xml
p551
sa(dp552
g3
VSTD-Stafford-1966
p553
sg5
S'PMC476133'
p554
sg7
g530
sg9
V977774.xml
p555
sa(dp556
g3
VSTD-Junghans-2005
p557
sg5
S'PMC1261191'
p558
sg7
g530
sg9
V16157604.xml
p559
sa(dp560
g3
VSTD-Deehan-1997
p561
sg5
S'PMC1312912'
p562
sg7
g530
sg9
V9101691.xml
p563
sa(dp564
g3
VSTD-Jacobs-1986
p565
sg5
S'PMC1517029'
p566
sg7
g530
sg9
V18738566.xml
p567
sa(dp568
g3
VSTD-Etter-1998b
p569
sg5
S'PMC1756667'
p570
sg7
g530
sg9
V9578862.xml
p571
sa(dp572
g3
VSTD-Dorman-1997
p573
sg5
S'PMC2127345'
p574
sg7
g530
sg9
V9284664.xml
p575
sa(dp576
g3
VSTD-Roberts-1993
p577
sg5
S'PMC1059805'
p578
sg7
g530
sg9
V8228774.xml
p579
sa(dp580
g3
VSTD-Leigh-Brown-1997
p581
sg5
S'PMC1060522'
p582
sg7
g530
sg9
V9328560.xml
p583
sa(dp584
g3
VSTD-Morrison-2003
p585
sg5
S'PMC1732498'
p586
sg7
g530
sg9
V12821704.xml
p587
sa(dp588
g3
VSTD-Clark-2001
p589
sg5
S'PMC1731952'
p590
sg7
g530
sg9
V11449019.xml
p591
sa(dp592
g3
VSTD-Ashing_x002d_Giwa-2000
p593
sg5
S'PMC2568330'
p594
sg7
g530
sg9
V11152085.xml
p595
sa(dp596
g3
VSTD-Sloan-1997
p597
sg5
S'PMC2127714'
p598
sg7
g530
sg9
V9374887.xml
p599
sa(dp600
g3
VSTD-Leece-2006a
p601
sg5
S'PMC1550620'
p602
sg7
g530
sg9
V15631963.xml
p603
sa(dp604
g3
VSTD-Roberts-2000
p605
sg5
S'PMC1731530'
p606
sg7
g530
sg9
V10692967.xml
p607
sa(dp608
g3
VSTD-Roberts-2004
p609
sg5
S'PMC534094'
p610
sg7
g530
sg9
V15533256.xml
p611
sa(dp612
g3
VSTD-McKenzie_x002d_McHarg-2005
p613
sg5
S'PMC1190172'
p614
sg7
g530
sg9
V16091137.xml
p615
sa(dp616
g3
VSTD-Salim-Silva-2002
p617
sg5
S'PMC1732073'
p618
sg7
g530
sg9
V11812810.xml
p619
sa(dp620
g3
VSTD-Smith-1985
p621
sg5
S'PMC1418119'
p622
sg7
g530
sg9
V3933719.xml
p623
sa(dp624
g3
VSTD-Mortagy-1985
p625
sg5
S'PMC1052430'
p626
sg7
g530
sg9
V4009104.xml
p627
sa(dp628
g3
VSTD-Salvesen-1992
p629
sg5
S'PMC1059502'
p630
sg7
g530
sg9
V1573369.xml
p631
sa(dp632
g3
VSTD-Barker-1996
p633
sg5
S'PMC1060390'
p634
sg7
g530
sg9
V9039392.xml
p635
sa(dp636
g3
VSTD-Peters-1998
p637
sg5
S'PMC1756664'
p638
sg7
g530
sg9
V9578863.xml
p639
sa(dp640
g3
VSTD-Mullner-1982
p641
sg5
S'PMC1424368'
p642
sg7
g530
sg9
V7122824.xml
p643
sa(dp644
g3
VSTD-Mann-2005
p645
sg5
S'PMC1179175'
p646
sg7
g530
sg9
V5484686.xml
p647
sa(dp648
g3
VSTD-Shaw-2001
p649
sg5
S'PMC1089193'
p650
sg7
g530
sg9
V11221822.xml
p651
sa(dp652
g3
VSTD-Shah-2001
p653
sg5
S'PMC1313955'
p654
sg7
g530
sg9
V11255905.xml
p655
sa(dp656
g3
VSTD-Kaplan-1970b
p657
sg5
S'PMC1059291'
p658
sg7
g530
sg9
V5496532.xml
p659
sa(dp660
g3
VSTD-Kaplan-1970a
p661
sg5
S'PMC1059291'
p662
sg7
g530
sg9
V5496532.xml
p663
sa(dp664
g3
VSTD-Martin-1994
p665
sg5
S'PMC3628293'
p666
sg7
g530
sg9
V23252713.xml
p667
sa(dp668
g3
VSTD-Kenyon-2005
p669
sg5
S'PMC1201139'
p670
sg7
g530
sg9
V16109160.xml
p671
sa(dp672
g3
VSTD-Tambor-1993
p673
sg5
S'PMC1694880'
p674
sg7
g530
sg9
V8238685.xml
p675
sa(dp676
g3
VSTD-Marsh-1999
p677
sg5
S'PMC1730548'
p678
sg7
g530
sg9
V10628925.xml
p679
sa(dp680
g3
VSTD-Miller-1994
p681
sg5
S'PMC3754053'
p682
sg7
g530
sg9
V23760252.xml
p683
sa(dp684
g3
VSTD-Maheux-1989b
p685
sg5
S'PMC1349512'
p686
sg7
g530
sg9
V2705601.xml
p687
sa(dp688
g3
VSTD-Maheux-1989a
p689
sg5
S'PMC1349512'
p690
sg7
g530
sg9
V2705601.xml
p691
sa(dp692
g3
VSTD-Leece-2006b
p693
sg5
S'PMC1550620'
p694
sg7
g530
sg9
V15631963.xml
p695
sa(dp696
g3
VSTD-Br_x00f8_gger-2007
p697
sg5
S'PMC2270416'
p698
sg7
g530
sg9
V18174120.xml
p699
sa(dp700
g3
VSTD-Lavelle-2008
p701
sg5
S'PMC2427026'
p702
sg7
g530
sg9
V18507819.xml
p703
sa(dp704
g3
VSTD-Harrison-2004
p705
sg5
S'PMC534787'
p706
sg7
g530
sg9
V15537429.xml
p707
sa(dp708
g3
VSTD-Paul-2005
p709
sg5
S'PMC1732979'
p710
sg7
g530
sg9
V16286502.xml
p711
sa(dp712
g3
VSTD-Moses-2004
p713
sg5
S'PMC449720'
p714
sg7
g530
sg9
V15222889.xml
p715
sa(dp716
g3
VSTD-Windsor-1992
p717
sg5
S'PMC1059500'
p718
sg7
g530
sg9
V1573368.xml
p719
sa(dp720
g3
VSTD-Clark-TJ-2001
p721
sg5
S'PMC64502'
p722
sg7
g530
sg9
V11782286.xml
p723
sa(dp724
g3
VSTD-Slesnick-2005
p725
sg5
S'PMC1933523'
p726
sg7
VCD007501 v. 2.0 Interventions to modify sexual risk behaviours for preventing HIV in homeless youth.rm5
p727
sg9
V15878048.xml
p728
sa(dp729
g3
VSTD-Slesnick-2008
p730
sg5
S'PMC2430633'
p731
sg7
g727
sg9
V17940861.xml
p732
sa(dp733
g3
VSTD-Kochiadakis-2000
p734
sg5
S'PMC1760955'
p735
sg7
VCD005049 v. 5.0 Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.rm5
p736
sg9
V10956284.xml
p737
sa(dp738
g3
VSTD-Sodermark-1975
p739
sg5
S'PMC482826'
p740
sg7
g736
sg9
V1093559.xml
p741
sa(dp742
g3
VSTD-Hillestad-1971
p743
sg5
S'PMC487206'
p744
sg7
g736
sg9
V4934041.xml
p745
sa(dp746
g3
VSTD-Byrne_x002d_Quinn-1970
p747
sg5
S'PMC487336'
p748
sg7
g736
sg9
V4911757.xml
p749
sa(dp750
g3
VSTD-A-ba_x002d_bai_x002d_ke_x002d_re-2011
p751
sg5
S'PMC3070018'
p752
sg7
VCD004322 v. 6.0 Phlebotonics for haemorrhoids.rm5
p753
sg9
V21472103.xml
p754
sa(dp755
g3
VSTD-Body-2004
p756
sg5
S'PMC2409647'
p757
sg7
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p758
sg9
V15026791.xml
p759
sa(dp760
g3
VSTD-Hershman-2008
p761
sg5
S'PMC2653138'
p762
sg7
g758
sg9
V18711172.xml
p763
sa(dp764
g3
VSTD-Sutton-1988
p765
sg5
S'PMC461097'
p766
sg7
VCD008351 v. 2.3 Airway clearance techniques for bronchiectasis.rm5
p767
sg9
V3353875.xml
p768
sa(dp769
g3
VSTD-Schnelle-1983
p770
sg5
S'PMC1307878'
p771
sg7
VCD002113 v. 5.0 Prompted voiding for the management of urinary incontinence in adults.rm5
p772
sg9
V6885672.xml
p773
sa(dp774
g3
VSTD-Dougados-2005
p775
sg5
S'PMC1755199'
p776
sg7
VCD002047 v. 9.2 Leflunomide for the treatment of rheumatoid arthritis.rm5
p777
sg9
V15271770.xml
p778
sa(dp779
g3
VSTD-Scott-2001
p780
sg5
S'PMC1753377'
p781
sg7
g777
sg9
V11557646.xml
p782
sa(dp783
g3
VSTD-Ellis-2009
p784
sg5
S'PMC3066045'
p785
sg7
VCD005175 v. 4.0 The medical use of cannabis for reducing morbidity and mortality in patients with HIVAIDS.rm5
p786
sg9
V18688212.xml
p787
sa(dp788
g3
VSTD-Osman-1994
p789
sg5
S'PMC2539560'
p790
sg7
VCD001005 v. 3.0 Limited (information only) patient education programs for adults with asthma.rm5
p791
sg9
V8093148.xml
p792
sa(dp793
g3
VSTD-Jenkinson-1988
p794
sg5
S'PMC1833935'
p795
sg7
g791
sg9
V3416147.xml
p796
sa(dp797
g3
VSTD-Moldofsky-1979
p798
sg5
S'PMC1819150'
p799
sg7
g791
sg9
V436049.xml
p800
sa(dp801
g3
VSTD-Hagel-2006
p802
sg5
S'PMC2586783'
p803
sg7
VCD005401 v. 8.0 Bicycle helmet legislation for the uptake of helmet use and prevention of head injuries.rm5
p804
sg9
V16887950.xml
p805
sa(dp806
g3
VSTD-Swan-2010
p807
sg5
S'PMC2879135'
p808
sg7
VCD009670 v. 3.0 Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.rm5
p809
sg9
V20409497.xml
p810
sa(dp811
g3
VSTD-Aveyard-2007
p812
sg5
S'PMC2094265'
p813
sg7
g809
sg9
V17483139.xml
p814
sa(dp815
g3
VSTD-Williams-2010
p816
sg5
S'PMC2859987'
p817
sg7
g809
sg9
V20363089.xml
p818
sa(dp819
g3
VSTD-Reid-1999
p820
sg5
S'PMC1230362'
p821
sg7
g809
sg9
V10373999.xml
p822
sa(dp823
g3
VSTD-Gariti-2009
p824
sg5
S'PMC2778325'
p825
sg7
g809
sg9
V19339135.xml
p826
sa(dp827
g3
VSTD-Ellerbeck-2009
p828
sg5
S'PMC2825176'
p829
sg7
g809
sg9
V19349629.xml
p830
sa(dp831
g3
VSTD-Lando-1997
p832
sg5
S'PMC1381132'
p833
sg7
g809
sg9
V9357351.xml
p834
sa(dp835
g3
VSTD-Hollis-2007
p836
sg5
S'PMC2598511'
p837
sg7
g809
sg9
V18048633.xml
p838
sa(dp839
g3
VSTD-Wu-2009
p840
sg5
S'PMC2784492'
p841
sg7
g809
sg9
V19915080.xml
p842
sa(dp843
g3
VSTD-Lloyd_x002d_Richardson-2009
p844
sg5
S'PMC2763031'
p845
sg7
g809
sg9
V19719796.xml
p846
sa(dp847
g3
VSTD-Hall-2009
p848
sg5
S'PMC2718733'
p849
sg7
g809
sg9
V19392908.xml
p850
sa(dp851
g3
VSTD-Hovell-2003
p852
sg5
S'PMC1448065'
p853
sg7
VCD003974 v. 5.0 Placebo interventions for all clinical conditions.rm5
p854
sg9
V14600055.xml
p855
sa(dp856
g3
VSTD-Kaptchuk-2008
p857
sg5
S'PMC2364862'
p858
sg7
g854
sg9
V18390493.xml
p859
sa(dp860
g3
VSTD-Robinson-2001
p861
sg5
S'PMC1760991'
p862
sg7
g854
sg9
V11423594.xml
p863
sa(dp864
g3
VSTD-Tarrier-1998
p865
sg5
S'PMC28621'
p866
sg7
g854
sg9
V9685273.xml
p867
sa(dp868
g3
VSTD-Thomas-1987
p869
sg5
S'PMC1246362'
p870
sg7
g854
sg9
V3109581.xml
p871
sa(dp872
g3
VSTD-Thomas-2002b
p873
sg5
S'PMC128377'
p874
sg7
g854
sg9
V12364304.xml
p875
sa(dp876
g3
VSTD-Thomas-2002a
p877
sg5
S'PMC128377'
p878
sg7
g854
sg9
V12364304.xml
p879
sa(dp880
g3
VSTD-Melchart-2005
p881
sg5
S'PMC1184247'
p882
sg7
g854
sg9
V16055451.xml
p883
sa(dp884
g3
VSTD-Foster-2007
p885
sg5
S'PMC1962890'
p886
sg7
g854
sg9
V17699546.xml
p887
sa(dp888
g3
VSTD-Conn-1986
p889
sg5
S'PMC2498376'
p890
sg7
g854
sg9
V3538985.xml
p891
sa(dp892
g3
VSTD-Carbajal-1999
p893
sg5
S'PMC28282'
p894
sg7
g854
sg9
V10574854.xml
p895
sa(dp896
g3
VSTD-Dundee-1986
p897
sg5
S'PMC1341376'
p898
sg7
g854
sg9
V3092933.xml
p899
sa(dp900
g3
VSTD-Carlson-2007
p901
sg5
S'PMC1955332'
p902
sg7
VCD006858 v. 2.9 Personal assistance for children and adolescents (0-18) with intellectual impairments.rm5
p903
sg9
V17244293.xml
p904
sa(dp905
g3
VSTD-Ziboh-2004
p906
sg5
S'PMC2275406'
p907
sg7
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p908
sg9
V15154607.xml
p909
sa(dp910
g3
VSTD-Hederos-1996
p911
sg5
S'PMC1511801'
p912
sg7
g908
sg9
V9014601.xml
p913
sa(dp914
g3
VSTD-Lincoln-2002
p915
sg5
S'PMC1737698'
p916
sg7
VCD004431 v. 5.0 Psychological interventions for multiple sclerosis.rm5
p917
sg9
V11784832.xml
p918
sa(dp919
g3
VSTD-Quist_x002d_Paulsen-2003
p920
sg5
S'PMC286243'
p921
sg7
VCD006886 v. 2.0 Psychosocial interventions for smoking cessation in patients with coronary heart disease.rm5
p922
sg9
V14644967.xml
p923
sa(dp924
g3
VSTD-Carlsson-1997
p925
sg5
S'PMC484693'
p926
sg7
g922
sg9
V9093045.xml
p927
sa(dp928
g3
VSTD-Hajek-2002
p929
sg5
S'PMC64504'
p930
sg7
g922
sg9
V11786452.xml
p931
sa(dp932
g3
VSTD-Becker_x002d_Fort-Worth
p933
sg5
S'PMC3372084'
p934
sg7
VCD003080 v. 6.0 Vocational rehabilitation for people with severe mental illness.rm5
p935
sg9
V18953116.xml
p936
sa(dp937
g3
VSTD-Thomas-1987
p938
sg5
S'PMC1246283'
p939
sg7
VCD000155 v. 9.0 Ovulation suppression for endometriosis for women with subfertility.rm5
p940
sg9
V3107721.xml
p941
sa(dp942
g3
VSTD-Flach-2000
p943
sg5
S'PMC1298216'
p944
sg7
VCD003738 v. 6.0 Interventions for preventing posterior capsule opacification.rm5
p945
sg9
V11190013.xml
p946
sa(dp947
g3
VSTD-Hayashi-2004
p948
sg5
S'PMC1771981'
p949
sg7
g945
sg9
V14736768.xml
p950
sa(dp951
g3
VSTD-Nejima-2004
p952
sg5
S'PMC1772204'
p953
sg7
g945
sg9
V15148204.xml
p954
sa(dp955
g3
VSTD-Rabsilber-2007
p956
sg5
S'PMC1955631'
p957
sg7
g945
sg9
V17202203.xml
p958
sa(dp959
g3
VSTD-Laurell-2002
p960
sg5
S'PMC1771439'
p961
sg7
g945
sg9
V12446370.xml
p962
sa(dp963
g3
VSTD-Zemaitiene-2007
p964
sg5
S'PMC1954737'
p965
sg7
g945
sg9
V17124239.xml
p966
sa(dp967
g3
VSTD-Mullany-2006
p968
sg5
S'PMC2367116'
p969
sg7
VCD008635 v. 2.3 Umbilical cord antiseptics for preventing sepsis and death among newborns.rm5
p970
sg9
V16546539.xml
p971
sa(dp972
g3
VSTD-Al_x002d_Binali-2006
p973
sg5
S'PMC3074703'
p974
sg7
g970
sg9
V21509239.xml
p975
sa(dp976
g3
VSTD-Arad-1981
p977
sg5
S'PMC1627396'
p978
sg7
g970
sg9
V7030227.xml
p979
sa(dp980
g3
VSTD-Duan-2000
p981
sg5
S'PMC1447636'
p982
sg7
VCD006903 v. 3.0 Peer support telephone calls for improving health.rm5
p983
sg9
V10983211.xml
p984
sa(dp985
g3
VSTD-Dennis-2002a
p986
sg5
S'PMC99222'
p987
sg7
g983
sg9
V11800243.xml
p988
sa(dp989
g3
VSTD-Mackenzie-1991
p990
sg5
S'PMC1295464'
p991
sg7
VCD002192 v. 10.0 Premedication for anxiety in adult day surgery.rm5
p992
sg9
V1744867.xml
p993
sa(dp994
g3
VSTD-Majowski-1991
p995
sg5
S'PMC2499479'
p996
sg7
VCD001888 v. 10.0 Cell salvage for minimising perioperative allogeneic blood transfusion.rm5
p997
sg9
V1759769.xml
p998
sa(dp999
g3
VSTD-Zacharopoulos-2007
p1000
sg5
S'PMC2267590'
p1001
sg7
g997
sg9
V16810542.xml
p1002
sa(dp1003
g3
VSTD-McGill-2002
p1004
sg5
S'PMC113763'
p1005
sg7
g997
sg9
V12039820.xml
p1006
sa(dp1007
g3
VSTD-Altinel-2007
p1008
sg5
S'PMC2266671'
p1009
sg7
g997
sg9
V17115155.xml
p1010
sa(dp1011
g3
VSTD-Abuzakuk-2007
p1012
sg5
S'PMC2267563'
p1013
sg7
g997
sg9
V16761149.xml
p1014
sa(dp1015
g3
VSTD-Peters-1999
p1016
sg5
S'PMC1727665'
p1017
sg7
VCD004060 v. 8.0 Treatment for Barrett's oesophagus.rm5
p1018
sg9
V10486353.xml
p1019
sa(dp1020
g3
VSTD-Hage-2004
p1021
sg5
S'PMC1774080'
p1022
sg7
g1018
sg9
V15138203.xml
p1023
sa(dp1024
g3
VSTD-Ackroyd-2000
p1025
sg5
S'PMC1728096'
p1026
sg7
g1018
sg9
V11034574.xml
p1027
sa(dp1028
g3
VSTD-Heath-2007
p1029
sg5
S'PMC3755596'
p1030
sg7
g1018
sg9
V17405999.xml
p1031
sa(dp1032
g3
VSTD-Sharma-2006
p1033
sg5
S'PMC1860010'
p1034
sg7
g1018
sg9
V16905695.xml
p1035
sa(dp1036
g3
VSTD-Parrilla-2003
p1037
sg5
S'PMC1514316'
p1038
sg7
g1018
sg9
V12616111.xml
p1039
sa(dp1040
g3
VSTD-Thorne-2008
p1041
sg5
S'PMC2671217'
p1042
sg7
VCD006605 v. 5.0 Long-term opioid management for chronic noncancer pain.rm5
p1043
sg9
V18443671.xml
p1044
sa(dp1045
g3
VSTD-Barlow-2007
p1046
sg5
S'PMC2111288'
p1047
sg7
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p1048
sg9
V16928714.xml
p1049
sa(dp1050
g3
VSTD-Doern-1994
p1051
sg5
S'PMC263786'
p1052
sg7
g1048
sg9
V7929770.xml
p1053
sa(dp1054
g3
VSTD-Fridkin-2002
p1055
sg5
S'PMC3369588'
p1056
sg7
g1048
sg9
V12095438.xml
p1057
sa(dp1058
g3
VSTD-Trenholme-1989
p1059
sg5
S'PMC267554'
p1060
sg7
g1048
sg9
V2473995.xml
p1061
sa(dp1062
g3
VSTD-Salama-1996
p1063
sg5
S'PMC3327382'
p1064
sg7
g1048
sg9
V22514426.xml
p1065
sa(dp1066
g3
VSTD-Wyatt-1998
p1067
sg5
S'PMC28686'
p1068
sg7
g1048
sg9
V9774287.xml
p1069
sa(dp1070
g3
VSTD-Kumana-2001
p1071
sg5
S'PMC2014574'
p1072
sg7
g1048
sg9
V11678786.xml
p1073
sa(dp1074
g3
VSTD-Shojania-1998
p1075
sg5
S'PMC61335'
p1076
sg7
g1048
sg9
V9824802.xml
p1077
sa(dp1078
g3
VSTD-D_x0027_Souza-1991
p1079
sg5
S'PMC1792889'
p1080
sg7
VCD004848 v. 16.0 Common antiepileptic drugs in pregnancy in women with epilepsy.rm5
p1081
sg9
V2025009.xml
p1082
sa(dp1083
g3
VSTD-Ornoy-1996
p1084
sg5
S'PMC1511819'
p1085
sg7
g1081
sg9
V9014606.xml
p1086
sa(dp1087
g3
VSTD-Luabeya-2007
p1088
sg5
S'PMC1891438'
p1089
sg7
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p1090
sg9
V17593956.xml
p1091
sa(dp1092
g3
VSTD-Arpadi-2009
p1093
sg5
S'PMC3110671'
p1094
sg7
g1090
sg9
V19117833.xml
p1095
sa(dp1096
g3
VSTD-Kupka-2008
p1097
sg5
S'PMC2474659'
p1098
sg7
g1090
sg9
V18541571.xml
p1099
sa(dp1100
g3
VSTD-Coutsoudis-1995
p1101
sg5
S'PMC1615817'
p1102
sg7
g1090
sg9
V7625499.xml
p1103
sa(dp1104
g3
VSTD-Villamor-2008
p1105
sg5
S'PMC2564793'
p1106
sg7
g1090
sg9
V18471061.xml
p1107
sa(dp1108
g3
VSTD-Del-Romero-2010
p1109
sg5
S'PMC2871073'
p1110
sg7
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p1111
sg9
V20472675.xml
p1112
sa(dp1113
g3
VSTD-Donnell-2010
p1114
sg5
S'PMC2922041'
p1115
sg7
g1111
sg9
V20537376.xml
p1116
sa(dp1117
g3
VSTD-Reynolds-2011
p1118
sg5
S'PMC3261071'
p1119
sg7
g1111
sg9
V21160416.xml
p1120
sa(dp1121
g3
VSTD-Sharp-1996
p1122
sg5
S'PMC1312921'
p1123
sg7
VCD004364 v. 4.0 Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.rm5
p1124
sg9
V9167318.xml
p1125
sa(dp1126
g3
VSTD-Sharp-1996i
p1127
sg5
S'PMC1312921'
p1128
sg7
g1124
sg9
V9167318.xml
p1129
sa(dp1130
g3
VSTD-Sharp-1996ii
p1131
sg5
S'PMC1312921'
p1132
sg7
g1124
sg9
V9167318.xml
p1133
sa(dp1134
g3
VSTD-Chrystyn-1988
p1135
sg5
S'PMC1835250'
p1136
sg7
VCD003902 v. 5.0 Oral theophylline for chronic obstructive pulmonary disease.rm5
p1137
sg9
V3147048.xml
p1138
sa(dp1139
g3
VSTD-Fink-1994
p1140
sg5
S'PMC475365'
p1141
sg7
g1137
sg9
V8202902.xml
p1142
sa(dp1143
g3
VSTD-McKeith-2000
p1144
sg5
S'PMC3739737'
p1145
sg7
VCD006504 v. 4.0 Cholinesterase inhibitors for dementia with Lewy bodies Parkinson's disease dementia and cognitive .rm5
p1146
sg9
V23951200.xml
p1147
sa(dp1148
g3
VSTD-Aarsland-2002a
p1149
sg5
S'PMC1737925'
p1150
sg7
g1146
sg9
V12023410.xml
p1151
sa(dp1152
g3
VSTD-Ravina-2005
p1153
sg5
S'PMC1739697'
p1154
sg7
g1146
sg9
V15965198.xml
p1155
sa(dp1156
g3
VSTD-Morris-1977
p1157
sg5
S'PMC1605162'
p1158
sg7
VCD000305 v. 8.0 Heparin low molecular weight heparin and physical methods for preventing deep vein thrombosis and p.rm5
p1159
sg9
V843794.xml
p1160
sa(dp1161
g3
VSTD-Eskander-1997
p1162
sg5
S'PMC3617695'
p1163
sg7
g1159
sg9
V9349964.xml
p1164
sa(dp1165
g3
VSTD-Walson-2008
p1166
sg5
S'PMC2637615'
p1167
sg7
VCD006419 v. 4.0 Deworming helminth co-infected individuals for delaying HIV disease progression.rm5
p1168
sg9
V18670219.xml
p1169
sa(dp1170
g3
VSTD-Johnston-2000
p1171
sg5
S'PMC1730673'
p1172
sg7
VCD004334 v. 5.0 Interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles.rm5
p1173
sg9
V11144634.xml
p1174
sa(dp1175
g3
VSTD-Stevens-2000
p1176
sg5
S'PMC3584800'
p1177
sg7
g1173
sg9
V23678285.xml
p1178
sa(dp1179
g3
VSTD-Kark-1982a
p1180
sg5
S'PMC1052206'
p1181
sg7
VCD004181 v. 6.0 Immunoglobulins for preventing hepatitis A.rm5
p1182
sg9
V6754845.xml
p1183
sa(dp1184
g3
VSTD-Hely-1994
p1185
sg5
S'PMC1073071'
p1186
sg7
VCD002258 v. 4.0 Bromocriptine versus levodopa in early Parkinson's disease.rm5
p1187
sg9
V8057111.xml
p1188
sa(dp1189
g3
VSTD-UK_x002d_PDRG-1993
p1190
sg5
S'PMC2551499'
p1191
sg7
g1187
sg9
V8555803.xml
p1192
sa(dp1193
g3
VSTD-Cohen-2004
p1194
sg5
S'PMC1755108'
p1195
sg7
VCD005121 v. 3.0 Anakinra for rheumatoid arthritis.rm5
p1196
sg9
V15082469.xml
p1197
sa(dp1198
g3
VSTD-McKeith-2000
p1199
sg5
S'PMC3739737'
p1200
sg7
VCD003672 v. 7.0 Cholinesterase inhibitors for dementia with Lewy bodies.rm5
p1201
sg9
V23951200.xml
p1202
sa(dp1203
g3
VSTD-Yang-2001
p1204
sg5
S'PMC3414298'
p1205
sg7
VCD008510 v. 3.7 Chinese herbal medicines for threatened miscarriage.rm5
p1206
sg9
V22904831.xml
p1207
sa(dp1208
g3
VSTD-Liu-2008
p1209
sg5
S'PMC3629611'
p1210
sg7
g1206
sg9
V23634098.xml
p1211
sa(dp1212
g3
VSTD-Djibuti-2009
p1213
sg5
S'PMC3226230'
p1214
sg7
VCD008145 v. 2.2 Interventions for improving coverage of child immunization in low- and middle-income countries.rm5
p1215
sg9
V19828055.xml
p1216
sa(dp1217
g3
VSTD-Brugha-1996
p1218
sg5
S'PMC2486871'
p1219
sg7
g1215
sg9
V9002332.xml
p1220
sa(dp1221
g3
VSTD-Andersson-2009
p1222
sg5
S'PMC3226240'
p1223
sg7
g1215
sg9
V19828066.xml
p1224
sa(dp1225
g3
VSTD-Dey-1999
p1226
sg5
S'PMC1313349'
p1227
sg7
VCD004305 v. 8.4 Healthcare financing systems for increasing the use of tobacco dependence treatment.rm5
p1228
sg9
V10326267.xml
p1229
sa(dp1230
g3
VSTD-Schauffler-2001
p1231
sg5
S'PMC1747566'
p1232
sg7
g1228
sg9
V11387540.xml
p1233
sa(dp1234
g3
VSTD-Joyce-2008
p1235
sg5
S'PMC2614005'
p1236
sg7
g1228
sg9
V18783459.xml
p1237
sa(dp1238
g3
VSTD-Twardella-2007
p1239
sg5
S'PMC2598437'
p1240
sg7
g1228
sg9
V17297068.xml
p1241
sa(dp1242
g3
VSTD-Tan-1994
p1243
sg5
S'PMC1364731'
p1244
sg7
VCD000561 v. 13.0 Antidepressants versus placebo for the depressed elderly.rm5
p1245
sg9
V8018452.xml
p1246
sa(dp1247
g3
VSTD-Maryland
p1248
sg5
S'PMC1508998'
p1249
sg7
VCD004168 v. 3.0 Alcohol ignition interlock programmes for reducing drink driving recidivism.rm5
p1250
sg9
V10553391.xml
p1251
sa(dp1252
g3
VSTD-Tonwe_x002d_Gold-2007
p1253
sg5
S'PMC1949842'
p1254
sg7
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p1255
sg9
V17713983.xml
p1256
sa(dp1257
g3
VSTD-Lehman-2008
p1258
sg5
S'PMC2765916'
p1259
sg7
g1255
sg9
V18614871.xml
p1260
sa(dp1261
g3
VSTD-Bae-2008
p1262
sg5
S'PMC2664540'
p1263
sg7
g1255
sg9
V18670224.xml
p1264
sa(dp1265
g3
VSTD-Tsifetaki-2003
p1266
sg5
S'PMC1754388'
p1267
sg7
VCD006775 v. 5.2 Punctal occlusion for dry eye syndrome.rm5
p1268
sg9
V14644860.xml
p1269
sa(dp1270
g3
VSTD-Conde-2009
p1271
sg5
S'PMC2866651'
p1272
sg7
VCD004795 v. 6.0 Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).rm5
p1273
sg9
V19345831.xml
p1274
sa(dp1275
g3
VSTD-Bhasin-2000_x0028_i_x0029__x002d_no-e
p1276
sg5
S'PMC3173037'
p1277
sg7
VCD005483 v. 3.0 Anabolic steroids for the treatment of weight loss in HIV-infected individuals.rm5
p1278
sg9
V10683055.xml
p1279
sa(dp1280
g3
VSTD-Weinstein-2006
p1281
sg5
S'PMC2562254'
p1282
sg7
VCD001350 v. 9.4 Surgical interventions for lumbar disc prolapse.rm5
p1283
sg9
V17119141.xml
p1284
sa(dp1285
g3
VSTD-Krugluger-2000
p1286
sg5
S'PMC3619876'
p1287
sg7
g1283
sg9
V10990391.xml
p1288
sa(dp1289
g3
VSTD-Domenge-2000
p1290
sg5
S'PMC2363468'
p1291
sg7
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p1292
sg9
V11189100.xml
p1293
sa(dp1294
g3
VSTD-Chauhan-2008
p1295
sg5
S'PMC2583266'
p1296
sg7
g1292
sg9
V19357741.xml
p1297
sa(dp1298
g3
VSTD-UKHAN-2010
p1299
sg5
S'PMC2806549'
p1300
sg7
g1292
sg9
V19875337.xml
p1301
sa(dp1302
g3
VSTD-Coyle-2001
p1303
sg5
S'PMC1913682'
p1304
sg7
VCD007006 v. 2.1 Abstinence-plus programs for HIV infection prevention in high-income countries.rm5
p1305
sg9
V11889277.xml
p1306
sa(dp1307
g3
VSTD-Coyle-2004
p1308
sg5
S'PMC1448347'
p1309
sg7
g1305
sg9
V15117710.xml
p1310
sa(dp1311
g3
VSTD-Villarruel-2006
p1312
sg5
S'PMC3034476'
p1313
sg7
g1305
sg9
V16894074.xml
p1314
sa(dp1315
g3
VSTD-Harvey_x002d_Berino-2010
p1316
sg5
S'PMC3101104'
p1317
sg7
VCD007675 v. 2.0 Interactive computer-based interventions for weight loss or weight maintenance in overweight or obes.rm5
p1318
sg9
V20478333.xml
p1319
sa(dp1320
g3
VSTD-Bennett-2010
p1321
sg5
S'PMC3710670'
p1322
sg7
g1318
sg9
V19696764.xml
p1323
sa(dp1324
g3
VSTD-Wilkinson-1995
p1325
sg5
S'PMC1239372'
p1326
sg7
VCD007612 v. 2.0 Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica.rm5
p1327
sg9
V7546872.xml
p1328
sa(dp1329
g3
VSTD-Gilbert-1985
p1330
sg5
S'PMC1417150'
p1331
sg7
g1327
sg9
V2931153.xml
p1332
sa(dp1333
g3
VSTD-Lenssen-2008
p1334
sg5
S'PMC2386789'
p1335
sg7
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p1336
sg9
V18442423.xml
p1337
sa(dp1338
g3
VSTD-Johnson-1992
p1339
sg5
S'PMC2497687'
p1340
sg7
g1336
sg9
V1471839.xml
p1341
sa(dp1342
g3
VSTD-Drew-2001
p1343
sg5
S'PMC26593'
p1344
sg7
VCD003852 v. 7.0 Ginkgo biloba for tinnitus.rm5
p1345
sg9
V11154618.xml
p1346
sa(dp1347
g3
VSTD-UK-Trial-1991
p1348
sg5
S'PMC1590363'
p1349
sg7
VCD001402 v. 10.0 Newborn screening for cystic fibrosis.rm5
p1350
sg9
V1996888.xml
p1351
sa(dp1352
g3
VSTD-Luger-2008
p1353
sg5
S'PMC2790732'
p1354
sg7
VCD005028 v. 6.0 Topical treatments for chronic plaque psoriasis.rm5
p1355
sg9
V18787325.xml
p1356
sa(dp1357
g3
VSTD-Cheesbrough-1992
p1358
sg5
S'PMC1115105'
p1359
sg7
g1355
sg9
V10066222.xml
p1360
sa(dp1361
g3
VSTD-Maier-2004
p1362
sg5
S'PMC3627666'
p1363
sg7
g1355
sg9
V23328491.xml
p1364
sa(dp1365
g3
VSTD-Kosgei-2011
p1366
sg5
S'PMC3779789'
p1367
sg7
VCD010243 v. 3.0 Behavioral interventions for improving contraceptive use among women living with HIV.rm5
p1368
sg9
V21963940.xml
p1369
sa(dp1370
g3
VSTD-Allen-1993
p1371
sg5
S'PMC1694707'
p1372
sg7
g1368
sg9
V8484453.xml
p1373
sa(dp1374
g3
VSTD-Davis-1988
p1375
sg5
S'PMC3195724'
p1376
sg7
VCD002124 v. 5.0 Herbal and dietary therapies for primary and secondary dysmenorrhoea.rm5
p1377
sg9
V21961521.xml
p1378
sa(dp1379
g3
VSTD-Sorensen-1996
p1380
sg5
S'PMC1380434'
p1381
sg7
VCD003440 v. 10.6 Workplace interventions for smoking cessation.rm5
p1382
sg9
V8669517.xml
p1383
sa(dp1384
g3
VSTD-Sorensen-1998
p1385
sg5
S'PMC1508574'
p1386
sg7
g1382
sg9
V9807537.xml
p1387
sa(dp1388
g3
VSTD-Lang-2000
p1389
sg5
S'PMC1731676'
p1390
sg7
g1382
sg9
V10814655.xml
p1391
sa(dp1392
g3
VSTD-Rodriguez-2003
p1393
sg5
S'PMC1740534'
p1394
sg7
g1382
sg9
V12709522.xml
p1395
sa(dp1396
g3
VSTD-Cambien-1981
p1397
sg5
S'PMC1052130'
p1398
sg7
g1382
sg9
V7299342.xml
p1399
sa(dp1400
g3
VSTD-Gomel-1993a
p1401
sg5
S'PMC1694995'
p1402
sg7
g1382
sg9
V8362997.xml
p1403
sa(dp1404
g3
VSTD-Sutton-1987
p1405
sg5
S'PMC1647001'
p1406
sg7
g1382
sg9
V3303976.xml
p1407
sa(dp1408
g3
VSTD-Hennrikus-2002
p1409
sg5
S'PMC1447056'
p1410
sg7
g1382
sg9
V11818305.xml
p1411
sa(dp1412
g3
VSTD-Glasgow-1995
p1413
sg5
S'PMC1615302'
p1414
sg7
g1382
sg9
V7856780.xml
p1415
sa(dp1416
g3
VSTD-Malott-1984
p1417
sg5
S'PMC1307970'
p1418
sg7
g1382
sg9
V6441794.xml
p1419
sa(dp1420
g3
VSTD-Shaw-2003
p1421
sg5
S'PMC139930'
p1422
sg7
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p1423
sg9
V12521968.xml
p1424
sa(dp1425
g3
VSTD-Kerse-2008
p1426
sg5
S'PMC2565754'
p1427
sg7
g1423
sg9
V18845605.xml
p1428
sa(dp1429
g3
VSTD-Lapane-2011
p1430
sg5
S'PMC3157676'
p1431
sg7
g1423
sg9
V21649623.xml
p1432
sa(dp1433
g3
VSTD-Crotty-2004b
p1434
sg5
S'PMC415557'
p1435
sg7
g1423
sg9
V15066200.xml
p1436
sa(dp1437
g3
VSTD-Cumming-2008
p1438
sg5
S'PMC2287238'
p1439
sg7
g1423
sg9
V18332052.xml
p1440
sa(dp1441
g3
VSTD-Haines-2004
p1442
sg5
S'PMC381222'
p1443
sg7
g1423
sg9
V15031238.xml
p1444
sa(dp1445
g3
VSTD-Dykes-2010
p1446
sg5
S'PMC3107709'
p1447
sg7
g1423
sg9
V21045097.xml
p1448
sa(dp1449
g3
VSTD-Stenvall-2007
p1450
sg5
S'PMC1766476'
p1451
sg7
g1423
sg9
V17061151.xml
p1452
sa(dp1453
g3
VSTD-Li-2006
p1454
sg5
S'PMC1764949'
p1455
sg7
VCD006806 v. 4.2 Peri-operative glycaemic control regimens for preventing surgical site infections in adults.rm5
p1456
sg9
V17215967.xml
p1457
sa(dp1458
g3
VSTD-TREC_x002d_Rio-2003
p1459
sg5
S'PMC200800'
p1460
sg7
VCD006391 v. 5.4 Benzodiazepines for schizophrenia.rm5
p1461
sg9
V14512476.xml
p1462
sa(dp1463
g3
VSTD-Hay-1999
p1464
sg5
S'PMC28251'
p1465
sg7
VCD003686 v. 7.0 Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.rm5
p1466
sg9
V10514160.xml
p1467
sa(dp1468
g3
VSTD-Huang-1988
p1469
sg5
S'PMC2491139'
p1470
sg7
VCD000386 v. 9.0 Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malari.rm5
p1471
sg9
V3048759.xml
p1472
sa(dp1473
g3
VSTD-Schapira-1988
p1474
sg5
S'PMC2491050'
p1475
sg7
g1471
sg9
V3293827.xml
p1476
sa(dp1477
g3
VSTD-Basco-2002
p1478
sg5
S'PMC2567565'
p1479
sg7
g1471
sg9
V12163917.xml
p1480
sa(dp1481
g3
VSTD-CPPRG-1999
p1482
sg5
S'PMC2762610'
p1483
sg7
VCD004606 v. 6.0 School-based secondary prevention programmes for preventing violence.rm5
p1484
sg9
V10535230.xml
p1485
sa(dp1486
g3
VSTD-Cavell-2000
p1487
sg5
S'PMC2664521'
p1488
sg7
g1484
sg9
V19283597.xml
p1489
sa(dp1490
g3
VSTD-Quinn-1995
p1491
sg5
S'PMC2774204'
p1492
sg7
g1484
sg9
V19890177.xml
p1493
sa(dp1494
g3
VSTD-Hughes-1993
p1495
sg5
S'PMC3053018'
p1496
sg7
g1484
sg9
V21215834.xml
p1497
sa(dp1498
g3
VSTD-White-2003
p1499
sg5
S'PMC1746635'
p1500
sg7
VCD000353 v. 9.0 Homeopathy for chronic asthma.rm5
p1501
sg9
V12668794.xml
p1502
sa(dp1503
g3
VSTD-Lewith-2002
p1504
sg5
S'PMC1121932'
p1505
sg7
g1501
sg9
V11777781.xml
p1506
sa(dp1507
g3
VSTD-Yamamura-1997
p1508
sg5
S'PMC163989'
p1509
sg7
VCD003038 v. 9.2 Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeni.rm5
p1510
sg9
V9257745.xml
p1511
sa(dp1512
g3
VSTD-Cornelissen-1992
p1513
sg5
S'PMC189424'
p1514
sg7
g1510
sg9
V1503442.xml
p1515
sa(dp1516
g3
VSTD-Gribble-1983
p1517
sg5
S'PMC185330'
p1518
sg7
g1510
sg9
V6357076.xml
p1519
sa(dp1520
g3
VSTD-Piccart-1984
p1521
sg5
S'PMC180041'
p1522
sg7
g1510
sg9
V6524903.xml
p1523
sa(dp1524
g3
VSTD-Cometta-1996
p1525
sg5
S'PMC163274'
p1526
sg7
g1510
sg9
V8723449.xml
p1527
sa(dp1528
g3
VSTD-Sinclair-1998
p1529
sg5
S'PMC1763872'
p1530
sg7
VCD003698 v. 6.2 Community pharmacy personnel interventions for smoking cessation.rm5
p1531
sg9
V9825420.xml
p1532
sa(dp1533
g3
VSTD-DIAS_x002d_2
p1534
sg5
S'PMC2730486'
p1535
sg7
VCD000514 v. 6.0 Thrombolysis (different doses routes of administration and agents) for acute ischaemic stroke.rm5
p1536
sg9
V19097942.xml
p1537
sa(dp1538
g3
VSTD-TNK_x002d_S2B
p1539
sg5
S'PMC2860601'
p1540
sg7
g1536
sg9
V20185783.xml
p1541
sa(dp1542
g3
VSTD-Stiell-2008
p1543
sg5
S'PMC2292763'
p1544
sg7
VCD003109 v. 6.0 Advanced trauma life support training for ambulance crews.rm5
p1545
sg9
V18427089.xml
p1546
sa(dp1547
g3
VSTD-Ernst-1997
p1548
sg5
S'PMC1304430'
p1549
sg7
VCD005364 v. 9.0 Topical anaesthetics for repair of dermal laceration.rm5
p1550
sg9
V9291744.xml
p1551
sa(dp1552
g3
VSTD-Kendall-1996
p1553
sg5
S'PMC1342653'
p1554
sg7
g1550
sg9
V8653235.xml
p1555
sa(dp1556
g3
VSTD-Johnson-2005
p1557
sg5
S'PMC1215550'
p1558
sg7
VCD001087 v. 13.4 Crisis intervention for people with severe mental illnesses.rm5
p1559
sg9
V16103032.xml
p1560
sa(dp1561
g3
VSTD-Smith-2010
p1562
sg5
S'PMC3140031'
p1563
sg7
VCD007854 v. 3.0 Acupuncture for dysmenorrhoea.rm5
p1564
sg9
V21799683.xml
p1565
sa(dp1566
g3
VSTD-Ebenbichler-1998
p1567
sg5
S'PMC28476'
p1568
sg7
VCD009601 v. 2.0 Therapeutic ultrasound for carpal tunnel syndrome.rm5
p1569
sg9
V9529407.xml
p1570
sa(dp1571
g3
VSTD-Hobbs-2005
p1572
sg5
S'PMC1952508'
p1573
sg7
VCD009586 v. 2.0 Effectiveness of systematic screening for the detection of atrial fibrillation.rm5
p1574
sg9
V17673732.xml
p1575
sa(dp1576
g3
VSTD-Hermiz-2002
p1577
sg5
S'PMC130059'
p1578
sg7
VCD000994 v. 9.4 Home care by outreach nursing for chronic obstructive pulmonary disease.rm5
p1579
sg9
V12399344.xml
p1580
sa(dp1581
g3
VSTD-Littlejohns-1991
p1582
sg5
S'PMC463273'
p1583
sg7
g1579
sg9
V1926024.xml
p1584
sa(dp1585
g3
VSTD-Cockcroft-1987
p1586
sg5
S'PMC1245234'
p1587
sg7
g1579
sg9
V3101821.xml
p1588
sa(dp1589
g3
VSTD-Scanlon-1992
p1590
sg5
S'PMC1590510'
p1591
sg7
VCD000273 v. 8.0 Caffeine versus theophylline for apnea in preterm infants.rm5
p1592
sg9
V1586184.xml
p1593
sa(dp1594
g3
VSTD-Morrell-1986
p1595
sg5
S'PMC1339978'
p1596
sg7
VCD003540 v. 5.0 Effects of interventions aimed at changing the length of primary care physicians' consultation.rm5
p1597
sg9
V3083919.xml
p1598
sa(dp1599
g3
VSTD-Ridsdale-1989
p1600
sg5
S'PMC1712205'
p1601
sg7
g1597
sg9
V2558202.xml
p1602
sa(dp1603
g3
VSTD-Wilson-1992
p1604
sg5
S'PMC1881485'
p1605
sg7
g1597
sg9
V1739798.xml
p1606
sa(dp1607
g3
VSTD-Sandborn-2007b
p1608
sg5
S'PMC2701613'
p1609
sg7
VCD006893 v. 3.2 Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.rm5
p1610
sg9
V17299059.xml
p1611
sa(dp1612
g3
VSTD-Sandborn-2004
p1613
sg5
S'PMC1774244'
p1614
sg7
g1610
sg9
V15361500.xml
p1615
sa(dp1616
g3
VSTD-Konrad-1992
p1617
sg5
S'PMC1004758'
p1618
sg7
VCD003010 v. 8.0 Traction for low-back pain with or without sciatica.rm5
p1619
sg9
V1535495.xml
p1620
sa(dp1621
g3
VSTD-Bernstein-1991
p1622
sg5
S'PMC3680006'
p1623
sg7
VCD006971 v. 2.0 Intracervical prostaglandins for induction of labour.rm5
p1624
sg9
V23652486.xml
p1625
sa(dp1626
g3
VSTD-Gilson-1993
p1627
sg5
S'PMC1022221'
p1628
sg7
g1624
sg9
V8212680.xml
p1629
sa(dp1630
g3
VSTD-WISDOM-2007
p1631
sg5
S'PMC1939792'
p1632
sg7
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p1633
sg9
V17626056.xml
p1634
sa(dp1635
g3
VSTD-EPHT-2006
p1636
sg5
S'PMC2330032'
p1637
sg7
g1633
sg9
V18366766.xml
p1638
sa(dp1639
g3
VSTD-O_x0027_Neill-1996
p1640
sg5
S'PMC1060285'
p1641
sg7
VCD009849 v. 2.3 Steroidal contraceptives and bone fractures in women evidence from observational studies.rm5
p1642
sg9
V8935460.xml
p1643
sa(dp1644
g3
VSTD-Arkinstall-1989
p1645
sg5
S'PMC1268755'
p1646
sg7
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p1647
sg9
V2645988.xml
p1648
sa(dp1649
g3
VSTD-Lauretti-2003
p1650
sg5
S'PMC2376845'
p1651
sg7
g1647
sg9
V14647133.xml
p1652
sa(dp1653
g3
VSTD-Melzack-1979
p1654
sg5
S'PMC1818901'
p1655
sg7
g1647
sg9
V376079.xml
p1656
sa(dp1657
g3
VSTD-Cant-1986
p1658
sg5
S'PMC1341170'
p1659
sg7
VCD000133 v. 7.0 Maternal dietary antigen avoidance during pregnancy or lactation or both for preventing or treatin.rm5
p1660
sg9
V3089466.xml
p1661
sa(dp1662
g3
VSTD-Smith-1998
p1663
sg5
S'PMC1717450'
p1664
sg7
VCD001507 v. 12.0 Tyrosine supplementation for phenylketonuria.rm5
p1665
sg9
V9579151.xml
p1666
sa(dp1667
g3
VSTD-Dahl_x002d_Jorgensen-1986
p1668
sg5
S'PMC1341978'
p1669
sg7
VCD007543 v. 2.2 Enhanced glucose control for preventing and treating diabetic neuropathy.rm5
p1670
sg9
V3096429.xml
p1671
sa(dp1672
g3
VSTD-Campos-2007
p1673
sg5
S'PMC3476141'
p1674
sg7
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p1675
sg9
V17563840.xml
p1676
sa(dp1677
g3
VSTD-Eljamel-1990
p1678
sg5
S'PMC488052'
p1679
sg7
g1675
sg9
V2351965.xml
p1680
sa(dp1681
g3
VSTD-Dougados-1988_x0028_4.6mg_x002f_kg_x002f_d_x0029_
p1682
sg5
S'PMC1003464'
p1683
sg7
VCD007893 v. 2.0 Effect of cyclosporine on blood pressure.rm5
p1684
sg9
V3281603.xml
p1685
sa(dp1686
g3
VSTD-Swan-2010
p1687
sg5
S'PMC2879135'
p1688
sg7
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p1689
sg9
V20409497.xml
p1690
sa(dp1691
g3
VSTD-Aubin-2008
p1692
sg5
S'PMC2569194'
p1693
sg7
g1689
sg9
V18263663.xml
p1694
sa(dp1695
g3
VSTD-Rennard-2011
p1696
sg5
S'PMC3281242'
p1697
sg7
g1689
sg9
V22080588.xml
p1698
sa(dp1699
g3
VSTD-van-der-Schans-1991
p1700
sg5
S'PMC463090'
p1701
sg7
VCD001401 v. 10.0 Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.rm5
p1702
sg9
V2038733.xml
p1703
sa(dp1704
g3
VSTD-Avasthi-2001
p1705
sg5
S'PMC2956152'
p1706
sg7
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p1707
sg9
V21407865.xml
p1708
sa(dp1709
g3
VSTD-Williams-1985
p1710
sg5
S'PMC1040623'
p1711
sg7
VCD001861 v. 7.5 Interventions for recurrent corneal erosions.rm5
p1712
sg9
V3873960.xml
p1713
sa(dp1714
g3
VSTD-CITT-2005a
p1715
sg5
S'PMC1772876'
p1716
sg7
VCD006768 v. 4.0 Non-surgical interventions for convergence insufficiency.rm5
p1717
sg9
V16170124.xml
p1718
sa(dp1719
g3
VSTD-CITT-2008
p1720
sg5
S'PMC2779032'
p1721
sg7
g1717
sg9
V18852411.xml
p1722
sa(dp1723
g3
VSTD-Strang-2002
p1724
sg5
S'PMC434753'
p1725
sg7
VCD001027 v. 14.0 Cognitive behaviour therapy for chronic fatigue syndrome in adults.rm5
p1726
sg9
V16693831.xml
p1727
sa(dp1728
g3
VSTD-King-1999
p1729
sg5
S'PMC2722588'
p1730
sg7
g1726
sg9
V19594903.xml
p1731
sa(dp1732
g3
VSTD-Becker-2010
p1733
sg5
S'PMC2888216'
p1734
sg7
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p1735
sg9
V20370912.xml
p1736
sa(dp1737
g3
VSTD-UK-Trial-1997
p1738
sg5
S'PMC1717269'
p1739
sg7
VCD001915 v. 11.2 Inhaled corticosteroids for cystic fibrosis.rm5
p1740
sg9
V9301350.xml
p1741
sa(dp1742
g3
VSTD-Seymour-1996
p1743
sg5
S'PMC2042618'
p1744
sg7
VCD004487 v. 6.0 Paracetamol for pain relief after surgical removal of lower wisdom teeth.rm5
p1745
sg9
V8799525.xml
p1746
sa(dp1747
g3
VSTD-Roberts-2006
p1748
sg5
S'PMC1828217'
p1749
sg7
VCD005110 v. 4.0 Hypnotherapy for treatment of irritable bowel syndrome.rm5
p1750
sg9
V16464325.xml
p1751
sa(dp1752
g3
VSTD-Sugaya-2010
p1753
sg5
S'PMC2876358'
p1754
sg7
VCD002744 v. 10.0 Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).rm5
p1755
sg9
V20368393.xml
p1756
sa(dp1757
g3
VSTD-Barer-1988-propanolol
p1758
sg5
S'PMC2545364'
p1759
sg7
VCD002839 v. 6.0 Vasoactive drugs for acute stroke.rm5
p1760
sg9
V3126956.xml
p1761
sa(dp1762
g3
VSTD-Barer-1988_x002f_50-mg
p1763
sg5
S'PMC2545364'
p1764
sg7
g1760
sg9
V3126956.xml
p1765
sa(dp1766
g3
VSTD-Barer-1988_x002f_80-mg
p1767
sg5
S'PMC2545364'
p1768
sg7
g1760
sg9
V3126956.xml
p1769
sa(dp1770
g3
VSTD-Barer-1988-atenolol
p1771
sg5
S'PMC2545364'
p1772
sg7
g1760
sg9
V3126956.xml
p1773
sa(dp1774
g3
VSTD-Carbajal-2003
p1775
sg5
S'PMC139493'
p1776
sg7
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p1777
sg9
V12511452.xml
p1778
sa(dp1779
g3
VSTD-Whipple-2004
p1780
sg5
S'PMC3110955'
p1781
sg7
g1777
sg9
V21632824.xml
p1782
sa(dp1783
g3
VSTD-Kostandy-2008
p1784
sg5
S'PMC2647362'
p1785
sg7
g1777
sg9
V18513662.xml
p1786
sa(dp1787
g3
VSTD-Curtis-2007
p1788
sg5
S'PMC1950500'
p1789
sg7
g1777
sg9
V17640375.xml
p1790
sa(dp1791
g3
VSTD-Carbajal-1999
p1792
sg5
S'PMC28282'
p1793
sg7
g1777
sg9
V10574854.xml
p1794
sa(dp1795
g3
VSTD-Elserafy-2009
p1796
sg5
S'PMC2813645'
p1797
sg7
g1777
sg9
V19448377.xml
p1798
sa(dp1799
g3
VSTD-Whitelaw-1988
p1800
sg5
S'PMC1779160'
p1801
sg7
VCD002771 v. 6.0 Kangaroo mother care to reduce morbidity and mortality in low birthweight infants.rm5
p1802
sg9
V3060024.xml
p1803
sa(dp1804
g3
VSTD-Neu-2010
p1805
sg5
S'PMC2935695'
p1806
sg7
g1802
sg9
V20629927.xml
p1807
sa(dp1808
g3
VSTD-Spooner-1993
p1809
sg5
S'PMC2379872'
p1810
sg7
VCD003219 v. 9.0 Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome.rm5
p1811
sg9
V8219859.xml
p1812
sa(dp1813
g3
VSTD-Ebenbichler-1998
p1814
sg5
S'PMC28476'
p1815
sg7
g1811
sg9
V9529407.xml
p1816
sa(dp1817
g3
VSTD-Hui-2001
p1818
sg5
S'PMC1753810'
p1819
sg7
g1811
sg9
V11482310.xml
p1820
sa(dp1821
g3
VSTD-Jones-1994
p1822
sg5
S'PMC475231'
p1823
sg7
VCD001385 v. 8.0 Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contai.rm5
p1824
sg9
V7974313.xml
p1825
sa(dp1826
g3
VSTD-Taylor-1998
p1827
sg5
S'PMC1745306'
p1828
sg7
g1824
sg9
V10319056.xml
p1829
sa(dp1830
g3
VSTD-Newnham-1995
p1831
sg5
S'PMC1021218'
p1832
sg7
g1824
sg9
V7597661.xml
p1833
sa(dp1834
g3
VSTD-Booth-1993
p1835
sg5
S'PMC464894'
p1836
sg7
g1824
sg9
V8296255.xml
p1837
sa(dp1838
g3
VSTD-Berry-1974
p1839
sg5
S'PMC1006318'
p1840
sg7
VCD000189 v. 12.0 Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid.rm5
p1841
sg9
V4613287.xml
p1842
sa(dp1843
g3
VSTD-Kirwan-2004
p1844
sg5
S'PMC1755023'
p1845
sg7
g1841
sg9
V15140776.xml
p1846
sa(dp1847
g3
VSTD-Jasani-1968
p1848
sg5
S'PMC1031152'
p1849
sg7
g1841
sg9
V4283768.xml
p1850
sa(dp1851
g3
VSTD-Boardman-1967
p1852
sg5
S'PMC1748911'
p1853
sg7
g1841
sg9
V4861386.xml
p1854
sa(dp1855
g3
VSTD-Carmichael-1990
p1856
sg5
S'PMC1042200'
p1857
sg7
VCD005430 v. 4.0 Topical corticosteroids as adjunctive therapy for bacterial keratitis.rm5
p1858
sg9
V2203467.xml
p1859
sa(dp1860
g3
VSTD-London-1999
p1861
sg5
S'PMC2127677'
p1862
sg7
VCD000443 v. 7.0 Services for reducing duration of hospital care for acute stroke patients.rm5
p1863
sg9
V9366727.xml
p1864
sa(dp1865
g3
VSTD-Griffiths-2005
p1866
sg5
S'PMC1570787'
p1867
sg7
VCD005108 v. 4.0 Self-management education programmes by lay leaders for people with chronic conditions.rm5
p1868
sg9
V16281998.xml
p1869
sa(dp1870
g3
VSTD-Fu-2003
p1871
sg5
S'PMC2572423'
p1872
sg7
g1868
sg9
V12764513.xml
p1873
sa(dp1874
g3
VSTD-Buszewicz-2006
p1875
sg5
S'PMC1626290'
p1876
sg7
g1868
sg9
V17040926.xml
p1877
sa(dp1878
g3
VSTD-Kennedy-2007
p1879
sg5
S'PMC2652924'
p1880
sg7
g1868
sg9
V17325405.xml
p1881
sa(dp1882
g3
VSTD-Nieuwboer-2007
p1883
sg5
S'PMC2077658'
p1884
sg7
VCD002817 v. 10.2 Physiotherapy versus placebo or no intervention in Parkinson's disease.rm5
p1885
sg9
V17229744.xml
p1886
sa(dp1887
g3
VSTD-Schilling-2008
p1888
sg5
S'PMC2957327'
p1889
sg7
g1885
sg9
V20976096.xml
p1890
sa(dp1891
g3
VSTD-de-Bruin-2010a
p1892
sg5
S'PMC2957229'
p1893
sg7
g1885
sg9
V20976086.xml
p1894
sa(dp1895
g3
VSTD-de-Bruin-2010b
p1896
sg5
S'PMC2957229'
p1897
sg7
g1885
sg9
V20976086.xml
p1898
sa(dp1899
g3
VSTD-Hackney-2009
p1900
sg5
S'PMC2783812'
p1901
sg7
g1885
sg9
V19329350.xml
p1902
sa(dp1903
g3
VSTD-Ashburn-2007
p1904
sg5
S'PMC2117667'
p1905
sg7
g1885
sg9
V17119004.xml
p1906
sa(dp1907
g3
VSTD-Fisher-2008
p1908
sg5
S'PMC2989816'
p1909
sg7
g1885
sg9
V18534554.xml
p1910
sa(dp1911
g3
VSTD-Zador-1976
p1912
sg5
S'PMC3153731'
p1913
sg7
VCD005242 v. 4.4 Increased police patrols for preventing alcohol-impaired driving.rm5
p1914
sg9
V21819824.xml
p1915
sa(dp1916
g3
VSTD-Campbell-1981
p1917
sg5
S'PMC3150899'
p1918
sg7
g1914
sg9
V21768380.xml
p1919
sa(dp1920
g3
VSTD-Hingson-1996
p1921
sg5
S'PMC1380396'
p1922
sg7
g1914
sg9
V8659651.xml
p1923
sa(dp1924
g3
VSTD-Black-2002
p1925
sg5
S'PMC1743616'
p1926
sg7
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p1927
sg9
V12448802.xml
p1928
sa(dp1929
g3
VSTD-Dobbins-2009
p1930
sg5
S'PMC2936828'
p1931
sg7
g1927
sg9
V19775439.xml
p1932
sa(dp1933
g3
VSTD-Mason-2001
p1934
sg5
S'PMC59683'
p1935
sg7
g1927
sg9
V11701573.xml
p1936
sa(dp1937
g3
VSTD-Wyatt-1998
p1938
sg5
S'PMC28686'
p1939
sg7
g1927
sg9
V9774287.xml
p1940
sa(dp1941
g3
VSTD-Francis-2008
p1942
sg5
S'PMC3749169'
p1943
sg7
VCD006170 v. 4.2 Methods of milk expression for lactating women.rm5
p1944
sg9
V23991112.xml
p1945
sa(dp1946
g3
VSTD-Jones-2001
p1947
sg5
S'PMC1721311'
p1948
sg7
g1944
sg9
V11517200.xml
p1949
sa(dp1950
g3
VSTD-Moorcroft-2004
p1951
sg5
S'PMC1746905'
p1952
sg7
VCD002768 v. 11.0 Physical training for cystic fibrosis.rm5
p1953
sg9
V15563708.xml
p1954
sa(dp1955
g3
VSTD-Tchivileva-et-al-2010
p1956
sg5
S'PMC2876724'
p1957
sg7
VCD004715 v. 6.0 Pharmacological interventions for pain in patients with temporomandibular disorders.rm5
p1958
sg9
V20216107.xml
p1959
sa(dp1960
g3
VSTD-Vaezi-1999
p1961
sg5
S'PMC1727388'
p1962
sg7
VCD005046 v. 9.0 Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasi.rm5
p1963
sg9
V9895383.xml
p1964
sa(dp1965
g3
VSTD-Sinclair-1979
p1966
sg5
S'PMC1597640'
p1967
sg7
VCD003566 v. 5.0 Cardioselective beta-blockers for chronic obstructive pulmonary disease.rm5
p1968
sg9
V369647.xml
p1969
sa(dp1970
g3
VSTD-Lammers-1985a
p1971
sg5
S'PMC1400701'
p1972
sg7
g1968
sg9
V4041341.xml
p1973
sa(dp1974
g3
VSTD-Perks-1978
p1975
sg5
S'PMC1429247'
p1976
sg7
g1968
sg9
V339932.xml
p1977
sa(dp1978
g3
VSTD-Macquin_x002d_Mavier-1988
p1979
sg5
S'PMC1386540'
p1980
sg7
g1968
sg9
V2902873.xml
p1981
sa(dp1982
g3
VSTD-Prabhu-2010
p1983
sg5
S'PMC2827594'
p1984
sg7
VCD005279 v. 5.0 Ultrasound use for the placement of haemodialysis catheters.rm5
p1985
sg9
V19965532.xml
p1986
sa(dp1987
g3
VSTD-Marteau-1998
p1988
sg5
S'PMC1727004'
p1989
sg7
VCD004118 v. 4.0 Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1990
sg9
V9536943.xml
p1991
sa(dp1992
g3
VSTD-Itoh-2010
p1993
sg5
S'PMC2852376'
p1994
sg7
VCD007070 v. 3.5 Acupuncture for treating fibromyalgia.rm5
p1995
sg9
V20331844.xml
p1996
sa(dp1997
g3
VSTD-Deluze-1992
p1998
sg5
S'PMC1883744'
p1999
sg7
g1995
sg9
V1477566.xml
p2000
sa(dp2001
g3
VSTD-Harris-2009
p2002
sg5
S'PMC2757074'
p2003
sg7
g1995
sg9
V19501658.xml
p2004
sa(dp2005
g3
VSTD-Bauman-2001
p2006
sg5
S'PMC1446646'
p2007
sg7
VCD004493 v. 8.2 Family-based programmes for preventing smoking by children and adolescents.rm5
p2008
sg9
V11291373.xml
p2009
sa(dp2010
g3
VSTD-Schinke-2004
p2011
sg5
S'PMC2795165'
p2012
sg7
g2008
sg9
V15376818.xml
p2013
sa(dp2014
g3
VSTD-Nutbeam-1993
p2015
sg5
S'PMC1676653'
p2016
sg7
g2008
sg9
V8435601.xml
p2017
sa(dp2018
g3
VSTD-Jackson-2006
p2019
sg5
S'PMC1759106'
p2020
sg7
g2008
sg9
V12612363.xml
p2021
sa(dp2022
g3
VSTD-Trenkwalder-2004b
p2023
sg5
S'PMC1757460'
p2024
sg7
VCD006009 v. 4.0 Dopamine agonists for the treatment of restless legs syndrome.rm5
p2025
sg9
V14707315.xml
p2026
sa(dp2027
g3
VSTD-Zhang-2011
p2028
sg5
S'PMC3193968'
p2029
sg7
VCD000434 v. 11.2 Interventions for treating proximal humeral fractures in adults.rm5
p2030
sg9
V21387176.xml
p2031
sa(dp2032
g3
VSTD-Scott-1983
p2033
sg5
S'PMC1027296'
p2034
sg7
VCD002814 v. 9.26 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.rm5
p2035
sg9
V6842217.xml
p2036
sa(dp2037
g3
VSTD-Lieberman-1992
p2038
sg5
S'PMC463751'
p2039
sg7
VCD000436 v. 7.0 Dietary sodium manipulation and asthma.rm5
p2040
sg9
V1609379.xml
p2041
sa(dp2042
g3
VSTD-Burney-1989
p2043
sg5
S'PMC461661'
p2044
sg7
g2040
sg9
V2928987.xml
p2045
sa(dp2046
g3
VSTD-Carey-1993
p2047
sg5
S'PMC464652'
p2048
sg7
g2040
sg9
V8153919.xml
p2049
sa(dp2050
g3
VSTD-Payne-1986
p2051
sg5
S'PMC2498399'
p2052
sg7
VCD005640 v. 6.5 T-tube drainage versus primary closure after open common bile duct exploration.rm5
p2053
sg9
V3538986.xml
p2054
sa(dp2055
g3
VSTD-Naik-2010
p2056
sg5
S'PMC3169962'
p2057
sg7
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p2058
sg9
V21935312.xml
p2059
sa(dp2060
g3
VSTD-Brusasco-2003
p2061
sg5
S'PMC1746668'
p2062
sg7
g2058
sg9
V12728159.xml
p2063
sa(dp2064
g3
VSTD-Rutten_x002d_van-Molken-2007
p2065
sg5
S'PMC1913175'
p2066
sg7
g2058
sg9
V17370096.xml
p2067
sa(dp2068
g3
VSTD-Vandenburg-1994
p2069
sg5
S'PMC1364758'
p2070
sg7
VCD003823 v. 7.0 Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hyper.rm5
p2071
sg9
V8198936.xml
p2072
sa(dp2073
g3
VSTD-Gomez-1989
p2074
sg5
S'PMC1379991'
p2075
sg7
g2071
sg9
V2556172.xml
p2076
sa(dp2077
g3
VSTD-Scholze-1998
p2078
sg5
S'PMC1873536'
p2079
sg7
g2071
sg9
V9643623.xml
p2080
sa(dp2081
g3
VSTD-Kayanakis-1987
p2082
sg5
S'PMC1386051'
p2083
sg7
g2071
sg9
V3555588.xml
p2084
sa(dp2085
g3
VSTD-Holland-2003
p2086
sg5
S'PMC1746478'
p2087
sg7
VCD002769 v. 11.0 Non-invasive ventilation for cystic fibrosis.rm5
p2088
sg9
V14514944.xml
p2089
sa(dp2090
g3
VSTD-Springer-1987
p2091
sg5
S'PMC1778496'
p2092
sg7
VCD003530 v. 4.0 Beclomethasone versus budesonide for chronic asthma.rm5
p2093
sg9
V3662586.xml
p2094
sa(dp2095
g3
VSTD-Field-1982
p2096
sg5
S'PMC1628026'
p2097
sg7
g2093
sg9
V6756319.xml
p2098
sa(dp2099
g3
VSTD-Ebden-1986
p2100
sg5
S'PMC460512'
p2101
sg7
g2093
sg9
V3547757.xml
p2102
sa(dp2103
g3
VSTD-Gent_x002d_AMI-1968
p2104
sg5
S'PMC1912602'
p2105
sg7
VCD001820 v. 8.0 Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.rm5
p2106
sg9
V4879059.xml
p2107
sa(dp2108
g3
VSTD-MacDonald-1989
p2109
sg5
S'PMC172499'
p2110
sg7
VCD007933 v. 2.2 Genital ulcer disease treatment for reducing sexual acquisition of HIV.rm5
p2111
sg9
V2502065.xml
p2112
sa(dp2113
g3
VSTD-Balasubramanian-2006
p2114
sg5
S'PMC1856614'
p2115
sg7
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p2116
sg9
V17060756.xml
p2117
sa(dp2118
g3
VSTD-Ethgen-2009
p2119
sg5
S'PMC2679061'
p2120
sg7
g2116
sg9
V19358717.xml
p2121
sa(dp2122
g3
VSTD-Yu-2010
p2123
sg5
S'PMC2886040'
p2124
sg7
g2116
sg9
V20482769.xml
p2125
sa(dp2126
g3
VSTD-Hopewell-2010
p2127
sg5
S'PMC2844941'
p2128
sg7
g2116
sg9
V20332510.xml
p2129
sa(dp2130
g3
VSTD-Partsinevelou-2009
p2131
sg5
S'PMC2788535'
p2132
sg7
g2116
sg9
V19930576.xml
p2133
sa(dp2134
g3
VSTD-Prady-2008
p2135
sg5
S'PMC2216683'
p2136
sg7
g2116
sg9
V18270568.xml
p2137
sa(dp2138
g3
VSTD-Hewitt-2005
p2139
sg5
S'PMC557225'
p2140
sg7
g2116
sg9
V15760970.xml
p2141
sa(dp2142
g3
VSTD-Thoma-2006
p2143
sg5
S'PMC2686052'
p2144
sg7
g2116
sg9
V19554136.xml
p2145
sa(dp2146
g3
VSTD-Han-2008
p2147
sg5
S'PMC3489160'
p2148
sg7
g2116
sg9
V19070681.xml
p2149
sa(dp2150
g3
VSTD-Montan_x00e9_-2010
p2151
sg5
S'PMC2822812'
p2152
sg7
g2116
sg9
V20067642.xml
p2153
sa(dp2154
g3
VSTD-Lipman-2005
p2155
sg5
S'PMC1316160'
p2156
sg7
VCD002020 v. 11.2 Group-based parent training programmes for improving parental psychosocial health.rm5
p2157
sg9
V16293780.xml
p2158
sa(dp2159
g3
VSTD-Gross-2009
p2160
sg5
S'PMC2770507'
p2161
sg7
g2157
sg9
V19067166.xml
p2162
sa(dp2163
g3
VSTD-Patterson-2002
p2164
sg5
S'PMC1755810'
p2165
sg7
g2157
sg9
V12456542.xml
p2166
sa(dp2167
g3
VSTD-Fanning-2007
p2168
sg5
S'PMC1781028'
p2169
sg7
g2157
sg9
V18747059.xml
p2170
sa(dp2171
g3
VSTD-Hiscock-2008
p2172
sg5
S'PMC2234515'
p2173
sg7
g2157
sg9
V18244958.xml
p2174
sa(dp2175
g3
VSTD-Senkus_x002d_Konefka-2005
p2176
sg5
S'PMC2361948'
p2177
sg7
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p2178
sg9
V15770205.xml
p2179
sa(dp2180
g3
VSTD-MRC-1991
p2181
sg5
S'PMC1971762'
p2182
sg7
g2178
sg9
V1705140.xml
p2183
sa(dp2184
g3
VSTD-MRC-1992
p2185
sg5
S'PMC1977779'
p2186
sg7
g2178
sg9
V1377484.xml
p2187
sa(dp2188
g3
VSTD-Charlton-1990
p2189
sg5
S'PMC1664498'
p2190
sg7
VCD005306 v. 3.1 Written action plans for asthma in children.rm5
p2191
sg9
V2148702.xml
p2192
sa(dp2193
g3
VSTD-Detry-1994
p2194
sg5
S'PMC1364760'
p2195
sg7
VCD003614 v. 5.2 Trimetazidine for stable angina.rm5
p2196
sg9
V8198938.xml
p2197
sa(dp2198
g3
VSTD-Manchanda-1997
p2199
sg5
S'PMC1892273'
p2200
sg7
g2196
sg9
V9404250.xml
p2201
sa(dp2202
g3
VSTD-Frankel-2010
p2203
sg5
S'PMC2890979'
p2204
sg7
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p2205
sg9
V20058059.xml
p2206
sa(dp2207
g3
VSTD-Brown-2001
p2208
sg5
S'PMC2375236'
p2209
sg7
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p2210
sg9
V11720460.xml
p2211
sa(dp2212
g3
VSTD-Ho-2008
p2213
sg5
S'PMC3149814'
p2214
sg7
g2210
sg9
V18777429.xml
p2215
sa(dp2216
g3
VSTD-Kennedy-2004
p2217
sg5
S'PMC1774266'
p2218
sg7
g2210
sg9
V15479685.xml
p2219
sa(dp2220
g3
VSTD-Harmsen-2005
p2221
sg5
S'PMC1463156'
p2222
sg7
g2210
sg9
V15904552.xml
p2223
sa(dp2224
g3
VSTD-Longo-2006
p2225
sg5
S'PMC1821413'
p2226
sg7
g2210
sg9
V16438813.xml
p2227
sa(dp2228
g3
VSTD-Krones-2008
p2229
sg5
S'PMC2384995'
p2230
sg7
g2210
sg9
V18474884.xml
p2231
sa(dp2232
g3
VSTD-Glasgow-2004
p2233
sg5
S'PMC1492587'
p2234
sg7
g2210
sg9
V15610326.xml
p2235
sa(dp2236
g3
VSTD-McLean-2004
p2237
sg5
S'PMC1326066'
p2238
sg7
g2210
sg9
V15353051.xml
p2239
sa(dp2240
g3
VSTD-Stewart-2007
p2241
sg5
S'PMC2000315'
p2242
sg7
g2210
sg9
V17893379.xml
p2243
sa(dp2244
g3
VSTD-Hobma-2006
p2245
sg5
S'PMC1874521'
p2246
sg7
g2210
sg9
V16882375.xml
p2247
sa(dp2248
g3
VSTD-Kinmonth-1998
p2249
sg5
S'PMC28704'
p2250
sg7
g2210
sg9
V9794859.xml
p2251
sa(dp2252
g3
VSTD-Smith-2006
p2253
sg5
S'PMC1924714'
p2254
sg7
g2210
sg9
V16808764.xml
p2255
sa(dp2256
g3
VSTD-Howe-1996
p2257
sg5
S'PMC1239692'
p2258
sg7
g2210
sg9
V8776911.xml
p2259
sa(dp2260
g3
VSTD-Woodfine-2011
p2261
sg5
S'PMC3207090'
p2262
sg7
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p2263
sg9
V22054336.xml
p2264
sa(dp2265
g3
VSTD-Rosen-2006
p2266
sg5
S'PMC3734469'
p2267
sg7
g2263
sg9
V23863613.xml
p2268
sa(dp2269
g3
VSTD-Lumley-2006
p2270
sg5
S'PMC305350'
p2271
sg7
g2263
sg9
V14629776.xml
p2272
sa(dp2273
g3
VSTD-Florence-2011
p2274
sg5
S'PMC3116927'
p2275
sg7
g2263
sg9
V21680632.xml
p2276
sa(dp2277
g3
VSTD-Hawkey-2001
p2278
sg5
S'PMC1728427'
p2279
sg7
VCD005415 v. 9.0 Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bl.rm5
p2280
sg9
V11511559.xml
p2281
sa(dp2282
g3
VSTD-Daneshmend-1992
p2283
sg5
S'PMC1881159'
p2284
sg7
g2280
sg9
V1737157.xml
p2285
sa(dp2286
g3
VSTD-Karat-1970
p2287
sg5
S'PMC1699291'
p2288
sg7
VCD006949 v. 5.0 Interventions for erythema nodosum leprosum.rm5
p2289
sg9
V4904935.xml
p2290
sa(dp2291
g3
VSTD-Iyer-1971
p2292
sg5
S'PMC2427977'
p2293
sg7
g2289
sg9
V4947831.xml
p2294
sa(dp2295
g3
VSTD-Tejedor-1998
p2296
sg5
S'PMC1722471'
p2297
sg7
VCD006499 v. 4.0 Botulinum toxin for the treatment of strabismus.rm5
p2298
sg9
V9613374.xml
p2299
sa(dp2300
g3
VSTD-Tejedor-1999
p2301
sg5
S'PMC1723128'
p2302
sg7
g2298
sg9
V10381663.xml
p2303
sa(dp2304
g3
VSTD-Leroi-2005
p2305
sg5
S'PMC1409867'
p2306
sg7
VCD004464 v. 6.0 Sacral nerve stimulation for faecal incontinence and constipation in adults.rm5
p2307
sg9
V16244539.xml
p2308
sa(dp2309
g3
VSTD-Likosky-1991
p2310
sg5
S'PMC1014677'
p2311
sg7
VCD002819 v. 6.0 Cyclophosphamide for multiple sclerosis.rm5
p2312
sg9
V1783915.xml
p2313
sa(dp2314
g3
VSTD-Padmanabhan-2007
p2315
sg5
S'PMC1964741'
p2316
sg7
VCD007705 v. 2.0 Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal surgery.rm5
p2317
sg9
V17394704.xml
p2318
sa(dp2319
g3
VSTD-Keitz-2001
p2320
sg5
S'PMC1495270'
p2321
sg7
VCD003938 v. 6.0 Provider training and experience for people living with HIVAIDS.rm5
p2322
sg9
V11556937.xml
p2323
sa(dp2324
g3
VSTD-Landon-2003
p2325
sg5
S'PMC1494839'
p2326
sg7
g2322
sg9
V12709089.xml
p2327
sa(dp2328
g3
VSTD-Shaw-1993
p2329
sg5
S'PMC1029588'
p2330
sg7
VCD002773 v. 4.0 Neuromuscular paralysis for newborn infants receiving mechanical ventilation.rm5
p2331
sg9
V8285749.xml
p2332
sa(dp2333
g3
VSTD-ENGAGE-2009
p2334
sg5
S'PMC2777786'
p2335
sg7
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p2336
sg9
V19684043.xml
p2337
sa(dp2338
g3
VSTD-Pavesi-1993
p2339
sg5
S'PMC3640956'
p2340
sg7
VCD003993 v. 4.0 Thymic peptides for treatment of cancer patients.rm5
p2341
sg9
V23618554.xml
p2342
sa(dp2343
g3
VSTD-Bergh-2002
p2344
sg5
S'PMC123167'
p2345
sg7
VCD003909 v. 12.0 Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa.rm5
p2346
sg9
V12082182.xml
p2347
sa(dp2348
g3
VSTD-Bachar-1999
p2349
sg5
S'PMC3330539'
p2350
sg7
g2346
sg9
V10079459.xml
p2351
sa(dp2352
g3
VSTD-Lahteenmaki-1998
p2353
sg5
S'PMC28513'
p2354
sg7
VCD002126 v. 5.2 Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.rm5
p2355
sg9
V9552948.xml
p2356
sa(dp2357
g3
VSTD-Pozzilli-2002
p2358
sg5
S'PMC1738043'
p2359
sg7
VCD006036 v. 5.0 Multidisciplinary rehabilitation for adults with multiple sclerosis.rm5
p2360
sg9
V12185154.xml
p2361
sa(dp2362
g3
VSTD-Craig-2003
p2363
sg5
S'PMC1738635'
p2364
sg7
g2360
sg9
V12933923.xml
p2365
sa(dp2366
g3
VSTD-Tamblyn-2003
p2367
sg5
S'PMC191278'
p2368
sg7
VCD001096 v. 6.0 The effects of on-screen point of care computer reminders on processes and outcomes of care.rm5
p2369
sg9
V12975221.xml
p2370
sa(dp2371
g3
VSTD-Hicks-2008
p2372
sg5
S'PMC2359515'
p2373
sg7
g2369
sg9
V18373141.xml
p2374
sa(dp2375
g3
VSTD-Kenealy-2005
p2376
sg5
S'PMC1490216'
p2377
sg7
g2369
sg9
V16191138.xml
p2378
sa(dp2379
g3
VSTD-Tierney-2003
p2380
sg5
S'PMC1494965'
p2381
sg7
g2369
sg9
V14687254.xml
p2382
sa(dp2383
g3
VSTD-Flottorp-2002
p2384
sg5
S'PMC117890'
p2385
sg7
g2369
sg9
V12183309.xml
p2386
sa(dp2387
g3
VSTD-Tierney-2005
p2388
sg5
S'PMC1361152'
p2389
sg7
g2369
sg9
V15762903.xml
p2390
sa(dp2391
g3
VSTD-Eccles-2002a
p2392
sg5
S'PMC130060'
p2393
sg7
g2369
sg9
V12399345.xml
p2394
sa(dp2395
g3
VSTD-Sequist-2005
p2396
sg5
S'PMC1174888'
p2397
sg7
g2369
sg9
V15802479.xml
p2398
sa(dp2399
g3
VSTD-Overhage-1997
p2400
sg5
S'PMC61254'
p2401
sg7
g2369
sg9
V9292842.xml
p2402
sa(dp2403
g3
VSTD-Judge-2006
p2404
sg5
S'PMC1513672'
p2405
sg7
g2369
sg9
V16622171.xml
p2406
sa(dp2407
g3
VSTD-Abdelmassih-2005
p2408
sg5
S'PMC3455286'
p2409
sg7
VCD003719 v. 7.0 Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in I.rm5
p2410
sg9
V16021858.xml
p2411
sa(dp2412
g3
VSTD-Farrag-2008
p2413
sg5
S'PMC2582096'
p2414
sg7
g2410
sg9
V18925430.xml
p2415
sa(dp2416
g3
VSTD-Cowley-1994
p2417
sg5
S'PMC1025506'
p2418
sg7
VCD002230 v. 5.0 Phosphodiesterase III inhibitors for heart failure.rm5
p2419
sg9
V7946771.xml
p2420
sa(dp2421
g3
VSTD-PICO-1996
p2422
sg5
S'PMC484511'
p2423
sg7
g2419
sg9
V8868980.xml
p2424
sa(dp2425
g3
VSTD-Freeman-1986
p2426
sg5
S'PMC1339642'
p2427
sg7
VCD009356 v. 2.7 Hypnosis for pain management during labour and childbirth.rm5
p2428
sg9
V3081212.xml
p2429
sa(dp2430
g3
VSTD-Stott-1976
p2431
sg5
S'PMC1688091'
p2432
sg7
VCD000245 v. 16.0 Antibiotics for acute bronchitis.rm5
p2433
sg9
V786428.xml
p2434
sa(dp2435
g3
VSTD-Verheij-1994
p2436
sg5
S'PMC1238988'
p2437
sg7
g2433
sg9
V8790652.xml
p2438
sa(dp2439
g3
VSTD-Million-1981
p2440
sg5
S'PMC1000779'
p2441
sg7
VCD001823 v. 10.0 Lumbar supports for prevention and treatment of low back pain.rm5
p2442
sg9
V6458250.xml
p2443
sa(dp2444
g3
VSTD-Doran-1975
p2445
sg5
S'PMC1675960'
p2446
sg7
g2442
sg9
V123815.xml
p2447
sa(dp2448
g3
VSTD-CALBG-9712
p2449
sg5
S'PMC3084002'
p2450
sg7
VCD008079 v. 2.0 Rituximab ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.rm5
p2451
sg9
V21321292.xml
p2452
sa(dp2453
g3
VSTD-Rojas-de-Arias-1999
p2454
sg5
S'PMC2557652'
p2455
sg7
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p2456
sg9
V10327712.xml
p2457
sa(dp2458
g3
VSTD-Barnes-2003
p2459
sg5
S'PMC3779532'
p2460
sg7
g2456
sg9
V23751246.xml
p2461
sa(dp2462
g3
VSTD-Howden_x002d_Chapman-2007
p2463
sg5
S'PMC1808149'
p2464
sg7
g2456
sg9
V17324975.xml
p2465
sa(dp2466
g3
VSTD-Hopton-1996
p2467
sg5
S'PMC1060205'
p2468
sg7
g2456
sg9
V8762355.xml
p2469
sa(dp2470
g3
VSTD-Ambrose-2000
p2471
sg5
S'PMC3294956'
p2472
sg7
g2456
sg9
V22155834.xml
p2473
sa(dp2474
g3
VSTD-Wilner-1960
p2475
sg5
S'PMC1373218'
p2476
sg7
g2456
sg9
V13845013.xml
p2477
sa(dp2478
g3
VSTD-CHARISMA-2011
p2479
sg5
S'PMC3207090'
p2480
sg7
g2456
sg9
V22054336.xml
p2481
sa(dp2482
g3
VSTD-Breysse-2011
p2483
sg5
S'PMC3072905'
p2484
sg7
g2456
sg9
V21563714.xml
p2485
sa(dp2486
g3
VSTD-Howden_x002d_Chapman-2008
p2487
sg5
S'PMC2658826'
p2488
sg7
g2456
sg9
V18812366.xml
p2489
sa(dp2490
g3
VSTD-Thomson-2007
p2491
sg5
S'PMC2652910'
p2492
sg7
g2456
sg9
V17325397.xml
p2493
sa(dp2494
g3
VSTD-Barton-2007
p2495
sg5
S'PMC2659999'
p2496
sg7
g2456
sg9
V17699530.xml
p2497
sa(dp2498
g3
VSTD-Manary-2004
p2499
sg5
S'PMC1719944'
p2500
sg7
VCD009000 v. 2.2 Ready-to-use therapeutic food for home-based treatment of severe acute malnutrition in children from.rm5
p2501
sg9
V15155403.xml
p2502
sa(dp2503
g3
VSTD-Oakley-2010
p2504
sg5
S'PMC2981006'
p2505
sg7
g2501
sg9
V20980648.xml
p2506
sa(dp2507
g3
VSTD-Neumark-2007
p2508
sg5
S'PMC3379776'
p2509
sg7
VCD000219 v. 16.0 Antibiotics for acute otitis media in children.rm5
p2510
sg9
V17846935.xml
p2511
sa(dp2512
g3
VSTD-Burke-1991
p2513
sg5
S'PMC1670875'
p2514
sg7
g2510
sg9
V1912887.xml
p2515
sa(dp2516
g3
VSTD-Le-Saux-2005
p2517
sg5
S'PMC545757'
p2518
sg7
g2510
sg9
V15684116.xml
p2519
sa(dp2520
g3
VSTD-Laxdal-1970
p2521
sg5
S'PMC1946394'
p2522
sg7
g2510
sg9
V4190002.xml
p2523
sa(dp2524
g3
VSTD-Appelman-1991
p2525
sg5
S'PMC1671677'
p2526
sg7
g2510
sg9
V1773154.xml
p2527
sa(dp2528
g3
VSTD-Little-2001
p2529
sg5
S'PMC26576'
p2530
sg7
g2510
sg9
V11159657.xml
p2531
sa(dp2532
g3
VSTD-Damoiseaux-2000
p2533
sg5
S'PMC27282'
p2534
sg7
g2510
sg9
V10657332.xml
p2535
sa(dp2536
g3
VSTD-Hoberman-2011
p2537
sg5
S'PMC3042231'
p2538
sg7
g2510
sg9
V21226576.xml
p2539
sa(dp2540
g3
VSTD-Nishimoto-2007-_x0028_SAMURAI_x0029_
p2541
sg5
S'PMC1955155'
p2542
sg7
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p2543
sg9
V17485422.xml
p2544
sa(dp2545
g3
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p2546
sg5
S'PMC2638601'
p2547
sg7
g2543
sg9
V18979150.xml
p2548
sa(dp2549
g3
VSTD-Sinclair-1992
p2550
sg5
S'PMC1491724'
p2551
sg7
VCD005632 v. 3.0 Steroid avoidance or withdrawal for kidney transplant recipients.rm5
p2552
sg9
V8462048.xml
p2553
sa(dp2554
g3
VSTD-Driver-2011-age-matched
p2555
sg5
S'PMC3023971'
p2556
sg7
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p2557
sg9
V21252104.xml
p2558
sa(dp2559
g3
VSTD-Gao-2011
p2560
sg5
S'PMC3059148'
p2561
sg7
g2557
sg9
V21368281.xml
p2562
sa(dp2563
g3
VSTD-Driver-2011-age_x002b_-matched
p2564
sg5
S'PMC3023971'
p2565
sg7
g2557
sg9
V21252104.xml
p2566
sa(dp2567
g3
VSTD-Siriwardena-2002
p2568
sg5
S'PMC1314414'
p2569
sg7
VCD005188 v. 6.0 Interventions to increase influenza vaccination rates of those 60 years and older in the community.rm5
p2570
sg9
V12236277.xml
p2571
sa(dp2572
g3
VSTD-Baker-1998
p2573
sg5
S'PMC1496989'
p2574
sg7
g2570
sg9
V9686713.xml
p2575
sa(dp2576
g3
VSTD-Dalby-2000
p2577
sg5
S'PMC1231166'
p2578
sg7
g2570
sg9
V10701382.xml
p2579
sa(dp2580
g3
VSTD-Hull-2002
p2581
sg5
S'PMC1314410'
p2582
sg7
g2570
sg9
V12236273.xml
p2583
sa(dp2584
g3
VSTD-Arthur-2002
p2585
sg5
S'PMC1314411'
p2586
sg7
g2570
sg9
V12236274.xml
p2587
sa(dp2588
g3
VSTD-Lukasik-1987
p2589
sg5
S'PMC2218648'
p2590
sg7
g2570
sg9
V21263970.xml
p2591
sa(dp2592
g3
VSTD-Black-1993
p2593
sg5
S'PMC1694928'
p2594
sg7
g2570
sg9
V8259810.xml
p2595
sa(dp2596
g3
VSTD-Lemelin-2001
p2597
sg5
S'PMC80870'
p2598
sg7
g2570
sg9
V11276541.xml
p2599
sa(dp2600
g3
VSTD-McDowell-1986
p2601
sg5
S'PMC1491283'
p2602
sg7
g2570
sg9
V3093045.xml
p2603
sa(dp2604
g3
VSTD-Clayton-1999
p2605
sg5
S'PMC1508682'
p2606
sg7
g2570
sg9
V10432913.xml
p2607
sa(dp2608
g3
VSTD-Kerse-1999
p2609
sg5
S'PMC28221'
p2610
sg7
g2570
sg9
V10480825.xml
p2611
sa(dp2612
g3
VSTD-Mullooly-1987
p2613
sg5
S'PMC1647052'
p2614
sg7
g2570
sg9
V3565663.xml
p2615
sa(dp2616
g3
VSTD-Hogg-1998
p2617
sg5
S'PMC2277568'
p2618
sg7
g2570
sg9
V9481466.xml
p2619
sa(dp2620
g3
VSTD-Yin-2005
p2621
sg5
S'PMC3523975'
p2622
sg7
VCD002900 v. 6.0 Surgical methods for first trimester termination of pregnancy.rm5
p2623
sg9
V23040108.xml
p2624
sa(dp2625
g3
VSTD-Change-of-Heart--1999
p2626
sg5
S'PMC28246'
p2627
sg7
VCD001561 v. 10.0 Multiple risk factor interventions for primary prevention of coronary heart disease.rm5
p2628
sg9
V10514155.xml
p2629
sa(dp2630
g3
VSTD-Abingdon-1990
p2631
sg5
S'PMC1371239'
p2632
sg7
g2628
sg9
V2115348.xml
p2633
sa(dp2634
g3
VSTD-Johns-Hopkins
p2635
sg5
S'PMC1650522'
p2636
sg7
g2628
sg9
V6849473.xml
p2637
sa(dp2638
g3
VSTD-CELL-Study-1995
p2639
sg5
S'PMC2549500'
p2640
sg7
g2628
sg9
V7742677.xml
p2641
sa(dp2642
g3
VSTD-OXCHECK-1994
p2643
sg5
S'PMC2539253'
p2644
sg7
g2628
sg9
V8124120.xml
p2645
sa(dp2646
g3
VSTD-Okayama-2004
p2647
sg5
S'PMC2723573'
p2648
sg7
g2628
sg9
V21432327.xml
p2649
sa(dp2650
g3
VSTD-Family-Heart-1994-F
p2651
sg5
S'PMC2539278'
p2652
sg7
g2628
sg9
V8124121.xml
p2653
sa(dp2654
g3
VSTD-Toobert-_x0028_MLP_x0029_-2005
p2655
sg5
S'PMC1557654'
p2656
sg7
g2628
sg9
V15823786.xml
p2657
sa(dp2658
g3
VSTD-Family-Heart--1994-M
p2659
sg5
S'PMC2539278'
p2660
sg7
g2628
sg9
V8124121.xml
p2661
sa(dp2662
g3
VSTD-Take-Heart-1995
p2663
sg5
S'PMC1615302'
p2664
sg7
g2628
sg9
V7856780.xml
p2665
sa(dp2666
g3
VSTD-Desjardins-1986
p2667
sg5
S'PMC2175477'
p2668
sg7
VCD001547 v. 6.2 Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults.rm5
p2669
sg9
V3461726.xml
p2670
sa(dp2671
g3
VSTD-Barry-1974
p2672
sg5
S'PMC1610120'
p2673
sg7
VCD004450 v. 5.0 Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-depende.rm5
p2674
sg9
V4821036.xml
p2675
sa(dp2676
g3
VSTD-Collins-1978
p2677
sg5
S'PMC1608676'
p2678
sg7
VCD000175 v. 8.0 Prophylactic intravenous preloading for regional analgesia in labour.rm5
p2679
sg9
V719463.xml
p2680
sa(dp2681
g3
VSTD-Nikolaus-2003
p2682
sg5
S'PMC1773804'
p2683
sg7
VCD006790 v. 3.0 Type I interferons for induction of remission in ulcerative colitis.rm5
p2684
sg9
V12912859.xml
p2685
sa(dp2686
g3
VSTD-Tilg-2003
p2687
sg5
S'PMC1773891'
p2688
sg7
g2684
sg9
V14633951.xml
p2689
sa(dp2690
g3
VSTD-Burton-2006
p2691
sg5
S'PMC3216418'
p2692
sg7
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p2693
sg9
V16508640.xml
p2694
sa(dp2695
g3
VSTD-Thomson-2007
p2696
sg5
S'PMC2083581'
p2697
sg7
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p2698
sg9
V17626140.xml
p2699
sa(dp2700
g3
VSTD-Rafati-2011
p2701
sg5
S'PMC3232099'
p2702
sg7
g2698
sg9
V22615652.xml
p2703
sa(dp2704
g3
VSTD-Voskujl-2004
p2705
sg5
S'PMC1774276'
p2706
sg7
g2698
sg9
V15479678.xml
p2707
sa(dp2708
g3
VSTD-Goldstein-2003
p2709
sg5
S'PMC1746667'
p2710
sg7
VCD001001 v. 8.0 Lung volume reduction surgery for diffuse emphysema.rm5
p2711
sg9
V12728160.xml
p2712
sa(dp2713
g3
VSTD-West-1999
p2714
sg5
S'PMC27760'
p2715
sg7
VCD008666 v. 3.0 Vitamin A supplementation during pregnancy for maternal and newborn outcomes.rm5
p2716
sg9
V10037634.xml
p2717
sa(dp2718
g3
VSTD-LEADER
p2719
sg5
S'PMC133451'
p2720
sg7
VCD000123 v. 8.0 Lipid-lowering for peripheral arterial disease of the lower limb.rm5
p2721
sg9
V12433762.xml
p2722
sa(dp2723
g3
VSTD-Teo-2011
p2724
sg5
S'PMC3187313'
p2725
sg7
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p2726
sg9
V21865419.xml
p2727
sa(dp2728
g3
VSTD-Boehme-2010d
p2729
sg5
S'PMC2947799'
p2730
sg7
g2726
sg9
V20825313.xml
p2731
sa(dp2732
g3
VSTD-Boehme-2010e
p2733
sg5
S'PMC2947799'
p2734
sg7
g2726
sg9
V20825313.xml
p2735
sa(dp2736
g3
VSTD-Miller-2011
p2737
sg5
S'PMC3187315'
p2738
sg7
g2726
sg9
V21849695.xml
p2739
sa(dp2740
g3
VSTD-Boehme-2010a
p2741
sg5
S'PMC2947799'
p2742
sg7
g2726
sg9
V20825313.xml
p2743
sa(dp2744
g3
VSTD-Boehme-2010b
p2745
sg5
S'PMC2947799'
p2746
sg7
g2726
sg9
V20825313.xml
p2747
sa(dp2748
g3
VSTD-Boehme-2010c
p2749
sg5
S'PMC2947799'
p2750
sg7
g2726
sg9
V20825313.xml
p2751
sa(dp2752
g3
VSTD-Helb-2010
p2753
sg5
S'PMC2812290'
p2754
sg7
g2726
sg9
V19864480.xml
p2755
sa(dp2756
g3
VSTD-Rachow-2011
p2757
sg5
S'PMC3126807'
p2758
sg7
g2726
sg9
V21738575.xml
p2759
sa(dp2760
g3
VSTD-Friedrich-2011
p2761
sg5
S'PMC3147741'
p2762
sg7
g2726
sg9
V21653771.xml
p2763
sa(dp2764
g3
VSTD-Marlowe-2011
p2765
sg5
S'PMC3122817'
p2766
sg7
g2726
sg9
V21289151.xml
p2767
sa(dp2768
g3
VSTD-Scott-2011
p2769
sg5
S'PMC3144192'
p2770
sg7
g2726
sg9
V21814495.xml
p2771
sa(dp2772
g3
VSTD-Boehme-2011f
p2773
sg5
S'PMC3085933'
p2774
sg7
g2726
sg9
V21507477.xml
p2775
sa(dp2776
g3
VSTD-Boehme-2011e
p2777
sg5
S'PMC3085933'
p2778
sg7
g2726
sg9
V21507477.xml
p2779
sa(dp2780
g3
VSTD-Boehme-2011d
p2781
sg5
S'PMC3085933'
p2782
sg7
g2726
sg9
V21507477.xml
p2783
sa(dp2784
g3
VSTD-Boehme-2011c
p2785
sg5
S'PMC3085933'
p2786
sg7
g2726
sg9
V21507477.xml
p2787
sa(dp2788
g3
VSTD-Boehme-2011b
p2789
sg5
S'PMC3085933'
p2790
sg7
g2726
sg9
V21507477.xml
p2791
sa(dp2792
g3
VSTD-Boehme-2011a
p2793
sg5
S'PMC3085933'
p2794
sg7
g2726
sg9
V21507477.xml
p2795
sa(dp2796
g3
VSTD-Ioannidis-2011
p2797
sg5
S'PMC3147726'
p2798
sg7
g2726
sg9
V21677069.xml
p2799
sa(dp2800
g3
VSTD-Moure-2011
p2801
sg5
S'PMC3067676'
p2802
sg7
g2726
sg9
V21191053.xml
p2803
sa(dp2804
g3
VSTD-Lawn-2011
p2805
sg5
S'PMC3144215'
p2806
sg7
g2726
sg9
V21818180.xml
p2807
sa(dp2808
g3
VSTD-Zeka-2011
p2809
sg5
S'PMC3232962'
p2810
sg7
g2726
sg9
V21956978.xml
p2811
sa(dp2812
g3
VSTD-Silverberg-1977
p2813
sg5
S'PMC1605638'
p2814
sg7
VCD008320 v. 3.0 Pharmacological interventions for pruritus in adult palliative care patients.rm5
p2815
sg9
V322794.xml
p2816
sa(dp2817
g3
VSTD-Duncan-1984
p2818
sg5
S'PMC1442057'
p2819
sg7
g2815
sg9
V6145483.xml
p2820
sa(dp2821
g3
VSTD-Williams-1981
p2822
sg5
S'PMC1675841'
p2823
sg7
VCD002988 v. 6.5 Intravenous beta2-agonists for acute asthma in the emergency department.rm5
p2824
sg9
V1106817.xml
p2825
sa(dp2826
g3
VSTD-Williams-1975
p2827
sg5
S'PMC471658'
p2828
sg7
g2824
sg9
V7031975.xml
p2829
sa(dp2830
g3
VSTD-Hambleton-1979
p2831
sg5
S'PMC1545558'
p2832
sg7
g2824
sg9
V383024.xml
p2833
sa(dp2834
g3
VSTD-Femi_x002d_Pearse-2-1977
p2835
sg5
S'PMC1605098'
p2836
sg7
g2824
sg9
V319876.xml
p2837
sa(dp2838
g3
VSTD-Femi_x002d_Pearse-1-1977
p2839
sg5
S'PMC1605098'
p2840
sg7
g2824
sg9
V319876.xml
p2841
sa(dp2842
g3
VSTD-Bloomfield-1979
p2843
sg5
S'PMC1598545'
p2844
sg7
g2824
sg9
V373852.xml
p2845
sa(dp2846
g3
VSTD-Johnson-1978
p2847
sg5
S'PMC1603977'
p2848
sg7
g2824
sg9
V638577.xml
p2849
sa(dp2850
g3
VSTD-Lawford-1978
p2851
sg5
S'PMC1602586'
p2852
sg7
g2824
sg9
V339993.xml
p2853
sa(dp2854
g3
VSTD-Cheong-1988
p2855
sg5
S'PMC1833883'
p2856
sg7
g2824
sg9
V3139138.xml
p2857
sa(dp2858
g3
VSTD-Barth-2005
p2859
sg5
S'PMC2736492'
p2860
sg7
VCD008012 v. 3.0 Psychological and pharmacological interventions for depression in patients with coronary artery dise.rm5
p2861
sg9
V19742062.xml
p2862
sa(dp2863
g3
VSTD-McLaughlin-2005
p2864
sg5
S'PMC1490273'
p2865
sg7
g2861
sg9
V16423095.xml
p2866
sa(dp2867
g3
VSTD-Garly-2006
p2868
sg5
S'PMC1702442'
p2869
sg7
VCD001477 v. 11.0 Antibiotics for preventing complications in children with measles.rm5
p2870
sg9
V17060336.xml
p2871
sa(dp2872
g3
VSTD-Malcolm-2002
p2873
sg5
S'PMC1495040'
p2874
sg7
VCD005064 v. 9.0 Anticonvulsants for alcohol withdrawal.rm5
p2875
sg9
V12047731.xml
p2876
sa(dp2877
g3
VSTD-Viegas-1982a
p2878
sg5
S'PMC1499417'
p2879
sg7
VCD000032 v. 8.0 Antenatal dietary advice and supplementation to increase energy and protein intake.rm5
p2880
sg9
V6819028.xml
p2881
sa(dp2882
g3
VSTD-Viegas-1982b
p2883
sg5
S'PMC1499470'
p2884
sg7
g2880
sg9
V6819029.xml
p2885
sa(dp2886
g3
VSTD-Ceesay-1997
p2887
sg5
S'PMC2127544'
p2888
sg7
g2880
sg9
V9345173.xml
p2889
sa(dp2890
g3
VSTD-Innes-2002
p2891
sg5
S'PMC1758800'
p2892
sg7
VCD001115 v. 9.0 Continuous versus intermittent beta-agonists for acute asthma.rm5
p2893
sg9
V12454298.xml
p2894
sa(dp2895
g3
VSTD-Pakasi-2010
p2896
sg5
S'PMC2957385'
p2897
sg7
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p2898
sg9
V20920186.xml
p2899
sa(dp2900
g3
VSTD-Villamor-2008
p2901
sg5
S'PMC2564793'
p2902
sg7
g2898
sg9
V18471061.xml
p2903
sa(dp2904
g3
VSTD-Martins-2009
p2905
sg5
S'PMC2767482'
p2906
sg7
g2898
sg9
V19858174.xml
p2907
sa(dp2908
g3
VSTD-Rieder-1987
p2909
sg5
S'PMC1491956'
p2910
sg7
VCD005365 v. 3.0 Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts.rm5
p2911
sg9
V3552176.xml
p2912
sa(dp2913
g3
VSTD-Johansson-2008
p2914
sg5
S'PMC2607225'
p2915
sg7
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p2916
sg9
V19018255.xml
p2917
sa(dp2918
g3
VSTD-Moynihan-1998
p2919
sg5
S'PMC2665582'
p2920
sg7
g2916
sg9
V9492666.xml
p2921
sa(dp2922
g3
VSTD-Parker-2009
p2923
sg5
S'PMC2716938'
p2924
sg7
g2916
sg9
V19349551.xml
p2925
sa(dp2926
g3
VSTD-McArdle-1996
p2927
sg5
S'PMC2350687'
p2928
sg7
g2916
sg9
V8608288.xml
p2929
sa(dp2930
g3
VSTD-Ogawa-2008
p2931
sg5
S'PMC2390947'
p2932
sg7
VCD008834 v. 3.0 Antiplatelet agents for chronic kidney disease.rm5
p2933
sg9
V18235151.xml
p2934
sa(dp2935
g3
VSTD-Ghorbani-2009
p2936
sg5
S'PMC2847809'
p2937
sg7
g2933
sg9
V20368925.xml
p2938
sa(dp2939
g3
VSTD-Kraft-2009
p2940
sg5
S'PMC2574639'
p2941
sg7
VCD002059 v. 6.0 Opiate treatment for opiate withdrawal in newborn infants.rm5
p2942
sg9
V18694901.xml
p2943
sa(dp2944
g3
VSTD-Jackson-2004
p2945
sg5
S'PMC1721707'
p2946
sg7
g2942
sg9
V15210660.xml
p2947
sa(dp2948
g3
VSTD-Eriksen-1997
p2949
sg5
S'PMC2364551'
p2950
sg7
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p2951
sg9
V18476153.xml
p2952
sa(dp2953
g3
VSTD-PUNE
p2954
sg5
S'PMC1771720'
p2955
sg7
VCD001323 v. 7.2 Surgical interventions for age-related cataract.rm5
p2956
sg9
V12770957.xml
p2957
sa(dp2958
g3
VSTD-OCTET
p2959
sg5
S'PMC1041029'
p2960
sg7
g2956
sg9
V2872913.xml
p2961
sa(dp2962
g3
VSTD-Waddell-2004
p2963
sg5
S'PMC1772160'
p2964
sg7
g2956
sg9
V15148202.xml
p2965
sa(dp2966
g3
VSTD-Van-den-Ende-1996
p2967
sg5
S'PMC1010314'
p2968
sg7
VCD006853 v. 3.0 Dynamic exercise programs (aerobic capacity andor muscle strength training) in patients with rheuma.rm5
p2969
sg9
V8976635.xml
p2970
sa(dp2971
g3
VSTD-Fernandez_x002d_Cruz-2012
p2972
sg5
S'PMC3633042'
p2973
sg7
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p2974
sg9
V23557411.xml
p2975
sa(dp2976
g3
VSTD-Yeo-2000
p2977
sg5
S'PMC1421155'
p2978
sg7
g2974
sg9
V10973392.xml
p2979
sa(dp2980
g3
VSTD-Katsourakis-2010
p2981
sg5
S'PMC3108665'
p2982
sg7
g2974
sg9
V21694864.xml
p2983
sa(dp2984
g3
VSTD-Westphal-2003
p2985
sg5
S'PMC1920672'
p2986
sg7
VCD007294 v. 4.2 Chemotherapy wafers for high grade glioma.rm5
p2987
sg9
V12672279.xml
p2988
sa(dp2989
g3
VSTD-Cornuz-2008
p2990
sg5
S'PMC2432028'
p2991
sg7
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p2992
sg9
V18575629.xml
p2993
sa(dp2994
g3
VSTD-Jones-1995
p2995
sg5
S'PMC474903'
p2996
sg7
VCD001117 v. 7.0 Self-management education and regular practitioner review for adults with asthma.rm5
p2997
sg9
V7570436.xml
p2998
sa(dp2999
g3
VSTD-Lahdensuo-1996
p3000
sg5
S'PMC2350456'
p3001
sg7
g2997
sg9
V8605463.xml
p3002
sa(dp3003
g3
VSTD-Yoon-1993
p3004
sg5
S'PMC464888'
p3005
sg7
g2997
sg9
V8296253.xml
p3006
sa(dp3007
g3
VSTD-Moudgil-2000
p3008
sg5
S'PMC1745690'
p3009
sg7
g2997
sg9
V10679534.xml
p3010
sa(dp3011
g3
VSTD-Allen-1995
p3012
sg5
S'PMC474644'
p3013
sg7
g2997
sg9
V7570406.xml
p3014
sa(dp3015
g3
VSTD-Abdulwadud-1999
p3016
sg5
S'PMC1745497'
p3017
sg7
g2997
sg9
V10335002.xml
p3018
sa(dp3019
g3
VSTD-Garret-1994
p3020
sg5
S'PMC475232'
p3021
sg7
g2997
sg9
V7974314.xml
p3022
sa(dp3023
g3
VSTD-Kennedy-1997
p3024
sg5
S'PMC1720640'
p3025
sg7
VCD000122 v. 8.0 Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.rm5
p3026
sg9
V9175946.xml
p3027
sa(dp3028
g3
VSTD-Llewellyn-1970
p3029
sg5
S'PMC1647632'
p3030
sg7
VCD002770 v. 8.0 Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease.rm5
p3031
sg9
V5506931.xml
p3032
sa(dp3033
g3
VSTD-Murdock-1970
p3034
sg5
S'PMC1647512'
p3035
sg7
g3031
sg9
V4920541.xml
p3036
sa(dp3037
g3
VSTD-Corbett-1989
p3038
sg5
S'PMC2498882'
p3039
sg7
VCD001486 v. 9.0 Surgery for varicose veins use of tourniquet.rm5
p3040
sg9
V2647025.xml
p3041
sa(dp3042
g3
VSTD-Sykes-2000
p3043
sg5
S'PMC2503503'
p3044
sg7
g3040
sg9
V10932665.xml
p3045
sa(dp3046
g3
VSTD-Thompson-1990
p3047
sg5
S'PMC2499114'
p3048
sg7
g3040
sg9
V2185680.xml
p3049
sa(dp3050
g3
VSTD-Yu-1995
p3051
sg5
S'PMC3616209'
p3052
sg7
VCD003183 v. 6.0 Medicinal herbs for hepatitis C virus infection.rm5
p3053
sg9
V23573108.xml
p3054
sa(dp3055
g3
VSTD-Jiang-1999
p3056
sg5
S'PMC3659167'
p3057
sg7
g3053
sg9
V23583105.xml
p3058
sa(dp3059
g3
VSTD-He-2008
p3060
sg5
S'PMC3142497'
p3061
sg7
VCD008960 v. 2.0 Phyllanthus species for chronic hepatitis B virus infection.rm5
p3062
sg9
V21672207.xml
p3063
sa(dp3064
g3
VSTD-Hirsch-1979
p3065
sg5
S'PMC1597797'
p3066
sg7
VCD000384 v. 7.0 Length of hospitalisation for people with severe mental illness.rm5
p3067
sg9
V427401.xml
p3068
sa(dp3069
g3
VSTD-Gitlin-2010
p3070
sg5
S'PMC2955191'
p3071
sg7
VCD006929 v. 4.0 Functional analysis-based interventions for challenging behaviour in dementia.rm5
p3072
sg9
V20662955.xml
p3073
sa(dp3074
g3
VSTD-Burgio-2003
p3075
sg5
S'PMC2579272'
p3076
sg7
g3072
sg9
V12937335.xml
p3077
sa(dp3078
g3
VSTD-Fossey-2006
p3079
sg5
S'PMC1420717'
p3080
sg7
g3072
sg9
V16543297.xml
p3081
sa(dp3082
g3
VSTD-Nacul-1997
p3083
sg5
S'PMC2127384'
p3084
sg7
VCD003700 v. 11.3 Vitamin A for non-measles pneumonia in children.rm5
p3085
sg9
V9329303.xml
p3086
sa(dp3087
g3
VSTD-Morino-2006
p3088
sg5
S'PMC1856631'
p3089
sg7
VCD007683 v. 3.2 Laparoscopy for the management of acute lower abdominal pain in women of childbearing age.rm5
p3090
sg9
V17122613.xml
p3091
sa(dp3092
g3
VSTD-Scotto-1997
p3093
sg5
S'PMC3496235'
p3094
sg7
VCD003181 v. 6.0 Bile acids for viral hepatitis.rm5
p3095
sg9
V22682344.xml
p3096
sa(dp3097
g3
VSTD-Kawata-1994
p3098
sg5
S'PMC2363838'
p3099
sg7
g3095
sg9
V11286466.xml
p3100
sa(dp3101
g3
VSTD-Katkhouda-2005
p3102
sg5
S'PMC1357752'
p3103
sg7
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p3104
sg9
V16135930.xml
p3105
sa(dp3106
g3
VSTD-Martin-1995
p3107
sg5
S'PMC1234801'
p3108
sg7
g3104
sg9
V7677456.xml
p3109
sa(dp3110
g3
VSTD-Frazee-1994
p3111
sg5
S'PMC1243232'
p3112
sg7
g3104
sg9
V8203983.xml
p3113
sa(dp3114
g3
VSTD-Ricca-2007
p3115
sg5
S'PMC3015793'
p3116
sg7
g3104
sg9
V17663093.xml
p3117
sa(dp3118
g3
VSTD-O_x0027_Dwyer-1992
p3119
sg5
S'PMC2399524'
p3120
sg7
VCD004788 v. 7.0 Small-incision versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p3121
sg9
V1461854.xml
p3122
sa(dp3123
g3
VSTD-Van-Overmeire-1997
p3124
sg5
S'PMC1720646'
p3125
sg7
VCD003481 v. 9.0 Ibuprofen for the treatment of patent ductus arteriosus in preterm andor low birth weight infants.rm5
p3126
sg9
V9175948.xml
p3127
sa(dp3128
g3
VSTD-Wu-2006
p3129
sg5
S'PMC1448924'
p3130
sg7
VCD008085 v. 1.6 Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver re.rm5
p3131
sg9
V16432349.xml
p3132
sa(dp3133
g3
VSTD-Ataoglu-2003
p3134
sg5
S'PMC3055095'
p3135
sg7
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p3136
sg9
V12923337.xml
p3137
sa(dp3138
g3
VSTD-Durand-2003
p3139
sg5
S'PMC1314596'
p3140
sg7
VCD000562 v. 15.0 Psychological treatments for bulimia nervosa and binging.rm5
p3141
sg9
V12830564.xml
p3142
sa(dp3143
g3
VSTD-Burton-2006
p3144
sg5
S'PMC1618764'
p3145
sg7
g3141
sg9
V16458252.xml
p3146
sa(dp3147
g3
VSTD-Bachar-1999
p3148
sg5
S'PMC3330539'
p3149
sg7
g3141
sg9
V10079459.xml
p3150
sa(dp3151
g3
VSTD-Mowat-1970
p3152
sg5
S'PMC1700846'
p3153
sg7
VCD007396 v. 4.0 Parenteral opioids for maternal pain management in labour.rm5
p3154
sg9
V4913784.xml
p3155
sa(dp3156
g3
VSTD-Hidalgo-1997
p3157
sg5
S'PMC163876'
p3158
sg7
VCD004386 v. 7.2 Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemother.rm5
p3159
sg9
V9145895.xml
p3160
sa(dp3161
g3
VSTD-Liang-1990
p3162
sg5
S'PMC171559'
p3163
sg7
g3159
sg9
V2327768.xml
p3164
sa(dp3165
g3
VSTD-Talbot-1993
p3166
sg5
S'PMC187695'
p3167
sg7
g3159
sg9
V8460916.xml
p3168
sa(dp3169
g3
VSTD-Kern-1994b
p3170
sg5
S'PMC284481'
p3171
sg7
g3159
sg9
V8203838.xml
p3172
sa(dp3173
g3
VSTD-Broun-1994
p3174
sg5
S'PMC284500'
p3175
sg7
g3159
sg9
V8203857.xml
p3176
sa(dp3177
g3
VSTD-Bender-1979
p3178
sg5
S'PMC352683'
p3179
sg7
g3159
sg9
V464573.xml
p3180
sa(dp3181
g3
VSTD-Hargadon-1981
p3182
sg5
S'PMC181762'
p3183
sg7
g3159
sg9
V6275778.xml
p3184
sa(dp3185
g3
VSTD-Ford-1998
p3186
sg5
S'PMC105612'
p3187
sg7
g3159
sg9
V9624484.xml
p3188
sa(dp3189
g3
VSTD-Quist_x002d_Paulsen-2003
p3190
sg5
S'PMC286243'
p3191
sg7
VCD001837 v. 12.4 Interventions for smoking cessation in hospitalised patients.rm5
p3192
sg9
V14644967.xml
p3193
sa(dp3194
g3
VSTD-Hajek-2002
p3195
sg5
S'PMC64504'
p3196
sg7
g3192
sg9
V11786452.xml
p3197
sa(dp3198
g3
VSTD-Smith-2009
p3199
sg5
S'PMC2696525'
p3200
sg7
g3192
sg9
V19546455.xml
p3201
sa(dp3202
g3
VSTD-Molyneux-2003
p3203
sg5
S'PMC1746718'
p3204
sg7
g3192
sg9
V12775857.xml
p3205
sa(dp3206
g3
VSTD-Deshpande-1986
p3207
sg5
S'PMC1340908'
p3208
sg7
VCD000195 v. 8.0 Corticosteroids for preventing relapse following acute exacerbations of asthma.rm5
p3209
sg9
V3089439.xml
p3210
sa(dp3211
g3
VSTD-Mimura-2004
p3212
sg5
S'PMC1773918'
p3213
sg7
VCD001176 v. 5.0 Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative coli.rm5
p3214
sg9
V14684584.xml
p3215
sa(dp3216
g3
VSTD-Ettinger-2009
p3217
sg5
S'PMC2627861'
p3218
sg7
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p3219
sg9
V19165383.xml
p3220
sa(dp3221
g3
VSTD-England-2000
p3222
sg5
S'PMC1727856'
p3223
sg7
VCD004200 v. 10.0 Palliative biliary stents for obstructing pancreatic carcinoma.rm5
p3224
sg9
V10673303.xml
p3225
sa(dp3226
g3
VSTD-Andersen-1989
p3227
sg5
S'PMC1434171'
p3228
sg7
g3224
sg9
V2475392.xml
p3229
sa(dp3230
g3
VSTD-Isayama-2004
p3231
sg5
S'PMC1774024'
p3232
sg7
g3224
sg9
V15082593.xml
p3233
sa(dp3234
g3
VSTD-Agthe-2009
p3235
sg5
S'PMC2746902'
p3236
sg7
VCD002053 v. 5.0 Sedatives for opiate withdrawal in newborn infants.rm5
p3237
sg9
V19398463.xml
p3238
sa(dp3239
g3
VSTD-Freeman-2010
p3240
sg5
S'PMC3651198'
p3241
sg7
VCD001396 v. 7.3 Selective serotonin reuptake inhibitors for premenstrual syndrome.rm5
p3242
sg9
V23675477.xml
p3243
sa(dp3244
g3
VSTD-Menkes-1992
p3245
sg5
S'PMC1883028'
p3246
sg7
g3242
sg9
V1392887.xml
p3247
sa(dp3248
g3
VSTD-Yeboah_x002d_Antwi-2010
p3249
sg5
S'PMC2943441'
p3250
sg7
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p3251
sg9
V20877714.xml
p3252
sa(dp3253
g3
VSTD-Kouyate-2008
p3254
sg5
S'PMC2287184'
p3255
sg7
g3251
sg9
V18364043.xml
p3256
sa(dp3257
g3
VSTD-Delacollette-1996
p3258
sg5
S'PMC2486885'
p3259
sg7
g3251
sg9
V8823965.xml
p3260
sa(dp3261
g3
VSTD-Mubi-2011
p3262
sg5
S'PMC3130036'
p3263
sg7
g3251
sg9
V21750697.xml
p3264
sa(dp3265
g3
VSTD-Kangwana-2011
p3266
sg5
S'PMC3104978'
p3267
sg7
g3251
sg9
V21655317.xml
p3268
sa(dp3269
g3
VSTD-Eriksen-2010
p3270
sg5
S'PMC3052812'
p3271
sg7
g3251
sg9
V21416034.xml
p3272
sa(dp3273
g3
VSTD-Sperber-1989
p3274
sg5
S'PMC1807791'
p3275
sg7
VCD006362 v. 8.0 Non-steroidal anti-inflammatory drugs for the common cold.rm5
p3276
sg9
V2557947.xml
p3277
sa(dp3278
g3
VSTD-Amsterdam-2009
p3279
sg5
S'PMC3600411'
p3280
sg7
VCD007244 v. 4.0 Black cohosh (Cimicifuga spp.) for menopausal symptoms.rm5
p3281
sg9
V19745648.xml
p3282
sa(dp3283
g3
VSTD-Geller--2009
p3284
sg5
S'PMC2783540'
p3285
sg7
g3281
sg9
V19609225.xml
p3286
sa(dp3287
g3
VSTD-Pelz-2001
p3288
sg5
S'PMC1421284'
p3289
sg7
VCD004920 v. 7.0 Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.rm5
p3290
sg9
V11303137.xml
p3291
sa(dp3292
g3
VSTD-Matijevic-2006
p3293
sg5
S'PMC2080361'
p3294
sg7
VCD003927 v. 7.3 Oral betamimetics for maintenance therapy after threatened preterm labour.rm5
p3295
sg9
V16489694.xml
p3296
sa(dp3297
g3
VSTD-Barratt-1994
p3298
sg5
S'PMC1615036'
p3299
sg7
VCD001366 v. 5.2 Dietary advice given by a dietitian versus other health professional or self-help resources to reduc.rm5
p3300
sg9
V8179048.xml
p3301
sa(dp3302
g3
VSTD-Neil-1995
p3303
sg5
S'PMC2548942'
p3304
sg7
g3300
sg9
V7888933.xml
p3305
sa(dp3306
g3
VSTD-Gosselin-1996
p3307
sg5
S'PMC2146929'
p3308
sg7
g3300
sg9
V8974552.xml
p3309
sa(dp3310
g3
VSTD-Joyce-1992
p3311
sg5
S'PMC2497688'
p3312
sg7
VCD004651 v. 6.0 Oral water soluble contrast for the management of adhesive small bowel obstruction.rm5
p3313
sg9
V1306666.xml
p3314
sa(dp3315
g3
VSTD-Neighbors-2006
p3316
sg5
S'PMC2474672'
p3317
sg7
VCD006748 v. 4.0 Social norms interventions to reduce alcohol misuse in University or College students.rm5
p3318
sg9
V17014274.xml
p3319
sa(dp3320
g3
VSTD-Carey--2006
p3321
sg5
S'PMC2442891'
p3322
sg7
g3318
sg9
V17032098.xml
p3323
sa(dp3324
g3
VSTD-Lewis-2007b
p3325
sg5
S'PMC2969166'
p3326
sg7
g3318
sg9
V17658695.xml
p3327
sa(dp3328
g3
VSTD-Lewis-2007a
p3329
sg5
S'PMC2459320'
p3330
sg7
g3318
sg9
V17286341.xml
p3331
sa(dp3332
g3
VSTD-Baer-2001
p3333
sg5
S'PMC1446766'
p3334
sg7
g3318
sg9
V11499124.xml
p3335
sa(dp3336
g3
VSTD-Lewis-2007a_x002c_-Female
p3337
sg5
S'PMC2459320'
p3338
sg7
g3318
sg9
V17286341.xml
p3339
sa(dp3340
g3
VSTD-Borsari-2005
p3341
sg5
S'PMC2663045'
p3342
sg7
g3318
sg9
V16187809.xml
p3343
sa(dp3344
g3
VSTD-Lewis-2007a_x002c_-Male
p3345
sg5
S'PMC2459320'
p3346
sg7
g3318
sg9
V17286341.xml
p3347
sa(dp3348
g3
VSTD-Finer-1992
p3349
sg5
S'PMC1293638'
p3350
sg7
VCD003344 v. 5.0 Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy .rm5
p3351
sg9
V1433118.xml
p3352
sa(dp3353
g3
VSTD-Cone-1985
p3354
sg5
S'PMC176304'
p3355
sg7
g3351
sg9
V3899005.xml
p3356
sa(dp3357
g3
VSTD-Bergeron-1988
p3358
sg5
S'PMC172383'
p3359
sg7
g3351
sg9
V3056255.xml
p3360
sa(dp3361
g3
VSTD-Coppens-1983
p3362
sg5
S'PMC184612'
p3363
sg7
g3351
sg9
V6550482.xml
p3364
sa(dp3365
g3
VSTD-Dupont-2000
p3366
sg5
S'PMC90009'
p3367
sg7
g3351
sg9
V10898671.xml
p3368
sa(dp3369
g3
VSTD-Cometta-1994
p3370
sg5
S'PMC188203'
p3371
sg7
g3351
sg9
V8092830.xml
p3372
sa(dp3373
g3
VSTD-Piccart-1984
p3374
sg5
S'PMC180041'
p3375
sg7
g3351
sg9
V6524903.xml
p3376
sa(dp3377
g3
VSTD-Jaspers-1998
p3378
sg5
S'PMC105786'
p3379
sg7
g3351
sg9
V9593156.xml
p3380
sa(dp3381
g3
VSTD-Links-1988
p3382
sg5
S'PMC1033016'
p3383
sg7
VCD005045 v. 4.0 Treatment for periodic paralysis.rm5
p3384
sg9
V3066848.xml
p3385
sa(dp3386
g3
VSTD-Frennesson-1995
p3387
sg5
S'PMC1722362'
p3388
sg7
VCD006537 v. 3.4 Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.rm5
p3389
sg9
V9924306.xml
p3390
sa(dp3391
g3
VSTD-Wang-2009
p3392
sg5
S'PMC2667658'
p3393
sg7
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p3394
sg9
V19158208.xml
p3395
sa(dp3396
g3
VSTD-Akhter-2009
p3397
sg5
S'PMC2695684'
p3398
sg7
g3394
sg9
V19417743.xml
p3399
sa(dp3400
g3
VSTD-Bobe-2008
p3401
sg5
S'PMC2517243'
p3402
sg7
g3394
sg9
V18559549.xml
p3403
sa(dp3404
g3
VSTD-Cutler-2008
p3405
sg5
S'PMC2572165'
p3406
sg7
g3394
sg9
V18491403.xml
p3407
sa(dp3408
g3
VSTD-Trevisan-2008
p3409
sg5
S'PMC2447590'
p3410
sg7
VCD004127 v. 7.0 Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respirator.rm5
p3411
sg9
V18439326.xml
p3412
sa(dp3413
g3
VSTD-Albers-2005
p3414
sg5
S'PMC1350988'
p3415
sg7
VCD006672 v. 4.2 Perineal techniques during the second stage of labour for reducing perineal trauma.rm5
p3416
sg9
V16154062.xml
p3417
sa(dp3418
g3
VSTD-Stamp-2001
p3419
sg5
S'PMC31922'
p3420
sg7
g3416
sg9
V11375230.xml
p3421
sa(dp3422
g3
VSTD-Greenough-1989
p3423
sg5
S'PMC1792547'
p3424
sg7
VCD004503 v. 3.0 Long versus short inspiratory times in neonates receiving mechanical ventilation.rm5
p3425
sg9
V2505689.xml
p3426
sa(dp3427
g3
VSTD-OCTAVE-1991
p3428
sg5
S'PMC1590232'
p3429
sg7
g3425
sg9
V1863121.xml
p3430
sa(dp3431
g3
VSTD-Gravie--2005
p3432
sg5
S'PMC1357701'
p3433
sg7
VCD005393 v. 6.2 Stapled versus conventional surgery for hemorrhoids.rm5
p3434
sg9
V15973098.xml
p3435
sa(dp3436
g3
VSTD-Channabasavanna-1987
p3437
sg5
S'PMC3172444'
p3438
sg7
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p3439
sg9
V21927264.xml
p3440
sa(dp3441
g3
VSTD-Van-Praag-1971
p3442
sg5
S'PMC1799991'
p3443
sg7
g3439
sg9
V4943034.xml
p3444
sa(dp3445
g3
VSTD-SPRINT-2008
p3446
sg5
S'PMC2663330'
p3447
sg7
VCD008241 v. 2.5 Intramedullary nailing for tibial shaft fractures in adults.rm5
p3448
sg9
V19047701.xml
p3449
sa(dp3450
g3
VSTD-Carmichael-1978
p3451
sg5
S'PMC1607388'
p3452
sg7
VCD002879 v. 5.0 Beclomethasone at different doses for chronic asthma.rm5
p3453
sg9
V359091.xml
p3454
sa(dp3455
g3
VSTD-Smith-1986
p3456
sg5
S'PMC460555'
p3457
sg7
g3453
sg9
V3296296.xml
p3458
sa(dp3459
g3
VSTD-Wolthers-1993
p3460
sg5
S'PMC1029340'
p3461
sg7
g3453
sg9
V8323338.xml
p3462
sa(dp3463
g3
VSTD-Pandya-2005
p3464
sg5
S'PMC1627210'
p3465
sg7
VCD004923 v. 7.0 Non-hormonal interventions for hot flushes in women with a history of breast cancer.rm5
p3466
sg9
V16139656.xml
p3467
sa(dp3468
g3
VSTD-Steenstra-2006
p3469
sg5
S'PMC2077992'
p3470
sg7
VCD001822 v. 11.1 Physical conditioning programs for improving work outcomes in workers with back pain.rm5
p3471
sg9
V16847036.xml
p3472
sa(dp3473
g3
VSTD-Thornton-2006
p3474
sg5
S'PMC3564866'
p3475
sg7
VCD008137 v. 1.0 The impact of conditional cash transfers on health outcomes and use of health services in low and mi.rm5
p3476
sg9
V23393551.xml
p3477
sa(dp3478
g3
VSTD-Behrman-2005
p3479
sg5
S'PMC2762161'
p3480
sg7
g3476
sg9
V19793851.xml
p3481
sa(dp3482
g3
VSTD-Silva-2001
p3483
sg5
S'PMC80627'
p3484
sg7
VCD005544 v. 3.0 Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalis.rm5
p3485
sg9
V11202662.xml
p3486
sa(dp3487
g3
VSTD-Atapour-2006
p3488
sg5
S'PMC3748638'
p3489
sg7
VCD006894 v. 4.0 Interventions for preventing infectious complications in haemodialysis patients with central venous .rm5
p3490
sg9
V23977660.xml
p3491
sa(dp3492
g3
VSTD-Kretschmer-1990
p3493
sg5
S'PMC64503'
p3494
sg7
VCD001458 v. 5.0 Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy.rm5
p3495
sg9
V11786451.xml
p3496
sa(dp3497
g3
VSTD-Beck-2007
p3498
sg5
S'PMC1896161'
p3499
sg7
VCD003123 v. 11.0 Epinephrine for bronchiolitis.rm5
p3500
sg9
V17543129.xml
p3501
sa(dp3502
g3
VSTD-Abul_x002d_Ainine-2002
p3503
sg5
S'PMC1719150'
p3504
sg7
g3500
sg9
V11919104.xml
p3505
sa(dp3506
g3
VSTD-Begg-1989
p3507
sg5
S'PMC1379894'
p3508
sg7
VCD002894 v. 6.0 Computerized advice on drug dosage to improve prescribing practice.rm5
p3509
sg9
V2775618.xml
p3510
sa(dp3511
g3
VSTD-Vadher-1997
p3512
sg5
S'PMC2126598'
p3513
sg7
g3509
sg9
V9154031.xml
p3514
sa(dp3515
g3
VSTD-ATICH
p3516
sg5
S'PMC2972357'
p3517
sg7
VCD005951 v. 4.0 Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.rm5
p3518
sg9
V20736966.xml
p3519
sa(dp3520
g3
VSTD-Champion-2007
p3521
sg5
S'PMC1858664'
p3522
sg7
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p3523
sg9
V17196358.xml
p3524
sa(dp3525
g3
VSTD-Sequist-2011
p3526
sg5
S'PMC3169179'
p3527
sg7
g3523
sg9
V21149743.xml
p3528
sa(dp3529
g3
VSTD-Bodurtha-2009
p3530
sg5
S'PMC2945922'
p3531
sg7
g3523
sg9
V19105686.xml
p3532
sa(dp3533
g3
VSTD-Smith-2010
p3534
sg5
S'PMC2965151'
p3535
sg7
g3523
sg9
V20978060.xml
p3536
sa(dp3537
g3
VSTD-Rawl-2008
p3538
sg5
S'PMC2492833'
p3539
sg7
g3523
sg9
V18308500.xml
p3540
sa(dp3541
g3
VSTD-Manne-2009
p3542
sg5
S'PMC2707254'
p3543
sg7
g3523
sg9
V19418107.xml
p3544
sa(dp3545
g3
VSTD-Hutchison-1998
p3546
sg5
S'PMC28524'
p3547
sg7
g3523
sg9
V9552998.xml
p3548
sa(dp3549
g3
VSTD-Schwartz-1999
p3550
sg5
S'PMC1508646'
p3551
sg7
g3523
sg9
V10358689.xml
p3552
sa(dp3553
g3
VSTD-Steckelberg-2011
p3554
sg5
S'PMC3106362'
p3555
sg7
g3523
sg9
V21636633.xml
p3556
sa(dp3557
g3
VSTD-Skinner-1994
p3558
sg5
S'PMC1614921'
p3559
sg7
g3523
sg9
V8279610.xml
p3560
sa(dp3561
g3
VSTD-Manne-2010
p3562
sg5
S'PMC3058834'
p3563
sg7
g3523
sg9
V21090893.xml
p3564
sa(dp3565
g3
VSTD-Vadillo_x002d_Ortega-2011
p3566
sg5
S'PMC3100912'
p3567
sg7
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p3568
sg9
V21596735.xml
p3569
sa(dp3570
g3
VSTD-Christian-2003
p3571
sg5
S'PMC151518'
p3572
sg7
g3568
sg9
V12637400.xml
p3573
sa(dp3574
g3
VSTD-Zeng-2008
p3575
sg5
S'PMC2577799'
p3576
sg7
g3568
sg9
V18996930.xml
p3577
sa(dp3578
g3
VSTD-Stabile-1988
p3579
sg5
S'PMC1778825'
p3580
sg7
VCD000361 v. 10.0 Intravenous immunoglobulin for preventing infection in preterm andor low birth weight infants.rm5
p3581
sg9
V3284483.xml
p3582
sa(dp3583
g3
VSTD-Fry-2003
p3584
sg5
S'PMC2376929'
p3585
sg7
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p3586
sg9
V12915873.xml
p3587
sa(dp3588
g3
VSTD-Young-2006
p3589
sg5
S'PMC2360713'
p3590
sg7
g3586
sg9
V17047645.xml
p3591
sa(dp3592
g3
VSTD-Mitchell-1976
p3593
sg5
S'PMC1687559'
p3594
sg7
VCD003558 v. 5.0 Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.rm5
p3595
sg9
V821577.xml
p3596
sa(dp3597
g3
VSTD-Ng-1977
p3598
sg5
S'PMC2496657'
p3599
sg7
g3595
sg9
V407559.xml
p3600
sa(dp3601
g3
VSTD-Hofmeyr-1986
p3602
sg5
S'PMC460551'
p3603
sg7
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p3604
sg9
V3296295.xml
p3605
sa(dp3606
g3
VSTD-Pryor-1979
p3607
sg5
S'PMC1595668'
p3608
sg7
g3604
sg9
V486968.xml
p3609
sa(dp3610
g3
VSTD-Miller-1995
p3611
sg5
S'PMC473916'
p3612
sg7
g3604
sg9
V7701456.xml
p3613
sa(dp3614
g3
VSTD-Holland-2003
p3615
sg5
S'PMC1746478'
p3616
sg7
g3604
sg9
V14514944.xml
p3617
sa(dp3618
g3
VSTD-Osman-2008
p3619
sg5
S'PMC2922723'
p3620
sg7
g3604
sg9
V19703826.xml
p3621
sa(dp3622
g3
VSTD-Mooney-2009
p3623
sg5
S'PMC2742691'
p3624
sg7
VCD007380 v. 4.0 Efficacy of Psychostimulant Drugs for Cocaine Dependence.rm5
p3625
sg9
V19058926.xml
p3626
sa(dp3627
g3
VSTD-Pazirandeh-2007
p3628
sg5
S'PMC3202978'
p3629
sg7
VCD007605 v. 2.2 Nutritional interventions for liver-transplanted patients.rm5
p3630
sg9
V17947609.xml
p3631
sa(dp3632
g3
VSTD-Smith-1989
p3633
sg5
S'PMC172623'
p3634
sg7
VCD007022 v. 3.0 Teicoplanin versus vancomycin for proven or suspected infection.rm5
p3635
sg9
V2529814.xml
p3636
sa(dp3637
g3
VSTD-MMD_x002d_009-1992
p3638
sg5
S'PMC244945'
p3639
sg7
g3635
sg9
V1826594.xml
p3640
sa(dp3641
g3
VSTD-Menichetti-1994
p3642
sg5
S'PMC284681'
p3643
sg7
g3635
sg9
V7811016.xml
p3644
sa(dp3645
g3
VSTD-Nelson-1985
p3646
sg5
S'PMC2148530'
p3647
sg7
VCD007357 v. 4.0 Single dose oral etodolac for acute postoperative pain in adults.rm5
p3648
sg9
V2934008.xml
p3649
sa(dp3650
g3
VSTD-Marlowe-2007
p3651
sg5
S'PMC1885231'
p3652
sg7
VCD007668 v. 2.0 Psychological interventions for antisocial personality disorder.rm5
p3653
sg9
V17071020.xml
p3654
sa(dp3655
g3
VSTD-Havens-2007
p3656
sg5
S'PMC2231639'
p3657
sg7
g3653
sg9
V17334939.xml
p3658
sa(dp3659
g3
VSTD-Neufeld-2008
p3660
sg5
S'PMC2193670'
p3661
sg7
g3653
sg9
V17574801.xml
p3662
sa(dp3663
g3
VSTD-McLellan-1989
p3664
sg5
S'PMC2429442'
p3665
sg7
VCD000194 v. 9.0 Spironolactone versus placebo or in combination with steroids for hirsutism andor acne.rm5
p3666
sg9
V2690044.xml
p3667
sa(dp3668
g3
VSTD-Wiener-1977b
p3669
sg5
S'PMC1631362'
p3670
sg7
VCD003483 v. 6.3 Naloxone for opiate-exposed newborn infants.rm5
p3671
sg9
V884446.xml
p3672
sa(dp3673
g3
VSTD-Wiener-1977a
p3674
sg5
S'PMC1631408'
p3675
sg7
g3671
sg9
V328108.xml
p3676
sa(dp3677
g3
VSTD-Evans-1976
p3678
sg5
S'PMC1689462'
p3679
sg7
g3671
sg9
V990784.xml
p3680
sa(dp3681
g3
VSTD-Brice-1979a
p3682
sg5
S'PMC1545576'
p3683
sg7
g3671
sg9
V383023.xml
p3684
sa(dp3685
g3
VSTD-Bradford
p3686
sg5
S'PMC2351368'
p3687
sg7
VCD005066 v. 6.0 Stroke liaison workers for stroke patients and carers an individual patient data meta-analysis.rm5
p3688
sg9
V8664717.xml
p3689
sa(dp3690
g3
VSTD-Edinburgh
p3691
sg5
S'PMC2126479'
p3692
sg7
g3688
sg9
V9133884.xml
p3693
sa(dp3694
g3
VSTD-Melbourne-_x0028_SHIPS_x0029_
p3695
sg5
S'PMC2755679'
p3696
sg7
g3688
sg9
V19542219.xml
p3697
sa(dp3698
g3
VSTD-Aukett-1986
p3699
sg5
S'PMC1778027'
p3700
sg7
VCD001444 v. 6.4 Iron therapy for improving psychomotor development and cognitive function in children under the age .rm5
p3701
sg9
V2429622.xml
p3702
sa(dp3703
g3
VSTD-Ataoglu-2003
p3704
sg5
S'PMC3055095'
p3705
sg7
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p3706
sg9
V12923337.xml
p3707
sa(dp3708
g3
VSTD-Dellinger-2007
p3709
sg5
S'PMC1877078'
p3710
sg7
VCD002941 v. 8.0 Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.rm5
p3711
sg9
V17457158.xml
p3712
sa(dp3713
g3
VSTD-Pepin-2000
p3714
sg5
S'PMC2560627'
p3715
sg7
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p3716
sg9
V11143188.xml
p3717
sa(dp3718
g3
VSTD-Priotto-2006
p3719
sg5
S'PMC1687208'
p3720
sg7
g3716
sg9
V17160135.xml
p3721
sa(dp3722
g3
VSTD-Benn-2008
p3723
sg5
S'PMC2432170'
p3724
sg7
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p3725
sg9
V18558641.xml
p3726
sa(dp3727
g3
VSTD-Rahmathullah-2003
p3728
sg5
S'PMC167159'
p3729
sg7
g3725
sg9
V12896935.xml
p3730
sa(dp3731
g3
VSTD-Benn-2010
p3732
sg5
S'PMC2835853'
p3733
sg7
g3725
sg9
V20215360.xml
p3734
sa(dp3735
g3
VSTD-Lewindon-1998
p3736
sg5
S'PMC1717567'
p3737
sg7
VCD008411 v. 4.0 Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age.rm5
p3738
sg9
V9659093.xml
p3739
sa(dp3740
g3
VSTD-Dowrick-1995
p3741
sg5
S'PMC2551186'
p3742
sg7
VCD002792 v. 8.0 Screening and case finding instruments for depression.rm5
p3743
sg9
V7496238.xml
p3744
sa(dp3745
g3
VSTD-Whooley-2000
p3746
sg5
S'PMC1495458'
p3747
sg7
g3743
sg9
V10840264.xml
p3748
sa(dp3749
g3
VSTD-Smith-1994
p3750
sg5
S'PMC3644009'
p3751
sg7
VCD010182 v. 3.0 Alginate dressings for venous leg ulcers.rm5
p3752
sg9
V23179315.xml
p3753
sa(dp3754
g3
VSTD-Robinson-2008
p3755
sg5
S'PMC2743160'
p3756
sg7
VCD009286 v. 2.5 Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.rm5
p3757
sg9
V18505948.xml
p3758
sa(dp3759
g3
VSTD-Louie-2009
p3760
sg5
S'PMC2612138'
p3761
sg7
VCD004610 v. 8.0 Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.rm5
p3762
sg9
V18955525.xml
p3763
sa(dp3764
g3
VSTD-Keighley-1978
p3765
sg5
S'PMC1609009'
p3766
sg7
g3762
sg9
V367509.xml
p3767
sa(dp3768
g3
VSTD-de-Lalla-1992
p3769
sg5
S'PMC245474'
p3770
sg7
g3762
sg9
V1444298.xml
p3771
sa(dp3772
g3
VSTD-Selli-2002
p3773
sg5
S'PMC1769701'
p3774
sg7
VCD006019 v. 5.0 Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.rm5
p3775
sg9
V12101195.xml
p3776
sa(dp3777
g3
VSTD-Dugmore-1999
p3778
sg5
S'PMC1729018'
p3779
sg7
VCD001800 v. 13.0 Exercise-based cardiac rehabilitation for coronary heart disease.rm5
p3780
sg9
V10092561.xml
p3781
sa(dp3782
g3
VSTD-Bethell-1990
p3783
sg5
S'PMC1224812'
p3784
sg7
g3780
sg9
V2271343.xml
p3785
sa(dp3786
g3
VSTD-Auerbach-2002a
p3787
sg5
S'PMC3507824'
p3788
sg7
VCD005321 v. 3.0 Viscosupplementation for the treatment of osteoarthritis of the knee.rm5
p3789
sg9
V23209545.xml
p3790
sa(dp3791
g3
VSTD-Lohmander-1996
p3792
sg5
S'PMC1010204'
p3793
sg7
g3789
sg9
V8774159.xml
p3794
sa(dp3795
g3
VSTD-Pham-2004
p3796
sg5
S'PMC1754857'
p3797
sg7
g3789
sg9
V15331394.xml
p3798
sa(dp3799
g3
VSTD-Henderson-1994
p3800
sg5
S'PMC1005394'
p3801
sg7
g3789
sg9
V7944639.xml
p3802
sa(dp3803
g3
VSTD-Muirhead-2006
p3804
sg5
S'PMC1828262'
p3805
sg7
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p3806
sg9
V16536959.xml
p3807
sa(dp3808
g3
VSTD-Su-2007
p3809
sg5
S'PMC1989016'
p3810
sg7
g3806
sg9
V17670909.xml
p3811
sa(dp3812
g3
VSTD-Ellis-1984
p3813
sg5
S'PMC2153583'
p3814
sg7
g3806
sg9
V21278959.xml
p3815
sa(dp3816
g3
VSTD-Graffy-2004
p3817
sg5
S'PMC313903'
p3818
sg7
g3806
sg9
V14703543.xml
p3819
sa(dp3820
g3
VSTD-Jones-1985
p3821
sg5
S'PMC1777420'
p3822
sg7
g3806
sg9
V4037866.xml
p3823
sa(dp3824
g3
VSTD-Morrell-2000
p3825
sg5
S'PMC27472'
p3826
sg7
g3806
sg9
V10977833.xml
p3827
sa(dp3828
g3
VSTD-Sinclair-2007
p3829
sg5
S'PMC3471286'
p3830
sg7
g3806
sg9
V22733107.xml
p3831
sa(dp3832
g3
VSTD-Ransjo_x002d_Arvidson-1998
p3833
sg5
S'PMC1756723'
p3834
sg7
g3806
sg9
V9764260.xml
p3835
sa(dp3836
g3
VSTD-Froozani-1999
p3837
sg5
S'PMC2557680'
p3838
sg7
g3806
sg9
V10361754.xml
p3839
sa(dp3840
g3
VSTD-Hoddinott-2009
p3841
sg5
S'PMC2635594'
p3842
sg7
g3806
sg9
V19181729.xml
p3843
sa(dp3844
g3
VSTD-Pugh-2007
p3845
sg5
S'PMC2818063'
p3846
sg7
g3806
sg9
V19854119.xml
p3847
sa(dp3848
g3
VSTD-Dennis-2002
p3849
sg5
S'PMC99222'
p3850
sg7
g3806
sg9
V11800243.xml
p3851
sa(dp3852
g3
VSTD-Flores-1989
p3853
sg5
S'PMC267349'
p3854
sg7
VCD002848 v. 8.3 Rotavirus vaccine for preventing diarrhoea.rm5
p3855
sg9
V2541168.xml
p3856
sa(dp3857
g3
VSTD-Flores-1993
p3858
sg5
S'PMC265775'
p3859
sg7
g3855
sg9
V8408569.xml
p3860
sa(dp3861
g3
VSTD-Linhares-1996
p3862
sg5
S'PMC2486862'
p3863
sg7
g3855
sg9
V9002329.xml
p3864
sa(dp3865
g3
VSTD-Perez_x002d_Schael-1990c
p3866
sg5
S'PMC269661'
p3867
sg7
g3855
sg9
V2157737.xml
p3868
sa(dp3869
g3
VSTD-Corbett-2006
p3870
sg5
S'PMC1483908'
p3871
sg7
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p3872
sg9
V16796402.xml
p3873
sa(dp3874
g3
VSTD-Bing-2008
p3875
sg5
S'PMC2822543'
p3876
sg7
g3872
sg9
V18324469.xml
p3877
sa(dp3878
g3
VSTD-Essien-2010
p3879
sg5
S'PMC3059739'
p3880
sg7
g3872
sg9
V21106284.xml
p3881
sa(dp3882
g3
VSTD-Bourchier-1997
p3883
sg5
S'PMC1720650'
p3884
sg7
VCD003662 v. 6.0 Corticosteroids for treating hypotension in preterm infants.rm5
p3885
sg9
V9175947.xml
p3886
sa(dp3887
g3
VSTD-Coskun-2011
p3888
sg5
S'PMC3109380'
p3889
sg7
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p3890
sg9
V21789385.xml
p3891
sa(dp3892
g3
VSTD-Dias-1982
p3893
sg5
S'PMC1437652'
p3894
sg7
VCD000008 v. 8.2 Acupuncture for chronic asthma.rm5
p3895
sg9
V7040659.xml
p3896
sa(dp3897
g3
VSTD-Evans-1976
p3898
sg5
S'PMC2129830'
p3899
sg7
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p3900
sg9
V1069813.xml
p3901
sa(dp3902
g3
VSTD-Waldman-1969a
p3903
sg5
S'PMC2427722'
p3904
sg7
g3900
sg9
V4908340.xml
p3905
sa(dp3906
g3
VSTD-Forsyth-1967
p3907
sg5
S'PMC2130402'
p3908
sg7
g3900
sg9
V5235254.xml
p3909
sa(dp3910
g3
VSTD-Waldman-1969c
p3911
sg5
S'PMC2427722'
p3912
sg7
g3900
sg9
V4908340.xml
p3913
sa(dp3914
g3
VSTD-Waldman-1969b
p3915
sg5
S'PMC2427722'
p3916
sg7
g3900
sg9
V4908340.xml
p3917
sa(dp3918
g3
VSTD-Waldman-1969d
p3919
sg5
S'PMC2427722'
p3920
sg7
g3900
sg9
V4908340.xml
p3921
sa(dp3922
g3
VSTD-Beran-2009a
p3923
sg5
S'PMC2639595'
p3924
sg7
g3900
sg9
V19149900.xml
p3925
sa(dp3926
g3
VSTD-Rocchi-1979b
p3927
sg5
S'PMC2130165'
p3928
sg7
g3900
sg9
V512351.xml
p3929
sa(dp3930
g3
VSTD-Rocchi-1979a
p3931
sg5
S'PMC2130165'
p3932
sg7
g3900
sg9
V512351.xml
p3933
sa(dp3934
g3
VSTD-Goodeve-1983
p3935
sg5
S'PMC2134195'
p3936
sg7
g3900
sg9
V6822725.xml
p3937
sa(dp3938
g3
VSTD-Spencer-1977
p3939
sg5
S'PMC274660'
p3940
sg7
g3900
sg9
V328526.xml
p3941
sa(dp3942
g3
VSTD-Smith-1980
p3943
sg5
S'PMC1344856'
p3944
sg7
VCD004539 v. 5.0 Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults.rm5
p3945
sg9
V6996625.xml
p3946
sa(dp3947
g3
VSTD-Cohn-2000
p3948
sg5
S'PMC1421138'
p3949
sg7
g3945
sg9
V10903605.xml
p3950
sa(dp3951
g3
VSTD-Gozenbach-1987
p3952
sg5
S'PMC1492722'
p3953
sg7
g3945
sg9
V3548611.xml
p3954
sa(dp3955
g3
VSTD-Solomkin-2001
p3956
sg5
S'PMC1421170'
p3957
sg7
g3945
sg9
V11141229.xml
p3958
sa(dp3959
g3
VSTD-Jaccard-1998
p3960
sg5
S'PMC105974'
p3961
sg7
g3945
sg9
V9797234.xml
p3962
sa(dp3963
g3
VSTD-Brismar-1992
p3964
sg5
S'PMC245542'
p3965
sg7
g3945
sg9
V1336347.xml
p3966
sa(dp3967
g3
VSTD-Dupont-2000
p3968
sg5
S'PMC90009'
p3969
sg7
g3945
sg9
V10898671.xml
p3970
sa(dp3971
g3
VSTD-Walker-1993
p3972
sg5
S'PMC1242749'
p3973
sg7
g3945
sg9
V8439209.xml
p3974
sa(dp3975
g3
VSTD-Berne-1987
p3976
sg5
S'PMC1492815'
p3977
sg7
g3945
sg9
V3545106.xml
p3978
sa(dp3979
g3
VSTD-Kiarie-2003
p3980
sg5
S'PMC3387271'
p3981
sg7
VCD003510 v. 8.0 Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.rm5
p3982
sg9
V12478070.xml
p3983
sa(dp3984
g3
VSTD-Chung-2005
p3985
sg5
S'PMC3381340'
p3986
sg7
g3982
sg9
V16103773.xml
p3987
sa(dp3988
g3
VSTD-Chung-2008
p3989
sg5
S'PMC2859833'
p3990
sg7
g3982
sg9
V18839781.xml
p3991
sa(dp3992
g3
VSTD-Mma-Bana
p3993
sg5
S'PMC2999916'
p3994
sg7
g3982
sg9
V20554983.xml
p3995
sa(dp3996
g3
VSTD-APN-2008
p3997
sg5
S'PMC2730636'
p3998
sg7
VCD003594 v. 12.0 Interventions for idiopathic steroid-resistant nephrotic syndrome in children.rm5
p3999
sg9
V18481113.xml
p4000
sa(dp4001
g3
VSTD-BAXTER1991
p4002
sg5
S'PMC3479430'
p4003
sg7
VCD007192 v. 3.0 Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in dr.rm5
p4004
sg9
V23084638.xml
p4005
sa(dp4006
g3
VSTD-SCHILLING1991
p4007
sg5
S'PMC1580245'
p4008
sg7
g4004
sg9
V1905051.xml
p4009
sa(dp4010
g3
VSTD-WECHSBERG2004
p4011
sg5
S'PMC1448416'
p4012
sg7
g4004
sg9
V15226138.xml
p4013
sa(dp4014
g3
VSTD-Mikami-2010
p4015
sg5
S'PMC2903643'
p4016
sg7
VCD003018 v. 6.2 Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5.rm5
p4017
sg9
V20339911.xml
p4018
sa(dp4019
g3
VSTD-Surratt-2010
p4020
sg5
S'PMC2879022'
p4021
sg7
VCD006045 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
p4022
sg9
V20391059.xml
p4023
sa(dp4024
g3
VSTD-Carroll-2004-arm-b
p4025
sg5
S'PMC3675448'
p4026
sg7
VCD007024 v. 3.0 Disulfiram for the treatment of cocaine dependence.rm5
p4027
sg9
V14993114.xml
p4028
sa(dp4029
g3
VSTD-Pettinati-2008-arm-a
p4030
sg5
S'PMC2374760'
p4031
sg7
g4027
sg9
V18079068.xml
p4032
sa(dp4033
g3
VSTD-Carroll-2004-arm-a
p4034
sg5
S'PMC3675448'
p4035
sg7
g4027
sg9
V14993114.xml
p4036
sa(dp4037
g3
VSTD-Pettinati-2008-arm-b
p4038
sg5
S'PMC2374760'
p4039
sg7
g4027
sg9
V18079068.xml
p4040
sa(dp4041
g3
VSTD-Dixon-1975
p4042
sg5
S'PMC1006442'
p4043
sg7
VCD001460 v. 6.0 Penicillamine for treating rheumatoid arthritis.rm5
p4044
sg9
V769707.xml
p4045
sa(dp4046
g3
VSTD-Clarke-2009
p4047
sg5
S'PMC2727290'
p4048
sg7
VCD007415 v. 4.18 Temozolomide for high grade glioma.rm5
p4049
sg9
V19506159.xml
p4050
sa(dp4051
g3
VSTD-Ye-2009
p4052
sg5
S'PMC2654939'
p4053
sg7
VCD001750 v. 8.20 Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.rm5
p4054
sg9
V19225876.xml
p4055
sa(dp4056
g3
VSTD-Kurzawa-2008
p4057
sg5
S'PMC2582126'
p4058
sg7
g4054
sg9
V18802744.xml
p4059
sa(dp4060
g3
VSTD-Jacobson-2010
p4061
sg5
S'PMC2856743'
p4062
sg7
VCD008439 v. 3.0 Monoclonal CCR5 antibody for treatment of people with HIV infection.rm5
p4063
sg9
V20377413.xml
p4064
sa(dp4065
g3
VSTD-Cade-2000
p4066
sg5
S'PMC1718208'
p4067
sg7
VCD004878 v. 10.0 Glucocorticoids for acute viral bronchiolitis in infants and young children.rm5
p4068
sg9
V10648365.xml
p4069
sa(dp4070
g3
VSTD-Gustafson-2001
p4071
sg5
S'PMC1495237'
p4072
sg7
VCD004274 v. 5.0 Interactive Health Communication Applications for people with chronic disease.rm5
p4073
sg9
V11520380.xml
p4074
sa(dp4075
g3
VSTD-Shegog-2001
p4076
sg5
S'PMC134591'
p4077
sg7
g4073
sg9
V11141512.xml
p4078
sa(dp4079
g3
VSTD-Dragone-2002
p4080
sg5
S'PMC3307387'
p4081
sg7
g4073
sg9
V11932129.xml
p4082
sa(dp4083
g3
VSTD-Mahoney-2002
p4084
sg5
S'PMC346625'
p4085
sg7
g4073
sg9
V12087119.xml
p4086
sa(dp4087
g3
VSTD-Burke-1996
p4088
sg5
S'PMC472647'
p4089
sg7
VCD003274 v. 4.0 Budesonide versus placebo for chronic asthma in children and adults.rm5
p4090
sg9
V8977599.xml
p4091
sa(dp4092
g3
VSTD-Henriksen-1985
p4093
sg5
S'PMC1416830'
p4094
sg7
g4090
sg9
V3926141.xml
p4095
sa(dp4096
g3
VSTD-Gleeson-1988
p4097
sg5
S'PMC1834236'
p4098
sg7
g4090
sg9
V3044506.xml
p4099
sa(dp4100
g3
VSTD-Lorentzson-1990
p4101
sg5
S'PMC462715'
p4102
sg7
g4090
sg9
V1978947.xml
p4103
sa(dp4104
g3
VSTD-Varkey-2011
p4105
sg5
S'PMC3236524'
p4106
sg7
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p4107
sg9
V21890526.xml
p4108
sa(dp4109
g3
VSTD-Bahadoran-2010
p4110
sg5
S'PMC3208940'
p4111
sg7
VCD007426 v. 3.0 Relaxation therapy for preventing and treating preterm labour.rm5
p4112
sg9
V22069407.xml
p4113
sa(dp4114
g3
VSTD-Riley-2005
p4115
sg5
S'PMC3479413'
p4116
sg7
VCD008033 v. 3.2 Reduction versus abrupt cessation in smokers who want to quit.rm5
p4117
sg9
V22852768.xml
p4118
sa(dp4119
g3
VSTD-Hughes-2010
p4120
sg5
S'PMC2930079'
p4121
sg7
g4117
sg9
V20537810.xml
p4122
sa(dp4123
g3
VSTD-Williams-1988
p4124
sg5
S'PMC1778891'
p4125
sg7
VCD008243 v. 4.0 Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis.rm5
p4126
sg9
V3389899.xml
p4127
sa(dp4128
g3
VSTD-Lau-1996
p4129
sg5
S'PMC1235333'
p4130
sg7
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p4131
sg9
V8757375.xml
p4132
sa(dp4133
g3
VSTD-Bertleff-2009
p4134
sg5
S'PMC2691927'
p4135
sg7
g4131
sg9
V19430829.xml
p4136
sa(dp4137
g3
VSTD-Siu-2002
p4138
sg5
S'PMC1422436'
p4139
sg7
g4131
sg9
V11882751.xml
p4140
sa(dp4141
g3
VSTD-Levens-2009
p4142
sg5
S'PMC2745125'
p4143
sg7
VCD004634 v. 4.0 Follicular flushing during oocyte retrieval in assisted reproductive techniques.rm5
p4144
sg9
V18675970.xml
p4145
sa(dp4146
g3
VSTD-Vogel-2004
p4147
sg5
S'PMC332712'
p4148
sg7
VCD001535 v. 8.0 Antibiotic duration for treating uncomplicated symptomatic lower urinary tract infections in elderl.rm5
p4149
sg9
V14970093.xml
p4150
sa(dp4151
g3
VSTD-Raz-1996
p4152
sg5
S'PMC163499'
p4153
sg7
g4149
sg9
V8878607.xml
p4154
sa(dp4155
g3
VSTD-Dow-1984
p4156
sg5
S'PMC1440107'
p4157
sg7
VCD002849 v. 11.0 Anxiolytics for smoking cessation.rm5
p4158
sg9
V6384510.xml
p4159
sa(dp4160
g3
VSTD-Trienekens-1989
p4161
sg5
S'PMC1838181'
p4162
sg7
VCD004682 v. 7.0 Duration of antibacterial treatment for uncomplicated urinary tract infection in women.rm5
p4163
sg9
V2513939.xml
p4164
sa(dp4165
g3
VSTD-Hooton-1991
p4166
sg5
S'PMC245194'
p4167
sg7
g4163
sg9
V1929311.xml
p4168
sa(dp4169
g3
VSTD-Trienekens-1993
p4170
sg5
S'PMC2379759'
p4171
sg7
g4163
sg9
V8471899.xml
p4172
sa(dp4173
g3
VSTD-Rapoport-1981
p4174
sg5
S'PMC1507721'
p4175
sg7
g4163
sg9
V6794832.xml
p4176
sa(dp4177
g3
VSTD-Jones-1993
p4178
sg5
S'PMC1055149'
p4179
sg7
VCD005471 v. 5.0 Interventions to improve outpatient referrals from primary care to secondary care.rm5
p4180
sg9
V10132454.xml
p4181
sa(dp4182
g3
VSTD-Banait-2000
p4183
sg5
S'PMC1314507'
p4184
sg7
g4180
sg9
V12817353.xml
p4185
sa(dp4186
g3
VSTD-Coulter-1993
p4187
sg5
S'PMC1676519'
p4188
sg7
g4180
sg9
V8461728.xml
p4189
sa(dp4190
g3
VSTD-Bridgman-2005
p4191
sg5
S'PMC1464070'
p4192
sg7
g4180
sg9
V16176738.xml
p4193
sa(dp4194
g3
VSTD-Emslie-1993
p4195
sg5
S'PMC1678278'
p4196
sg7
g4180
sg9
V8280213.xml
p4197
sa(dp4198
g3
VSTD-Morrison-2001
p4199
sg5
S'PMC31924'
p4200
sg7
g4180
sg9
V11375232.xml
p4201
sa(dp4202
g3
VSTD-O_x0027_Cathain-1995
p4203
sg5
S'PMC1239296'
p4204
sg7
g4180
sg9
V7612338.xml
p4205
sa(dp4206
g3
VSTD-Kammerling-1996
p4207
sg5
S'PMC2351139'
p4208
sg7
g4180
sg9
V8646099.xml
p4209
sa(dp4210
g3
VSTD-Brox-1993
p4211
sg5
S'PMC1679023'
p4212
sg7
VCD005619 v. 3.0 Surgery for rotator cuff disease.rm5
p4213
sg9
V8241852.xml
p4214
sa(dp4215
g3
VSTD-Rost-2004
p4216
sg5
S'PMC1350979'
p4217
sg7
VCD006237 v. 4.0 Interventions to improve occupational health in depressed people.rm5
p4218
sg9
V15550800.xml
p4219
sa(dp4220
g3
VSTD-Strozzi-2007
p4221
sg5
S'PMC2080548'
p4222
sg7
VCD004587 v. 4.0 Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.rm5
p4223
sg9
V17589978.xml
p4224
sa(dp4225
g3
VSTD-Hatlebakk-1999
p4226
sg5
S'PMC28208'
p4227
sg7
VCD002095 v. 12.0 Short-term treatment with proton pump inhibitors H2-receptor antagonists and prokinetics for gastro.rm5
p4228
sg9
V10463897.xml
p4229
sa(dp4230
g3
VSTD-Watson-1997
p4231
sg5
S'PMC1027158'
p4232
sg7
g4228
sg9
V9203934.xml
p4233
sa(dp4234
g3
VSTD-Bardhan-1999
p4235
sg5
S'PMC27748'
p4236
sg7
g4228
sg9
V10024259.xml
p4237
sa(dp4238
g3
VSTD-Wynn-2007
p4239
sg5
S'PMC2716219'
p4240
sg7
VCD006654 v. 6.0 Olanzapine versus other atypical antipsychotics for schizophrenia.rm5
p4241
sg9
V17662577.xml
p4242
sa(dp4243
g3
VSTD-Lange-2011
p4244
sg5
S'PMC3272183'
p4245
sg7
VCD008228 v. 2.0 Face-down positioning or posturing after macular hole surgery.rm5
p4246
sg9
V21941361.xml
p4247
sa(dp4248
g3
VSTD-Explore-2004_x002a_
p4249
sg5
S'PMC1447873'
p4250
sg7
VCD001230 v. 3.2 Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with m.rm5
p4251
sg9
V12773358.xml
p4252
sa(dp4253
g3
VSTD-R_x002d_B-2004-phone_x0040_
p4254
sg5
S'PMC2843590'
p4255
sg7
g4251
sg9
V15385902.xml
p4256
sa(dp4257
g3
VSTD-Rotheram_x002d_Borus-2001_x0040_
p4258
sg5
S'PMC1446609'
p4259
sg7
g4251
sg9
V11236404.xml
p4260
sa(dp4261
g3
VSTD-CDC-ACDP-1999_x0040_
p4262
sg5
S'PMC1508588'
p4263
sg7
g4251
sg9
V10076482.xml
p4264
sa(dp4265
g3
VSTD-R_x002d_B-2004-in-person_x0040_
p4266
sg5
S'PMC2843590'
p4267
sg7
g4251
sg9
V15385902.xml
p4268
sa(dp4269
g3
VSTD-Kelly-1991
p4270
sg5
S'PMC1404968'
p4271
sg7
g4251
sg9
V1990853.xml
p4272
sa(dp4273
g3
VSTD-Imrie-2001_x002a__x0040_
p4274
sg5
S'PMC32307'
p4275
sg7
g4251
sg9
V11408300.xml
p4276
sa(dp4277
g3
VSTD-Coates-1989_x0040_
p4278
sg5
S'PMC1349674'
p4279
sg7
g4251
sg9
V2735479.xml
p4280
sa(dp4281
g3
VSTD-Picciano-2001_x0023_
p4282
sg5
S'PMC3352672'
p4283
sg7
g4251
sg9
V17927556.xml
p4284
sa(dp4285
g3
VSTD-Kegeles-1996_x0040_
p4286
sg5
S'PMC1380625'
p4287
sg7
g4251
sg9
V8712273.xml
p4288
sa(dp4289
g3
VSTD-Chen-2009
p4290
sg5
S'PMC2666722'
p4291
sg7
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p4292
sg9
V19284644.xml
p4293
sa(dp4294
g3
VSTD-Cowling-2008
p4295
sg5
S'PMC2364646'
p4296
sg7
g4292
sg9
V18461182.xml
p4297
sa(dp4298
g3
VSTD-Teleman-2004
p4299
sg5
S'PMC2870165'
p4300
sg7
g4292
sg9
V15473141.xml
p4301
sa(dp4302
g3
VSTD-Wang-2007
p4303
sg5
S'PMC1963277'
p4304
sg7
g4292
sg9
V17666681.xml
p4305
sa(dp4306
g3
VSTD-Larson-2010
p4307
sg5
S'PMC2821845'
p4308
sg7
g4292
sg9
V20297744.xml
p4309
sa(dp4310
g3
VSTD-Wu-2004
p4311
sg5
S'PMC3322931'
p4312
sg7
g4292
sg9
V15030685.xml
p4313
sa(dp4314
g3
VSTD-MacIntyre-2009
p4315
sg5
S'PMC2662657'
p4316
sg7
g4292
sg9
V19193267.xml
p4317
sa(dp4318
g3
VSTD-Lau-2004a
p4319
sg5
S'PMC3323085'
p4320
sg7
g4292
sg9
V15200846.xml
p4321
sa(dp4322
g3
VSTD-Isaacs-1991
p4323
sg5
S'PMC1792812'
p4324
sg7
g4292
sg9
V2001109.xml
p4325
sa(dp4326
g3
VSTD-Cowling-2010
p4327
sg5
S'PMC3152767'
p4328
sg7
g4292
sg9
V20353566.xml
p4329
sa(dp4330
g3
VSTD-Turner-2004b
p4331
sg5
S'PMC434190'
p4332
sg7
g4292
sg9
V15215114.xml
p4333
sa(dp4334
g3
VSTD-Turner-2004a
p4335
sg5
S'PMC434190'
p4336
sg7
g4292
sg9
V15215114.xml
p4337
sa(dp4338
g3
VSTD-Li-2010
p4339
sg5
S'PMC2849689'
p4340
sg7
VCD005016 v. 7.0 High-flux versus low-flux membranes for end-stage kidney disease.rm5
p4341
sg9
V20203165.xml
p4342
sa(dp4343
g3
VSTD-MPO-2009
p4344
sg5
S'PMC2653681'
p4345
sg7
g4341
sg9
V19092122.xml
p4346
sa(dp4347
g3
VSTD-Hickson-2007
p4348
sg5
S'PMC1914504'
p4349
sg7
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p4350
sg9
V17604300.xml
p4351
sa(dp4352
g3
VSTD-Psaradellis-2010
p4353
sg5
S'PMC3278944'
p4354
sg7
g4350
sg9
V22371721.xml
p4355
sa(dp4356
g3
VSTD-Beausoleil-2007
p4357
sg5
S'PMC2658588'
p4358
sg7
g4350
sg9
V18026577.xml
p4359
sa(dp4360
g3
VSTD-de-Wit-1999
p4361
sg5
S'PMC1420944'
p4362
sg7
VCD003641 v. 10.0 Surgery for obesity.rm5
p4363
sg9
V10615935.xml
p4364
sa(dp4365
g3
VSTD-Nguyen-2006
p4366
sg5
S'PMC1422019'
p4367
sg7
g4363
sg9
V11524581.xml
p4368
sa(dp4369
g3
VSTD-Sugerman-1987
p4370
sg5
S'PMC1493086'
p4371
sg7
g4363
sg9
V3296971.xml
p4372
sa(dp4373
g3
VSTD-Lujan-2004
p4374
sg5
S'PMC1356246'
p4375
sg7
g4363
sg9
V15024302.xml
p4376
sa(dp4377
g3
VSTD-Morino-2003
p4378
sg5
S'PMC1356165'
p4379
sg7
g4363
sg9
V14631220.xml
p4380
sa(dp4381
g3
VSTD-Kupka-2008
p4382
sg5
S'PMC2474659'
p4383
sg7
VCD009755 v. 1.0 Micronutrient supplementation in pregnant women with HIV infection.rm5
p4384
sg9
V18541571.xml
p4385
sa(dp4386
g3
VSTD-Kawai-2010
p4387
sg5
S'PMC2806894'
p4388
sg7
g4384
sg9
V19939985.xml
p4389
sa(dp4390
g3
VSTD-Harris-1984
p4391
sg5
S'PMC2573581'
p4392
sg7
VCD003539 v. 7.0 Interventions to improve antibiotic prescribing practices in ambulatory care.rm5
p4393
sg9
V6726669.xml
p4394
sa(dp4395
g3
VSTD-Little-2001
p4396
sg5
S'PMC26576'
p4397
sg7
g4393
sg9
V11159657.xml
p4398
sa(dp4399
g3
VSTD-McConnell-1982
p4400
sg5
S'PMC1274191'
p4401
sg7
g4393
sg9
V6891147.xml
p4402
sa(dp4403
g3
VSTD-Dowell-2001
p4404
sg5
S'PMC1313951'
p4405
sg7
g4393
sg9
V11255901.xml
p4406
sa(dp4407
g3
VSTD-O_x0027_Connell-1999
p4408
sg5
S'PMC27749'
p4409
sg7
g4393
sg9
V10024260.xml
p4410
sa(dp4411
g3
VSTD-Ilett-2000
p4412
sg5
S'PMC2014897'
p4413
sg7
g4393
sg9
V10671912.xml
p4414
sa(dp4415
g3
VSTD-Hux-1999
p4416
sg5
S'PMC1230539'
p4417
sg7
g4393
sg9
V10478162.xml
p4418
sa(dp4419
g3
VSTD-Lagerlov-2000
p4420
sg5
S'PMC1743532'
p4421
sg7
g4393
sg9
V10980076.xml
p4422
sa(dp4423
g3
VSTD-Stewart-2000
p4424
sg5
S'PMC2144801'
p4425
sg7
g4393
sg9
V10790817.xml
p4426
sa(dp4427
g3
VSTD-Flottorp-2002
p4428
sg5
S'PMC117890'
p4429
sg7
g4393
sg9
V12183309.xml
p4430
sa(dp4431
g3
VSTD-Macfarlane-2002
p4432
sg5
S'PMC64506'
p4433
sg7
g4393
sg9
V11786454.xml
p4434
sa(dp4435
g3
VSTD-van-der-Windt-1998
p4436
sg5
S'PMC28713'
p4437
sg7
VCD004258 v. 7.0 Physiotherapy interventions for shoulder pain.rm5
p4438
sg9
V9804720.xml
p4439
sa(dp4440
g3
VSTD-Dacre1989
p4441
sg5
S'PMC1003749'
p4442
sg7
g4438
sg9
V2712613.xml
p4443
sa(dp4444
g3
VSTD-Winters-1997_x002f_9
p4445
sg5
S'PMC27885'
p4446
sg7
g4438
sg9
V10334751.xml
p4447
sa(dp4448
g3
VSTD-Bulgen-1984
p4449
sg5
S'PMC1001344'
p4450
sg7
g4438
sg9
V6742895.xml
p4451
sa(dp4452
g3
VSTD-Atzpodien-2002
p4453
sg5
S'PMC2375173'
p4454
sg7
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p4455
sg9
V11870502.xml
p4456
sa(dp4457
g3
VSTD-Atkins-2003
p4458
sg5
S'PMC2645104'
p4459
sg7
g4455
sg9
V19001327.xml
p4460
sa(dp4461
g3
VSTD-Johnston-1998
p4462
sg5
S'PMC2150174'
p4463
sg7
g4455
sg9
V9579834.xml
p4464
sa(dp4465
g3
VSTD-Christensen-2001
p4466
sg5
S'PMC3620612'
p4467
sg7
VCD003324 v. 10.0 Rehabilitation for distal radial fractures in adults.rm5
p4468
sg9
V11374267.xml
p4469
sa(dp4470
g3
VSTD-Kristjansson-1999
p4471
sg5
S'PMC3402187'
p4472
sg7
VCD003195 v. 6.4 Urodynamic studies for management of urinary incontinence in children and adults.rm5
p4473
sg9
V22833787.xml
p4474
sa(dp4475
g3
VSTD-Seabrook-2005
p4476
sg5
S'PMC2722618'
p4477
sg7
VCD005230 v. 4.8 Complementary and miscellaneous interventions for nocturnal enuresis in children.rm5
p4478
sg9
V19668674.xml
p4479
sa(dp4480
g3
VSTD-McKendry-1975
p4481
sg5
S'PMC1956570'
p4482
sg7
g4478
sg9
V1192312.xml
p4483
sa(dp4484
g3
VSTD-Izbicki-1998
p4485
sg5
S'PMC1191184'
p4486
sg7
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p4487
sg9
V9445122.xml
p4488
sa(dp4489
g3
VSTD-Shepherd-1998
p4490
sg5
S'PMC2063048'
p4491
sg7
g4487
sg9
V9744511.xml
p4492
sa(dp4493
g3
VSTD-Lin-2005
p4494
sg5
S'PMC1550679'
p4495
sg7
VCD007978 v. 3.0 Email for clinical communication between patientscaregivers and healthcare professionals.rm5
p4496
sg9
V16236699.xml
p4497
sa(dp4498
g3
VSTD-Ross-2004
p4499
sg5
S'PMC1550594'
p4500
sg7
g4496
sg9
V15249261.xml
p4501
sa(dp4502
g3
VSTD-Katz-2003
p4503
sg5
S'PMC1494914'
p4504
sg7
g4496
sg9
V12950483.xml
p4505
sa(dp4506
g3
VSTD-Sahota-2001
p4507
sg5
S'PMC59380'
p4508
sg7
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p4509
sg9
V11691758.xml
p4510
sa(dp4511
g3
VSTD-Gentile-2009
p4512
sg5
S'PMC2758893'
p4513
sg7
g4509
sg9
V19765270.xml
p4514
sa(dp4515
g3
VSTD-Donnelly-2009
p4516
sg5
S'PMC2766439'
p4517
sg7
g4509
sg9
V19665037.xml
p4518
sa(dp4519
g3
VSTD-James-2004
p4520
sg5
S'PMC416601'
p4521
sg7
g4509
sg9
V15107313.xml
p4522
sa(dp4523
g3
VSTD-Webber-2008
p4524
sg5
S'PMC2275165'
p4525
sg7
g4509
sg9
V18312804.xml
p4526
sa(dp4527
g3
VSTD-Reilly-2006
p4528
sg5
S'PMC1647320'
p4529
sg7
g4509
sg9
V17028105.xml
p4530
sa(dp4531
g3
VSTD-Pate-2005
p4532
sg5
S'PMC1449401'
p4533
sg7
g4509
sg9
V16118370.xml
p4534
sa(dp4535
g3
VSTD-Lazaar-2007
p4536
sg5
S'PMC2040215'
p4537
sg7
g4509
sg9
V17718785.xml
p4538
sa(dp4539
g3
VSTD-OXCHECK-1989
p4540
sg5
S'PMC2549499'
p4541
sg7
VCD009009 v. 3.0 General health checks in adults for reducing morbidity and mortality from disease.rm5
p4542
sg9
V7742676.xml
p4543
sa(dp4544
g3
VSTD-New-York-1971
p4545
sg5
S'PMC1067443'
p4546
sg7
g4542
sg9
V4569090.xml
p4547
sa(dp4548
g3
VSTD-Family-Heart-1990
p4549
sg5
S'PMC2539278'
p4550
sg7
g4542
sg9
V8124121.xml
p4551
sa(dp4552
g3
VSTD-Tamblyn-2003
p4553
sg5
S'PMC191278'
p4554
sg7
VCD008165 v. 2.0 Interventions to improve the appropriate use of polypharmacy for older people.rm5
p4555
sg9
V12975221.xml
p4556
sa(dp4557
g3
VSTD-Freelander-1984
p4558
sg5
S'PMC1441767'
p4559
sg7
VCD000052 v. 12.3 Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.rm5
p4560
sg9
V6428582.xml
p4561
sa(dp4562
g3
VSTD-Parkin-1995
p4563
sg5
S'PMC1511081'
p4564
sg7
g4560
sg9
V7741574.xml
p4565
sa(dp4566
g3
VSTD-Lin-1995
p4567
sg5
S'PMC1511067'
p4568
sg7
g4560
sg9
V7741566.xml
p4569
sa(dp4570
g3
VSTD-Dewar-1999
p4571
sg5
S'PMC1717926'
p4572
sg7
g4560
sg9
V10208945.xml
p4573
sa(dp4574
g3
VSTD-Hakim-2000
p4575
sg5
S'PMC1760932'
p4576
sg7
VCD000526 v. 7.2 Interventions for treating tuberculous pericarditis.rm5
p4577
sg9
V10908256.xml
p4578
sa(dp4579
g3
VSTD-Woodruff-2003
p4580
sg5
S'PMC3673685'
p4581
sg7
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p4582
sg9
V12582801.xml
p4583
sa(dp4584
g3
VSTD-Rosenberg-2007
p4585
sg5
S'PMC1964758'
p4586
sg7
g4582
sg9
V17683577.xml
p4587
sa(dp4588
g3
VSTD-Nuki-1973
p4589
sg5
S'PMC1006142'
p4590
sg7
VCD003113 v. 7.0 Opioid therapy for treating rheumatoid arthritis pain.rm5
p4591
sg9
V4584572.xml
p4592
sa(dp4593
g3
VSTD-Egsmose-1965
p4594
sg5
S'PMC2475854'
p4595
sg7
VCD001363 v. 7.0 Isoniazid for preventing tuberculosis in non-HIV infected persons.rm5
p4596
sg9
V5321762.xml
p4597
sa(dp4598
g3
VSTD-Zucherman-2004
p4599
sg5
S'PMC3468027'
p4600
sg7
VCD001352 v. 7.8 Surgery for degenerative lumbar spondylosis.rm5
p4601
sg9
V14685830.xml
p4602
sa(dp4603
g3
VSTD-Madan-2003
p4604
sg5
S'PMC3467791'
p4605
sg7
g4601
sg9
V12955608.xml
p4606
sa(dp4607
g3
VSTD-Griffiths-2004
p4608
sg5
S'PMC314511'
p4609
sg7
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p4610
sg9
V14718266.xml
p4611
sa(dp4612
g3
VSTD-Siriwardena-2002
p4613
sg5
S'PMC1314414'
p4614
sg7
g4610
sg9
V12236277.xml
p4615
sa(dp4616
g3
VSTD-Kerse--1999
p4617
sg5
S'PMC28221'
p4618
sg7
g4610
sg9
V10480825.xml
p4619
sa(dp4620
g3
VSTD-Crotty-2004
p4621
sg5
S'PMC415557'
p4622
sg7
g4610
sg9
V15066200.xml
p4623
sa(dp4624
g3
VSTD-McConnell-1982
p4625
sg5
S'PMC1274191'
p4626
sg7
g4610
sg9
V6891147.xml
p4627
sa(dp4628
g3
VSTD-Newton_x002d_Syms-1992
p4629
sg5
S'PMC1381201'
p4630
sg7
g4610
sg9
V1540493.xml
p4631
sa(dp4632
g3
VSTD-Fretheim-2006
p4633
sg5
S'PMC1472698'
p4634
sg7
g4610
sg9
V16737349.xml
p4635
sa(dp4636
g3
VSTD-Borgiel-1999
p4637
sg5
S'PMC1230705'
p4638
sg7
g4610
sg9
V10551192.xml
p4639
sa(dp4640
g3
VSTD-Dey-2004
p4641
sg5
S'PMC1314775'
p4642
sg7
g4610
sg9
V14965404.xml
p4643
sa(dp4644
g3
VSTD-Cockburn--1992
p4645
sg5
S'PMC1881508'
p4646
sg7
g4610
sg9
V1571645.xml
p4647
sa(dp4648
g3
VSTD-Freemantle-2000
p4649
sg5
S'PMC2014899'
p4650
sg7
g4610
sg9
V10671913.xml
p4651
sa(dp4652
g3
VSTD-Martin-2004
p4653
sg5
S'PMC315525'
p4654
sg7
g4610
sg9
V14734433.xml
p4655
sa(dp4656
g3
VSTD-vanden-Hombergh-1999
p4657
sg5
S'PMC2483655'
p4658
sg7
g4610
sg9
V10847872.xml
p4659
sa(dp4660
g3
VSTD-Kaner-1999
p4661
sg5
S'PMC1313496'
p4662
sg7
g4610
sg9
V10756610.xml
p4663
sa(dp4664
g3
VSTD-Putnam-1985
p4665
sg5
S'PMC1346180'
p4666
sg7
g4610
sg9
V3986727.xml
p4667
sa(dp4668
g3
VSTD-Lemelin-2001
p4669
sg5
S'PMC80870'
p4670
sg7
g4610
sg9
V11276541.xml
p4671
sa(dp4672
g3
VSTD-Frijling-2003
p4673
sg5
S'PMC1743704'
p4674
sg7
g4610
sg9
V12792007.xml
p4675
sa(dp4676
g3
VSTD-Loeb-2005
p4677
sg5
S'PMC1226247'
p4678
sg7
g4610
sg9
V16150741.xml
p4679
sa(dp4680
g3
VSTD-Fender-1999
p4681
sg5
S'PMC27863'
p4682
sg7
g4610
sg9
V10231255.xml
p4683
sa(dp4684
g3
VSTD-Premaratne-1999
p4685
sg5
S'PMC27864'
p4686
sg7
g4610
sg9
V10231256.xml
p4687
sa(dp4688
g3
VSTD-Freemantle-2002
p4689
sg5
S'PMC1314269'
p4690
sg7
g4610
sg9
V11942445.xml
p4691
sa(dp4692
g3
VSTD-Feder-1995
p4693
sg5
S'PMC2543702'
p4694
sg7
g4610
sg9
V8520339.xml
p4695
sa(dp4696
g3
VSTD-Modell-1998
p4697
sg5
S'PMC28672'
p4698
sg7
g4610
sg9
V9740569.xml
p4699
sa(dp4700
g3
VSTD-van-Eijk-2001
p4701
sg5
S'PMC1119296'
p4702
sg7
g4610
sg9
V11141128.xml
p4703
sa(dp4704
g3
VSTD-Walsh-2005
p4705
sg5
S'PMC1490293'
p4706
sg7
g4610
sg9
V16423097.xml
p4707
sa(dp4708
g3
VSTD-Ilett-2000
p4709
sg5
S'PMC2014897'
p4710
sg7
g4610
sg9
V10671912.xml
p4711
sa(dp4712
g3
VSTD-Wyatt-1998
p4713
sg5
S'PMC28686'
p4714
sg7
g4610
sg9
V9774287.xml
p4715
sa(dp4716
g3
VSTD-Chang-1998
p4717
sg5
S'PMC1717639'
p4718
sg7
VCD005373 v. 6.0 Inhaled beta2-agonists for non-specific chronic cough in children.rm5
p4719
sg9
V9771244.xml
p4720
sa(dp4721
g3
VSTD-Galarza-1995
p4722
sg5
S'PMC1021356'
p4723
sg7
VCD001876 v. 8.0 Corticosteroids for tuberculous pleurisy.rm5
p4724
sg9
V8553306.xml
p4725
sa(dp4726
g3
VSTD-Gaziano-2009
p4727
sg5
S'PMC2774210'
p4728
sg7
VCD002141 v. 10.0 Drugs for preventing lung cancer in healthy people.rm5
p4729
sg9
V19066368.xml
p4730
sa(dp4731
g3
VSTD-Lin-2009
p4732
sg5
S'PMC2615459'
p4733
sg7
g4729
sg9
V19116389.xml
p4734
sa(dp4735
g3
VSTD-Lippman-2009
p4736
sg5
S'PMC3682779'
p4737
sg7
g4729
sg9
V19066370.xml
p4738
sa(dp4739
g3
VSTD-Allen-1977
p4740
sg5
S'PMC1544580'
p4741
sg7
VCD002975 v. 7.0 Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome .rm5
p4742
sg9
V326199.xml
p4743
sa(dp4744
g3
VSTD-Darouiche-2005
p4745
sg5
S'PMC1357724'
p4746
sg7
VCD007878 v. 4.0 Catheter impregnation coating or bonding for reducing central venous catheter-related infections in.rm5
p4747
sg9
V16041209.xml
p4748
sa(dp4749
g3
VSTD-Sherertz-1996
p4750
sg5
S'PMC163461'
p4751
sg7
g4747
sg9
V8878569.xml
p4752
sa(dp4753
g3
VSTD-Bong-2003
p4754
sg5
S'PMC1770068'
p4755
sg7
g4747
sg9
V14514774.xml
p4756
sa(dp4757
g3
VSTD-Prantera-2002a
p4758
sg5
S'PMC1773351'
p4759
sg7
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p4760
sg9
V12171964.xml
p4761
sa(dp4762
g3
VSTD-Schultz-2004
p4763
sg5
S'PMC394324'
p4764
sg7
g4760
sg9
V15113451.xml
p4765
sa(dp4766
g3
VSTD-Schwandner-2011
p4767
sg5
S'PMC3196995'
p4768
sg7
VCD002111 v. 8.0 Biofeedback andor sphincter exercises for the treatment of faecal incontinence in adults.rm5
p4769
sg9
V22013492.xml
p4770
sa(dp4771
g3
VSTD-Callaway-2010
p4772
sg5
S'PMC2890340'
p4773
sg7
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p4774
sg9
V20357374.xml
p4775
sa(dp4776
g3
VSTD-Strandberg-1995
p4777
sg5
S'PMC484055'
p4778
sg7
VMR000009 v. 8.2 Outcomes of patients who participate in randomized controlled trials compared to similar patients re.rm5
p4779
sg9
V7488463.xml
p4780
sa(dp4781
g3
VSTD-Mahon-1996
p4782
sg5
S'PMC2350863'
p4783
sg7
g4779
sg9
V8616414.xml
p4784
sa(dp4785
g3
VSTD-Dahan-1986
p4786
sg5
S'PMC1341050'
p4787
sg7
g4779
sg9
V3089521.xml
p4788
sa(dp4789
g3
VSTD-Chilvers-2001a
p4790
sg5
S'PMC30555'
p4791
sg7
g4779
sg9
V11282864.xml
p4792
sa(dp4793
g3
VSTD-Chilvers-2001b
p4794
sg5
S'PMC30555'
p4795
sg7
g4779
sg9
V11282864.xml
p4796
sa(dp4797
g3
VSTD-Bijker-2000b
p4798
sg5
S'PMC2364244'
p4799
sg7
g4779
sg9
V12237770.xml
p4800
sa(dp4801
g3
VSTD-Henshaw-1993a
p4802
sg5
S'PMC1678709'
p4803
sg7
g4779
sg9
V8401094.xml
p4804
sa(dp4805
g3
VSTD-Henshaw-1993b
p4806
sg5
S'PMC1678709'
p4807
sg7
g4779
sg9
V8401094.xml
p4808
sa(dp4809
g3
VSTD-Bijker-2000a
p4810
sg5
S'PMC2364244'
p4811
sg7
g4779
sg9
V12237770.xml
p4812
sa(dp4813
g3
VSTD-Bradshaw-1975
p4814
sg5
S'PMC1083241'
p4815
sg7
VCD000248 v. 6.0 Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or tr.rm5
p4816
sg9
V1159434.xml
p4817
sa(dp4818
g3
VSTD-Vermeulen-1993
p4819
sg5
S'PMC1014761'
p4820
sg7
VCD001797 v. 7.0 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.rm5
p4821
sg9
V8429321.xml
p4822
sa(dp4823
g3
VSTD-Whitley-1980
p4824
sg5
S'PMC3290126'
p4825
sg7
VCD004206 v. 4.0 Antiviral agents for treatment of herpes simplex virus infection in neonates.rm5
p4826
sg9
V22341538.xml
p4827
sa(dp4828
g3
VSTD-Kumana-2003
p4829
sg5
S'PMC1884301'
p4830
sg7
VCD003598 v. 8.0 Antihypertensive treatment for kidney transplant recipients.rm5
p4831
sg9
V14616428.xml
p4832
sa(dp4833
g3
VSTD-Benders-2006
p4834
sg5
S'PMC2672696'
p4835
sg7
VCD006817 v. 4.0 Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encepha.rm5
p4836
sg9
V16428356.xml
p4837
sa(dp4838
g3
VSTD-Phelan-2011
p4839
sg5
S'PMC3057546'
p4840
sg7
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p4841
sg9
V21310836.xml
p4842
sa(dp4843
g3
VSTD-Callaway-2010
p4844
sg5
S'PMC2890340'
p4845
sg7
g4841
sg9
V20357374.xml
p4846
sa(dp4847
g3
VSTD-Rhodes-2010
p4848
sg5
S'PMC2980957'
p4849
sg7
g4841
sg9
V20962162.xml
p4850
sa(dp4851
g3
VSTD-Korpi_x002d_Hyovalti-2011
p4852
sg5
S'PMC3078095'
p4853
sg7
g4841
sg9
V21429234.xml
p4854
sa(dp4855
g3
VSTD-Moses-2009
p4856
sg5
S'PMC2681032'
p4857
sg7
g4841
sg9
V19279301.xml
p4858
sa(dp4859
g3
VSTD-Luoto-2011
p4860
sg5
S'PMC3096610'
p4861
sg7
g4841
sg9
V21610860.xml
p4862
sa(dp4863
g3
VSTD-Dodd-2006
p4864
sg5
S'PMC1388124'
p4865
sg7
VCD001338 v. 7.0 Oral misoprostol for induction of labour.rm5
p4866
sg9
V16455695.xml
p4867
sa(dp4868
g3
VSTD-Ott-1998
p4869
sg5
S'PMC3015252'
p4870
sg7
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p4871
sg9
V10036122.xml
p4872
sa(dp4873
g3
VSTD-Taylor--1977
p4874
sg5
S'PMC1631450'
p4875
sg7
VCD000247 v. 11.0 Antibiotics for the common cold and acute purulent rhinitis.rm5
p4876
sg9
V329949.xml
p4877
sa(dp4878
g3
VSTD-Wu-2002
p4879
sg5
S'PMC1447358'
p4880
sg7
VCD005030 v. 9.0 Interventions for prevention of drug use by young people delivered in non-school settings.rm5
p4881
sg9
V12453815.xml
p4882
sa(dp4883
g3
VSTD-Biglan-2000
p4884
sg5
S'PMC1748303'
p4885
sg7
g4881
sg9
V10691755.xml
p4886
sa(dp4887
g3
VSTD-Flay-2004
p4888
sg5
S'PMC2386246'
p4889
sg7
g4881
sg9
V15066879.xml
p4890
sa(dp4891
g3
VSTD-Wiberg_x002d_Itzel-2008
p4892
sg5
S'PMC2413392'
p4893
sg7
VCD006174 v. 4.0 Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fe.rm5
p4894
sg9
V18503103.xml
p4895
sa(dp4896
g3
VSTD-Pachowsky-2011
p4897
sg5
S'PMC3311811'
p4898
sg7
VCD009261 v. 4.0 Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention.rm5
p4899
sg9
V21761149.xml
p4900
sa(dp4901
g3
VSTD-Llanos-2006
p4902
sg5
S'PMC1856589'
p4903
sg7
g4899
sg9
V17060762.xml
p4904
sa(dp4905
g3
VSTD-Kiss-2004
p4906
sg5
S'PMC509340'
p4907
sg7
VCD006178 v. 6.0 Antenatal lower genital tract infection screening and treatment programs for preventing preterm deli.rm5
p4908
sg9
V15294856.xml
p4909
sa(dp4910
g3
VSTD-Garbutt-2012
p4911
sg5
S'PMC3667493'
p4912
sg7
VCD006089 v. 8.1 Antibiotics for clinically diagnosed acute rhinosinusitis in adults.rm5
p4913
sg9
V22337680.xml
p4914
sa(dp4915
g3
VSTD-Stalman-1997
p4916
sg5
S'PMC1410064'
p4917
sg7
g4913
sg9
V9463979.xml
p4918
sa(dp4919
g3
VSTD-Scott-2002
p4920
sg5
S'PMC1784606'
p4921
sg7
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p4922
sg9
V12530483.xml
p4923
sa(dp4924
g3
VSTD-Aronstam-1977
p4925
sg5
S'PMC476643'
p4926
sg7
VCD003429 v. 9.0 Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people .rm5
p4927
sg9
V320230.xml
p4928
sa(dp4929
g3
VSTD-Boogaerts-2003
p4930
sg5
S'PMC2376376'
p4931
sg7
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p4932
sg9
V12671693.xml
p4933
sa(dp4934
g3
VSTD-Wilkinson-2006
p4935
sg5
S'PMC2361228'
p4936
sg7
g4932
sg9
V16570051.xml
p4937
sa(dp4938
g3
VSTD-Moore-1991
p4939
sg5
S'PMC1014522'
p4940
sg7
VCD003633 v. 3.0 Botulinum toxin type A therapy for cervical dystonia.rm5
p4941
sg9
V1955900.xml
p4942
sa(dp4943
g3
VSTD-Blackie-1990
p4944
sg5
S'PMC488163'
p4945
sg7
g4941
sg9
V2213040.xml
p4946
sa(dp4947
g3
VSTD-Poewe-2000
p4948
sg5
S'PMC2169893'
p4949
sg7
g4941
sg9
V9436721.xml
p4950
sa(dp4951
g3
VSTD-Lindor-2009
p4952
sg5
S'PMC2758780'
p4953
sg7
VCD003626 v. 6.0 Bile acids for primary sclerosing cholangitis.rm5
p4954
sg9
V19585548.xml
p4955
sa(dp4956
g3
VSTD-Weitoft-2003
p4957
sg5
S'PMC1754327'
p4958
sg7
VCD002824 v. 5.0 Intra-articular steroids and splintsrest for children with juvenile idiopathic arthritis and adults.rm5
p4959
sg9
V12972485.xml
p4960
sa(dp4961
g3
VSTD-Ros-2001
p4962
sg5
S'PMC1422133'
p4963
sg7
VCD006229 v. 2.2 Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p4964
sg9
V11729380.xml
p4965
sa(dp4966
g3
VSTD-Floyd-2007
p4967
sg5
S'PMC2888541'
p4968
sg7
VCD007249 v. 3.0 Theory-based interventions for contraception.rm5
p4969
sg9
V17218187.xml
p4970
sa(dp4971
g3
VSTD-Ingersoll-2005
p4972
sg5
S'PMC2875062'
p4973
sg7
g4969
sg9
V16183466.xml
p4974
sa(dp4975
g3
VSTD-Barnet-2009
p4976
sg5
S'PMC2746510'
p4977
sg7
g4969
sg9
V19752472.xml
p4978
sa(dp4979
g3
VSTD-Kirby-2010
p4980
sg5
S'PMC3153424'
p4981
sg7
g4969
sg9
V21126301.xml
p4982
sa(dp4983
g3
VSTD-Peipert-2008
p4984
sg5
S'PMC2535847'
p4985
sg7
g4969
sg9
V18395692.xml
p4986
sa(dp4987
g3
VSTD-Coyle-2001
p4988
sg5
S'PMC1913682'
p4989
sg7
g4969
sg9
V11889277.xml
p4990
sa(dp4991
g3
VSTD-Wight-2002
p4992
sg5
S'PMC115856'
p4993
sg7
g4969
sg9
V12065268.xml
p4994
sa(dp4995
g3
VSTD-Gabriel-1977
p4996
sg5
S'PMC1653741'
p4997
sg7
VCD004804 v. 6.0 Interventions for improving adherence to treatment in patients with high blood pressure in ambulator.rm5
p4998
sg9
V911007.xml
p4999
sa(dp5000
g3
VSTD-Johnson-1978
p5001
sg5
S'PMC1819059'
p5002
sg7
g4998
sg9
V369673.xml
p5003
sa(dp5004
g3
VSTD-Asplund-1984
p5005
sg5
S'PMC1463452'
p5006
sg7
g4998
sg9
V6375710.xml
p5007
sa(dp5008
g3
VSTD-Goodman-2006
p5009
sg5
S'PMC2670780'
p5010
sg7
VCD003401 v. 6.0 Combined spinal-epidural versus epidural analgesia in labour.rm5
p5011
sg9
V19095858.xml
p5012
sa(dp5013
g3
VSTD-Klaber-Moffet-2005
p5014
sg5
S'PMC543869'
p5015
sg7
VCD005106 v. 9.0 Patient education for neck pain.rm5
p5016
sg9
V15585539.xml
p5017
sa(dp5018
g3
VSTD-Sherman-2009
p5019
sg5
S'PMC2664516'
p5020
sg7
g5016
sg9
V19333174.xml
p5021
sa(dp5022
g3
VSTD-Lemmens-2007
p5023
sg5
S'PMC2944304'
p5024
sg7
VCD007362 v. 2.11 Sugammadex a selective reversal medication for preventing postoperative residual neuromuscular bloc.rm5
p5025
sg9
V20809967.xml
p5026
sa(dp5027
g3
VSTD-Harrison-1996
p5028
sg5
S'PMC3340390'
p5029
sg7
VCD007355 v. 6.0 Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults.rm5
p5030
sg9
V22558179.xml
p5031
sa(dp5032
g3
VSTD-Seymour-1996
p5033
sg5
S'PMC2042618'
p5034
sg7
g5030
sg9
V8799525.xml
p5035
sa(dp5036
g3
VSTD-Rathbun-2012
p5037
sg5
S'PMC3343207'
p5038
sg7
VCD004982 v. 8.0 Treatment for superficial thrombophlebitis of the leg.rm5
p5039
sg9
V22360152.xml
p5040
sa(dp5041
g3
VSTD-Gorecka-1997
p5042
sg5
S'PMC1758616'
p5043
sg7
VCD001744 v. 10.0 Domiciliary oxygen for chronic obstructive pulmonary disease.rm5
p5044
sg9
V9337824.xml
p5045
sa(dp5046
g3
VSTD-Humphrey-1996
p5047
sg5
S'PMC2486738'
p5048
sg7
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p5049
sg9
V7867131.xml
p5050
sa(dp5051
g3
VSTD-Benn-2008
p5052
sg5
S'PMC2432170'
p5053
sg7
g5049
sg9
V18558641.xml
p5054
sa(dp5055
g3
VSTD-Benn-2010
p5056
sg5
S'PMC2835853'
p5057
sg7
g5049
sg9
V20215360.xml
p5058
sa(dp5059
g3
VSTD-Owen-2009
p5060
sg5
S'PMC2768604'
p5061
sg7
VCD008991 v. 2.0 Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.rm5
p5062
sg9
V19788970.xml
p5063
sa(dp5064
g3
VSTD-MacKie-Child-1990
p5065
sg5
S'PMC3417576'
p5066
sg7
VCD004416 v. 6.0 Oral evening primrose oil and borage oil for eczema.rm5
p5067
sg9
V22905031.xml
p5068
sa(dp5069
g3
VSTD-MacKie-Adult-1990
p5070
sg5
S'PMC3417576'
p5071
sg7
g5067
sg9
V22905031.xml
p5072
sa(dp5073
g3
VSTD-Takwale-2003
p5074
sg5
S'PMC292992'
p5075
sg7
g5067
sg9
V14670885.xml
p5076
sa(dp5077
g3
VSTD-Hederos-1996
p5078
sg5
S'PMC1511801'
p5079
sg7
g5067
sg9
V9014601.xml
p5080
sa(dp5081
g3
VSTD-Zwart-2000
p5082
sg5
S'PMC27262'
p5083
sg7
VCD000023 v. 20.0 Antibiotics for sore throat.rm5
p5084
sg9
V10634735.xml
p5085
sa(dp5086
g3
VSTD-Zwart-2003
p5087
sg5
S'PMC286321'
p5088
sg7
g5084
sg9
V14656841.xml
p5089
sa(dp5090
g3
VSTD-Little-1997
p5091
sg5
S'PMC2126131'
p5092
sg7
g5084
sg9
V9116551.xml
p5093
sa(dp5094
g3
VSTD-Landsman-1951
p5095
sg5
S'PMC2068130'
p5096
sg7
g5084
sg9
V14821407.xml
p5097
sa(dp5098
g3
VSTD-Petersen-1997
p5099
sg5
S'PMC1497066'
p5100
sg7
g5084
sg9
V9051558.xml
p5101
sa(dp5102
g3
VSTD-Howe-1997
p5103
sg5
S'PMC1313000'
p5104
sg7
g5084
sg9
V9219402.xml
p5105
sa(dp5106
g3
VSTD-MacDonald-1951
p5107
sg5
S'PMC2068133'
p5108
sg7
g5084
sg9
V14821406.xml
p5109
sa(dp5110
g3
VSTD-Dagnelie-1996
p5111
sg5
S'PMC1239783'
p5112
sg7
g5084
sg9
V8945796.xml
p5113
sa(dp5114
g3
VSTD-Taylor-1977
p5115
sg5
S'PMC1631450'
p5116
sg7
g5084
sg9
V329949.xml
p5117
sa(dp5118
g3
VSTD-Moorthy-2004b
p5119
sg5
S'PMC524376'
p5120
sg7
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p5121
sg9
V15526058.xml
p5122
sa(dp5123
g3
VSTD-Gomez_x002d_Jimenez-1993
p5124
sg5
S'PMC188024'
p5125
sg7
VCD002232 v. 8.9 Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients.rm5
p5126
sg9
V8215267.xml
p5127
sa(dp5128
g3
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p5129
sg5
S'PMC2575601'
p5130
sg7
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p5131
sg9
V18759980.xml
p5132
sa(dp5133
g3
VSTD-P_x002d_Hilton_x002d_Jones_x0028_D_x0029_
p5134
sg5
S'PMC1083170'
p5135
sg7
VCD001790 v. 7.0 Posture and fluids for preventing post-dural puncture headache.rm5
p5136
sg9
V7131001.xml
p5137
sa(dp5138
g3
VSTD-Kirby-2010
p5139
sg5
S'PMC3153424'
p5140
sg7
VCD004317 v. 8.0 Strategies to improve adherence and acceptability of hormonal methods of contraception.rm5
p5141
sg9
V21126301.xml
p5142
sa(dp5143
g3
VSTD-Toll-2010a
p5144
sg5
S'PMC3771701'
p5145
sg7
VCD003086 v. 10.2 Opioid antagonists for smoking cessation.rm5
p5146
sg9
V20542391.xml
p5147
sa(dp5148
g3
VSTD-_x00b0_O_x0027_Malley-1998
p5149
sg5
S'PMC3094855'
p5150
sg7
g5146
sg9
V18796184.xml
p5151
sa(dp5152
g3
VSTD-Dundee-1986
p5153
sg5
S'PMC1341376'
p5154
sg7
VCD003281 v. 6.0 Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting.rm5
p5155
sg9
V3092933.xml
p5156
sa(dp5157
g3
VSTD-Barsoum-1990
p5158
sg5
S'PMC1292503'
p5159
sg7
g5155
sg9
V2181138.xml
p5160
sa(dp5161
g3
VSTD-Ko-2009
p5162
sg5
S'PMC2650992'
p5163
sg7
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p5164
sg9
V19270819.xml
p5165
sa(dp5166
g3
VSTD-Lennox-2001
p5167
sg5
S'PMC32255'
p5168
sg7
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p5169
sg9
V11397745.xml
p5170
sa(dp5171
g3
VSTD-Prochaska-2008
p5172
sg5
S'PMC3384542'
p5173
sg7
g5169
sg9
V18155287.xml
p5174
sa(dp5175
g3
VSTD-Meyer-2008
p5176
sg5
S'PMC2253708'
p5177
sg7
g5169
sg9
V17995993.xml
p5178
sa(dp5179
g3
VSTD-Prokhorov-2008
p5180
sg5
S'PMC2365030'
p5181
sg7
g5169
sg9
V18280668.xml
p5182
sa(dp5183
g3
VSTD-Young-2008
p5184
sg5
S'PMC2268921'
p5185
sg7
g5169
sg9
V18304363.xml
p5186
sa(dp5187
g3
VSTD-Stoltzfus-2001
p5188
sg5
S'PMC60982'
p5189
sg7
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p5190
sg9
V11744561.xml
p5191
sa(dp5192
g3
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p5193
sg5
S'PMC2291568'
p5194
sg7
g5190
sg9
V18414647.xml
p5195
sa(dp5196
g3
VSTD-Alderman-2006-_x0028_Cluster_x0029_
p5197
sg5
S'PMC1502184'
p5198
sg7
g5190
sg9
V16790460.xml
p5199
sa(dp5200
g3
VSTD-Kirwan-2010
p5201
sg5
S'PMC3161357'
p5202
sg7
g5190
sg9
V20858280.xml
p5203
sa(dp5204
g3
VSTD-Willett-1979
p5205
sg5
S'PMC1619153'
p5206
sg7
g5190
sg9
V384815.xml
p5207
sa(dp5208
g3
VSTD-Baram-1996
p5209
sg5
S'PMC3100715'
p5210
sg7
VCD001770 v. 17.10 Treatment of infantile spasms.rm5
p5211
sg9
V8604274.xml
p5212
sa(dp5213
g3
VSTD-WACS-2007
p5214
sg5
S'PMC2034519'
p5215
sg7
VCD004183 v. 10.0 Antioxidant supplements for preventing gastrointestinal cancers.rm5
p5216
sg9
V17698683.xml
p5217
sa(dp5218
g3
VSTD-Chu-2004
p5219
sg5
S'PMC3181213'
p5220
sg7
VCD008186 v. 2.0 Water-based exercises for improving activities of daily living after stroke.rm5
p5221
sg9
V15179638.xml
p5222
sa(dp5223
g3
VSTD-van-der-Molen-1997
p5224
sg5
S'PMC1758577'
p5225
sg7
VCD006923 v. 6.0 Regular treatment with formoterol for chronic asthma serious adverse events.rm5
p5226
sg9
V9227720.xml
p5227
sa(dp5228
g3
VSTD-Chalela-2007
p5229
sg5
S'PMC1859855'
p5230
sg7
VCD007424 v. 2.0 Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in pat.rm5
p5231
sg9
V17258669.xml
p5232
sa(dp5233
g3
VSTD-Rashiq-1986
p5234
sg5
S'PMC1339971'
p5235
sg7
VCD005185 v. 6.2 Thiazide diuretics and the risk of hip fracture.rm5
p5236
sg9
V3083912.xml
p5237
sa(dp5238
g3
VSTD-Atroshi-2006
p5239
sg5
S'PMC1482334'
p5240
sg7
VCD003905 v. 8.0 Surgical treatment options for carpal tunnel syndrome.rm5
p5241
sg9
V16777857.xml
p5242
sa(dp5243
g3
VSTD-Yip-2002
p5244
sg5
S'PMC3620974'
p5245
sg7
VCD000168 v. 10.0 Pre-operative traction for hip fractures in adults.rm5
p5246
sg9
V12466869.xml
p5247
sa(dp5248
g3
VSTD-Bogner-2008
p5249
sg5
S'PMC2478504'
p5250
sg7
VCD006560 v. 4.0 Interventions for improving outcomes in patients with multimorbidity in primary care and community s.rm5
p5251
sg9
V18626028.xml
p5252
sa(dp5253
g3
VSTD-Hogg-2009
p5254
sg5
S'PMC2793206'
p5255
sg7
g5251
sg9
V20008582.xml
p5256
sa(dp5257
g3
VSTD-Fung-1991
p5258
sg5
S'PMC2950613'
p5259
sg7
VCD005161 v. 6.0 Cyclosporin versus tacrolimus for liver transplanted patients.rm5
p5260
sg9
V1721333.xml
p5261
sa(dp5262
g3
VSTD-Narvekar-2010
p5263
sg5
S'PMC2890904'
p5264
sg7
VCD009517 v. 2.6 Endometrial injury in women undergoing assisted reproductive techniques.rm5
p5265
sg9
V20607003.xml
p5266
sa(dp5267
g3
VSTD-Tang-2006
p5268
sg5
S'PMC1448972'
p5269
sg7
VCD005080 v. 3.0 Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction af.rm5
p5270
sg9
V16552194.xml
p5271
sa(dp5272
g3
VSTD-Vrijiland-2002
p5273
sg5
S'PMC1422414'
p5274
sg7
g5270
sg9
V11807358.xml
p5275
sa(dp5276
g3
VSTD-Shim-2012
p5277
sg5
S'PMC3260973'
p5278
sg7
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p5279
sg9
V22048460.xml
p5280
sa(dp5281
g3
VSTD-_x005e_Horst-2005
p5282
sg5
S'PMC2424122'
p5283
sg7
g5279
sg9
V18568115.xml
p5284
sa(dp5285
g3
VSTD-_x002a_Williams-2012
p5286
sg5
S'PMC2955947'
p5287
sg7
g5279
sg9
V21407853.xml
p5288
sa(dp5289
g3
VSTD-Weinberger-2008
p5290
sg5
S'PMC3675443'
p5291
sg7
g5279
sg9
V18344743.xml
p5292
sa(dp5293
g3
VSTD-_x002a_George-2008
p5294
sg5
S'PMC2693008'
p5295
sg7
g5279
sg9
V18096137.xml
p5296
sa(dp5297
g3
VSTD-_x002b_Tidey-2011
p5298
sg5
S'PMC3685403'
p5299
sg7
g5279
sg9
V21475970.xml
p5300
sa(dp5301
g3
VSTD-Kelly-2008
p5302
sg5
S'PMC2547986'
p5303
sg7
g5279
sg9
V18550339.xml
p5304
sa(dp5305
g3
VSTD-_x002b_Steinberg-2003
p5306
sg5
S'PMC3058670'
p5307
sg7
g5279
sg9
V21198231.xml
p5308
sa(dp5309
g3
VSTD-_x002a_Weiner-2011
p5310
sg5
S'PMC3691956'
p5311
sg7
g5279
sg9
V21376537.xml
p5312
sa(dp5313
g3
VSTD-Hong-2011
p5314
sg5
S'PMC3618988'
p5315
sg7
g5279
sg9
V21810630.xml
p5316
sa(dp5317
g3
VSTD-Subhedar-1997
p5318
sg5
S'PMC1720712'
p5319
sg7
VCD000509 v. 11.0 Inhaled nitric oxide for respiratory failure in preterm infants.rm5
p5320
sg9
V9462187.xml
p5321
sa(dp5322
g3
VSTD-Ziegler-2010
p5323
sg5
S'PMC2845038'
p5324
sg7
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p5325
sg9
V20067958.xml
p5326
sa(dp5327
g3
VSTD-DICE-1994
p5328
sg5
S'PMC2540045'
p5329
sg7
VCD004910 v. 4.0 Effectiveness of shared care across the interface between primary and specialty care in chronic dise.rm5
p5330
sg9
V8180540.xml
p5331
sa(dp5332
g3
VSTD-McGhee-1994
p5333
sg5
S'PMC1239016'
p5334
sg7
g5330
sg9
V7748631.xml
p5335
sa(dp5336
g3
VSTD-Drummond-1994
p5337
sg5
S'PMC2539573'
p5338
sg7
g5330
sg9
V8148678.xml
p5339
sa(dp5340
g3
VSTD-Llewelyn_x002d_Jones-1999
p5341
sg5
S'PMC28220'
p5342
sg7
g5330
sg9
V10480824.xml
p5343
sa(dp5344
g3
VSTD-Byng-2004
p5345
sg5
S'PMC1314850'
p5346
sg7
g5330
sg9
V15113492.xml
p5347
sa(dp5348
g3
VSTD-Qu-2007
p5349
sg5
S'PMC1810361'
p5350
sg7
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p5351
sg9
V17342250.xml
p5352
sa(dp5353
g3
VSTD-Kariminia-2004
p5354
sg5
S'PMC351839'
p5355
sg7
VCD001063 v. 5.0 Hands and knees posture in late pregnancy or labour for fetal malposition (lateral or posterior).rm5
p5356
sg9
V14744821.xml
p5357
sa(dp5358
g3
VSTD-Sulke-1992
p5359
sg5
S'PMC1024703'
p5360
sg7
VCD003710 v. 6.0 Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricul.rm5
p5361
sg9
V1739528.xml
p5362
sa(dp5363
g3
VSTD-Mitsuoka
p5364
sg5
S'PMC1216582'
p5365
sg7
g5361
sg9
V3056477.xml
p5366
sa(dp5367
g3
VSTD-Boon
p5368
sg5
S'PMC1277244'
p5369
sg7
g5361
sg9
V3304370.xml
p5370
sa(dp5371
g3
VSTD-Hargreaves
p5372
sg5
S'PMC484046'
p5373
sg7
g5361
sg9
V7488454.xml
p5374
sa(dp5375
g3
VSTD-Kenny
p5376
sg5
S'PMC1236894'
p5377
sg7
g5361
sg9
V3790382.xml
p5378
sa(dp5379
g3
VSTD-Oldroyd
p5380
sg5
S'PMC1024577'
p5381
sg7
g5361
sg9
V1827588.xml
p5382
sa(dp5383
g3
VSTD-Perrins
p5384
sg5
S'PMC481382'
p5385
sg7
g5361
sg9
V6349666.xml
p5386
sa(dp5387
g3
VSTD-Morisky-2001
p5388
sg5
S'PMC1497389'
p5389
sg7
VCD004808 v. 6.2 Contracts between patients and healthcare practitioners for improving patients' adherence to treatme.rm5
p5390
sg9
V12196616.xml
p5391
sa(dp5392
g3
VSTD-Aragona-1975
p5393
sg5
S'PMC1311852'
p5394
sg7
g5390
sg9
V1184491.xml
p5395
sa(dp5396
g3
VSTD-Campbell_x002d_Brown-1987
p5397
sg5
S'PMC1246728'
p5398
sg7
VCD007855 v. 2.0 Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy.rm5
p5399
sg9
V3113538.xml
p5400
sa(dp5401
g3
VSTD-Creed_x002d_UK_x002d_1996
p5402
sg5
S'PMC2126667'
p5403
sg7
VCD004026 v. 6.0 Day hospital versus admission for acute psychiatric disorders.rm5
p5404
sg9
V9161310.xml
p5405
sa(dp5406
g3
VSTD-Creed_x002d_UK_x002d_1990
p5407
sg5
S'PMC1662770'
p5408
sg7
g5404
sg9
V2188696.xml
p5409
sa(dp5410
g3
VSTD-Fadella-1996
p5411
sg5
S'PMC1061173'
p5412
sg7
VCD000375 v. 7.0 Longchain polyunsaturated fatty acid supplementation in preterm infants.rm5
p5413
sg9
V8949693.xml
p5414
sa(dp5415
g3
VSTD-Cochrane-1990
p5416
sg5
S'PMC462468'
p5417
sg7
VCD001116 v. 9.2 Physical training for asthma.rm5
p5418
sg9
V2116678.xml
p5419
sa(dp5420
g3
VSTD-Matsumoto-1999
p5421
sg5
S'PMC1745437'
p5422
sg7
g5418
sg9
V10325893.xml
p5423
sa(dp5424
g3
VSTD-Macdonald-1992
p5425
sg5
S'PMC1590483'
p5426
sg7
VCD001819 v. 6.0 Continuous nasogastric milk feeding versus intermittent bolus milk feeding for premature infants les.rm5
p5427
sg9
V1586185.xml
p5428
sa(dp5429
g3
VSTD-Bouzari-2011
p5430
sg5
S'PMC3217057'
p5431
sg7
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p5432
sg9
V22026956.xml
p5433
sa(dp5434
g3
VSTD-Yekta-2011
p5435
sg5
S'PMC3233526'
p5436
sg7
g5432
sg9
V22162919.xml
p5437
sa(dp5438
g3
VSTD-Egan-1983
p5439
sg5
S'PMC3582081'
p5440
sg7
VCD005463 v. 3.2 Individual and group-based parenting programmes for the treatment of physical child abuse and neglec.rm5
p5441
sg9
V23476865.xml
p5442
sa(dp5443
g3
VSTD-Boscoe-1983
p5444
sg5
S'PMC1549862'
p5445
sg7
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p5446
sg9
V6416575.xml
p5447
sa(dp5448
g3
VSTD-Starobin-2007
p5449
sg5
S'PMC1892551'
p5450
sg7
g5446
sg9
V17547746.xml
p5451
sa(dp5452
g3
VSTD-Maartense-2004a
p5453
sg5
S'PMC1356514'
p5454
sg7
VCD006267 v. 3.3 Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial .rm5
p5455
sg9
V15570204.xml
p5456
sa(dp5457
g3
VSTD-Larson-2006
p5458
sg5
S'PMC1570559'
p5459
sg7
g5455
sg9
V16633002.xml
p5460
sa(dp5461
g3
VSTD-Brown-2007
p5462
sg5
S'PMC2213513'
p5463
sg7
VCD000031 v. 17.0 Antidepressants for smoking cessation.rm5
p5464
sg9
V17577801.xml
p5465
sa(dp5466
g3
VSTD-Aveyard-2008
p5467
sg5
S'PMC2405820'
p5468
sg7
g5464
sg9
V18441375.xml
p5469
sa(dp5470
g3
VSTD-George-2008
p5471
sg5
S'PMC2693008'
p5472
sg7
g5464
sg9
V18096137.xml
p5473
sa(dp5474
g3
VSTD-Grant-2007
p5475
sg5
S'PMC2064868'
p5476
sg7
g5464
sg9
V17889314.xml
p5477
sa(dp5478
g3
VSTD-Piper-2007
p5479
sg5
S'PMC3030120'
p5480
sg7
g5464
sg9
V17763111.xml
p5481
sa(dp5482
g3
VSTD-Niaura-2002
p5483
sg5
S'PMC1852538'
p5484
sg7
g5464
sg9
V12182272.xml
p5485
sa(dp5486
g3
VSTD-Holt-2005
p5487
sg5
S'PMC1747282'
p5488
sg7
g5464
sg9
V15681499.xml
p5489
sa(dp5490
g3
VSTD-Matts-1964
p5491
sg5
S'PMC2482577'
p5492
sg7
VCD003971 v. 9.0 Methadone for cancer pain.rm5
p5493
sg9
V14122903.xml
p5494
sa(dp5495
g3
VSTD-Tan-2008
p5496
sg5
S'PMC2780654'
p5497
sg7
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p5498
sg9
V18545884.xml
p5499
sa(dp5500
g3
VSTD-de-Lalla-2001
p5501
sg5
S'PMC90429'
p5502
sg7
VCD006810 v. 4.2 Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.rm5
p5503
sg9
V11257020.xml
p5504
sa(dp5505
g3
VSTD-Wamalwa-2009
p5506
sg5
S'PMC2708138'
p5507
sg7
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p5508
sg9
V19549342.xml
p5509
sa(dp5510
g3
VSTD-Bolam-1998
p5511
sg5
S'PMC28481'
p5512
sg7
VCD010038 v. 2.2 Face to face interventions for informing or educating parents about early childhood vaccination.rm5
p5513
sg9
V9549449.xml
p5514
sa(dp5515
g3
VSTD-Usman-2011
p5516
sg5
S'PMC3763701'
p5517
sg7
g5513
sg9
V21159080.xml
p5518
sa(dp5519
g3
VSTD-Steiner-2001
p5520
sg5
S'PMC26560'
p5521
sg7
VCD002214 v. 6.0 Effectiveness of intermediate care in nursing-led in-patient units.rm5
p5522
sg9
V11222419.xml
p5523
sa(dp5524
g3
VSTD-Patel-2009
p5525
sg5
S'PMC2684117'
p5526
sg7
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p5527
sg9
V19416499.xml
p5528
sa(dp5529
g3
VSTD-Roy-1997
p5530
sg5
S'PMC1717301'
p5531
sg7
g5527
sg9
V9370894.xml
p5532
sa(dp5533
g3
VSTD-Patel-2009a-_x0028_zinc_x0029_
p5534
sg5
S'PMC2684117'
p5535
sg7
g5527
sg9
V19416499.xml
p5536
sa(dp5537
g3
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p5538
sg5
S'PMC2684117'
p5539
sg7
g5527
sg9
V19416499.xml
p5540
sa(dp5541
g3
VSTD-b-MOCCSG-1980
p5542
sg5
S'PMC3385043'
p5543
sg7
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p5544
sg9
V22768013.xml
p5545
sa(dp5546
g3
VSTD-d-SGCTG-1986
p5547
sg5
S'PMC1977737'
p5548
sg7
g5544
sg9
V1739629.xml
p5549
sa(dp5550
g3
VSTD-Stenson-1998
p5551
sg5
S'PMC1720861'
p5552
sg7
VCD001815 v. 6.6 Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.rm5
p5553
sg9
V10194995.xml
p5554
sa(dp5555
g3
VSTD-Ng-PC-2001
p5556
sg5
S'PMC1721258'
p5557
sg7
g5553
sg9
V11320044.xml
p5558
sa(dp5559
g3
VSTD-Nicolle-1989
p5560
sg5
S'PMC176057'
p5561
sg7
VCD001209 v. 11.0 Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.rm5
p5562
sg9
V2675752.xml
p5563
sa(dp5564
g3
VSTD-Louis-2009
p5565
sg5
S'PMC2826448'
p5566
sg7
VCD008535 v. 2.0 Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease evidence from observati.rm5
p5567
sg9
V19696520.xml
p5568
sa(dp5569
g3
VSTD-Simon-2010
p5570
sg5
S'PMC2939261'
p5571
sg7
g5567
sg9
V20669249.xml
p5572
sa(dp5573
g3
VSTD-Ritz-2010
p5574
sg5
S'PMC2917467'
p5575
sg7
g5567
sg9
V20437557.xml
p5576
sa(dp5577
g3
VSTD-Ton-2007
p5578
sg5
S'PMC1893113'
p5579
sg7
g5567
sg9
V17055323.xml
p5580
sa(dp5581
g3
VSTD-Slama-1990
p5582
sg5
S'PMC1663307'
p5583
sg7
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p5584
sg9
V2202445.xml
p5585
sa(dp5586
g3
VSTD-Marshall-1985
p5587
sg5
S'PMC1415622'
p5588
sg7
g5584
sg9
V3922510.xml
p5589
sa(dp5590
g3
VSTD-Lang-2000
p5591
sg5
S'PMC1731676'
p5592
sg7
g5584
sg9
V10814655.xml
p5593
sa(dp5594
g3
VSTD-Rose-78_x002d_92
p5595
sg5
S'PMC1060968'
p5596
sg7
g5584
sg9
V370171.xml
p5597
sa(dp5598
g3
VSTD-Russell-1979
p5599
sg5
S'PMC1595592'
p5600
sg7
g5584
sg9
V476401.xml
p5601
sa(dp5602
g3
VSTD-Janz-1987
p5603
sg5
S'PMC1647206'
p5604
sg7
g5584
sg9
V3592033.xml
p5605
sa(dp5606
g3
VSTD-Meyer-2008
p5607
sg5
S'PMC2253708'
p5608
sg7
g5584
sg9
V17995993.xml
p5609
sa(dp5610
g3
VSTD-BTS-1990a
p5611
sg5
S'PMC462779'
p5612
sg7
g5584
sg9
V2256010.xml
p5613
sa(dp5614
g3
VSTD-Richmond-1986
p5615
sg5
S'PMC1339727'
p5616
sg7
g5584
sg9
V3082450.xml
p5617
sa(dp5618
g3
VSTD-McDowell-1985
p5619
sg5
S'PMC2327690'
p5620
sg7
g5584
sg9
V21274108.xml
p5621
sa(dp5622
g3
VSTD-Jamrozik-1984
p5623
sg5
S'PMC1441184'
p5624
sg7
g5584
sg9
V6426618.xml
p5625
sa(dp5626
g3
VSTD-Unrod-2007
p5627
sg5
S'PMC1829425'
p5628
sg7
g5584
sg9
V17372796.xml
p5629
sa(dp5630
g3
VSTD-Stewart-1982
p5631
sg5
S'PMC1863274'
p5632
sg7
g5584
sg9
V7074505.xml
p5633
sa(dp5634
g3
VSTD-Wilson-1982
p5635
sg5
S'PMC1862918'
p5636
sg7
g5584
sg9
V7037143.xml
p5637
sa(dp5638
g3
VSTD-BTS-1990b
p5639
sg5
S'PMC462779'
p5640
sg7
g5584
sg9
V2256010.xml
p5641
sa(dp5642
g3
VSTD-Russell-1983
p5643
sg5
S'PMC1549849'
p5644
sg7
g5584
sg9
V6416593.xml
p5645
sa(dp5646
g3
VSTD-Lalit-2004
p5647
sg5
S'PMC2950952'
p5648
sg7
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p5649
sg9
V21206792.xml
p5650
sa(dp5651
g3
VSTD-Ekberg-1994
p5652
sg5
S'PMC1128125'
p5653
sg7
VCD002194 v. 8.1 Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults.rm5
p5654
sg9
V7849868.xml
p5655
sa(dp5656
g3
VSTD-Windbichler-2000
p5657
sg5
S'PMC2363351'
p5658
sg7
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p5659
sg9
V10735496.xml
p5660
sa(dp5661
g3
VSTD-Hall-2004
p5662
sg5
S'PMC2364769'
p5663
sg7
g5659
sg9
V15305182.xml
p5664
sa(dp5665
g3
VSTD-Ridsdale-1999
p5666
sg5
S'PMC1313394'
p5667
sg7
VCD006244 v. 6.0 Care delivery and self-management strategies for adults with epilepsy.rm5
p5668
sg9
V10736906.xml
p5669
sa(dp5670
g3
VSTD-Thapar-2002
p5671
sg5
S'PMC1314230'
p5672
sg7
g5668
sg9
V11885833.xml
p5673
sa(dp5674
g3
VSTD-Ridsdale-1997
p5675
sg5
S'PMC2125629'
p5676
sg7
g5668
sg9
V9006472.xml
p5677
sa(dp5678
g3
VSTD-Kalilani-2007
p5679
sg5
S'PMC2048661'
p5680
sg7
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p5681
sg9
V18000538.xml
p5682
sa(dp5683
g3
VSTD-Coulibaly-2006
p5684
sg5
S'PMC1533839'
p5685
sg7
g5681
sg9
V16776817.xml
p5686
sa(dp5687
g3
VSTD-Newschaffer-1998b
p5688
sg5
S'PMC3456288'
p5689
sg7
VCD004348 v. 4.0 Setting and organization of care for persons living with HIVAIDS.rm5
p5690
sg9
V9663974.xml
p5691
sa(dp5692
g3
VSTD-Smith-1996
p5693
sg5
S'PMC2350105'
p5694
sg7
g5690
sg9
V8601114.xml
p5695
sa(dp5696
g3
VSTD-Turner-1998
p5697
sg5
S'PMC1496898'
p5698
sg7
g5690
sg9
V9462490.xml
p5699
sa(dp5700
g3
VSTD-Keitz-2001
p5701
sg5
S'PMC1495270'
p5702
sg7
g5690
sg9
V11556937.xml
p5703
sa(dp5704
g3
VSTD-Hendrickse-1965
p5705
sg5
S'PMC1944076'
p5706
sg7
VCD003954 v. 4.0 Diazepam for treating tetanus.rm5
p5707
sg9
V5917405.xml
p5708
sa(dp5709
g3
VSTD-Sehgal-1994
p5710
sg5
S'PMC2607653'
p5711
sg7
VCD000144 v. 6.0 Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.rm5
p5712
sg9
V8151722.xml
p5713
sa(dp5714
g3
VSTD-Park-2001
p5715
sg5
S'PMC1422079'
p5716
sg7
VCD005059 v. 7.0 Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.rm5
p5717
sg9
V11573049.xml
p5718
sa(dp5719
g3
VSTD-Hawthorne-1992
p5720
sg5
S'PMC1882467'
p5721
sg7
VCD000478 v. 6.0 Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.rm5
p5722
sg9
V1638191.xml
p5723
sa(dp5724
g3
VSTD-Jewell-1974
p5725
sg5
S'PMC1612983'
p5726
sg7
g5722
sg9
V4441827.xml
p5727
sa(dp5728
g3
VSTD-Szegedi-2005
p5729
sg5
S'PMC552808'
p5730
sg7
VCD000448 v. 10.0 St John's wort for major depression.rm5
p5731
sg9
V15708844.xml
p5732
sa(dp5733
g3
VSTD-Woelk-2000
p5734
sg5
S'PMC27467'
p5735
sg7
g5731
sg9
V10968813.xml
p5736
sa(dp5737
g3
VSTD-van-Gurp-2002
p5738
sg5
S'PMC2214056'
p5739
sg7
g5731
sg9
V12053635.xml
p5740
sa(dp5741
g3
VSTD-Kasper-2006
p5742
sg5
S'PMC1538611'
p5743
sg7
g5731
sg9
V16796730.xml
p5744
sa(dp5745
g3
VSTD-Philipp-1999
p5746
sg5
S'PMC28296'
p5747
sg7
g5731
sg9
V10591711.xml
p5748
sa(dp5749
g3
VSTD-Van-Den-Brenk-1968
p5750
sg5
S'PMC2009013'
p5751
sg7
VCD005007 v. 5.3 Hyperbaric oxygenation for tumour sensitisation to radiotherapy.rm5
p5752
sg9
V4854060.xml
p5753
sa(dp5754
g3
VSTD-UKPDS-39
p5755
sg5
S'PMC28660'
p5756
sg7
VCD001841 v. 7.0 First-line drugs for hypertension.rm5
p5757
sg9
V9732338.xml
p5758
sa(dp5759
g3
VSTD-Carter
p5760
sg5
S'PMC3662830'
p5761
sg7
g5757
sg9
V23704171.xml
p5762
sa(dp5763
g3
VSTD-MRC_x002d_O
p5764
sg5
S'PMC1995577'
p5765
sg7
g5757
sg9
V1445513.xml
p5766
sa(dp5767
g3
VSTD-MRC_x002d_TMH
p5768
sg5
S'PMC1416260'
p5769
sg7
g5757
sg9
V2861880.xml
p5770
sa(dp5771
g3
VSTD-Sooch-1965
p5772
sg5
S'PMC2555234'
p5773
sg7
VCD003819 v. 4.2 Iodine supplementation for preventing iodine deficiency disorders in children.rm5
p5774
sg9
V14315706.xml
p5775
sa(dp5776
g3
VSTD-Stutchfield-2005
p5777
sg5
S'PMC1226243'
p5778
sg7
VCD006614 v. 4.0 Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at te.rm5
p5779
sg9
V16115831.xml
p5780
sa(dp5781
g3
VSTD-Woody-2008
p5782
sg5
S'PMC2610690'
p5783
sg7
VCD006749 v. 4.2 Detoxification treatments for opiate dependent adolescents.rm5
p5784
sg9
V18984887.xml
p5785
sa(dp5786
g3
VSTD-Blanc-1993-_x002d_-AHE
p5787
sg5
S'PMC1374099'
p5788
sg7
VCD003044 v. 7.0 Nonabsorbable disaccharides for hepatic encephalopathy.rm5
p5789
sg9
V8432451.xml
p5790
sa(dp5791
g3
VSTD-Chamberlain-1984
p5792
sg5
S'PMC2494468'
p5793
sg7
VCD002929 v. 10.0 Disposable surgical face masks for preventing surgical wound infection in clean surgery.rm5
p5794
sg9
V6391343.xml
p5795
sa(dp5796
g3
VSTD-Crowther-1986
p5797
sg5
S'PMC3655914'
p5798
sg7
VCD003514 v. 7.0 Bed rest with or without hospitalisation for hypertension during pregnancy.rm5
p5799
sg9
V23642125.xml
p5800
sa(dp5801
g3
VSTD-Predel-2004
p5802
sg5
S'PMC1724805'
p5803
sg7
VCD007402 v. 4.0 Topical NSAIDs for acute pain in adults.rm5
p5804
sg9
V15155436.xml
p5805
sa(dp5806
g3
VSTD-Campbell-1994
p5807
sg5
S'PMC1342427'
p5808
sg7
g5804
sg9
V7804585.xml
p5809
sa(dp5810
g3
VSTD-Weller-1980
p5811
sg5
S'PMC471218'
p5812
sg7
VCD007168 v. 3.0 Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.rm5
p5813
sg9
V6767295.xml
p5814
sa(dp5815
g3
VSTD-Nyman-1983
p5816
sg5
S'PMC1040004'
p5817
sg7
VCD005137 v. 5.0 Interventions for unilateral and bilateral refractive amblyopia.rm5
p5818
sg9
V6337623.xml
p5819
sa(dp5820
g3
VSTD-Clarke-2003
p5821
sg5
S'PMC286242'
p5822
sg7
g5818
sg9
V14644966.xml
p5823
sa(dp5824
g3
VSTD-Stewart-2007a
p5825
sg5
S'PMC2001048'
p5826
sg7
g5818
sg9
V17855283.xml
p5827
sa(dp5828
g3
VSTD-PEDIG-2006a
p5829
sg5
S'PMC1609192'
p5830
sg7
g5818
sg9
V16751033.xml
p5831
sa(dp5832
g3
VSTD-PEDIG-2008
p5833
sg5
S'PMC2615691'
p5834
sg7
g5818
sg9
V18789533.xml
p5835
sa(dp5836
g3
VSTD-Brown-2003
p5837
sg5
S'PMC1766133'
p5838
sg7
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p5839
sg9
V14645934.xml
p5840
sa(dp5841
g3
VSTD-Horn-2007
p5842
sg5
S'PMC1832131'
p5843
sg7
g5839
sg9
V17173716.xml
p5844
sa(dp5845
g3
VSTD-Peterson-2009
p5846
sg5
S'PMC2765261'
p5847
sg7
g5839
sg9
V19822836.xml
p5848
sa(dp5849
g3
VSTD-Robinson-2003
p5850
sg5
S'PMC1766134'
p5851
sg7
g5839
sg9
V14645937.xml
p5852
sa(dp5853
g3
VSTD-Yung-1998
p5854
sg5
S'PMC1717748'
p5855
sg7
VCD001276 v. 9.0 Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronc.rm5
p5856
sg9
V10193252.xml
p5857
sa(dp5858
g3
VSTD-Abdalla-2004
p5859
sg5
S'PMC1356290'
p5860
sg7
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p5861
sg9
V15166961.xml
p5862
sa(dp5863
g3
VSTD-McKay-2009
p5864
sg5
S'PMC2817867'
p5865
sg7
g5861
sg9
V20148084.xml
p5866
sa(dp5867
g3
VSTD-Kim-2011
p5868
sg5
S'PMC3204557'
p5869
sg7
g5861
sg9
V22066097.xml
p5870
sa(dp5871
g3
VSTD-USA-2005
p5872
sg5
S'PMC3070486'
p5873
sg7
VCD007388 v. 4.0 Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.rm5
p5874
sg9
V18293201.xml
p5875
sa(dp5876
g3
VSTD-Peeters-1996
p5877
sg5
S'PMC1010292'
p5878
sg7
VCD000332 v. 9.0 Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.rm5
p5879
sg9
V8984939.xml
p5880
sa(dp5881
g3
VSTD-Webb-1985
p5882
sg5
S'PMC1777652'
p5883
sg7
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p5884
sg9
V3907510.xml
p5885
sa(dp5886
g3
VSTD-Gajdos-2010
p5887
sg5
S'PMC2946956'
p5888
sg7
g5884
sg9
V20927359.xml
p5889
sa(dp5890
g3
VSTD-Elden-2005
p5891
sg5
S'PMC555879'
p5892
sg7
VCD001139 v. 5.0 Interventions for preventing and treating pelvic and back pain in pregnancy.rm5
p5893
sg9
V15778231.xml
p5894
sa(dp5895
g3
VSTD-Meier-2003
p5896
sg5
S'PMC1069018'
p5897
sg7
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p5898
sg9
V15931282.xml
p5899
sa(dp5900
g3
VSTD-Zeng-2008-_x0028_C_x0029_
p5901
sg5
S'PMC2577799'
p5902
sg7
g5898
sg9
V18996930.xml
p5903
sa(dp5904
g3
VSTD-Chanarin-1971
p5905
sg5
S'PMC1795515'
p5906
sg7
g5898
sg9
V5551272.xml
p5907
sa(dp5908
g3
VSTD-Butler-1968
p5909
sg5
S'PMC3076126'
p5910
sg7
g5898
sg9
V21439473.xml
p5911
sa(dp5912
g3
VSTD-Christian-2003-_x0028_C_x0029_
p5913
sg5
S'PMC151518'
p5914
sg7
g5898
sg9
V12637400.xml
p5915
sa(dp5916
g3
VSTD-Chanarin-1965
p5917
sg5
S'PMC2165857'
p5918
sg7
g5898
sg9
V14238675.xml
p5919
sa(dp5920
g3
VSTD-Lofdahl-1999
p5921
sg5
S'PMC28156'
p5922
sg7
VCD003133 v. 10.0 Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.rm5
p5923
sg9
V10398629.xml
p5924
sa(dp5925
g3
VSTD-Price-2003
p5926
sg5
S'PMC1746596'
p5927
sg7
g5923
sg9
V12612295.xml
p5928
sa(dp5929
g3
VSTD-Vaquerizo-2003
p5930
sg5
S'PMC1746619'
p5931
sg7
g5923
sg9
V12612294.xml
p5932
sa(dp5933
g3
VSTD-Humphrey-2006
p5934
sg5
S'PMC3007097'
p5935
sg7
VCD003648 v. 8.0 Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.rm5
p5936
sg9
V21177735.xml
p5937
sa(dp5938
g3
VSTD-De-Jong-1994
p5939
sg5
S'PMC2542786'
p5940
sg7
VCD003838 v. 8.2 Diuretics for heart failure.rm5
p5941
sg9
V8136670.xml
p5942
sa(dp5943
g3
VSTD-Walma-1997
p5944
sg5
S'PMC2127314'
p5945
sg7
g5941
sg9
V9284668.xml
p5946
sa(dp5947
g3
VSTD-Resick-2002
p5948
sg5
S'PMC2977927'
p5949
sg7
VCD003388 v. 13.0 Psychological treatment of post-traumatic stress disorder (PTSD).rm5
p5950
sg9
V12182270.xml
p5951
sa(dp5952
g3
VSTD-Resick-2002b
p5953
sg5
S'PMC2977927'
p5954
sg7
g5950
sg9
V12182270.xml
p5955
sa(dp5956
g3
VSTD-Faglia-2010
p5957
sg5
S'PMC2890332'
p5958
sg7
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p5959
sg9
V20357377.xml
p5960
sa(dp5961
g3
VSTD-McClure-2000
p5962
sg5
S'PMC1721038'
p5963
sg7
VCD000504 v. 6.0 Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants.rm5
p5964
sg9
V10634838.xml
p5965
sa(dp5966
g3
VSTD-van-Elburg-2004
p5967
sg5
S'PMC1721703'
p5968
sg7
g5964
sg9
V15210658.xml
p5969
sa(dp5970
g3
VSTD-Hewlett-1999
p5971
sg5
S'PMC3086034'
p5972
sg7
VCD003688 v. 7.0 Patient education for adults with rheumatoid arthritis.rm5
p5973
sg9
V21540202.xml
p5974
sa(dp5975
g3
VSTD-Hill-2001
p5976
sg5
S'PMC1753835'
p5977
sg7
g5973
sg9
V11502614.xml
p5978
sa(dp5979
g3
VSTD-Berry-2007
p5980
sg5
S'PMC1945054'
p5981
sg7
VCD001872 v. 6.15 Interventions for treating obesity in children.rm5
p5982
sg9
V17481469.xml
p5983
sa(dp5984
g3
VSTD-Jiang-2005
p5985
sg5
S'PMC1720215'
p5986
sg7
g5982
sg9
V16188958.xml
p5987
sa(dp5988
g3
VSTD-Schwingshandl-1999
p5989
sg5
S'PMC1718135'
p5990
sg7
g5982
sg9
V10519718.xml
p5991
sa(dp5992
g3
VSTD-Epstein-2008a
p5993
sg5
S'PMC2408744'
p5994
sg7
g5982
sg9
V18239639.xml
p5995
sa(dp5996
g3
VSTD-Karbwang-1994
p5997
sg5
S'PMC2486514'
p5998
sg7
VCD004531 v. 5.0 Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.rm5
p5999
sg9
V8131255.xml
p6000
sa(dp6001
g3
VSTD-Watters-1997
p6002
sg5
S'PMC1191041'
p6003
sg7
VCD006832 v. 2.2 Interventions for preventing critical illness polyneuropathy and critical illness myopathy.rm5
p6004
sg9
V9339943.xml
p6005
sa(dp6006
g3
VSTD-MRC-LU11
p6007
sg5
S'PMC2074683'
p6008
sg7
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p6009
sg9
V8761382.xml
p6010
sa(dp6011
g3
VSTD-Furrie-2005
p6012
sg5
S'PMC1774839'
p6013
sg7
VCD005573 v. 4.0 Probiotics for induction of remission in ulcerative colitis.rm5
p6014
sg9
V15647189.xml
p6015
sa(dp6016
g3
VSTD-Venning-2000
p6017
sg5
S'PMC27348'
p6018
sg7
VCD001271 v. 4.4 Substitution of doctors by nurses in primary care.rm5
p6019
sg9
V10764367.xml
p6020
sa(dp6021
g3
VSTD-Kinnersley-2000
p6022
sg5
S'PMC27347'
p6023
sg7
g6019
sg9
V10764366.xml
p6024
sa(dp6025
g3
VSTD-Moher-2001
p6026
sg5
S'PMC32168'
p6027
sg7
g6019
sg9
V11387182.xml
p6028
sa(dp6029
g3
VSTD-Shum-2000
p6030
sg5
S'PMC27346'
p6031
sg7
g6019
sg9
V10764365.xml
p6032
sa(dp6033
g3
VSTD-Lattimer-1998
p6034
sg5
S'PMC28690'
p6035
sg7
g6019
sg9
V9774295.xml
p6036
sa(dp6037
g3
VSTD-Flynn-1974
p6038
sg5
S'PMC1775498'
p6039
sg7
g6019
sg9
V4829073.xml
p6040
sa(dp6041
g3
VSTD-McIntosh-1997
p6042
sg5
S'PMC2255191'
p6043
sg7
g6019
sg9
V9386883.xml
p6044
sa(dp6045
g3
VSTD-Eke-1983
p6046
sg5
S'PMC1628291'
p6047
sg7
VCD008327 v. 1.0 Interventions for bone disease in children with chronic kidney disease.rm5
p6048
sg9
V6357106.xml
p6049
sa(dp6050
g3
VSTD-Mak-1985
p6051
sg5
S'PMC1417527'
p6052
sg7
g6048
sg9
V3928054.xml
p6053
sa(dp6054
g3
VSTD-Faithfull-2001
p6055
sg5
S'PMC2364007'
p6056
sg7
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p6057
sg9
V11747326.xml
p6058
sa(dp6059
g3
VSTD-GAL_x002d_INT_x002d_1-Wilcock
p6060
sg5
S'PMC27547'
p6061
sg7
VCD005593 v. 9.0 Cholinesterase inhibitors for Alzheimer's disease.rm5
p6062
sg9
V11110737.xml
p6063
sa(dp6064
g3
VSTD-de-Vries-2007a
p6065
sg5
S'PMC1913177'
p6066
sg7
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p6067
sg9
V17372669.xml
p6068
sa(dp6069
g3
VSTD-Burger-2004
p6070
sg5
S'PMC1356459'
p6071
sg7
g6067
sg9
V15383785.xml
p6072
sa(dp6073
g3
VSTD-Amadori-2005
p6074
sg5
S'PMC1895135'
p6075
sg7
VCD008238 v. 3.0 Colony-stimulating factors for prevention and treatment of infectious complications in patients with.rm5
p6076
sg9
V15761020.xml
p6077
sa(dp6078
g3
VSTD-Sekhavat-2012
p6079
sg5
S'PMC3598277'
p6080
sg7
VCD009243 v. 3.0 Antispasmodics for labour.rm5
p6081
sg9
V23515202.xml
p6082
sa(dp6083
g3
VSTD-Makvandi-2010
p6084
sg5
S'PMC3081214'
p6085
sg7
g6081
sg9
V21495198.xml
p6086
sa(dp6087
g3
VSTD-Wallace-1988
p6088
sg5
S'PMC1834369'
p6089
sg7
VCD004148 v. 10.0 Effectiveness of brief alcohol interventions in primary care populations.rm5
p6090
sg9
V3052668.xml
p6091
sa(dp6092
g3
VSTD-Heather-1987
p6093
sg5
S'PMC1711039'
p6094
sg7
g6090
sg9
V3448228.xml
p6095
sa(dp6096
g3
VSTD-McIntosh-1997
p6097
sg5
S'PMC2255191'
p6098
sg7
g6090
sg9
V9386883.xml
p6099
sa(dp6100
g3
VSTD-Gentillelo-1999
p6101
sg5
S'PMC1420896'
p6102
sg7
g6090
sg9
V10522717.xml
p6103
sa(dp6104
g3
VSTD-Horita-2007
p6105
sg5
S'PMC2409178'
p6106
sg7
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p6107
sg9
V17497466.xml
p6108
sa(dp6109
g3
VSTD-Lask-1979
p6110
sg5
S'PMC1545376'
p6111
sg7
VCD000089 v. 11.0 Family therapy for asthma in children.rm5
p6112
sg9
V373642.xml
p6113
sa(dp6114
g3
VSTD-Mariette-1997
p6115
sg5
S'PMC2169620'
p6116
sg7
VCD002827 v. 10.0 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropat.rm5
p6117
sg9
V9221964.xml
p6118
sa(dp6119
g3
VSTD-Mariette-2000
p6120
sg5
S'PMC1737051'
p6121
sg7
g6117
sg9
V10960293.xml
p6122
sa(dp6123
g3
VSTD-Oksenhendler-1995
p6124
sg5
S'PMC486020'
p6125
sg7
g6117
sg9
V7673949.xml
p6126
sa(dp6127
g3
VSTD-Soltanian-2010
p6128
sg5
S'PMC3302710'
p6129
sg7
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p6130
sg9
V22427772.xml
p6131
sa(dp6132
g3
VSTD-Wang-2012
p6133
sg5
S'PMC3292236'
p6134
sg7
g6130
sg9
V22454655.xml
p6135
sa(dp6136
g3
VSTD-Randall-2000
p6137
sg5
S'PMC1298033'
p6138
sg7
g6130
sg9
V10911825.xml
p6139
sa(dp6140
g3
VSTD-McGuiness-1971
p6141
sg5
S'PMC2156454'
p6142
sg7
VCD007575 v. 2.0 Interventions for nausea and vomiting in early pregnancy.rm5
p6143
sg9
V4937061.xml
p6144
sa(dp6145
g3
VSTD-Lahat-2000
p6146
sg5
S'PMC27427'
p6147
sg7
VCD001905 v. 10.0 Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in childr.rm5
p6148
sg9
V10884257.xml
p6149
sa(dp6150
g3
VSTD-Perez-1993
p6151
sg5
S'PMC1374020'
p6152
sg7
VCD000345 v. 7.0 Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for .rm5
p6153
sg9
V8314497.xml
p6154
sa(dp6155
g3
VSTD-Holland-1988
p6156
sg5
S'PMC1386569'
p6157
sg7
VCD002067 v. 10.0 Single dose oral aspirin for acute postoperative pain in adults.rm5
p6158
sg9
V3190996.xml
p6159
sa(dp6160
g3
VSTD-Seymour-1992
p6161
sg5
S'PMC1381328'
p6162
sg7
g6158
sg9
V1576068.xml
p6163
sa(dp6164
g3
VSTD-Nelson-1985
p6165
sg5
S'PMC2148530'
p6166
sg7
g6158
sg9
V2934008.xml
p6167
sa(dp6168
g3
VSTD-Parkhouse-1969
p6169
sg5
S'PMC1946013'
p6170
sg7
g6158
sg9
V4891424.xml
p6171
sa(dp6172
g3
VSTD-Sydney
p6173
sg5
S'PMC1736543'
p6174
sg7
VCD006564 v. 4.0 Dopamine agonist therapy in early Parkinson's disease.rm5
p6175
sg9
V10449550.xml
p6176
sa(dp6177
g3
VSTD-Grunfeld
p6178
sg5
S'PMC2351993'
p6179
sg7
VCD001768 v. 9.0 Follow-up strategies for women treated for early breast cancer.rm5
p6180
sg9
V8811760.xml
p6181
sa(dp6182
g3
VSTD-Gulliford
p6183
sg5
S'PMC2125684'
p6184
sg7
g6180
sg9
V9022429.xml
p6185
sa(dp6186
g3
VSTD-Lagro_x002d_Janssen-1991
p6187
sg5
S'PMC1371786'
p6188
sg7
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p6189
sg9
V1807303.xml
p6190
sa(dp6191
g3
VSTD-B_x00f8_-1999
p6192
sg5
S'PMC27740'
p6193
sg7
g6189
sg9
V10024253.xml
p6194
sa(dp6195
g3
VSTD-Castro-2008
p6196
sg5
S'PMC2664121'
p6197
sg7
g6189
sg9
V18719756.xml
p6198
sa(dp6199
g3
VSTD-Klopper-1962
p6200
sg5
S'PMC1926558'
p6201
sg7
VCD003393 v. 6.0 Oestrogens alone or with amniotomy for cervical ripening or induction of labour.rm5
p6202
sg9
V14033615.xml
p6203
sa(dp6204
g3
VSTD-Tromans-1981
p6205
sg5
S'PMC1504503'
p6206
sg7
g6202
sg9
V6781613.xml
p6207
sa(dp6208
g3
VSTD-Pras-1995
p6209
sg5
S'PMC3399783'
p6210
sg7
VCD008285 v. 2.0 Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer individual patien.rm5
p6211
sg9
V22815624.xml
p6212
sa(dp6213
g3
VSTD-Bowen-2007
p6214
sg5
S'PMC2639555'
p6215
sg7
VCD006483 v. 3.8 Interactive computer-based interventions for sexual health promotion.rm5
p6216
sg9
V16849391.xml
p6217
sa(dp6218
g3
VSTD-Di-Noia-2004
p6219
sg5
S'PMC1524876'
p6220
sg7
g6216
sg9
V15193576.xml
p6221
sa(dp6222
g3
VSTD-SELECT-2009
p6223
sg5
S'PMC3682779'
p6224
sg7
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p6225
sg9
V19066370.xml
p6226
sa(dp6227
g3
VSTD-Salonen-1985
p6228
sg5
S'PMC1417771'
p6229
sg7
g6225
sg9
V3918611.xml
p6230
sa(dp6231
g3
VSTD-Epplein-2009
p6232
sg5
S'PMC2755047'
p6233
sg7
g6225
sg9
V19531680.xml
p6234
sa(dp6235
g3
VSTD-Peters-2007
p6236
sg5
S'PMC1839923'
p6237
sg7
g6225
sg9
V17209198.xml
p6238
sa(dp6239
g3
VSTD-Michaud-2005
p6240
sg5
S'PMC2361644'
p6241
sg7
g6225
sg9
V16175184.xml
p6242
sa(dp6243
g3
VSTD-Dong-2008
p6244
sg5
S'PMC2366201'
p6245
sg7
g6225
sg9
V18444134.xml
p6246
sa(dp6247
g3
VSTD-Peters-2008
p6248
sg5
S'PMC2729504'
p6249
sg7
g6225
sg9
V19687417.xml
p6250
sa(dp6251
g3
VSTD-Ringstad-1988
p6252
sg5
S'PMC1141475'
p6253
sg7
g6225
sg9
V3366933.xml
p6254
sa(dp6255
g3
VSTD-Jones-1996
p6256
sg5
S'PMC2353074'
p6257
sg7
VCD002902 v. 9.0 Psychological interventions for coronary heart disease.rm5
p6258
sg9
V8978226.xml
p6259
sa(dp6260
g3
VSTD-McLaughlin-2005
p6261
sg5
S'PMC1490273'
p6262
sg7
g6258
sg9
V16423095.xml
p6263
sa(dp6264
g3
VSTD-aa-Rudenko-1996a
p6265
sg5
S'PMC2486837'
p6266
sg7
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p6267
sg9
V8653819.xml
p6268
sa(dp6269
g3
VSTD-ba-Kissling-2011
p6270
sg5
S'PMC3216983'
p6271
sg7
g6267
sg9
V22110695.xml
p6272
sa(dp6273
g3
VSTD-ba-Valenciano-2011
p6274
sg5
S'PMC3019108'
p6275
sg7
g6267
sg9
V21379316.xml
p6276
sa(dp6277
g3
VSTD-aa-Principi-2003
p6278
sg5
S'PMC1719733'
p6279
sg7
g6267
sg9
V15499051.xml
p6280
sa(dp6281
g3
VSTD-ba-Eisenberg-2008a
p6282
sg5
S'PMC3695734'
p6283
sg7
g6267
sg9
V18977968.xml
p6284
sa(dp6285
g3
VSTD-ba-Eisenberg-2008b
p6286
sg5
S'PMC3695734'
p6287
sg7
g6267
sg9
V18977968.xml
p6288
sa(dp6289
g3
VSTD-ab-Mallory-2010
p6290
sg5
S'PMC2966412'
p6291
sg7
g6267
sg9
V21060780.xml
p6292
sa(dp6293
g3
VSTD-AMCT_x002d_010--2005
p6294
sg5
S'PMC1895225'
p6295
sg7
VCD005419 v. 4.0 Interventions for previously untreated patients with AIDS-associated Non-Hodgkins Lymphoma.rm5
p6296
sg9
V15914552.xml
p6297
sa(dp6298
g3
VSTD-Macaulay-1988
p6299
sg5
S'PMC1245577'
p6300
sg7
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p6301
sg9
V3103764.xml
p6302
sa(dp6303
g3
VSTD-Song-2006
p6304
sg5
S'PMC2721929'
p6305
sg7
g6301
sg9
V17179687.xml
p6306
sa(dp6307
g3
VSTD-Chancellor-2008
p6308
sg5
S'PMC2325270'
p6309
sg7
g6301
sg9
V18324952.xml
p6310
sa(dp6311
g3
VSTD-Burgio-2008
p6312
sg5
S'PMC3201984'
p6313
sg7
g6301
sg9
V18678843.xml
p6314
sa(dp6315
g3
VSTD-Kim-2001
p6316
sg5
S'PMC3349651'
p6317
sg7
VCD003316 v. 6.0 Physical fitness training for stroke patients.rm5
p6318
sg9
V17903837.xml
p6319
sa(dp6320
g3
VSTD-Sanderson-1987
p6321
sg5
S'PMC1778272'
p6322
sg7
VCD003873 v. 5.0 Interventions for growth failure in childhood Crohn's disease.rm5
p6323
sg9
V3548602.xml
p6324
sa(dp6325
g3
VSTD-Seymour-1996
p6326
sg5
S'PMC2042618'
p6327
sg7
VCD004602 v. 6.3 Single dose oral paracetamol (acetaminophen) for postoperative pain in adults.rm5
p6328
sg9
V8799525.xml
p6329
sa(dp6330
g3
VSTD-Cooper-1986
p6331
sg5
S'PMC2175476'
p6332
sg7
g6328
sg9
V3461725.xml
p6333
sa(dp6334
g3
VSTD-Bautmans-2005
p6335
sg5
S'PMC1368976'
p6336
sg7
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p6337
sg9
V16372905.xml
p6338
sa(dp6339
g3
VSTD-Kerse-2008
p6340
sg5
S'PMC2565754'
p6341
sg7
g6337
sg9
V18845605.xml
p6342
sa(dp6343
g3
VSTD-Sackley-2009
p6344
sg5
S'PMC2736373'
p6345
sg7
g6337
sg9
V19723707.xml
p6346
sa(dp6347
g3
VSTD-Makita-2006
p6348
sg5
S'PMC2723343'
p6349
sg7
g6337
sg9
V21432349.xml
p6350
sa(dp6351
g3
VSTD-Tappen-2000
p6352
sg5
S'PMC1950269'
p6353
sg7
g6337
sg9
V11186596.xml
p6354
sa(dp6355
g3
VSTD-Chin-A-Paw-2004
p6356
sg5
S'PMC471553'
p6357
sg7
g6337
sg9
V15233841.xml
p6358
sa(dp6359
g3
VSTD-Tappen-1994
p6360
sg5
S'PMC1952655'
p6361
sg7
g6337
sg9
V8184127.xml
p6362
sa(dp6363
g3
VSTD-Mattar-2005
p6364
sg5
S'PMC1402345'
p6365
sg7
VCD007340 v. 3.0 Bariatric surgery for non-alcoholic steatohepatitis in obese patients.rm5
p6366
sg9
V16192822.xml
p6367
sa(dp6368
g3
VSTD-Chittenden-1997
p6369
sg5
S'PMC1722170'
p6370
sg7
VCD006291 v. 4.0 Sub-Tenon's anaesthesia versus topical anaesthesia for cataract surgery.rm5
p6371
sg9
V9215056.xml
p6372
sa(dp6373
g3
VSTD-R_x00fc_schen-2005
p6374
sg5
S'PMC1772574'
p6375
sg7
g6371
sg9
V15722306.xml
p6376
sa(dp6377
g3
VSTD-Study-315
p6378
sg5
S'PMC2962290'
p6379
sg7
VCD001190 v. 14.0 Donepezil for dementia due to Alzheimer's disease.rm5
p6380
sg9
V21455360.xml
p6381
sa(dp6382
g3
VSTD-Kucuk-2007
p6383
sg5
S'PMC3454992'
p6384
sg7
VCD004379 v. 5.4 Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertil.rm5
p6385
sg9
V18008156.xml
p6386
sa(dp6387
g3
VSTD-Gebbia-1996
p6388
sg5
S'PMC2074540'
p6389
sg7
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p6390
sg9
V8664133.xml
p6391
sa(dp6392
g3
VSTD-Field-1966
p6393
sg5
S'PMC1843176'
p6394
sg7
VCD005189 v. 11.0 Antibiotics for bronchiolitis in children.rm5
p6395
sg9
V5323069.xml
p6396
sa(dp6397
g3
VSTD-Subrahmanyam-1996a
p6398
sg5
S'PMC2991644'
p6399
sg7
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p6400
sg9
V21189872.xml
p6401
sa(dp6402
g3
VSTD-Subrahmanyam-1996c
p6403
sg5
S'PMC2894501'
p6404
sg7
g6400
sg9
V20640210.xml
p6405
sa(dp6406
g3
VSTD-Nilforoushzadeh-2007
p6407
sg5
S'PMC1891315'
p6408
sg7
g6400
sg9
V17466071.xml
p6409
sa(dp6410
g3
VSTD-Baghel-2009
p6411
sg5
S'PMC2845359'
p6412
sg7
g6400
sg9
V20368852.xml
p6413
sa(dp6414
g3
VSTD-Subrahmanyam-1993b
p6415
sg5
S'PMC2894501'
p6416
sg7
g6400
sg9
V20640210.xml
p6417
sa(dp6418
g3
VSTD-Richens-1994
p6419
sg5
S'PMC1072969'
p6420
sg7
VCD001030 v. 11.2 Carbamazepine versus valproate monotherapy for epilepsy.rm5
p6421
sg9
V8006647.xml
p6422
sa(dp6423
g3
VSTD-Callaghan-1985
p6424
sg5
S'PMC1028404'
p6425
sg7
g6421
sg9
V3928820.xml
p6426
sa(dp6427
g3
VSTD-Heller-1995
p6428
sg5
S'PMC1073267'
p6429
sg7
g6421
sg9
V7823066.xml
p6430
sa(dp6431
g3
VSTD-Wang-1996
p6432
sg5
S'PMC472613'
p6433
sg7
VCD001146 v. 8.0 Early ( 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.rm5
p6434
sg9
V8984701.xml
p6435
sa(dp6436
g3
VSTD-Subhedar-1997
p6437
sg5
S'PMC1720712'
p6438
sg7
g6434
sg9
V9462187.xml
p6439
sa(dp6440
g3
VSTD-Shinwell-1996
p6441
sg5
S'PMC2528319'
p6442
sg7
g6434
sg9
V8653433.xml
p6443
sa(dp6444
g3
VSTD-Elmes-1957
p6445
sg5
S'PMC1963159'
p6446
sg7
VCD010257 v. 1.2 Antibiotics for exacerbations of chronic obstructive pulmonary disease.rm5
p6447
sg9
V13479695.xml
p6448
sa(dp6449
g3
VSTD-Sachs-1995
p6450
sg5
S'PMC474649'
p6451
sg7
g6447
sg9
V7570411.xml
p6452
sa(dp6453
g3
VSTD-Pines-1968
p6454
sg5
S'PMC1991661'
p6455
sg7
g6447
sg9
V4872151.xml
p6456
sa(dp6457
g3
VSTD-McCaul-1984
p6458
sg5
S'PMC1307916'
p6459
sg7
VCD005031 v. 13.0 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxificat.rm5
p6460
sg9
V6725168.xml
p6461
sa(dp6462
g3
VSTD-Katz-2011
p6463
sg5
S'PMC3090541'
p6464
sg7
g6460
sg9
V21277704.xml
p6465
sa(dp6466
g3
VSTD-Campbell-2009
p6467
sg5
S'PMC2779725'
p6468
sg7
g6460
sg9
V19586142.xml
p6469
sa(dp6470
g3
VSTD-Schmidt-1975
p6471
sg5
S'PMC492284'
p6472
sg7
VCD001332 v. 6.0 Anti-spasticity agents for multiple sclerosis.rm5
p6473
sg9
V778344.xml
p6474
sa(dp6475
g3
VSTD-Hyman-2000
p6476
sg5
S'PMC1736956'
p6477
sg7
g6473
sg9
V10811692.xml
p6478
sa(dp6479
g3
VSTD-a01-MRC-LU02
p6480
sg5
S'PMC1977284'
p6481
sg7
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p6482
sg9
V3907687.xml
p6483
sa(dp6484
g3
VSTD-c11-Gwent-1
p6485
sg5
S'PMC471474'
p6486
sg7
g6482
sg9
V7281085.xml
p6487
sa(dp6488
g3
VSTD-d04-RLW-8351
p6489
sg5
S'PMC1971367'
p6490
sg7
g6482
sg9
V1691921.xml
p6491
sa(dp6492
g3
VSTD-d06-Southampton
p6493
sg5
S'PMC1971367'
p6494
sg7
g6482
sg9
V1691921.xml
p6495
sa(dp6496
g3
VSTD-Pescovitz-2004
p6497
sg5
S'PMC2198786'
p6498
sg7
VCD004290 v. 8.0 Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in ki.rm5
p6499
sg9
V17555465.xml
p6500
sa(dp6501
g3
VSTD-Macdonald-1954
p6502
sg5
S'PMC2011610'
p6503
sg7
VCD001167 v. 5.2 Antimicrobials for treating symptomatic non-typhoidal Salmonella infection.rm5
p6504
sg9
V13159368.xml
p6505
sa(dp6506
g3
VSTD-Pugh-1989
p6507
sg5
S'PMC1216711'
p6508
sg7
VCD002901 v. 10.0 Digitalis for treatment of heart failure in patients in sinus rhythm.rm5
p6509
sg9
V2503017.xml
p6510
sa(dp6511
g3
VSTD-Bye-1980
p6512
sg5
S'PMC1713673'
p6513
sg7
VCD004976 v. 8.5 Oral antihistamine-decongestant-analgesic combinations for the common cold.rm5
p6514
sg9
V6996784.xml
p6515
sa(dp6516
g3
VSTD-Sperber-1989
p6517
sg5
S'PMC1807791'
p6518
sg7
g6514
sg9
V2557947.xml
p6519
sa(dp6520
g3
VSTD-Canata-2003
p6521
sg5
S'PMC3270172'
p6522
sg7
VCD005259 v. 6.0 Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.rm5
p6523
sg9
V21842298.xml
p6524
sa(dp6525
g3
VSTD-Motzer_x0028_1_x0029_-2010
p6526
sg5
S'PMC3646307'
p6527
sg7
VCD006017 v. 4.4 Targeted therapy for advanced renal cell carcinoma.rm5
p6528
sg9
V19487381.xml
p6529
sa(dp6530
g3
VSTD-Rini-2010
p6531
sg5
S'PMC2651074'
p6532
sg7
g6528
sg9
V18936475.xml
p6533
sa(dp6534
g3
VSTD-Yang-2003
p6535
sg5
S'PMC2275324'
p6536
sg7
g6528
sg9
V12890841.xml
p6537
sa(dp6538
g3
VSTD-Madhusudan-2004
p6539
sg5
S'PMC2394342'
p6540
sg7
g6528
sg9
V14562010.xml
p6541
sa(dp6542
g3
VSTD-Li-2003
p6543
sg5
S'PMC3707322'
p6544
sg7
VCD006625 v. 3.0 Quetiapine versus other atypical antipsychotics for schizophrenia.rm5
p6545
sg9
V23869281.xml
p6546
sa(dp6547
g3
VSTD-Pinion-1994
p6548
sg5
S'PMC2541307'
p6549
sg7
VCD000329 v. 7.0 Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.rm5
p6550
sg9
V7772106.xml
p6551
sa(dp6552
g3
VSTD-Gannon-1991
p6553
sg5
S'PMC1671634'
p6554
sg7
g6550
sg9
V1760601.xml
p6555
sa(dp6556
g3
VSTD-Rosenfeldt-2011
p6557
sg5
S'PMC3063826'
p6558
sg7
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p6559
sg9
V21385466.xml
p6560
sa(dp6561
g3
VSTD-Daniell-2006
p6562
sg5
S'PMC1857014'
p6563
sg7
VCD009078 v. 3.2 Topical cyclosporine for atopic keratoconjunctivitis.rm5
p6564
sg9
V16547328.xml
p6565
sa(dp6566
g3
VSTD-Thompson-1999
p6567
sg5
S'PMC1230704'
p6568
sg7
VCD003286 v. 4.0 Specialist nurses in diabetes mellitus.rm5
p6569
sg9
V10551191.xml
p6570
sa(dp6571
g3
VSTD-Garc_x00ed_a_x002d_Toro-2001-c
p6572
sg5
S'PMC1763496'
p6573
sg7
VCD003493 v. 10.0 Transcranial magnetic stimulation for treating depression.rm5
p6574
sg9
V11561046.xml
p6575
sa(dp6576
g3
VSTD-Sargent-2009a
p6577
sg5
S'PMC3719160'
p6578
sg7
VCD003439 v. 6.5 Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.rm5
p6579
sg9
V19413793.xml
p6580
sa(dp6581
g3
VSTD-Gilpin-2007
p6582
sg5
S'PMC1931446'
p6583
sg7
g6579
sg9
V17600271.xml
p6584
sa(dp6585
g3
VSTD-While-1996
p6586
sg5
S'PMC2351819'
p6587
sg7
g6579
sg9
V8761227.xml
p6588
sa(dp6589
g3
VSTD-Biener-2000
p6590
sg5
S'PMC1446173'
p6591
sg7
g6579
sg9
V10705860.xml
p6592
sa(dp6593
g3
VSTD-Henriksen-2010
p6594
sg5
S'PMC3046636'
p6595
sg7
g6579
sg9
V20643725.xml
p6596
sa(dp6597
g3
VSTD-Sargent-2009b
p6598
sg5
S'PMC2707779'
p6599
sg7
g6579
sg9
V18948391.xml
p6600
sa(dp6601
g3
VSTD-Ward-2002
p6602
sg5
S'PMC117136'
p6603
sg7
VCD006375 v. 4.6 Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women.rm5
p6604
sg9
V12114234.xml
p6605
sa(dp6606
g3
VSTD-Tibbutt-1974
p6607
sg5
S'PMC1633603'
p6608
sg7
VCD004437 v. 6.0 Thrombolytic therapy for pulmonary embolism.rm5
p6609
sg9
V4594580.xml
p6610
sa(dp6611
g3
VSTD-Kylmala-1997
p6612
sg5
S'PMC2228066'
p6613
sg7
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p6614
sg9
V9328156.xml
p6615
sa(dp6616
g3
VSTD-Morice-2007
p6617
sg5
S'PMC2228375'
p6618
sg7
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p6619
sg9
V17887990.xml
p6620
sa(dp6621
g3
VSTD-Price-2002
p6622
sg5
S'PMC1746437'
p6623
sg7
g6619
sg9
V12200524.xml
p6624
sa(dp6625
g3
VSTD-Hawthorne-1992
p6626
sg5
S'PMC1379405'
p6627
sg7
VCD006443 v. 3.0 Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.rm5
p6628
sg9
V1353742.xml
p6629
sa(dp6630
g3
VSTD-Lindenmuth-1989
p6631
sg5
S'PMC2190635'
p6632
sg7
VCD007440 v. 6.0 Single dose oral diflunisal for acute postoperative pain in adults.rm5
p6633
sg9
V2490035.xml
p6634
sa(dp6635
g3
VSTD-Chaowagul-2005
p6636
sg5
S'PMC1251512'
p6637
sg7
VCD001263 v. 8.2 Interventions for treating melioidosis.rm5
p6638
sg9
V16189075.xml
p6639
sa(dp6640
g3
VSTD-Sookpranee-1992
p6641
sg5
S'PMC189245'
p6642
sg7
g6638
sg9
V1590682.xml
p6643
sa(dp6644
g3
VSTD-Trinder-2006
p6645
sg5
S'PMC1471967'
p6646
sg7
VCD007223 v. 4.0 Medical treatments for incomplete miscarriage.rm5
p6647
sg9
V16707509.xml
p6648
sa(dp6649
g3
VSTD-Richards-2002
p6650
sg5
S'PMC135495'
p6651
sg7
VCD004180 v. 5.0 Telephone consultation and triage effects on health care use and patient satisfaction.rm5
p6652
sg9
V12446539.xml
p6653
sa(dp6654
g3
VSTD-Jiwa-2002
p6655
sg5
S'PMC1314295'
p6656
sg7
g6652
sg9
V12014537.xml
p6657
sa(dp6658
g3
VSTD-McKinstry-2002
p6659
sg5
S'PMC1314272'
p6660
sg7
g6652
sg9
V11942448.xml
p6661
sa(dp6662
g3
VSTD-Thompson-1999
p6663
sg5
S'PMC28285'
p6664
sg7
g6652
sg9
V10574857.xml
p6665
sa(dp6666
g3
VSTD-Lattimer-1998
p6667
sg5
S'PMC28690'
p6668
sg7
g6652
sg9
V9774295.xml
p6669
sa(dp6670
g3
VSTD-Majumdar-2008
p6671
sg5
S'PMC2244663'
p6672
sg7
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p6673
sg9
V18299546.xml
p6674
sa(dp6675
g3
VSTD-Hollingworth-2002
p6676
sg5
S'PMC1314323'
p6677
sg7
g6673
sg9
V12051212.xml
p6678
sa(dp6679
g3
VSTD-Oakeshott-1994
p6680
sg5
S'PMC1238864'
p6681
sg7
g6673
sg9
V8204331.xml
p6682
sa(dp6683
g3
VSTD-Dey-2004
p6684
sg5
S'PMC1314775'
p6685
sg7
g6673
sg9
V14965404.xml
p6686
sa(dp6687
g3
VSTD-Schectman-2003
p6688
sg5
S'PMC1494929'
p6689
sg7
g6673
sg9
V14521638.xml
p6690
sa(dp6691
g3
VSTD-Solomon-2007a
p6692
sg5
S'PMC1824772'
p6693
sg7
g6673
sg9
V17356969.xml
p6694
sa(dp6695
g3
VSTD-Lafata-2007
p6696
sg5
S'PMC1824751'
p6697
sg7
g6673
sg9
V17356966.xml
p6698
sa(dp6699
g3
VSTD-Wallace-1979b
p6700
sg5
S'PMC1595877'
p6701
sg7
VCD001541 v. 9.0 Interventions for ingrowing toenails.rm5
p6702
sg9
V466336.xml
p6703
sa(dp6704
g3
VSTD-Sykes-1988c
p6705
sg5
S'PMC1834063'
p6706
sg7
g6702
sg9
V3416165.xml
p6707
sa(dp6708
g3
VSTD-Sykes-1988b
p6709
sg5
S'PMC1834063'
p6710
sg7
g6702
sg9
V3416165.xml
p6711
sa(dp6712
g3
VSTD-Pavord-2007
p6713
sg5
S'PMC2174463'
p6714
sg7
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p6715
sg9
V17897478.xml
p6716
sa(dp6717
g3
VSTD-Bjermer-2003
p6718
sg5
S'PMC218809'
p6719
sg7
g6715
sg9
V14563743.xml
p6720
sa(dp6721
g3
VSTD-Lemanske-2010
p6722
sg5
S'PMC2989902'
p6723
sg7
g6715
sg9
V20197425.xml
p6724
sa(dp6725
g3
VSTD-Nikolaizik-2008
p6726
sg5
S'PMC2679548'
p6727
sg7
VCD001021 v. 12.0 Inhaled antibiotics for long-term therapy in cystic fibrosis.rm5
p6728
sg9
V18716688.xml
p6729
sa(dp6730
g3
VSTD-McCoy-2008
p6731
sg5
S'PMC2577727'
p6732
sg7
g6728
sg9
V18658109.xml
p6733
sa(dp6734
g3
VSTD-Gardner-2008
p6735
sg5
S'PMC2748261'
p6736
sg7
VCD006888 v. 4.0 Ginkgo biloba for intermittent claudication.rm5
p6737
sg9
V18628657.xml
p6738
sa(dp6739
g3
VSTD-Mortimore-1998
p6740
sg5
S'PMC1745186'
p6741
sg7
VCD005308 v. 8.0 Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea.rm5
p6742
sg9
V9741373.xml
p6743
sa(dp6744
g3
VSTD-Chen-2008
p6745
sg5
S'PMC2170466'
p6746
sg7
VCD007458 v. 2.3 Mobile phone messaging reminders for attendance at healthcare appointments.rm5
p6747
sg9
V18196610.xml
p6748
sa(dp6749
g3
VSTD-Renner-2001
p6750
sg5
S'PMC1745899'
p6751
sg7
VCD008037 v. 5.0 Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.rm5
p6752
sg9
V11120904.xml
p6753
sa(dp6754
g3
VSTD-van-Woensel-2003
p6755
sg5
S'PMC1746666'
p6756
sg7
VCD007720 v. 6.3 Corticosteroids for pneumonia.rm5
p6757
sg9
V12728156.xml
p6758
sa(dp6759
g3
VSTD-McHardy-1972
p6760
sg5
S'PMC1786783'
p6761
sg7
g6757
sg9
V4404939.xml
p6762
sa(dp6763
g3
VSTD-Ling-2005
p6764
sg5
S'PMC1480367'
p6765
sg7
VCD002025 v. 13.0 Buprenorphine for the management of opioid withdrawal.rm5
p6766
sg9
V16042639.xml
p6767
sa(dp6768
g3
VSTD-Pras-2000
p6769
sg5
S'PMC3399783'
p6770
sg7
VCD002225 v. 7.0 Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.rm5
p6771
sg9
V22815624.xml
p6772
sa(dp6773
g3
VSTD-Petticrew-1999
p6774
sg5
S'PMC1756922'
p6775
sg7
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p6776
sg9
V10492742.xml
p6777
sa(dp6778
g3
VSTD-Todd-1997
p6779
sg5
S'PMC3055815'
p6780
sg7
g6776
sg9
V21324139.xml
p6781
sa(dp6782
g3
VSTD-Riordan-2000
p6783
sg5
S'PMC1718573'
p6784
sg7
g6776
sg9
V11087295.xml
p6785
sa(dp6786
g3
VSTD-Sanders-2001
p6787
sg5
S'PMC1728360'
p6788
sg7
g6776
sg9
V11444234.xml
p6789
sa(dp6790
g3
VSTD-Timmer-2002
p6791
sg5
S'PMC115863'
p6792
sg7
g6776
sg9
V11978183.xml
p6793
sa(dp6794
g3
VSTD-Aloia-2005
p6795
sg5
S'PMC1464166'
p6796
sg7
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p6797
sg9
V16043680.xml
p6798
sa(dp6799
g3
VSTD-Campbell-2005
p6800
sg5
S'PMC1246082'
p6801
sg7
g6797
sg9
V16183652.xml
p6802
sa(dp6803
g3
VSTD-Trivedi-2003
p6804
sg5
S'PMC150177'
p6805
sg7
g6797
sg9
V12609940.xml
p6806
sa(dp6807
g3
VSTD-Porthouse-2005
p6808
sg5
S'PMC557150'
p6809
sg7
g6797
sg9
V15860827.xml
p6810
sa(dp6811
g3
VSTD-Chel-2008
p6812
sg5
S'PMC2277446'
p6813
sg7
g6797
sg9
V17874029.xml
p6814
sa(dp6815
g3
VSTD-Sato-1999a
p6816
sg5
S'PMC1736147'
p6817
sg7
g6797
sg9
V9886454.xml
p6818
sa(dp6819
g3
VSTD-Turner-1987
p6820
sg5
S'PMC1247354'
p6821
sg7
VCD000389 v. 7.0 Mass media interventions effects on health services utilisation.rm5
p6822
sg9
V3117190.xml
p6823
sa(dp6824
g3
VSTD-Rachmilewitz-1989
p6825
sg5
S'PMC1835436'
p6826
sg7
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p6827
sg9
V2563951.xml
p6828
sa(dp6829
g3
VSTD-Riley-1988
p6830
sg5
S'PMC1433642'
p6831
sg7
g6827
sg9
V2899536.xml
p6832
sa(dp6833
g3
VSTD-Ito-2010
p6834
sg5
S'PMC2972638'
p6835
sg7
g6827
sg9
V20049950.xml
p6836
sa(dp6837
g3
VSTD-Rao-1989
p6838
sg5
S'PMC1434223'
p6839
sg7
g6827
sg9
V2567266.xml
p6840
sa(dp6841
g3
VSTD-Hanauer-2007
p6842
sg5
S'PMC2658575'
p6843
sg7
g6827
sg9
V18080055.xml
p6844
sa(dp6845
g3
VSTD-Kruis-2009
p6846
sg5
S'PMC3269751'
p6847
sg7
g6827
sg9
V18832520.xml
p6848
sa(dp6849
g3
VSTD-Feurle-1989
p6850
sg5
S'PMC1434384'
p6851
sg7
g6827
sg9
V2684804.xml
p6852
sa(dp6853
g3
VSTD-Hetherington-1986
p6854
sg5
S'PMC1339208'
p6855
sg7
VCD004137 v. 8.0 Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for acute renal colic.rm5
p6856
sg9
V3081085.xml
p6857
sa(dp6858
g3
VSTD-Thompson-1989
p6859
sg5
S'PMC1838035'
p6860
sg7
g6856
sg9
V2513026.xml
p6861
sa(dp6862
g3
VSTD-Bolam-1998
p6863
sg5
S'PMC28481'
p6864
sg7
VCD004068 v. 5.0 Postnatal parental education for optimizing infant general health and parent-infant relationships.rm5
p6865
sg9
V9549449.xml
p6866
sa(dp6867
g3
VSTD-Goetter-2005
p6868
sg5
S'PMC1595267'
p6869
sg7
g6865
sg9
V17273449.xml
p6870
sa(dp6871
g3
VSTD-Browning-1983
p6872
sg5
S'PMC1549550'
p6873
sg7
VCD005608 v. 2.0 Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eard.rm5
p6874
sg9
V6412934.xml
p6875
sa(dp6876
g3
VSTD-Ho-2002b
p6877
sg5
S'PMC1422548'
p6878
sg7
VCD006040 v. 3.0 Reconstructive Techniques After Rectal Resection for Rectal Cancer.rm5
p6879
sg9
V12131085.xml
p6880
sa(dp6881
g3
VSTD-Hallbook-1996
p6882
sg5
S'PMC1235247'
p6883
sg7
g6879
sg9
V8678619.xml
p6884
sa(dp6885
g3
VSTD-Machado-2003
p6886
sg5
S'PMC1422690'
p6887
sg7
g6879
sg9
V12894014.xml
p6888
sa(dp6889
g3
VSTD-Smellie-1996
p6890
sg5
S'PMC1511665'
p6891
sg7
VCD002117 v. 7.0 Tricyclic and related drugs for nocturnal enuresis in children.rm5
p6892
sg9
V8813873.xml
p6893
sa(dp6894
g3
VSTD-Khorana-1972
p6895
sg5
S'PMC3013192'
p6896
sg7
g6892
sg9
V22058522.xml
p6897
sa(dp6898
g3
VSTD-Alderton-1970_x0023_
p6899
sg5
S'PMC1930205'
p6900
sg7
g6892
sg9
V4911961.xml
p6901
sa(dp6902
g3
VSTD-Netley-1984
p6903
sg5
S'PMC1483635'
p6904
sg7
g6892
sg9
V6478342.xml
p6905
sa(dp6906
g3
VSTD-McKendry-1975
p6907
sg5
S'PMC1956570'
p6908
sg7
g6892
sg9
V1192312.xml
p6909
sa(dp6910
g3
VSTD-Shaffer-1968_x0023_
p6911
sg5
S'PMC2020147'
p6912
sg7
g6892
sg9
V4883146.xml
p6913
sa(dp6914
g3
VSTD-Hodes-1973
p6915
sg5
S'PMC2157147'
p6916
sg7
g6892
sg9
V4753483.xml
p6917
sa(dp6918
g3
VSTD-Battacharya-2008
p6919
sg5
S'PMC2505091'
p6920
sg7
VCD000057 v. 7.0 Clomiphene citrate for unexplained subfertility in women.rm5
p6921
sg9
V18687718.xml
p6922
sa(dp6923
g3
VSTD-Bui-2002
p6924
sg5
S'PMC2007405'
p6925
sg7
VCD003877 v. 6.0 Sedation of children undergoing dental treatment.rm5
p6926
sg9
V12779109.xml
p6927
sa(dp6928
g3
VSTD-Abrams-1993
p6929
sg5
S'PMC2148744'
p6930
sg7
g6926
sg9
V7645790.xml
p6931
sa(dp6932
g3
VSTD-Roelofse-1998
p6933
sg5
S'PMC2148942'
p6934
sg7
g6926
sg9
V9790003.xml
p6935
sa(dp6936
g3
VSTD-Lam-2005
p6937
sg5
S'PMC2527044'
p6938
sg7
g6926
sg9
V16048152.xml
p6939
sa(dp6940
g3
VSTD-Newall-2000b
p6941
sg5
S'PMC1747238'
p6942
sg7
VCD002166 v. 7.0 Physical training for bronchiectasis.rm5
p6943
sg9
V15994254.xml
p6944
sa(dp6945
g3
VSTD-Kiderman-2005
p6946
sg5
S'PMC1463093'
p6947
sg7
VCD008268 v. 4.0 Corticosteroids as standalone or add-on treatment for sore throat.rm5
p6948
sg9
V15808038.xml
p6949
sa(dp6950
g3
VSTD-Cao-2009
p6951
sg5
S'PMC2726958'
p6952
sg7
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p6953
sg9
V19508995.xml
p6954
sa(dp6955
g3
VSTD-Roncalli-2010
p6956
sg5
S'PMC3386167'
p6957
sg7
g6953
sg9
V21127322.xml
p6958
sa(dp6959
g3
VSTD-Traverse-2010
p6960
sg5
S'PMC2939727'
p6961
sg7
g6953
sg9
V20826249.xml
p6962
sa(dp6963
g3
VSTD-Ge-2006
p6964
sg5
S'PMC1861266'
p6965
sg7
g6953
sg9
V16775089.xml
p6966
sa(dp6967
g3
VSTD-Cuervo-2006
p6968
sg5
S'PMC1468428'
p6969
sg7
VCD000330 v. 12.0 Enemas during labour.rm5
p6970
sg9
V16545140.xml
p6971
sa(dp6972
g3
VSTD-Potter-2008
p6973
sg5
S'PMC2745056'
p6974
sg7
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p6975
sg9
V17984757.xml
p6976
sa(dp6977
g3
VSTD-Bahwere-2008
p6978
sg5
S'PMC2536666'
p6979
sg7
g6975
sg9
V18671876.xml
p6980
sa(dp6981
g3
VSTD-Gillespie-2009
p6982
sg5
S'PMC2770289'
p6983
sg7
g6975
sg9
V20072773.xml
p6984
sa(dp6985
g3
VSTD-Downey-2009
p6986
sg5
S'PMC2858762'
p6987
sg7
VCD007544 v. 2.0 Spiritual and religious interventions for well-being of adults in the terminal phase of disease.rm5
p6988
sg9
V19678461.xml
p6989
sa(dp6990
g3
VSTD-Mabin-1995
p6991
sg5
S'PMC1511267'
p6992
sg7
VCD005203 v. 4.0 Dietary exclusions for established atopic eczema.rm5
p6993
sg9
V7492155.xml
p6994
sa(dp6995
g3
VSTD-Cant-1986
p6996
sg5
S'PMC1341170'
p6997
sg7
g6993
sg9
V3089466.xml
p6998
sa(dp6999
g3
VSTD-Tieffenberg-2000
p7000
sg5
S'PMC3456130'
p7001
sg7
VCD006245 v. 7.0 Care delivery and self-management strategies for children with epilepsy.rm5
p7002
sg9
V10856009.xml
p7003
sa(dp7004
g3
VSTD-Zwick-2009
p7005
sg5
S'PMC2745452'
p7006
sg7
VCD008602 v. 3.2 Interventions for congenital talipes equinovarus (clubfoot).rm5
p7007
sg9
V19350335.xml
p7008
sa(dp7009
g3
VSTD-Rijal-2010
p7010
sg5
S'PMC2856397'
p7011
sg7
g7007
sg9
V20419009.xml
p7012
sa(dp7013
g3
VSTD-Sud-2008
p7014
sg5
S'PMC2323422'
p7015
sg7
g7007
sg9
V17323092.xml
p7016
sa(dp7017
g3
VSTD-Lago-1998
p7018
sg5
S'PMC1720853'
p7019
sg7
VCD004212 v. 6.0 Opioids for neonates receiving mechanical ventilation.rm5
p7020
sg9
V10194990.xml
p7021
sa(dp7022
g3
VSTD-Saarenmaa-1996
p7023
sg5
S'PMC1061172'
p7024
sg7
g7020
sg9
V8949692.xml
p7025
sa(dp7026
g3
VSTD-Lillemoe-1993
p7027
sg5
S'PMC1242819'
p7028
sg7
VCD007519 v. 3.0 Celiac plexus block for pancreatic cancer pain in adults.rm5
p7029
sg9
V7683868.xml
p7030
sa(dp7031
g3
VSTD-Lidwell-1971
p7032
sg5
S'PMC2130854'
p7033
sg7
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p7034
sg9
V5291743.xml
p7035
sa(dp7036
g3
VSTD-Chlan-1998
p7037
sg5
S'PMC3124305'
p7038
sg7
g7034
sg9
V21543962.xml
p7039
sa(dp7040
g3
VSTD-Kotwal-1998
p7041
sg5
S'PMC2362603'
p7042
sg7
g7034
sg9
V18493472.xml
p7043
sa(dp7044
g3
VSTD-Barnason-1995_x002f_1996
p7045
sg5
S'PMC2583060'
p7046
sg7
g7034
sg9
V18620100.xml
p7047
sa(dp7048
g3
VSTD-Nixon-2006
p7049
sg5
S'PMC1479635'
p7050
sg7
VCD009490 v. 1.0 Support surfaces for treating pressure ulcers.rm5
p7051
sg9
V16740528.xml
p7052
sa(dp7053
g3
VSTD-Jones-1996
p7054
sg5
S'PMC1010319'
p7055
sg7
VCD005328 v. 4.0 Intraarticular corticosteroid for treatment of osteoarthritis of the knee.rm5
p7056
sg9
V8976640.xml
p7057
sa(dp7058
g3
VSTD-Wright-1960
p7059
sg5
S'PMC1007152'
p7060
sg7
g7056
sg9
V13786828.xml
p7061
sa(dp7062
g3
VSTD-Gaffney-1995
p7063
sg5
S'PMC1005598'
p7064
sg7
g7056
sg9
V7794044.xml
p7065
sa(dp7066
g3
VSTD-Hoghton-1996
p7067
sg5
S'PMC1239579'
p7068
sg7
VCD007296 v. 2.0 Early versus Delayed Refeeding for Children with Acute Diarrhoea.rm5
p7069
sg9
V8731625.xml
p7070
sa(dp7071
g3
VSTD-Conway-1989
p7072
sg5
S'PMC1791816'
p7073
sg7
g7069
sg9
V2647038.xml
p7074
sa(dp7075
g3
VSTD-Khin_x002d_Maung_x002d_U-1985
p7076
sg5
S'PMC1417304'
p7077
sg7
g7069
sg9
V3918683.xml
p7078
sa(dp7079
g3
VSTD-Hawkins-2009
p7080
sg5
S'PMC2740999'
p7081
sg7
VCD009307 v. 1.0 Universal multi-component prevention programs for alcohol misuse in young people.rm5
p7082
sg9
V19736331.xml
p7083
sa(dp7084
g3
VSTD-Spoth-2007
p7085
sg5
S'PMC2869212'
p7086
sg7
g7082
sg9
V17478265.xml
p7087
sa(dp7088
g3
VSTD-Perry-1996
p7089
sg5
S'PMC1380436'
p7090
sg7
g7082
sg9
V8669519.xml
p7091
sa(dp7092
g3
VSTD-Schinke-2004
p7093
sg5
S'PMC2795165'
p7094
sg7
g7082
sg9
V15376818.xml
p7095
sa(dp7096
g3
VSTD-Kabir-1986
p7097
sg5
S'PMC180459'
p7098
sg7
VCD006784 v. 5.0 Antibiotic therapy for Shigella dysentery.rm5
p7099
sg9
V3518625.xml
p7100
sa(dp7101
g3
VSTD-Gotuzzo-1989
p7102
sg5
S'PMC176069'
p7103
sg7
g7099
sg9
V2675757.xml
p7104
sa(dp7105
g3
VSTD-Haltalin-1973
p7106
sg5
S'PMC1648332'
p7107
sg7
g7099
sg9
V4574641.xml
p7108
sa(dp7109
g3
VSTD-Schwartz-2009
p7110
sg5
S'PMC2744567'
p7111
sg7
VCD003917 v. 10.0 Cardioprotective interventions for cancer patients receiving anthracyclines.rm5
p7112
sg9
V19584400.xml
p7113
sa(dp7114
g3
VSTD-Schinke-2009a
p7115
sg5
S'PMC2629623'
p7116
sg7
VCD009308 v. 1.0 Universal family-based prevention programs for alcohol misuse in young people.rm5
p7117
sg9
V19118394.xml
p7118
sa(dp7119
g3
VSTD-Schinke-2009b
p7120
sg5
S'PMC2783411'
p7121
sg7
g7117
sg9
V19682490.xml
p7122
sa(dp7123
g3
VSTD-Schinke-2009c
p7124
sg5
S'PMC2741484'
p7125
sg7
g7117
sg9
V19632053.xml
p7126
sa(dp7127
g3
VSTD-Preclik-1999
p7128
sg5
S'PMC28241'
p7129
sg7
VCD005571 v. 7.0 Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy.rm5
p7130
sg9
V10506041.xml
p7131
sa(dp7132
g3
VSTD-Conway-2007
p7133
sg5
S'PMC2084134'
p7134
sg7
VCD004827 v. 6.3 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.rm5
p7135
sg9
V18252070.xml
p7136
sa(dp7137
g3
VSTD-Destura-unpublished
p7138
sg5
S'PMC543444'
p7139
sg7
g7135
sg9
V15546485.xml
p7140
sa(dp7141
g3
VSTD-Baker-1998T96
p7142
sg5
S'PMC1496989'
p7143
sg7
VCD003941 v. 8.0 Patient reminder and recall systems to improve immunization rates.rm5
p7144
sg9
V9686713.xml
p7145
sa(dp7146
g3
VSTD-Stehr_x002d_Green1993T10
p7147
sg5
S'PMC1403403'
p7148
sg7
g7144
sg9
V8341774.xml
p7149
sa(dp7150
g3
VSTD-Young1980T63
p7151
sg5
S'PMC1619400'
p7152
sg7
g7144
sg9
V7361966.xml
p7153
sa(dp7154
g3
VSTD-Hull2002T511
p7155
sg5
S'PMC1314410'
p7156
sg7
g7144
sg9
V12236273.xml
p7157
sa(dp7158
g3
VSTD-Rosser1992T47
p7159
sg5
S'PMC1488617'
p7160
sg7
g7144
sg9
V1544078.xml
p7161
sa(dp7162
g3
VSTD-Rosser1991T61
p7163
sg5
S'PMC1335900'
p7164
sg7
g7144
sg9
V1913409.xml
p7165
sa(dp7166
g3
VSTD-Mullooly1987T67
p7167
sg5
S'PMC1647052'
p7168
sg7
g7144
sg9
V3565663.xml
p7169
sa(dp7170
g3
VSTD-McDowell1986T46
p7171
sg5
S'PMC1488617'
p7172
sg7
g7144
sg9
V1544078.xml
p7173
sa(dp7174
g3
VSTD-Hogg1998T101
p7175
sg5
S'PMC2277568'
p7176
sg7
g7144
sg9
V9481466.xml
p7177
sa(dp7178
g3
VSTD-Lukasik1987T85
p7179
sg5
S'PMC2218648'
p7180
sg7
g7144
sg9
V21263970.xml
p7181
sa(dp7182
g3
VSTD-WACS-2007Low
p7183
sg5
S'PMC2034519'
p7184
sg7
VCD007176 v. 7.4 Antioxidant supplements for prevention of mortality in healthy participants and patients with variou.rm5
p7185
sg9
V17698683.xml
p7186
sa(dp7187
g3
VSTD-AREDS-2001Low
p7188
sg5
S'PMC1472812'
p7189
sg7
g7185
sg9
V11594943.xml
p7190
sa(dp7191
g3
VSTD-PHS-2008Low
p7192
sg5
S'PMC2586922'
p7193
sg7
g7185
sg9
V18997197.xml
p7194
sa(dp7195
g3
VSTD-SELECT-2009Low
p7196
sg5
S'PMC3682779'
p7197
sg7
g7185
sg9
V19066370.xml
p7198
sa(dp7199
g3
VSTD-MAVIS-2005-Low
p7200
sg5
S'PMC1183131'
p7201
sg7
g7185
sg9
V16081445.xml
p7202
sa(dp7203
g3
VSTD-Meydani-2004Low
p7204
sg5
S'PMC2377357'
p7205
sg7
g7185
sg9
V15315997.xml
p7206
sa(dp7207
g3
VSTD-Ali-2005
p7208
sg5
S'PMC3609347'
p7209
sg7
VCD008133 v. 1.0 The impact of contracting out on health outcomes and use of health services in low and middle-income.rm5
p7210
sg9
V23569973.xml
p7211
sa(dp7212
g3
VSTD-Leach-2008
p7213
sg5
S'PMC2443129'
p7214
sg7
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p7215
sg9
V18513453.xml
p7216
sa(dp7217
g3
VSTD-Choung-2008
p7218
sg5
S'PMC2671765'
p7219
sg7
g7215
sg9
V19434268.xml
p7220
sa(dp7221
g3
VSTD-Figved-2009
p7222
sg5
S'PMC2866935'
p7223
sg7
VCD001706 v. 9.0 Arthroplasties (with and without bone cement) for proximal femoral fractures in adults.rm5
p7224
sg9
V19130162.xml
p7225
sa(dp7226
g3
VSTD-Mouzopoulos-2008
p7227
sg5
S'PMC2323425'
p7228
sg7
g7224
sg9
V17431621.xml
p7229
sa(dp7230
g3
VSTD-Huh-2009
p7231
sg5
S'PMC2688140'
p7232
sg7
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p7233
sg9
V19239703.xml
p7234
sa(dp7235
g3
VSTD-Clark-2000a
p7236
sg5
S'PMC1753277'
p7237
sg7
VCD006717 v. 3.0 Patellar taping for patellofemoral pain syndrome in adults.rm5
p7238
sg9
V10976083.xml
p7239
sa(dp7240
g3
VSTD-Mattick-2002a
p7241
sg5
S'PMC1725943'
p7242
sg7
VCD003326 v. 9.0 Tissue adhesives for traumatic lacerations in children and adults.rm5
p7243
sg9
V12204985.xml
p7244
sa(dp7245
g3
VSTD-Littlejohns-1991
p7246
sg5
S'PMC463273'
p7247
sg7
VCD002990 v. 11.0 Self-management education for patients with chronic obstructive pulmonary disease.rm5
p7248
sg9
V1926024.xml
p7249
sa(dp7250
g3
VSTD-Cockcroft-1987
p7251
sg5
S'PMC1245234'
p7252
sg7
g7248
sg9
V3101821.xml
p7253
sa(dp7254
g3
VSTD-Bollen-2005
p7255
sg5
S'PMC1269459'
p7256
sg7
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p7257
sg9
V16137357.xml
p7258
sa(dp7259
g3
VSTD-Dyhr-2003
p7260
sg5
S'PMC154111'
p7261
sg7
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p7262
sg9
V12617741.xml
p7263
sa(dp7264
g3
VSTD-Harkins-1964
p7265
sg5
S'PMC1927374'
p7266
sg7
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p7267
sg9
V14180526.xml
p7268
sa(dp7269
g3
VSTD-Makvandi-2011
p7270
sg5
S'PMC3081214'
p7271
sg7
g7267
sg9
V21495198.xml
p7272
sa(dp7273
g3
VSTD-Meijer-1999
p7274
sg5
S'PMC1745367'
p7275
sg7
VCD003534 v. 9.2 Fluticasone at different doses for chronic asthma in adults and children.rm5
p7276
sg9
V10491451.xml
p7277
sa(dp7278
g3
VSTD-Verona-2003
p7279
sg5
S'PMC1763114'
p7280
sg7
g7276
sg9
V12765916.xml
p7281
sa(dp7282
g3
VSTD-Vichinsky-2007
p7283
sg5
S'PMC1974786'
p7284
sg7
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p7285
sg9
V17233848.xml
p7286
sa(dp7287
g3
VSTD-Ellickson-2003
p7288
sg5
S'PMC1448059'
p7289
sg7
VCD003020 v. 9.0 School-based prevention for illicit drugs' use.rm5
p7290
sg9
V14600049.xml
p7291
sa(dp7292
g3
VSTD-WISDOM-2007
p7293
sg5
S'PMC1939792'
p7294
sg7
VCD002229 v. 11.6 Hormone therapy for preventing cardiovascular disease in post-menopausal women.rm5
p7295
sg9
V17626056.xml
p7296
sa(dp7297
g3
VSTD-_x0031_018-SE-Watt-1983
p7298
sg5
S'PMC1546779'
p7299
sg7
VCD004022 v. 8.7 Effects of low sodium diet versus high sodium diet on blood pressure renin aldosterone catecholam.rm5
p7300
sg9
V6401551.xml
p7301
sa(dp7302
g3
VSTD-_x0031_027-P-Fagerberg-1984
p7303
sg5
S'PMC1444105'
p7304
sg7
g7300
sg9
V6418295.xml
p7305
sa(dp7306
g3
VSTD-_x0031_200-SE-Pimenta-2009
p7307
sg5
S'PMC2771382'
p7308
sg7
g7300
sg9
V19620517.xml
p7309
sa(dp7310
g3
VSTD-_x0031_107-SE-MacFadyen-1994
p7311
sg5
S'PMC1364776'
p7312
sg7
g7300
sg9
V7833222.xml
p7313
sa(dp7314
g3
VSTD-_x0031_035-SE-Watt-1985-b
p7315
sg5
S'PMC1418187'
p7316
sg7
g7300
sg9
V3933736.xml
p7317
sa(dp7318
g3
VSTD-_x0031_047-MacGregor-1987
p7319
sg5
S'PMC1245574'
p7320
sg7
g7300
sg9
V3103761.xml
p7321
sa(dp7322
g3
VSTD-_x0031_024-P-Erwteman-1984
p7323
sg5
S'PMC1442440'
p7324
sg7
g7300
sg9
V6432119.xml
p7325
sa(dp7326
g3
VSTD-_x0031_034-SE-Watt-1985
p7327
sg5
S'PMC1418187'
p7328
sg7
g7300
sg9
V3933736.xml
p7329
sa(dp7330
g3
VSTD-_x0031_199-P-Meland-2009
p7331
sg5
S'PMC3410469'
p7332
sg7
g7300
sg9
V19140039.xml
p7333
sa(dp7334
g3
VSTD-Mantovani-2010a
p7335
sg5
S'PMC3227938'
p7336
sg7
VCD008664 v. 2.0 Thalidomide for managing cancer cachexia.rm5
p7337
sg9
V20156909.xml
p7338
sa(dp7339
g3
VSTD-Gordon-2005
p7340
sg5
S'PMC1774430'
p7341
sg7
g7337
sg9
V15753541.xml
p7342
sa(dp7343
g3
VSTD-Varney-1991
p7344
sg5
S'PMC1668945'
p7345
sg7
VCD001936 v. 4.0 Allergen injection immunotherapy for seasonal allergic rhinitis.rm5
p7346
sg9
V1998791.xml
p7347
sa(dp7348
g3
VSTD-Bafna-2011
p7349
sg5
S'PMC3146157'
p7350
sg7
VCD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
p7351
sg9
V21804705.xml
p7352
sa(dp7353
g3
VSTD-Montazeri-2011
p7354
sg5
S'PMC3252769'
p7355
sg7
g7351
sg9
V22247722.xml
p7356
sa(dp7357
g3
VSTD-Fujisaka-2011
p7358
sg5
S'PMC3241560'
p7359
sg7
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p7360
sg9
V21959870.xml
p7361
sa(dp7362
g3
VSTD-Thatcher-1999b
p7363
sg5
S'PMC2362337'
p7364
sg7
g7360
sg9
V10408844.xml
p7365
sa(dp7366
g3
VSTD-Thatcher-1999a
p7367
sg5
S'PMC2362337'
p7368
sg7
g7360
sg9
V10408844.xml
p7369
sa(dp7370
g3
VSTD-Boogaerts-2003
p7371
sg5
S'PMC2376376'
p7372
sg7
g7360
sg9
V12671693.xml
p7373
sa(dp7374
g3
VSTD-Smith-2003b
p7375
sg5
S'PMC2741110'
p7376
sg7
g7360
sg9
V12799626.xml
p7377
sa(dp7378
g3
VSTD-Smith-2003c
p7379
sg5
S'PMC2741110'
p7380
sg7
g7360
sg9
V12799626.xml
p7381
sa(dp7382
g3
VSTD-Smith-2003a
p7383
sg5
S'PMC2741110'
p7384
sg7
g7360
sg9
V12799626.xml
p7385
sa(dp7386
g3
VSTD-Thomas-2008
p7387
sg5
S'PMC2350198'
p7388
sg7
g7360
sg9
V18037478.xml
p7389
sa(dp7390
g3
VSTD-Wilkinson-2006
p7391
sg5
S'PMC2361228'
p7392
sg7
g7360
sg9
V16570051.xml
p7393
sa(dp7394
g3
VSTD-Pronzato-2010
p7395
sg5
S'PMC3228044'
p7396
sg7
g7360
sg9
V20798194.xml
p7397
sa(dp7398
g3
VSTD-Sweeney-1998
p7399
sg5
S'PMC2150364'
p7400
sg7
g7360
sg9
V9667681.xml
p7401
sa(dp7402
g3
VSTD-Thatcher-1999
p7403
sg5
S'PMC2362337'
p7404
sg7
g7360
sg9
V10408844.xml
p7405
sa(dp7406
g3
VSTD-Smith-2003
p7407
sg5
S'PMC2741110'
p7408
sg7
g7360
sg9
V12799626.xml
p7409
sa(dp7410
g3
VSTD-Boogaerts-Coiffier-2001
p7411
sg5
S'PMC2376376'
p7412
sg7
g7360
sg9
V12671693.xml
p7413
sa(dp7414
g3
VSTD-Ghalaut-2007
p7415
sg5
S'PMC3453121'
p7416
sg7
VCD005197 v. 7.0 Anti-pseudomonal beta-lactams for the initial empirical treatment of febrile neutropenia comparis.rm5
p7417
sg9
V23100925.xml
p7418
sa(dp7419
g3
VSTD-Liang-1990
p7420
sg5
S'PMC175977'
p7421
sg7
g7417
sg9
V2201252.xml
p7422
sa(dp7423
g3
VSTD-Underwood-2004
p7424
sg5
S'PMC3471981'
p7425
sg7
VCD003978 v. 7.0 Prescription of prosthetic ankle-foot mechanisms after lower limb amputation.rm5
p7426
sg9
V15234485.xml
p7427
sa(dp7428
g3
VSTD-Kitajima-1997
p7429
sg5
S'PMC1720633'
p7430
sg7
VCD005496 v. 6.0 Probiotics for prevention of necrotizing enterocolitis in preterm infants.rm5
p7431
sg9
V9135288.xml
p7432
sa(dp7433
g3
VSTD-Mohan-2006
p7434
sg5
S'PMC1698302'
p7435
sg7
g7431
sg9
V16971641.xml
p7436
sa(dp7437
g3
VSTD-Millar-1993
p7438
sg5
S'PMC1029589'
p7439
sg7
g7431
sg9
V8285750.xml
p7440
sa(dp7441
g3
VSTD-Currie-2002
p7442
sg5
S'PMC1746197'
p7443
sg7
VCD005309 v. 8.0 Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and chil.rm5
p7444
sg9
V12324672.xml
p7445
sa(dp7446
g3
VSTD-Mannel-2011
p7447
sg5
S'PMC3110746'
p7448
sg7
VCD007414 v. 5.6 Maintenance chemotherapy for ovarian cancer.rm5
p7449
sg9
V21529904.xml
p7450
sa(dp7451
g3
VSTD-Amir-2004
p7452
sg5
S'PMC1630426'
p7453
sg7
VCD007239 v. 4.0 Interventions for preventing mastitis after childbirth.rm5
p7454
sg9
V17032458.xml
p7455
sa(dp7456
g3
VSTD-Britton-1985
p7457
sg5
S'PMC1416077'
p7458
sg7
VCD006338 v. 9.2 Chest physiotherapy for pneumonia in adults.rm5
p7459
sg9
V3924221.xml
p7460
sa(dp7461
g3
VSTD-Galloway-2005
p7462
sg5
S'PMC1087493'
p7463
sg7
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p7464
sg9
V15804355.xml
p7465
sa(dp7466
g3
VSTD-Hulse-2005
p7467
sg5
S'PMC1646626'
p7468
sg7
g7464
sg9
V15899557.xml
p7469
sa(dp7470
g3
VSTD-Keystone-2009
p7471
sg5
S'PMC2674549'
p7472
sg7
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p7473
sg9
V19066176.xml
p7474
sa(dp7475
g3
VSTD-Jun-2006
p7476
sg5
S'PMC2722000'
p7477
sg7
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p7478
sg9
V17043424.xml
p7479
sa(dp7480
g3
VSTD-Hallman-1986
p7481
sg5
S'PMC1778095'
p7482
sg7
VCD000366 v. 8.0 Inositol for respiratory distress syndrome in preterm infants.rm5
p7483
sg9
V3539028.xml
p7484
sa(dp7485
g3
VSTD-Lakhani-1984
p7486
sg5
S'PMC1628817'
p7487
sg7
VCD002099 v. 4.0 Nursing record systems effects on nursing practice and healthcare outcomes.rm5
p7488
sg9
V6508341.xml
p7489
sa(dp7490
g3
VSTD-Spranzo--1993
p7491
sg5
S'PMC2247491'
p7492
sg7
g7488
sg9
V1807627.xml
p7493
sa(dp7494
g3
VSTD-Mutrie-2002
p7495
sg5
S'PMC1732165'
p7496
sg7
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p7497
sg9
V12011193.xml
p7498
sa(dp7499
g3
VSTD-TAPESTRY-Herts-2003
p7500
sg5
S'PMC2676106'
p7501
sg7
g7497
sg9
V18684108.xml
p7502
sa(dp7503
g3
VSTD-McKee-2007
p7504
sg5
S'PMC2703799'
p7505
sg7
g7497
sg9
V17699538.xml
p7506
sa(dp7507
g3
VSTD-Rowland-2003
p7508
sg5
S'PMC1719287'
p7509
sg7
g7497
sg9
V12495948.xml
p7510
sa(dp7511
g3
VSTD-Mendoza-2009
p7512
sg5
S'PMC2680829'
p7513
sg7
g7497
sg9
V19413910.xml
p7514
sa(dp7515
g3
VSTD-TAPESTRY-Dublin-2003
p7516
sg5
S'PMC3720922'
p7517
sg7
g7497
sg9
V23894666.xml
p7518
sa(dp7519
g3
VSTD-Di-Bisceglie-2008
p7520
sg5
S'PMC2606037'
p7521
sg7
VCD003617 v. 6.55 Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.rm5
p7522
sg9
V19052125.xml
p7523
sa(dp7524
g3
VSTD-Lai-1987
p7525
sg5
S'PMC1248243'
p7526
sg7
VCD003965 v. 11.0 Immunosuppressive agents for treating IgA nephropathy.rm5
p7527
sg9
V3120928.xml
p7528
sa(dp7529
g3
VSTD-Gombocz-2007
p7530
sg5
S'PMC2206488'
p7531
sg7
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p7532
sg9
V17697359.xml
p7533
sa(dp7534
g3
VSTD-Akech-2006
p7535
sg5
S'PMC1569382'
p7536
sg7
g7532
sg9
V16998584.xml
p7537
sa(dp7538
g3
VSTD-Gold-1990
p7539
sg5
S'PMC1358036'
p7540
sg7
g7532
sg9
V1690974.xml
p7541
sa(dp7542
g3
VSTD-England-1996
p7543
sg5
S'PMC2350357'
p7544
sg7
VCD000934 v. 8.0 Alternative versus standard packages of antenatal care for low-risk pregnancy.rm5
p7545
sg9
V8595286.xml
p7546
sa(dp7547
g3
VSTD-Berlauk-1991
p7548
sg5
S'PMC1358649'
p7549
sg7
VCD003408 v. 10.4 Pulmonary artery catheters for adult patients in intensive care.rm5
p7550
sg9
V1929610.xml
p7551
sa(dp7552
g3
VSTD-Bender-1997
p7553
sg5
S'PMC1191013'
p7554
sg7
g7550
sg9
V9339929.xml
p7555
sa(dp7556
g3
VSTD-Chawarski-2011
p7557
sg5
S'PMC3076517'
p7558
sg7
VCD004147 v. 10.0 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alon.rm5
p7559
sg9
V21159452.xml
p7560
sa(dp7561
g3
VSTD-Epstein-2009
p7562
sg5
S'PMC2943844'
p7563
sg7
g7559
sg9
V19101098.xml
p7564
sa(dp7565
g3
VSTD-Bickel-2008
p7566
sg5
S'PMC2746734'
p7567
sg7
g7559
sg9
V18489017.xml
p7568
sa(dp7569
g3
VSTD-Chopra-2009
p7570
sg5
S'PMC2852314'
p7571
sg7
g7559
sg9
V19653788.xml
p7572
sa(dp7573
g3
VSTD-Ghitza-2008
p7574
sg5
S'PMC2271179'
p7575
sg7
g7559
sg9
V18068905.xml
p7576
sa(dp7577
g3
VSTD-Luthar-2000
p7578
sg5
S'PMC2190295'
p7579
sg7
g7559
sg9
V17241493.xml
p7580
sa(dp7581
g3
VSTD-Neufeld-2008
p7582
sg5
S'PMC2193670'
p7583
sg7
g7559
sg9
V17574801.xml
p7584
sa(dp7585
g3
VSTD-Daniels-1996
p7586
sg5
S'PMC2528339'
p7587
sg7
VCD003312 v. 4.0 Selenium supplementation to prevent short-term morbidity in preterm neonates.rm5
p7588
sg9
V8777677.xml
p7589
sa(dp7590
g3
VSTD-GAL_x002d_INT_x002d_1-Wilcock
p7591
sg5
S'PMC27547'
p7592
sg7
VCD001747 v. 11.0 Galantamine for Alzheimer's disease and mild cognitive impairment.rm5
p7593
sg9
V11110737.xml
p7594
sa(dp7595
g3
VSTD-GAL_x002d_INT_x002d_2-Rockwood
p7596
sg5
S'PMC1737604'
p7597
sg7
g7593
sg9
V11606667.xml
p7598
sa(dp7599
g3
VSTD-Sherwood-1983
p7600
sg5
S'PMC1650873'
p7601
sg7
VCD006855 v. 3.0 Personal assistance for older adults (65) without dementia.rm5
p7602
sg9
V6405641.xml
p7603
sa(dp7604
g3
VSTD-Carlson-2007
p7605
sg5
S'PMC1955332'
p7606
sg7
g7602
sg9
V17244293.xml
p7607
sa(dp7608
g3
VSTD-Feldman-1996
p7609
sg5
S'PMC1070133'
p7610
sg7
g7602
sg9
V8885860.xml
p7611
sa(dp7612
g3
VSTD-ATBC-1998
p7613
sg5
S'PMC1756731'
p7614
sg7
VCD004567 v. 5.0 Antioxidant vitamin supplementation for preventing and slowing the progression of age-related catara.rm5
p7615
sg9
V9799882.xml
p7616
sa(dp7617
g3
VSTD-APC-2006
p7618
sg5
S'PMC1857154'
p7619
sg7
g7615
sg9
V16556618.xml
p7620
sa(dp7621
g3
VSTD-PHS-II-2010
p7622
sg5
S'PMC3051399'
p7623
sg7
g7615
sg9
V21060040.xml
p7624
sa(dp7625
g3
VSTD-AREDS-2001
p7626
sg5
S'PMC1472812'
p7627
sg7
g7615
sg9
V11594943.xml
p7628
sa(dp7629
g3
VSTD-Graham-2002
p7630
sg5
S'PMC111106'
p7631
sg7
VCD005215 v. 6.0 Interventions for preventing unintended pregnancies among adolescents.rm5
p7632
sg9
V12016180.xml
p7633
sa(dp7634
g3
VSTD-Henderson-2007
p7635
sg5
S'PMC1779834'
p7636
sg7
g7632
sg9
V17118950.xml
p7637
sa(dp7638
g3
VSTD-Coyle-2004
p7639
sg5
S'PMC1448347'
p7640
sg7
g7632
sg9
V15117710.xml
p7641
sa(dp7642
g3
VSTD-Dilorio-2007
p7643
sg5
S'PMC1874204'
p7644
sg7
g7632
sg9
V17463382.xml
p7645
sa(dp7646
g3
VSTD-Villarruel-2006
p7647
sg5
S'PMC3034476'
p7648
sg7
g7632
sg9
V16894074.xml
p7649
sa(dp7650
g3
VSTD-Walker-2006
p7651
sg5
S'PMC1463960'
p7652
sg7
g7632
sg9
V16682420.xml
p7653
sa(dp7654
g3
VSTD-Wight-2002
p7655
sg5
S'PMC115856'
p7656
sg7
g7632
sg9
V12065268.xml
p7657
sa(dp7658
g3
VSTD-Bent-2011
p7659
sg5
S'PMC3076562'
p7660
sg7
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p7661
sg9
V20683766.xml
p7662
sa(dp7663
g3
VSTD-Creinin-2006
p7664
sg5
S'PMC2853373'
p7665
sg7
VCD001324 v. 10.0 Interventions for emergency contraception.rm5
p7666
sg9
V17077229.xml
p7667
sa(dp7668
g3
VSTD-Webb-1992
p7669
sg5
S'PMC1883543'
p7670
sg7
g7666
sg9
V1458074.xml
p7671
sa(dp7672
g3
VSTD-Lou-C-2002
p7673
sg5
S'PMC3530567'
p7674
sg7
g7666
sg9
V23300530.xml
p7675
sa(dp7676
g3
VSTD-Giardiello-2002
p7677
sg5
S'PMC2225537'
p7678
sg7
VCD004079 v. 5.0 Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and car.rm5
p7679
sg9
V11932472.xml
p7680
sa(dp7681
g3
VSTD-Berg-2009
p7682
sg5
S'PMC2899375'
p7683
sg7
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p7684
sg9
V19506919.xml
p7685
sa(dp7686
g3
VSTD-Hellum-2011
p7687
sg5
S'PMC3100911'
p7688
sg7
g7684
sg9
V21596740.xml
p7689
sa(dp7690
g3
VSTD-Dew-1983a
p7691
sg5
S'PMC1548114'
p7692
sg7
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p7693
sg9
V6134565.xml
p7694
sa(dp7695
g3
VSTD-Ito-2010
p7696
sg5
S'PMC2972641'
p7697
sg7
g7693
sg9
V20049949.xml
p7698
sa(dp7699
g3
VSTD-Kane-2008a
p7700
sg5
S'PMC2770408'
p7701
sg7
g7693
sg9
V19920971.xml
p7702
sa(dp7703
g3
VSTD-Kamm-2008
p7704
sg5
S'PMC2564831'
p7705
sg7
g7693
sg9
V18272546.xml
p7706
sa(dp7707
g3
VSTD-Travis-1994
p7708
sg5
S'PMC1375708'
p7709
sg7
g7693
sg9
V7959238.xml
p7710
sa(dp7711
g3
VSTD-Hawthorne-2011
p7712
sg5
S'PMC3746130'
p7713
sg7
g7693
sg9
V22081522.xml
p7714
sa(dp7715
g3
VSTD-Kiilerich-1992
p7716
sg5
S'PMC1373939'
p7717
sg7
g7693
sg9
V1347280.xml
p7718
sa(dp7719
g3
VSTD-Kruis-2001
p7720
sg5
S'PMC1728533'
p7721
sg7
g7693
sg9
V11709512.xml
p7722
sa(dp7723
g3
VSTD-Ireland-1988
p7724
sg5
S'PMC1433723'
p7725
sg7
g7693
sg9
V2898422.xml
p7726
sa(dp7727
g3
VSTD-Green-2010
p7728
sg5
S'PMC2890859'
p7729
sg7
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p7730
sg9
V20494434.xml
p7731
sa(dp7732
g3
VSTD-Siller-2012
p7733
sg5
S'PMC3511916'
p7734
sg7
g7730
sg9
V22825926.xml
p7735
sa(dp7736
g3
VSTD-Kasari-2010
p7737
sg5
S'PMC2922697'
p7738
sg7
g7730
sg9
V20145986.xml
p7739
sa(dp7740
g3
VSTD-Bech-2007
p7741
sg5
S'PMC1804137'
p7742
sg7
VCD006965 v. 6.0 Effects of restricted caffeine intake by mother on fetal neonatal and pregnancy outcome.rm5
p7743
sg9
V17259189.xml
p7744
sa(dp7745
g3
VSTD-Johnson-1985
p7746
sg5
S'PMC1418227'
p7747
sg7
VCD002286 v. 7.3 Feverfew for preventing migraine.rm5
p7748
sg9
V3929876.xml
p7749
sa(dp7750
g3
VSTD-Bystrova-2008
p7751
sg5
S'PMC1878468'
p7752
sg7
VCD006641 v. 3.0 Separate care for new mother and infant versus rooming-in for increasing the duration of breastfeedi.rm5
p7753
sg9
V17488524.xml
p7754
sa(dp7755
g3
VSTD-Sindrup-1990b
p7756
sg5
S'PMC1368167'
p7757
sg7
VCD005454 v. 11.0 Antidepressants for neuropathic pain.rm5
p7758
sg9
V2271367.xml
p7759
sa(dp7760
g3
VSTD-Hampf-1989
p7761
sg5
S'PMC2148641'
p7762
sg7
g7758
sg9
V2574958.xml
p7763
sa(dp7764
g3
VSTD-Feinmann-1984
p7765
sg5
S'PMC1444752'
p7766
sg7
g7758
sg9
V6419955.xml
p7767
sa(dp7768
g3
VSTD-McCleane-2000a
p7769
sg5
S'PMC2015036'
p7770
sg7
g7758
sg9
V10848721.xml
p7771
sa(dp7772
g3
VSTD-Shepperd-1998
p7773
sg5
S'PMC28578'
p7774
sg7
VCD004957 v. 4.0 Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chron.rm5
p7775
sg9
V9624068.xml
p7776
sa(dp7777
g3
VSTD-Jaffe-1983
p7778
sg5
S'PMC481332'
p7779
sg7
VCD006743 v. 5.0 Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients .rm5
p7780
sg9
V6404289.xml
p7781
sa(dp7782
g3
VSTD-Hargreaves-1992
p7783
sg5
S'PMC1025134'
p7784
sg7
g7780
sg9
V1449918.xml
p7785
sa(dp7786
g3
VSTD-Norris-1980
p7787
sg5
S'PMC482762'
p7788
sg7
g7780
sg9
V7426142.xml
p7789
sa(dp7790
g3
VSTD-Self-1983
p7791
sg5
S'PMC1874805'
p7792
sg7
VCD008416 v. 2.2 Multimedia educational interventions for consumers about prescribed and over-the-counter medications.rm5
p7793
sg9
V6848154.xml
p7794
sa(dp7795
g3
VSTD-Acosta-2009
p7796
sg5
S'PMC3732483'
p7797
sg7
g7793
sg9
V23770676.xml
p7798
sa(dp7799
g3
VSTD-Schwarz-2008a
p7800
sg5
S'PMC2517895'
p7801
sg7
g7793
sg9
V18398664.xml
p7802
sa(dp7803
g3
VSTD-Emond-2002
p7804
sg5
S'PMC1719107'
p7805
sg7
VCD006020 v. 6.0 Parenting interventions for the prevention of unintentional injuries in childhood.rm5
p7806
sg9
V11861228.xml
p7807
sa(dp7808
g3
VSTD-Johnson-1993
p7809
sg5
S'PMC1677859'
p7810
sg7
g7806
sg9
V8518642.xml
p7811
sa(dp7812
g3
VSTD-Barlow-2007
p7813
sg5
S'PMC2083433'
p7814
sg7
g7806
sg9
V17068074.xml
p7815
sa(dp7816
g3
VSTD-McCormack-1983
p7817
sg5
S'PMC2494372'
p7818
sg7
VCD006003 v. 6.2 Routine abdominal drainage for uncomplicated open cholecystectomy.rm5
p7819
sg9
V6614773.xml
p7820
sa(dp7821
g3
VSTD-Salam-1984
p7822
sg5
S'PMC2492550'
p7823
sg7
g7819
sg9
V6721407.xml
p7824
sa(dp7825
g3
VSTD-Fraser-1982
p7826
sg5
S'PMC2493965'
p7827
sg7
g7819
sg9
V7081917.xml
p7828
sa(dp7829
g3
VSTD-O_x0027_Kane-2008
p7830
sg5
S'PMC2394643'
p7831
sg7
VCD005060 v. 6.0 Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.rm5
p7832
sg9
V18420662.xml
p7833
sa(dp7834
g3
VSTD-DiGEM-trial-2007
p7835
sg5
S'PMC1925177'
p7836
sg7
g7832
sg9
V17591623.xml
p7837
sa(dp7838
g3
VSTD-Henderson-1986
p7839
sg5
S'PMC1341513'
p7840
sg7
VCD004640 v. 11.0 Magnesium supplementation for the management of primary hypertension in adults.rm5
p7841
sg9
V3092972.xml
p7842
sa(dp7843
g3
VSTD-McKinney-1989
p7844
sg5
S'PMC1837927'
p7845
sg7
VCD003338 v. 9.0 Conservative treatments for whiplash.rm5
p7846
sg9
V2511939.xml
p7847
sa(dp7848
g3
VSTD-Schnabel-2004
p7849
sg5
S'PMC1726332'
p7850
sg7
g7846
sg9
V15107368.xml
p7851
sa(dp7852
g3
VSTD-Mealy-1986
p7853
sg5
S'PMC1339641'
p7854
sg7
g7846
sg9
V3081211.xml
p7855
sa(dp7856
g3
VSTD-Kumar-2011
p7857
sg5
S'PMC3116809'
p7858
sg7
VCD000323 v. 8.1 Interventions for dysphagia and nutritional support in acute and subacute stroke.rm5
p7859
sg9
V21441148.xml
p7860
sa(dp7861
g3
VSTD-Norton-1996
p7862
sg5
S'PMC2349687'
p7863
sg7
g7859
sg9
V8555849.xml
p7864
sa(dp7865
g3
VSTD-Coope-1981
p7866
sg5
S'PMC1971963'
p7867
sg7
VCD002978 v. 3.0 Oral oestrogen and combined oestrogenprogestogen therapy versus placebo for hot flushes.rm5
p7868
sg9
V6268783.xml
p7869
sa(dp7870
g3
VSTD-Coope-1975
p7871
sg5
S'PMC1674796'
p7872
sg7
g7868
sg9
V172181.xml
p7873
sa(dp7874
g3
VSTD-Sesay-2011
p7875
sg5
S'PMC3024263'
p7876
sg7
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p7877
sg9
V21214940.xml
p7878
sa(dp7879
g3
VSTD-Konate-2011
p7880
sg5
S'PMC3032552'
p7881
sg7
g7877
sg9
V21304925.xml
p7882
sa(dp7883
g3
VSTD-Kweku-2008
p7884
sg5
S'PMC2602973'
p7885
sg7
g7877
sg9
V19098989.xml
p7886
sa(dp7887
g3
VSTD-Dicko-2011
p7888
sg5
S'PMC3032550'
p7889
sg7
g7877
sg9
V21304923.xml
p7890
sa(dp7891
g3
VSTD-Dicko-2008
p7892
sg5
S'PMC2500037'
p7893
sg7
g7877
sg9
V18611271.xml
p7894
sa(dp7895
g3
VSTD-Kari-1993
p7896
sg5
S'PMC1029304'
p7897
sg7
VCD001144 v. 7.0 Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preter.rm5
p7898
sg9
V8323356.xml
p7899
sa(dp7900
g3
VSTD-Sandrini-2007
p7901
sg5
S'PMC1974802'
p7902
sg7
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p7903
sg9
V17627707.xml
p7904
sa(dp7905
g3
VSTD-Tfelt_x002d_Hansen-2006
p7906
sg5
S'PMC3452229'
p7907
sg7
g7903
sg9
V17164991.xml
p7908
sa(dp7909
g3
VSTD-Bacon-1981b
p7910
sg5
S'PMC1627392'
p7911
sg7
VCD003031 v. 7.0 Prophylactic drug management for febrile seizures in children.rm5
p7912
sg9
V7305427.xml
p7913
sa(dp7914
g3
VSTD-Knudsen-1985b
p7915
sg5
S'PMC1777614'
p7916
sg7
g7912
sg9
V3907504.xml
p7917
sa(dp7918
g3
VSTD-Knudsen-1996
p7919
sg5
S'PMC1511589'
p7920
sg7
g7912
sg9
V8660037.xml
p7921
sa(dp7922
g3
VSTD-Heckmatt-1976
p7923
sg5
S'PMC1639342'
p7924
sg7
g7912
sg9
V1260273.xml
p7925
sa(dp7926
g3
VSTD-Ngwane-1980
p7927
sg5
S'PMC1626746'
p7928
sg7
g7912
sg9
V6770760.xml
p7929
sa(dp7930
g3
VSTD-Calis-2000
p7931
sg5
S'PMC1752990'
p7932
sg7
VCD007427 v. 2.0 Physical tests for shoulder impingements and local lesions of bursa tendon or labrum that may accom.rm5
p7933
sg9
V10627426.xml
p7934
sa(dp7935
g3
VSTD-Naredo--2002
p7936
sg5
S'PMC1754006'
p7937
sg7
g7933
sg9
V11796399.xml
p7938
sa(dp7939
g3
VSTD-Figueras-2007
p7940
sg5
S'PMC1877032'
p7941
sg7
VCD004171 v. 5.11 Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.rm5
p7942
sg9
V17414601.xml
p7943
sa(dp7944
g3
VSTD-Oniki-2003
p7945
sg5
S'PMC150371'
p7946
sg7
VCD001175 v. 6.7 Computer-generated reminders delivered on paper to healthcare professionals; effects on professional.rm5
p7947
sg9
V12595407.xml
p7948
sa(dp7949
g3
VSTD-McAlister-2009
p7950
sg5
S'PMC2789127'
p7951
sg7
g7947
sg9
V19933787.xml
p7952
sa(dp7953
g3
VSTD-Nilasena-1995
p7954
sg5
S'PMC2579172'
p7955
sg7
g7947
sg9
V8563365.xml
p7956
sa(dp7957
g3
VSTD-Rossi-1997
p7958
sg5
S'PMC1497186'
p7959
sg7
g7947
sg9
V9383135.xml
p7960
sa(dp7961
g3
VSTD-Rosser-1991
p7962
sg5
S'PMC1335900'
p7963
sg7
g7947
sg9
V1913409.xml
p7964
sa(dp7965
g3
VSTD-Wolter-2002
p7966
sg5
S'PMC1746273'
p7967
sg7
VCD002203 v. 10.0 Macrolide antibiotics for cystic fibrosis.rm5
p7968
sg9
V11867823.xml
p7969
sa(dp7970
g3
VSTD-Clement-2006
p7971
sg5
S'PMC2104771'
p7972
sg7
g7968
sg9
V16809416.xml
p7973
sa(dp7974
g3
VSTD-Choi-2008
p7975
sg5
S'PMC2636470'
p7976
sg7
VCD001035 v. 8.0 Interventions for encouraging sexual behaviours intended to prevent cervical cancer.rm5
p7977
sg9
V18703460.xml
p7978
sa(dp7979
g3
VSTD-Morrison_x002d_Beedy-2005
p7980
sg5
S'PMC2430924'
p7981
sg7
g7977
sg9
V15625713.xml
p7982
sa(dp7983
g3
VSTD-Kershaw-2009
p7984
sg5
S'PMC2759789'
p7985
sg7
g7977
sg9
V19762662.xml
p7986
sa(dp7987
g3
VSTD-Jaworski-2001
p7988
sg5
S'PMC2423731'
p7989
sg7
g7977
sg9
V11728891.xml
p7990
sa(dp7991
g3
VSTD-Peipert-2008
p7992
sg5
S'PMC2535847'
p7993
sg7
g7977
sg9
V18395692.xml
p7994
sa(dp7995
g3
VSTD-Thio-B-2000
p7996
sg5
S'PMC1745622'
p7997
sg7
VCD003570 v. 5.0 Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis.rm5
p7998
sg9
V10992533.xml
p7999
sa(dp8000
g3
VSTD-Thio-A-2000
p8001
sg5
S'PMC1745622'
p8002
sg7
g7998
sg9
V10992533.xml
p8003
sa(dp8004
g3
VSTD-Thio-C-2000
p8005
sg5
S'PMC1745622'
p8006
sg7
g7998
sg9
V10992533.xml
p8007
sa(dp8008
g3
VSTD-McKee-1991
p8009
sg5
S'PMC1368499'
p8010
sg7
VCD007124 v. 5.0 Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.rm5
p8011
sg9
V1888646.xml
p8012
sa(dp8013
g3
VSTD-BCIRG006
p8014
sg5
S'PMC3268553'
p8015
sg7
VCD006243 v. 4.0 Trastuzumab containing regimens for early breast cancer.rm5
p8016
sg9
V21991949.xml
p8017
sa(dp8018
g3
VSTD-Khawaja-1992
p8019
sg5
S'PMC1881859'
p8020
sg7
VCD006213 v. 9.0 Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.rm5
p8021
sg9
V1606429.xml
p8022
sa(dp8023
g3
VSTD-Jatakanon-1999
p8024
sg5
S'PMC1745406'
p8025
sg7
VCD004109 v. 4.0 High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and c.rm5
p8026
sg9
V10325913.xml
p8027
sa(dp8028
g3
VSTD-Lorentzson-1990
p8029
sg5
S'PMC462715'
p8030
sg7
g8026
sg9
V1978947.xml
p8031
sa(dp8032
g3
VSTD-Holloway-1989
p8033
sg5
S'PMC1026946'
p8034
sg7
VCD003557 v. 8.2 Antibiotics and antiseptics for venous leg ulcers.rm5
p8035
sg9
V2669345.xml
p8036
sa(dp8037
g3
VSTD-Ormiston-1985
p8038
sg5
S'PMC1416577'
p8039
sg7
g8035
sg9
V3926169.xml
p8040
sa(dp8041
g3
VSTD-Greene-1983
p8042
sg5
S'PMC1549780'
p8043
sg7
VCD003816 v. 4.9 'Human' insulin versus animal insulin in people with diabetes mellitus.rm5
p8044
sg9
V6416510.xml
p8045
sa(dp8046
g3
VSTD-Holman-1984
p8047
sg5
S'PMC1444374'
p8048
sg7
g8044
sg9
V6421424.xml
p8049
sa(dp8050
g3
VSTD-Maran-1993
p8051
sg5
S'PMC1676615'
p8052
sg7
g8044
sg9
V8443479.xml
p8053
sa(dp8054
g3
VSTD-Mann-1983
p8055
sg5
S'PMC1549785'
p8056
sg7
g8044
sg9
V6416511.xml
p8057
sa(dp8058
g3
VSTD-Egger-1991
p8059
sg5
S'PMC1671054'
p8060
sg7
g8044
sg9
V1932903.xml
p8061
sa(dp8062
g3
VSTD-Fossey-2006
p8063
sg5
S'PMC1420717'
p8064
sg7
VCD008634 v. 2.0 Psychosocial interventions for reducing antipsychotic medication in care home residents.rm5
p8065
sg9
V16543297.xml
p8066
sa(dp8067
g3
VSTD-Duoll-1997
p8068
sg5
S'PMC2127557'
p8069
sg7
VCD001107 v. 3.0 Inhaled steroids for episodic viral wheeze of childhood.rm5
p8070
sg9
V9353508.xml
p8071
sa(dp8072
g3
VSTD-Connett--1993
p8073
sg5
S'PMC1029187'
p8074
sg7
g8070
sg9
V8435016.xml
p8075
sa(dp8076
g3
VSTD-Wilson-1995
p8077
sg5
S'PMC1511243'
p8078
sg7
g8070
sg9
V7763063.xml
p8079
sa(dp8080
g3
VSTD-Wilson-1990
p8081
sg5
S'PMC1792186'
p8082
sg7
g8070
sg9
V2189367.xml
p8083
sa(dp8084
g3
VSTD-Wallin-1977
p8085
sg5
S'PMC1045406'
p8086
sg7
VCD006562 v. 3.0 5-FU for genital warts in non-immunocompromised individuals.rm5
p8087
sg9
V922458.xml
p8088
sa(dp8089
g3
VSTD-Cryz-1993
p8090
sg5
S'PMC302854'
p8091
sg7
VCD001261 v. 5.0 Vaccines for preventing typhoid fever.rm5
p8092
sg9
V8432597.xml
p8093
sa(dp8094
g3
VSTD-Wahdan-1980a
p8095
sg5
S'PMC2395909'
p8096
sg7
g8092
sg9
V6998594.xml
p8097
sa(dp8098
g3
VSTD-Yang-2001
p8099
sg5
S'PMC2566475'
p8100
sg7
g8092
sg9
V11477965.xml
p8101
sa(dp8102
g3
VSTD-Wahdan-1980b
p8103
sg5
S'PMC2395909'
p8104
sg7
g8092
sg9
V6998594.xml
p8105
sa(dp8106
g3
VSTD-Burton-1988
p8107
sg5
S'PMC3454541'
p8108
sg7
VCD001821 v. 8.0 Orthotic devices for the treatment of tennis elbow.rm5
p8109
sg9
V16550446.xml
p8110
sa(dp8111
g3
VSTD-Kari-1993
p8112
sg5
S'PMC1029304'
p8113
sg7
VCD001145 v. 7.0 Late (7 days) postnatal corticosteroids for chronic lung disease in preterm infants.rm5
p8114
sg9
V8323356.xml
p8115
sa(dp8116
g3
VSTD-Liu-2004
p8117
sg5
S'PMC1356212'
p8118
sg7
VCD006232 v. 5.2 Routine abdominal drainage for uncomplicated liver resection.rm5
p8119
sg9
V14745327.xml
p8120
sa(dp8121
g3
VSTD-Szewczyk-2010
p8122
sg5
S'PMC3298351'
p8123
sg7
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p8124
sg9
V22419941.xml
p8125
sa(dp8126
g3
VSTD-Morrell-1998
p8127
sg5
S'PMC28546'
p8128
sg7
g8124
sg9
V9582132.xml
p8129
sa(dp8130
g3
VSTD-Scriven-1998
p8131
sg5
S'PMC2503021'
p8132
sg7
g8124
sg9
V9682649.xml
p8133
sa(dp8134
g3
VSTD-Roland-1989
p8135
sg5
S'PMC1711929'
p8136
sg7
VCD004057 v. 9.0 Individual patient education for low back pain.rm5
p8137
sg9
V2556518.xml
p8138
sa(dp8139
g3
VSTD-Jellema-2005
p8140
sg5
S'PMC558614'
p8141
sg7
g8137
sg9
V15967762.xml
p8142
sa(dp8143
g3
VSTD-Frost-2004
p8144
sg5
S'PMC518892'
p8145
sg7
g8137
sg9
V15377573.xml
p8146
sa(dp8147
g3
VSTD-Rapha_x00eb_l-2001
p8148
sg5
S'PMC1737513'
p8149
sg7
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p8150
sg9
V11459901.xml
p8151
sa(dp8152
g3
VSTD-El_x002d_Bayoumi-2011
p8153
sg5
S'PMC3387601'
p8154
sg7
g8150
sg9
V21745374.xml
p8155
sa(dp8156
g3
VSTD-Arm-1988
p8157
sg5
S'PMC1020747'
p8158
sg7
VCD001283 v. 11.1 Dietary marine fatty acids (fish oil) for asthma in adults and children.rm5
p8159
sg9
V3353893.xml
p8160
sa(dp8161
g3
VSTD-Petry-2008
p8162
sg5
S'PMC2738749'
p8163
sg7
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p8164
sg9
V18377127.xml
p8165
sa(dp8166
g3
VSTD-Grant-2009
p8167
sg5
S'PMC2801822'
p8168
sg7
g8164
sg9
V19721120.xml
p8169
sa(dp8170
g3
VSTD-Carlbring-2010
p8171
sg5
S'PMC2882846'
p8172
sg7
g8164
sg9
V19967577.xml
p8173
sa(dp8174
g3
VSTD-Petry-2009
p8175
sg5
S'PMC2758481'
p8176
sg7
g8164
sg9
V19686527.xml
p8177
sa(dp8178
g3
VSTD-Tebutt-2003
p8179
sg5
S'PMC1773619'
p8180
sg7
VCD008997 v. 2.0 Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stag.rm5
p8181
sg9
V12631671.xml
p8182
sa(dp8183
g3
VSTD-PATAF
p8184
sg5
S'PMC28250'
p8185
sg7
VCD006186 v. 4.0 Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular .rm5
p8186
sg9
V10514159.xml
p8187
sa(dp8188
g3
VSTD-Chapman-2000
p8189
sg5
S'PMC27395'
p8190
sg7
VCD004726 v. 4.3 Education of children and adolescents for the prevention of dog bite injuries.rm5
p8191
sg9
V10834894.xml
p8192
sa(dp8193
g3
VSTD-Hawthorne-1997
p8194
sg5
S'PMC1313005'
p8195
sg7
VCD005268 v. 2.2 Individual patient education for people with type 2 diabetes mellitus.rm5
p8196
sg9
V9219407.xml
p8197
sa(dp8198
g3
VSTD-Santos-2010-_x0028_preD_x002f_Dial_x0029_
p8199
sg5
S'PMC2893059'
p8200
sg7
VCD003264 v. 11.0 Growth hormone for children with chronic kidney disease.rm5
p8201
sg9
V20522533.xml
p8202
sa(dp8203
g3
VSTD-Maxwell-1998a-_x0028_TP_x0029_
p8204
sg5
S'PMC1717762'
p8205
sg7
g8201
sg9
V10210991.xml
p8206
sa(dp8207
g3
VSTD-Maxwell-1998b-_x0028_TP_x0029_
p8208
sg5
S'PMC1717762'
p8209
sg7
g8201
sg9
V10210991.xml
p8210
sa(dp8211
g3
VSTD-Holford-1976
p8212
sg5
S'PMC1689300'
p8213
sg7
VCD001484 v. 9.0 Elastic compression stockings for prevention of deep vein thrombosis.rm5
p8214
sg9
V788855.xml
p8215
sa(dp8216
g3
VSTD-Trivedi-2003
p8217
sg5
S'PMC150177'
p8218
sg7
VCD000227 v. 9.0 Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-men.rm5
p8219
sg9
V12609940.xml
p8220
sa(dp8221
g3
VSTD-Porthouse-2005
p8222
sg5
S'PMC557150'
p8223
sg7
g8219
sg9
V15860827.xml
p8224
sa(dp8225
g3
VSTD-Sato-1999a
p8226
sg5
S'PMC1736147'
p8227
sg7
g8219
sg9
V9886454.xml
p8228
sa(dp8229
g3
VSTD-Melchart-2005
p8230
sg5
S'PMC1184247'
p8231
sg7
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p8232
sg9
V16055451.xml
p8233
sa(dp8234
g3
VSTD-Endres-2007
p8235
sg5
S'PMC3476149'
p8236
sg7
g8232
sg9
V17955168.xml
p8237
sa(dp8238
g3
VSTD-MacDonald-2006b
p8239
sg5
S'PMC2082836'
p8240
sg7
VCD004731 v. 9.0 Protein substitute for children and adults with phenylketonuria.rm5
p8241
sg9
V16547085.xml
p8242
sa(dp8243
g3
VSTD-Litt-2010
p8244
sg5
S'PMC2939176'
p8245
sg7
VCD008456 v. 2.0 Psychosocial interventions for the management of chronic orofacial pain.rm5
p8246
sg9
V20655662.xml
p8247
sa(dp8248
g3
VSTD-Katz-2010
p8249
sg5
S'PMC2884332'
p8250
sg7
VCD007991 v. 2.16 Zinc supplementation for mental and motor development in children.rm5
p8251
sg9
V20484548.xml
p8252
sa(dp8253
g3
VSTD-Kuhn-2008
p8254
sg5
S'PMC2577610'
p8255
sg7
VCD006734 v. 4.0 Interventions for preventing late postnatal mother-to-child transmission of HIV.rm5
p8256
sg9
V18525036.xml
p8257
sa(dp8258
g3
VSTD-Safarinejad-2009
p8259
sg5
S'PMC3720081'
p8260
sg7
VCD007411 v. 11.0 Antioxidants for male subfertility.rm5
p8261
sg9
V22659579.xml
p8262
sa(dp8263
g3
VSTD-Watts-1994
p8264
sg5
S'PMC2366143'
p8265
sg7
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p8266
sg9
V18472878.xml
p8267
sa(dp8268
g3
VSTD-Hibbard-1998
p8269
sg5
S'PMC1784771'
p8270
sg7
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p8271
sg9
V9678143.xml
p8272
sa(dp8273
g3
VSTD-Laing-1986
p8274
sg5
S'PMC1777578'
p8275
sg7
VCD003487 v. 5.2 Transpyloric versus gastric tube feeding for preterm infants.rm5
p8276
sg9
V3082297.xml
p8277
sa(dp8278
g3
VSTD-Macdonald-1992
p8279
sg5
S'PMC1590483'
p8280
sg7
g8276
sg9
V1586185.xml
p8281
sa(dp8282
g3
VSTD-Whitfield-1982
p8283
sg5
S'PMC1627713'
p8284
sg7
g8276
sg9
V6810764.xml
p8285
sa(dp8286
g3
VSTD-Webster-2010a
p8287
sg5
S'PMC2958861'
p8288
sg7
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p8289
sg9
V20937130.xml
p8290
sa(dp8291
g3
VSTD-Farrokhi-2010
p8292
sg5
S'PMC2989232'
p8293
sg7
VCD009073 v. 2.0 Pedicle screw fixation for traumatic fractures of the thoracic and lumbar spine.rm5
p8294
sg9
V20495932.xml
p8295
sa(dp8296
g3
VSTD-Daniel-1972
p8297
sg5
S'PMC1215343'
p8298
sg7
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p8299
sg9
V5079408.xml
p8300
sa(dp8301
g3
VSTD-Hung-1984
p8302
sg5
S'PMC1040361'
p8303
sg7
g8299
sg9
V6372855.xml
p8304
sa(dp8305
g3
VSTD-Colin-2007a
p8306
sg5
S'PMC2704535'
p8307
sg7
g8299
sg9
V19668521.xml
p8308
sa(dp8309
g3
VSTD-Colin-2007b
p8310
sg5
S'PMC2704535'
p8311
sg7
g8299
sg9
V19668521.xml
p8312
sa(dp8313
g3
VSTD-de-Koning-1982
p8314
sg5
S'PMC1039837'
p8315
sg7
g8299
sg9
V6179534.xml
p8316
sa(dp8317
g3
VSTD-MacKenzie-1964
p8318
sg5
S'PMC505953'
p8319
sg7
g8299
sg9
V14193681.xml
p8320
sa(dp8321
g3
VSTD-Davidson-1964
p8322
sg5
S'PMC506041'
p8323
sg7
g8299
sg9
V14249189.xml
p8324
sa(dp8325
g3
VSTD-Laibson-1977
p8326
sg5
S'PMC1311553'
p8327
sg7
g8299
sg9
V418546.xml
p8328
sa(dp8329
g3
VSTD-Coster-1980
p8330
sg5
S'PMC1043812'
p8331
sg7
g8299
sg9
V7000170.xml
p8332
sa(dp8333
g3
VSTD-Yeakley-1981
p8334
sg5
S'PMC1312181'
p8335
sg7
g8299
sg9
V7043864.xml
p8336
sa(dp8337
g3
VSTD-Yamazaki-1984b
p8338
sg5
S'PMC3689032'
p8339
sg7
g8299
sg9
V23801989.xml
p8340
sa(dp8341
g3
VSTD-Kitano-1985
p8342
sg5
S'PMC3650034'
p8343
sg7
g8299
sg9
V23671647.xml
p8344
sa(dp8345
g3
VSTD-Luntz-1963
p8346
sg5
S'PMC505831'
p8347
sg7
g8299
sg9
V14189714.xml
p8348
sa(dp8349
g3
VSTD-La-Lau-1982
p8350
sg5
S'PMC1039836'
p8351
sg7
g8299
sg9
V6809036.xml
p8352
sa(dp8353
g3
VSTD-Coster-1979
p8354
sg5
S'PMC1043501'
p8355
sg7
g8299
sg9
V111704.xml
p8356
sa(dp8357
g3
VSTD-Yamazaki-1984c
p8358
sg5
S'PMC3689032'
p8359
sg7
g8299
sg9
V23801989.xml
p8360
sa(dp8361
g3
VSTD-Collum-1980
p8362
sg5
S'PMC1043813'
p8363
sg7
g8299
sg9
V7000171.xml
p8364
sa(dp8365
g3
VSTD-Power-1991
p8366
sg5
S'PMC1042518'
p8367
sg7
g8299
sg9
V1751456.xml
p8368
sa(dp8369
g3
VSTD-Collum-1985
p8370
sg5
S'PMC1040757'
p8371
sg7
g8299
sg9
V3904820.xml
p8372
sa(dp8373
g3
VSTD-Collum-1986
p8374
sg5
S'PMC1041036'
p8375
sg7
g8299
sg9
V3521717.xml
p8376
sa(dp8377
g3
VSTD-Van-Bijsterveld-1989
p8378
sg5
S'PMC1041826'
p8379
sg7
g8299
sg9
V2669938.xml
p8380
sa(dp8381
g3
VSTD-Young-1982
p8382
sg5
S'PMC1039800'
p8383
sg7
g8299
sg9
V7044411.xml
p8384
sa(dp8385
g3
VSTD-Van-Bijsterveld-1980
p8386
sg5
S'PMC1039344'
p8387
sg7
g8299
sg9
V6766733.xml
p8388
sa(dp8389
g3
VSTD-Schachter-1980
p8390
sg5
S'PMC490494'
p8391
sg7
VCD003724 v. 6.0 Antidepressant drugs for narcolepsy.rm5
p8392
sg9
V6766990.xml
p8393
sa(dp8394
g3
VSTD-Mitler-1990
p8395
sg5
S'PMC2254143'
p8396
sg7
g8392
sg9
V1968069.xml
p8397
sa(dp8398
g3
VSTD-Wang-2006
p8399
sg5
S'PMC3747914'
p8400
sg7
VCD006765 v. 4.2 Chuanxiong preparations for preventing stroke.rm5
p8401
sg9
V23970729.xml
p8402
sa(dp8403
g3
VSTD-van-Rensen-1999
p8404
sg5
S'PMC1763792'
p8405
sg7
VCD003135 v. 7.0 Fluticasone versus placebo for chronic asthma in adults and children.rm5
p8406
sg9
V10212103.xml
p8407
sa(dp8408
g3
VSTD-Phillips-2004
p8409
sg5
S'PMC1758859'
p8410
sg7
g8406
sg9
V14694242.xml
p8411
sa(dp8412
g3
VSTD-Jayaram-2005
p8413
sg5
S'PMC1747311'
p8414
sg7
g8406
sg9
V15681495.xml
p8415
sa(dp8416
g3
VSTD-Faul-1998
p8417
sg5
S'PMC1745308'
p8418
sg7
g8406
sg9
V10319057.xml
p8419
sa(dp8420
g3
VSTD-Sovij_x00e4_rvi-2003
p8421
sg5
S'PMC1746689'
p8422
sg7
g8406
sg9
V12775860.xml
p8423
sa(dp8424
g3
VSTD-Ward-2001
p8425
sg5
S'PMC1746305'
p8426
sg7
g8406
sg9
V11923548.xml
p8427
sa(dp8428
g3
VSTD-Albrecht-2004
p8429
sg5
S'PMC2395315'
p8430
sg7
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p8431
sg9
V14710214.xml
p8432
sa(dp8433
g3
VSTD-Francini-1993
p8434
sg5
S'PMC1968505'
p8435
sg7
g8431
sg9
V8512828.xml
p8436
sa(dp8437
g3
VSTD-Fan-2009
p8438
sg5
S'PMC2781155'
p8439
sg7
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p8440
sg9
V19666658.xml
p8441
sa(dp8442
g3
VSTD-Cheng-2008
p8443
sg5
S'PMC2440276'
p8444
sg7
g8440
sg9
V18385391.xml
p8445
sa(dp8446
g3
VSTD-McIntyre-2009
p8447
sg5
S'PMC2637599'
p8448
sg7
g8440
sg9
V19158369.xml
p8449
sa(dp8450
g3
VSTD-Ferreira-2008
p8451
sg5
S'PMC2396748'
p8452
sg7
g8440
sg9
V18199805.xml
p8453
sa(dp8454
g3
VSTD-FORESEE-Study-2008
p8455
sg5
S'PMC2518797'
p8456
sg7
g8440
sg9
V18579668.xml
p8457
sa(dp8458
g3
VSTD-Sprague-2009a
p8459
sg5
S'PMC2615694'
p8460
sg7
g8440
sg9
V19056618.xml
p8461
sa(dp8462
g3
VSTD-Tzanakis-2008
p8463
sg5
S'PMC2268719'
p8464
sg7
g8440
sg9
V18193489.xml
p8465
sa(dp8466
g3
VSTD-Bolden-1972
p8467
sg5
S'PMC2156555'
p8468
sg7
VCD004402 v. 10.4 Steroids for symptom control in infectious mononucleosis.rm5
p8469
sg9
V4556193.xml
p8470
sa(dp8471
g3
VSTD-Mayon_x002d_White-1956
p8472
sg5
S'PMC1979017'
p8473
sg7
VCD002238 v. 8.0 Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).rm5
p8474
sg9
V13293381.xml
p8475
sa(dp8476
g3
VSTD-Schultz-2004
p8477
sg5
S'PMC394324'
p8478
sg7
VCD006634 v. 2.0 Probiotics for induction of remission in Crohn's disease.rm5
p8479
sg9
V15113451.xml
p8480
sa(dp8481
g3
VSTD-Fan-2003
p8482
sg5
S'PMC3386091'
p8483
sg7
VCD005569 v. 3.0 Chuanxiong-type preparations for acute ischemic stroke.rm5
p8484
sg9
V22645373.xml
p8485
sa(dp8486
g3
VSTD-Mynors_x002d_Wallis-1995
p8487
sg5
S'PMC2548821'
p8488
sg7
VCD003494 v. 11.0 Psychosocial interventions by general practitioners.rm5
p8489
sg9
V7873952.xml
p8490
sa(dp8491
g3
VSTD-Mynors_x002d_Wallis-2000
p8492
sg5
S'PMC27250'
p8493
sg7
g8489
sg9
V10617523.xml
p8494
sa(dp8495
g3
VSTD-McIntosh-1997
p8496
sg5
S'PMC2255191'
p8497
sg7
g8489
sg9
V9386883.xml
p8498
sa(dp8499
g3
VSTD-Clark-2000
p8500
sg5
S'PMC1753277'
p8501
sg7
VCD003472 v. 4.0 Exercise therapy for patellofemoral pain syndrome.rm5
p8502
sg9
V10976083.xml
p8503
sa(dp8504
g3
VSTD-Hillstroem-1977
p8505
sg5
S'PMC1045390'
p8506
sg7
VCD000218 v. 8.0 Interventions for treating trichomoniasis in women.rm5
p8507
sg9
V326349.xml
p8508
sa(dp8509
g3
VSTD-Hayward-1976
p8510
sg5
S'PMC1045214'
p8511
sg7
g8507
sg9
V769913.xml
p8512
sa(dp8513
g3
VSTD-Lean-1972
p8514
sg5
S'PMC1044856'
p8515
sg7
g8507
sg9
V4348437.xml
p8516
sa(dp8517
g3
VSTD-Notowicz-1977
p8518
sg5
S'PMC1045370'
p8519
sg7
g8507
sg9
V322823.xml
p8520
sa(dp8521
g3
VSTD-Evans-1971
p8522
sg5
S'PMC1799017'
p8523
sg7
g8507
sg9
V4939601.xml
p8524
sa(dp8525
g3
VSTD-McClean-1972
p8526
sg5
S'PMC1048274'
p8527
sg7
g8507
sg9
V5015963.xml
p8528
sa(dp8529
g3
VSTD-Thin-1979
p8530
sg5
S'PMC1045680'
p8531
sg7
g8507
sg9
V389352.xml
p8532
sa(dp8533
g3
VSTD-Evans-1970
p8534
sg5
S'PMC1700140'
p8535
sg7
g8507
sg9
V4913962.xml
p8536
sa(dp8537
g3
VSTD-Austin-1982
p8538
sg5
S'PMC1046021'
p8539
sg7
g8507
sg9
V7039761.xml
p8540
sa(dp8541
g3
VSTD-Wigfield-1975
p8542
sg5
S'PMC1045112'
p8543
sg7
g8507
sg9
V1092425.xml
p8544
sa(dp8545
g3
VSTD-Barnes-1957
p8546
sg5
S'PMC1973492'
p8547
sg7
g8507
sg9
V13426568.xml
p8548
sa(dp8549
g3
VSTD-Roy-1975
p8550
sg5
S'PMC1046566'
p8551
sg7
g8507
sg9
V1098732.xml
p8552
sa(dp8553
g3
VSTD-Block-1972
p8554
sg5
S'PMC3675863'
p8555
sg7
g8507
sg9
V23761847.xml
p8556
sa(dp8557
g3
VSTD-Eriksson-1976
p8558
sg5
S'PMC1045280'
p8559
sg7
g8507
sg9
V963493.xml
p8560
sa(dp8561
g3
VSTD-Grootendorst-2007
p8562
sg5
S'PMC2094292'
p8563
sg7
VCD002309 v. 5.4 Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.rm5
p8564
sg9
V17573446.xml
p8565
sa(dp8566
g3
VSTD-Brubaker-2008
p8567
sg5
S'PMC2614233'
p8568
sg7
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p8569
sg9
V18591307.xml
p8570
sa(dp8571
g3
VSTD-Dietz-2010
p8572
sg5
S'PMC2808513'
p8573
sg7
g8569
sg9
V19834635.xml
p8574
sa(dp8575
g3
VSTD-Sung-2012
p8576
sg5
S'PMC3244827'
p8577
sg7
g8569
sg9
V22183220.xml
p8578
sa(dp8579
g3
VSTD-Carey-2009
p8580
sg5
S'PMC2774153'
p8581
sg7
g8569
sg9
V19583714.xml
p8582
sa(dp8583
g3
VSTD-Wei-2011
p8584
sg5
S'PMC3433843'
p8585
sg7
g8569
sg9
V22716974.xml
p8586
sa(dp8587
g3
VSTD-Freeman--2008
p8588
sg5
S'PMC2820297'
p8589
sg7
VCD004856 v. 6.0 Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adol.rm5
p8590
sg9
V18356758.xml
p8591
sa(dp8592
g3
VSTD-Foley-2003
p8593
sg5
S'PMC1754378'
p8594
sg7
VCD005523 v. 4.0 Aquatic exercise for the treatment of knee and hip osteoarthritis.rm5
p8595
sg9
V14644853.xml
p8596
sa(dp8597
g3
VSTD-Katzenstein-2009
p8598
sg5
S'PMC2795100'
p8599
sg7
VCD009219 v. 3.0 Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.rm5
p8600
sg9
V19813275.xml
p8601
sa(dp8602
g3
VSTD-LaGrone-2012
p8603
sg5
S'PMC3238461'
p8604
sg7
VCD009584 v. 2.0 Specially formulated foods for treating children with moderate acute malnutrition in low- and middle.rm5
p8605
sg9
V22170366.xml
p8606
sa(dp8607
g3
VSTD-Matilsky-2009
p8608
sg5
S'PMC3151028'
p8609
sg7
g8605
sg9
V19225128.xml
p8610
sa(dp8611
g3
VSTD-Hossain-2011
p8612
sg5
S'PMC3020319'
p8613
sg7
g8605
sg9
V20871416.xml
p8614
sa(dp8615
g3
VSTD-Philipp_x0028_100_x0029_
p8616
sg5
S'PMC28296'
p8617
sg7
VCD003197 v. 8.0 Low dosage tricyclic antidepressants for depression.rm5
p8618
sg9
V10591711.xml
p8619
sa(dp8620
g3
VSTD-Blashki_x0028_75_x0026_150_x0029_
p8621
sg5
S'PMC1795147'
p8622
sg7
g8618
sg9
V4923928.xml
p8623
sa(dp8624
g3
VSTD-Tan_x0028_70_x0029_
p8625
sg5
S'PMC1364731'
p8626
sg7
g8618
sg9
V8018452.xml
p8627
sa(dp8628
g3
VSTD-Feary-2009a
p8629
sg5
S'PMC2728895'
p8630
sg7
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p8631
sg9
V19400893.xml
p8632
sa(dp8633
g3
VSTD-Cornelissen-1992
p8634
sg5
S'PMC1793939'
p8635
sg7
VCD002776 v. 4.0 Prophylactic vitamin K for vitamin K deficiency bleeding in neonates.rm5
p8636
sg9
V1444522.xml
p8637
sa(dp8638
g3
VSTD-Greer-1998
p8639
sg5
S'PMC1717721'
p8640
sg7
g8636
sg9
V9875038.xml
p8641
sa(dp8642
g3
VSTD-Choudari-1994
p8643
sg5
S'PMC1374741'
p8644
sg7
VCD005584 v. 5.0 Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleed.rm5
p8645
sg9
V8200551.xml
p8646
sa(dp8647
g3
VSTD-Lin-1999
p8648
sg5
S'PMC1727515'
p8649
sg7
g8645
sg9
V10205211.xml
p8650
sa(dp8651
g3
VSTD-Lin-1993
p8652
sg5
S'PMC1375450'
p8653
sg7
g8645
sg9
V8406150.xml
p8654
sa(dp8655
g3
VSTD-Loizou-1991
p8656
sg5
S'PMC1379366'
p8657
sg7
g8645
sg9
V1955161.xml
p8658
sa(dp8659
g3
VSTD-Chung-1997
p8660
sg5
S'PMC2126544'
p8661
sg7
g8645
sg9
V9158465.xml
p8662
sa(dp8663
g3
VSTD-Gyr-1996
p8664
sg5
S'PMC1383318'
p8665
sg7
VCD002798 v. 11.0 Benzodiazepine receptor antagonists for hepatic encephalopathy.rm5
p8666
sg9
V8977350.xml
p8667
sa(dp8668
g3
VSTD-Neuberger-1985
p8669
sg5
S'PMC1432420'
p8670
sg7
VCD004789 v. 7.0 D-penicillamine for primary biliary cirrhosis.rm5
p8671
sg9
V3881323.xml
p8672
sa(dp8673
g3
VSTD-Van-Gurp-2002
p8674
sg5
S'PMC2214056'
p8675
sg7
VCD006117 v. 10.0 Sertraline versus other antidepressive agents for depression.rm5
p8676
sg9
V12053635.xml
p8677
sa(dp8678
g3
VSTD-Stehl-2009
p8679
sg5
S'PMC2734126'
p8680
sg7
VCD009660 v. 2.0 Psychological interventions for parents of children and adolescents with chronic illness.rm5
p8681
sg9
V19091806.xml
p8682
sa(dp8683
g3
VSTD-Barakat-2010
p8684
sg5
S'PMC2950888'
p8685
sg7
g8681
sg9
V20686425.xml
p8686
sa(dp8687
g3
VSTD-Levy-2010
p8688
sg5
S'PMC2887246'
p8689
sg7
g8681
sg9
V20216531.xml
p8690
sa(dp8691
g3
VSTD-Lehmkuhl-2010
p8692
sg5
S'PMC2825642'
p8693
sg7
g8681
sg9
V20167185.xml
p8694
sa(dp8695
g3
VSTD-Kashikar_x002d_Zuck-2012
p8696
sg5
S'PMC3690664'
p8697
sg7
g8681
sg9
V22108765.xml
p8698
sa(dp8699
g3
VSTD-Askins-2009
p8700
sg5
S'PMC2684487'
p8701
sg7
g8681
sg9
V19091804.xml
p8702
sa(dp8703
g3
VSTD-Ambrosino-2008
p8704
sg5
S'PMC2936820'
p8705
sg7
g8681
sg9
V18540868.xml
p8706
sa(dp8707
g3
VSTD-Wade-2011
p8708
sg5
S'PMC3387908'
p8709
sg7
g8681
sg9
V21890828.xml
p8710
sa(dp8711
g3
VSTD-Grey-2011
p8712
sg5
S'PMC3134246'
p8713
sg7
g8681
sg9
V21522034.xml
p8714
sa(dp8715
g3
VSTD-Lask-1979
p8716
sg5
S'PMC1545376'
p8717
sg7
g8681
sg9
V373642.xml
p8718
sa(dp8719
g3
VSTD-Palermo-2009
p8720
sg5
S'PMC2760656'
p8721
sg7
g8681
sg9
V19695776.xml
p8722
sa(dp8723
g3
VSTD-Widman-2002
p8724
sg5
S'PMC3620860'
p8725
sg7
VCD006836 v. 4.0 Bone grafts and bone substitutes for treating distal radial fractures in adults.rm5
p8726
sg9
V11954842.xml
p8727
sa(dp8728
g3
VSTD-Appleby-1997
p8729
sg5
S'PMC2126383'
p8730
sg7
VCD002018 v. 6.0 Antidepressant treatment for post-natal depression.rm5
p8731
sg9
V9099116.xml
p8732
sa(dp8733
g3
VSTD-MacKenzie-2001
p8734
sg5
S'PMC55924'
p8735
sg7
VCD006373 v. 3.0 Interventions for treating functional dysphonia in adults.rm5
p8736
sg9
V11566828.xml
p8737
sa(dp8738
g3
VSTD-Dormuth-2004
p8739
sg5
S'PMC526331'
p8740
sg7
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p8741
sg9
V15505268.xml
p8742
sa(dp8743
g3
VSTD-Perria-2007
p8744
sg5
S'PMC1904445'
p8745
sg7
g8741
sg9
V17547760.xml
p8746
sa(dp8747
g3
VSTD-Black-2002
p8748
sg5
S'PMC1743616'
p8749
sg7
g8741
sg9
V12448802.xml
p8750
sa(dp8751
g3
VSTD-Kabir-2007
p8752
sg5
S'PMC2000662'
p8753
sg7
g8741
sg9
V17610535.xml
p8754
sa(dp8755
g3
VSTD-Mason-2001
p8756
sg5
S'PMC59683'
p8757
sg7
g8741
sg9
V11701573.xml
p8758
sa(dp8759
g3
VSTD-Oakeshott-1994
p8760
sg5
S'PMC1238864'
p8761
sg7
g8741
sg9
V8204331.xml
p8762
sa(dp8763
g3
VSTD-Evans-1993b
p8764
sg5
S'PMC1679014'
p8765
sg7
VCD001434 v. 12.5 Topical treatments for fungal infections of the skin and nails of the foot..rm5
p8766
sg9
V8401048.xml
p8767
sa(dp8768
g3
VSTD-Crane-2004
p8769
sg5
S'PMC1726258'
p8770
sg7
VCD005351 v. 3.2 Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.rm5
p8771
sg9
V14988338.xml
p8772
sa(dp8773
g3
VSTD-Kirwan-2006
p8774
sg5
S'PMC1633773'
p8775
sg7
VCD003433 v. 7.0 Beta radiation for glaucoma surgery.rm5
p8776
sg9
V17023435.xml
p8777
sa(dp8778
g3
VSTD-Carey-2005
p8779
sg5
S'PMC547907'
p8780
sg7
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p8781
sg9
V15667657.xml
p8782
sa(dp8783
g3
VSTD-Banani-1994
p8784
sg5
S'PMC1030063'
p8785
sg7
VCD008300 v. 2.2 Treating BCG-induced disease in children.rm5
p8786
sg9
V7826118.xml
p8787
sa(dp8788
g3
VSTD-Norrkoping
p8789
sg5
S'PMC3069219'
p8790
sg7
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p8791
sg9
V21454449.xml
p8792
sa(dp8793
g3
VSTD-PLCO
p8794
sg5
S'PMC3260132'
p8795
sg7
g8791
sg9
V22228146.xml
p8796
sa(dp8797
g3
VSTD-Bonduelle-1991
p8798
sg5
S'PMC2399106'
p8799
sg7
VCD001016 v. 5.0 Cyclical progestogens for heavy menstrual bleeding.rm5
p8800
sg9
V1835005.xml
p8801
sa(dp8802
g3
VSTD-Liang-1990
p8803
sg5
S'PMC171559'
p8804
sg7
VCD005590 v. 5.0 Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.rm5
p8805
sg9
V2327768.xml
p8806
sa(dp8807
g3
VSTD-Van-de-Putte-2003
p8808
sg5
S'PMC1754401'
p8809
sg7
VCD005113 v. 5.0 Adalimumab for treating rheumatoid arthritis.rm5
p8810
sg9
V14644854.xml
p8811
sa(dp8812
g3
VSTD-Van-de-Putte-2004
p8813
sg5
S'PMC1755008'
p8814
sg7
g8810
sg9
V15082480.xml
p8815
sa(dp8816
g3
VSTD-Yasuda-2001
p8817
sg5
S'PMC1728521'
p8818
sg7
VCD004890 v. 7.0 Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct .rm5
p8819
sg9
V11600473.xml
p8820
sa(dp8821
g3
VSTD-Vlavianos-2003
p8822
sg5
S'PMC1773772'
p8823
sg7
g8819
sg9
V12865276.xml
p8824
sa(dp8825
g3
VSTD-Oria-2007
p8826
sg5
S'PMC1867927'
p8827
sg7
VCD009779 v. 2.0 Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative mana.rm5
p8828
sg9
V17197959.xml
p8829
sa(dp8830
g3
VSTD-Montoya-1994
p8831
sg5
S'PMC2633654'
p8832
sg7
VCD006754 v. 5.0 Anticonvulsants for cocaine dependence.rm5
p8833
sg9
V7555621.xml
p8834
sa(dp8835
g3
VSTD-Beales-1972
p8836
sg5
S'PMC1788331'
p8837
sg7
VCD008886 v. 2.0 Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis ankylosing .rm5
p8838
sg9
V4555545.xml
p8839
sa(dp8840
g3
VSTD-Grennan-1979
p8841
sg5
S'PMC1429811'
p8842
sg7
g8838
sg9
V389264.xml
p8843
sa(dp8844
g3
VSTD-Sperryn-1973
p8845
sg5
S'PMC1006067'
p8846
sg7
g8838
sg9
V4571392.xml
p8847
sa(dp8848
g3
VSTD-Belanger-2002
p8849
sg5
S'PMC2661342'
p8850
sg7
VCD006546 v. 4.0 Kinship care for the safety permanency and well-being of children removed from the home for maltre.rm5
p8851
sg9
V19436468.xml
p8852
sa(dp8853
g3
VSTD-Jonson_x002d_Reid-2003
p8854
sg5
S'PMC3340591'
p8855
sg7
g8851
sg9
V22529281.xml
p8856
sa(dp8857
g3
VSTD-Christopher-1998
p8858
sg5
S'PMC3654563'
p8859
sg7
g8851
sg9
V23517028.xml
p8860
sa(dp8861
g3
VSTD-Harvey-1998
p8862
sg5
S'PMC1410004'
p8863
sg7
VCD001025 v. 14.0 Counselling for mental health and psychosocial problems in primary care.rm5
p8864
sg9
V9624744.xml
p8865
sa(dp8866
g3
VSTD-Chilvers-2001
p8867
sg5
S'PMC30555'
p8868
sg7
g8864
sg9
V11282864.xml
p8869
sa(dp8870
g3
VSTD-Bennett-1982
p8871
sg5
S'PMC1352659'
p8872
sg7
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p8873
sg9
V7082061.xml
p8874
sa(dp8875
g3
VSTD-Rosen-1998
p8876
sg5
S'PMC3015270'
p8877
sg7
g8873
sg9
V9876706.xml
p8878
sa(dp8879
g3
VSTD-Lantz-1995
p8880
sg5
S'PMC1615506'
p8881
sg7
VCD002943 v. 6.0 Strategies for increasing the participation of women in community breast cancer screening.rm5
p8882
sg9
V7646664.xml
p8883
sa(dp8884
g3
VSTD-Lerman-1992
p8885
sg5
S'PMC1694134'
p8886
sg7
g8882
sg9
V1566953.xml
p8887
sa(dp8888
g3
VSTD-Sutton-1994
p8889
sg5
S'PMC1059897'
p8890
sg7
g8882
sg9
V8138773.xml
p8891
sa(dp8892
g3
VSTD-Sung-1992
p8893
sg5
S'PMC1403667'
p8894
sg7
g8882
sg9
V1641433.xml
p8895
sa(dp8896
g3
VSTD-Atri-1997
p8897
sg5
S'PMC2127854'
p8898
sg7
g8882
sg9
V9402779.xml
p8899
sa(dp8900
g3
VSTD-Janz-1997
p8901
sg5
S'PMC1381136'
p8902
sg7
g8882
sg9
V9357355.xml
p8903
sa(dp8904
g3
VSTD-Barbanel-2003
p8905
sg5
S'PMC1746491'
p8906
sg7
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p8907
sg9
V14514935.xml
p8908
sa(dp8909
g3
VSTD-Willems-2007a
p8910
sg5
S'PMC2000864'
p8911
sg7
g8907
sg9
V17662113.xml
p8912
sa(dp8913
g3
VSTD-Pinnock-2003
p8914
sg5
S'PMC150181'
p8915
sg7
g8907
sg9
V12609944.xml
p8916
sa(dp8917
g3
VSTD-Pinnock-2005
p8918
sg5
S'PMC1463186'
p8919
sg7
g8907
sg9
V15720933.xml
p8920
sa(dp8921
g3
VSTD-Pinnock-2007
p8922
sg5
S'PMC2151786'
p8923
sg7
g8907
sg9
V17761059.xml
p8924
sa(dp8925
g3
VSTD-Gruffydd_x002d_Jones-2005
p8926
sg5
S'PMC1570530'
p8927
sg7
g8907
sg9
V16378560.xml
p8928
sa(dp8929
g3
VSTD-Herndon-1990
p8930
sg5
S'PMC1358272'
p8931
sg7
VCD008990 v. 2.0 Recombinant human growth hormone for treating burns and donor sites.rm5
p8932
sg9
V2121109.xml
p8933
sa(dp8934
g3
VSTD-Gilpin-1994
p8935
sg5
S'PMC1234282'
p8936
sg7
g8932
sg9
V8024354.xml
p8937
sa(dp8938
g3
VSTD-Przkora-2006
p8939
sg5
S'PMC1479605'
p8940
sg7
g8932
sg9
V16772783.xml
p8941
sa(dp8942
g3
VSTD-Kalra-2004
p8943
sg5
S'PMC313879'
p8944
sg7
VCD008179 v. 2.1 Non-pharmacological interventions for caregivers of stroke survivors.rm5
p8945
sg9
V14703521.xml
p8946
sa(dp8947
g3
VSTD-Madigan-1994
p8948
sg5
S'PMC3268331'
p8949
sg7
VCD001880 v. 10.0 Nutritional supplementation for hip fracture aftercare in older people.rm5
p8950
sg9
V22232695.xml
p8951
sa(dp8952
g3
VSTD-Bastow-1983
p8953
sg5
S'PMC1549800'
p8954
sg7
g8950
sg9
V6416514.xml
p8955
sa(dp8956
g3
VSTD-De-Santis-2009
p8957
sg5
S'PMC2792956'
p8958
sg7
VCD008976 v. 2.0 Gemcitabine for unresectable locally advanced or metastatic bladder cancer.rm5
p8959
sg9
V19786668.xml
p8960
sa(dp8961
g3
VSTD-Johnston-1969
p8962
sg5
S'PMC1629696'
p8963
sg7
VCD004105 v. 5.0 Prophylactic antibiotic therapy for chronic bronchitis.rm5
p8964
sg9
V4899454.xml
p8965
sa(dp8966
g3
VSTD-Francis-1960
p8967
sg5
S'PMC1966487'
p8968
sg7
g8964
sg9
V13824401.xml
p8969
sa(dp8970
g3
VSTD-Johnston-1961
p8971
sg5
S'PMC1970174'
p8972
sg7
g8964
sg9
V14452159.xml
p8973
sa(dp8974
g3
VSTD-Francis-1960-arm-1
p8975
sg5
S'PMC1966487'
p8976
sg7
g8964
sg9
V13824401.xml
p8977
sa(dp8978
g3
VSTD-Francis-1960-arm-2
p8979
sg5
S'PMC1966487'
p8980
sg7
g8964
sg9
V13824401.xml
p8981
sa(dp8982
g3
VSTD-Kruis-2004
p8983
sg5
S'PMC1774300'
p8984
sg7
VCD007443 v. 2.0 Probiotics for maintenance of remission in ulcerative colitis.rm5
p8985
sg9
V15479682.xml
p8986
sa(dp8987
g3
VSTD-Sadighi-2006
p8988
sg5
S'PMC1693922'
p8989
sg7
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p8990
sg9
V17147808.xml
p8991
sa(dp8992
g3
VSTD-Moehler-2005
p8993
sg5
S'PMC2361806'
p8994
sg7
g8990
sg9
V15942629.xml
p8995
sa(dp8996
g3
VSTD-Pyrh_x00f6_nen-1995
p8997
sg5
S'PMC2033628'
p8998
sg7
g8990
sg9
V7533517.xml
p8999
sa(dp9000
g3
VSTD-de-Benedictis-1994b
p9001
sg5
S'PMC2365597'
p9002
sg7
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p9003
sg9
V18475602.xml
p9004
sa(dp9005
g3
VSTD-Ly-2009
p9006
sg5
S'PMC2686207'
p9007
sg7
VCD000320 v. 14.0 Interventions for treating scabies.rm5
p9008
sg9
V19565120.xml
p9009
sa(dp9010
g3
VSTD-Bachewar-2009
p9011
sg5
S'PMC2825021'
p9012
sg7
g9008
sg9
V20177574.xml
p9013
sa(dp9014
g3
VSTD-Lambert-2000
p9015
sg5
S'PMC2503543'
p9016
sg7
VCD005538 v. 8.0 Diclofenac for acute pain in children.rm5
p9017
sg9
V10743430.xml
p9018
sa(dp9019
g3
VSTD-Davies-1999
p9020
sg5
S'PMC1717983'
p9021
sg7
VCD004231 v. 6.0 Inhaled corticosteroids for non-specific chronic cough in children.rm5
p9022
sg9
V10373132.xml
p9023
sa(dp9024
g3
VSTD-Chang-1998
p9025
sg5
S'PMC1717639'
p9026
sg7
g9022
sg9
V9771244.xml
p9027
sa(dp9028
g3
VSTD-Allen-1983
p9029
sg5
S'PMC1547272'
p9030
sg7
VCD004154 v. 12.0 Clobazam as an add-on in the management of refractory epilepsy.rm5
p9031
sg9
V6404410.xml
p9032
sa(dp9033
g3
VSTD-Woody-2008
p9034
sg5
S'PMC2610690'
p9035
sg7
VCD007210 v. 2.2 Maintenance treatments for opiate dependent adolescent.rm5
p9036
sg9
V18984887.xml
p9037
sa(dp9038
g3
VSTD-Eckstein-1999
p9039
sg5
S'PMC1723028'
p9040
sg7
VCD003171 v. 6.0 Surgical interventions for bilateral congenital cataract.rm5
p9041
sg9
V10216048.xml
p9042
sa(dp9043
g3
VSTD-Popelut-2010
p9044
sg5
S'PMC2858083'
p9045
sg7
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p9046
sg9
V20422000.xml
p9047
sa(dp9048
g3
VSTD-Booth-2008
p9049
sg5
S'PMC2651075'
p9050
sg7
g9046
sg9
V18955452.xml
p9051
sa(dp9052
g3
VSTD-Bero-2007
p9053
sg5
S'PMC1885451'
p9054
sg7
g9046
sg9
V17550302.xml
p9055
sa(dp9056
g3
VSTD-Clifford-2002
p9057
sg5
S'PMC126226'
p9058
sg7
g9046
sg9
V12213183.xml
p9059
sa(dp9060
g3
VSTD-Kemmeren-2001
p9061
sg5
S'PMC34722'
p9062
sg7
g9046
sg9
V11463678.xml
p9063
sa(dp9064
g3
VSTD-Bourgeois-2010
p9065
sg5
S'PMC3374868'
p9066
sg7
g9046
sg9
V20679560.xml
p9067
sa(dp9068
g3
VSTD-Jefferson-2009
p9069
sg5
S'PMC2643439'
p9070
sg7
g9046
sg9
V19213766.xml
p9071
sa(dp9072
g3
VSTD-Rasmussen-2009
p9073
sg5
S'PMC2811705'
p9074
sg7
g9046
sg9
V20015404.xml
p9075
sa(dp9076
g3
VSTD-Bhandari-2004
p9077
sg5
S'PMC332713'
p9078
sg7
g9046
sg9
V14970094.xml
p9079
sa(dp9080
g3
VSTD-Kjaergard-2002
p9081
sg5
S'PMC117638'
p9082
sg7
g9046
sg9
V12153921.xml
p9083
sa(dp9084
g3
VSTD-Rattinger-2009
p9085
sg5
S'PMC2688752'
p9086
sg7
g9046
sg9
V19503811.xml
p9087
sa(dp9088
g3
VSTD-Chard-2000
p9089
sg5
S'PMC1753176'
p9090
sg7
g9046
sg9
V10834855.xml
p9091
sa(dp9092
g3
VSTD-Ekeberg-2009
p9093
sg5
S'PMC2769057'
p9094
sg7
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p9095
sg9
V19168537.xml
p9096
sa(dp9097
g3
VSTD-Xiao-2008
p9098
sg5
S'PMC2447617'
p9099
sg7
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p9100
sg9
V18447940.xml
p9101
sa(dp9102
g3
VSTD-Siebert-2009
p9103
sg5
S'PMC2682185'
p9104
sg7
VCD003053 v. 10.2 Insulin-sensitising drugs (metformin rosiglitazone pioglitazone D-chiro-inositol) for women with .rm5
p9105
sg9
V19396538.xml
p9106
sa(dp9107
g3
VSTD-Moll-2006
p9108
sg5
S'PMC1482338'
p9109
sg7
g9105
sg9
V16769748.xml
p9110
sa(dp9111
g3
VSTD-Sturrock-2002
p9112
sg5
S'PMC1874363'
p9113
sg7
g9105
sg9
V11994052.xml
p9114
sa(dp9115
g3
VSTD-Ladson-2011
p9116
sg5
S'PMC3073705'
p9117
sg7
g9105
sg9
V21193187.xml
p9118
sa(dp9119
g3
VSTD-Legro-2007
p9120
sg5
S'PMC2515084'
p9121
sg7
g9105
sg9
V18505764.xml
p9122
sa(dp9123
g3
VSTD-Barakat-2010
p9124
sg5
S'PMC2950888'
p9125
sg7
VCD003968 v. 11.0 Psychological therapies for the management of chronic and recurrent pain in children and adolescents.rm5
p9126
sg9
V20686425.xml
p9127
sa(dp9128
g3
VSTD-Levy-2010
p9129
sg5
S'PMC2887246'
p9130
sg7
g9126
sg9
V20216531.xml
p9131
sa(dp9132
g3
VSTD-Kashikar_x002d_Zuck-2012
p9133
sg5
S'PMC3690664'
p9134
sg7
g9126
sg9
V22108765.xml
p9135
sa(dp9136
g3
VSTD-Palermo-2009
p9137
sg5
S'PMC2760656'
p9138
sg7
g9126
sg9
V19695776.xml
p9139
sa(dp9140
g3
VSTD-Greally-1994
p9141
sg5
S'PMC1029909'
p9142
sg7
VCD000407 v. 19.0 Oral steroids for long-term use in cystic fibrosis.rm5
p9143
sg9
V8067791.xml
p9144
sa(dp9145
g3
VSTD-Dalton-1962
p9146
sg5
S'PMC3557890'
p9147
sg7
VCD006175 v. 4.0 Progesterone for preventing pre-eclampsia and its complications.rm5
p9148
sg9
V23171812.xml
p9149
sa(dp9150
g3
VSTD-van-de-Vusse-2004
p9151
sg5
S'PMC523854'
p9152
sg7
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p9153
sg9
V15453912.xml
p9154
sa(dp9155
g3
VSTD-Gorson-1999
p9156
sg5
S'PMC1736215'
p9157
sg7
g9153
sg9
V10071116.xml
p9158
sa(dp9159
g3
VSTD-Lillemoe-1999
p9160
sg5
S'PMC1420877'
p9161
sg7
VCD008533 v. 4.0 Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.rm5
p9162
sg9
V10493479.xml
p9163
sa(dp9164
g3
VSTD-Van-Heek-2003
p9165
sg5
S'PMC1356171'
p9166
sg7
g9162
sg9
V14631226.xml
p9167
sa(dp9168
g3
VSTD-Rashidi-2011
p9169
sg5
S'PMC3446117'
p9170
sg7
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p9171
sg9
V23056757.xml
p9172
sa(dp9173
g3
VSTD-Ulrich-2007
p9174
sg5
S'PMC2493058'
p9175
sg7
VCD004415 v. 4.4 Interventions for actinic keratoses.rm5
p9176
sg9
V18067628.xml
p9177
sa(dp9178
g3
VSTD-Perrett-2007
p9179
sg5
S'PMC2423222'
p9180
sg7
g9176
sg9
V17223873.xml
p9181
sa(dp9182
g3
VSTD-Kakkar-1969
p9183
sg5
S'PMC1982488'
p9184
sg7
VCD002783 v. 7.0 Thrombolysis for acute deep vein thrombosis.rm5
p9185
sg9
V5774077.xml
p9186
sa(dp9187
g3
VSTD-Fowler-2005
p9188
sg5
S'PMC1739638'
p9189
sg7
VCD009427 v. 2.0 Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.rm5
p9190
sg9
V15834030.xml
p9191
sa(dp9192
g3
VSTD-Chudry-1987
p9193
sg5
S'PMC1778341'
p9194
sg7
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p9195
sg9
V3036020.xml
p9196
sa(dp9197
g3
VSTD-De-Benedictis-1994b
p9198
sg5
S'PMC2365597'
p9199
sg7
g9195
sg9
V18475602.xml
p9200
sa(dp9201
g3
VSTD-Keulemans-1998
p9202
sg5
S'PMC1191590'
p9203
sg7
VCD006798 v. 3.4 Day-case versus overnight stay for laparoscopic cholecystectomy.rm5
p9204
sg9
V9860471.xml
p9205
sa(dp9206
g3
VSTD-O_x0027_Donnell-2003
p9207
sg5
S'PMC214016'
p9208
sg7
VCD000011 v. 8.4 Interventions for enhancing medication adherence.rm5
p9209
sg9
V14551096.xml
p9210
sa(dp9211
g3
VSTD-Kemp-1996
p9212
sg5
S'PMC2350295'
p9213
sg7
g9209
sg9
V8611831.xml
p9214
sa(dp9215
g3
VSTD-Johnson-1978
p9216
sg5
S'PMC1819059'
p9217
sg7
g9209
sg9
V369673.xml
p9218
sa(dp9219
g3
VSTD-Peveler-1999
p9220
sg5
S'PMC28214'
p9221
sg7
g9209
sg9
V10473477.xml
p9222
sa(dp9223
g3
VSTD-Brus-1998
p9224
sg5
S'PMC1752549'
p9225
sg7
g9209
sg9
V9640129.xml
p9226
sa(dp9227
g3
VSTD-Sadik-2005
p9228
sg5
S'PMC1884928'
p9229
sg7
g9209
sg9
V16042672.xml
p9230
sa(dp9231
g3
VSTD-Al_x002d_Eidan-2002
p9232
sg5
S'PMC1874294'
p9233
sg7
g9209
sg9
V11851640.xml
p9234
sa(dp9235
g3
VSTD-Stevens-2002
p9236
sg5
S'PMC1071673'
p9237
sg7
g9209
sg9
V11897728.xml
p9238
sa(dp9239
g3
VSTD-Hill-2001
p9240
sg5
S'PMC1753835'
p9241
sg7
g9209
sg9
V11502614.xml
p9242
sa(dp9243
g3
VSTD-Gajdos-1993
p9244
sg5
S'PMC489815'
p9245
sg7
VCD005224 v. 4.0 Immunosuppressive agents for myasthenia gravis.rm5
p9246
sg9
V8229026.xml
p9247
sa(dp9248
g3
VSTD-Abdou-2010
p9249
sg5
S'PMC2867063'
p9250
sg7
VCD004003 v. 7.3 Environmental sanitary interventions for preventing active trachoma.rm5
p9251
sg9
V20409284.xml
p9252
sa(dp9253
g3
VSTD-Stoller-2011
p9254
sg5
S'PMC3139980'
p9255
sg7
g9251
sg9
V21785663.xml
p9256
sa(dp9257
g3
VSTD-Ickovics-2007a
p9258
sg5
S'PMC2276878'
p9259
sg7
VCD007622 v. 2.0 Group versus conventional antenatal care for women.rm5
p9260
sg9
V17666608.xml
p9261
sa(dp9262
g3
VSTD-Healthy-Choices-2009
p9263
sg5
S'PMC3282587'
p9264
sg7
VCD009748 v. 3.5 Motivational interviewing for improving outcomes in youth living with HIV.rm5
p9265
sg9
V21783053.xml
p9266
sa(dp9267
g3
VSTD-A_x003a_-Rigaud-1991
p9268
sg5
S'PMC1379249'
p9269
sg7
VCD000542 v. 8.0 Enteral nutritional therapy for induction of remission in Crohn's disease.rm5
p9270
sg9
V1773955.xml
p9271
sa(dp9272
g3
VSTD-A_x003a_-Leiper-2001
p9273
sg5
S'PMC1728544'
p9274
sg7
g9270
sg9
V11709513.xml
p9275
sa(dp9276
g3
VSTD-A_x003a_-Mansfield-1995
p9277
sg5
S'PMC1382354'
p9278
sg7
g9270
sg9
V7890238.xml
p9279
sa(dp9280
g3
VSTD-B_x003a_-Gonzalez_x002d_Huix-_x0027_93
p9281
sg5
S'PMC1374261'
p9282
sg7
g9270
sg9
V8314510.xml
p9283
sa(dp9284
g3
VSTD-A_x003a_-Raouf-1991
p9285
sg5
S'PMC1378894'
p9286
sg7
g9270
sg9
V1905672.xml
p9287
sa(dp9288
g3
VSTD-A_x003a_-Gassull-2002
p9289
sg5
S'PMC1773299'
p9290
sg7
g9270
sg9
V12117873.xml
p9291
sa(dp9292
g3
VSTD-A_x003a_-Royall-1994
p9293
sg5
S'PMC1374879'
p9294
sg7
g9270
sg9
V8020806.xml
p9295
sa(dp9296
g3
VSTD-Szefler-2008
p9297
sg5
S'PMC2610850'
p9298
sg7
VCD006340 v. 4.0 Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children.rm5
p9299
sg9
V18805335.xml
p9300
sa(dp9301
g3
VSTD-Nealon-1993
p9302
sg5
S'PMC1242821'
p9303
sg7
VCD007884 v. 2.12 Endoscopic or surgical intervention for painful obstructive chronic pancreatitis.rm5
p9304
sg9
V8489308.xml
p9305
sa(dp9306
g3
VSTD-Brown-2002
p9307
sg5
S'PMC2134805'
p9308
sg7
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p9309
sg9
V11815493.xml
p9310
sa(dp9311
g3
VSTD-Hawthorne-1997
p9312
sg5
S'PMC1313005'
p9313
sg7
g9309
sg9
V9219407.xml
p9314
sa(dp9315
g3
VSTD-Baradaran-2006
p9316
sg5
S'PMC1489930'
p9317
sg7
g9309
sg9
V16709243.xml
p9318
sa(dp9319
g3
VSTD-Osborne-2011
p9320
sg5
S'PMC3068058'
p9321
sg7
VCD007102 v. 5.2 First-line chemotherapy in low-risk gestational trophoblastic neoplasia.rm5
p9322
sg9
V21263100.xml
p9323
sa(dp9324
g3
VSTD-Prouse-1982
p9325
sg5
S'PMC1001616'
p9326
sg7
VCD002048 v. 6.0 Auranofin versus placebo in rheumatoid arthritis.rm5
p9327
sg9
V3872636.xml
p9328
sa(dp9329
g3
VSTD-Allegrante-2007
p9330
sg5
S'PMC2504100'
p9331
sg7
VCD007624 v. 3.0 Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture .rm5
p9332
sg9
V18751772.xml
p9333
sa(dp9334
g3
VSTD-Kaste-1976
p9335
sg5
S'PMC1690349'
p9336
sg7
VCD000103 v. 4.0 Haemodilution for acute ischaemic stroke.rm5
p9337
sg9
V795498.xml
p9338
sa(dp9339
g3
VSTD-Bonderup-2003
p9340
sg5
S'PMC1774966'
p9341
sg7
VCD003575 v. 14.0 Interventions for treating collagenous colitis.rm5
p9342
sg9
V12524408.xml
p9343
sa(dp9344
g3
VSTD-Ramos-1996
p9345
sg5
S'PMC2352260'
p9346
sg7
VCD001329 v. 7.0 Lactational amenorrhea for family planning.rm5
p9347
sg9
V8876092.xml
p9348
sa(dp9349
g3
VSTD-Shearman-1963
p9350
sg5
S'PMC2123785'
p9351
sg7
VCD003511 v. 8.0 Progestogen for preventing miscarriage.rm5
p9352
sg9
V13977012.xml
p9353
sa(dp9354
g3
VSTD-Gray-1991
p9355
sg5
S'PMC1972556'
p9356
sg7
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p9357
sg9
V2069842.xml
p9358
sa(dp9359
g3
VSTD-Vaillant-2000
p9360
sg5
S'PMC1421018'
p9361
sg7
g9357
sg9
V10749603.xml
p9362
sa(dp9363
g3
VSTD-Taal-2001
p9364
sg5
S'PMC2363941'
p9365
sg7
g9357
sg9
V11720425.xml
p9366
sa(dp9367
g3
VSTD-Henderson-2004-a
p9368
sg5
S'PMC478218'
p9369
sg7
VCD005963 v. 8.0 Advance treatment directives for people with severe mental illness.rm5
p9370
sg9
V15240438.xml
p9371
sa(dp9372
g3
VSTD-EORTC-40954-2010
p9373
sg5
S'PMC3020693'
p9374
sg7
VCD008107 v. 2.0 Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomac.rm5
p9375
sg9
V21060024.xml
p9376
sa(dp9377
g3
VSTD-Gehrman-2009
p9378
sg5
S'PMC2630117'
p9379
sg7
VCD003802 v. 9.0 Melatonin for the treatment of dementia.rm5
p9380
sg9
V19155748.xml
p9381
sa(dp9382
g3
VSTD-Feldman-2011
p9383
sg5
S'PMC3191344'
p9384
sg7
VCD009269 v. 2.2 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit d.rm5
p9385
sg9
V21849027.xml
p9386
sa(dp9387
g3
VSTD-Nyamathi-2010
p9388
sg5
S'PMC3383096'
p9389
sg7
g9385
sg9
V19836904.xml
p9390
sa(dp9391
g3
VSTD-Mikamo-_x0028_1_x0029_-1995
p9392
sg5
S'PMC2364408'
p9393
sg7
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p9394
sg9
V18475414.xml
p9395
sa(dp9396
g3
VSTD-Seidman-2005
p9397
sg5
S'PMC1784583'
p9398
sg7
g9394
sg9
V16338779.xml
p9399
sa(dp9400
g3
VSTD-Stein-1993
p9401
sg5
S'PMC187610'
p9402
sg7
g9394
sg9
V8381643.xml
p9403
sa(dp9404
g3
VSTD-Tobin-1992
p9405
sg5
S'PMC1194795'
p9406
sg7
g9394
sg9
V1312506.xml
p9407
sa(dp9408
g3
VSTD-Boag-1991
p9409
sg5
S'PMC1194678'
p9410
sg7
g9394
sg9
V2071126.xml
p9411
sa(dp9412
g3
VSTD-Mikamo-_x0028_2_x0029_-1995
p9413
sg5
S'PMC2364408'
p9414
sg7
g9394
sg9
V18475414.xml
p9415
sa(dp9416
g3
VSTD-Zoumboulakis-1973
p9417
sg5
S'PMC1647791'
p9418
sg7
VCD003257 v. 9.0 Symptomatic treatment of the cough in whooping cough.rm5
p9419
sg9
V4568265.xml
p9420
sa(dp9421
g3
VSTD-Menon-2007
p9422
sg5
S'PMC2636008'
p9423
sg7
VCD001430 v. 10.0 Corticosteroids for treating optic neuritis.rm5
p9424
sg9
V17699944.xml
p9425
sa(dp9426
g3
VSTD-Luabeya-2007
p9427
sg5
S'PMC1891438'
p9428
sg7
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p9429
sg9
V17593956.xml
p9430
sa(dp9431
g3
VSTD-Coutsoudis-1995
p9432
sg5
S'PMC1615817'
p9433
sg7
g9429
sg9
V7625499.xml
p9434
sa(dp9435
g3
VSTD-Sovani-2008
p9436
sg5
S'PMC2148237'
p9437
sg7
VCD007313 v. 5.0 Combination formoterol and budesonide as maintenance and reliever therapy versus current best practi.rm5
p9438
sg9
V18186995.xml
p9439
sa(dp9440
g3
VSTD-Blockey-1954
p9441
sg5
S'PMC2085434'
p9442
sg7
VCD006189 v. 2.0 Oral steroids for adhesive capsulitis.rm5
p9443
sg9
V13160496.xml
p9444
sa(dp9445
g3
VSTD-Buchbinder-2004
p9446
sg5
S'PMC1754804'
p9447
sg7
g9443
sg9
V15479896.xml
p9448
sa(dp9449
g3
VSTD-Saha-2007
p9450
sg5
S'PMC1924983'
p9451
sg7
VCD003094 v. 9.0 Treatments for iron-deficiency anaemia in pregnancy.rm5
p9452
sg9
V17435611.xml
p9453
sa(dp9454
g3
VSTD-Byrnes-2000
p9455
sg5
S'PMC1745864'
p9456
sg7
VCD003901 v. 5.0 Regular treatment with long acting beta agonists versus daily regular treatment with short acting be.rm5
p9457
sg9
V10950898.xml
p9458
sa(dp9459
g3
VSTD-Lundback-1993
p9460
sg5
S'PMC464292'
p9461
sg7
g9457
sg9
V8493629.xml
p9462
sa(dp9463
g3
VSTD-Castle-1993
p9464
sg5
S'PMC1676982'
p9465
sg7
g9457
sg9
V8098238.xml
p9466
sa(dp9467
g3
VSTD-Taylor-1998
p9468
sg5
S'PMC1745306'
p9469
sg7
g9457
sg9
V10319056.xml
p9470
sa(dp9471
g3
VSTD-MRC-1957
p9472
sg5
S'PMC1961737'
p9473
sg7
VCD001392 v. 8.0 Prolonged antibiotics for purulent bronchiectasis in children and adults.rm5
p9474
sg9
V13446452.xml
p9475
sa(dp9476
g3
VSTD-Ng-2006
p9477
sg5
S'PMC1964052'
p9478
sg7
VCD005391 v. 4.6 Workload and surgeons specialty for outcome after colorectal cancer surgery.rm5
p9479
sg9
V16551415.xml
p9480
sa(dp9481
g3
VSTD-Harmon-1999
p9482
sg5
S'PMC1420885'
p9483
sg7
g9479
sg9
V10493487.xml
p9484
sa(dp9485
g3
VSTD-Urbach-2004
p9486
sg5
S'PMC381322'
p9487
sg7
g9479
sg9
V15020356.xml
p9488
sa(dp9489
g3
VSTD-Simunovic-2006
p9490
sg5
S'PMC3207572'
p9491
sg7
g9479
sg9
V16948883.xml
p9492
sa(dp9493
g3
VSTD-Schrag-2002
p9494
sg5
S'PMC1422616'
p9495
sg7
g9479
sg9
V12409664.xml
p9496
sa(dp9497
g3
VSTD-Rogers-2006
p9498
sg5
S'PMC1856632'
p9499
sg7
g9479
sg9
V17122626.xml
p9500
sa(dp9501
g3
VSTD-Akpinarli-1999
p9502
sg5
S'PMC1717973'
p9503
sg7
VCD007949 v. 2.2 Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.rm5
p9504
sg9
V10373134.xml
p9505
sa(dp9506
g3
VSTD-Heuck-2000
p9507
sg5
S'PMC1718508'
p9508
sg7
g9504
sg9
V10999872.xml
p9509
sa(dp9510
g3
VSTD-Dolan-2006
p9511
sg5
S'PMC3205443'
p9512
sg7
VCD005417 v. 3.0 Home-based care for reducing morbidity and mortality in people infected with HIVAIDS.rm5
p9513
sg9
V16772251.xml
p9514
sa(dp9515
g3
VSTD-Baker-1997
p9516
sg5
S'PMC1055438'
p9517
sg7
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p9518
sg9
V10166596.xml
p9519
sa(dp9520
g3
VSTD-Lagerl_x00f8_v-2000
p9521
sg5
S'PMC1743532'
p9522
sg7
g9518
sg9
V10980076.xml
p9523
sa(dp9524
g3
VSTD-Van-den-Hombergh-1999
p9525
sg5
S'PMC2483655'
p9526
sg7
g9518
sg9
V10847872.xml
p9527
sa(dp9528
g3
VSTD-O_x0027_Connor-2009
p9529
sg5
S'PMC2699722'
p9530
sg7
g9518
sg9
V19366977.xml
p9531
sa(dp9532
g3
VSTD-Thomas-2007
p9533
sg5
S'PMC2219846'
p9534
sg7
g9518
sg9
V17973175.xml
p9535
sa(dp9536
g3
VSTD-Baker-2003A
p9537
sg5
S'PMC1314570'
p9538
sg7
g9518
sg9
V12879828.xml
p9539
sa(dp9540
g3
VSTD-Schneider-2008
p9541
sg5
S'PMC2440309'
p9542
sg7
g9518
sg9
V18093108.xml
p9543
sa(dp9544
g3
VSTD-Eltayeb-2005
p9545
sg5
S'PMC1745049'
p9546
sg7
g9518
sg9
V16199745.xml
p9547
sa(dp9548
g3
VSTD-Svetkey-2009
p9549
sg5
S'PMC2784648'
p9550
sg7
g9518
sg9
V19920081.xml
p9551
sa(dp9552
g3
VSTD-Moher-2001
p9553
sg5
S'PMC32168'
p9554
sg7
g9518
sg9
V11387182.xml
p9555
sa(dp9556
g3
VSTD-Laskshminarayan-2010
p9557
sg5
S'PMC2875128'
p9558
sg7
g9518
sg9
V20479363.xml
p9559
sa(dp9560
g3
VSTD-McConnell-1982
p9561
sg5
S'PMC1274191'
p9562
sg7
g9518
sg9
V6891147.xml
p9563
sa(dp9564
g3
VSTD-Hux-1999
p9565
sg5
S'PMC1230539'
p9566
sg7
g9518
sg9
V10478162.xml
p9567
sa(dp9568
g3
VSTD-Pimlott-2003
p9569
sg5
S'PMC151988'
p9570
sg7
g9518
sg9
V12668540.xml
p9571
sa(dp9572
g3
VSTD-Schectman-2003
p9573
sg5
S'PMC1494929'
p9574
sg7
g9518
sg9
V14521638.xml
p9575
sa(dp9576
g3
VSTD-Mitchell-2005
p9577
sg5
S'PMC1463214'
p9578
sg7
g9518
sg9
V15720929.xml
p9579
sa(dp9580
g3
VSTD-Hillman-1998
p9581
sg5
S'PMC1508575'
p9582
sg7
g9518
sg9
V9807540.xml
p9583
sa(dp9584
g3
VSTD-Siriwardena-2002
p9585
sg5
S'PMC1314414'
p9586
sg7
g9518
sg9
V12236277.xml
p9587
sa(dp9588
g3
VSTD-Gama-1992
p9589
sg5
S'PMC495487'
p9590
sg7
g9518
sg9
V1556235.xml
p9591
sa(dp9592
g3
VSTD-Verstappen-2004
p9593
sg5
S'PMC1466745'
p9594
sg7
g9518
sg9
V15576543.xml
p9595
sa(dp9596
g3
VSTD-Buntinx-1993
p9597
sg5
S'PMC1372391'
p9598
sg7
g9518
sg9
V8347386.xml
p9599
sa(dp9600
g3
VSTD-Fairbrother-1999
p9601
sg5
S'PMC1508536'
p9602
sg7
g9518
sg9
V9949744.xml
p9603
sa(dp9604
g3
VSTD-Frijiling-2003
p9605
sg5
S'PMC1743704'
p9606
sg7
g9518
sg9
V12792007.xml
p9607
sa(dp9608
g3
VSTD-Wadland-2007
p9609
sg5
S'PMC1838696'
p9610
sg7
g9518
sg9
V17389537.xml
p9611
sa(dp9612
g3
VSTD-Kinsinger-1998
p9613
sg5
S'PMC1497003'
p9614
sg7
g9518
sg9
V9734786.xml
p9615
sa(dp9616
g3
VSTD-Vingerhoets-2001
p9617
sg5
S'PMC1743447'
p9618
sg7
g9518
sg9
V11743151.xml
p9619
sa(dp9620
g3
VSTD-Foster-2007
p9621
sg5
S'PMC1868738'
p9622
sg7
g9518
sg9
V17456241.xml
p9623
sa(dp9624
g3
VSTD-O_x0027_Connell-1999
p9625
sg5
S'PMC27749'
p9626
sg7
g9518
sg9
V10024260.xml
p9627
sa(dp9628
g3
VSTD-McAlister-1986
p9629
sg5
S'PMC1341518'
p9630
sg7
g9518
sg9
V3092976.xml
p9631
sa(dp9632
g3
VSTD-Mayer-1998
p9633
sg5
S'PMC1508276'
p9634
sg7
g9518
sg9
V9663162.xml
p9635
sa(dp9636
g3
VSTD-Herrin-2006
p9637
sg5
S'PMC1426180'
p9638
sg7
g9518
sg9
V16609732.xml
p9639
sa(dp9640
g3
VSTD-McCartney-1997
p9641
sg5
S'PMC2127027'
p9642
sg7
g9518
sg9
V9233326.xml
p9643
sa(dp9644
g3
VSTD-Hemminki-2008
p9645
sg5
S'PMC2442595'
p9646
sg7
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p9647
sg9
V18547413.xml
p9648
sa(dp9649
g3
VSTD-Montgomery-2007
p9650
sg5
S'PMC1895676'
p9651
sg7
g9647
sg9
V17540908.xml
p9652
sa(dp9653
g3
VSTD-Hurst-1998
p9654
sg5
S'PMC3455419'
p9655
sg7
VCD001894 v. 12.0 Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm in.rm5
p9656
sg9
V9513842.xml
p9657
sa(dp9658
g3
VSTD-Baruffi-2000
p9659
sg5
S'PMC3455458'
p9660
sg7
g9656
sg9
V11212860.xml
p9661
sa(dp9662
g3
VSTD-Kutlu-2010
p9663
sg5
S'PMC2941589'
p9664
sg7
g9656
sg9
V20467801.xml
p9665
sa(dp9666
g3
VSTD-Isik-2000
p9667
sg5
S'PMC3455664'
p9668
sg7
g9656
sg9
V10911572.xml
p9669
sa(dp9670
g3
VSTD-Montini-2003
p9671
sg5
S'PMC1955287'
p9672
sg7
VCD003772 v. 12.0 Antibiotics for acute pyelonephritis in children.rm5
p9673
sg9
V17611232.xml
p9674
sa(dp9675
g3
VSTD-Benador-2001
p9676
sg5
S'PMC1718672'
p9677
sg7
g9673
sg9
V11207174.xml
p9678
sa(dp9679
g3
VSTD-Vigano-1992
p9680
sg5
S'PMC191611'
p9681
sg7
g9673
sg9
V1510446.xml
p9682
sa(dp9683
g3
VSTD-Magpie-2006
p9684
sg5
S'PMC2063969'
p9685
sg7
VCD004661 v. 7.0 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.rm5
p9686
sg9
V17166221.xml
p9687
sa(dp9688
g3
VSTD-Rouse-2008
p9689
sg5
S'PMC2803083'
p9690
sg7
g9686
sg9
V18753646.xml
p9691
sa(dp9692
g3
VSTD-Mann-1982
p9693
sg5
S'PMC459250'
p9694
sg7
VCD003535 v. 10.0 Anticholinergic therapy for chronic asthma in children over two years of age.rm5
p9695
sg9
V6461943.xml
p9696
sa(dp9697
g3
VSTD-Sly-1987
p9698
sg5
S'PMC460756'
p9699
sg7
g9695
sg9
V2958950.xml
p9700
sa(dp9701
g3
VSTD-Langford-1983
p9702
sg5
S'PMC1628912'
p9703
sg7
VCD001399 v. 15.0 Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.rm5
p9704
sg9
V6441523.xml
p9705
sa(dp9706
g3
VSTD-D_x00f6_ring-2007
p9707
sg5
S'PMC1904125'
p9708
sg7
g9704
sg9
V17585011.xml
p9709
sa(dp9710
g3
VSTD-Kneyber-2009
p9711
sg5
S'PMC2717432'
p9712
sg7
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p9713
sg9
V19450268.xml
p9714
sa(dp9715
g3
VSTD-Al_x002d_Mizyen-2000
p9716
sg5
S'PMC3455662'
p9717
sg7
VCD001122 v. 12.0 Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary .rm5
p9718
sg9
V10911573.xml
p9719
sa(dp9720
g3
VSTD-Carbon-1992
p9721
sg5
S'PMC189443'
p9722
sg7
VCD004418 v. 13.0 Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized a.rm5
p9723
sg9
V1323954.xml
p9724
sa(dp9725
g3
VSTD-Mooney-2007-b
p9726
sg5
S'PMC2693095'
p9727
sg7
VCD003352 v. 8.0 Dopamine agonists for the treatment of cocaine dependence.rm5
p9728
sg9
V17134849.xml
p9729
sa(dp9730
g3
VSTD-Schmitz-2010
p9731
sg5
S'PMC3164487'
p9732
sg7
g9728
sg9
V20545388.xml
p9733
sa(dp9734
g3
VSTD-Mooney-2007-a
p9735
sg5
S'PMC2693095'
p9736
sg7
g9728
sg9
V17134849.xml
p9737
sa(dp9738
g3
VSTD-Schmitz-2008
p9739
sg5
S'PMC2293271'
p9740
sg7
g9728
sg9
V18164144.xml
p9741
sa(dp9742
g3
VSTD-Man-2004
p9743
sg5
S'PMC529363'
p9744
sg7
VCD005305 v. 4.0 Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.rm5
p9745
sg9
V15504763.xml
p9746
sa(dp9747
g3
VSTD-Burger-1987
p9748
sg5
S'PMC1246001'
p9749
sg7
VCD004509 v. 6.0 Testosterone for peri and postmenopausal women.rm5
p9750
sg9
V3107663.xml
p9751
sa(dp9752
g3
VSTD-Chan-1993
p9753
sg5
S'PMC1029305'
p9754
sg7
VCD000143 v. 10.0 Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in p.rm5
p9755
sg9
V8323357.xml
p9756
sa(dp9757
g3
VSTD-So-1995
p9758
sg5
S'PMC2528452'
p9759
sg7
g9755
sg9
V7796237.xml
p9760
sa(dp9761
g3
VSTD-Davis-1998
p9762
sg5
S'PMC1720820'
p9763
sg7
g9755
sg9
V9797626.xml
p9764
sa(dp9765
g3
VSTD-Razavi-2002
p9766
sg5
S'PMC2364281'
p9767
sg7
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p9768
sg9
V12085247.xml
p9769
sa(dp9770
g3
VSTD-Tulsky-2011
p9771
sg5
S'PMC3368370'
p9772
sg7
g9768
sg9
V22041948.xml
p9773
sa(dp9774
g3
VSTD-Lienard-2010
p9775
sg5
S'PMC2906741'
p9776
sg7
g9768
sg9
V20628395.xml
p9777
sa(dp9778
g3
VSTD-Stewart-2007
p9779
sg5
S'PMC2000315'
p9780
sg7
g9768
sg9
V17893379.xml
p9781
sa(dp9782
g3
VSTD-Alberts-2004
p9783
sg5
S'PMC3579584'
p9784
sg7
VCD004433 v. 5.0 Constraint-induced movement therapy for upper extremities in stroke patients.rm5
p9785
sg9
V15537995.xml
p9786
sa(dp9787
g3
VSTD-Elsinga-2006
p9788
sg5
S'PMC1552064'
p9789
sg7
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p9790
sg9
V16824233.xml
p9791
sa(dp9792
g3
VSTD-Floyd-2007
p9793
sg5
S'PMC2888541'
p9794
sg7
g9790
sg9
V17218187.xml
p9795
sa(dp9796
g3
VSTD-Lumley-2006
p9797
sg5
S'PMC1712341'
p9798
sg7
g9790
sg9
V17156466.xml
p9799
sa(dp9800
g3
VSTD-Reis-Neto-2002
p9801
sg5
S'PMC3043413'
p9802
sg7
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p9803
sg9
V12113422.xml
p9804
sa(dp9805
g3
VSTD-Chen-2002
p9806
sg5
S'PMC3043440'
p9807
sg7
g9803
sg9
V12500834.xml
p9808
sa(dp9809
g3
VSTD-Leung-2000-a
p9810
sg5
S'PMC1421025'
p9811
sg7
g9803
sg9
V10749610.xml
p9812
sa(dp9813
g3
VSTD-Morino-2003
p9814
sg5
S'PMC1514324'
p9815
sg7
g9803
sg9
V12616116.xml
p9816
sa(dp9817
g3
VSTD-BRAIN-2009
p9818
sg5
S'PMC2794266'
p9819
sg7
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p9820
sg9
V19958521.xml
p9821
sa(dp9822
g3
VSTD-Wiles-2001
p9823
sg5
S'PMC1737210'
p9824
sg7
VCD003980 v. 7.0 Exercise therapy for multiple sclerosis.rm5
p9825
sg9
V11160464.xml
p9826
sa(dp9827
g3
VSTD-Riccardi-1994
p9828
sg5
S'PMC2033710'
p9829
sg7
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p9830
sg9
V7981078.xml
p9831
sa(dp9832
g3
VSTD-Riccardi-2000
p9833
sg5
S'PMC2374495'
p9834
sg7
g9830
sg9
V10755397.xml
p9835
sa(dp9836
g3
VSTD-Morell-1992
p9837
sg5
S'PMC463918'
p9838
sg7
VCD001740 v. 7.0 Corticosteroids for acute severe asthma in hospitalised patients.rm5
p9839
sg9
V1412113.xml
p9840
sa(dp9841
g3
VSTD-Bowler-1992
p9842
sg5
S'PMC463917'
p9843
sg7
g9839
sg9
V1412112.xml
p9844
sa(dp9845
g3
VSTD-Bow-1984
p9846
sg5
S'PMC1875734'
p9847
sg7
VCD005339 v. 4.0 Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunct.rm5
p9848
sg9
V6697270.xml
p9849
sa(dp9850
g3
VSTD-Chow-1987
p9851
sg5
S'PMC1248603'
p9852
sg7
VCD000333 v. 9.0 Exercise for preventing and treating osteoporosis in postmenopausal women.rm5
p9853
sg9
V3121055.xml
p9854
sa(dp9855
g3
VSTD-Gogate-2003
p9856
sg5
S'PMC1771720'
p9857
sg7
VCD008811 v. 2.0 Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extrac.rm5
p9858
sg9
V12770957.xml
p9859
sa(dp9860
g3
VSTD-Richards-2002
p9861
sg5
S'PMC117444'
p9862
sg7
VCD003786 v. 7.0 Exercise for treating fibromyalgia syndrome.rm5
p9863
sg9
V12142304.xml
p9864
sa(dp9865
g3
VSTD-Hakkinen-2001
p9866
sg5
S'PMC1753355'
p9867
sg7
g9863
sg9
V11114277.xml
p9868
sa(dp9869
g3
VSTD-Cedraschi-2004
p9870
sg5
S'PMC1754921'
p9871
sg7
g9863
sg9
V14962965.xml
p9872
sa(dp9873
g3
VSTD-Richards-2003
p9874
sg5
S'PMC1314708'
p9875
sg7
VCD000532 v. 5.0 On-site mental health workers delivering psychological therapy and psychosocial interventions to pat.rm5
p9876
sg9
V14601351.xml
p9877
sa(dp9878
g3
VSTD-Baker-1996
p9879
sg5
S'PMC1410018'
p9880
sg7
g9876
sg9
V9624745.xml
p9881
sa(dp9882
g3
VSTD-Blakey-1986
p9883
sg5
S'PMC1960439'
p9884
sg7
g9876
sg9
V3746764.xml
p9885
sa(dp9886
g3
VSTD-Benson-1988
p9887
sg5
S'PMC1711670'
p9888
sg7
g9876
sg9
V3267741.xml
p9889
sa(dp9890
g3
VSTD-Robson-1984
p9891
sg5
S'PMC1441852'
p9892
sg7
g9876
sg9
V6428555.xml
p9893
sa(dp9894
g3
VSTD-Earll-1982
p9895
sg5
S'PMC1970973'
p9896
sg7
g9876
sg9
V7086742.xml
p9897
sa(dp9898
g3
VSTD-Lester-2007
p9899
sg5
S'PMC2042545'
p9900
sg7
g9876
sg9
V17359606.xml
p9901
sa(dp9902
g3
VSTD-Harvey-1998
p9903
sg5
S'PMC1410004'
p9904
sg7
g9876
sg9
V9624744.xml
p9905
sa(dp9906
g3
VSTD-King-2000b
p9907
sg5
S'PMC27543'
p9908
sg7
g9876
sg9
V11099285.xml
p9909
sa(dp9910
g3
VSTD-King-2000a
p9911
sg5
S'PMC27543'
p9912
sg7
g9876
sg9
V11099285.xml
p9913
sa(dp9914
g3
VSTD-Ritchie-1979
p9915
sg5
S'PMC1597979'
p9916
sg7
VCD003460 v. 9.0 Bulking agents antispasmodics and antidepressants for the treatment of irritable bowel syndrome.rm5
p9917
sg9
V32949.xml
p9918
sa(dp9919
g3
VSTD-Lucey-1987
p9920
sg5
S'PMC1432984'
p9921
sg7
g9917
sg9
V3030904.xml
p9922
sa(dp9923
g3
VSTD-Prior-1987
p9924
sg5
S'PMC1433676'
p9925
sg7
g9917
sg9
V3322956.xml
p9926
sa(dp9927
g3
VSTD-Tack-2006a
p9928
sg5
S'PMC1856276'
p9929
sg7
g9917
sg9
V16401691.xml
p9930
sa(dp9931
g3
VSTD-Dobrilla-1990
p9932
sg5
S'PMC1378284'
p9933
sg7
g9917
sg9
V2182401.xml
p9934
sa(dp9935
g3
VSTD-Duvan-2006
p9936
sg5
S'PMC3455434'
p9937
sg7
VCD005996 v. 5.0 Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.rm5
p9938
sg9
V16518579.xml
p9939
sa(dp9940
g3
VSTD-Lee-2004
p9941
sg5
S'PMC1884548'
p9942
sg7
VCD007031 v. 3.0 Ciclesonide versus other inhaled steroids for chronic asthma in children and adults.rm5
p9943
sg9
V15206989.xml
p9944
sa(dp9945
g3
VSTD-Nicolle-1993
p9946
sg5
S'PMC187709'
p9947
sg7
VCD003597 v. 6.0 Quinolones for uncomplicated acute cystitis in women.rm5
p9948
sg9
V8384818.xml
p9949
sa(dp9950
g3
VSTD-Jardin-1995
p9951
sg5
S'PMC162511'
p9952
sg7
g9948
sg9
V7695309.xml
p9953
sa(dp9954
g3
VSTD-Henry-1998
p9955
sg5
S'PMC105806'
p9956
sg7
g9948
sg9
V9736546.xml
p9957
sa(dp9958
g3
VSTD-Pfizer-2011
p9959
sg5
S'PMC2962290'
p9960
sg7
VCD010245 v. 3.0 Tranexamic acid for reducing mortality in emergency and urgent surgery.rm5
p9961
sg9
V21455360.xml
p9962
sa(dp9963
g3
VSTD-McEwan-1990
p9964
sg5
S'PMC1371072'
p9965
sg7
VCD001054 v. 10.4 Community screening for visual impairment in the elderly.rm5
p9966
sg9
V2112022.xml
p9967
sa(dp9968
g3
VSTD-Smeeth-2003
p9969
sg5
S'PMC261660'
p9970
sg7
g9966
sg9
V14593039.xml
p9971
sa(dp9972
g3
VSTD-Wagner-1994
p9973
sg5
S'PMC1615188'
p9974
sg7
g9966
sg9
V7977921.xml
p9975
sa(dp9976
g3
VSTD-Vetter-1992
p9977
sg5
S'PMC1882829'
p9978
sg7
g9966
sg9
V1392755.xml
p9979
sa(dp9980
g3
VSTD-Vetter-1984
p9981
sg5
S'PMC1444201'
p9982
sg7
g9966
sg9
V6229314.xml
p9983
sa(dp9984
g3
VSTD-Van-Rossum-1993
p9985
sg5
S'PMC1678489'
p9986
sg7
g9966
sg9
V8343668.xml
p9987
sa(dp9988
g3
VSTD-Schlagenhauf-2003a
p9989
sg5
S'PMC261741'
p9990
sg7
VCD006491 v. 5.0 Drugs for preventing malaria in travellers.rm5
p9991
sg9
V14604928.xml
p9992
sa(dp9993
g3
VSTD-REACT_x002d_UK
p9994
sg5
S'PMC1432213'
p9995
sg7
VCD007906 v. 4.0 Intensive case management for severe mental illness.rm5
p9996
sg9
V16543298.xml
p9997
sa(dp9998
g3
VSTD-Shern_x002d_USA1
p9999
sg5
S'PMC1446423'
p10000
sg7
g9996
sg9
V11111259.xml
p10001
sa(dp10002
g3
VSTD-Salkever_x002d_SCarolina
p10003
sg5
S'PMC1089024'
p10004
sg7
g9996
sg9
V10357291.xml
p10005
sa(dp10006
g3
VSTD-Denis-1978
p10007
sg5
S'PMC1412181'
p10008
sg7
VCD003628 v. 6.0 Artificial and bioartificial support systems for liver failure.rm5
p10009
sg9
V710967.xml
p10010
sa(dp10011
g3
VSTD-Icli-F-2005
p10012
sg5
S'PMC2361864'
p10013
sg7
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p10014
sg9
V15726120.xml
p10015
sa(dp10016
g3
VSTD-Fraser-S-1993
p10017
sg5
S'PMC1968186'
p10018
sg7
g10014
sg9
V8431375.xml
p10019
sa(dp10020
g3
VSTD-Bonneterre--J-2002
p10021
sg5
S'PMC2408916'
p10022
sg7
g10014
sg9
V12439707.xml
p10023
sa(dp10024
g3
VSTD-Rubens-RD-1975
p10025
sg5
S'PMC2025018'
p10026
sg7
g10014
sg9
V766800.xml
p10027
sa(dp10028
g3
VSTD-Khoury-1986
p10029
sg5
S'PMC2498441'
p10030
sg7
VCD004647 v. 3.0 Ileostomy or colostomy for temporary decompression of colorectal anastomosis.rm5
p10031
sg9
V3566123.xml
p10032
sa(dp10033
g3
VSTD-Western-Canada-1968
p10034
sg5
S'PMC1946029'
p10035
sg7
VCD000021 v. 6.0 Anti-D administration after childbirth for preventing Rhesus alloimmunisation.rm5
p10036
sg9
V4977545.xml
p10037
sa(dp10038
g3
VSTD-MRC-1974
p10039
sg5
S'PMC1610688'
p10040
sg7
g10036
sg9
V4207590.xml
p10041
sa(dp10042
g3
VSTD-Netherlands-1968
p10043
sg5
S'PMC1912672'
p10044
sg7
g10036
sg9
V4177613.xml
p10045
sa(dp10046
g3
VSTD-Matthiessen-2007
p10047
sg5
S'PMC1933561'
p10048
sg7
VCD006878 v. 3.0 Covering ileo- or colostomy in anterior resection for rectal carcinoma.rm5
p10049
sg9
V17667498.xml
p10050
sa(dp10051
g3
VSTD-Harstad_x002c_-Norway
p10052
sg5
S'PMC1730374'
p10053
sg7
VCD004445 v. 8.0 The 'WHO Safe Communities' model for the prevention of injury in whole populations.rm5
p10054
sg9
V9788086.xml
p10055
sa(dp10056
g3
VSTD-Lidkoping_x002c_-Sweden
p10057
sg5
S'PMC1067586'
p10058
sg7
g10054
sg9
V9346020.xml
p10059
sa(dp10060
g3
VSTD-Shire-of-Bulla_x002c_-Australia
p10061
sg5
S'PMC1730817'
p10062
sg7
g10054
sg9
V11928967.xml
p10063
sa(dp10064
g3
VSTD-Falkoping_x002c_-Sweden
p10065
sg5
S'PMC1067586'
p10066
sg7
g10054
sg9
V9346020.xml
p10067
sa(dp10068
g3
VSTD-Collins-2004
p10069
sg5
S'PMC487729'
p10070
sg7
VCD005092 v. 3.0 Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully b.rm5
p10071
sg9
V15208209.xml
p10072
sa(dp10073
g3
VSTD-LEAD_x002d_3-2006
p10074
sg5
S'PMC3084519'
p10075
sg7
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p10076
sg9
V21205128.xml
p10077
sa(dp10078
g3
VSTD-Kanda-1998
p10079
sg5
S'PMC3699156'
p10080
sg7
g10076
sg9
V23943707.xml
p10081
sa(dp10082
g3
VSTD-Alvarsson-2010
p10083
sg5
S'PMC3061612'
p10084
sg7
g10076
sg9
V21409314.xml
p10085
sa(dp10086
g3
VSTD-Quinn-N
p10087
sg5
S'PMC1027949'
p10088
sg7
VCD006456 v. 3.0 Therapeutic interventions for symptomatic treatment in Huntington's disease.rm5
p10089
sg9
V6236286.xml
p10090
sa(dp10091
g3
VSTD-van-Vugt-J
p10092
sg5
S'PMC2169648'
p10093
sg7
g10089
sg9
V9221965.xml
p10094
sa(dp10095
g3
VSTD-Flach-1998
p10096
sg5
S'PMC1298410'
p10097
sg7
VCD004239 v. 5.2 Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surger.rm5
p10098
sg9
V10360304.xml
p10099
sa(dp10100
g3
VSTD-Sun-2008
p10101
sg5
S'PMC2784033'
p10102
sg7
VCD009113 v. 1.0 Universal school-based prevention programs for alcohol misuse in young people.rm5
p10103
sg9
V18675294.xml
p10104
sa(dp10105
g3
VSTD-Kellam-2008
p10106
sg5
S'PMC2512256'
p10107
sg7
g10103
sg9
V18343607.xml
p10108
sa(dp10109
g3
VSTD-Johnson-2009
p10110
sg5
S'PMC3735174'
p10111
sg7
g10103
sg9
V19440837.xml
p10112
sa(dp10113
g3
VSTD-Werch-2008
p10114
sg5
S'PMC2898909'
p10115
sg7
g10103
sg9
V19004157.xml
p10116
sa(dp10117
g3
VSTD-Ellickson-2003
p10118
sg5
S'PMC1448059'
p10119
sg7
g10103
sg9
V14600049.xml
p10120
sa(dp10121
g3
VSTD-Werch-2010
p10122
sg5
S'PMC2845326'
p10123
sg7
g10103
sg9
V20307126.xml
p10124
sa(dp10125
g3
VSTD-Bond-2004
p10126
sg5
S'PMC1732649'
p10127
sg7
g10103
sg9
V15547059.xml
p10128
sa(dp10129
g3
VSTD-Britt-1998
p10130
sg5
S'PMC1730419'
p10131
sg7
VCD003985 v. 8.0 Non-legislative interventions for the promotion of cycle helmet wearing by children.rm5
p10132
sg9
V9887419.xml
p10133
sa(dp10134
g3
VSTD-Kendrick-2004
p10135
sg5
S'PMC1719862'
p10136
sg7
g10132
sg9
V15033841.xml
p10137
sa(dp10138
g3
VSTD-Hendrickson-1998
p10139
sg5
S'PMC1730341'
p10140
sg7
g10132
sg9
V9666367.xml
p10141
sa(dp10142
g3
VSTD-Cushman-1991b
p10143
sg5
S'PMC1405730'
p10144
sg7
g10132
sg9
V1853997.xml
p10145
sa(dp10146
g3
VSTD-Macarthur-1998
p10147
sg5
S'PMC1730356'
p10148
sg7
g10132
sg9
V9666365.xml
p10149
sa(dp10150
g3
VSTD-Farley-1996
p10151
sg5
S'PMC1380359'
p10152
sg7
g10132
sg9
V8561241.xml
p10153
sa(dp10154
g3
VSTD-Kim-1997
p10155
sg5
S'PMC1067762'
p10156
sg7
g10132
sg9
V9113846.xml
p10157
sa(dp10158
g3
VSTD-Wright-1995
p10159
sg5
S'PMC1067557'
p10160
sg7
g10132
sg9
V9346001.xml
p10161
sa(dp10162
g3
VSTD-Azeredo-2003
p10163
sg5
S'PMC1731011'
p10164
sg7
g10132
sg9
V12966021.xml
p10165
sa(dp10166
g3
VSTD-Lee-2000
p10167
sg5
S'PMC1730614'
p10168
sg7
g10132
sg9
V10875675.xml
p10169
sa(dp10170
g3
VSTD-Law-1987
p10171
sg5
S'PMC2428199'
p10172
sg7
VCD003091 v. 5.2 Dressings for the prevention of surgical site infection.rm5
p10173
sg9
V3671224.xml
p10174
sa(dp10175
g3
VSTD-Hewlett-1996
p10176
sg5
S'PMC3214045'
p10177
sg7
g10173
sg9
V22096550.xml
p10178
sa(dp10179
g3
VSTD-Ali_x002d_Melkkila-1993
p10180
sg5
S'PMC504652'
p10181
sg7
VCD004083 v. 5.0 Peribulbar versus retrobulbar anaesthesia for cataract surgery.rm5
p10182
sg9
V8110669.xml
p10183
sa(dp10184
g3
VSTD-Bourbeau-1998
p10185
sg5
S'PMC1745246'
p10186
sg7
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p10187
sg9
V9713447.xml
p10188
sa(dp10189
g3
VSTD-Auffarth-1991
p10190
sg5
S'PMC1020969'
p10191
sg7
g10187
sg9
V2068695.xml
p10192
sa(dp10193
g3
VSTD-Calverley-2008
p10194
sg5
S'PMC2644301'
p10195
sg7
g10187
sg9
V19014549.xml
p10196
sa(dp10197
g3
VSTD-Weir-1990a
p10198
sg5
S'PMC462320'
p10199
sg7
g10187
sg9
V2180105.xml
p10200
sa(dp10201
g3
VSTD-Bourbeau-2007
p10202
sg5
S'PMC2117108'
p10203
sg7
g10187
sg9
V17557771.xml
p10204
sa(dp10205
g3
VSTD-Verhoeven-2002
p10206
sg5
S'PMC1746396'
p10207
sg7
g10187
sg9
V12149529.xml
p10208
sa(dp10209
g3
VSTD-Schermer-2009
p10210
sg5
S'PMC2793071'
p10211
sg7
g10187
sg9
V20037682.xml
p10212
sa(dp10213
g3
VSTD-Wempe-1992
p10214
sg5
S'PMC463924'
p10215
sg7
g10187
sg9
V1412119.xml
p10216
sa(dp10217
g3
VSTD-Burge-2000
p10218
sg5
S'PMC27372'
p10219
sg7
g10187
sg9
V10807619.xml
p10220
sa(dp10221
g3
VSTD-van-Grunsven-1999
p10222
sg5
S'PMC1745350'
p10223
sg7
g10187
sg9
V10343624.xml
p10224
sa(dp10225
g3
VSTD-Brightling-2005
p10226
sg5
S'PMC1747331'
p10227
sg7
g10187
sg9
V15741434.xml
p10228
sa(dp10229
g3
VSTD-Colacone-1990
p10230
sg5
S'PMC462648'
p10231
sg7
VCD001112 v. 8.3 Caffeine for asthma.rm5
p10232
sg9
V2205947.xml
p10233
sa(dp10234
g3
VSTD-Halm-2009
p10235
sg5
S'PMC2690844'
p10236
sg7
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p10237
sg9
V19259615.xml
p10238
sa(dp10239
g3
VSTD-Clonazepam-2007_x002c_-CHN
p10240
sg5
S'PMC3531732'
p10241
sg7
VCD003079 v. 8.0 Benzodiazepines for psychosis-induced aggression or agitation.rm5
p10242
sg9
V23135283.xml
p10243
sa(dp10244
g3
VSTD-Midazolam-2003_x002c_-BZ
p10245
sg5
S'PMC200800'
p10246
sg7
g10242
sg9
V14512476.xml
p10247
sa(dp10248
g3
VSTD-Rotheram_x002d_Borus-2004
p10249
sg5
S'PMC2843590'
p10250
sg7
VCD009189 v. 2.43 Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection.rm5
p10251
sg9
V15385902.xml
p10252
sa(dp10253
g3
VSTD-Kalichman-2011
p10254
sg5
S'PMC3085946'
p10255
sg7
g10251
sg9
V21457056.xml
p10256
sa(dp10257
g3
VSTD-Yoon-1993
p10258
sg5
S'PMC464888'
p10259
sg7
VCD003000 v. 9.0 Education interventions for adults who attend the emergency room for acute asthma.rm5
p10260
sg9
V8296253.xml
p10261
sa(dp10262
g3
VSTD-Osman-2002
p10263
sg5
S'PMC1746210'
p10264
sg7
g10260
sg9
V12324673.xml
p10265
sa(dp10266
g3
VSTD-Krudsood-2010
p10267
sg5
S'PMC2912575'
p10268
sg7
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p10269
sg9
V20595477.xml
p10270
sa(dp10271
g3
VSTD-Matsegui-2008
p10272
sg5
S'PMC2409363'
p10273
sg7
g10269
sg9
V18503714.xml
p10274
sa(dp10275
g3
VSTD-Kofoed-2011
p10276
sg5
S'PMC3123603'
p10277
sg7
g10269
sg9
V21631932.xml
p10278
sa(dp10279
g3
VSTD-Champlin-2007
p10280
sg5
S'PMC1885491'
p10281
sg7
VCD009159 v. 2.0 Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogenei.rm5
p10282
sg9
V17272503.xml
p10283
sa(dp10284
g3
VSTD-Nagarathna-1985
p10285
sg5
S'PMC1417003'
p10286
sg7
VCD001277 v. 10.0 Breathing exercises for asthma.rm5
p10287
sg9
V3931802.xml
p10288
sa(dp10289
g3
VSTD-Thomas-2003
p10290
sg5
S'PMC1746567'
p10291
sg7
g10287
sg9
V12554890.xml
p10292
sa(dp10293
g3
VSTD-Lichtenstein-2000
p10294
sg5
S'PMC1748368'
p10295
sg7
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p10296
sg9
V10982577.xml
p10297
sa(dp10298
g3
VSTD-Etter-2004
p10299
sg5
S'PMC1763345'
p10300
sg7
g10296
sg9
V15365111.xml
p10301
sa(dp10302
g3
VSTD-Campbell-1986
p10303
sg5
S'PMC1020629'
p10304
sg7
g10296
sg9
V3529480.xml
p10305
sa(dp10306
g3
VSTD-Lennox-2001
p10307
sg5
S'PMC32255'
p10308
sg7
g10296
sg9
V11397745.xml
p10309
sa(dp10310
g3
VSTD-Janz-1987
p10311
sg5
S'PMC1647206'
p10312
sg7
g10296
sg9
V3592033.xml
p10313
sa(dp10314
g3
VSTD-Meyer-2008
p10315
sg5
S'PMC2253708'
p10316
sg7
g10296
sg9
V17995993.xml
p10317
sa(dp10318
g3
VSTD-ICRF-1994
p10319
sg5
S'PMC1677770'
p10320
sg7
g10296
sg9
V8518571.xml
p10321
sa(dp10322
g3
VSTD-BTS-1983
p10323
sg5
S'PMC1546807'
p10324
sg7
g10296
sg9
V6402162.xml
p10325
sa(dp10326
g3
VSTD-Orleans-2000
p10327
sg5
S'PMC1766256'
p10328
sg7
g10296
sg9
V10688938.xml
p10329
sa(dp10330
g3
VSTD-Davis-1984
p10331
sg5
S'PMC1652036'
p10332
sg7
g10296
sg9
V6437257.xml
p10333
sa(dp10334
g3
VSTD-Hansen-1999
p10335
sg5
S'PMC1752793'
p10336
sg7
VCD006356 v. 4.0 Effects of glucocorticoids on radiological progression in rheumatoid arthritis.rm5
p10337
sg9
V10531077.xml
p10338
sa(dp10339
g3
VSTD-Joint-1959
p10340
sg5
S'PMC1007099'
p10341
sg7
g10337
sg9
V13856637.xml
p10342
sa(dp10343
g3
VSTD-Choy-2005
p10344
sg5
S'PMC1755652'
p10345
sg7
g10337
sg9
V15760929.xml
p10346
sa(dp10347
g3
VSTD-Capell-2004
p10348
sg5
S'PMC1755058'
p10349
sg7
g10337
sg9
V15194574.xml
p10350
sa(dp10351
g3
VSTD-Empire-1957
p10352
sg5
S'PMC1006963'
p10353
sg7
g10337
sg9
V13470729.xml
p10354
sa(dp10355
g3
VSTD-Empire-1955
p10356
sg5
S'PMC1006832'
p10357
sg7
g10337
sg9
V13275875.xml
p10358
sa(dp10359
g3
VSTD-Donskov_x0028_ii_x0029_-2005
p10360
sg5
S'PMC2361635'
p10361
sg7
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p10362
sg9
V16136045.xml
p10363
sa(dp10364
g3
VSTD-Jayson-1998
p10365
sg5
S'PMC2063040'
p10366
sg7
g10362
sg9
V9703284.xml
p10367
sa(dp10368
g3
VSTD-DeMulder-1995
p10369
sg5
S'PMC2033601'
p10370
sg7
g10362
sg9
V7841054.xml
p10371
sa(dp10372
g3
VSTD-Donskov_x0028_i_x0029_-2005
p10373
sg5
S'PMC2361635'
p10374
sg7
g10362
sg9
V16136045.xml
p10375
sa(dp10376
g3
VSTD-Henriksson-1998
p10377
sg5
S'PMC2150170'
p10378
sg7
g10362
sg9
V9579838.xml
p10379
sa(dp10380
g3
VSTD-Yang-2003_x0028_ii_x0029_
p10381
sg5
S'PMC2275327'
p10382
sg7
g10362
sg9
V12915604.xml
p10383
sa(dp10384
g3
VSTD-Yang-2003_x0028_i_x0029_
p10385
sg5
S'PMC2275327'
p10386
sg7
g10362
sg9
V12915604.xml
p10387
sa(dp10388
g3
VSTD-Atzpodien-2001
p10389
sg5
S'PMC2375150'
p10390
sg7
g10362
sg9
V11710825.xml
p10391
sa(dp10392
g3
VSTD-Brooner-1998
p10393
sg5
S'PMC1307735'
p10394
sg7
VCD004145 v. 10.0 Oral substitution treatment of injecting opioid users for prevention of HIV infection.rm5
p10395
sg9
V9722818.xml
p10396
sa(dp10397
g3
VSTD-Willner_x002d_Reid-2008
p10398
sg5
S'PMC2600879'
p10399
sg7
g10395
sg9
V17931826.xml
p10400
sa(dp10401
g3
VSTD-Stark-1996
p10402
sg5
S'PMC1060345'
p10403
sg7
g10395
sg9
V8944860.xml
p10404
sa(dp10405
g3
VSTD-Thiede-2000
p10406
sg5
S'PMC3456044'
p10407
sg7
g10395
sg9
V10976608.xml
p10408
sa(dp10409
g3
VSTD-Callaghan-1985
p10410
sg5
S'PMC1028404'
p10411
sg7
VCD001911 v. 10.0 Carbamazepine versus phenytoin monotherapy for epilepsy.rm5
p10412
sg9
V3928820.xml
p10413
sa(dp10414
g3
VSTD-Heller-1995
p10415
sg5
S'PMC1073267'
p10416
sg7
g10412
sg9
V7823066.xml
p10417
sa(dp10418
g3
VSTD-Glasgow-Trial-1988
p10419
sg5
S'PMC1041614'
p10420
sg7
VCD004399 v. 6.1 Medical versus surgical interventions for open angle glaucoma.rm5
p10421
sg9
V3067743.xml
p10422
sa(dp10423
g3
VSTD-Lucas-1992
p10424
sg5
S'PMC1793654'
p10425
sg7
VCD004696 v. 6.0 Nutrient-enriched formula versus standard term formula for preterm infants following hospital discha.rm5
p10426
sg9
V1575558.xml
p10427
sa(dp10428
g3
VSTD-Thomas-2001
p10429
sg5
S'PMC1760980'
p10430
sg7
VCD003087 v. 9.0 Double gloving to reduce surgical cross-infection.rm5
p10431
sg9
V11423598.xml
p10432
sa(dp10433
g3
VSTD-Wilson-1996
p10434
sg5
S'PMC2502654'
p10435
sg7
g10431
sg9
V8659967.xml
p10436
sa(dp10437
g3
VSTD-Huf-2007
p10438
sg5
S'PMC2043463'
p10439
sg7
VCD009377 v. 2.3 Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).rm5
p10440
sg9
V17954515.xml
p10441
sa(dp10442
g3
VSTD-Huijgens-1999
p10443
sg5
S'PMC1023076'
p10444
sg7
VCD003807 v. 5.2 Interventions for preventing oral candidiasis for patients with cancer receiving treatment.rm5
p10445
sg9
V10560360.xml
p10446
sa(dp10447
g3
VSTD-Nathan-1991
p10448
sg5
S'PMC2499492'
p10449
sg7
VCD004929 v. 5.0 Prophylactic nasogastric decompression after abdominal surgery.rm5
p10450
sg9
V1929130.xml
p10451
sa(dp10452
g3
VSTD-Cheadle-1985
p10453
sg5
S'PMC1250919'
p10454
sg7
g10450
sg9
V4037908.xml
p10455
sa(dp10456
g3
VSTD-Wolff-1989
p10457
sg5
S'PMC1494121'
p10458
sg7
g10450
sg9
V2658880.xml
p10459
sa(dp10460
g3
VSTD-Hurlstone-2004
p10461
sg5
S'PMC1773964'
p10462
sg7
VCD006439 v. 4.0 Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum.rm5
p10463
sg9
V14960519.xml
p10464
sa(dp10465
g3
VSTD-Stoffel-2008
p10466
sg5
S'PMC2701380'
p10467
sg7
g10463
sg9
V19139000.xml
p10468
sa(dp10469
g3
VSTD-Reissman-1995
p10470
sg5
S'PMC1234758'
p10471
sg7
VCD004080 v. 7.0 Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for po.rm5
p10472
sg9
V7618972.xml
p10473
sa(dp10474
g3
VSTD-Watters-1997
p10475
sg5
S'PMC1191041'
p10476
sg7
g10472
sg9
V9339943.xml
p10477
sa(dp10478
g3
VSTD-Beier_x002d_Holgersen-1996
p10479
sg5
S'PMC1383455'
p10480
sg7
g10472
sg9
V9038665.xml
p10481
sa(dp10482
g3
VSTD-Heslin-1997
p10483
sg5
S'PMC1191079'
p10484
sg7
g10472
sg9
V9351723.xml
p10485
sa(dp10486
g3
VSTD-Whittaker-2011
p10487
sg5
S'PMC3221331'
p10488
sg7
VCD006611 v. 4.4 Mobile phone-based interventions for smoking cessation.rm5
p10489
sg9
V21371991.xml
p10490
sa(dp10491
g3
VSTD-Rodgers-2005
p10492
sg5
S'PMC1748056'
p10493
sg7
g10489
sg9
V16046689.xml
p10494
sa(dp10495
g3
VSTD-Free-2011
p10496
sg5
S'PMC3143315'
p10497
sg7
g10489
sg9
V21722952.xml
p10498
sa(dp10499
g3
VSTD-Wolthers-1991
p10500
sg5
S'PMC1670402'
p10501
sg7
VCD003271 v. 5.0 Budesonide at different doses for chronic asthma.rm5
p10502
sg9
V1878641.xml
p10503
sa(dp10504
g3
VSTD-Oddy-1999
p10505
sg5
S'PMC314207'
p10506
sg7
VCD003517 v. 5.0 Optimal duration of exclusive breastfeeding.rm5
p10507
sg9
V10496824.xml
p10508
sa(dp10509
g3
VSTD-Savilahti-1987a
p10510
sg5
S'PMC1778320'
p10511
sg7
g10507
sg9
V3566318.xml
p10512
sa(dp10513
g3
VSTD-COMPASS
p10514
sg5
S'PMC1920547'
p10515
sg7
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p10516
sg9
V17362472.xml
p10517
sa(dp10518
g3
VSTD-McMurdo-2009
p10519
sg5
S'PMC2639265'
p10520
sg7
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p10521
sg9
V19042940.xml
p10522
sa(dp10523
g3
VSTD-Barbosa_x002d_Cesnik-2011
p10524
sg5
S'PMC3060891'
p10525
sg7
g10521
sg9
V21148516.xml
p10526
sa(dp10527
g3
VSTD-Kontiokari-2001
p10528
sg5
S'PMC33514'
p10529
sg7
g10521
sg9
V11431298.xml
p10530
sa(dp10531
g3
VSTD-Lichtenstein-2000
p10532
sg5
S'PMC1748368'
p10533
sg7
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p10534
sg9
V10982577.xml
p10535
sa(dp10536
g3
VSTD-Reid-1999
p10537
sg5
S'PMC1230362'
p10538
sg7
g10534
sg9
V10373999.xml
p10539
sa(dp10540
g3
VSTD-McBride-1999b
p10541
sg5
S'PMC1508743'
p10542
sg7
g10534
sg9
V10224982.xml
p10543
sa(dp10544
g3
VSTD-Lando-1997
p10545
sg5
S'PMC1381132'
p10546
sg7
g10534
sg9
V9357351.xml
p10547
sa(dp10548
g3
VSTD-Lando-1992
p10549
sg5
S'PMC1694411'
p10550
sg7
g10534
sg9
V1536333.xml
p10551
sa(dp10552
g3
VSTD-Hollis-2007
p10553
sg5
S'PMC2598511'
p10554
sg7
g10534
sg9
V18048633.xml
p10555
sa(dp10556
g3
VSTD-Ossip_x002d_Klein-1997
p10557
sg5
S'PMC1759567'
p10558
sg7
g10534
sg9
V9396102.xml
p10559
sa(dp10560
g3
VSTD-Sood-2009
p10561
sg5
S'PMC2773358'
p10562
sg7
g10534
sg9
V19225061.xml
p10563
sa(dp10564
g3
VSTD-Rabius-2007
p10565
sg5
S'PMC2598518'
p10566
sg7
g10534
sg9
V18048636.xml
p10567
sa(dp10568
g3
VSTD-Hennrikus-2002
p10569
sg5
S'PMC1447056'
p10570
sg7
g10534
sg9
V11818305.xml
p10571
sa(dp10572
g3
VSTD-Holmes_x002d_Rovner-2008
p10573
sg5
S'PMC2517997'
p10574
sg7
g10534
sg9
V18618189.xml
p10575
sa(dp10576
g3
VSTD-Young-2008
p10577
sg5
S'PMC2268921'
p10578
sg7
g10534
sg9
V18304363.xml
p10579
sa(dp10580
g3
VSTD-Joyce-2008
p10581
sg5
S'PMC2614005'
p10582
sg7
g10534
sg9
V18783459.xml
p10583
sa(dp10584
g3
VSTD-Bonny-2009
p10585
sg5
S'PMC2749597'
p10586
sg7
VCD008815 v. 3.0 Progestin-only contraceptives effects on weight.rm5
p10587
sg9
V19766950.xml
p10588
sa(dp10589
g3
VSTD-Grootendorst-2005
p10590
sg5
S'PMC1361214'
p10591
sg7
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p10592
sg9
V16174135.xml
p10593
sa(dp10594
g3
VSTD-Bursey-2000
p10595
sg5
S'PMC1231278'
p10596
sg7
g10592
sg9
V10750472.xml
p10597
sa(dp10598
g3
VSTD-Fretheim-2007
p10599
sg5
S'PMC1904466'
p10600
sg7
g10592
sg9
V17622192.xml
p10601
sa(dp10602
g3
VSTD-Marshall-2002
p10603
sg5
S'PMC116151'
p10604
sg7
g10592
sg9
V12126319.xml
p10605
sa(dp10606
g3
VSTD-Sakshaug-2007
p10607
sg5
S'PMC2048565'
p10608
sg7
g10592
sg9
V17441934.xml
p10609
sa(dp10610
g3
VSTD-Schneeweiss-2004
p10611
sg5
S'PMC313925'
p10612
sg7
g10592
sg9
V14703526.xml
p10613
sa(dp10614
g3
VSTD-COMTI-_x0028_E_x0029__x003a_-UK_x002f_Irish
p10615
sg5
S'PMC1738605'
p10616
sg7
VCD007166 v. 3.0 Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinsons disea.rm5
p10617
sg9
V12876237.xml
p10618
sa(dp10619
g3
VSTD-DA-_x0028_Pr_x0029__x003a_-Aust_x002f_Germ
p10620
sg5
S'PMC1736320'
p10621
sg7
g10617
sg9
V10201413.xml
p10622
sa(dp10623
g3
VSTD-COMTI-_x0028_T_x0029__x003a_-Europe
p10624
sg5
S'PMC2169755'
p10625
sg7
g10617
sg9
V9343116.xml
p10626
sa(dp10627
g3
VSTD-Lee-2007
p10628
sg5
S'PMC2206510'
p10629
sg7
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p10630
sg9
V17705879.xml
p10631
sa(dp10632
g3
VSTD-Levy-1983
p10633
sg5
S'PMC1028443'
p10634
sg7
VCD001015 v. 10.0 Lecithin for dementia and cognitive impairment.rm5
p10635
sg9
V3897460.xml
p10636
sa(dp10637
g3
VSTD-Ebbert-2009
p10638
sg5
S'PMC2784490'
p10639
sg7
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p10640
sg9
V19880578.xml
p10641
sa(dp10642
g3
VSTD-Walsh-1999
p10643
sg5
S'PMC1508522'
p10644
sg7
g10640
sg9
V9949754.xml
p10645
sa(dp10646
g3
VSTD-Fagerstrom-2010
p10647
sg5
S'PMC2997603'
p10648
sg7
g10640
sg9
V21134997.xml
p10649
sa(dp10650
g3
VSTD-Walsh-2010
p10651
sg5
S'PMC2902861'
p10652
sg7
g10640
sg9
V20439384.xml
p10653
sa(dp10654
g3
VSTD-Ebbert-2010a
p10655
sg5
S'PMC2850207'
p10656
sg7
g10640
sg9
V20060229.xml
p10657
sa(dp10658
g3
VSTD-Stevens-1995
p10659
sg5
S'PMC1615327'
p10660
sg7
g10640
sg9
V7856783.xml
p10661
sa(dp10662
g3
VSTD-Stotts-2003
p10663
sg5
S'PMC1766135'
p10664
sg7
g10640
sg9
V14645935.xml
p10665
sa(dp10666
g3
VSTD-Dale-2007
p10667
sg5
S'PMC1994655'
p10668
sg7
g10640
sg9
V17353101.xml
p10669
sa(dp10670
g3
VSTD-Davies-1977
p10671
sg5
S'PMC1544654'
p10672
sg7
VCD002971 v. 6.0 Formula milk versus donor breast milk for feeding preterm or low birth weight infants.rm5
p10673
sg9
V558739.xml
p10674
sa(dp10675
g3
VSTD-Lucas-1984b
p10676
sg5
S'PMC1628628'
p10677
sg7
g10673
sg9
V6476868.xml
p10678
sa(dp10679
g3
VSTD-Lucas-1984a
p10680
sg5
S'PMC1628628'
p10681
sg7
g10673
sg9
V6476868.xml
p10682
sa(dp10683
g3
VSTD-Ballmann-2002
p10684
sg5
S'PMC1745320'
p10685
sg7
VCD001127 v. 14.0 Dornase alfa for cystic fibrosis.rm5
p10686
sg9
V10319054.xml
p10687
sa(dp10688
g3
VSTD-White-2007
p10689
sg5
S'PMC1831486'
p10690
sg7
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p10691
sg9
V17359519.xml
p10692
sa(dp10693
g3
VSTD-Waite-1998
p10694
sg5
S'PMC1313196'
p10695
sg7
g10691
sg9
V10024707.xml
p10696
sa(dp10697
g3
VSTD-Leung-1991
p10698
sg5
S'PMC1286114'
p10699
sg7
g10691
sg9
V3417584.xml
p10700
sa(dp10701
g3
VSTD-Bier-2002
p10702
sg5
S'PMC1447300'
p10703
sg7
g10691
sg9
V12356614.xml
p10704
sa(dp10705
g3
VSTD-Clavel-1985
p10706
sg5
S'PMC1418170'
p10707
sg7
g10691
sg9
V3933739.xml
p10708
sa(dp10709
g3
VSTD-Wickizer-2004
p10710
sg5
S'PMC1360996'
p10711
sg7
VCD006251 v. 7.0 Interventions to prevent injuries in construction workers.rm5
p10712
sg9
V14965079.xml
p10713
sa(dp10714
g3
VSTD-Scott-1968
p10715
sg5
S'PMC2019943'
p10716
sg7
VCD001532 v. 11.0 Interventions for primary vesicoureteric reflux.rm5
p10717
sg9
V5652710.xml
p10718
sa(dp10719
g3
VSTD-Muscle-Study-Group-2011
p10720
sg5
S'PMC3170432'
p10721
sg7
VCD003643 v. 10.0 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.rm5
p10722
sg9
V21688301.xml
p10723
sa(dp10724
g3
VSTD-Geisser-2005a
p10725
sg5
S'PMC1360691'
p10726
sg7
VCD001929 v. 11.0 Massage for low-back pain.rm5
p10727
sg9
V16215330.xml
p10728
sa(dp10729
g3
VSTD-Hsieh-2006
p10730
sg5
S'PMC1325109'
p10731
sg7
g10727
sg9
V16399707.xml
p10732
sa(dp10733
g3
VSTD-Preyde-2000
p10734
sg5
S'PMC1231369'
p10735
sg7
g10727
sg9
V10906914.xml
p10736
sa(dp10737
g3
VSTD-de-Wilde-1983
p10738
sg5
S'PMC1427657'
p10739
sg7
VCD006114 v. 6.0 Fluvoxamine versus other anti-depressive agents for depression.rm5
p10740
sg9
V6407503.xml
p10741
sa(dp10742
g3
VSTD-Itil-1983
p10743
sg5
S'PMC1427663'
p10744
sg7
g10740
sg9
V6407504.xml
p10745
sa(dp10746
g3
VSTD-Dick-1983
p10747
sg5
S'PMC1427654'
p10748
sg7
g10740
sg9
V6407502.xml
p10749
sa(dp10750
g3
VSTD-Bonham-1963
p10751
sg5
S'PMC1873904'
p10752
sg7
VCD001808 v. 9.0 Prophylactic oxytocin for the third stage of labour.rm5
p10753
sg9
V14066183.xml
p10754
sa(dp10755
g3
VSTD-Symon-1995
p10756
sg5
S'PMC1510964'
p10757
sg7
VCD003017 v. 5.2 Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) .rm5
p10758
sg9
V7717738.xml
p10759
sa(dp10760
g3
VSTD-Chiarelli-2002
p10761
sg5
S'PMC113274'
p10762
sg7
VCD007471 v. 3.0 Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in ante.rm5
p10763
sg9
V12028976.xml
p10764
sa(dp10765
g3
VSTD-Dannecker-2004
p10766
sg5
S'PMC2896999'
p10767
sg7
g10763
sg9
V20607084.xml
p10768
sa(dp10769
g3
VSTD-Glazener-2001
p10770
sg5
S'PMC1120656'
p10771
sg7
g10763
sg9
V11440920.xml
p10772
sa(dp10773
g3
VSTD-Bolam-1998
p10774
sg5
S'PMC28481'
p10775
sg7
VCD001863 v. 8.0 Education for contraceptive use by women after childbirth.rm5
p10776
sg9
V9549449.xml
p10777
sa(dp10778
g3
VSTD-Barnet-2009
p10779
sg5
S'PMC2746510'
p10780
sg7
g10776
sg9
V19752472.xml
p10781
sa(dp10782
g3
VSTD-Luabeya-2007
p10783
sg5
S'PMC1891438'
p10784
sg7
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p10785
sg9
V17593956.xml
p10786
sa(dp10787
g3
VSTD-Bhandari-2002b
p10788
sg5
S'PMC115208'
p10789
sg7
g10785
sg9
V12052800.xml
p10790
sa(dp10791
g3
VSTD-Bhandari-2002a
p10792
sg5
S'PMC115208'
p10793
sg7
g10785
sg9
V12052800.xml
p10794
sa(dp10795
g3
VSTD-Stern-1997
p10796
sg5
S'PMC2127436'
p10797
sg7
VMR000006 v. 5.0 Publication bias in clinical trials due to statistical significance or direction of trial results.rm5
p10798
sg9
V9310565.xml
p10799
sa(dp10800
g3
VSTD-Bardy-1998
p10801
sg5
S'PMC1873669'
p10802
sg7
g10798
sg9
V9723823.xml
p10803
sa(dp10804
g3
VSTD-Mohide-1996
p10805
sg5
S'PMC2074537'
p10806
sg7
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p10807
sg9
V8664135.xml
p10808
sa(dp10809
g3
VSTD-Heller-1995
p10810
sg5
S'PMC1073267'
p10811
sg7
VCD001904 v. 9.4 Carbamazepine versus phenobarbitone monotherapy for epilepsy.rm5
p10812
sg9
V7823066.xml
p10813
sa(dp10814
g3
VSTD-Yang-TB-2002
p10815
sg5
S'PMC3689487'
p10816
sg7
VCD003642 v. 3.0 Chinese herbal medicines for type 2 diabetes mellitus.rm5
p10817
sg9
V23901377.xml
p10818
sa(dp10819
g3
VSTD-Desai-1998
p10820
sg5
S'PMC2170369'
p10821
sg7
VCD004583 v. 3.0 Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.rm5
p10822
sg9
V9810966.xml
p10823
sa(dp10824
g3
VSTD-Poustie-2006
p10825
sg5
S'PMC1403226'
p10826
sg7
VCD000406 v. 16.0 Oral calorie supplements for cystic fibrosis.rm5
p10827
sg9
V16467348.xml
p10828
sa(dp10829
g3
VSTD-Smith-1989
p10830
sg5
S'PMC172506'
p10831
sg7
VCD001364 v. 16.0 Zinc for the common cold.rm5
p10832
sg9
V2665639.xml
p10833
sa(dp10834
g3
VSTD-Farr-1987a
p10835
sg5
S'PMC174900'
p10836
sg7
g10832
sg9
V2820298.xml
p10837
sa(dp10838
g3
VSTD-Douglas-1987
p10839
sg5
S'PMC174915'
p10840
sg7
g10832
sg9
V3307620.xml
p10841
sa(dp10842
g3
VSTD-Christiansen-1973a
p10843
sg5
S'PMC1587877'
p10844
sg7
VCD004304 v. 5.1 Vitamins for epilepsy.rm5
p10845
sg9
V4776883.xml
p10846
sa(dp10847
g3
VSTD-Grant-1970
p10848
sg5
S'PMC1820248'
p10849
sg7
g10845
sg9
V4922754.xml
p10850
sa(dp10851
g3
VSTD-van-der-Ende-1988
p10852
sg5
S'PMC1834851'
p10853
sg7
VCD003255 v. 10.0 Condom effectiveness in reducing heterosexual HIV transmission.rm5
p10854
sg9
V3143442.xml
p10855
sa(dp10856
g3
VSTD-Allen-1992
p10857
sg5
S'PMC1881972'
p10858
sg7
g10854
sg9
V1628088.xml
p10859
sa(dp10860
g3
VSTD-Hemsell-1993
p10861
sg5
S'PMC2364680'
p10862
sg7
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p10863
sg9
V18476202.xml
p10864
sa(dp10865
g3
VSTD-Woodland-1981
p10866
sg5
S'PMC1000728'
p10867
sg7
VCD001461 v. 6.0 Azathioprine for treating rheumatoid arthritis.rm5
p10868
sg9
V7020612.xml
p10869
sa(dp10870
g3
VSTD-Parving-1989
p10871
sg5
S'PMC1837371'
p10872
sg7
VCD006257 v. 7.0 Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the .rm5
p10873
sg9
V2507061.xml
p10874
sa(dp10875
g3
VSTD-DIABHYCAR-2004
p10876
sg5
S'PMC351842'
p10877
sg7
g10873
sg9
V14960504.xml
p10878
sa(dp10879
g3
VSTD-Marre-1987
p10880
sg5
S'PMC1246608'
p10881
sg7
g10873
sg9
V3038254.xml
p10882
sa(dp10883
g3
VSTD-Guyer-1989
p10884
sg5
S'PMC1349806'
p10885
sg7
VCD004335 v. 11.0 Community-based interventions for the prevention of burns and scalds in children.rm5
p10886
sg9
V2817165.xml
p10887
sa(dp10888
g3
VSTD-MacKay-1982
p10889
sg5
S'PMC1649800'
p10890
sg7
g10886
sg9
V7058964.xml
p10891
sa(dp10892
g3
VSTD-Hawkey-2001
p10893
sg5
S'PMC1728427'
p10894
sg7
VCD006640 v. 4.12 Tranexamic acid for upper gastrointestinal bleeding.rm5
p10895
sg9
V11511559.xml
p10896
sa(dp10897
g3
VSTD-Biggs-1976
p10898
sg5
S'PMC1411285'
p10899
sg7
g10895
sg9
V789186.xml
p10900
sa(dp10901
g3
VSTD-Holstein-1987
p10902
sg5
S'PMC1245035'
p10903
sg7
g10895
sg9
V3101804.xml
p10904
sa(dp10905
g3
VSTD-Seymour-2002
p10906
sg5
S'PMC1422600'
p10907
sg7
VCD006575 v. 2.0 Virtual reality training for surgical trainees in laparoscopic surgery.rm5
p10908
sg9
V12368674.xml
p10909
sa(dp10910
g3
VSTD-Leykin-2008
p10911
sg5
S'PMC2615351'
p10912
sg7
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p10913
sg9
V18581586.xml
p10914
sa(dp10915
g3
VSTD-Williams-1969
p10916
sg5
S'PMC1984002'
p10917
sg7
VCD000490 v. 6.2 Antibiotics for asymptomatic bacteriuria in pregnancy.rm5
p10918
sg9
V5792611.xml
p10919
sa(dp10920
g3
VSTD-Foley-1987
p10921
sg5
S'PMC1247109'
p10922
sg7
g10918
sg9
V3115406.xml
p10923
sa(dp10924
g3
VSTD-Solomon-1991
p10925
sg5
S'PMC1671261'
p10926
sg7
VCD005508 v. 3.0 Beta blockers for peripheral arterial disease.rm5
p10927
sg9
V1747577.xml
p10928
sa(dp10929
g3
VSTD-Lepantalo-1984a
p10930
sg5
S'PMC1463567'
p10931
sg7
g10927
sg9
V6378235.xml
p10932
sa(dp10933
g3
VSTD-Henry-1983
p10934
sg5
S'PMC1628387'
p10935
sg7
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p10936
sg9
V6228197.xml
p10937
sa(dp10938
g3
VSTD-Totapally-2002
p10939
sg5
S'PMC111183'
p10940
sg7
g10936
sg9
V11983043.xml
p10941
sa(dp10942
g3
VSTD-Wang-1992
p10943
sg5
S'PMC1793648'
p10944
sg7
g10936
sg9
V1533504.xml
p10945
sa(dp10946
g3
VSTD-Ho-1991
p10947
sg5
S'PMC1793026'
p10948
sg7
g10936
sg9
V1929514.xml
p10949
sa(dp10950
g3
VSTD-McCarty-1992a
p10951
sg5
S'PMC3618531'
p10952
sg7
VCD004406 v. 8.4 Different antibiotic treatments for group A streptococcal pharyngitis.rm5
p10953
sg9
V23403631.xml
p10954
sa(dp10955
g3
VSTD-Watkins-1997
p10956
sg5
S'PMC163662'
p10957
sg7
g10953
sg9
V8980757.xml
p10958
sa(dp10959
g3
VSTD-Djulbegovic-2008
p10960
sg5
S'PMC2773511'
p10961
sg7
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p10962
sg9
V18362256.xml
p10963
sa(dp10964
g3
VSTD-Dent-2011
p10965
sg5
S'PMC3113983'
p10966
sg7
g10962
sg9
V21542934.xml
p10967
sa(dp10968
g3
VSTD-Downer-1993
p10969
sg5
S'PMC1968469'
p10970
sg7
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p10971
sg9
V8494706.xml
p10972
sa(dp10973
g3
VSTD-Smith-2003
p10974
sg5
S'PMC2741110'
p10975
sg7
g10971
sg9
V12799626.xml
p10976
sa(dp10977
g3
VSTD-Boogaerts-2003
p10978
sg5
S'PMC2376376'
p10979
sg7
g10971
sg9
V12671693.xml
p10980
sa(dp10981
g3
VSTD-Thatcher-1999
p10982
sg5
S'PMC2362337'
p10983
sg7
g10971
sg9
V10408844.xml
p10984
sa(dp10985
g3
VSTD-Wilkinson-2006
p10986
sg5
S'PMC2361228'
p10987
sg7
g10971
sg9
V16570051.xml
p10988
sa(dp10989
g3
VSTD-Levy-1998
p10990
sg5
S'PMC1307738'
p10991
sg7
VCD002843 v. 5.0 Strategies for partner notification for sexually transmitted diseases.rm5
p10992
sg9
V9722821.xml
p10993
sa(dp10994
g3
VSTD-Potterat-et-al_x002c_-1977
p10995
sg5
S'PMC1653534'
p10996
sg7
g10992
sg9
V835764.xml
p10997
sa(dp10998
g3
VSTD-Andersen-et-al_x002c_-1998
p10999
sg5
S'PMC2665537'
p11000
sg7
g10992
sg9
V9487169.xml
p11001
sa(dp11002
g3
VSTD-Montesinos_x002c_-1990
p11003
sg5
S'PMC1286239'
p11004
sg7
g10992
sg9
V2249964.xml
p11005
sa(dp11006
g3
VSTD-MRC-1970
p11007
sg5
S'PMC1699836'
p11008
sg7
VCD009351 v. 2.0 Inhaled analgesia for pain management in labour.rm5
p11009
sg9
V5440545.xml
p11010
sa(dp11011
g3
VSTD-Jones-1969
p11012
sg5
S'PMC1984038'
p11013
sg7
g11009
sg9
V4895338.xml
p11014
sa(dp11015
g3
VSTD-Jones-1969a
p11016
sg5
S'PMC1984080'
p11017
sg7
g11009
sg9
V4895339.xml
p11018
sa(dp11019
g3
VSTD-Garrod-2000
p11020
sg5
S'PMC1745814'
p11021
sg7
VCD005372 v. 5.0 Oxygen therapy during exercise training in chronic obstructive pulmonary disease.rm5
p11022
sg9
V10856310.xml
p11023
sa(dp11024
g3
VSTD-Howe-1983
p11025
sg5
S'PMC1973006'
p11026
sg7
VCD001878 v. 6.0 Non-invasive physical treatments for chronicrecurrent headache.rm5
p11027
sg9
V6355460.xml
p11028
sa(dp11029
g3
VSTD-Tsang-2005
p11030
sg5
S'PMC1747352'
p11031
sg7
VCD000996 v. 6.0 Inhaled steroids for bronchiectasis.rm5
p11032
sg9
V15741443.xml
p11033
sa(dp11034
g3
VSTD-Wright-2011
p11035
sg5
S'PMC3223774'
p11036
sg7
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p11037
sg9
V22137413.xml
p11038
sa(dp11039
g3
VSTD-Madlung_x002d_Kratzer-2009
p11040
sg5
S'PMC2773536'
p11041
sg7
g11037
sg9
V19686525.xml
p11042
sa(dp11043
g3
VSTD-Scotland-1990
p11044
sg5
S'PMC1663720'
p11045
sg7
VCD002863 v. 7.0 Oral beta-blockers for mild to moderate hypertension during pregnancy.rm5
p11046
sg9
V2242456.xml
p11047
sa(dp11048
g3
VSTD-England-1983
p11049
sg5
S'PMC1548251'
p11050
sg7
g11046
sg9
V6407638.xml
p11051
sa(dp11052
g3
VSTD-Australia-1985
p11053
sg5
S'PMC1418204'
p11054
sg7
g11046
sg9
V3929874.xml
p11055
sa(dp11056
g3
VSTD-Probert-2003
p11057
sg5
S'PMC1773722'
p11058
sg7
VCD005112 v. 5.0 Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.rm5
p11059
sg9
V12801957.xml
p11060
sa(dp11061
g3
VSTD-Hayward-2006
p11062
sg5
S'PMC1702427'
p11063
sg7
VCD005187 v. 7.0 Influenza vaccination for healthcare workers who work with the elderly.rm5
p11064
sg9
V17142257.xml
p11065
sa(dp11066
g3
VSTD-Bramwell-2006c
p11067
sg5
S'PMC1526944'
p11068
sg7
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p11069
sg9
V16840441.xml
p11070
sa(dp11071
g3
VSTD-Bucher-1994
p11072
sg5
S'PMC2541000'
p11073
sg7
g11069
sg9
V7950558.xml
p11074
sa(dp11075
g3
VSTD-Misselbrook-2001
p11076
sg5
S'PMC1313976'
p11077
sg7
g11069
sg9
V11458479.xml
p11078
sa(dp11079
g3
VSTD-Adily-2004
p11080
sg5
S'PMC1732789'
p11081
sg7
g11069
sg9
V15143111.xml
p11082
sa(dp11083
g3
VSTD-Sheridan-2003
p11084
sg5
S'PMC1494938'
p11085
sg7
g11069
sg9
V14687273.xml
p11086
sa(dp11087
g3
VSTD-Carling-2009
p11088
sg5
S'PMC2724738'
p11089
sg7
g11069
sg9
V19707575.xml
p11090
sa(dp11091
g3
VSTD-Carling-2008
p11092
sg5
S'PMC2585274'
p11093
sg7
g11069
sg9
V19030110.xml
p11094
sa(dp11095
g3
VSTD-Nikolajevic_x002d_S-1999
p11096
sg5
S'PMC1496748'
p11097
sg7
g11069
sg9
V10571703.xml
p11098
sa(dp11099
g3
VSTD-Fahey-1995
p11100
sg5
S'PMC2551363'
p11101
sg7
g11069
sg9
V7580661.xml
p11102
sa(dp11103
g3
VSTD-Bramwell-2006d
p11104
sg5
S'PMC1526944'
p11105
sg7
g11069
sg9
V16840441.xml
p11106
sa(dp11107
g3
VSTD-Bramwell-2006b
p11108
sg5
S'PMC1526944'
p11109
sg7
g11069
sg9
V16840441.xml
p11110
sa(dp11111
g3
VSTD-Bramwell-2006a
p11112
sg5
S'PMC1526944'
p11113
sg7
g11069
sg9
V16840441.xml
p11114
sa(dp11115
g3
VSTD-Cranney-1996
p11116
sg5
S'PMC1239820'
p11117
sg7
g11069
sg9
V8978112.xml
p11118
sa(dp11119
g3
VSTD-O_x0027_Connor-2007
p11120
sg5
S'PMC1781394'
p11121
sg7
VCD004228 v. 4.0 Psychological andor educational interventions for reducing alcohol consumption in pregnant women an.rm5
p11122
sg9
V17194863.xml
p11123
sa(dp11124
g3
VSTD-Sharafi-2010
p11125
sg5
S'PMC3446002'
p11126
sg7
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p11127
sg9
V23056681.xml
p11128
sa(dp11129
g3
VSTD-Lorente-2006
p11130
sg5
S'PMC1750976'
p11131
sg7
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p11132
sg9
V16884530.xml
p11133
sa(dp11134
g3
VSTD-Thomachot-2001
p11135
sg5
S'PMC29053'
p11136
sg7
g11132
sg9
V11178222.xml
p11137
sa(dp11138
g3
VSTD-NSABP-B_x002d_24-Trial-2011
p11139
sg5
S'PMC3107729'
p11140
sg7
VCD007847 v. 2.0 Postoperative tamoxifen for ductal carcinoma in situ.rm5
p11141
sg9
V21398619.xml
p11142
sa(dp11143
g3
VSTD-UK-ANZ-Trial-2011
p11144
sg5
S'PMC3018565'
p11145
sg7
g11141
sg9
V21145284.xml
p11146
sa(dp11147
g3
VSTD-Attar-1999
p11148
sg5
S'PMC1727381'
p11149
sg7
VCD007570 v. 4.0 Lactulose versus Polyethylene Glycol for Chronic Constipation.rm5
p11150
sg9
V9895382.xml
p11151
sa(dp11152
g3
VSTD-Voskuijl-2004
p11153
sg5
S'PMC1774276'
p11154
sg7
g11150
sg9
V15479678.xml
p11155
sa(dp11156
g3
VSTD-Robinson-1997
p11157
sg5
S'PMC1758438'
p11158
sg7
VCD001506 v. 10.0 Nebulised hypertonic saline for cystic fibrosis.rm5
p11159
sg9
V9404379.xml
p11160
sa(dp11161
g3
VSTD-Ballmann-1998
p11162
sg5
S'PMC1745320'
p11163
sg7
g11159
sg9
V10319054.xml
p11164
sa(dp11165
g3
VSTD-Weller-1980
p11166
sg5
S'PMC471218'
p11167
sg7
g11159
sg9
V6767295.xml
p11168
sa(dp11169
g3
VSTD-Ray-2001
p11170
sg5
S'PMC3455875'
p11171
sg7
VCD005272 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
p11172
sg9
V11796805.xml
p11173
sa(dp11174
g3
VSTD-Basu-2004
p11175
sg5
S'PMC2826108'
p11176
sg7
g11172
sg9
V15213569.xml
p11177
sa(dp11178
g3
VSTD-Li-2006
p11179
sg5
S'PMC1933388'
p11180
sg7
g11172
sg9
V17067252.xml
p11181
sa(dp11182
g3
VSTD-Hoke-2007
p11183
sg5
S'PMC2598714'
p11184
sg7
g11172
sg9
V17591662.xml
p11185
sa(dp11186
g3
VSTD-Chiao-2009
p11187
sg5
S'PMC3103188'
p11188
sg7
g11172
sg9
V18543095.xml
p11189
sa(dp11190
g3
VSTD-Feldblum-2005
p11191
sg5
S'PMC1764680'
p11192
sg7
g11172
sg9
V15800098.xml
p11193
sa(dp11194
g3
VSTD-Swendeman-2009
p11195
sg5
S'PMC2824563'
p11196
sg7
g11172
sg9
V19716639.xml
p11197
sa(dp11198
g3
VSTD-Patterson-2008
p11199
sg5
S'PMC2633868'
p11200
sg7
g11172
sg9
V18799768.xml
p11201
sa(dp11202
g3
VSTD-Hayes-1976
p11203
sg5
S'PMC483116'
p11204
sg7
VCD003836 v. 6.0 Bed rest for acute uncomplicated myocardial infarction.rm5
p11205
sg9
V971383.xml
p11206
sa(dp11207
g3
VSTD-West-1979
p11208
sg5
S'PMC482171'
p11209
sg7
g11205
sg9
V389259.xml
p11210
sa(dp11211
g3
VSTD-Hayes-1974
p11212
sg5
S'PMC1611338'
p11213
sg7
g11205
sg9
V4835462.xml
p11214
sa(dp11215
g3
VSTD-Banaszewska-2009
p11216
sg5
S'PMC2795658'
p11217
sg7
VCD008565 v. 3.2 Statins for women with polycystic ovary syndrome not actively trying to conceive.rm5
p11218
sg9
V19890022.xml
p11219
sa(dp11220
g3
VSTD-Ogata-2006
p11221
sg5
S'PMC1860021'
p11222
sg7
VCD007216 v. 1.0 Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis.rm5
p11223
sg9
V16484504.xml
p11224
sa(dp11225
g3
VSTD-Park-1998
p11226
sg5
S'PMC3619600'
p11227
sg7
VCD000093 v. 9.0 Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsula.rm5
p11228
sg9
V9728307.xml
p11229
sa(dp11230
g3
VSTD-Stringer-2007
p11231
sg5
S'PMC2730754'
p11232
sg7
VCD007043 v. 4.0 Copper containing intra-uterine devices versus depot progestogens for contraception.rm5
p11233
sg9
V17689627.xml
p11234
sa(dp11235
g3
VSTD-Perry-1999
p11236
sg5
S'PMC27688'
p11237
sg7
VCD004854 v. 6.0 Interventions for helping people recognise early signs of recurrence in bipolar disorder.rm5
p11238
sg9
V9888904.xml
p11239
sa(dp11240
g3
VSTD-Chadha-1983
p11241
sg5
S'PMC1428071'
p11242
sg7
VCD007187 v. 3.0 Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.rm5
p11243
sg9
V6357258.xml
p11244
sa(dp11245
g3
VSTD-Weinberger-1982
p11246
sg5
S'PMC1427520'
p11247
sg7
g11243
sg9
V6753893.xml
p11248
sa(dp11249
g3
VSTD-Kayanakis-1987
p11250
sg5
S'PMC1386051'
p11251
sg7
g11243
sg9
V3555588.xml
p11252
sa(dp11253
g3
VSTD-Wolf-2000
p11254
sg5
S'PMC1495322'
p11255
sg7
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p11256
sg9
V10632830.xml
p11257
sa(dp11258
g3
VSTD-McBride-2002
p11259
sg5
S'PMC1447199'
p11260
sg7
g11256
sg9
V12084693.xml
p11261
sa(dp11262
g3
VSTD-Krist-2007
p11263
sg5
S'PMC1838687'
p11264
sg7
g11256
sg9
V17389534.xml
p11265
sa(dp11266
g3
VSTD-Frosch-2003
p11267
sg5
S'PMC1494924'
p11268
sg7
g11256
sg9
V14521639.xml
p11269
sa(dp11270
g3
VSTD-Vodermaier-2009
p11271
sg5
S'PMC2653746'
p11272
sg7
g11256
sg9
V19209172.xml
p11273
sa(dp11274
g3
VSTD-McAlister-2005
p11275
sg5
S'PMC1188186'
p11276
sg7
g11256
sg9
V16129870.xml
p11277
sa(dp11278
g3
VSTD-Sheridan-2006
p11279
sg5
S'PMC1626460'
p11280
sg7
g11256
sg9
V17005051.xml
p11281
sa(dp11282
g3
VSTD-Montgomery-2003
p11283
sg5
S'PMC1314618'
p11284
sg7
g11256
sg9
V12939889.xml
p11285
sa(dp11286
g3
VSTD-Montgomery-2007
p11287
sg5
S'PMC1895676'
p11288
sg7
g11256
sg9
V17540908.xml
p11289
sa(dp11290
g3
VSTD-Green-2004
p11291
sg5
S'PMC1237120'
p11292
sg7
g11256
sg9
V15280342.xml
p11293
sa(dp11294
g3
VSTD-Volk-2008
p11295
sg5
S'PMC2867348'
p11296
sg7
g11256
sg9
V18760888.xml
p11297
sa(dp11298
g3
VSTD-Murray-2001b
p11299
sg5
S'PMC48137'
p11300
sg7
g11256
sg9
V11532844.xml
p11301
sa(dp11302
g3
VSTD-Murray-2001a
p11303
sg5
S'PMC48138'
p11304
sg7
g11256
sg9
V11532845.xml
p11305
sa(dp11306
g3
VSTD-Dodin-2001
p11307
sg5
S'PMC2018543'
p11308
sg7
g11256
sg9
V11561335.xml
p11309
sa(dp11310
g3
VSTD-Schwartz-2009
p11311
sg5
S'PMC3580845'
p11312
sg7
g11256
sg9
V19210013.xml
p11313
sa(dp11314
g3
VSTD-Morgan-2000
p11315
sg5
S'PMC1495608'
p11316
sg7
g11256
sg9
V11089711.xml
p11317
sa(dp11318
g3
VSTD-Myers-2005a
p11319
sg5
S'PMC2576013'
p11320
sg7
g11256
sg9
V16173330.xml
p11321
sa(dp11322
g3
VSTD-Thomson-2007
p11323
sg5
S'PMC1781432'
p11324
sg7
g11256
sg9
V17214891.xml
p11325
sa(dp11326
g3
VSTD-Kendrick-2001
p11327
sg5
S'PMC1763305'
p11328
sg7
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p11329
sg9
V11604444.xml
p11330
sa(dp11331
g3
VSTD-Bentley-2004
p11332
sg5
S'PMC1733848'
p11333
sg7
g11329
sg9
V15173366.xml
p11334
sa(dp11335
g3
VSTD-Simes-1986
p11336
sg5
S'PMC1341916'
p11337
sg7
g11329
sg9
V3094776.xml
p11338
sa(dp11339
g3
VSTD-Welton-1999
p11340
sg5
S'PMC27847'
p11341
sg7
g11329
sg9
V10213724.xml
p11342
sa(dp11343
g3
VSTD-Weinfurt-2008b
p11344
sg5
S'PMC2908285'
p11345
sg7
g11329
sg9
V18946893.xml
p11346
sa(dp11347
g3
VSTD-Weinfurt-2008a
p11348
sg5
S'PMC2517900'
p11349
sg7
g11329
sg9
V18386101.xml
p11350
sa(dp11351
g3
VSTD-Trevena-2006
p11352
sg5
S'PMC2563378'
p11353
sg7
g11329
sg9
V16877628.xml
p11354
sa(dp11355
g3
VSTD-Jeste-2009
p11356
sg5
S'PMC2696362'
p11357
sg7
g11329
sg9
V18245061.xml
p11358
sa(dp11359
g3
VSTD-Hutchison-2007
p11360
sg5
S'PMC2360384'
p11361
sg7
g11329
sg9
V17848908.xml
p11362
sa(dp11363
g3
VSTD-Slichter-2010
p11364
sg5
S'PMC2951321'
p11365
sg7
VCD004269 v. 10.6 Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorde.rm5
p11366
sg9
V20164484.xml
p11367
sa(dp11368
g3
VSTD-DRCRnet
p11369
sg5
S'PMC2937272'
p11370
sg7
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p11371
sg9
V20427088.xml
p11372
sa(dp11373
g3
VSTD-RESOLVE
p11374
sg5
S'PMC2963502'
p11375
sg7
g11371
sg9
V20980427.xml
p11376
sa(dp11377
g3
VSTD-Lundgren-1989
p11378
sg5
S'PMC1493950'
p11379
sg7
VCD000990 v. 8.6 Exercise for intermittent claudication.rm5
p11380
sg9
V2647051.xml
p11381
sa(dp11382
g3
VSTD-Greenfield-1975b
p11383
sg5
S'PMC1129908'
p11384
sg7
VCD000349 v. 4.2 Guidelines in professions allied to medicine.rm5
p11385
sg9
V128907.xml
p11386
sa(dp11387
g3
VSTD-Dixon-1992
p11388
sg5
S'PMC1977824'
p11389
sg7
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p11390
sg9
V1503915.xml
p11391
sa(dp11392
g3
VSTD-Priestman-1978
p11393
sg5
S'PMC1608971'
p11394
sg7
g11390
sg9
V367510.xml
p11395
sa(dp11396
g3
VSTD-Zeloni-2002
p11397
sg5
S'PMC1737996'
p11398
sg7
VCD003586 v. 5.0 Cognitive rehabilitation for spatial neglect following stroke.rm5
p11399
sg9
V12122183.xml
p11400
sa(dp11401
g3
VSTD-Caldwell-1979
p11402
sg5
S'PMC1397199'
p11403
sg7
VCD002045 v. 9.1 Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients.rm5
p11404
sg9
V36048.xml
p11405
sa(dp11406
g3
VSTD-Cole-2002
p11407
sg5
S'PMC126506'
p11408
sg7
VCD006632 v. 5.0 Clinical pathways effects on professional practice patient outcomes length of stay and hospital c.rm5
p11409
sg9
V12389836.xml
p11410
sa(dp11411
g3
VSTD-Brattebo-2002
p11412
sg5
S'PMC1123333'
p11413
sg7
g11409
sg9
V12052813.xml
p11414
sa(dp11415
g3
VSTD-Brookfield-2009
p11416
sg5
S'PMC2612742'
p11417
sg7
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p11418
sg9
V19125205.xml
p11419
sa(dp11420
g3
VSTD-Stockton-2000
p11421
sg5
S'PMC2363169'
p11422
sg7
g11418
sg9
V10638991.xml
p11423
sa(dp11424
g3
VSTD-Carling-2010
p11425
sg5
S'PMC2830888'
p11426
sg7
VCD006777 v. 3.0 Framing of health information messages.rm5
p11427
sg9
V20209127.xml
p11428
sa(dp11429
g3
VSTD-Kroll-2005
p11430
sg5
S'PMC1207298'
p11431
sg7
g11427
sg9
V8722765.xml
p11432
sa(dp11433
g3
VSTD-Mann-2004
p11434
sg5
S'PMC2575807'
p11435
sg7
g11427
sg9
V15099176.xml
p11436
sa(dp11437
g3
VSTD-Lerman-1992
p11438
sg5
S'PMC1694134'
p11439
sg7
g11427
sg9
V1566953.xml
p11440
sa(dp11441
g3
VSTD-Steward-2002
p11442
sg5
S'PMC3482419'
p11443
sg7
g11427
sg9
V22282878.xml
p11444
sa(dp11445
g3
VSTD-Lewis-2003
p11446
sg5
S'PMC1494949'
p11447
sg7
g11427
sg9
V14687272.xml
p11448
sa(dp11449
g3
VSTD-Schlickau-2005a
p11450
sg5
S'PMC1595264'
p11451
sg7
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p11452
sg9
V17273450.xml
p11453
sa(dp11454
g3
VSTD-MacArthur-2009
p11455
sg5
S'PMC2636685'
p11456
sg7
g11452
sg9
V19181730.xml
p11457
sa(dp11458
g3
VSTD-Efstathopoulos-2007
p11459
sg5
S'PMC2267541'
p11460
sg7
VCD004961 v. 5.0 Intramedullary nails for extracapsular hip fractures in adults.rm5
p11461
sg9
V16736148.xml
p11462
sa(dp11463
g3
VSTD-Herrera-2002
p11464
sg5
S'PMC3620972'
p11465
sg7
g11461
sg9
V12466870.xml
p11466
sa(dp11467
g3
VSTD-Foley_x002d_Nolan-1997
p11468
sg5
S'PMC1721990'
p11469
sg7
VCD006460 v. 6.0 Conventional occlusion versus pharmacologic penalization for amblyopia.rm5
p11470
sg9
V9135409.xml
p11471
sa(dp11472
g3
VSTD-PEDIG-2002
p11473
sg5
S'PMC2614923'
p11474
sg7
g11470
sg9
V17502505.xml
p11475
sa(dp11476
g3
VSTD-Watt-1985-_x0028_LL_x0029_
p11477
sg5
S'PMC1418187'
p11478
sg7
VCD004937 v. 6.12 Effect of longer-term modest salt reduction on blood pressure.rm5
p11479
sg9
V3933736.xml
p11480
sa(dp11481
g3
VSTD-Erwteman-1984
p11482
sg5
S'PMC1442440'
p11483
sg7
g11479
sg9
V6432119.xml
p11484
sa(dp11485
g3
VSTD-Watt-1985-_x0028_HH_x0029_
p11486
sg5
S'PMC1418187'
p11487
sg7
g11479
sg9
V3933736.xml
p11488
sa(dp11489
g3
VSTD-Watt-1983
p11490
sg5
S'PMC1546779'
p11491
sg7
g11479
sg9
V6401551.xml
p11492
sa(dp11493
g3
VSTD-Schaad-2000
p11494
sg5
S'PMC89839'
p11495
sg7
VCD001753 v. 11.0 Vaccines for preventing influenza in people with cystic fibrosis.rm5
p11496
sg9
V10770746.xml
p11497
sa(dp11498
g3
VSTD-Girgis-1999-EGY
p11499
sg5
S'PMC89293'
p11500
sg7
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p11501
sg9
V10348767.xml
p11502
sa(dp11503
g3
VSTD-Vinh-1996-VNM
p11504
sg5
S'PMC163238'
p11505
sg7
g11501
sg9
V8849259.xml
p11506
sa(dp11507
g3
VSTD-Gasem-2003-IDN
p11508
sg5
S'PMC153327'
p11509
sg7
g11501
sg9
V12709347.xml
p11510
sa(dp11511
g3
VSTD-Arjyal-2011
p11512
sg5
S'PMC3108101'
p11513
sg7
g11501
sg9
V21531174.xml
p11514
sa(dp11515
g3
VSTD-Unal-1996-TUR
p11516
sg5
S'PMC163645'
p11517
sg7
g11501
sg9
V9124864.xml
p11518
sa(dp11519
g3
VSTD-Parry-2007-VNM
p11520
sg5
S'PMC1803150'
p11521
sg7
g11501
sg9
V17145784.xml
p11522
sa(dp11523
g3
VSTD-Pandit-2007-NPL
p11524
sg5
S'PMC1891439'
p11525
sg7
g11501
sg9
V17593957.xml
p11526
sa(dp11527
g3
VSTD-Chinh-2000-VNM
p11528
sg5
S'PMC89974'
p11529
sg7
g11501
sg9
V10858343.xml
p11530
sa(dp11531
g3
VSTD-Dolecek-2008-VNM
p11532
sg5
S'PMC2374894'
p11533
sg7
g11501
sg9
V18493312.xml
p11534
sa(dp11535
g3
VSTD-Smith-1994-VNM
p11536
sg5
S'PMC284627'
p11537
sg7
g11501
sg9
V7986000.xml
p11538
sa(dp11539
g3
VSTD-Nasrallah-2010
p11540
sg5
S'PMC3055301'
p11541
sg7
VCD008296 v. 3.2 Paliperidone palmitate for schizophrenia.rm5
p11542
sg9
V20555312.xml
p11543
sa(dp11544
g3
VSTD-McLeod-2001
p11545
sg5
S'PMC1421263'
p11546
sg7
VCD009447 v. 2.0 Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in p.rm5
p11547
sg9
V11224634.xml
p11548
sa(dp11549
g3
VSTD-Goodall-1981
p11550
sg5
S'PMC471453'
p11551
sg7
VCD001496 v. 4.0 Gastro-oesophageal reflux treatment for asthma in adults and children.rm5
p11552
sg9
V7022737.xml
p11553
sa(dp11554
g3
VSTD-Ekstrom-1989
p11555
sg5
S'PMC461658'
p11556
sg7
g11552
sg9
V2648642.xml
p11557
sa(dp11558
g3
VSTD-Ford-1994
p11559
sg5
S'PMC2397596'
p11560
sg7
g11552
sg9
V8016006.xml
p11561
sa(dp11562
g3
VSTD-Nagel-1988
p11563
sg5
S'PMC1835086'
p11564
sg7
g11552
sg9
V3146369.xml
p11565
sa(dp11566
g3
VSTD-McVey-2000
p11567
sg5
S'PMC1748378'
p11568
sg7
VCD004704 v. 8.0 Mass media interventions for smoking cessation in adults.rm5
p11569
sg9
V10982571.xml
p11570
sa(dp11571
g3
VSTD-Jenkins-1997
p11572
sg5
S'PMC1380945'
p11573
sg7
g11569
sg9
V9224191.xml
p11574
sa(dp11575
g3
VSTD-North-Coast-QFL-1983
p11576
sg5
S'PMC1549317'
p11577
sg7
g11569
sg9
V6414597.xml
p11578
sa(dp11579
g3
VSTD-Lima-2010
p11580
sg5
S'PMC2830290'
p11581
sg7
VCD008524 v. 4.0 Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 year.rm5
p11582
sg9
V20038852.xml
p11583
sa(dp11584
g3
VSTD-Daulaire-1992
p11585
sg5
S'PMC1881470'
p11586
sg7
g11582
sg9
V1739794.xml
p11587
sa(dp11588
g3
VSTD-Rahman-2001
p11589
sg5
S'PMC37318'
p11590
sg7
g11582
sg9
V11498488.xml
p11591
sa(dp11592
g3
VSTD-Pant-1996
p11593
sg5
S'PMC2486860'
p11594
sg7
g11582
sg9
V9002334.xml
p11595
sa(dp11596
g3
VSTD-Chang-1987
p11597
sg5
S'PMC1493315'
p11598
sg7
VCD007823 v. 3.0 Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable.rm5
p11599
sg9
V2961314.xml
p11600
sa(dp11601
g3
VSTD-Thunander-2010
p11602
sg5
S'PMC3022338'
p11603
sg7
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p11604
sg9
V21088056.xml
p11605
sa(dp11606
g3
VSTD-Roze-1993
p11607
sg5
S'PMC1029401'
p11608
sg7
VCD001242 v. 4.0 Dopamine versus dobutamine for hypotensive preterm infants.rm5
p11609
sg9
V8346957.xml
p11610
sa(dp11611
g3
VSTD-Manche-2011
p11612
sg5
S'PMC3259671'
p11613
sg7
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p11614
sg9
V22253488.xml
p11615
sa(dp11616
g3
VSTD-Hatch-2011
p11617
sg5
S'PMC3090298'
p11618
sg7
g11614
sg9
V21573091.xml
p11619
sa(dp11620
g3
VSTD-Minnis-2001
p11621
sg5
S'PMC1718714'
p11622
sg7
VCD003760 v. 8.3 Behavioural and cognitive behavioural training interventions for assisting foster carers in the mana.rm5
p11623
sg9
V11259226.xml
p11624
sa(dp11625
g3
VSTD-Eddleston-2009
p11626
sg5
S'PMC2696321'
p11627
sg7
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p11628
sg9
V19564902.xml
p11629
sa(dp11630
g3
VSTD-Woodcock-1984
p11631
sg5
S'PMC1444358'
p11632
sg7
VCD003833 v. 10.0 Omega-3 fatty acids for intermittent claudication.rm5
p11633
sg9
V6320945.xml
p11634
sa(dp11635
g3
VSTD-Gold-1990
p11636
sg5
S'PMC1358036'
p11637
sg7
VCD000991 v. 5.0 Intravenous fluids for abdominal aortic surgery.rm5
p11638
sg9
V1690974.xml
p11639
sa(dp11640
g3
VSTD-Ghosh-1994
p11641
sg5
S'PMC1375266'
p11642
sg7
VCD003043 v. 5.0 Ursodeoxycholic acid andor antibiotics for prevention of biliary stent occlusion.rm5
p11643
sg9
V7829015.xml
p11644
sa(dp11645
g3
VSTD-Cupples-1994
p11646
sg5
S'PMC2541257'
p11647
sg7
VCD008895 v. 2.2 Patient education in the management of coronary heart disease.rm5
p11648
sg9
V7950723.xml
p11649
sa(dp11650
g3
VSTD-Clark-2009
p11651
sg5
S'PMC3331992'
p11652
sg7
g11648
sg9
V18084052.xml
p11653
sa(dp11654
g3
VSTD-Muniyappa-2008
p11655
sg5
S'PMC2969165'
p11656
sg7
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p11657
sg9
V19064532.xml
p11658
sa(dp11659
g3
VSTD-Ried-2009
p11660
sg5
S'PMC2712451'
p11661
sg7
g11657
sg9
V19583878.xml
p11662
sa(dp11663
g3
VSTD-Al_x002d_Faris-2008
p11664
sg5
S'PMC3551122'
p11665
sg7
g11657
sg9
V23572796.xml
p11666
sa(dp11667
g3
VSTD-Fraga-2005
p11668
sg5
S'PMC2270716'
p11669
sg7
g11657
sg9
V15712594.xml
p11670
sa(dp11671
g3
VSTD-Friedlaender-2001
p11672
sg5
S'PMC1425155'
p11673
sg7
VCD006950 v. 3.0 Bone morphogenetic protein (BMP) for fracture healing in adults.rm5
p11674
sg9
V11314793.xml
p11675
sa(dp11676
g3
VSTD-Hutchings-2007a
p11677
sg5
S'PMC1839187'
p11678
sg7
VCD008225 v. 2.6 Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct probl.rm5
p11679
sg9
V17350966.xml
p11680
sa(dp11681
g3
VSTD-Edwards-2007
p11682
sg5
S'PMC1839236'
p11683
sg7
g11679
sg9
V17350965.xml
p11684
sa(dp11685
g3
VSTD-Scott-2001a
p11686
sg5
S'PMC35270'
p11687
sg7
g11679
sg9
V11473908.xml
p11688
sa(dp11689
g3
VSTD-Burke--2001
p11690
sg5
S'PMC3202064'
p11691
sg7
VCD006411 v. 7.2 Educational games for health professionals.rm5
p11692
sg9
V21959057.xml
p11693
sa(dp11694
g3
VSTD-Telner-2010
p11695
sg5
S'PMC2939136'
p11696
sg7
g11692
sg9
V20841574.xml
p11697
sa(dp11698
g3
VSTD-Dickey-2003
p11699
sg5
S'PMC270000'
p11700
sg7
VCD005354 v. 7.0 Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology.rm5
p11701
sg9
V14609434.xml
p11702
sa(dp11703
g3
VSTD-GESICA-2005-_x0028_DIAL_x0029_
p11704
sg5
S'PMC1188105'
p11705
sg7
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p11706
sg9
V16061499.xml
p11707
sa(dp11708
g3
VSTD-DeWalt-2006
p11709
sg5
S'PMC1475568'
p11710
sg7
g11706
sg9
V16533388.xml
p11711
sa(dp11712
g3
VSTD-Ytterstad-1996
p11713
sg5
S'PMC1060349'
p11714
sg7
VCD004441 v. 8.0 Population-based interventions for the prevention of fall-related injuries in older people.rm5
p11715
sg9
V8944864.xml
p11716
sa(dp11717
g3
VSTD-Malotte-1998
p11718
sg5
S'PMC1508952'
p11719
sg7
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p11720
sg9
V9585747.xml
p11721
sa(dp11722
g3
VSTD-Martins-2009
p11723
sg5
S'PMC2767482'
p11724
sg7
g11720
sg9
V19858174.xml
p11725
sa(dp11726
g3
VSTD-Morisky-2001
p11727
sg5
S'PMC1497389'
p11728
sg7
g11720
sg9
V12196616.xml
p11729
sa(dp11730
g3
VSTD-Bell-2005
p11731
sg5
S'PMC2866196'
p11732
sg7
VCD000512 v. 4.0 Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity a.rm5
p11733
sg9
V15930233.xml
p11734
sa(dp11735
g3
VSTD-Slesnick-2007_x002f_08
p11736
sg5
S'PMC2430633'
p11737
sg7
VCD009823 v. 3.0 Interventions for promoting reintegration and reducing harmful behaviour and lifestyles in street-co.rm5
p11738
sg9
V17940861.xml
p11739
sa(dp11740
g3
VSTD-Slesnick-2009-EBFT
p11741
sg5
S'PMC2697451'
p11742
sg7
g11738
sg9
V19522781.xml
p11743
sa(dp11744
g3
VSTD-Slesnick-2005
p11745
sg5
S'PMC1933523'
p11746
sg7
g11738
sg9
V15878048.xml
p11747
sa(dp11748
g3
VSTD-Milburn-2012
p11749
sg5
S'PMC3313467'
p11750
sg7
g11738
sg9
V22443839.xml
p11751
sa(dp11752
g3
VSTD-Tischler-2002
p11753
sg5
S'PMC1719131'
p11754
sg7
g11738
sg9
V11861229.xml
p11755
sa(dp11756
g3
VSTD-Slesnick-2009-FFT
p11757
sg5
S'PMC2697451'
p11758
sg7
g11738
sg9
V19522781.xml
p11759
sa(dp11760
g3
VSTD-Fearon-2003
p11761
sg5
S'PMC1773823'
p11762
sg7
VCD004597 v. 8.0 Eicosapentaenoic acid (EPA an omega-3 fatty acid from fish oils) for the treatment of cancer cachex.rm5
p11763
sg9
V12970142.xml
p11764
sa(dp11765
g3
VSTD-Poovorawan-1997
p11766
sg5
S'PMC1720659'
p11767
sg7
VCD004790 v. 4.0 Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.rm5
p11768
sg9
V9279183.xml
p11769
sa(dp11770
g3
VSTD-Cockayne-2011
p11771
sg5
S'PMC3109952'
p11772
sg7
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p11773
sg9
V21652750.xml
p11774
sa(dp11775
g3
VSTD-Fuchs-2004
p11776
sg5
S'PMC2703213'
p11777
sg7
g11773
sg9
V19675691.xml
p11778
sa(dp11779
g3
VSTD-Steele-1988a
p11780
sg5
S'PMC1711371'
p11781
sg7
g11773
sg9
V3255811.xml
p11782
sa(dp11783
g3
VSTD-Bruggink-2010
p11784
sg5
S'PMC2952009'
p11785
sg7
g11773
sg9
V20837684.xml
p11786
sa(dp11787
g3
VSTD-Meyer-1977
p11788
sg5
S'PMC1605575'
p11789
sg7
VCD005411 v. 3.2 Systemic interventions for recurrent aphthous stomatitis (mouth ulcers).rm5
p11790
sg9
V321087.xml
p11791
sa(dp11792
g3
VSTD-Kerigan-1977
p11793
sg5
S'PMC1879363'
p11794
sg7
VCD002738 v. 5.0 Beclomethasone versus placebo for chronic asthma.rm5
p11795
sg9
V851928.xml
p11796
sa(dp11797
g3
VSTD-Chan-1993
p11798
sg5
S'PMC1029424'
p11799
sg7
g11795
sg9
V8024293.xml
p11800
sa(dp11801
g3
VSTD-Cameron-1973
p11802
sg5
S'PMC1587268'
p11803
sg7
g11795
sg9
V4357135.xml
p11804
sa(dp11805
g3
VSTD-TXT-Group
p11806
sg5
S'PMC2408916'
p11807
sg7
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p11808
sg9
V12439707.xml
p11809
sa(dp11810
g3
VSTD-Talbot
p11811
sg5
S'PMC2375384'
p11812
sg7
g11808
sg9
V11986765.xml
p11813
sa(dp11814
g3
VSTD-McCaughey-1994
p11815
sg5
S'PMC1029971'
p11816
sg7
VCD004440 v. 3.0 Recombinant growth hormone for idiopathic short stature in children and adolescents.rm5
p11817
sg9
V7979491.xml
p11818
sa(dp11819
g3
VSTD-Kamp-2002
p11820
sg5
S'PMC1719235'
p11821
sg7
g11817
sg9
V12193430.xml
p11822
sa(dp11823
g3
VSTD-Gunerhan-2009
p11824
sg5
S'PMC2653369'
p11825
sg7
VCD008879 v. 2.0 Pre-operative Nutrition Support in Patients Undergoing Gastrointestinal Surgery..rm5
p11826
sg9
V19152452.xml
p11827
sa(dp11828
g3
VSTD-Mathews-1988
p11829
sg5
S'PMC2849101'
p11830
sg7
VCD002246 v. 6.0 Interventions for promoting smoke alarm ownership and function.rm5
p11831
sg9
V20141242.xml
p11832
sa(dp11833
g3
VSTD-Miller-1982
p11834
sg5
S'PMC1649895'
p11835
sg7
g11831
sg9
V7065320.xml
p11836
sa(dp11837
g3
VSTD-Clamp-1998
p11838
sg5
S'PMC28560'
p11839
sg7
g11831
sg9
V9596598.xml
p11840
sa(dp11841
g3
VSTD-Project-Burn-1979
p11842
sg5
S'PMC1649807'
p11843
sg7
g11831
sg9
V7058963.xml
p11844
sa(dp11845
g3
VSTD-Schwarz-1993
p11846
sg5
S'PMC1694716'
p11847
sg7
g11831
sg9
V8484447.xml
p11848
sa(dp11849
g3
VSTD-DiGuiseppi-2002
p11850
sg5
S'PMC131023'
p11851
sg7
g11831
sg9
V12411355.xml
p11852
sa(dp11853
g3
VSTD-Johnston-2000
p11854
sg5
S'PMC1730673'
p11855
sg7
g11831
sg9
V11144634.xml
p11856
sa(dp11857
g3
VSTD-Kendrick-1999
p11858
sg5
S'PMC27827'
p11859
sg7
g11831
sg9
V10195971.xml
p11860
sa(dp11861
g3
VSTD-Hendrickson-2000
p11862
sg5
S'PMC2699618'
p11863
sg7
g11831
sg9
V19005266.xml
p11864
sa(dp11865
g3
VSTD-Watson-2005
p11866
sg5
S'PMC544992'
p11867
sg7
g11831
sg9
V15604156.xml
p11868
sa(dp11869
g3
VSTD-Ozanne_x002d_Smith-2002
p11870
sg5
S'PMC1730817'
p11871
sg7
g11831
sg9
V11928967.xml
p11872
sa(dp11873
g3
VSTD-SCIPP-1989
p11874
sg5
S'PMC1349806'
p11875
sg7
g11831
sg9
V2817165.xml
p11876
sa(dp11877
g3
VSTD-Spaulding-1976
p11878
sg5
S'PMC1957107'
p11879
sg7
VCD004099 v. 4.0 Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabet.rm5
p11880
sg9
V1268789.xml
p11881
sa(dp11882
g3
VSTD-Skopnik-1992
p11883
sg5
S'PMC1590339'
p11884
sg7
VCD005091 v. 4.0 One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or prov.rm5
p11885
sg9
V1346956.xml
p11886
sa(dp11887
g3
VSTD-Hagan-2002
p11888
sg5
S'PMC3315829'
p11889
sg7
g11885
sg9
V20878961.xml
p11890
sa(dp11891
g3
VSTD-Lindbaek-1996a
p11892
sg5
S'PMC2351776'
p11893
sg7
VCD000243 v. 10.0 Antibiotics for acute maxillary sinusitis.rm5
p11894
sg9
V8760738.xml
p11895
sa(dp11896
g3
VSTD-Lindbaek-1996b
p11897
sg5
S'PMC2351776'
p11898
sg7
g11894
sg9
V8760738.xml
p11899
sa(dp11900
g3
VSTD-Henry-2003
p11901
sg5
S'PMC182642'
p11902
sg7
g11894
sg9
V12936972.xml
p11903
sa(dp11904
g3
VSTD-Gwaltney-1997
p11905
sg5
S'PMC163951'
p11906
sg7
g11894
sg9
V9210677.xml
p11907
sa(dp11908
g3
VSTD-Ferguson-1997
p11909
sg5
S'PMC1758547'
p11910
sg7
VCD001106 v. 7.0 Continuous positive airways pressure for obstructive sleep apnoea in adults.rm5
p11911
sg9
V9196520.xml
p11912
sa(dp11913
g3
VSTD-Engleman-1998
p11914
sg5
S'PMC1745223'
p11915
sg7
g11911
sg9
V9708223.xml
p11916
sa(dp11917
g3
VSTD-Marshall-2005
p11918
sg5
S'PMC1758913'
p11919
sg7
g11911
sg9
V15860720.xml
p11920
sa(dp11921
g3
VSTD-Engleman-1997
p11922
sg5
S'PMC1758499'
p11923
sg7
g11911
sg9
V9059469.xml
p11924
sa(dp11925
g3
VSTD-Sugawara-2006
p11926
sg5
S'PMC1856608'
p11927
sg7
VCD006933 v. 3.2 Methods of decreasing infection to improve outcomes after liver resections.rm5
p11928
sg9
V17060763.xml
p11929
sa(dp11930
g3
VSTD-Wiezer-2000
p11931
sg5
S'PMC1421132'
p11932
sg7
g11928
sg9
V10903599.xml
p11933
sa(dp11934
g3
VSTD-Davies-1997
p11935
sg5
S'PMC1758567'
p11936
sg7
VCD002312 v. 5.0 Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneu.rm5
p11937
sg9
V9176531.xml
p11938
sa(dp11939
g3
VSTD-Zuckerman-1997
p11940
sg5
S'PMC2125835'
p11941
sg7
VCD000100 v. 6.0 Vaccines for preventing hepatitis B in health-care workers.rm5
p11942
sg9
V9040320.xml
p11943
sa(dp11944
g3
VSTD-Powell-2001
p11945
sg5
S'PMC26565'
p11946
sg7
VCD003200 v. 7.0 Exercise therapy for chronic fatigue syndrome.rm5
p11947
sg9
V11179154.xml
p11948
sa(dp11949
g3
VSTD-Fulcher-1997
p11950
sg5
S'PMC2126868'
p11951
sg7
g11947
sg9
V9180065.xml
p11952
sa(dp11953
g3
VSTD-Dragone-2002
p11954
sg5
S'PMC3307387'
p11955
sg7
VCD002969 v. 6.0 Interventions for improving communication with children and adolescents about their cancer.rm5
p11956
sg9
V11932129.xml
p11957
sa(dp11958
g3
VSTD-Lindell-2008
p11959
sg5
S'PMC2649916'
p11960
sg7
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p11961
sg9
V19116007.xml
p11962
sa(dp11963
g3
VSTD-Litt-2009
p11964
sg5
S'PMC2735598'
p11965
sg7
g11961
sg9
V19553018.xml
p11966
sa(dp11967
g3
VSTD-Ersek-2008
p11968
sg5
S'PMC2536565'
p11969
sg7
g11961
sg9
V18086516.xml
p11970
sa(dp11971
g3
VSTD-Toouli-2000
p11972
sg5
S'PMC1727795'
p11973
sg7
VCD001509 v. 6.0 Sphincterotomy for biliary sphincter of Oddi dysfunction.rm5
p11974
sg9
V10601063.xml
p11975
sa(dp11976
g3
VSTD-Pathak-2003
p11977
sg5
S'PMC1721575'
p11978
sg7
VCD003665 v. 7.0 Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.rm5
p11979
sg9
V12819167.xml
p11980
sa(dp11981
g3
VSTD-Chiswick-1983
p11982
sg5
S'PMC1548339'
p11983
sg7
g11979
sg9
V6407714.xml
p11984
sa(dp11985
g3
VSTD-Kotwal-1998
p11986
sg5
S'PMC2362603'
p11987
sg7
VCD004843 v. 10.2 Music for pain relief.rm5
p11988
sg9
V18493472.xml
p11989
sa(dp11990
g3
VSTD-Angus-1996
p11991
sg5
S'PMC472663'
p11992
sg7
VCD000223 v. 7.0 Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.rm5
p11993
sg9
V8977608.xml
p11994
sa(dp11995
g3
VSTD-Founds-2006
p11996
sg5
S'PMC3628770'
p11997
sg7
VCD000051 v. 10.0 Cephalic version by postural management for breech presentation.rm5
p11998
sg9
V16814225.xml
p11999
sa(dp12000
g3
VSTD-Leve-2005
p12001
sg5
S'PMC1904478'
p12002
sg7
VCD005649 v. 3.3 Treatment Foster Care for improving outcomes in children and young people.rm5
p12003
sg9
V16392991.xml
p12004
sa(dp12005
g3
VSTD-Hermiz-2002
p12006
sg5
S'PMC130059'
p12007
sg7
VCD005623 v. 7.0 Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-maligna.rm5
p12008
sg9
V12399344.xml
p12009
sa(dp12010
g3
VSTD-Neder-2002
p12011
sg5
S'PMC1746295'
p12012
sg7
g12008
sg9
V11923552.xml
p12013
sa(dp12014
g3
VSTD-Bourjeily_x002d_Habr-2002
p12015
sg5
S'PMC1758803'
p12016
sg7
g12008
sg9
V12454299.xml
p12017
sa(dp12018
g3
VSTD-Bredin-1999
p12019
sg5
S'PMC27809'
p12020
sg7
g12008
sg9
V10102851.xml
p12021
sa(dp12022
g3
VSTD-Vickers-2005
p12023
sg5
S'PMC1208905'
p12024
sg7
g12008
sg9
V16109163.xml
p12025
sa(dp12026
g3
VSTD-Moore-2002
p12027
sg5
S'PMC133453'
p12028
sg7
g12008
sg9
V12433764.xml
p12029
sa(dp12030
g3
VSTD-MRC
p12031
sg5
S'PMC1416260'
p12032
sg7
VCD006742 v. 5.0 Pharmacotherapy for mild hypertension.rm5
p12033
sg9
V2861880.xml
p12034
sa(dp12035
g3
VSTD-Hutchings-2007
p12036
sg5
S'PMC1839187'
p12037
sg7
VCD003680 v. 13.6 Group-based parent-training programmes for improving emotional and behavioural adjustment in childre.rm5
p12038
sg9
V17350966.xml
p12039
sa(dp12040
g3
VSTD-Rennard-2009
p12041
sg5
S'PMC3580134'
p12042
sg7
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p12043
sg9
V19368417.xml
p12044
sa(dp12045
g3
VSTD-Van-Hees-1981
p12046
sg5
S'PMC1419240'
p12047
sg7
VCD008870 v. 2.0 Aminosalicylates for induction of remission or response in Crohn's disease.rm5
p12048
sg9
V6114023.xml
p12049
sa(dp12050
g3
VSTD-Grootendorst-2002
p12051
sg5
S'PMC1361214'
p12052
sg7
VCD005979 v. 5.0 Pharmaceutical policies effects of reference pricing other pricing and purchasing policies.rm5
p12053
sg9
V16174135.xml
p12054
sa(dp12055
g3
VSTD-Narine-2001
p12056
sg5
S'PMC1230507'
p12057
sg7
g12053
sg9
V10463052.xml
p12058
sa(dp12059
g3
VSTD-Marshall-2002
p12060
sg5
S'PMC116151'
p12061
sg7
g12053
sg9
V12126319.xml
p12062
sa(dp12063
g3
VSTD-Schneeweiss-2002
p12064
sg5
S'PMC99452'
p12065
sg7
g12053
sg9
V11944760.xml
p12066
sa(dp12067
g3
VSTD-White-2005
p12068
sg5
S'PMC1153728'
p12069
sg7
VCD007394 v. 2.0 Galactomannan detection for invasive aspergillosis in immunocompromized patients.rm5
p12070
sg9
V15872239.xml
p12071
sa(dp12072
g3
VSTD-Pazos-2005
p12073
sg5
S'PMC540165'
p12074
sg7
g12070
sg9
V15634986.xml
p12075
sa(dp12076
g3
VSTD-Challier-2004
p12077
sg5
S'PMC344496'
p12078
sg7
g12070
sg9
V14766869.xml
p12079
sa(dp12080
g3
VSTD-Kawazu-2004
p12081
sg5
S'PMC427860'
p12082
sg7
g12070
sg9
V15184460.xml
p12083
sa(dp12084
g3
VSTD-Pinel-2003
p12085
sg5
S'PMC154675'
p12086
sg7
g12070
sg9
V12734275.xml
p12087
sa(dp12088
g3
VSTD-Verweij-1995
p12089
sg5
S'PMC228662'
p12090
sg7
g12070
sg9
V8586691.xml
p12091
sa(dp12092
g3
VSTD-Williamson-2000
p12093
sg5
S'PMC1731188'
p12094
sg7
g12070
sg9
V10889818.xml
p12095
sa(dp12096
g3
VSTD-Wilson-1980
p12097
sg5
S'PMC471402'
p12098
sg7
VCD001495 v. 7.0 Short-acting beta2-agonists for stable chronic obstructive pulmonary disease.rm5
p12099
sg9
V7013150.xml
p12100
sa(dp12101
g3
VSTD-Tandon-1990
p12102
sg5
S'PMC463088'
p12103
sg7
g12099
sg9
V2038732.xml
p12104
sa(dp12105
g3
VSTD-Jaeschke-1991
p12106
sg5
S'PMC1452523'
p12107
sg7
g12099
sg9
V1984814.xml
p12108
sa(dp12109
g3
VSTD-Carbajal-2003
p12110
sg5
S'PMC139493'
p12111
sg7
VCD004950 v. 5.0 Breastfeeding or breast milk for procedural pain in neonates.rm5
p12112
sg9
V12511452.xml
p12113
sa(dp12114
g3
VSTD-Towle-1989
p12115
sg5
S'PMC1032308'
p12116
sg7
VCD003437 v. 4.2 Interventions for treating depression after stroke.rm5
p12117
sg9
V2738596.xml
p12118
sa(dp12119
g3
VSTD-Aranda-2006
p12120
sg5
S'PMC2360523'
p12121
sg7
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p12122
sg9
V16967054.xml
p12123
sa(dp12124
g3
VSTD-Low-2010
p12125
sg5
S'PMC3128513'
p12126
sg7
g12122
sg9
V20658835.xml
p12127
sa(dp12128
g3
VSTD-Bayne_x002d_Smith-2004
p12129
sg5
S'PMC1448490'
p12130
sg7
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p12131
sg9
V15333311.xml
p12132
sa(dp12133
g3
VSTD-Dorgo-2009
p12134
sg5
S'PMC2907740'
p12135
sg7
g12131
sg9
V19826296.xml
p12136
sa(dp12137
g3
VSTD-Wilson-2011
p12138
sg5
S'PMC3417297'
p12139
sg7
g12131
sg9
V21534677.xml
p12140
sa(dp12141
g3
VSTD-Jones-2008
p12142
sg5
S'PMC2556688'
p12143
sg7
g12131
sg9
V18718012.xml
p12144
sa(dp12145
g3
VSTD-Kriemler-2010
p12146
sg5
S'PMC2827713'
p12147
sg7
g12131
sg9
V20179126.xml
p12148
sa(dp12149
g3
VSTD-Gentile-2009
p12150
sg5
S'PMC2758893'
p12151
sg7
g12131
sg9
V19765270.xml
p12152
sa(dp12153
g3
VSTD-Neumark_x002d_Sztainer-2009
p12154
sg5
S'PMC2682640'
p12155
sg7
g12131
sg9
V18622011.xml
p12156
sa(dp12157
g3
VSTD-Donnelly-2009
p12158
sg5
S'PMC2766439'
p12159
sg7
g12131
sg9
V19665037.xml
p12160
sa(dp12161
g3
VSTD-Ewart-1998
p12162
sg5
S'PMC1508242'
p12163
sg7
g12131
sg9
V9618627.xml
p12164
sa(dp12165
g3
VSTD-Neumark_x002d_Sztainer-2010
p12166
sg5
S'PMC2978965'
p12167
sg7
g12131
sg9
V20965379.xml
p12168
sa(dp12169
g3
VSTD-Webber-2008
p12170
sg5
S'PMC2275165'
p12171
sg7
g12131
sg9
V18312804.xml
p12172
sa(dp12173
g3
VSTD-Trevino-2004
p12174
sg5
S'PMC1364479'
p12175
sg7
g12131
sg9
V15351759.xml
p12176
sa(dp12177
g3
VSTD-Lepcha-2002
p12178
sg5
S'PMC3450470'
p12179
sg7
VCD006286 v. 4.2 Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoida.rm5
p12180
sg9
V23119911.xml
p12181
sa(dp12182
g3
VSTD-Woodcock-1981
p12183
sg5
S'PMC1506180'
p12184
sg7
VCD007354 v. 7.0 Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in.rm5
p12185
sg9
V6788319.xml
p12186
sa(dp12187
g3
VSTD-Poikolainen-2008
p12188
sg5
S'PMC2265283'
p12189
sg7
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p12190
sg9
V18218147.xml
p12191
sa(dp12192
g3
VSTD-Steiner-2003
p12193
sg5
S'PMC1746806'
p12194
sg7
VCD000998 v. 11.0 Nutritional supplementation for stable chronic obstructive pulmonary disease.rm5
p12195
sg9
V12947128.xml
p12196
sa(dp12197
g3
VSTD-GLANCE-2009
p12198
sg5
S'PMC2821836'
p12199
sg7
VCD007621 v. 5.0 Natalizumab for relapsing remitting multiple sclerosis.rm5
p12200
sg9
V19255407.xml
p12201
sa(dp12202
g3
VSTD-Tucker-1984
p12203
sg5
S'PMC1443331'
p12204
sg7
VCD001730 v. 5.0 Medical day hospital care for the elderly versus alternative forms of care.rm5
p12205
sg9
V6437487.xml
p12206
sa(dp12207
g3
VSTD-Eagle-1991
p12208
sg5
S'PMC1453052'
p12209
sg7
g12205
sg9
V1998929.xml
p12210
sa(dp12211
g3
VSTD-Hogan-2001
p12212
sg5
S'PMC81411'
p12213
sg7
VCD003600 v. 10.6 Modification of the home environment for the reduction of injuries.rm5
p12214
sg9
V11563205.xml
p12215
sa(dp12216
g3
VSTD-Shaw-2003
p12217
sg5
S'PMC139930'
p12218
sg7
g12214
sg9
V12521968.xml
p12219
sa(dp12220
g3
VSTD-Campbell-2005
p12221
sg5
S'PMC1246082'
p12222
sg7
g12214
sg9
V16183652.xml
p12223
sa(dp12224
g3
VSTD-Clamp-1998
p12225
sg5
S'PMC28560'
p12226
sg7
g12214
sg9
V9596598.xml
p12227
sa(dp12228
g3
VSTD-Day-2002
p12229
sg5
S'PMC117228'
p12230
sg7
g12214
sg9
V12130606.xml
p12231
sa(dp12232
g3
VSTD-Kendrick-1999
p12233
sg5
S'PMC27827'
p12234
sg7
g12214
sg9
V10195971.xml
p12235
sa(dp12236
g3
VSTD-King-2005
p12237
sg5
S'PMC1730192'
p12238
sg7
g12214
sg9
V15805440.xml
p12239
sa(dp12240
g3
VSTD-Hendrickson-2005
p12241
sg5
S'PMC1730268'
p12242
sg7
g12214
sg9
V16203842.xml
p12243
sa(dp12244
g3
VSTD-Watson-2005
p12245
sg5
S'PMC544992'
p12246
sg7
g12214
sg9
V15604156.xml
p12247
sa(dp12248
g3
VSTD-Vetter-1992
p12249
sg5
S'PMC1882829'
p12250
sg7
g12214
sg9
V1392755.xml
p12251
sa(dp12252
g3
VSTD-Van-Haastregt-2000b
p12253
sg5
S'PMC27508'
p12254
sg7
g12214
sg9
V11039967.xml
p12255
sa(dp12256
g3
VSTD-Davies-2002
p12257
sg5
S'PMC121963'
p12258
sg7
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p12259
sg9
V12240812.xml
p12260
sa(dp12261
g3
VSTD-Schouten-2007
p12262
sg5
S'PMC2653154'
p12263
sg7
g12259
sg9
V17403764.xml
p12264
sa(dp12265
g3
VSTD-Fretheim-2006
p12266
sg5
S'PMC1472695'
p12267
sg7
g12259
sg9
V16737346.xml
p12268
sa(dp12269
g3
VSTD-Baker-2001
p12270
sg5
S'PMC1314102'
p12271
sg7
g12259
sg9
V11593835.xml
p12272
sa(dp12273
g3
VSTD-Flottorp-2002
p12274
sg5
S'PMC117890'
p12275
sg7
g12259
sg9
V12183309.xml
p12276
sa(dp12277
g3
VSTD-Hux-1999
p12278
sg5
S'PMC1230539'
p12279
sg7
g12259
sg9
V10478162.xml
p12280
sa(dp12281
g3
VSTD-Langham-2002
p12282
sg5
S'PMC1316085'
p12283
sg7
g12259
sg9
V12392122.xml
p12284
sa(dp12285
g3
VSTD-Kamps-2003
p12286
sg5
S'PMC1746504'
p12287
sg7
VCD009296 v. 2.3 Nurse versus physician-led care for the management of asthma.rm5
p12288
sg9
V14586050.xml
p12289
sa(dp12290
g3
VSTD-Klerman-2001
p12291
sg5
S'PMC1446489'
p12292
sg7
VCD002869 v. 6.0 Individual or group antenatal education for childbirth or parenthood or both.rm5
p12293
sg9
V11189800.xml
p12294
sa(dp12295
g3
VSTD-Shepperd-1998
p12296
sg5
S'PMC28578'
p12297
sg7
VCD000356 v. 8.0 Hospital at home early discharge.rm5
p12298
sg9
V9624068.xml
p12299
sa(dp12300
g3
VSTD-Ojoo-2002
p12301
sg5
S'PMC1746235'
p12302
sg7
g12298
sg9
V11828049.xml
p12303
sa(dp12304
g3
VSTD-Cotton-2002
p12305
sg5
S'PMC1745631'
p12306
sg7
g12298
sg9
V11050257.xml
p12307
sa(dp12308
g3
VSTD-Skwarska-2000
p12309
sg5
S'PMC1745644'
p12310
sg7
g12298
sg9
V11050258.xml
p12311
sa(dp12312
g3
VSTD-Adler-1978
p12313
sg5
S'PMC1060932'
p12314
sg7
g12298
sg9
V98548.xml
p12315
sa(dp12316
g3
VSTD-Richards-1998
p12317
sg5
S'PMC28581'
p12318
sg7
g12298
sg9
V9624074.xml
p12319
sa(dp12320
g3
VSTD-Booth-2004
p12321
sg5
S'PMC1768555'
p12322
sg7
g12298
sg9
V15486143.xml
p12323
sa(dp12324
g3
VSTD-Rudd-1997
p12325
sg5
S'PMC2127677'
p12326
sg7
g12298
sg9
V9366727.xml
p12327
sa(dp12328
g3
VSTD-Pop_x002d_Eleches-2011
p12329
sg5
S'PMC3718389'
p12330
sg7
VCD009756 v. 2.0 Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV i.rm5
p12331
sg9
V21252632.xml
p12332
sa(dp12333
g3
VSTD-Cameron-2001
p12334
sg5
S'PMC2363881'
p12335
sg7
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p12336
sg9
V11379605.xml
p12337
sa(dp12338
g3
VSTD-Hawking-1967
p12339
sg5
S'PMC2554262'
p12340
sg7
VCD003758 v. 5.0 Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis.rm5
p12341
sg9
V5301383.xml
p12342
sa(dp12343
g3
VSTD-Davis-1969
p12344
sg5
S'PMC2427415'
p12345
sg7
g12341
sg9
V5308697.xml
p12346
sa(dp12347
g3
VSTD-Rapaport-2006
p12348
sg5
S'PMC2788739'
p12349
sg7
VCD008121 v. 3.0 Second-generation antipsychotics for major depressive disorder and dysthymia.rm5
p12350
sg9
V17928573.xml
p12351
sa(dp12352
g3
VSTD-Keitner-2009
p12353
sg5
S'PMC3685867'
p12354
sg7
g12350
sg9
V18586273.xml
p12355
sa(dp12356
g3
VSTD-Elavsky-2009
p12357
sg5
S'PMC2728615'
p12358
sg7
VCD006108 v. 9.0 Exercise for vasomotor menopausal symptoms.rm5
p12359
sg9
V19169167.xml
p12360
sa(dp12361
g3
VSTD-Keiser-2005
p12362
sg5
S'PMC548524'
p12363
sg7
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p12364
sg9
V15647105.xml
p12365
sa(dp12366
g3
VSTD-Nilasena-1995
p12367
sg5
S'PMC2579172'
p12368
sg7
VCD001481 v. 5.0 Interventions to improve the management of diabetes mellitus in primary care outpatient and communi.rm5
p12369
sg9
V8563365.xml
p12370
sa(dp12371
g3
VSTD-Hurwitz-1993
p12372
sg5
S'PMC1676949'
p12373
sg7
g12369
sg9
V8461815.xml
p12374
sa(dp12375
g3
VSTD-Naji-1994
p12376
sg5
S'PMC2540045'
p12377
sg7
g12369
sg9
V8180540.xml
p12378
sa(dp12379
g3
VSTD-Kinmonth-1998
p12380
sg5
S'PMC28704'
p12381
sg7
g12369
sg9
V9794859.xml
p12382
sa(dp12383
g3
VSTD-Feder-1995
p12384
sg5
S'PMC2543702'
p12385
sg7
g12369
sg9
V8520339.xml
p12386
sa(dp12387
g3
VSTD-Chow-2000
p12388
sg5
S'PMC95987'
p12389
sg7
VCD005360 v. 8.0 Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.rm5
p12390
sg9
V11063500.xml
p12391
sa(dp12392
g3
VSTD-Wang-2010
p12393
sg5
S'PMC3719192'
p12394
sg7
VCD005096 v. 8.2 Chinese herbal medicines for induction of remission in advanced or late gastric cancer.rm5
p12395
sg9
V23882420.xml
p12396
sa(dp12397
g3
VSTD-Xie-2006
p12398
sg5
S'PMC3747414'
p12399
sg7
g12395
sg9
V23983775.xml
p12400
sa(dp12401
g3
VSTD-Foley-2003
p12402
sg5
S'PMC1754378'
p12403
sg7
VCD007912 v. 1.2 Exercise for osteoarthritis of the hip.rm5
p12404
sg9
V14644853.xml
p12405
sa(dp12406
g3
VSTD-Veldt-2003
p12407
sg5
S'PMC222984'
p12408
sg7
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p12409
sg9
V12948399.xml
p12410
sa(dp12411
g3
VSTD-Khakoo-1998
p12412
sg5
S'PMC1873804'
p12413
sg7
g12409
sg9
V9862245.xml
p12414
sa(dp12415
g3
VSTD-Ramhamdany-1989
p12416
sg5
S'PMC1434178'
p12417
sg7
VCD004931 v. 5.0 Intragastric balloon for obesity.rm5
p12418
sg9
V2767500.xml
p12419
sa(dp12420
g3
VSTD-Win-MYA-89_x002d_91
p12421
sg5
S'PMC2393408'
p12422
sg7
VCD000527 v. 10.0 Artemisinin derivatives for treating severe malaria.rm5
p12423
sg9
V1486675.xml
p12424
sa(dp12425
g3
VSTD-McClure-1994
p12426
sg5
S'PMC1029715'
p12427
sg7
VCD003235 v. 7.0 Emergency interventions for hyperkalaemia.rm5
p12428
sg9
V8129434.xml
p12429
sa(dp12430
g3
VSTD-Hawkins-2009
p12431
sg5
S'PMC2740999'
p12432
sg7
VCD001291 v. 9.0 Community interventions for preventing smoking in young people.rm5
p12433
sg9
V19736331.xml
p12434
sa(dp12435
g3
VSTD-Biglan-2000
p12436
sg5
S'PMC1748303'
p12437
sg7
g12433
sg9
V10691755.xml
p12438
sa(dp12439
g3
VSTD-Perry-2008
p12440
sg5
S'PMC2667859'
p12441
sg7
g12433
sg9
V19299670.xml
p12442
sa(dp12443
g3
VSTD-Tang-1997
p12444
sg5
S'PMC1759627'
p12445
sg7
g12433
sg9
V9706752.xml
p12446
sa(dp12447
g3
VSTD-Vartiainen-1998
p12448
sg5
S'PMC1508381'
p12449
sg7
g12433
sg9
V9584038.xml
p12450
sa(dp12451
g3
VSTD-Klein-2009
p12452
sg5
S'PMC2741406'
p12453
sg7
g12433
sg9
V19103639.xml
p12454
sa(dp12455
g3
VSTD-Walkup-2008
p12456
sg5
S'PMC2702984'
p12457
sg7
VCD005170 v. 7.2 Pharmacotherapy for anxiety disorders in children and adolescents.rm5
p12458
sg9
V18974308.xml
p12459
sa(dp12460
g3
VSTD-Williams-1962
p12461
sg5
S'PMC1849381'
p12462
sg7
VCD000987 v. 4.0 Vitamin E for intermittent claudication.rm5
p12463
sg9
V14007174.xml
p12464
sa(dp12465
g3
VSTD-Bo-2007
p12466
sg5
S'PMC2219825'
p12467
sg7
VCD003054 v. 5.3 Exercise or exercise and diet for preventing type 2 diabetes mellitus.rm5
p12468
sg9
V17922167.xml
p12469
sa(dp12470
g3
VSTD-DPP-2002
p12471
sg5
S'PMC1370926'
p12472
sg7
g12468
sg9
V11832527.xml
p12473
sa(dp12474
g3
VSTD-Beenen-1999
p12475
sg5
S'PMC1736591'
p12476
sg7
VCD007286 v. 3.0 Antiepileptic drugs as prophylaxis for post-craniotomy seizures.rm5
p12477
sg9
V10486394.xml
p12478
sa(dp12479
g3
VSTD-Foy-1992
p12480
sg5
S'PMC1015096'
p12481
sg7
g12477
sg9
V1402964.xml
p12482
sa(dp12483
g3
VSTD-Calderon-2008
p12484
sg5
S'PMC2242423'
p12485
sg7
VCD009414 v. 2.1 Interventions for preventing or reducing domestic violence against pregnant women.rm5
p12486
sg9
V18201643.xml
p12487
sa(dp12488
g3
VSTD-Zlotnick-2011
p12489
sg5
S'PMC3042850'
p12490
sg7
g12486
sg9
V21153559.xml
p12491
sa(dp12492
g3
VSTD-Cripe-2010
p12493
sg5
S'PMC3741342'
p12494
sg7
g12486
sg9
V20145196.xml
p12495
sa(dp12496
g3
VSTD-Kiely-2010
p12497
sg5
S'PMC2917915'
p12498
sg7
g12486
sg9
V20093899.xml
p12499
sa(dp12500
g3
VSTD-O_x0027_Sullivan-2009
p12501
sg5
S'PMC2660391'
p12502
sg7
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p12503
sg9
V19318702.xml
p12504
sa(dp12505
g3
VSTD-Netherlands-1989
p12506
sg5
S'PMC3398037'
p12507
sg7
VCD004659 v. 5.0 Antiplatelet agents for preventing pre-eclampsia and its complications.rm5
p12508
sg9
V22815699.xml
p12509
sa(dp12510
g3
VSTD-Bouchard-2008
p12511
sg5
S'PMC2592568'
p12512
sg7
VCD003602 v. 6.0 Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.rm5
p12513
sg9
V19057729.xml
p12514
sa(dp12515
g3
VSTD-Hopper-1984
p12516
sg5
S'PMC1651641'
p12517
sg7
VCD003638 v. 4.0 Interventions for improving adherence to treatment recommendations in people with type 2 diabetes me.rm5
p12518
sg9
V6721016.xml
p12519
sa(dp12520
g3
VSTD-Admani-1978
p12521
sg5
S'PMC1608980'
p12522
sg7
VCD005478 v. 3.0 Naftidrofuryl for acute stroke.rm5
p12523
sg9
V367511.xml
p12524
sa(dp12525
g3
VSTD-Tisdall-1951
p12526
sg5
S'PMC1821925'
p12527
sg7
VCD004676 v. 8.0 School feeding for improving the physical and psychosocial health of disadvantaged students.rm5
p12528
sg9
V14839578.xml
p12529
sa(dp12530
g3
VSTD-Baker-1980-_x0028_-boys_x0029_
p12531
sg5
S'PMC1052036'
p12532
sg7
g12528
sg9
V6892711.xml
p12533
sa(dp12534
g3
VSTD-Baker-total-1980
p12535
sg5
S'PMC1052036'
p12536
sg7
g12528
sg9
V6892711.xml
p12537
sa(dp12538
g3
VSTD-Baker-girls-1980
p12539
sg5
S'PMC1052036'
p12540
sg7
g12528
sg9
V6892711.xml
p12541
sa(dp12542
g3
VSTD-Bonnar-1996
p12543
sg5
S'PMC2352023'
p12544
sg7
VCD000249 v. 7.2 Antifibrinolytics for heavy menstrual bleeding.rm5
p12545
sg9
V8806245.xml
p12546
sa(dp12547
g3
VSTD-Callender-1970
p12548
sg5
S'PMC1819762'
p12549
sg7
g12545
sg9
V4919554.xml
p12550
sa(dp12551
g3
VSTD-von-Brevern-2006
p12552
sg5
S'PMC2077628'
p12553
sg7
VCD003162 v. 8.0 The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo.rm5
p12554
sg9
V16549410.xml
p12555
sa(dp12556
g3
VSTD-Sinclair-1997
p12557
sg5
S'PMC2127619'
p12558
sg7
VCD003004 v. 7.0 Perioperative fluid volume optimization following proximal femoral fracture.rm5
p12559
sg9
V9361539.xml
p12560
sa(dp12561
g3
VSTD-Van-Vugt-1998a
p12562
sg5
S'PMC105468'
p12563
sg7
VCD005965 v. 3.0 Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria.rm5
p12564
sg9
V9449273.xml
p12565
sa(dp12566
g3
VSTD-Beattie-2000
p12567
sg5
S'PMC1756438'
p12568
sg7
VCD002008 v. 10.0 Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adul.rm5
p12569
sg9
V10807893.xml
p12570
sa(dp12571
g3
VSTD-Chandra-1985
p12572
sg5
S'PMC1416637'
p12573
sg7
g12569
sg9
V3929906.xml
p12574
sa(dp12575
g3
VSTD-Carson-2011
p12576
sg5
S'PMC3268062'
p12577
sg7
VCD002042 v. 8.0 Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.rm5
p12578
sg9
V22168590.xml
p12579
sa(dp12580
g3
VSTD-Bao--2008
p12581
sg5
S'PMC2551567'
p12582
sg7
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p12583
sg9
V18596121.xml
p12584
sa(dp12585
g3
VSTD-Clark-1981
p12586
sg5
S'PMC1862250'
p12587
sg7
g12583
sg9
V7272867.xml
p12588
sa(dp12589
g3
VSTD-MAINTAIN-Nephritis-Study
p12590
sg5
S'PMC3002764'
p12591
sg7
g12583
sg9
V20833738.xml
p12592
sa(dp12593
g3
VSTD-Yee-2004
p12594
sg5
S'PMC1755006'
p12595
sg7
g12583
sg9
V15082482.xml
p12596
sa(dp12597
g3
VSTD-Appel-2009
p12598
sg5
S'PMC2678035'
p12599
sg7
g12583
sg9
V19369404.xml
p12600
sa(dp12601
g3
VSTD-Bonduelle-1991
p12602
sg5
S'PMC2399106'
p12603
sg7
VCD001017 v. 5.2 Danazol for heavy menstrual bleeding.rm5
p12604
sg9
V1835005.xml
p12605
sa(dp12606
g3
VSTD-Wallon-2006
p12607
sg5
S'PMC3761389'
p12608
sg7
VCD006171 v. 3.1 Prenatal education for congenital toxoplasmosis.rm5
p12609
sg9
V23725556.xml
p12610
sa(dp12611
g3
VSTD-Carter-1989
p12612
sg5
S'PMC2249529'
p12613
sg7
g12609
sg9
V2606162.xml
p12614
sa(dp12615
g3
VSTD-Zar-2007
p12616
sg5
S'PMC1779846'
p12617
sg7
VCD006418 v. 3.0 Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.rm5
p12618
sg9
V17085459.xml
p12619
sa(dp12620
g3
VSTD-Shapiro-1991
p12621
sg5
S'PMC3035844'
p12622
sg7
VCD003961 v. 9.0 Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.rm5
p12623
sg9
V1721361.xml
p12624
sa(dp12625
g3
VSTD-Bourgeois-2010
p12626
sg5
S'PMC3374868'
p12627
sg7
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p12628
sg9
V20679560.xml
p12629
sa(dp12630
g3
VSTD-Charles-2009
p12631
sg5
S'PMC2680945'
p12632
sg7
g12628
sg9
V19435763.xml
p12633
sa(dp12634
g3
VSTD-Soares-2004
p12635
sg5
S'PMC313900'
p12636
sg7
g12628
sg9
V14703540.xml
p12637
sa(dp12638
g3
VSTD-Chan-2004b
p12639
sg5
S'PMC517858'
p12640
sg7
g12628
sg9
V15451835.xml
p12641
sa(dp12642
g3
VSTD-Ewart-2009
p12643
sg5
S'PMC2775624'
p12644
sg7
g12628
sg9
V19901314.xml
p12645
sa(dp12646
g3
VSTD-Thomson-1979
p12647
sg5
S'PMC2383381'
p12648
sg7
VCD003519 v. 6.0 Early skin-to-skin contact for mothers and their healthy newborn infants.rm5
p12649
sg9
V21297814.xml
p12650
sa(dp12651
g3
VSTD-Morris-1992
p12652
sg5
S'PMC1029623'
p12653
sg7
VCD003967 v. 11.0 Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.rm5
p12654
sg9
V8257180.xml
p12655
sa(dp12656
g3
VSTD-Amir-1997b
p12657
sg5
S'PMC2126953'
p12658
sg7
VCD006700 v. 2.0 Acyclovir for treating primary herpetic gingivostomatitis.rm5
p12659
sg9
V9224082.xml
p12660
sa(dp12661
g3
VSTD-Neuhaus-2009
p12662
sg5
S'PMC2634726'
p12663
sg7
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p12664
sg9
V19127261.xml
p12665
sa(dp12666
g3
VSTD-Johnston-1993
p12667
sg5
S'PMC1677411'
p12668
sg7
VCD004935 v. 9.0 Relaxation therapies for the management of primary hypertension in adults.rm5
p12669
sg9
V8490471.xml
p12670
sa(dp12671
g3
VSTD-Blanchard-1979
p12672
sg5
S'PMC1311352'
p12673
sg7
g12669
sg9
V468751.xml
p12674
sa(dp12675
g3
VSTD-van-Montfrans-1990
p12676
sg5
S'PMC1662994'
p12677
sg7
g12669
sg9
V2196946.xml
p12678
sa(dp12679
g3
VSTD-Patel-1988
p12680
sg5
S'PMC2544650'
p12681
sg7
g12669
sg9
V3122919.xml
p12682
sa(dp12683
g3
VSTD-Candy-1995
p12684
sg5
S'PMC1382873'
p12685
sg7
VCD000545 v. 10.6 Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.rm5
p12686
sg9
V8549944.xml
p12687
sa(dp12688
g3
VSTD-Jones-2006
p12689
sg5
S'PMC1856426'
p12690
sg7
VCD004101 v. 7.11 Psychological interventions for symptomatic management of non-specific chest pain in patients with n.rm5
p12691
sg9
V16627548.xml
p12692
sa(dp12693
g3
VSTD-MAM-01-GOCSI
p12694
sg5
S'PMC2362097'
p12695
sg7
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p12696
sg9
V15668708.xml
p12697
sa(dp12698
g3
VSTD-Guinea_x002d_Bissau-2005
p12699
sg5
S'PMC1239973'
p12700
sg7
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p12701
sg9
V16195287.xml
p12702
sa(dp12703
g3
VSTD-Pakistan-2011
p12704
sg5
S'PMC3041931'
p12705
sg7
g12701
sg9
V21176086.xml
p12706
sa(dp12707
g3
VSTD-Tibet-2009
p12708
sg5
S'PMC2791828'
p12709
sg7
g12701
sg9
V19249659.xml
p12710
sa(dp12711
g3
VSTD-Challenor-1991
p12712
sg5
S'PMC1368337'
p12713
sg7
VCD006687 v. 4.0 Oral vasodilators for primary Raynaud's phenomenon.rm5
p12714
sg9
V2049258.xml
p12715
sa(dp12716
g3
VSTD-Peuskens-2007
p12717
sg5
S'PMC2860517'
p12718
sg7
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p12719
sg9
V20428302.xml
p12720
sa(dp12721
g3
VSTD-Chen-2010
p12722
sg5
S'PMC2924475'
p12723
sg7
g12719
sg9
V20724402.xml
p12724
sa(dp12725
g3
VSTD-Channabasavanna-1987
p12726
sg5
S'PMC3172444'
p12727
sg7
g12719
sg9
V21927264.xml
p12728
sa(dp12729
g3
VSTD-Leff-1971
p12730
sg5
S'PMC1798790'
p12731
sg7
g12719
sg9
V4936538.xml
p12732
sa(dp12733
g3
VSTD-Hirsch-1973
p12734
sg5
S'PMC1588639'
p12735
sg7
g12719
sg9
V4571196.xml
p12736
sa(dp12737
g3
VSTD-Tyrrell-1986
p12738
sg5
S'PMC1777841'
p12739
sg7
VCD002011 v. 8.0 Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.rm5
p12740
sg9
V3524474.xml
p12741
sa(dp12742
g3
VSTD-Olszewer-1990
p12743
sg5
S'PMC2626030'
p12744
sg7
VCD002785 v. 5.0 Chelation therapy for atherosclerotic cardiovascular disease.rm5
p12745
sg9
V2108254.xml
p12746
sa(dp12747
g3
VSTD-Pyrhonen-1997
p12748
sg5
S'PMC2223944'
p12749
sg7
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p12750
sg9
V9231932.xml
p12751
sa(dp12752
g3
VSTD-Oryazgan-1992
p12753
sg5
S'PMC504238'
p12754
sg7
VCD001084 v. 6.0 Pharmacotherapy for Behcet's syndrome.rm5
p12755
sg9
V1390495.xml
p12756
sa(dp12757
g3
VSTD-Fernandez-2010
p12758
sg5
S'PMC2898783'
p12759
sg7
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p12760
sg9
V20525274.xml
p12761
sa(dp12762
g3
VSTD-Chirico-2009
p12763
sg5
S'PMC2687544'
p12764
sg7
g12760
sg9
V19490659.xml
p12765
sa(dp12766
g3
VSTD-Bentley-2011
p12767
sg5
S'PMC3735492'
p12768
sg7
g12760
sg9
V23919494.xml
p12769
sa(dp12770
g3
VSTD-Nuijten-2010
p12771
sg5
S'PMC2816247'
p12772
sg7
g12760
sg9
V19967425.xml
p12773
sa(dp12774
g3
VSTD-Roberts-2001
p12775
sg5
S'PMC2566389'
p12776
sg7
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p12777
sg9
V11357205.xml
p12778
sa(dp12779
g3
VSTD-Kirchhoff-1985
p12780
sg5
S'PMC2129411'
p12781
sg7
g12777
sg9
V2985691.xml
p12782
sa(dp12783
g3
VSTD-Crump-2004_x002d_i
p12784
sg5
S'PMC1199021'
p12785
sg7
g12777
sg9
V16046440.xml
p12786
sa(dp12787
g3
VSTD-Conroy-1999
p12788
sg5
S'PMC1718112'
p12789
sg7
g12777
sg9
V10490440.xml
p12790
sa(dp12791
g3
VSTD-Quick-1999
p12792
sg5
S'PMC2809591'
p12793
sg7
g12777
sg9
V10098789.xml
p12794
sa(dp12795
g3
VSTD-Chiller-2004
p12796
sg5
S'PMC2626515'
p12797
sg7
g12777
sg9
V16501712.xml
p12798
sa(dp12799
g3
VSTD-Crump-2004_x002d_ii
p12800
sg5
S'PMC1199021'
p12801
sg7
g12777
sg9
V16046440.xml
p12802
sa(dp12803
g3
VSTD-Colford-2002
p12804
sg5
S'PMC2730258'
p12805
sg7
g12777
sg9
V11749745.xml
p12806
sa(dp12807
g3
VSTD-vs-HLP-_x002d_-Purdon-2001
p12808
sg5
S'PMC1407745'
p12809
sg7
VCD007815 v. 2.124 Quetiapine versus typical antipsychotic medications for schizophrenia.rm5
p12810
sg9
V11291531.xml
p12811
sa(dp12812
g3
VSTD-Koning-2003
p12813
sg5
S'PMC64791'
p12814
sg7
VCD003261 v. 7.0 Interventions for impetigo.rm5
p12815
sg9
V11809642.xml
p12816
sa(dp12817
g3
VSTD-Goldfarb-1988
p12818
sg5
S'PMC176017'
p12819
sg7
g12815
sg9
V3149884.xml
p12820
sa(dp12821
g3
VSTD-Ginsburg-1978
p12822
sg5
S'PMC352342'
p12823
sg7
g12815
sg9
V666305.xml
p12824
sa(dp12825
g3
VSTD-Dagan-1992
p12826
sg5
S'PMC188356'
p12827
sg7
g12815
sg9
V1605593.xml
p12828
sa(dp12829
g3
VSTD-Tack-1997
p12830
sg5
S'PMC163785'
p12831
sg7
g12815
sg9
V9087480.xml
p12832
sa(dp12833
g3
VSTD-Farley-2002b
p12834
sg5
S'PMC1464003'
p12835
sg7
VCD004538 v. 5.28 Public release of performance data in changing the behaviour of healthcare consumers professionals .rm5
p12836
sg9
V12236394.xml
p12837
sa(dp12838
g3
VSTD-Konrad-1994
p12839
sg5
S'PMC3609515'
p12840
sg7
VCD003787 v. 7.0 Therapeutic ultrasound for the treatment of rheumatoid arthritis.rm5
p12841
sg9
V23238661.xml
p12842
sa(dp12843
g3
VSTD-Gardner-1988
p12844
sg5
S'PMC1349736'
p12845
sg7
VCD001256 v. 9.0 Interventions for preventing lower limb soft-tissue running injuries.rm5
p12846
sg9
V3056045.xml
p12847
sa(dp12848
g3
VSTD-Withnall-2006
p12849
sg5
S'PMC1325079'
p12850
sg7
g12846
sg9
V16388054.xml
p12851
sa(dp12852
g3
VSTD-Margrett-2006
p12853
sg5
S'PMC2856450'
p12854
sg7
VCD006220 v. 4.0 Cognition-based interventions for healthy older people and people with mild cognitive impairment.rm5
p12855
sg9
V16807197.xml
p12856
sa(dp12857
g3
VSTD-Ball-2002
p12858
sg5
S'PMC2916176'
p12859
sg7
g12855
sg9
V12425704.xml
p12860
sa(dp12861
g3
VSTD-Mahncke-2006
p12862
sg5
S'PMC1526649'
p12863
sg7
g12855
sg9
V16888038.xml
p12864
sa(dp12865
g3
VSTD-Koivunen-2004
p12866
sg5
S'PMC351838'
p12867
sg7
VCD007810 v. 5.0 Adenoidectomy for otitis media in children.rm5
p12868
sg9
V14769785.xml
p12869
sa(dp12870
g3
VSTD-Casselbrant-2009
p12871
sg5
S'PMC2787742'
p12872
sg7
g12868
sg9
V19819563.xml
p12873
sa(dp12874
g3
VSTD-Black-1990
p12875
sg5
S'PMC1663097'
p12876
sg7
g12868
sg9
V2196954.xml
p12877
sa(dp12878
g3
VSTD-Varma-2006
p12879
sg5
S'PMC1557355'
p12880
sg7
VCD006756 v. 4.0 Cesarean delivery for the prevention of anal incontinence.rm5
p12881
sg9
V16741640.xml
p12882
sa(dp12883
g3
VSTD-Eason-2002
p12884
sg5
S'PMC99311'
p12885
sg7
g12881
sg9
V11868640.xml
p12886
sa(dp12887
g3
VSTD-Kalra-2004
p12888
sg5
S'PMC406319'
p12889
sg7
VCD001919 v. 7.0 Information provision for stroke patients and their caregivers.rm5
p12890
sg9
V15130977.xml
p12891
sa(dp12892
g3
VSTD-Busuttil-1981-A
p12893
sg5
S'PMC1345331'
p12894
sg7
VCD001439 v. 11.0 Antibiotics versus placebo for prevention of postoperative infection after appendicectomy..rm5
p12895
sg9
V7025769.xml
p12896
sa(dp12897
g3
VSTD-Willis-1976
p12898
sg5
S'PMC1638715'
p12899
sg7
g12895
sg9
V764935.xml
p12900
sa(dp12901
g3
VSTD-Bauer-1989
p12902
sg5
S'PMC1493927'
p12903
sg7
g12895
sg9
V2647050.xml
p12904
sa(dp12905
g3
VSTD-Moskowitz-2011
p12906
sg5
S'PMC3479399'
p12907
sg7
VCD009528 v. 2.0 Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic f.rm5
p12908
sg9
V20963843.xml
p12909
sa(dp12910
g3
VSTD-Bierer-2009
p12911
sg5
S'PMC3086684'
p12912
sg7
VCD004868 v. 5.0 Late erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight inf.rm5
p12913
sg9
V19635302.xml
p12914
sa(dp12915
g3
VSTD-Bechensteen-1993
p12916
sg5
S'PMC1029391'
p12917
sg7
g12913
sg9
V8346946.xml
p12918
sa(dp12919
g3
VSTD-Emmerson-1993
p12920
sg5
S'PMC1590386'
p12921
sg7
g12913
sg9
V8466265.xml
p12922
sa(dp12923
g3
VSTD-Griffiths-1997
p12924
sg5
S'PMC1720643'
p12925
sg7
g12913
sg9
V9175950.xml
p12926
sa(dp12927
g3
VSTD-Brown-2002
p12928
sg5
S'PMC2134805'
p12929
sg7
VCD003417 v. 4.2 Group based training for self-management strategies in people with type 2 diabetes mellitus.rm5
p12930
sg9
V11815493.xml
p12931
sa(dp12932
g3
VSTD-Namutangula-2007
p12933
sg5
S'PMC2147028'
p12934
sg7
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p12935
sg9
V17958887.xml
p12936
sa(dp12937
g3
VSTD-Seymour-1999
p12938
sg5
S'PMC2014251'
p12939
sg7
VCD001548 v. 10.0 Single dose oral ibuprofen for acute postoperative pain in adults.rm5
p12940
sg9
V10383546.xml
p12941
sa(dp12942
g3
VSTD-Medve-2001
p12943
sg5
S'PMC2007376'
p12944
sg7
g12940
sg9
V11724223.xml
p12945
sa(dp12946
g3
VSTD-Seymour-1991-_x0028_study-2_x0029_
p12947
sg5
S'PMC1368416'
p12948
sg7
g12940
sg9
V2015175.xml
p12949
sa(dp12950
g3
VSTD-Seymour-1991-_x0028_study-1_x0029_
p12951
sg5
S'PMC1368416'
p12952
sg7
g12940
sg9
V2015175.xml
p12953
sa(dp12954
g3
VSTD-DPP-2002
p12955
sg5
S'PMC1370926'
p12956
sg7
VCD005270 v. 1.2 Long-term non-pharmacological weight loss interventions for adults with prediabetes.rm5
p12957
sg9
V11832527.xml
p12958
sa(dp12959
g3
VSTD-DPP-2000
p12960
sg5
S'PMC1360735'
p12961
sg7
g12957
sg9
V11092283.xml
p12962
sa(dp12963
g3
VSTD-DPP-2002a
p12964
sg5
S'PMC1282458'
p12965
sg7
g12957
sg9
V12453955.xml
p12966
sa(dp12967
g3
VSTD-Jarrett-1987
p12968
sg5
S'PMC1052600'
p12969
sg7
g12957
sg9
V3655634.xml
p12970
sa(dp12971
g3
VSTD-DPP-1999
p12972
sg5
S'PMC1351026'
p12973
sg7
g12957
sg9
V10189543.xml
p12974
sa(dp12975
g3
VSTD-Singh-2008
p12976
sg5
S'PMC2676172'
p12977
sg7
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p12978
sg9
V18638594.xml
p12979
sa(dp12980
g3
VSTD-Welder-2010
p12981
sg5
S'PMC2918453'
p12982
sg7
g12978
sg9
V20525997.xml
p12983
sa(dp12984
g3
VSTD-SToP-AF-2011
p12985
sg5
S'PMC3022954'
p12986
sg7
g12978
sg9
V20946227.xml
p12987
sa(dp12988
g3
VSTD-Rosenson-2009
p12989
sg5
S'PMC2681027'
p12990
sg7
g12978
sg9
V19265025.xml
p12991
sa(dp12992
g3
VSTD-Park-2010
p12993
sg5
S'PMC2829413'
p12994
sg7
g12978
sg9
V20195400.xml
p12995
sa(dp12996
g3
VSTD-Miramadi-2008
p12997
sg5
S'PMC2526235'
p12998
sg7
g12978
sg9
V18492126.xml
p12999
sa(dp13000
g3
VSTD-Koh-2010
p13001
sg5
S'PMC3016087'
p13002
sg7
g12978
sg9
V20298928.xml
p13003
sa(dp13004
g3
VSTD-Cho-2011
p13005
sg5
S'PMC3079135'
p13006
sg7
g12978
sg9
V21519514.xml
p13007
sa(dp13008
g3
VSTD-PULSAR--2006
p13009
sg5
S'PMC1779361'
p13010
sg7
g12978
sg9
V17184550.xml
p13011
sa(dp13012
g3
VSTD-STRENGTH-2008
p13013
sg5
S'PMC2995295'
p13014
sg7
g12978
sg9
V20031551.xml
p13015
sa(dp13016
g3
VSTD-Kom-2007
p13017
sg5
S'PMC2000588'
p13018
sg7
g12978
sg9
V17214829.xml
p13019
sa(dp13020
g3
VSTD-Davidson-1988
p13021
sg5
S'PMC461601'
p13022
sg7
VCD004356 v. 6.0 Short-term ambulatory oxygen for chronic obstructive pulmonary disease.rm5
p13023
sg9
V3238640.xml
p13024
sa(dp13025
g3
VSTD-Leggett-1977
p13026
sg5
S'PMC1630967'
p13027
sg7
g13023
sg9
V871805.xml
p13028
sa(dp13029
g3
VSTD-Leach-1992
p13030
sg5
S'PMC464043'
p13031
sg7
g13023
sg9
V1481177.xml
p13032
sa(dp13033
g3
VSTD-Garrod-1999
p13034
sg5
S'PMC1745430'
p13035
sg7
g13023
sg9
V10325901.xml
p13036
sa(dp13037
g3
VSTD-Garrod-2000
p13038
sg5
S'PMC1745814'
p13039
sg7
g13023
sg9
V10856310.xml
p13040
sa(dp13041
g3
VSTD-Louie-2011
p13042
sg5
S'PMC3198285'
p13043
sg7
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p13044
sg9
V21900148.xml
p13045
sa(dp13046
g3
VSTD-Moses-2009
p13047
sg5
S'PMC2681032'
p13048
sg7
g13044
sg9
V19279301.xml
p13049
sa(dp13050
g3
VSTD-Bonnar-1996
p13051
sg5
S'PMC2352023'
p13052
sg7
VCD000400 v. 8.0 Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.rm5
p13053
sg9
V8806245.xml
p13054
sa(dp13055
g3
VSTD-Hu-2005
p13056
sg5
S'PMC3776804'
p13057
sg7
VCD007796 v. 2.2 Chinese herbal medicine for diabetic peripheral neuropathy.rm5
p13058
sg9
V24058521.xml
p13059
sa(dp13060
g3
VSTD-Sanchez-2002
p13061
sg5
S'PMC1725780'
p13062
sg7
VCD003237 v. 7.2 Modes of administration of antibiotics for symptomatic severe urinary tract infections.rm5
p13063
sg9
V11777865.xml
p13064
sa(dp13065
g3
VSTD-Rabinowitz-2011
p13066
sg5
S'PMC3738059'
p13067
sg7
VCD006396 v. 4.0 Interventions to prevent occupational noise-induced hearing loss.rm5
p13068
sg9
V21193566.xml
p13069
sa(dp13070
g3
VSTD-Del-Giglio-2008
p13071
sg5
S'PMC2628928'
p13072
sg7
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p13073
sg9
V19014494.xml
p13074
sa(dp13075
g3
VSTD-Kinmonth-1992
p13076
sg5
S'PMC1883680'
p13077
sg7
VCD004264 v. 7.0 Physical methods versus drug placebo or no treatment for managing fever in children.rm5
p13078
sg9
V1463951.xml
p13079
sa(dp13080
g3
VSTD-Newman-1985
p13081
sg5
S'PMC1345783'
p13082
sg7
g13078
sg9
V3978484.xml
p13083
sa(dp13084
g3
VSTD-Sarsfield-1979
p13085
sg5
S'PMC1596085'
p13086
sg7
VCD003163 v. 6.0 Topical nasal steroids for intermittent and persistent allergic rhinitis in children.rm5
p13087
sg9
V380773.xml
p13088
sa(dp13089
g3
VSTD-Sarman-1989b
p13090
sg5
S'PMC1792015'
p13091
sg7
VCD003062 v. 5.0 Cot-nursing versus incubator care for preterm infants.rm5
p13092
sg9
V2730122.xml
p13093
sa(dp13094
g3
VSTD-Sarman-1989a
p13095
sg5
S'PMC1590066'
p13096
sg7
g13092
sg9
V2923482.xml
p13097
sa(dp13098
g3
VSTD-Kuyvenhoven-1997
p13099
sg5
S'PMC1312903'
p13100
sg7
VMR000021 v. 4.0 Incentives and disincentives to participation by clinicians in randomised controlled trials.rm5
p13101
sg9
V9101682.xml
p13102
sa(dp13103
g3
VSTD-Earp-1982
p13104
sg5
S'PMC1650178'
p13105
sg7
VCD005182 v. 7.0 Interventions used to improve control of blood pressure in patients with hypertension.rm5
p13106
sg9
V7114339.xml
p13107
sa(dp13108
g3
VSTD-Bogden-1998
p13109
sg5
S'PMC1497023'
p13110
sg7
g13106
sg9
V9824519.xml
p13111
sa(dp13112
g3
VSTD-McKinstry-2006
p13113
sg5
S'PMC1927092'
p13114
sg7
g13106
sg9
V17132351.xml
p13115
sa(dp13116
g3
VSTD-Johnson-1978
p13117
sg5
S'PMC1819059'
p13118
sg7
g13106
sg9
V369673.xml
p13119
sa(dp13120
g3
VSTD-Robson-1989
p13121
sg5
S'PMC1835698'
p13122
sg7
g13106
sg9
V2495053.xml
p13123
sa(dp13124
g3
VSTD-Midanik-1991
p13125
sg5
S'PMC1580210'
p13126
sg7
g13106
sg9
V1899945.xml
p13127
sa(dp13128
g3
VSTD-Bulpitt-1976
p13129
sg5
S'PMC1639159'
p13130
sg7
g13106
sg9
V1252881.xml
p13131
sa(dp13132
g3
VSTD-Krieger-1999
p13133
sg5
S'PMC1508657'
p13134
sg7
g13106
sg9
V10358675.xml
p13135
sa(dp13136
g3
VSTD-Tobe-2006
p13137
sg5
S'PMC1435956'
p13138
sg7
g13106
sg9
V16595786.xml
p13139
sa(dp13140
g3
VSTD-Watkins-1987
p13141
sg5
S'PMC1711180'
p13142
sg7
g13106
sg9
V3503941.xml
p13143
sa(dp13144
g3
VSTD-Montgomery-2000
p13145
sg5
S'PMC27312'
p13146
sg7
g13106
sg9
V10710578.xml
p13147
sa(dp13148
g3
VSTD-McAlister-1986
p13149
sg5
S'PMC1341518'
p13150
sg7
g13106
sg9
V3092976.xml
p13151
sa(dp13152
g3
VSTD-Morisky-1983
p13153
sg5
S'PMC1650522'
p13154
sg7
g13106
sg9
V6849473.xml
p13155
sa(dp13156
g3
VSTD-Hunt-2004
p13157
sg5
S'PMC1492526'
p13158
sg7
g13106
sg9
V15333056.xml
p13159
sa(dp13160
g3
VSTD-McManus-2005
p13161
sg5
S'PMC1199029'
p13162
sg7
g13106
sg9
V16115830.xml
p13163
sa(dp13164
g3
VSTD-van-der-Klink-2003
p13165
sg5
S'PMC1740545'
p13166
sg7
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p13167
sg9
V12771395.xml
p13168
sa(dp13169
g3
VSTD-Bakker-2007
p13170
sg5
S'PMC1885369'
p13171
sg7
g13167
sg9
V17549228.xml
p13172
sa(dp13173
g3
VSTD-Cogswell-1985
p13174
sg5
S'PMC1777416'
p13175
sg7
VCD002173 v. 10.0 Inhaled sodium cromoglycate for asthma in children.rm5
p13176
sg9
V3929698.xml
p13177
sa(dp13178
g3
VSTD-Henry-1984
p13179
sg5
S'PMC1628434'
p13180
sg7
g13176
sg9
V6230059.xml
p13181
sa(dp13182
g3
VSTD-Glass-1981
p13183
sg5
S'PMC1627266'
p13184
sg7
g13176
sg9
V6791596.xml
p13185
sa(dp13186
g3
VSTD-Hiller-1977
p13187
sg5
S'PMC1544812'
p13188
sg7
g13176
sg9
V413493.xml
p13189
sa(dp13190
g3
VSTD-Edmunds-1980
p13191
sg5
S'PMC1714307'
p13192
sg7
g13176
sg9
V6775752.xml
p13193
sa(dp13194
g3
VSTD-Furfaro-1994
p13195
sg5
S'PMC1030013'
p13196
sg7
g13176
sg9
V7979527.xml
p13197
sa(dp13198
g3
VSTD-Irnich-2001
p13199
sg5
S'PMC33515'
p13200
sg7
VCD004870 v. 7.2 Acupuncture for neck disorders.rm5
p13201
sg9
V11431299.xml
p13202
sa(dp13203
g3
VSTD-Sharp-2007
p13204
sg5
S'PMC3749812'
p13205
sg7
VCD006657 v. 4.0 Indoor residual spraying for preventing malaria.rm5
p13206
sg9
V17255227.xml
p13207
sa(dp13208
g3
VSTD-Sooch-1965
p13209
sg5
S'PMC2555234'
p13210
sg7
VCD003204 v. 5.0 Iodised salt for preventing iodine deficiency disorders.rm5
p13211
sg9
V14315706.xml
p13212
sa(dp13213
g3
VSTD-Oh-2010
p13214
sg5
S'PMC2826100'
p13215
sg7
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p13216
sg9
V19880433.xml
p13217
sa(dp13218
g3
VSTD-Dodd-2010
p13219
sg5
S'PMC2891044'
p13220
sg7
g13216
sg9
V20467301.xml
p13221
sa(dp13222
g3
VSTD-Brown-2009
p13223
sg5
S'PMC3040070'
p13224
sg7
VCD001867 v. 11.0 Opioid antagonists for alcohol dependence.rm5
p13225
sg9
V19673746.xml
p13226
sa(dp13227
g3
VSTD-Pettinati-2008b
p13228
sg5
S'PMC2600888'
p13229
sg7
g13225
sg9
V17664051.xml
p13230
sa(dp13231
g3
VSTD-Pettinati-2008a
p13232
sg5
S'PMC2374760'
p13233
sg7
g13225
sg9
V18079068.xml
p13234
sa(dp13235
g3
VSTD-Schmitz-2009
p13236
sg5
S'PMC2907651'
p13237
sg7
g13225
sg9
V19874153.xml
p13238
sa(dp13239
g3
VSTD-Oslin-2005
p13240
sg5
S'PMC3172720'
p13241
sg7
g13225
sg9
V15956269.xml
p13242
sa(dp13243
g3
VSTD-O_x0027_Malley-2008
p13244
sg5
S'PMC2746027'
p13245
sg7
g13225
sg9
V18482155.xml
p13246
sa(dp13247
g3
VSTD-Krudsood-2003
p13248
sg5
S'PMC3123522'
p13249
sg7
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p13250
sg9
V12971556.xml
p13251
sa(dp13252
g3
VSTD-Sutherland-2005
p13253
sg5
S'PMC1087200'
p13254
sg7
g13250
sg9
V15839740.xml
p13255
sa(dp13256
g3
VSTD-van-der-Schans-1991
p13257
sg5
S'PMC463090'
p13258
sg7
VCD003147 v. 6.0 Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.rm5
p13259
sg9
V2038733.xml
p13260
sa(dp13261
g3
VSTD-Tyrrell-1986
p13262
sg5
S'PMC1777841'
p13263
sg7
g13259
sg9
V3524474.xml
p13264
sa(dp13265
g3
VSTD-Hofmeyr-1986
p13266
sg5
S'PMC460551'
p13267
sg7
g13259
sg9
V3296295.xml
p13268
sa(dp13269
g3
VSTD-Petrie-1989
p13270
sg5
S'PMC1835985'
p13271
sg7
VCD001520 v. 11.0 Melatonin for the prevention and treatment of jet lag.rm5
p13272
sg9
V2496815.xml
p13273
sa(dp13274
g3
VSTD-Burge-1982
p13275
sg5
S'PMC459315'
p13276
sg7
VCD006308 v. 4.0 Workplace interventions for treatment of occupational asthma.rm5
p13277
sg9
V7112471.xml
p13278
sa(dp13279
g3
VSTD-Lin-1996
p13280
sg5
S'PMC1128593'
p13281
sg7
g13277
sg9
V9038799.xml
p13282
sa(dp13283
g3
VSTD-Ridgway-2007
p13284
sg5
S'PMC1964725'
p13285
sg7
VCD004287 v. 8.0 Tissue adhesives for closure of surgical incisions.rm5
p13286
sg9
V17394707.xml
p13287
sa(dp13288
g3
VSTD-Rietveld-2005
p13289
sg5
S'PMC1570507'
p13290
sg7
VCD001211 v. 13.2 Antibiotics versus placebo for acute bacterial conjunctivitis.rm5
p13291
sg9
V16378561.xml
p13292
sa(dp13293
g3
VSTD-Taylor-2004
p13294
sg5
S'PMC539272'
p13295
sg7
VCD001270 v. 6.0 Teaching critical appraisal skills in healthcare settings.rm5
p13296
sg9
V15585061.xml
p13297
sa(dp13298
g3
VSTD-Ciliberto-2005
p13299
sg5
S'PMC557886'
p13300
sg7
VCD008147 v. 2.0 Supplementary vitamin E selenium cysteine and riboflavin for preventing kwashiorkor in preschool c.rm5
p13301
sg9
V15851401.xml
p13302
sa(dp13303
g3
VSTD-Silverman-1982
p13304
sg5
S'PMC1352475'
p13305
sg7
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p13306
sg9
V6979982.xml
p13307
sa(dp13308
g3
VSTD-Eslami-2005
p13309
sg5
S'PMC1502073'
p13310
sg7
g13306
sg9
V16943938.xml
p13311
sa(dp13312
g3
VSTD-Butler-1993
p13313
sg5
S'PMC1025229'
p13314
sg7
g13306
sg9
V8038000.xml
p13315
sa(dp13316
g3
VSTD-Chavan-2010
p13317
sg5
S'PMC3034455'
p13318
sg7
g13306
sg9
V21358799.xml
p13319
sa(dp13320
g3
VSTD-Ormerod-1984
p13321
sg5
S'PMC481561'
p13322
sg7
g13306
sg9
V6610435.xml
p13323
sa(dp13324
g3
VSTD-Irnich-2001
p13325
sg5
S'PMC33515'
p13326
sg7
VCD004871 v. 10.0 Massage for mechanical neck disorders.rm5
p13327
sg9
V11431299.xml
p13328
sa(dp13329
g3
VSTD-Briem-2007
p13330
sg5
S'PMC2565604'
p13331
sg7
g13327
sg9
V19066648.xml
p13332
sa(dp13333
g3
VSTD-Sherman-2009
p13334
sg5
S'PMC2664516'
p13335
sg7
g13327
sg9
V19333174.xml
p13336
sa(dp13337
g3
VSTD-Helitzer-2011
p13338
sg5
S'PMC3539754'
p13339
sg7
VCD002213 v. 7.5 Interprofessional education effects on professional practice and healthcare outcomes (update).rm5
p13340
sg9
V20219315.xml
p13341
sa(dp13342
g3
VSTD-Morey-2002
p13343
sg5
S'PMC1464040'
p13344
sg7
g13340
sg9
V12546286.xml
p13345
sa(dp13346
g3
VSTD-Taylor-2007
p13347
sg5
S'PMC2464938'
p13348
sg7
g13340
sg9
V17693668.xml
p13349
sa(dp13350
g3
VSTD-Bialosky-2009
p13351
sg5
S'PMC2864088'
p13352
sg7
VCD009899 v. 1.0 Exercise and mobilisation interventions for carpal tunnel syndrome.rm5
p13353
sg9
V19801812.xml
p13354
sa(dp13355
g3
VSTD-Barth-2011
p13356
sg5
S'PMC3109880'
p13357
sg7
VCD002277 v. 10.0 Intravenous immunoglobulin for myasthenia gravis.rm5
p13358
sg9
V21562253.xml
p13359
sa(dp13360
g3
VSTD-FACS-2010
p13361
sg5
S'PMC2886041'
p13362
sg7
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p13363
sg9
V20500832.xml
p13364
sa(dp13365
g3
VSTD-O_x0027_Donnell-2003
p13366
sg5
S'PMC214016'
p13367
sg7
VCD008712 v. 4.0 Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.rm5
p13368
sg9
V14551096.xml
p13369
sa(dp13370
g3
VSTD-Kemp-1998
p13371
sg5
S'PMC2350295'
p13372
sg7
g13368
sg9
V8611831.xml
p13373
sa(dp13374
g3
VSTD-DiFrancisco-2007
p13375
sg5
S'PMC2465144'
p13376
sg7
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p13377
sg9
V17062657.xml
p13378
sa(dp13379
g3
VSTD-Jette-1999
p13380
sg5
S'PMC1508501'
p13381
sg7
g13377
sg9
V9987467.xml
p13382
sa(dp13383
g3
VSTD-Foley-2003
p13384
sg5
S'PMC1754378'
p13385
sg7
g13377
sg9
V14644853.xml
p13386
sa(dp13387
g3
VSTD-Rhodes-2000
p13388
sg5
S'PMC1724140'
p13389
sg7
g13377
sg9
V10690445.xml
p13390
sa(dp13391
g3
VSTD-Collier-1997
p13392
sg5
S'PMC213374'
p13393
sg7
g13377
sg9
V2141834.xml
p13394
sa(dp13395
g3
VSTD-Fatouros-2005
p13396
sg5
S'PMC1725040'
p13397
sg7
g13377
sg9
V16183776.xml
p13398
sa(dp13399
g3
VSTD-Simpson-1992
p13400
sg5
S'PMC463573'
p13401
sg7
g13377
sg9
V1549826.xml
p13402
sa(dp13403
g3
VSTD-Sims-2006
p13404
sg5
S'PMC1698486'
p13405
sg7
g13377
sg9
V17134517.xml
p13406
sa(dp13407
g3
VSTD-Kluger-2007
p13408
sg5
S'PMC2206502'
p13409
sg7
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p13410
sg9
V17686152.xml
p13411
sa(dp13412
g3
VSTD-Lal-2006
p13413
sg5
S'PMC1488906'
p13414
sg7
VCD007779 v. 4.0 Levomepromazine for schizophrenia.rm5
p13415
sg9
V16862245.xml
p13416
sa(dp13417
g3
VSTD-Lofberg-1996
p13418
sg5
S'PMC1383237'
p13419
sg7
VCD002913 v. 6.2 Budesonide for maintenance of remission in Crohn's disease.rm5
p13420
sg9
V8881815.xml
p13421
sa(dp13422
g3
VSTD-Cortot-2001
p13423
sg5
S'PMC1728198'
p13424
sg7
g13420
sg9
V11156638.xml
p13425
sa(dp13426
g3
VSTD-Gross-1998
p13427
sg5
S'PMC1727061'
p13428
sg7
g13420
sg9
V9616309.xml
p13429
sa(dp13430
g3
VSTD-Cashman-1961
p13431
sg5
S'PMC1953822'
p13432
sg7
VCD005993 v. 5.0 Procaine treatments for cognition and dementia.rm5
p13433
sg9
V13691281.xml
p13434
sa(dp13435
g3
VSTD-Rossi-1986-_x002d_-AHE
p13436
sg5
S'PMC1434629'
p13437
sg7
VCD001939 v. 8.0 Branched-chain amino acids for hepatic encephalopathy.rm5
p13438
sg9
V3539709.xml
p13439
sa(dp13440
g3
VSTD-Tyrrell-1989a
p13441
sg5
S'PMC1836535'
p13442
sg7
VCD001728 v. 13.0 Heated humidified air for the common cold.rm5
p13443
sg9
V2500196.xml
p13444
sa(dp13445
g3
VSTD-Tyrrell-1989b
p13446
sg5
S'PMC1836535'
p13447
sg7
g13443
sg9
V2500196.xml
p13448
sa(dp13449
g3
VSTD-Prabhu-1997
p13450
sg5
S'PMC1720662'
p13451
sg7
VCD001694 v. 8.0 Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.rm5
p13452
sg9
V9279180.xml
p13453
sa(dp13454
g3
VSTD-Montgomery-1983
p13455
sg5
S'PMC1427879'
p13456
sg7
VCD001764 v. 17.0 Psychosocial and pharmacological treatments for deliberate self harm.rm5
p13457
sg9
V6824553.xml
p13458
sa(dp13459
g3
VSTD-Hindle-1972
p13460
sg5
S'PMC1518609'
p13461
sg7
VCD004252 v. 7.2 Muscle relaxants for non-specific low-back pain.rm5
p13462
sg9
V4262210.xml
p13463
sa(dp13464
g3
VSTD-Fleming-1995
p13465
sg5
S'PMC2271576'
p13466
sg7
VCD004876 v. 9.0 Vaccines for preventing influenza in the elderly.rm5
p13467
sg9
V8557090.xml
p13468
sa(dp13469
g3
VSTD-Puig_x002d_Barber_x00e0_-1997
p13470
sg5
S'PMC1060539'
p13471
sg7
g13467
sg9
V9425463.xml
p13472
sa(dp13473
g3
VSTD-Nicholson-1999
p13474
sg5
S'PMC2810733'
p13475
sg7
g13467
sg9
V10487646.xml
p13476
sa(dp13477
g3
VSTD-Ahmed-1997
p13478
sg5
S'PMC2808769'
p13479
sg7
g13467
sg9
V9042032.xml
p13480
sa(dp13481
g3
VSTD-Keitel-1996
p13482
sg5
S'PMC170397'
p13483
sg7
g13467
sg9
V8877126.xml
p13484
sa(dp13485
g3
VSTD-Govaert-1993
p13486
sg5
S'PMC1679213'
p13487
sg7
g13467
sg9
V8241913.xml
p13488
sa(dp13489
g3
VSTD-Mukerjee-1994
p13490
sg5
S'PMC1060042'
p13491
sg7
g13467
sg9
V7830018.xml
p13492
sa(dp13493
g3
VSTD-Horman-1986
p13494
sg5
S'PMC1646616'
p13495
sg7
g13467
sg9
V3963278.xml
p13496
sa(dp13497
g3
VSTD-Garry-2004
p13498
sg5
S'PMC314503'
p13499
sg7
VCD003677 v. 8.0 Surgical approach to hysterectomy for benign gynaecological disease.rm5
p13500
sg9
V14711749.xml
p13501
sa(dp13502
g3
VSTD-Warburton-2000
p13503
sg5
S'PMC1730594'
p13504
sg7
VCD005244 v. 9.2 Interventions in the alcohol server setting for preventing injuries.rm5
p13505
sg9
V10728540.xml
p13506
sa(dp13507
g3
VSTD-McKnight-1991
p13508
sg5
S'PMC3153620'
p13509
sg7
g13505
sg9
V22942862.xml
p13510
sa(dp13511
g3
VSTD-Howard_x002d_Pitney-1991
p13512
sg5
S'PMC1404951'
p13513
sg7
g13505
sg9
V1990858.xml
p13514
sa(dp13515
g3
VSTD-Russ-1987
p13516
sg5
S'PMC1647259'
p13517
sg7
g13505
sg9
V3605473.xml
p13518
sa(dp13519
g3
VSTD-Yu-2008
p13520
sg5
S'PMC2613766'
p13521
sg7
VCD002024 v. 15.2 Alpha2-adrenergic agonists for the management of opioid withdrawal.rm5
p13522
sg9
V18508207.xml
p13523
sa(dp13524
g3
VSTD-Pincus-a-2004
p13525
sg5
S'PMC1755088'
p13526
sg7
VCD004257 v. 6.0 Acetaminophen for osteoarthritis.rm5
p13527
sg9
V15082468.xml
p13528
sa(dp13529
g3
VSTD-Boureau-2004
p13530
sg5
S'PMC1755112'
p13531
sg7
g13527
sg9
V15308513.xml
p13532
sa(dp13533
g3
VSTD-Miceli_x002d_Richard-2004
p13534
sg5
S'PMC1755093'
p13535
sg7
g13527
sg9
V15249319.xml
p13536
sa(dp13537
g3
VSTD-Pincus-b-2004
p13538
sg5
S'PMC1755088'
p13539
sg7
g13527
sg9
V15082468.xml
p13540
sa(dp13541
g3
VSTD-Gibbons-2001
p13542
sg5
S'PMC3620829'
p13543
sg7
VCD007911 v. 2.0 Cryotherapy following total knee replacement.rm5
p13544
sg9
V11561502.xml
p13545
sa(dp13546
g3
VSTD-Poustie-2006
p13547
sg5
S'PMC1403226'
p13548
sg7
VCD001914 v. 8.0 Oral protein calorie supplementation for children with chronic disease.rm5
p13549
sg9
V16467348.xml
p13550
sa(dp13551
g3
VSTD-Dougados-1988
p13552
sg5
S'PMC1003464'
p13553
sg7
VCD001083 v. 7.0 Cyclosporine for treating rheumatoid arthritis.rm5
p13554
sg9
V3281603.xml
p13555
sa(dp13556
g3
VSTD-Dorward-1988
p13557
sg5
S'PMC1020749'
p13558
sg7
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p13559
sg9
V3353895.xml
p13560
sa(dp13561
g3
VSTD-de-Vries-2007
p13562
sg5
S'PMC2042544'
p13563
sg7
g13559
sg9
V17359604.xml
p13564
sa(dp13565
g3
VSTD-Warner-1993
p13566
sg5
S'PMC464427'
p13567
sg7
g13559
sg9
V8511730.xml
p13568
sa(dp13569
g3
VSTD-Sheikh-2002
p13570
sg5
S'PMC116603'
p13571
sg7
g13559
sg9
V12079502.xml
p13572
sa(dp13573
g3
VSTD-Burr-1980A
p13574
sg5
S'PMC471322'
p13575
sg7
g13559
sg9
V7001667.xml
p13576
sa(dp13577
g3
VSTD-Burr-1980B
p13578
sg5
S'PMC471323'
p13579
sg7
g13559
sg9
V7001668.xml
p13580
sa(dp13581
g3
VSTD-Alfageme-2006
p13582
sg5
S'PMC2080738'
p13583
sg7
VCD001390 v. 7.0 Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmo.rm5
p13584
sg9
V16227328.xml
p13585
sa(dp13586
g3
VSTD-Leech-1987
p13587
sg5
S'PMC1492041'
p13588
sg7
g13584
sg9
V3545418.xml
p13589
sa(dp13590
g3
VSTD-Peterson-1967
p13591
sg5
S'PMC1914640'
p13592
sg7
VCD007868 v. 3.0 Fluoride toothpastes of different concentrations for preventing dental caries in children and adoles.rm5
p13593
sg9
V14485790.xml
p13594
sa(dp13595
g3
VSTD-Dickersin-1994
p13596
sg5
S'PMC2541778'
p13597
sg7
VMR000001 v. 5.0 Handsearching versus electronic searching to identify reports of randomized trials.rm5
p13598
sg9
V7718048.xml
p13599
sa(dp13600
g3
VSTD-Jadad-1993b
p13601
sg5
S'PMC1678459'
p13602
sg7
g13598
sg9
V8343701.xml
p13603
sa(dp13604
g3
VSTD-Silagy-1993
p13605
sg5
S'PMC57801'
p13606
sg7
g13598
sg9
V11597966.xml
p13607
sa(dp13608
g3
VSTD-Cullum-1997
p13609
sg5
S'PMC1055436'
p13610
sg7
g13598
sg9
V10166598.xml
p13611
sa(dp13612
g3
VSTD-von-Muhlen-2007
p13613
sg5
S'PMC2574781'
p13614
sg7
VCD006221 v. 4.0 Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.rm5
p13615
sg9
V18482290.xml
p13616
sa(dp13617
g3
VSTD-Garrett-1998
p13618
sg5
S'PMC1717626'
p13619
sg7
VCD007524 v. 3.0 Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adul.rm5
p13620
sg9
V9771245.xml
p13621
sa(dp13622
g3
VSTD-Fitzgerald-2004
p13623
sg5
S'PMC1747069'
p13624
sg7
g13620
sg9
V15223858.xml
p13625
sa(dp13626
g3
VSTD-Lincoln-2002
p13627
sg5
S'PMC1737698'
p13628
sg7
VCD008754 v. 2.1 Memory Rehabilitation for people with multiple sclerosis.rm5
p13629
sg9
V11784832.xml
p13630
sa(dp13631
g3
VSTD-Sokal-2004
p13632
sg5
S'PMC406425'
p13633
sg7
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p13634
sg9
V15056388.xml
p13635
sa(dp13636
g3
VSTD-Ryu-2006
p13637
sg5
S'PMC3489408'
p13638
sg7
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p13639
sg9
V15980998.xml
p13640
sa(dp13641
g3
VSTD-Zoega-2000
p13642
sg5
S'PMC3611372'
p13643
sg7
g13639
sg9
V10823430.xml
p13644
sa(dp13645
g3
VSTD-Stulik-2007
p13646
sg5
S'PMC2078301'
p13647
sg7
g13639
sg9
V17684777.xml
p13648
sa(dp13649
g3
VSTD-Lofgren-2010
p13650
sg5
S'PMC2899760'
p13651
sg7
g13639
sg9
V19763634.xml
p13652
sa(dp13653
g3
VSTD-Ruetten-2009
p13654
sg5
S'PMC2899164'
p13655
sg7
g13639
sg9
V19015851.xml
p13656
sa(dp13657
g3
VSTD-Dai-2008
p13658
sg5
S'PMC2367424'
p13659
sg7
g13639
sg9
V18301927.xml
p13660
sa(dp13661
g3
VSTD-Lind-2007
p13662
sg5
S'PMC2200784'
p13663
sg7
g13639
sg9
V17342510.xml
p13664
sa(dp13665
g3
VSTD-Hsu-2010
p13666
sg5
S'PMC2829694'
p13667
sg7
VCD007999 v. 2.52 Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.rm5
p13668
sg9
V20233195.xml
p13669
sa(dp13670
g3
VSTD-Tsai-2009
p13671
sg5
S'PMC2675043'
p13672
sg7
g13668
sg9
V19523014.xml
p13673
sa(dp13674
g3
VSTD-Southampton
p13675
sg5
S'PMC1971367'
p13676
sg7
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p13677
sg9
V1691921.xml
p13678
sa(dp13679
g3
VSTD-RLW-8351
p13680
sg5
S'PMC1971367'
p13681
sg7
g13677
sg9
V1691921.xml
p13682
sa(dp13683
g3
VSTD-BLT2
p13684
sg5
S'PMC1746842'
p13685
sg7
g13677
sg9
V15454647.xml
p13686
sa(dp13687
g3
VSTD-BLT1
p13688
sg5
S'PMC1746842'
p13689
sg7
g13677
sg9
V15454647.xml
p13690
sa(dp13691
g3
VSTD-Manchester-1
p13692
sg5
S'PMC2374661'
p13693
sg7
g13677
sg9
V10945489.xml
p13694
sa(dp13695
g3
VSTD-UK-BEAM-trial-2004
p13696
sg5
S'PMC535454'
p13697
sg7
VCD008112 v. 5.0 Spinal manipulative therapy for chronic low-back pain.rm5
p13698
sg9
V15556955.xml
p13699
sa(dp13700
g3
VSTD-Gudavalli-2006
p13701
sg5
S'PMC3233943'
p13702
sg7
g13698
sg9
V16341712.xml
p13703
sa(dp13704
g3
VSTD-Koes-1992
p13705
sg5
S'PMC1881307'
p13706
sg7
g13698
sg9
V1532760.xml
p13707
sa(dp13708
g3
VSTD-Charleston-1996
p13709
sg5
S'PMC2364502'
p13710
sg7
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p13711
sg9
V18476110.xml
p13712
sa(dp13713
g3
VSTD-Lim-2009
p13714
sg5
S'PMC2687520'
p13715
sg7
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p13716
sg9
V19169651.xml
p13717
sa(dp13718
g3
VSTD-Yamac-1995
p13719
sg5
S'PMC2398107'
p13720
sg7
VCD000026 v. 12.0 Routine versus selective antifungal administration for control of fungal infections in patients with.rm5
p13721
sg9
V7596933.xml
p13722
sa(dp13723
g3
VSTD-Lundgren-1989
p13724
sg5
S'PMC1493950'
p13725
sg7
VCD002000 v. 7.0 Bypass surgery for chronic lower limb ischaemia.rm5
p13726
sg9
V2647051.xml
p13727
sa(dp13728
g3
VSTD-Itoh-2008
p13729
sg5
S'PMC2268695'
p13730
sg7
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p13731
sg9
V18312661.xml
p13732
sa(dp13733
g3
VSTD-Charron_x002d_Prochownik-2008
p13734
sg5
S'PMC2453657'
p13735
sg7
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p13736
sg9
V18411239.xml
p13737
sa(dp13738
g3
VSTD-Sorenson-2008
p13739
sg5
S'PMC2617770'
p13740
sg7
VCD002064 v. 8.2 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sc.rm5
p13741
sg9
V19029516.xml
p13742
sa(dp13743
g3
VSTD-Bootsma-1995
p13744
sg5
S'PMC475016'
p13745
sg7
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p13746
sg9
V7491551.xml
p13747
sa(dp13748
g3
VSTD-Fitzgerald-1998
p13749
sg5
S'PMC1745293'
p13750
sg7
g13746
sg9
V9828851.xml
p13751
sa(dp13752
g3
VSTD-Currie-2002
p13753
sg5
S'PMC1746197'
p13754
sg7
g13746
sg9
V12324672.xml
p13755
sa(dp13756
g3
VSTD-Ringdal-1996
p13757
sg5
S'PMC2365805'
p13758
sg7
g13746
sg9
V18475734.xml
p13759
sa(dp13760
g3
VSTD-Harrison-2001
p13761
sg5
S'PMC1758787'
p13762
sg7
g13746
sg9
V11182010.xml
p13763
sa(dp13764
g3
VSTD-Fabbri-1993
p13765
sg5
S'PMC464708'
p13766
sg7
g13746
sg9
V8211872.xml
p13767
sa(dp13768
g3
VSTD-Phillips-2004
p13769
sg5
S'PMC1758859'
p13770
sg7
g13746
sg9
V14694242.xml
p13771
sa(dp13772
g3
VSTD-Hughes-1999b
p13773
sg5
S'PMC1745450'
p13774
sg7
g13746
sg9
V10325897.xml
p13775
sa(dp13776
g3
VSTD-Gustafsson-1993
p13777
sg5
S'PMC1029458'
p13778
sg7
g13746
sg9
V8215522.xml
p13779
sa(dp13780
g3
VSTD-Fonseca-2008
p13781
sg5
S'PMC2494667'
p13782
sg7
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p13783
sg9
V18458145.xml
p13784
sa(dp13785
g3
VSTD-Su-2012
p13786
sg5
S'PMC3674284'
p13787
sg7
VCD004547 v. 4.0 Chinese medicinal herbs for cholelithiasis.rm5
p13788
sg9
V23695700.xml
p13789
sa(dp13790
g3
VSTD-Ruottinen-1996-_x0028_a_x0029_
p13791
sg5
S'PMC486187'
p13792
sg7
VCD004554 v. 4.0 Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.rm5
p13793
sg9
V8558148.xml
p13794
sa(dp13795
g3
VSTD-Brooks-UK_x002d_IRISH-2003
p13796
sg5
S'PMC1738605'
p13797
sg7
g13793
sg9
V12876237.xml
p13798
sa(dp13799
g3
VSTD-Baas-1997
p13800
sg5
S'PMC2169755'
p13801
sg7
g13793
sg9
V9343116.xml
p13802
sa(dp13803
g3
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p13804
sg5
S'PMC2360162'
p13805
sg7
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p13806
sg9
V17375049.xml
p13807
sa(dp13808
g3
VSTD-Taal-2001-_x0028_NACCP_x0029_
p13809
sg5
S'PMC2363941'
p13810
sg7
g13806
sg9
V11720425.xml
p13811
sa(dp13812
g3
VSTD-Nucci-1999
p13813
sg5
S'PMC89294'
p13814
sg7
VCD000969 v. 11.0 Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.rm5
p13815
sg9
V10348768.xml
p13816
sa(dp13817
g3
VSTD-Nath-1999
p13818
sg5
S'PMC89289'
p13819
sg7
g13815
sg9
V10348763.xml
p13820
sa(dp13821
g3
VSTD-Pope-2008
p13822
sg5
S'PMC2632747'
p13823
sg7
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p13824
sg9
V18520677.xml
p13825
sa(dp13826
g3
VSTD-Leon-2010
p13827
sg5
S'PMC2825497'
p13828
sg7
g13824
sg9
V20205841.xml
p13829
sa(dp13830
g3
VSTD-Gregson-2007
p13831
sg5
S'PMC1831737'
p13832
sg7
g13824
sg9
V17388666.xml
p13833
sa(dp13834
g3
VSTD-Glasgow-2010
p13835
sg5
S'PMC2988142'
p13836
sg7
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p13837
sg9
V20714820.xml
p13838
sa(dp13839
g3
VSTD-Lorig-2010
p13840
sg5
S'PMC2875437'
p13841
sg7
g13837
sg9
V20299481.xml
p13842
sa(dp13843
g3
VSTD-Quinn-2011
p13844
sg5
S'PMC3161305'
p13845
sg7
g13837
sg9
V21788632.xml
p13846
sa(dp13847
g3
VSTD-Lim-2011
p13848
sg5
S'PMC3024339'
p13849
sg7
g13837
sg9
V21270188.xml
p13850
sa(dp13851
g3
VSTD-Walsh-1999
p13852
sg5
S'PMC1508522'
p13853
sg7
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p13854
sg9
V9949754.xml
p13855
sa(dp13856
g3
VSTD-Stevens-1995
p13857
sg5
S'PMC1615327'
p13858
sg7
g13854
sg9
V7856783.xml
p13859
sa(dp13860
g3
VSTD-Gordon-2010b
p13861
sg5
S'PMC2882418'
p13862
sg7
g13854
sg9
V20466951.xml
p13863
sa(dp13864
g3
VSTD-Binnie-2007
p13865
sg5
S'PMC1871574'
p13866
sg7
g13854
sg9
V17475005.xml
p13867
sa(dp13868
g3
VSTD-Gordon-2010a
p13869
sg5
S'PMC3780769'
p13870
sg7
g13854
sg9
V20675426.xml
p13871
sa(dp13872
g3
VSTD-Nohlert-2009
p13873
sg5
S'PMC2685131'
p13874
sg7
g13854
sg9
V19405969.xml
p13875
sa(dp13876
g3
VSTD-Horan-2009
p13877
sg5
S'PMC2653055'
p13878
sg7
VCD005147 v. 6.0 Training to recognise the early signs of recurrence in schizophrenia.rm5
p13879
sg9
V18930378.xml
p13880
sa(dp13881
g3
VSTD-Levy-1996
p13882
sg5
S'PMC1090518'
p13883
sg7
VCD002316 v. 9.14 Inhaled steroids for acute asthma following emergency department discharge.rm5
p13884
sg9
V8958890.xml
p13885
sa(dp13886
g3
VSTD-Gentry-1990
p13887
sg5
S'PMC171517'
p13888
sg7
VCD004439 v. 5.0 Antibiotics for treating chronic osteomyelitis in adults.rm5
p13889
sg9
V2183710.xml
p13890
sa(dp13891
g3
VSTD-Gentry-1991
p13892
sg5
S'PMC245046'
p13893
sg7
g13889
sg9
V2039205.xml
p13894
sa(dp13895
g3
VSTD-Greenberg-2000
p13896
sg5
S'PMC89644'
p13897
sg7
g13889
sg9
V10602739.xml
p13898
sa(dp13899
g3
VSTD-Sheftel-1986
p13900
sg5
S'PMC180374'
p13901
sg7
g13889
sg9
V3524419.xml
p13902
sa(dp13903
g3
VSTD-Brown-2001
p13904
sg5
S'PMC1832078'
p13905
sg7
VCD001007 v. 8.0 Group behaviour therapy programmes for smoking cessation.rm5
p13906
sg9
V11495176.xml
p13907
sa(dp13908
g3
VSTD-Brown-2007
p13909
sg5
S'PMC2213513'
p13910
sg7
g13906
sg9
V17577801.xml
p13911
sa(dp13912
g3
VSTD-Lando-1990
p13913
sg5
S'PMC1404660'
p13914
sg7
g13906
sg9
V2327531.xml
p13915
sa(dp13916
g3
VSTD-McDowell-1985
p13917
sg5
S'PMC2327690'
p13918
sg7
g13906
sg9
V21274108.xml
p13919
sa(dp13920
g3
VSTD-DePaul-1987
p13921
sg5
S'PMC1350178'
p13922
sg7
g13906
sg9
V2782506.xml
p13923
sa(dp13924
g3
VSTD-Rodgers-2005
p13925
sg5
S'PMC1748056'
p13926
sg7
VCD007457 v. 2.0 Mobile phone messaging for preventive health care.rm5
p13927
sg9
V16046689.xml
p13928
sa(dp13929
g3
VSTD-Shapiro-2008
p13930
sg5
S'PMC2592683'
p13931
sg7
g13927
sg9
V18984496.xml
p13932
sa(dp13933
g3
VSTD-Jack-2009
p13934
sg5
S'PMC2738592'
p13935
sg7
VCD000313 v. 7.9 Discharge planning from hospital to home.rm5
p13936
sg9
V19189907.xml
p13937
sa(dp13938
g3
VSTD-Moher-1992
p13939
sg5
S'PMC1488427'
p13940
sg7
g13936
sg9
V1737315.xml
p13941
sa(dp13942
g3
VSTD-Balaban-2008
p13943
sg5
S'PMC2517968'
p13944
sg7
g13936
sg9
V18452048.xml
p13945
sa(dp13946
g3
VSTD-Hassan-2001
p13947
sg5
S'PMC3455693'
p13948
sg7
VCD002249 v. 5.0 Clomiphene and anti-oestrogens for ovulation induction in PCOS.rm5
p13949
sg9
V11804430.xml
p13950
sa(dp13951
g3
VSTD-Rubenstein-1965
p13952
sg5
S'PMC2031530'
p13953
sg7
VCD007180 v. 3.0 Interventions to improve disposal of human excreta for preventing diarrhoea.rm5
p13954
sg9
V4982076.xml
p13955
sa(dp13956
g3
VSTD-Garrett-2008
p13957
sg5
S'PMC2870746'
p13958
sg7
g13954
sg9
V18205977.xml
p13959
sa(dp13960
g3
VSTD-McCabe-1957
p13961
sg5
S'PMC2031363'
p13962
sg7
g13954
sg9
V13465958.xml
p13963
sa(dp13964
g3
VSTD-van-Sprundel-2005
p13965
sg5
S'PMC2361560'
p13966
sg7
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p13967
sg9
V16052221.xml
p13968
sa(dp13969
g3
VSTD-Hatcher-2001
p13970
sg5
S'PMC26594'
p13971
sg7
g13967
sg9
V11154619.xml
p13972
sa(dp13973
g3
VSTD-Horton-1978
p13974
sg5
S'PMC1397010'
p13975
sg7
g13967
sg9
V736655.xml
p13976
sa(dp13977
g3
VSTD-Jenkins-1997
p13978
sg5
S'PMC1380945'
p13979
sg7
VCD001745 v. 8.0 Community interventions for reducing smoking among adults.rm5
p13980
sg9
V9224191.xml
p13981
sa(dp13982
g3
VSTD-Fisher-1998
p13983
sg5
S'PMC1508568'
p13984
sg7
g13980
sg9
V9807532.xml
p13985
sa(dp13986
g3
VSTD-Secker_x002d_Walker-2000
p13987
sg5
S'PMC1446253'
p13988
sg7
g13980
sg9
V10846513.xml
p13989
sa(dp13990
g3
VSTD-Egger-1983
p13991
sg5
S'PMC1549317'
p13992
sg7
g13980
sg9
V6414597.xml
p13993
sa(dp13994
g3
VSTD-Weinehall-1999
p13995
sg5
S'PMC1756863'
p13996
sg7
g13980
sg9
V10396552.xml
p13997
sa(dp13998
g3
VSTD-Lando-1995
p13999
sg5
S'PMC1615309'
p14000
sg7
g13980
sg9
V7856779.xml
p14001
sa(dp14002
g3
VSTD-Baxter-1997
p14003
sg5
S'PMC2127433'
p14004
sg7
g13980
sg9
V9302957.xml
p14005
sa(dp14006
g3
VSTD-Carleton-1995
p14007
sg5
S'PMC1615494'
p14008
sg7
g13980
sg9
V7762709.xml
p14009
sa(dp14010
g3
VSTD-COMMIT-1995
p14011
sg5
S'PMC1615326'
p14012
sg7
g13980
sg9
V7856777.xml
p14013
sa(dp14014
g3
VSTD-O_x0027_Loughlin-1999
p14015
sg5
S'PMC1509008'
p14016
sg7
g13980
sg9
V10589309.xml
p14017
sa(dp14018
g3
VSTD-Brownson-1996
p14019
sg5
S'PMC1380329'
p14020
sg7
g13980
sg9
V8633737.xml
p14021
sa(dp14022
g3
VSTD-Tudor_x002d_Smith-1998
p14023
sg5
S'PMC28483'
p14024
sg7
g13980
sg9
V9549451.xml
p14025
sa(dp14026
g3
VSTD-Innes-2003
p14027
sg5
S'PMC2394220'
p14028
sg7
VCD003992 v. 6.0 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.rm5
p14029
sg9
V12838298.xml
p14030
sa(dp14031
g3
VSTD-Giamarellou-2000
p14032
sg5
S'PMC90190'
p14033
sg7
g14029
sg9
V11083625.xml
p14034
sa(dp14035
g3
VSTD-Jacobs-1968
p14036
sg5
S'PMC1986152'
p14037
sg7
VCD000396 v. 11.0 Non-steroidal anti-inflammatory drugs for low back pain.rm5
p14038
sg9
V4232743.xml
p14039
sa(dp14040
g3
VSTD-Berry-1982
p14041
sg5
S'PMC1000895'
p14042
sg7
g14038
sg9
V6462116.xml
p14043
sa(dp14044
g3
VSTD-Jaffe-1974
p14045
sg5
S'PMC3737287'
p14046
sg7
g14038
sg9
V23642377.xml
p14047
sa(dp14048
g3
VSTD-Stenius-2000
p14049
sg5
S'PMC27319'
p14050
sg7
VCD004674 v. 4.0 Calorie controlled diet for chronic asthma.rm5
p14051
sg9
V10731173.xml
p14052
sa(dp14053
g3
VSTD-McEvoy-2010
p14054
sg5
S'PMC2878893'
p14055
sg7
VCD003935 v. 12.0 Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal h.rm5
p14056
sg9
V20227053.xml
p14057
sa(dp14058
g3
VSTD-Bowler-1995
p14059
sg5
S'PMC1511379'
p14060
sg7
VCD005087 v. 7.0 Sodium channel blockers for cystic fibrosis.rm5
p14061
sg9
V8554360.xml
p14062
sa(dp14063
g3
VSTD-Freeman-1986
p14064
sg5
S'PMC1339642'
p14065
sg7
VCD003521 v. 5.0 Complementary and alternative therapies for pain management in labour.rm5
p14066
sg9
V3081212.xml
p14067
sa(dp14068
g3
VSTD-Wysocki-2001
p14069
sg5
S'PMC90678'
p14070
sg7
VCD008481 v. 3.0 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.rm5
p14071
sg9
V11502515.xml
p14072
sa(dp14073
g3
VSTD-Sakka-2007
p14074
sg5
S'PMC2043189'
p14075
sg7
g14071
sg9
V17620371.xml
p14076
sa(dp14077
g3
VSTD-van-Zanten-2007
p14078
sg5
S'PMC2000713'
p14079
sg7
g14071
sg9
V16869814.xml
p14080
sa(dp14081
g3
VSTD-Lau-2006
p14082
sg5
S'PMC1635208'
p14083
sg7
g14071
sg9
V16940077.xml
p14084
sa(dp14085
g3
VSTD-Angus-2000
p14086
sg5
S'PMC2014958'
p14087
sg7
g14071
sg9
V10792202.xml
p14088
sa(dp14089
g3
VSTD-Cucchiara-1987
p14090
sg5
S'PMC1778411'
p14091
sg7
VCD002300 v. 14.0 Cisapride treatment for gastro-oesophageal reflux in children.rm5
p14092
sg9
V3300570.xml
p14093
sa(dp14094
g3
VSTD-Greally-1992
p14095
sg5
S'PMC1793694'
p14096
sg7
g14092
sg9
V1599300.xml
p14097
sa(dp14098
g3
VSTD-Casley_x002d_Smith-1993_x0028_2_x0029_
p14099
sg5
S'PMC1679230'
p14100
sg7
VCD003140 v. 11.0 Benzo-pyrones for reducing and controlling lymphoedema of the limbs.rm5
p14101
sg9
V8251778.xml
p14102
sa(dp14103
g3
VSTD-Sartain-2001
p14104
sg5
S'PMC1763073'
p14105
sg7
VCD004383 v. 5.2 Specialist home-based nursing services for children with acute and chronic illnesses.rm5
p14106
sg9
V12390903.xml
p14107
sa(dp14108
g3
VSTD-Burch-2000
p14109
sg5
S'PMC1421072'
p14110
sg7
VCD005477 v. 5.0 Single layer versus double layer suture anastomosis of the gastrointestinal tract.rm5
p14111
sg9
V10816626.xml
p14112
sa(dp14113
g3
VSTD-Kitchener-2009
p14114
sg5
S'PMC2646126'
p14115
sg7
VCD007585 v. 2.0 Lymphadenectomy for the management of endometrial cancer.rm5
p14116
sg9
V19070889.xml
p14117
sa(dp14118
g3
VSTD-Stevinson-2003
p14119
sg5
S'PMC539394'
p14120
sg7
VCD004158 v. 5.0 Rehabilitation following carpal tunnel release.rm5
p14121
sg9
V12562974.xml
p14122
sa(dp14123
g3
VSTD-Goorney-1989
p14124
sg5
S'PMC1194323'
p14125
sg7
VCD001036 v. 9.0 Collection devices for obtaining cervical cytology samples.rm5
p14126
sg9
V2759604.xml
p14127
sa(dp14128
g3
VSTD-Dey-1996
p14129
sg5
S'PMC2352129'
p14130
sg7
g14126
sg9
V8819441.xml
p14131
sa(dp14132
g3
VSTD-Szarewski-1990
p14133
sg5
S'PMC1194584'
p14134
sg7
g14126
sg9
V2265842.xml
p14135
sa(dp14136
g3
VSTD-Wolfendale-1987
p14137
sg5
S'PMC1245047'
p14138
sg7
g14126
sg9
V3101790.xml
p14139
sa(dp14140
g3
VSTD-Lai-2010
p14141
sg5
S'PMC3429157'
p14142
sg7
VCD005472 v. 6.2 Acupuncture for insomnia.rm5
p14143
sg9
V22542781.xml
p14144
sa(dp14145
g3
VSTD-Yeung-2009a
p14146
sg5
S'PMC2717194'
p14147
sg7
g14143
sg9
V19725255.xml
p14148
sa(dp14149
g3
VSTD-Du-2007
p14150
sg5
S'PMC1222461'
p14151
sg7
g14143
sg9
V11903057.xml
p14152
sa(dp14153
g3
VSTD-Merenstein-2010
p14154
sg5
S'PMC2906750'
p14155
sg7
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p14156
sg9
V20485304.xml
p14157
sa(dp14158
g3
VSTD-West-2011
p14159
sg5
S'PMC3083335'
p14160
sg7
g14156
sg9
V21477383.xml
p14161
sa(dp14162
g3
VSTD-Garc_x00ed_a-2005
p14163
sg5
S'PMC1087340'
p14164
sg7
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p14165
sg9
V15845509.xml
p14166
sa(dp14167
g3
VSTD-Migasena-1989a
p14168
sg5
S'PMC259791'
p14169
sg7
g14165
sg9
V2807523.xml
p14170
sa(dp14171
g3
VSTD-Lagos-1995
p14172
sg5
S'PMC173056'
p14173
sg7
g14165
sg9
V7822046.xml
p14174
sa(dp14175
g3
VSTD-Gotuzzo-1993
p14176
sg5
S'PMC281106'
p14177
sg7
g14165
sg9
V8359923.xml
p14178
sa(dp14179
g3
VSTD-Perry-1998
p14180
sg5
S'PMC2305629'
p14181
sg7
g14165
sg9
V9615498.xml
p14182
sa(dp14183
g3
VSTD-Cohen-2002
p14184
sg5
S'PMC127885'
p14185
sg7
g14165
sg9
V11895960.xml
p14186
sa(dp14187
g3
VSTD-Mahalanabis-2008
p14188
sg5
S'PMC2396289'
p14189
sg7
g14165
sg9
V18523643.xml
p14190
sa(dp14191
g3
VSTD-Tacket-1999
p14192
sg5
S'PMC97039'
p14193
sg7
g14165
sg9
V10569747.xml
p14194
sa(dp14195
g3
VSTD-Kotloff-1992
p14196
sg5
S'PMC257485'
p14197
sg7
g14165
sg9
V1398956.xml
p14198
sa(dp14199
g3
VSTD-Ben_x00ed_tez-1999
p14200
sg5
S'PMC96352'
p14201
sg7
g14165
sg9
V9916056.xml
p14202
sa(dp14203
g3
VSTD-Trach-2002
p14204
sg5
S'PMC2567633'
p14205
sg7
g14165
sg9
V11884967.xml
p14206
sa(dp14207
g3
VSTD-Rennie-1986a
p14208
sg5
S'PMC1777724'
p14209
sg7
VCD000174 v. 7.0 Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.rm5
p14210
sg9
V3516077.xml
p14211
sa(dp14212
g3
VSTD-WHO-BISG-1996
p14213
sg5
S'PMC1380435'
p14214
sg7
VCD001857 v. 7.0 Interventions for preventing injuries in problem drinkers.rm5
p14215
sg9
V8669518.xml
p14216
sa(dp14217
g3
VSTD-Gentilello-1999
p14218
sg5
S'PMC1420896'
p14219
sg7
g14215
sg9
V10522717.xml
p14220
sa(dp14221
g3
VSTD-Algotar-200_x03bc_g-2010
p14222
sg5
S'PMC2913148'
p14223
sg7
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p14224
sg9
V20670733.xml
p14225
sa(dp14226
g3
VSTD-Algotar-2010
p14227
sg5
S'PMC2913148'
p14228
sg7
g14224
sg9
V20670733.xml
p14229
sa(dp14230
g3
VSTD-Algotar-800_x03bc_g-2010
p14231
sg5
S'PMC2913148'
p14232
sg7
g14224
sg9
V20670733.xml
p14233
sa(dp14234
g3
VSTD-UK-PRECISE
p14235
sg5
S'PMC3446875'
p14236
sg7
g14224
sg9
V23028897.xml
p14237
sa(dp14238
g3
VSTD-Lincoln-2003
p14239
sg5
S'PMC1739598'
p14240
sg7
VCD001920 v. 5.0 Physiotherapy treatment approaches for the recovery of postural control and lower limb function foll.rm5
p14241
sg9
V15774435.xml
p14242
sa(dp14243
g3
VSTD-Wade-1992
p14244
sg5
S'PMC1881332'
p14245
sg7
g14241
sg9
V1559090.xml
p14246
sa(dp14247
g3
VSTD-Burnham-2004
p14248
sg5
S'PMC2585922'
p14249
sg7
VCD009094 v. 1.0 The impact of user fees on access to health services in low- and middle-income countries.rm5
p14250
sg9
V15112007.xml
p14251
sa(dp14252
g3
VSTD-Wilkinson-2001
p14253
sg5
S'PMC2566476'
p14254
sg7
g14250
sg9
V11477970.xml
p14255
sa(dp14256
g3
VSTD-Ridde-2003
p14257
sg5
S'PMC2572499'
p14258
sg7
g14250
sg9
V12973646.xml
p14259
sa(dp14260
g3
VSTD-Dershewitz-1977
p14261
sg5
S'PMC1653806'
p14262
sg7
VCD005014 v. 8.5 Home safety education and provision of safety equipment for injury prevention.rm5
p14263
sg9
V596497.xml
p14264
sa(dp14265
g3
VSTD-Phelan-2010
p14266
sg5
S'PMC3693223'
p14267
sg7
g14263
sg9
V21464382.xml
p14268
sa(dp14269
g3
VSTD-Schwarz-1993
p14270
sg5
S'PMC1694716'
p14271
sg7
g14263
sg9
V8484447.xml
p14272
sa(dp14273
g3
VSTD-Rowland-2002
p14274
sg5
S'PMC131024'
p14275
sg7
g14263
sg9
V12411356.xml
p14276
sa(dp14277
g3
VSTD-Schelp-1987
p14278
sg5
S'PMC1067711'
p14279
sg7
g14263
sg9
V9346097.xml
p14280
sa(dp14281
g3
VSTD-Mock-2003
p14282
sg5
S'PMC2572517'
p14283
sg7
g14263
sg9
V14576891.xml
p14284
sa(dp14285
g3
VSTD-Colver-1982
p14286
sg5
S'PMC1500158'
p14287
sg7
g14263
sg9
V6812798.xml
p14288
sa(dp14289
g3
VSTD-Coggan-2000
p14290
sg5
S'PMC1730604'
p14291
sg7
g14263
sg9
V10875670.xml
p14292
sa(dp14293
g3
VSTD-Watson-2005
p14294
sg5
S'PMC544992'
p14295
sg7
g14263
sg9
V15604156.xml
p14296
sa(dp14297
g3
VSTD-Nansel-2002
p14298
sg5
S'PMC2387242'
p14299
sg7
g14263
sg9
V11932115.xml
p14300
sa(dp14301
g3
VSTD-Kendrick-2007
p14302
sg5
S'PMC2610598'
p14303
sg7
g14263
sg9
V17446248.xml
p14304
sa(dp14305
g3
VSTD-Kendrick-2005
p14306
sg5
S'PMC1463224'
p14307
sg7
g14263
sg9
V16105365.xml
p14308
sa(dp14309
g3
VSTD-Nansel-2008
p14310
sg5
S'PMC2562892'
p14311
sg7
g14263
sg9
V17906313.xml
p14312
sa(dp14313
g3
VSTD-Kolko-2001
p14314
sg5
S'PMC3057358'
p14315
sg7
g14263
sg9
V20495474.xml
p14316
sa(dp14317
g3
VSTD-Miller-1982
p14318
sg5
S'PMC1649895'
p14319
sg7
g14263
sg9
V7065320.xml
p14320
sa(dp14321
g3
VSTD-Ohn-2005
p14322
sg5
S'PMC1117156'
p14323
sg7
g14263
sg9
V10574875.xml
p14324
sa(dp14325
g3
VSTD-Hendrickson-2002
p14326
sg5
S'PMC1730268'
p14327
sg7
g14263
sg9
V16203842.xml
p14328
sa(dp14329
g3
VSTD-Yorkston-2007
p14330
sg5
S'PMC2598383'
p14331
sg7
g14263
sg9
V17567977.xml
p14332
sa(dp14333
g3
VSTD-Schlesinger-1966
p14334
sg5
S'PMC1067824'
p14335
sg7
g14263
sg9
V9338837.xml
p14336
sa(dp14337
g3
VSTD-Emond-2002
p14338
sg5
S'PMC1719107'
p14339
sg7
g14263
sg9
V11861228.xml
p14340
sa(dp14341
g3
VSTD-DiGuiseppi-2002
p14342
sg5
S'PMC131023'
p14343
sg7
g14263
sg9
V12411355.xml
p14344
sa(dp14345
g3
VSTD-Kendrick-1999
p14346
sg5
S'PMC27827'
p14347
sg7
g14263
sg9
V10195971.xml
p14348
sa(dp14349
g3
VSTD-Ozanne_x002d_Smith-2002
p14350
sg5
S'PMC1730817'
p14351
sg7
g14263
sg9
V11928967.xml
p14352
sa(dp14353
g3
VSTD-Guyer-1989
p14354
sg5
S'PMC1349806'
p14355
sg7
g14263
sg9
V2817165.xml
p14356
sa(dp14357
g3
VSTD-McLoughlin-1982
p14358
sg5
S'PMC1649807'
p14359
sg7
g14263
sg9
V7058963.xml
p14360
sa(dp14361
g3
VSTD-Clamp-1998
p14362
sg5
S'PMC28560'
p14363
sg7
g14263
sg9
V9596598.xml
p14364
sa(dp14365
g3
VSTD-Svanstrom-1995
p14366
sg5
S'PMC1067586'
p14367
sg7
g14263
sg9
V9346020.xml
p14368
sa(dp14369
g3
VSTD-Hwang-2006
p14370
sg5
S'PMC2563473'
p14371
sg7
g14263
sg9
V17018679.xml
p14372
sa(dp14373
g3
VSTD-Matthews-1988
p14374
sg5
S'PMC3214915'
p14375
sg7
g14263
sg9
V21637293.xml
p14376
sa(dp14377
g3
VSTD-Lindqvist-1998a
p14378
sg5
S'PMC1730829'
p14379
sg7
g14263
sg9
V11928968.xml
p14380
sa(dp14381
g3
VSTD-Mackay-2002
p14382
sg5
S'PMC1649800'
p14383
sg7
g14263
sg9
V7058964.xml
p14384
sa(dp14385
g3
VSTD-Sznajder-2003
p14386
sg5
S'PMC1730977'
p14387
sg7
g14263
sg9
V12966017.xml
p14388
sa(dp14389
g3
VSTD-Johnston-2000
p14390
sg5
S'PMC1730673'
p14391
sg7
g14263
sg9
V11144634.xml
p14392
sa(dp14393
g3
VSTD-Leung-2000
p14394
sg5
S'PMC1421025'
p14395
sg7
VCD003145 v. 5.0 Short term benefits for laparoscopic colorectal resection.rm5
p14396
sg9
V10749610.xml
p14397
sa(dp14398
g3
VSTD-Braga-2002-b
p14399
sg5
S'PMC1422642'
p14400
sg7
g14396
sg9
V12454514.xml
p14401
sa(dp14402
g3
VSTD-Chen-2009
p14403
sg5
S'PMC3104850'
p14404
sg7
VCD003036 v. 10.0 Immediate post-partum insertion of intrauterine devices.rm5
p14405
sg9
V20966692.xml
p14406
sa(dp14407
g3
VSTD-Richter-2010
p14408
sg5
S'PMC2914312'
p14409
sg7
VCD001756 v. 10.0 Mechanical devices for urinary incontinence in women.rm5
p14410
sg9
V20177294.xml
p14411
sa(dp14412
g3
VSTD-Cattarelli-2006
p14413
sg5
S'PMC2672685'
p14414
sg7
VCD001454 v. 10.0 Diuretics for respiratory distress syndrome in preterm infants.rm5
p14415
sg9
V16204359.xml
p14416
sa(dp14417
g3
VSTD-Savage-1975
p14418
sg5
S'PMC1545637'
p14419
sg7
g14415
sg9
V1103753.xml
p14420
sa(dp14421
g3
VSTD-ANRS-1265
p14422
sg5
S'PMC1262556'
p14423
sg7
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p14424
sg9
V16231970.xml
p14425
sa(dp14426
g3
VSTD-SUPPORT-2010
p14427
sg5
S'PMC3071534'
p14428
sg7
VCD000510 v. 7.0 Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm inf.rm5
p14429
sg9
V20472939.xml
p14430
sa(dp14431
g3
VSTD-Stern-1997
p14432
sg5
S'PMC2127436'
p14433
sg7
VMR000011 v. 6.0 Time to publication for results of clinical trials.rm5
p14434
sg9
V9310565.xml
p14435
sa(dp14436
g3
VSTD-Winstanley-2011
p14437
sg5
S'PMC3078567'
p14438
sg7
VCD002950 v. 10.2 Antidepressants for cocaine dependence and problematic cocaine use.rm5
p14439
sg9
V21266301.xml
p14440
sa(dp14441
g3
VSTD-Man-1997
p14442
sg5
S'PMC1191142'
p14443
sg7
VCD007530 v. 1.7 Vascular occlusion for elective liver resections.rm5
p14444
sg9
V9409569.xml
p14445
sa(dp14446
g3
VSTD-London-1981
p14447
sg5
S'PMC1504295'
p14448
sg7
VCD002925 v. 6.0 Therapy-based rehabilitation services for stroke patients at home.rm5
p14449
sg9
V6780105.xml
p14450
sa(dp14451
g3
VSTD-Glasgow-2000
p14452
sg5
S'PMC27300'
p14453
sg7
g14449
sg9
V10698876.xml
p14454
sa(dp14455
g3
VSTD-McMahon-1979
p14456
sg5
S'PMC1597073'
p14457
sg7
VCD000053 v. 6.6 Drugs for treating urinary schistosomiasis.rm5
p14458
sg9
V519476.xml
p14459
sa(dp14460
g3
VSTD-Pugh-1983
p14461
sg5
S'PMC1546776'
p14462
sg7
g14458
sg9
V6401550.xml
p14463
sa(dp14464
g3
VSTD-Schwartz-1982a
p14465
sg5
S'PMC1627732'
p14466
sg7
VCD004401 v. 9.2 Antibiotics for the prevention of acute and chronic suppurative otitis media in children.rm5
p14467
sg9
V7051984.xml
p14468
sa(dp14469
g3
VSTD-Leach-2008
p14470
sg5
S'PMC2443129'
p14471
sg7
g14467
sg9
V18513453.xml
p14472
sa(dp14473
g3
VSTD-EC-Trial-Group-1994
p14474
sg5
S'PMC1061041'
p14475
sg7
VCD004343 v. 3.0 Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infant.rm5
p14476
sg9
V8198414.xml
p14477
sa(dp14478
g3
VSTD-Chant-1985
p14479
sg5
S'PMC1417967'
p14480
sg7
VCD008819 v. 2.2 Compression stockings for the initial treatment of varicose veins in patients without venous ulcerat.rm5
p14481
sg9
V3917751.xml
p14482
sa(dp14483
g3
VSTD-Dube-1981
p14484
sg5
S'PMC3012941'
p14485
sg7
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p14486
sg9
V22058537.xml
p14487
sa(dp14488
g3
VSTD-Kuna-2007
p14489
sg5
S'PMC1920547'
p14490
sg7
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p14491
sg9
V17362472.xml
p14492
sa(dp14493
g3
VSTD-Maspero-2010
p14494
sg5
S'PMC2993043'
p14495
sg7
g14491
sg9
V20874458.xml
p14496
sa(dp14497
g3
VSTD-van-Balen-2003
p14498
sg5
S'PMC274056'
p14499
sg7
VCD004740 v. 3.0 Interventions for acute otitis externa.rm5
p14500
sg9
V14630756.xml
p14501
sa(dp14502
g3
VSTD-Gerard-1988a
p14503
sg5
S'PMC1493780'
p14504
sg7
VCD002102 v. 6.0 Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma.rm5
p14505
sg9
V3056288.xml
p14506
sa(dp14507
g3
VSTD-Podas-2007
p14508
sg5
S'PMC2805936'
p14509
sg7
VCD006400 v. 2.2 Dietary interventions for rheumatoid arthritis.rm5
p14510
sg9
V17308218.xml
p14511
sa(dp14512
g3
VSTD-McKellar-2007
p14513
sg5
S'PMC1955146'
p14514
sg7
g14510
sg9
V17613557.xml
p14515
sa(dp14516
g3
VSTD-Sk_x00f6_ldstam-2003
p14517
sg5
S'PMC1754463'
p14518
sg7
g14510
sg9
V12594104.xml
p14519
sa(dp14520
g3
VSTD-Renner-2001
p14521
sg5
S'PMC1745899'
p14522
sg7
VCD007020 v. 7.0 Antioxidant micronutrients for lung disease in cystic fibrosis.rm5
p14523
sg9
V11120904.xml
p14524
sa(dp14525
g3
VSTD-Wheatley-1969-b
p14526
sg5
S'PMC3606375'
p14527
sg7
VCD006722 v. 3.0 Psychostimulants for depression.rm5
p14528
sg9
V23522244.xml
p14529
sa(dp14530
g3
VSTD-Wheatley-1969-a
p14531
sg5
S'PMC3606375'
p14532
sg7
g14528
sg9
V23522244.xml
p14533
sa(dp14534
g3
VSTD-Cantello-1989
p14535
sg5
S'PMC1032022'
p14536
sg7
g14528
sg9
V2664088.xml
p14537
sa(dp14538
g3
VSTD-Hare-1962
p14539
sg5
S'PMC1959255'
p14540
sg7
g14528
sg9
V13904675.xml
p14541
sa(dp14542
g3
VSTD-Hare-1964
p14543
sg5
S'PMC1815021'
p14544
sg7
g14528
sg9
V14097430.xml
p14545
sa(dp14546
g3
VSTD-Robin-1958
p14547
sg5
S'PMC497294'
p14548
sg7
g14528
sg9
V13514499.xml
p14549
sa(dp14550
g3
VSTD-Ramphal-1992
p14551
sg5
S'PMC188836'
p14552
sg7
VCD003914 v. 9.0 Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.rm5
p14553
sg9
V1510394.xml
p14554
sa(dp14555
g3
VSTD-Verhagen-1987
p14556
sg5
S'PMC174690'
p14557
sg7
g14553
sg9
V3551829.xml
p14558
sa(dp14559
g3
VSTD-De-Pauw-1985
p14560
sg5
S'PMC180337'
p14561
sg7
g14553
sg9
V3909956.xml
p14562
sa(dp14563
g3
VSTD-Novakova-1991
p14564
sg5
S'PMC245077'
p14565
sg7
g14553
sg9
V1829879.xml
p14566
sa(dp14567
g3
VSTD-Del-Favero-1987
p14568
sg5
S'PMC174882'
p14569
sg7
g14553
sg9
V2959198.xml
p14570
sa(dp14571
g3
VSTD-Kiely-2004
p14572
sg5
S'PMC1758841'
p14573
sg7
VCD003002 v. 9.4 Drug therapy for obstructive sleep apnoea in adults.rm5
p14574
sg9
V14694248.xml
p14575
sa(dp14576
g3
VSTD-Prasad-2010
p14577
sg5
S'PMC2894441'
p14578
sg7
g14574
sg9
V20614859.xml
p14579
sa(dp14580
g3
VSTD-Marshall-2008
p14581
sg5
S'PMC2442407'
p14582
sg7
g14574
sg9
V18548827.xml
p14583
sa(dp14584
g3
VSTD-Eckert-2011
p14585
sg5
S'PMC3415379'
p14586
sg7
g14574
sg9
V21269278.xml
p14587
sa(dp14588
g3
VSTD-Barclay-1987
p14589
sg5
S'PMC1245303'
p14590
sg7
VCD001479 v. 12.0 Vitamin A for treating measles in children.rm5
p14591
sg9
V3101849.xml
p14592
sa(dp14593
g3
VSTD-Dorman-2008
p14594
sg5
S'PMC2666004'
p14595
sg7
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p14596
sg9
V18427286.xml
p14597
sa(dp14598
g3
VSTD-Harley-2002
p14599
sg5
S'PMC3686948'
p14600
sg7
g14596
sg9
V12067170.xml
p14601
sa(dp14602
g3
VSTD-Penta-de-Peppo-1995
p14603
sg5
S'PMC325258'
p14604
sg7
g14596
sg9
V7580360.xml
p14605
sa(dp14606
g3
VSTD-Desai-2009
p14607
sg5
S'PMC2789288'
p14608
sg7
g14596
sg9
V19843776.xml
p14609
sa(dp14610
g3
VSTD-Berenholtz-2009
p14611
sg5
S'PMC2772136'
p14612
sg7
g14596
sg9
V19730217.xml
p14613
sa(dp14614
g3
VSTD-Jimenez-2007
p14615
sg5
S'PMC2246206'
p14616
sg7
g14596
sg9
V17988379.xml
p14617
sa(dp14618
g3
VSTD-Apostolakis-2008
p14619
sg5
S'PMC2287179'
p14620
sg7
g14596
sg9
V18361800.xml
p14621
sa(dp14622
g3
VSTD-Yamasaki-2004
p14623
sg5
S'PMC3474476'
p14624
sg7
g14596
sg9
V15224162.xml
p14625
sa(dp14626
g3
VSTD-Wu-2006
p14627
sg5
S'PMC1448924'
p14628
sg7
g14596
sg9
V16432349.xml
p14629
sa(dp14630
g3
VSTD-Hashimoto-2007
p14631
sg5
S'PMC1877080'
p14632
sg7
VCD007338 v. 3.0 Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver re.rm5
p14633
sg9
V17457160.xml
p14634
sa(dp14635
g3
VSTD-Estonian-blind-trial
p14636
sg5
S'PMC2702282'
p14637
sg7
VCD009672 v. 2.0 Hormone therapy for sexual function in perimenopausal and postmenopausal women.rm5
p14638
sg9
V19505307.xml
p14639
sa(dp14640
g3
VSTD-Estonian-non_x002d_blind-trial
p14641
sg5
S'PMC2702282'
p14642
sg7
g14638
sg9
V19505307.xml
p14643
sa(dp14644
g3
VSTD-Peng-2011
p14645
sg5
S'PMC3177872'
p14646
sg7
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p14647
sg9
V21835046.xml
p14648
sa(dp14649
g3
VSTD-Schmidt-2010
p14650
sg5
S'PMC2840249'
p14651
sg7
g14647
sg9
V20300220.xml
p14652
sa(dp14653
g3
VSTD-Krouse-2009
p14654
sg5
S'PMC2754912'
p14655
sg7
g14647
sg9
V19720920.xml
p14656
sa(dp14657
g3
VSTD-Engel-2003
p14658
sg5
S'PMC1422675'
p14659
sg7
g14647
sg9
V12894013.xml
p14660
sa(dp14661
g3
VSTD-Allal-2000
p14662
sg5
S'PMC2363346'
p14663
sg7
g14647
sg9
V10735495.xml
p14664
sa(dp14665
g3
VSTD-Campos_x002d_Lobato-2011
p14666
sg5
S'PMC3129949'
p14667
sg7
g14647
sg9
V21808871.xml
p14668
sa(dp14669
g3
VSTD-Grumann-2001
p14670
sg5
S'PMC1421194'
p14671
sg7
g14647
sg9
V11176118.xml
p14672
sa(dp14673
g3
VSTD-Smith_x002d_Gagen-2009
p14674
sg5
S'PMC2911491'
p14675
sg7
g14647
sg9
V19862692.xml
p14676
sa(dp14677
g3
VSTD-Jenkins-1989
p14678
sg5
S'PMC461992'
p14679
sg7
VCD004466 v. 5.0 Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft.rm5
p14680
sg9
V2799743.xml
p14681
sa(dp14682
g3
VSTD-Stenius-Aarniaala-2000
p14683
sg5
S'PMC27319'
p14684
sg7
VCD009339 v. 2.0 Weight loss interventions for chronic asthma.rm5
p14685
sg9
V10731173.xml
p14686
sa(dp14687
g3
VSTD-Martinuzzi-2007
p14688
sg5
S'PMC2949319'
p14689
sg7
VCD003458 v. 7.0 Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).rm5
p14690
sg9
V17915574.xml
p14691
sa(dp14692
g3
VSTD-Dowswell-1996
p14693
sg5
S'PMC2350434'
p14694
sg7
VCD000352 v. 11.0 Planned hospital birth versus planned home birth.rm5
p14695
sg9
V8605464.xml
p14696
sa(dp14697
g3
VSTD-Femi_x002d_Pearse-1977
p14698
sg5
S'PMC1605098'
p14699
sg7
VCD010256 v. 1.14 Intravenous beta2-agonists versus intravenous aminophylline for acute asthma.rm5
p14700
sg9
V319876.xml
p14701
sa(dp14702
g3
VSTD-Roberts-2003
p14703
sg5
S'PMC1746646'
p14704
sg7
g14700
sg9
V12668792.xml
p14705
sa(dp14706
g3
VSTD-Williams-1975
p14707
sg5
S'PMC1675841'
p14708
sg7
g14700
sg9
V1106817.xml
p14709
sa(dp14710
g3
VSTD-Hambleton-1979
p14711
sg5
S'PMC1545558'
p14712
sg7
g14700
sg9
V383024.xml
p14713
sa(dp14714
g3
VSTD-Johnson-1978
p14715
sg5
S'PMC1603977'
p14716
sg7
g14700
sg9
V638577.xml
p14717
sa(dp14718
g3
VSTD-SHIP-1999
p14719
sg5
S'PMC27782'
p14720
sg7
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p14721
sg9
V10074017.xml
p14722
sa(dp14723
g3
VSTD-Feder-1999
p14724
sg5
S'PMC27895'
p14725
sg7
g14721
sg9
V10356008.xml
p14726
sa(dp14727
g3
VSTD-Campbell-1998
p14728
sg5
S'PMC1728827'
p14729
sg7
g14721
sg9
V9930042.xml
p14730
sa(dp14731
g3
VSTD-Eccles-2002
p14732
sg5
S'PMC130060'
p14733
sg7
g14721
sg9
V12399345.xml
p14734
sa(dp14735
g3
VSTD-Kiessling-2002
p14736
sg5
S'PMC129638'
p14737
sg7
g14721
sg9
V12386042.xml
p14738
sa(dp14739
g3
VSTD-Moher-2001b-_x0028_nurse-led_x0029_
p14740
sg5
S'PMC32168'
p14741
sg7
g14721
sg9
V11387182.xml
p14742
sa(dp14743
g3
VSTD-Cupples-1994a
p14744
sg5
S'PMC2541257'
p14745
sg7
g14721
sg9
V7950723.xml
p14746
sa(dp14747
g3
VSTD-SPHERE
p14748
sg5
S'PMC2770592'
p14749
sg7
g14721
sg9
V19875426.xml
p14750
sa(dp14751
g3
VSTD-Moher-2001a-_x0028_GP-led_x0029_
p14752
sg5
S'PMC32168'
p14753
sg7
g14721
sg9
V11387182.xml
p14754
sa(dp14755
g3
VSTD-Campbell-1966
p14756
sg5
S'PMC496031'
p14757
sg7
VCD005451 v. 14.0 Carbamazepine for acute and chronic pain in adults.rm5
p14758
sg9
V5327969.xml
p14759
sa(dp14760
g3
VSTD-Knubben-2007
p14761
sg5
S'PMC2465130'
p14762
sg7
VCD004366 v. 11.2 Exercise for depression.rm5
p14763
sg9
V17062659.xml
p14764
sa(dp14765
g3
VSTD-Blumenthal-2007
p14766
sg5
S'PMC2702700'
p14767
sg7
g14763
sg9
V17846259.xml
p14768
sa(dp14769
g3
VSTD-Brenes-2007
p14770
sg5
S'PMC2885010'
p14771
sg7
g14763
sg9
V17164159.xml
p14772
sa(dp14773
g3
VSTD-Veale--1992
p14774
sg5
S'PMC1293641'
p14775
sg7
g14763
sg9
V1433121.xml
p14776
sa(dp14777
g3
VSTD-Martinsen-1985
p14778
sg5
S'PMC1416251'
p14779
sg7
g14763
sg9
V3926074.xml
p14780
sa(dp14781
g3
VSTD-Mutrie-1988
p14782
sg5
S'PMC3505536'
p14783
sg7
g14763
sg9
V22836201.xml
p14784
sa(dp14785
g3
VSTD-Williams-2008
p14786
sg5
S'PMC2475651'
p14787
sg7
g14763
sg9
V18297481.xml
p14788
sa(dp14789
g3
VSTD-Pilu-2007
p14790
sg5
S'PMC1976311'
p14791
sg7
g14763
sg9
V17620123.xml
p14792
sa(dp14793
g3
VSTD-Kumagai-1999
p14794
sg5
S'PMC3589943'
p14795
sg7
VCD003438 v. 9.8 Interventions for increasing pedestrian and cyclist visibility for the prevention of death and injur.rm5
p14796
sg9
V23263729.xml
p14797
sa(dp14798
g3
VSTD-Tartter-1992
p14799
sg5
S'PMC1242709'
p14800
sg7
VCD005033 v. 6.0 Perioperative blood transfusions and recurrence of colorectal cancer.rm5
p14801
sg9
V1466616.xml
p14802
sa(dp14803
g3
VSTD-Frankish-1985
p14804
sg5
S'PMC1415976'
p14805
sg7
g14801
sg9
V3924274.xml
p14806
sa(dp14807
g3
VSTD-Sene-1993
p14808
sg5
S'PMC2497917'
p14809
sg7
g14801
sg9
V8379630.xml
p14810
sa(dp14811
g3
VSTD-Creasy-1987
p14812
sg5
S'PMC2498481'
p14813
sg7
g14801
sg9
V3605994.xml
p14814
sa(dp14815
g3
VSTD-Cheslyn_x002d_Curtis-1990
p14816
sg5
S'PMC2499079'
p14817
sg7
g14801
sg9
V2405765.xml
p14818
sa(dp14819
g3
VSTD-Evans-2007
p14820
sg5
S'PMC2465009'
p14821
sg7
VCD005609 v. 3.4 Interventions to increase clinical incident reporting in health care.rm5
p14822
sg9
V17545341.xml
p14823
sa(dp14824
g3
VSTD-Pickard-1989
p14825
sg5
S'PMC1835889'
p14826
sg7
VCD000277 v. 7.0 Calcium antagonists for aneurysmal subarachnoid haemorrhage.rm5
p14827
sg9
V2496789.xml
p14828
sa(dp14829
g3
VSTD-Lawn-2005
p14830
sg5
S'PMC1721729'
p14831
sg7
VCD003215 v. 5.0 Base administration or fluid bolus for preventing morbidity and mortality in preterm infants with me.rm5
p14832
sg9
V15210676.xml
p14833
sa(dp14834
g3
VSTD-Humphreys-2011
p14835
sg5
S'PMC3053017'
p14836
sg7
VCD007007 v. 3.0 Screening women for intimate partner violence in healthcare settings.rm5
p14837
sg9
V21185737.xml
p14838
sa(dp14839
g3
VSTD-Carroll-2005
p14840
sg5
S'PMC1180654'
p14841
sg7
g14837
sg9
V16076821.xml
p14842
sa(dp14843
g3
VSTD-Kataoka-2010
p14844
sg5
S'PMC3017017'
p14845
sg7
g14837
sg9
V21182802.xml
p14846
sa(dp14847
g3
VSTD-Jensen-1990
p14848
sg5
S'PMC462778'
p14849
sg7
VCD000191 v. 8.2 Silver acetate for smoking cessation.rm5
p14850
sg9
V2256009.xml
p14851
sa(dp14852
g3
VSTD-ART_x002d_LINC-2009
p14853
sg5
S'PMC2956749'
p14854
sg7
VCD008494 v. 2.0 Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens .rm5
p14855
sg9
V19531928.xml
p14856
sa(dp14857
g3
VSTD-Ferguson-1997
p14858
sg5
S'PMC1758547'
p14859
sg7
VCD004435 v. 8.2 Oral appliances for obstructive sleep apnoea.rm5
p14860
sg9
V9196520.xml
p14861
sa(dp14862
g3
VSTD-Lam-2007
p14863
sg5
S'PMC2092459'
p14864
sg7
g14860
sg9
V17121868.xml
p14865
sa(dp14866
g3
VSTD-Dowell-2001
p14867
sg5
S'PMC1313951'
p14868
sg7
VCD004417 v. 13.0 Delayed antibiotics for respiratory infections.rm5
p14869
sg9
V11255901.xml
p14870
sa(dp14871
g3
VSTD-Little-1997
p14872
sg5
S'PMC2126131'
p14873
sg7
g14869
sg9
V9116551.xml
p14874
sa(dp14875
g3
VSTD-Little-2001
p14876
sg5
S'PMC26576'
p14877
sg7
g14869
sg9
V11159657.xml
p14878
sa(dp14879
g3
VSTD-Eime-2005
p14880
sg5
S'PMC1725311'
p14881
sg7
VCD006527 v. 4.2 Educational interventions for the prevention of eye injuries.rm5
p14882
sg9
V16118310.xml
p14883
sa(dp14884
g3
VSTD-McCulloch-1983
p14885
sg5
S'PMC1550062'
p14886
sg7
VCD008722 v. 2.0 Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in.rm5
p14887
sg9
V6423045.xml
p14888
sa(dp14889
g3
VSTD-Ell-2008
p14890
sg5
S'PMC2653113'
p14891
sg7
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p14892
sg9
V18802161.xml
p14893
sa(dp14894
g3
VSTD-Chew_x002d_Graham-2007
p14895
sg5
S'PMC2047010'
p14896
sg7
g14892
sg9
V17504586.xml
p14897
sa(dp14898
g3
VSTD-Cole-2006
p14899
sg5
S'PMC1319344'
p14900
sg7
g14892
sg9
V16330624.xml
p14901
sa(dp14902
g3
VSTD-Chaney-2011
p14903
sg5
S'PMC3219630'
p14904
sg7
g14892
sg9
V22032247.xml
p14905
sa(dp14906
g3
VSTD-Simon-2011
p14907
sg5
S'PMC3138593'
p14908
sg7
g14892
sg9
V21384219.xml
p14909
sa(dp14910
g3
VSTD-Vera-2010
p14911
sg5
S'PMC2900833'
p14912
sg7
g14892
sg9
V20123819.xml
p14913
sa(dp14914
g3
VSTD-Ell-2007
p14915
sg5
S'PMC1986637'
p14916
sg7
g14892
sg9
V17804354.xml
p14917
sa(dp14918
g3
VSTD-Gjerdingen-2009
p14919
sg5
S'PMC2791714'
p14920
sg7
g14892
sg9
V19734392.xml
p14921
sa(dp14922
g3
VSTD-Hilty-2007
p14923
sg5
S'PMC2922348'
p14924
sg7
g14892
sg9
V20805900.xml
p14925
sa(dp14926
g3
VSTD-Hedrick-2003
p14927
sg5
S'PMC1494801'
p14928
sg7
g14892
sg9
V12534758.xml
p14929
sa(dp14930
g3
VSTD-Bogner-2010
p14931
sg5
S'PMC2858776'
p14932
sg7
g14892
sg9
V20040705.xml
p14933
sa(dp14934
g3
VSTD-Landis-2007
p14935
sg5
S'PMC1838423'
p14936
sg7
g14892
sg9
V17338822.xml
p14937
sa(dp14938
g3
VSTD-Piette-2011
p14939
sg5
S'PMC3117978'
p14940
sg7
g14892
sg9
V21478777.xml
p14941
sa(dp14942
g3
VSTD-Fortney-2007
p14943
sg5
S'PMC2305730'
p14944
sg7
g14892
sg9
V17492326.xml
p14945
sa(dp14946
g3
VSTD-Kroenke-2010
p14947
sg5
S'PMC3010214'
p14948
sg7
g14892
sg9
V20628129.xml
p14949
sa(dp14950
g3
VSTD-Simon-2000a
p14951
sg5
S'PMC27299'
p14952
sg7
g14892
sg9
V10688563.xml
p14953
sa(dp14954
g3
VSTD-Simon-2000b
p14955
sg5
S'PMC27299'
p14956
sg7
g14892
sg9
V10688563.xml
p14957
sa(dp14958
g3
VSTD-Rubenstein-2002
p14959
sg5
S'PMC1464007'
p14960
sg7
g14892
sg9
V12236381.xml
p14961
sa(dp14962
g3
VSTD-Dietrich-2004
p14963
sg5
S'PMC516659'
p14964
sg7
g14892
sg9
V15345600.xml
p14965
sa(dp14966
g3
VSTD-Mann-1998
p14967
sg5
S'PMC1409896'
p14968
sg7
g14892
sg9
V9604408.xml
p14969
sa(dp14970
g3
VSTD-Rollman-2009
p14971
sg5
S'PMC3010227'
p14972
sg7
g14892
sg9
V19918088.xml
p14973
sa(dp14974
g3
VSTD-Richards-2012
p14975
sg5
S'PMC2770465'
p14976
sg7
g14892
sg9
V19832996.xml
p14977
sa(dp14978
g3
VSTD-Roy_x002d_Byrne-2010
p14979
sg5
S'PMC2928714'
p14980
sg7
g14892
sg9
V20483968.xml
p14981
sa(dp14982
g3
VSTD-Rost-2001a
p14983
sg5
S'PMC130058'
p14984
sg7
g14892
sg9
V12399343.xml
p14985
sa(dp14986
g3
VSTD-Waitzkin-2011
p14987
sg5
S'PMC3051073'
p14988
sg7
g14892
sg9
V20882400.xml
p14989
sa(dp14990
g3
VSTD-Buszewicz-2010
p14991
sg5
S'PMC2923105'
p14992
sg7
g14892
sg9
V20684786.xml
p14993
sa(dp14994
g3
VSTD-McMahon-2007
p14995
sg5
S'PMC2169311'
p14996
sg7
g14892
sg9
V17976288.xml
p14997
sa(dp14998
g3
VSTD-Roy_x002d_Byrne-2005
p14999
sg5
S'PMC1237029'
p15000
sg7
g14892
sg9
V15753242.xml
p15001
sa(dp15002
g3
VSTD-Yeung-2010
p15003
sg5
S'PMC2978195'
p15004
sg7
g14892
sg9
V20966373.xml
p15005
sa(dp15006
g3
VSTD-Bogner-2008
p15007
sg5
S'PMC2478504'
p15008
sg7
g14892
sg9
V18626028.xml
p15009
sa(dp15010
g3
VSTD-Katon-2010
p15011
sg5
S'PMC3312811'
p15012
sg7
g14892
sg9
V21190455.xml
p15013
sa(dp15014
g3
VSTD-Ell-2010
p15015
sg5
S'PMC2845010'
p15016
sg7
g14892
sg9
V20097780.xml
p15017
sa(dp15018
g3
VSTD-Ross-2008
p15019
sg5
S'PMC2518035'
p15020
sg7
g14892
sg9
V18498013.xml
p15021
sa(dp15022
g3
VSTD-Powis-1976
p15023
sg5
S'PMC1689580'
p15024
sg7
VCD004122 v. 8.2 Preoperative hair removal to reduce surgical site infection.rm5
p15025
sg9
V791444.xml
p15026
sa(dp15027
g3
VSTD-Ben_x002d_Dov-1983
p15028
sg5
S'PMC459615'
p15029
sg7
VCD002986 v. 10.0 Ionisers for chronic asthma.rm5
p15030
sg9
V6351332.xml
p15031
sa(dp15032
g3
VSTD-Lipin-1984
p15033
sg5
S'PMC1020511'
p15034
sg7
g15030
sg9
V6474386.xml
p15035
sa(dp15036
g3
VSTD-Nogrady-1983
p15037
sg5
S'PMC459697'
p15038
sg7
g15030
sg9
V6364442.xml
p15039
sa(dp15040
g3
VSTD-Warner-1993
p15041
sg5
S'PMC464427'
p15042
sg7
g15030
sg9
V8511730.xml
p15043
sa(dp15044
g3
VSTD-Grunewald-1994
p15045
sg5
S'PMC1073126'
p15046
sg7
VCD007302 v. 4.0 Vigabatrin for refractory partial epilepsy.rm5
p15047
sg9
V8089668.xml
p15048
sa(dp15049
g3
VSTD-AREDS
p15050
sg5
S'PMC1462955'
p15051
sg7
VCD000254 v. 14.2 Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degen.rm5
p15052
sg9
V11594942.xml
p15053
sa(dp15054
g3
VSTD-Lopez_x002d_Pousa-2005
p15055
sg5
S'PMC3546803'
p15056
sg7
VCD001191 v. 16.4 Rivastigmine for Alzheimer's disease.rm5
p15057
sg9
V23341737.xml
p15058
sa(dp15059
g3
VSTD-B304
p15060
sg5
S'PMC2117538'
p15061
sg7
g15057
sg9
V17353259.xml
p15062
sa(dp15063
g3
VSTD-Ballard-2005
p15064
sg5
S'PMC556156'
p15065
sg7
g15057
sg9
V15722369.xml
p15066
sa(dp15067
g3
VSTD-Saxena-2009
p15068
sg5
S'PMC2900101'
p15069
sg7
VCD009107 v. 4.0 Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain manag.rm5
p15070
sg9
V20640118.xml
p15071
sa(dp15072
g3
VSTD-Govaert-1993
p15073
sg5
S'PMC1679213'
p15074
sg7
VCD002733 v. 10.0 Influenza vaccine for patients with chronic obstructive pulmonary disease.rm5
p15075
sg9
V8241913.xml
p15076
sa(dp15077
g3
VSTD-Ginsberg-1999
p15078
sg5
S'PMC1230312'
p15079
sg7
VCD004177 v. 6.0 Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome.rm5
p15080
sg9
V10333832.xml
p15081
sa(dp15082
g3
VSTD-Schumer-1976
p15083
sg5
S'PMC1344393'
p15084
sg7
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p15085
sg9
V786190.xml
p15086
sa(dp15087
g3
VSTD-Yildiz-2002
p15088
sg5
S'PMC125315'
p15089
sg7
g15085
sg9
V12133187.xml
p15090
sa(dp15091
g3
VSTD-Burton-2010
p15092
sg5
S'PMC2882221'
p15093
sg7
VCD008422 v. 2.0 Vitamin D for the management of multiple sclerosis.rm5
p15094
sg9
V20427749.xml
p15095
sa(dp15096
g3
VSTD-Uludag-2009
p15097
sg5
S'PMC3015970'
p15098
sg7
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p15099
sg9
V19793473.xml
p15100
sa(dp15101
g3
VSTD-Harling-2000
p15102
sg5
S'PMC2503474'
p15103
sg7
g15099
sg9
V11103159.xml
p15104
sa(dp15105
g3
VSTD-Godfrey-1976
p15106
sg5
S'PMC470375'
p15107
sg7
VCD002307 v. 8.2 Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.rm5
p15108
sg9
V821168.xml
p15109
sa(dp15110
g3
VSTD-Tullett-1982
p15111
sg5
S'PMC459417'
p15112
sg7
g15108
sg9
V6218645.xml
p15113
sa(dp15114
g3
VSTD-Neijens-1981a
p15115
sg5
S'PMC1020434'
p15116
sg7
g15108
sg9
V6797085.xml
p15117
sa(dp15118
g3
VSTD-Thompson-1978
p15119
sg5
S'PMC470965'
p15120
sg7
g15108
sg9
V154747.xml
p15121
sa(dp15122
g3
VSTD-TORDIA
p15123
sg5
S'PMC3257891'
p15124
sg7
VCD007504 v. 4.0 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolesc.rm5
p15125
sg9
V20478877.xml
p15126
sa(dp15127
g3
VSTD-TADS
p15128
sg5
S'PMC2587406'
p15129
sg7
g15125
sg9
V18391133.xml
p15130
sa(dp15131
g3
VSTD-Emslie-2008
p15132
sg5
S'PMC2824429'
p15133
sg7
g15125
sg9
V18281410.xml
p15134
sa(dp15135
g3
VSTD-Kennard-2008
p15136
sg5
S'PMC2826176'
p15137
sg7
g15125
sg9
V18978634.xml
p15138
sa(dp15139
g3
VSTD-Hamdy-1995
p15140
sg5
S'PMC2548761'
p15141
sg7
VCD008175 v. 1.2 Vitamin D compounds for people with chronic kidney disease not requiring dialysis.rm5
p15142
sg9
V7677827.xml
p15143
sa(dp15144
g3
VSTD-Miller-2005
p15145
sg5
S'PMC1720314'
p15146
sg7
VCD004407 v. 8.2 Vaccines for measles mumps and rubella in children.rm5
p15147
sg9
V15723921.xml
p15148
sa(dp15149
g3
VSTD-Bremner-2005
p15150
sg5
S'PMC1720414'
p15151
sg7
g15147
sg9
V15908618.xml
p15152
sa(dp15153
g3
VSTD-Benjamin-1992
p15154
sg5
S'PMC1881909'
p15155
sg7
g15147
sg9
V1586818.xml
p15156
sa(dp15157
g3
VSTD-Schlegel-1999
p15158
sg5
S'PMC32261'
p15159
sg7
g15147
sg9
V10435956.xml
p15160
sa(dp15161
g3
VSTD-Mackenzie-2006
p15162
sg5
S'PMC1872063'
p15163
sg7
g15147
sg9
V16834879.xml
p15164
sa(dp15165
g3
VSTD-McKeever-2004
p15166
sg5
S'PMC1448377'
p15167
sg7
g15147
sg9
V15249303.xml
p15168
sa(dp15169
g3
VSTD-Robertson-1988
p15170
sg5
S'PMC1778844'
p15171
sg7
g15147
sg9
V3291787.xml
p15172
sa(dp15173
g3
VSTD-Freeman-1993
p15174
sg5
S'PMC1485961'
p15175
sg7
g15147
sg9
V8242506.xml
p15176
sa(dp15177
g3
VSTD-Black-2003
p15178
sg5
S'PMC1884189'
p15179
sg7
g15147
sg9
V12534647.xml
p15180
sa(dp15181
g3
VSTD-Seagroatt-2005
p15182
sg5
S'PMC557892'
p15183
sg7
g15147
sg9
V15837703.xml
p15184
sa(dp15185
g3
VSTD-Canada-2000
p15186
sg5
S'PMC1407745'
p15187
sg7
VCD000967 v. 13.0 Quetiapine for schizophrenia.rm5
p15188
sg9
V11291531.xml
p15189
sa(dp15190
g3
VSTD-Spittle-2009a
p15191
sg5
S'PMC2797495'
p15192
sg7
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p15193
sg9
V19954550.xml
p15194
sa(dp15195
g3
VSTD-APIP-1998
p15196
sg5
S'PMC1720827'
p15197
sg7
g15193
sg9
V9797618.xml
p15198
sa(dp15199
g3
VSTD-Stansfeld-1975
p15200
sg5
S'PMC1673626'
p15201
sg7
VCD001534 v. 10.0 Long-term antibiotics for preventing recurrent urinary tract infection in children.rm5
p15202
sg9
V1095132.xml
p15203
sa(dp15204
g3
VSTD-Connett-1994
p15205
sg5
S'PMC1029734'
p15206
sg7
VCD002886 v. 4.0 Corticosteroids for hospitalised children with acute asthma.rm5
p15207
sg9
V8135557.xml
p15208
sa(dp15209
g3
VSTD-Karlen-1998a
p15210
sg5
S'PMC1727094'
p15211
sg7
VCD000279 v. 7.0 Strategies for detecting colon cancer andor dysplasia in patients with inflammatory bowel disease.rm5
p15212
sg9
V9659169.xml
p15213
sa(dp15214
g3
VSTD-Taniguchi-2009
p15215
sg5
S'PMC2688118'
p15216
sg7
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p15217
sg9
V19171056.xml
p15218
sa(dp15219
g3
VSTD-Isle-of-Wight-2003
p15220
sg5
S'PMC1746711'
p15221
sg7
VCD006480 v. 4.0 Mono and multifaceted inhalant andor food allergen reduction interventions for preventing asthma in.rm5
p15222
sg9
V12775858.xml
p15223
sa(dp15224
g3
VSTD-zLondon-Kingsbury-94
p15225
sg5
S'PMC2495782'
p15226
sg7
VCD003177 v. 5.0 Omega 3 fatty acids for prevention and treatment of cardiovascular disease.rm5
p15227
sg9
V4469034.xml
p15228
sa(dp15229
g3
VSTD-zFinnish-Miettinen
p15230
sg5
S'PMC1500325'
p15231
sg7
g15227
sg9
V6812744.xml
p15232
sa(dp15233
g3
VSTD-Hawthorne-1992
p15234
sg5
S'PMC1379405'
p15235
sg7
g15227
sg9
V1353742.xml
p15236
sa(dp15237
g3
VSTD-Houghton-2007
p15238
sg5
S'PMC1971055'
p15239
sg7
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p15240
sg9
V17629923.xml
p15241
sa(dp15242
g3
VSTD-Koopmans-2006
p15243
sg5
S'PMC2104614'
p15244
sg7
g15240
sg9
V16449264.xml
p15245
sa(dp15246
g3
VSTD-Price-2002
p15247
sg5
S'PMC1746437'
p15248
sg7
g15240
sg9
V12200524.xml
p15249
sa(dp15250
g3
VSTD-van-der-Molen-1997
p15251
sg5
S'PMC1758577'
p15252
sg7
g15240
sg9
V9227720.xml
p15253
sa(dp15254
g3
VSTD-Akpinarli-1999
p15255
sg5
S'PMC1717973'
p15256
sg7
g15240
sg9
V10373134.xml
p15257
sa(dp15258
g3
VSTD-Morino-2005
p15259
sg5
S'PMC1409879'
p15260
sg7
VCD007886 v. 2.0 Energy source instruments for laparoscopic colectomy.rm5
p15261
sg9
V16327500.xml
p15262
sa(dp15263
g3
VSTD-Skowron-1966-A_x0026_B
p15264
sg5
S'PMC1936541'
p15265
sg7
VCD001955 v. 11.6 Glucocorticoids for croup.rm5
p15266
sg9
V5324105.xml
p15267
sa(dp15268
g3
VSTD-Husby-1993
p15269
sg5
S'PMC1793858'
p15270
sg7
g15266
sg9
V8466237.xml
p15271
sa(dp15272
g3
VSTD-Sparrow--2006
p15273
sg5
S'PMC2082835'
p15274
sg7
g15266
sg9
V16624882.xml
p15275
sa(dp15276
g3
VSTD-Godden-1997
p15277
sg5
S'PMC1717068'
p15278
sg7
g15266
sg9
V9068309.xml
p15279
sa(dp15280
g3
VSTD-Geelhoed-1996a
p15281
sg5
S'PMC2351559'
p15282
sg7
g15266
sg9
V8688774.xml
p15283
sa(dp15284
g3
VSTD-Skowron-1966a
p15285
sg5
S'PMC1936541'
p15286
sg7
g15266
sg9
V5324105.xml
p15287
sa(dp15288
g3
VSTD-Skowron-1966b
p15289
sg5
S'PMC1936541'
p15290
sg7
g15266
sg9
V5324105.xml
p15291
sa(dp15292
g3
VSTD-STOP-2-2005
p15293
sg5
S'PMC2867598'
p15294
sg7
VCD003146 v. 9.0 Blood transfusion for preventing stroke in people with sickle cell disease.rm5
p15295
sg9
V17243135.xml
p15296
sa(dp15297
g3
VSTD-Britt-1977
p15298
sg5
S'PMC351960'
p15299
sg7
VCD005428 v. 6.0 Antibiotic prophylaxis for short-term catheter bladder drainage in adults.rm5
p15300
sg9
V848927.xml
p15301
sa(dp15302
g3
VSTD-Wise-1989
p15303
sg5
S'PMC1874432'
p15304
sg7
VCD004096 v. 4.0 Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.rm5
p15305
sg9
V12236844.xml
p15306
sa(dp15307
g3
VSTD-Davies-2000
p15308
sg5
S'PMC27532'
p15309
sg7
VCD007491 v. 5.2 Hospital at home admission avoidance.rm5
p15310
sg9
V11082090.xml
p15311
sa(dp15312
g3
VSTD-Wilson-1999
p15313
sg5
S'PMC28299'
p15314
sg7
g15310
sg9
V10591717.xml
p15315
sa(dp15316
g3
VSTD-Corwin-2005
p15317
sg5
S'PMC544431'
p15318
sg7
g15310
sg9
V15604157.xml
p15319
sa(dp15320
g3
VSTD-Dippel-2003a
p15321
sg5
S'PMC101394'
p15322
sg7
VCD001247 v. 7.3 Cooling therapy for acute stroke.rm5
p15323
sg9
V11918829.xml
p15324
sa(dp15325
g3
VSTD-Campbell--1997
p15326
sg5
S'PMC2127698'
p15327
sg7
VCD004963 v. 6.0 Exercise for improving balance in older people.rm5
p15328
sg9
V9366737.xml
p15329
sa(dp15330
g3
VSTD-Spiro-1989
p15331
sg5
S'PMC2247136'
p15332
sg7
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p15333
sg9
V2540788.xml
p15334
sa(dp15335
g3
VSTD-Malcolm-2006
p15336
sg5
S'PMC2605430'
p15337
sg7
VCD008862 v. 3.0 Repetitive transcranial magnetic stimulation for improving function after stroke.rm5
p15338
sg9
V17709994.xml
p15339
sa(dp15340
g3
VSTD-Magill-1995
p15341
sg5
S'PMC1239433'
p15342
sg7
VCD003415 v. 8.0 Progesterone for premenstrual syndrome.rm5
p15343
sg9
V8554838.xml
p15344
sa(dp15345
g3
VSTD-Byrne-2005
p15346
sg5
S'PMC1409868'
p15347
sg7
VCD006321 v. 3.0 Human growth hormone and glutamine for patients with short bowel syndrome.rm5
p15348
sg9
V16244538.xml
p15349
sa(dp15350
g3
VSTD-Elleg_x00e5_rd-1997
p15351
sg5
S'PMC1190610'
p15352
sg7
g15348
sg9
V8998124.xml
p15353
sa(dp15354
g3
VSTD-Szkudlarek-2000
p15355
sg5
S'PMC1727998'
p15356
sg7
g15348
sg9
V10896910.xml
p15357
sa(dp15358
g3
VSTD-Congeni-1984
p15359
sg5
S'PMC185431'
p15360
sg7
VCD001832 v. 9.0 Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningi.rm5
p15361
sg9
V6322681.xml
p15362
sa(dp15363
g3
VSTD-Bryan-1985
p15364
sg5
S'PMC180254'
p15365
sg7
g15361
sg9
V4073858.xml
p15366
sa(dp15367
g3
VSTD-Wintzen-2007
p15368
sg5
S'PMC1915648'
p15369
sg7
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p15370
sg9
V17285226.xml
p15371
sa(dp15372
g3
VSTD-Koninckx-2008
p15373
sg5
S'PMC2517154'
p15374
sg7
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p15375
sg9
V18556683.xml
p15376
sa(dp15377
g3
VSTD-Dondorp-2010
p15378
sg5
S'PMC3033534'
p15379
sg7
VCD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
p15380
sg9
V21062666.xml
p15381
sa(dp15382
g3
VSTD-Glover-1974
p15383
sg5
S'PMC1009544'
p15384
sg7
VCD008880 v. 3.0 Spinal manipulative therapy for acute low-back pain.rm5
p15385
sg9
V4274488.xml
p15386
sa(dp15387
g3
VSTD-Seferlis-1998
p15388
sg5
S'PMC3611294'
p15389
sg7
g15385
sg9
V9883955.xml
p15390
sa(dp15391
g3
VSTD-Essen-1995
p15392
sg5
S'PMC1234752'
p15393
sg7
VCD006231 v. 2.0 Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p15394
sg9
V7618966.xml
p15395
sa(dp15396
g3
VSTD-Clavien-2003
p15397
sg5
S'PMC1356166'
p15398
sg7
VCD007629 v. 1.2 Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion.rm5
p15399
sg9
V14631221.xml
p15400
sa(dp15401
g3
VSTD-Balasch-2001
p15402
sg5
S'PMC3455335'
p15403
sg7
VCD005070 v. 5.0 Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproducti.rm5
p15404
sg9
V11464575.xml
p15405
sa(dp15406
g3
VSTD-De-Jong-2008
p15407
sg5
S'PMC2194921'
p15408
sg7
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p15409
sg9
V18213383.xml
p15410
sa(dp15411
g3
VSTD-Amirabdollahian-2007
p15412
sg5
S'PMC1819386'
p15413
sg7
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p15414
sg9
V17309791.xml
p15415
sa(dp15416
g3
VSTD-Kahn-2006
p15417
sg5
S'PMC1550245'
p15418
sg7
g15414
sg9
V16790067.xml
p15419
sa(dp15420
g3
VSTD-Flynn-2009
p15421
sg5
S'PMC2730562'
p15422
sg7
VCD005493 v. 7.10 Botulinum toxin injections for adults with overactive bladder syndrome.rm5
p15423
sg9
V19375091.xml
p15424
sa(dp15425
g3
VSTD-Brubaker-2008
p15426
sg5
S'PMC2597793'
p15427
sg7
g15423
sg9
V18499184.xml
p15428
sa(dp15429
g3
VSTD-BHACAS-I-_x002b_II-2002
p15430
sg5
S'PMC2836483'
p15431
sg7
VCD007224 v. 3.0 Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease.rm5
p15432
sg9
V19185140.xml
p15433
sa(dp15434
g3
VSTD-Zamvar-2002
p15435
sg5
S'PMC136922'
p15436
sg7
g15432
sg9
V12458242.xml
p15437
sa(dp15438
g3
VSTD-Gasz-2004
p15439
sg5
S'PMC2716259'
p15440
sg7
g15432
sg9
V19641693.xml
p15441
sa(dp15442
g3
VSTD-Al_x002d_Ruzzeh-2006
p15443
sg5
S'PMC1476725'
p15444
sg7
g15432
sg9
V16740529.xml
p15445
sa(dp15446
g3
VSTD-RASS-Study-2002
p15447
sg5
S'PMC2978030'
p15448
sg7
VCD004136 v. 12.2 Antihypertensive agents for preventing diabetic kidney disease.rm5
p15449
sg9
V19571282.xml
p15450
sa(dp15451
g3
VSTD-UKPDS-Study-1998
p15452
sg5
S'PMC28660'
p15453
sg7
g15449
sg9
V9732338.xml
p15454
sa(dp15455
g3
VSTD-ADVANCE-Study-2009
p15456
sg5
S'PMC2663832'
p15457
sg7
g15449
sg9
V19225038.xml
p15458
sa(dp15459
g3
VSTD-Cummings-2008
p15460
sg5
S'PMC3684062'
p15461
sg7
VCD008536 v. 3.3 Short and long term effects of tibolone in postmenopausal women.rm5
p15462
sg9
V18703472.xml
p15463
sa(dp15464
g3
VSTD-Ziaei-2010a
p15465
sg5
S'PMC3719303'
p15466
sg7
g15462
sg9
V23926488.xml
p15467
sa(dp15468
g3
VSTD-Redmond-2004
p15469
sg5
S'PMC2553778'
p15470
sg7
VCD006973 v. 3.0 Interventions for increasing ankle range of motion in patients with neuromuscular disease.rm5
p15471
sg9
V18822155.xml
p15472
sa(dp15473
g3
VSTD-Ellis-2004
p15474
sg5
S'PMC3348733'
p15475
sg7
VCD002199 v. 13.0 Operative procedures for fissure in ano.rm5
p15476
sg9
V23449341.xml
p15477
sa(dp15478
g3
VSTD-Jensen-1984
p15479
sg5
S'PMC1442742'
p15480
sg7
g15476
sg9
V6432173.xml
p15481
sa(dp15482
g3
VSTD-Murthy-1991
p15483
sg5
S'PMC2988295'
p15484
sg7
VCD007139 v. 3.0 Alprazolam for depression.rm5
p15485
sg9
V21897464.xml
p15486
sa(dp15487
g3
VSTD-Luengo-1994
p15488
sg5
S'PMC475269'
p15489
sg7
VCD001983 v. 7.0 Calcitonin for preventing and treating corticosteroid-induced osteoporosis.rm5
p15490
sg9
V7831624.xml
p15491
sa(dp15492
g3
VSTD-van-den-Berg-1995a
p15493
sg5
S'PMC486021'
p15494
sg7
VCD004429 v. 4.0 Intravenous immunoglobulin for multifocal motor neuropathy.rm5
p15495
sg9
V7673950.xml
p15496
sa(dp15497
g3
VSTD-Berlauk-1991
p15498
sg5
S'PMC1358649'
p15499
sg7
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p15500
sg9
V1929610.xml
p15501
sa(dp15502
g3
VSTD-Jhanji-2010
p15503
sg5
S'PMC2945135'
p15504
sg7
g15500
sg9
V20698956.xml
p15505
sa(dp15506
g3
VSTD-Mckendry-2004
p15507
sg5
S'PMC498021'
p15508
sg7
g15500
sg9
V15242867.xml
p15509
sa(dp15510
g3
VSTD-Sinclair-1997
p15511
sg5
S'PMC2127619'
p15512
sg7
g15500
sg9
V9361539.xml
p15513
sa(dp15514
g3
VSTD-Wilson-1999
p15515
sg5
S'PMC27840'
p15516
sg7
g15500
sg9
V10213716.xml
p15517
sa(dp15518
g3
VSTD-Cecconi-2011
p15519
sg5
S'PMC3218998'
p15520
sg7
g15500
sg9
V21624138.xml
p15521
sa(dp15522
g3
VSTD-Pearse-2005
p15523
sg5
S'PMC1414018'
p15524
sg7
g15500
sg9
V16356219.xml
p15525
sa(dp15526
g3
VSTD-Bender-1997
p15527
sg5
S'PMC1191013'
p15528
sg7
g15500
sg9
V9339929.xml
p15529
sa(dp15530
g3
VSTD-Mayer-2010
p15531
sg5
S'PMC2875533'
p15532
sg7
g15500
sg9
V20156348.xml
p15533
sa(dp15534
g3
VSTD-PHS-I
p15535
sg5
S'PMC1821351'
p15536
sg7
VCD000253 v. 17.6 Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.rm5
p15537
sg9
V17353403.xml
p15538
sa(dp15539
g3
VSTD-PROSPECT-1996
p15540
sg5
S'PMC1335066'
p15541
sg7
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p15542
sg9
V8911291.xml
p15543
sa(dp15544
g3
VSTD-Cote-1998
p15545
sg5
S'PMC2063039'
p15546
sg7
g15542
sg9
V9703292.xml
p15547
sa(dp15548
g3
VSTD-Kennedy-2005
p15549
sg5
S'PMC1188111'
p15550
sg7
VCD006442 v. 2.2 Psychological treatments for the management of irritable bowel syndrome.rm5
p15551
sg9
V16093252.xml
p15552
sa(dp15553
g3
VSTD-Joshi-2002
p15554
sg5
S'PMC3770113'
p15555
sg7
VCD010067 v. 2.5 Slum upgrading strategies involving physical environment and infrastructure interventions and their .rm5
p15556
sg9
V24027373.xml
p15557
sa(dp15558
g3
VSTD-Sylvester-2010
p15559
sg5
S'PMC2889174'
p15560
sg7
VCD006885 v. 4.0 Intravesical Bacillus Calmette-Gurin versus epirubicin for Ta and T1 bladder cancer.rm5
p15561
sg9
V20034729.xml
p15562
sa(dp15563
g3
VSTD-Vroomen-2002-_x0028_prim-care_x0029_
p15564
sg5
S'PMC1737860'
p15565
sg7
VCD007431 v. 4.0 Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain.rm5
p15566
sg9
V11971050.xml
p15567
sa(dp15568
g3
VSTD-Demircan-2002
p15569
sg5
S'PMC3610488'
p15570
sg7
g15566
sg9
V11931063.xml
p15571
sa(dp15572
g3
VSTD-Kerr-1988
p15573
sg5
S'PMC1031525'
p15574
sg7
g15566
sg9
V3346682.xml
p15575
sa(dp15576
g3
VSTD-Unrod-2007
p15577
sg5
S'PMC1829425'
p15578
sg7
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p15579
sg9
V17372796.xml
p15580
sa(dp15581
g3
VSTD-Cohen-_x0028_Doc_x0029_-1989
p15582
sg5
S'PMC1646917'
p15583
sg7
g15579
sg9
V3812837.xml
p15584
sa(dp15585
g3
VSTD-Gordon-2010
p15586
sg5
S'PMC2882418'
p15587
sg7
g15579
sg9
V20466951.xml
p15588
sa(dp15589
g3
VSTD-Sinclair-1998
p15590
sg5
S'PMC1763872'
p15591
sg7
g15579
sg9
V9825420.xml
p15592
sa(dp15593
g3
VSTD-Hymowitz-2007
p15594
sg5
S'PMC2258138'
p15595
sg7
g15579
sg9
V17707898.xml
p15596
sa(dp15597
g3
VSTD-Twardella-2007
p15598
sg5
S'PMC2598437'
p15599
sg7
g15579
sg9
V17297068.xml
p15600
sa(dp15601
g3
VSTD-Clifford-2002
p15602
sg5
S'PMC126226'
p15603
sg7
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p15604
sg9
V12213183.xml
p15605
sa(dp15606
g3
VSTD-Leehey-2009
p15607
sg5
S'PMC2796994'
p15608
sg7
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p15609
sg9
V20003224.xml
p15610
sa(dp15611
g3
VSTD-Chen-2010
p15612
sg5
S'PMC2902890'
p15613
sg7
g15609
sg9
V20100734.xml
p15614
sa(dp15615
g3
VSTD-Noel-2009
p15616
sg5
S'PMC2689909'
p15617
sg7
VCD003897 v. 11.0 Interleukin 2 receptor antagonists for kidney transplant recipients.rm5
p15618
sg9
V19470677.xml
p15619
sa(dp15620
g3
VSTD-Ritchie-1992
p15621
sg5
S'PMC1881680'
p15622
sg7
VCD000531 v. 4.5 Target payments in primary care effects on professional practice and health care outcomes.rm5
p15623
sg9
V1392710.xml
p15624
sa(dp15625
g3
VSTD-Bookman-2004
p15626
sg5
S'PMC509045'
p15627
sg7
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p15628
sg9
V15313991.xml
p15629
sa(dp15630
g3
VSTD-Baer-2005
p15631
sg5
S'PMC1201146'
p15632
sg7
g15628
sg9
V16086839.xml
p15633
sa(dp15634
g3
VSTD-Roth-2004
p15635
sg5
S'PMC1955127'
p15636
sg7
g15628
sg9
V17363401.xml
p15637
sa(dp15638
g3
VSTD-Andersen-2004-_x0028_Nordic_x0029_
p15639
sg5
S'PMC1763573'
p15640
sg7
VCD005181 v. 8.2 Interferon beta for secondary progressive multiple sclerosis.rm5
p15641
sg9
V15090564.xml
p15642
sa(dp15643
g3
VSTD-Lazarus-2007
p15644
sg5
S'PMC1899291'
p15645
sg7
VCD002314 v. 5.0 Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent andor ch.rm5
p15646
sg9
V17204725.xml
p15647
sa(dp15648
g3
VSTD-Jayaram-2005
p15649
sg5
S'PMC1747311'
p15650
sg7
g15646
sg9
V15681495.xml
p15651
sa(dp15652
g3
VSTD-Ducharme-2005
p15653
sg5
S'PMC1167811'
p15654
sg7
VCD002752 v. 9.0 Clinical service organisation for heart failure.rm5
p15655
sg9
V15997043.xml
p15656
sa(dp15657
g3
VSTD-Cline-1998
p15658
sg5
S'PMC1728835'
p15659
sg7
g15655
sg9
V9930041.xml
p15660
sa(dp15661
g3
VSTD-Mejhert-2004
p15662
sg5
S'PMC1768467'
p15663
sg7
g15655
sg9
V15310688.xml
p15664
sa(dp15665
g3
VSTD-Blue-2001
p15666
sg5
S'PMC56888'
p15667
sg7
g15655
sg9
V11576977.xml
p15668
sa(dp15669
g3
VSTD-Holland-2007
p15670
sg5
S'PMC1877883'
p15671
sg7
g15655
sg9
V17452390.xml
p15672
sa(dp15673
g3
VSTD-Howard-1974
p15674
sg5
S'PMC3760896'
p15675
sg7
VCD003082 v. 12.0 Haloperidol versus placebo for schizophrenia.rm5
p15676
sg9
V24019874.xml
p15677
sa(dp15678
g3
VSTD-Marigold-2005
p15679
sg5
S'PMC3226796'
p15680
sg7
VCD007513 v. 3.0 Circuit class therapy for improving mobility after stroke.rm5
p15681
sg9
V15743283.xml
p15682
sa(dp15683
g3
VSTD-Pang-2005
p15684
sg5
S'PMC3226792'
p15685
sg7
g15681
sg9
V16181164.xml
p15686
sa(dp15687
g3
VSTD-Valimaki-2010
p15688
sg5
S'PMC3627772'
p15689
sg7
VCD007198 v. 3.3 Information and communication technology in patient education and support for people with schizophre.rm5
p15690
sg9
V23502432.xml
p15691
sa(dp15692
g3
VSTD-Stewart-2007
p15693
sg5
S'PMC3163239'
p15694
sg7
VCD003552 v. 9.0 Skin patch and vaginal ring versus combined oral contraceptives for contraception.rm5
p15695
sg9
V18082856.xml
p15696
sa(dp15697
g3
VSTD-Hughes-1992
p15698
sg5
S'PMC1069857'
p15699
sg7
VCD009231 v. 2.2 Hospital at home home-based end of life care.rm5
p15700
sg9
V1737710.xml
p15701
sa(dp15702
g3
VSTD-Rawles-1976
p15703
sg5
S'PMC1639993'
p15704
sg7
VCD007160 v. 3.0 Oxygen therapy for acute myocardial infarction.rm5
p15705
sg9
V773507.xml
p15706
sa(dp15707
g3
VSTD-Cowett-1977
p15708
sg5
S'PMC2595562'
p15709
sg7
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p15710
sg9
V602256.xml
p15711
sa(dp15712
g3
VSTD-Bard-1973
p15713
sg5
S'PMC1648593'
p15714
sg7
g15710
sg9
V4783004.xml
p15715
sa(dp15716
g3
VSTD-Stepnowsky-2007
p15717
sg5
S'PMC1874716'
p15718
sg7
VCD007736 v. 2.0 Educational supportive and behavioural interventions to improve usage of continuous positive airway.rm5
p15719
sg9
V17513285.xml
p15720
sa(dp15721
g3
VSTD-Swanson-2009
p15722
sg5
S'PMC2825726'
p15723
sg7
VCD008679 v. 2.0 Follow-up for improving psychological well being for women after a miscarriage.rm5
p15724
sg9
V19630553.xml
p15725
sa(dp15726
g3
VSTD-Vathenen-1991
p15727
sg5
S'PMC1021035'
p15728
sg7
VCD002739 v. 6.0 Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction.rm5
p15729
sg9
V1771604.xml
p15730
sa(dp15731
g3
VSTD-Schibler-2003
p15732
sg5
S'PMC1719415'
p15733
sg7
VCD008901 v. 2.0 Recombinant growth hormone therapy for cystic fibrosis in children and young adults.rm5
p15734
sg9
V14670773.xml
p15735
sa(dp15736
g3
VSTD-Halpern-2008
p15737
sg5
S'PMC2582655'
p15738
sg7
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p15739
sg9
V19023429.xml
p15740
sa(dp15741
g3
VSTD-Peterson-2007
p15742
sg5
S'PMC2129116'
p15743
sg7
g15739
sg9
V18091987.xml
p15744
sa(dp15745
g3
VSTD-Abdool-Karim-2011
p15746
sg5
S'PMC3083640'
p15747
sg7
g15739
sg9
V21330907.xml
p15748
sa(dp15749
g3
VSTD-Abdool-Karim-2010
p15750
sg5
S'PMC3001187'
p15751
sg7
g15739
sg9
V20643915.xml
p15752
sa(dp15753
g3
VSTD-McCormack-2010
p15754
sg5
S'PMC2956883'
p15755
sg7
g15739
sg9
V20851460.xml
p15756
sa(dp15757
g3
VSTD-Feldblum-2008
p15758
sg5
S'PMC2190795'
p15759
sg7
g15739
sg9
V18213382.xml
p15760
sa(dp15761
g3
VSTD-Ahmedzai-2004
p15762
sg5
S'PMC2409543'
p15763
sg7
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p15764
sg9
V14735178.xml
p15765
sa(dp15766
g3
VSTD-Chua-1996
p15767
sg5
S'PMC484598'
p15768
sg7
g15764
sg9
V9014795.xml
p15769
sa(dp15770
g3
VSTD-Innes-2007
p15771
sg5
S'PMC2265270'
p15772
sg7
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p15773
sg9
V18096042.xml
p15774
sa(dp15775
g3
VSTD-Madge-1997
p15776
sg5
S'PMC1758505'
p15777
sg7
VCD000326 v. 6.0 Educational interventions for asthma in children.rm5
p15778
sg9
V9093336.xml
p15779
sa(dp15780
g3
VSTD-Hill-1991
p15781
sg5
S'PMC1671468'
p15782
sg7
g15778
sg9
V1747614.xml
p15783
sa(dp15784
g3
VSTD-Mitchell-1986
p15785
sg5
S'PMC1778203'
p15786
sg7
g15778
sg9
V3545094.xml
p15787
sa(dp15788
g3
VSTD-McNabb-1985
p15789
sg5
S'PMC1646372'
p15790
sg7
g15778
sg9
V4037168.xml
p15791
sa(dp15792
g3
VSTD-Charlton-1994
p15793
sg5
S'PMC1029785'
p15794
sg7
g15778
sg9
V8185365.xml
p15795
sa(dp15796
g3
VSTD-Shields-1990
p15797
sg5
S'PMC1404528'
p15798
sg7
g15778
sg9
V2293801.xml
p15799
sa(dp15800
g3
VSTD-Resch-2000
p15801
sg5
S'PMC1297969'
p15802
sg7
VMR000016 v. 7.0 Editorial peer review for improving the quality of reports of biomedical studies.rm5
p15803
sg9
V10844878.xml
p15804
sa(dp15805
g3
VSTD-van-Rooyen-1999
p15806
sg5
S'PMC27670'
p15807
sg7
g15803
sg9
V9872878.xml
p15808
sa(dp15809
g3
VSTD-Weller-1996
p15810
sg5
S'PMC226156'
p15811
sg7
g15803
sg9
V8883984.xml
p15812
sa(dp15813
g3
VSTD-Schroter-2004
p15814
sg5
S'PMC381220'
p15815
sg7
g15803
sg9
V14996698.xml
p15816
sa(dp15817
g3
VSTD-Forfar-1958
p15818
sg5
S'PMC2027064'
p15819
sg7
VCD003670 v. 9.0 Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mor.rm5
p15820
sg9
V13489318.xml
p15821
sa(dp15822
g3
VSTD-Mitchell-1986-Europeans
p15823
sg5
S'PMC1778203'
p15824
sg7
VCD008469 v. 3.0 Home-based educational interventions for children with asthma.rm5
p15825
sg9
V3545094.xml
p15826
sa(dp15827
g3
VSTD-Mitchell-1986-Polynesians
p15828
sg5
S'PMC1778203'
p15829
sg7
g15825
sg9
V3545094.xml
p15830
sa(dp15831
g3
VSTD-Mitchell-1986
p15832
sg5
S'PMC1778203'
p15833
sg7
g15825
sg9
V3545094.xml
p15834
sa(dp15835
g3
VSTD-Butz-2006
p15836
sg5
S'PMC2269706'
p15837
sg7
g15825
sg9
V16754825.xml
p15838
sa(dp15839
g3
VSTD-Hurwitz-2002
p15840
sg5
S'PMC1447299'
p15841
sg7
VCD004251 v. 9.2 Electrotherapy for neck pain.rm5
p15842
sg9
V12356613.xml
p15843
sa(dp15844
g3
VSTD-Aggarwal-2006
p15845
sg5
S'PMC2564084'
p15846
sg7
VCD003898 v. 8.10 Inhaled magnesium sulfate in the treatment of acute asthma.rm5
p15847
sg9
V16627836.xml
p15848
sa(dp15849
g3
VSTD-Sullivan-1991a
p15850
sg5
S'PMC3032855'
p15851
sg7
VCD005043 v. 6.1 Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial wel.rm5
p15852
sg9
V20848241.xml
p15853
sa(dp15854
g3
VSTD-Becker-1983
p15855
sg5
S'PMC3372084'
p15856
sg7
VCD002305 v. 10.0 Antidepressants for people with both schizophrenia and depression.rm5
p15857
sg9
V18953116.xml
p15858
sa(dp15859
g3
VSTD-Patriarca-1984
p15860
sg5
S'PMC179927'
p15861
sg7
VCD002745 v. 7.2 Amantadine and rimantadine for influenza A in children and the elderly.rm5
p15862
sg9
V6476812.xml
p15863
sa(dp15864
g3
VSTD-Monto-1995
p15865
sg5
S'PMC162919'
p15866
sg7
g15862
sg9
V8619572.xml
p15867
sa(dp15868
g3
VSTD-Pitt-1980
p15869
sg5
S'PMC1344917'
p15870
sg7
VCD003073 v. 7.0 Prevention of infection in arterial reconstruction.rm5
p15871
sg9
V6998390.xml
p15872
sa(dp15873
g3
VSTD-Hasselgren-1984
p15874
sg5
S'PMC1250399'
p15875
sg7
g15871
sg9
V6375599.xml
p15876
sa(dp15877
g3
VSTD-Earnshaw-1988
p15878
sg5
S'PMC2498719'
p15879
sg7
g15871
sg9
V3408172.xml
p15880
sa(dp15881
g3
VSTD-Kaiser-1978
p15882
sg5
S'PMC1396974'
p15883
sg7
g15871
sg9
V686894.xml
p15884
sa(dp15885
g3
VSTD-Chester-1983
p15886
sg5
S'PMC2494433'
p15887
sg7
g15871
sg9
V6638856.xml
p15888
sa(dp15889
g3
VSTD-Milan-1995
p15890
sg5
S'PMC1717175'
p15891
sg7
VCD000376 v. 8.0 Longchain polyunsaturated fatty acid supplementation in infants born at term.rm5
p15892
sg9
V9196357.xml
p15893
sa(dp15894
g3
VSTD-Tan-1994
p15895
sg5
S'PMC1364731'
p15896
sg7
VCD007503 v. 3.0 Antidepressants for depression in physically ill people.rm5
p15897
sg9
V8018452.xml
p15898
sa(dp15899
g3
VSTD-Xue-2004
p15900
sg5
S'PMC3772925'
p15901
sg7
g15897
sg9
V24058553.xml
p15902
sa(dp15903
g3
VSTD-Menza-2009
p15904
sg5
S'PMC2677475'
p15905
sg7
g15897
sg9
V19092112.xml
p15906
sa(dp15907
g3
VSTD-Menza-2009-_x0028_paroxetine_x0029_
p15908
sg5
S'PMC2677475'
p15909
sg7
g15897
sg9
V19092112.xml
p15910
sa(dp15911
g3
VSTD-Menza-2009_x0028_nortriptyline_x0029_
p15912
sg5
S'PMC2677475'
p15913
sg7
g15897
sg9
V19092112.xml
p15914
sa(dp15915
g3
VSTD-Weintraub-2009
p15916
sg5
S'PMC2918470'
p15917
sg7
g15897
sg9
V20679638.xml
p15918
sa(dp15919
g3
VSTD-Londahl-2010
p15920
sg5
S'PMC2858204'
p15921
sg7
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p15922
sg9
V20427683.xml
p15923
sa(dp15924
g3
VSTD-De-La-Cal-2005
p15925
sg5
S'PMC1356980'
p15926
sg7
VCD008738 v. 2.0 Antibiotic prophylaxis for preventing burn wound infection.rm5
p15927
sg9
V15729064.xml
p15928
sa(dp15929
g3
VSTD-Mann-1986
p15930
sg5
S'PMC1342106'
p15931
sg7
VCD001814 v. 5.0 Developmental care for promoting development and preventing morbidity in preterm infants.rm5
p15932
sg9
V3096460.xml
p15933
sa(dp15934
g3
VSTD-Field_x002d_Fote-2011
p15935
sg5
S'PMC3017322'
p15936
sg7
VCD006676 v. 4.8 Locomotor training for walking after spinal cord injury.rm5
p15937
sg9
V21051593.xml
p15938
sa(dp15939
g3
VSTD-Alexeeva-2011
p15940
sg5
S'PMC3152808'
p15941
sg7
g15937
sg9
V21903010.xml
p15942
sa(dp15943
g3
VSTD-Nguyen-2008
p15944
sg5
S'PMC2483918'
p15945
sg7
VCD007718 v. 3.0 Telehealthcare for chronic obstructive pulmonary disease.rm5
p15946
sg9
V18417444.xml
p15947
sa(dp15948
g3
VSTD-Hartvigsen-2005
p15949
sg5
S'PMC1740861'
p15950
sg7
VCD005958 v. 6.6 Manual material handling advice and assistive devices for preventing and treating back pain in worke.rm5
p15951
sg9
V15613603.xml
p15952
sa(dp15953
g3
VSTD-Ballotta-2000
p15954
sg5
S'PMC1421116'
p15955
sg7
VCD001921 v. 4.0 Eversion versus conventional carotid endarterectomy for preventing stroke.rm5
p15956
sg9
V10862204.xml
p15957
sa(dp15958
g3
VSTD-N0265041749
p15959
sg5
S'PMC3195130'
p15960
sg7
VCD004626 v. 10.7 First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high.rm5
p15961
sg9
V22022003.xml
p15962
sa(dp15963
g3
VSTD-Strauss-2008
p15964
sg5
S'PMC2883857'
p15965
sg7
VCD003248 v. 8.7 Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion .rm5
p15966
sg9
V18194383.xml
p15967
sa(dp15968
g3
VSTD-Kinmond-1993
p15969
sg5
S'PMC1676623'
p15970
sg7
g15966
sg9
V8443480.xml
p15971
sa(dp15972
g3
VSTD-Mercer-2006
p15973
sg5
S'PMC1564438'
p15974
sg7
g15966
sg9
V16585320.xml
p15975
sa(dp15976
g3
VSTD-Erie-County-1995
p15977
sg5
S'PMC1508243'
p15978
sg7
VCD001497 v. 6.0 Interventions for preventing tobacco sales to minors.rm5
p15979
sg9
V9618623.xml
p15980
sa(dp15981
g3
VSTD-Harlem-1993
p15982
sg5
S'PMC1508216'
p15983
sg7
g15979
sg9
V9618624.xml
p15984
sa(dp15985
g3
VSTD-California-1995
p15986
sg5
S'PMC1766282'
p15987
sg7
g15979
sg9
V10841587.xml
p15988
sa(dp15989
g3
VSTD-Chicago-1993
p15990
sg5
S'PMC1283996'
p15991
sg7
g15979
sg9
V8926225.xml
p15992
sa(dp15993
g3
VSTD-TPOP-1996
p15994
sg5
S'PMC1508321'
p15995
sg7
g15979
sg9
V9702146.xml
p15996
sa(dp15997
g3
VSTD-Everett-1990
p15998
sg5
S'PMC1403659'
p15999
sg7
g15979
sg9
V1594748.xml
p16000
sa(dp16001
g3
VSTD-St-Paul-1990
p16002
sg5
S'PMC1694336'
p16003
sg7
g15979
sg9
V1503160.xml
p16004
sa(dp16005
g3
VSTD-Sellwood-2007a
p16006
sg5
S'PMC2465319'
p16007
sg7
VCD008262 v. 2.2 Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise.rm5
p16008
sg9
V17261562.xml
p16009
sa(dp16010
g3
VSTD-Fok-1999
p16011
sg5
S'PMC1720936'
p16012
sg7
VCD001969 v. 6.4 Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated ve.rm5
p16013
sg9
V10212082.xml
p16014
sa(dp16015
g3
VSTD-Wyman-1987
p16016
sg5
S'PMC3384962'
p16017
sg7
VCD004374 v. 3.0 Short term urinary catheter policies following urogenital surgery in adults.rm5
p16018
sg9
V22778750.xml
p16019
sa(dp16020
g3
VSTD-Jones-1985
p16021
sg5
S'PMC2418305'
p16022
sg7
VCD001738 v. 6.0 Antibiotic prophylaxis for mammalian bites.rm5
p16023
sg9
V3895210.xml
p16024
sa(dp16025
g3
VSTD-Scheltinga-1991
p16026
sg5
S'PMC1358534'
p16027
sg7
VCD002920 v. 8.0 Nutrition support for bone marrow transplant patients.rm5
p16028
sg9
V1953094.xml
p16029
sa(dp16030
g3
VSTD-Gill-1993
p16031
sg5
S'PMC1029493'
p16032
sg7
VCD002056 v. 5.0 Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm inf.rm5
p16033
sg9
V8215566.xml
p16034
sa(dp16035
g3
VSTD-Bhasin-2000
p16036
sg5
S'PMC3173037'
p16037
sg7
VCD004248 v. 4.0 Progressive resistive exercise interventions for adults living with HIVAIDS.rm5
p16038
sg9
V10683055.xml
p16039
sa(dp16040
g3
VSTD-GICOG
p16041
sg5
S'PMC2360651'
p16042
sg7
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p16043
sg9
V16868539.xml
p16044
sa(dp16045
g3
VSTD-NSGO_x002c_-MaNGO-and-EORTC
p16046
sg5
S'PMC3552301'
p16047
sg7
g16043
sg9
V20619634.xml
p16048
sa(dp16049
g3
VSTD-MaNGO
p16050
sg5
S'PMC3552301'
p16051
sg7
g16043
sg9
V20619634.xml
p16052
sa(dp16053
g3
VSTD-Oosterhof-2006
p16054
sg5
S'PMC3476076'
p16055
sg7
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p16056
sg9
V16897618.xml
p16057
sa(dp16058
g3
VSTD-Lewis-1984
p16059
sg5
S'PMC1001217'
p16060
sg7
g16056
sg9
V6364997.xml
p16061
sa(dp16062
g3
VSTD-Blum-2008
p16063
sg5
S'PMC3608469'
p16064
sg7
VCD005652 v. 5.0 Psychological therapies for people with borderline personality disorder.rm5
p16065
sg9
V18281407.xml
p16066
sa(dp16067
g3
VSTD-Davidson-2006
p16068
sg5
S'PMC1852259'
p16069
sg7
g16065
sg9
V17032158.xml
p16070
sa(dp16071
g3
VSTD-Carroll-2005
p16072
sg5
S'PMC1180654'
p16073
sg7
VCD005124 v. 4.0 Antenatal psychosocial assessment for reducing perinatal mental health morbidity.rm5
p16074
sg9
V16076821.xml
p16075
sa(dp16076
g3
VSTD-Ewer-1986
p16077
sg5
S'PMC1341848'
p16078
sg7
VCD002982 v. 9.0 Psychological interventions for adults with asthma.rm5
p16079
sg9
V3094804.xml
p16080
sa(dp16081
g3
VSTD-Madigan-1994
p16082
sg5
S'PMC3268331'
p16083
sg7
VCD003288 v. 6.0 Protein and energy supplementation in elderly people at risk from malnutrition.rm5
p16084
sg9
V22232695.xml
p16085
sa(dp16086
g3
VSTD-Steiner-2003
p16087
sg5
S'PMC1746806'
p16088
sg7
g16084
sg9
V12947128.xml
p16089
sa(dp16090
g3
VSTD-Goldstein-1986
p16091
sg5
S'PMC3516240'
p16092
sg7
VCD004333 v. 6.0 Helmets for preventing injury in motorcycle riders.rm5
p16093
sg9
V23259013.xml
p16094
sa(dp16095
g3
VSTD-Rowland-1996
p16096
sg5
S'PMC1380358'
p16097
sg7
g16093
sg9
V8561240.xml
p16098
sa(dp16099
g3
VSTD-Murdock-1991
p16100
sg5
S'PMC1003016'
p16101
sg7
g16093
sg9
V1771873.xml
p16102
sa(dp16103
g3
VSTD-Luna-1981
p16104
sg5
S'PMC1273021'
p16105
sg7
g16093
sg9
V7281654.xml
p16106
sa(dp16107
g3
VSTD-McCurry-1998
p16108
sg5
S'PMC2398744'
p16109
sg7
VCD003161 v. 7.4 Cognitive behavioural interventions for sleep problems in adults aged 60.rm5
p16110
sg9
V18517044.xml
p16111
sa(dp16112
g3
VSTD-Maitra-1993
p16113
sg5
S'PMC1285998'
p16114
sg7
VCD004574 v. 4.0 Interventions for treating mallet finger injuries.rm5
p16115
sg9
V8216604.xml
p16116
sa(dp16117
g3
VSTD-Aveyard-2007
p16118
sg5
S'PMC2094265'
p16119
sg7
VCD001292 v. 7.0 Individual behavioural counselling for smoking cessation.rm5
p16120
sg9
V17483139.xml
p16121
sa(dp16122
g3
VSTD-Glasgow-2000
p16123
sg5
S'PMC1446229'
p16124
sg7
g16120
sg9
V10800431.xml
p16125
sa(dp16126
g3
VSTD-Molyneux-2003
p16127
sg5
S'PMC1746718'
p16128
sg7
g16120
sg9
V12775857.xml
p16129
sa(dp16130
g3
VSTD-Bentley-1981
p16131
sg5
S'PMC1000652'
p16132
sg7
VCD003470 v. 3.0 Pharmacotherapy for patellofemoral pain syndrome.rm5
p16133
sg9
V7008711.xml
p16134
sa(dp16135
g3
VSTD-Hay-1995
p16136
sg5
S'PMC1235020'
p16137
sg7
VCD001543 v. 6.0 Shouldice technique versus other open techniques for inguinal hernia repair.rm5
p16138
sg9
V8526578.xml
p16139
sa(dp16140
g3
VSTD-Wiles-2001
p16141
sg5
S'PMC1737210'
p16142
sg7
VCD005029 v. 5.0 Treatment for ataxia in multiple sclerosis.rm5
p16143
sg9
V11160464.xml
p16144
sa(dp16145
g3
VSTD-T_x00f8_nnesen-1999a
p16146
sg5
S'PMC27867'
p16147
sg7
VCD008343 v. 3.0 Preoperative alcohol cessation prior to elective surgery.rm5
p16148
sg9
V10323814.xml
p16149
sa(dp16150
g3
VSTD-Saps-2009
p16151
sg5
S'PMC2827243'
p16152
sg7
VCD008013 v. 3.0 Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in.rm5
p16153
sg9
V19596010.xml
p16154
sa(dp16155
g3
VSTD-Briggs-1984
p16156
sg5
S'PMC3765382'
p16157
sg7
VCD000980 v. 16.0 Vitamin C for preventing and treating the common cold.rm5
p16158
sg9
V23902583.xml
p16159
sa(dp16160
g3
VSTD-Anderson-1974f
p16161
sg5
S'PMC1947567'
p16162
sg7
g16158
sg9
V4601508.xml
p16163
sa(dp16164
g3
VSTD-Anderson-1974e
p16165
sg5
S'PMC1947567'
p16166
sg7
g16158
sg9
V4601508.xml
p16167
sa(dp16168
g3
VSTD-Anderson-1974b
p16169
sg5
S'PMC1947567'
p16170
sg7
g16158
sg9
V4601508.xml
p16171
sa(dp16172
g3
VSTD-Anderson-1974c
p16173
sg5
S'PMC1947567'
p16174
sg7
g16158
sg9
V4601508.xml
p16175
sa(dp16176
g3
VSTD-Anderson-1974a
p16177
sg5
S'PMC1947567'
p16178
sg7
g16158
sg9
V4601508.xml
p16179
sa(dp16180
g3
VSTD-Anderson-1974d
p16181
sg5
S'PMC1947567'
p16182
sg7
g16158
sg9
V4601508.xml
p16183
sa(dp16184
g3
VSTD-Tyrrell-1977
p16185
sg5
S'PMC479021'
p16186
sg7
g16158
sg9
V338079.xml
p16187
sa(dp16188
g3
VSTD-Walker-1967
p16189
sg5
S'PMC1841434'
p16190
sg7
g16158
sg9
V4290259.xml
p16191
sa(dp16192
g3
VSTD-Elwood-1976
p16193
sg5
S'PMC478963'
p16194
sg7
g16158
sg9
V788820.xml
p16195
sa(dp16196
g3
VSTD-Anderson-1975a
p16197
sg5
S'PMC1958969'
p16198
sg7
g16158
sg9
V1091343.xml
p16199
sa(dp16200
g3
VSTD-Anderson-1975b
p16201
sg5
S'PMC1958969'
p16202
sg7
g16158
sg9
V1091343.xml
p16203
sa(dp16204
g3
VSTD-Elliot-1973
p16205
sg5
S'PMC175560'
p16206
sg7
g16158
sg9
V9284173.xml
p16207
sa(dp16208
g3
VSTD-Gilbert-1985
p16209
sg5
S'PMC1417150'
p16210
sg7
VCD000335 v. 14.0 Exercise therapy for treatment of non-specific low back pain.rm5
p16211
sg9
V2931153.xml
p16212
sa(dp16213
g3
VSTD-Seferlis-1998
p16214
sg5
S'PMC3611294'
p16215
sg7
g16211
sg9
V9883955.xml
p16216
sa(dp16217
g3
VSTD-Frost-2004
p16218
sg5
S'PMC518892'
p16219
sg7
g16211
sg9
V15377573.xml
p16220
sa(dp16221
g3
VSTD-Moffett-1999
p16222
sg5
S'PMC28176'
p16223
sg7
g16211
sg9
V10426734.xml
p16224
sa(dp16225
g3
VSTD-Preyde-2000
p16226
sg5
S'PMC1231369'
p16227
sg7
g16211
sg9
V10906914.xml
p16228
sa(dp16229
g3
VSTD-Frost-1995
p16230
sg5
S'PMC2548554'
p16231
sg7
g16211
sg9
V7833752.xml
p16232
sa(dp16233
g3
VSTD-Van-Koningsveld-2004
p16234
sg5
S'PMC2778673'
p16235
sg7
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p16236
sg9
V17426908.xml
p16237
sa(dp16238
g3
VSTD-MacDonald-1983
p16239
sg5
S'PMC2494194'
p16240
sg7
VCD001351 v. 12.0 Acupuncture and dry-needling for low back pain.rm5
p16241
sg9
V6218776.xml
p16242
sa(dp16243
g3
VSTD-Kinmonth-1992
p16244
sg5
S'PMC1883680'
p16245
sg7
VCD003676 v. 7.0 Paracetamol versus placebo or physical methods for treating fever in children.rm5
p16246
sg9
V1463951.xml
p16247
sa(dp16248
g3
VSTD-Roberts-2003
p16249
sg5
S'PMC1693668'
p16250
sg7
VCD006398 v. 4.0 Interventions for preventing injuries in the agricultural industry.rm5
p16251
sg9
V14758405.xml
p16252
sa(dp16253
g3
VSTD-Lee-2004
p16254
sg5
S'PMC1448528'
p16255
sg7
g16251
sg9
V15451744.xml
p16256
sa(dp16257
g3
VSTD-Gadomski-2006
p16258
sg5
S'PMC1470549'
p16259
sg7
g16251
sg9
V16507741.xml
p16260
sa(dp16261
g3
VSTD-Cheetham-2001-_x0023_
p16262
sg5
S'PMC1760141'
p16263
sg7
VCD002116 v. 6.0 Drug treatment for faecal incontinence in adults.rm5
p16264
sg9
V11171825.xml
p16265
sa(dp16266
g3
VSTD-Arrowsmith-2000
p16267
sg5
S'PMC1718269'
p16268
sg7
VCD004236 v. 7.0 EMLA and Amethocaine for reduction of children's pain associated with needle insertion.rm5
p16269
sg9
V10735838.xml
p16270
sa(dp16271
g3
VSTD-Wang-1992
p16272
sg5
S'PMC1793648'
p16273
sg7
VCD001279 v. 9.0 Anticholinergic drugs for wheeze in children under the age of two years.rm5
p16274
sg9
V1533504.xml
p16275
sa(dp16276
g3
VSTD-Henry-1984
p16277
sg5
S'PMC1628434'
p16278
sg7
g16274
sg9
V6230059.xml
p16279
sa(dp16280
g3
VSTD-Ye-LJ-2000
p16281
sg5
S'PMC2961892'
p16282
sg7
VCD004116 v. 6.0 Herbal medicines for treatment of irritable bowel syndrome.rm5
p16283
sg9
V21202743.xml
p16284
sa(dp16285
g3
VSTD-Gu-XX-1999
p16286
sg5
S'PMC1810433'
p16287
sg7
g16283
sg9
V17375186.xml
p16288
sa(dp16289
g3
VSTD-Xie-YD-2001
p16290
sg5
S'PMC3208021'
p16291
sg7
g16283
sg9
V20040062.xml
p16292
sa(dp16293
g3
VSTD-Xu-XP-2002
p16294
sg5
S'PMC3702287'
p16295
sg7
g16283
sg9
V23788040.xml
p16296
sa(dp16297
g3
VSTD-Wyman-1987
p16298
sg5
S'PMC3384962'
p16299
sg7
VCD004011 v. 5.0 Strategies for the removal of short-term indwelling urethral catheters in adults.rm5
p16300
sg9
V22778750.xml
p16301
sa(dp16302
g3
VSTD-Hajipour-2006
p16303
sg5
S'PMC1963628'
p16304
sg7
VCD004288 v. 7.0 Surgical hand antisepsis to reduce surgical site infection.rm5
p16305
sg9
V16460630.xml
p16306
sa(dp16307
g3
VSTD-Firth-1969
p16308
sg5
S'PMC1982084'
p16309
sg7
VCD005937 v. 4.0 Treatments for suppression of lactation.rm5
p16310
sg9
V4883649.xml
p16311
sa(dp16312
g3
VSTD-European-1991
p16313
sg5
S'PMC1670075'
p16314
sg7
g16310
sg9
V1676318.xml
p16315
sa(dp16316
g3
VSTD-Varga-1972
p16317
sg5
S'PMC1788467'
p16318
sg7
g16310
sg9
V4556543.xml
p16319
sa(dp16320
g3
VSTD-Yuen-1977
p16321
sg5
S'PMC1880136'
p16322
sg7
g16310
sg9
V334356.xml
p16323
sa(dp16324
g3
VSTD-Senior-1969
p16325
sg5
S'PMC1982066'
p16326
sg7
g16310
sg9
V4883650.xml
p16327
sa(dp16328
g3
VSTD-Worth-2009
p16329
sg5
S'PMC2720945'
p16330
sg7
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p16331
sg9
V19624838.xml
p16332
sa(dp16333
g3
VSTD-McGavin-1985
p16334
sg5
S'PMC1020560'
p16335
sg7
g16331
sg9
V2866607.xml
p16336
sa(dp16337
g3
VSTD-Bateman-1978
p16338
sg5
S'PMC493239'
p16339
sg7
VCD001203 v. 4.0 Bromocriptine for levodopa-induced motor complications in Parkinson's disease.rm5
p16340
sg9
V366085.xml
p16341
sa(dp16342
g3
VSTD-MRC-elderly
p16343
sg5
S'PMC1995577'
p16344
sg7
VCD002146 v. 7.0 Pharmacotherapy for hypertension in women of different races.rm5
p16345
sg9
V1445513.xml
p16346
sa(dp16347
g3
VSTD-Coope
p16348
sg5
S'PMC1341855'
p16349
sg7
g16345
sg9
V3094811.xml
p16350
sa(dp16351
g3
VSTD-Steptoe-1999
p16352
sg5
S'PMC28246'
p16353
sg7
VCD001188 v. 9.0 Nursing interventions for smoking cessation.rm5
p16354
sg9
V10514155.xml
p16355
sa(dp16356
g3
VSTD-Quist_x002d_Paulsen-2003
p16357
sg5
S'PMC286243'
p16358
sg7
g16354
sg9
V14644967.xml
p16359
sa(dp16360
g3
VSTD-OXCHECK-1994
p16361
sg5
S'PMC2539253'
p16362
sg7
g16354
sg9
V8124120.xml
p16363
sa(dp16364
g3
VSTD-Janz-1987
p16365
sg5
S'PMC1647206'
p16366
sg7
g16354
sg9
V3592033.xml
p16367
sa(dp16368
g3
VSTD-Family-Heart-1994
p16369
sg5
S'PMC2539278'
p16370
sg7
g16354
sg9
V8124121.xml
p16371
sa(dp16372
g3
VSTD-Lancaster-1999
p16373
sg5
S'PMC1313370'
p16374
sg7
g16354
sg9
V10343421.xml
p16375
sa(dp16376
g3
VSTD-Carlsson-1997
p16377
sg5
S'PMC484693'
p16378
sg7
g16354
sg9
V9093045.xml
p16379
sa(dp16380
g3
VSTD-Campbell-1998
p16381
sg5
S'PMC1728827'
p16382
sg7
g16354
sg9
V9930042.xml
p16383
sa(dp16384
g3
VSTD-Hajek-2002
p16385
sg5
S'PMC64504'
p16386
sg7
g16354
sg9
V11786452.xml
p16387
sa(dp16388
g3
VSTD-Sanders-1989a
p16389
sg5
S'PMC1711904'
p16390
sg7
g16354
sg9
V2556540.xml
p16391
sa(dp16392
g3
VSTD-Sanders-1989b
p16393
sg5
S'PMC1711904'
p16394
sg7
g16354
sg9
V2556540.xml
p16395
sa(dp16396
g3
VSTD-Lyon-1998
p16397
sg5
S'PMC1720741'
p16398
sg7
VCD003744 v. 3.0 Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for or.rm5
p16399
sg9
V9536833.xml
p16400
sa(dp16401
g3
VSTD-Moroni-1996
p16402
sg5
S'PMC2074576'
p16403
sg7
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p16404
sg9
V8688342.xml
p16405
sa(dp16406
g3
VSTD-Olafsdottir-2001
p16407
sg5
S'PMC1718650'
p16408
sg7
VCD004796 v. 6.0 Manipulative therapies for infantile colic.rm5
p16409
sg9
V11159288.xml
p16410
sa(dp16411
g3
VSTD-Rahman-2001
p16412
sg5
S'PMC37318'
p16413
sg7
VCD006090 v. 8.0 Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of a.rm5
p16414
sg9
V11498488.xml
p16415
sa(dp16416
g3
VSTD-Bhandari-1994
p16417
sg5
S'PMC2541323'
p16418
sg7
g16414
sg9
V7819847.xml
p16419
sa(dp16420
g3
VSTD-Ferley-1989
p16421
sg5
S'PMC1379831'
p16422
sg7
VCD001957 v. 16.0 Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like illness.rm5
p16423
sg9
V2655683.xml
p16424
sa(dp16425
g3
VSTD-Maartense-2006
p16426
sg5
S'PMC1448907'
p16427
sg7
VCD006956 v. 3.2 Laparoscopic versus Open surgery for small bowel Crohn's disease.rm5
p16428
sg9
V16432345.xml
p16429
sa(dp16430
g3
VSTD-Webster-2008
p16431
sg5
S'PMC2483870'
p16432
sg7
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p16433
sg9
V18614482.xml
p16434
sa(dp16435
g3
VSTD-Barker-2004
p16436
sg5
S'PMC1964197'
p16437
sg7
g16433
sg9
V15239872.xml
p16438
sa(dp16439
g3
VSTD-Rickard-2010
p16440
sg5
S'PMC2944158'
p16441
sg7
g16433
sg9
V20831782.xml
p16442
sa(dp16443
g3
VSTD-Canani-2007
p16444
sg5
S'PMC1949444'
p16445
sg7
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p16446
sg9
V17690340.xml
p16447
sa(dp16448
g3
VSTD-Henker-2007a
p16449
sg5
S'PMC1802727'
p16450
sg7
g16446
sg9
V17287932.xml
p16451
sa(dp16452
g3
VSTD-Frigerio-1986
p16453
sg5
S'PMC2171037'
p16454
sg7
g16446
sg9
V17760859.xml
p16455
sa(dp16456
g3
VSTD-Kowalska_x002d_Duplaga-1999
p16457
sg5
S'PMC1760063'
p16458
sg7
g16446
sg9
V9862821.xml
p16459
sa(dp16460
g3
VSTD-Docherty-1995
p16461
sg5
S'PMC1234951'
p16462
sg7
VCD004320 v. 5.0 Stapled versus handsewn methods for ileocolic anastomoses.rm5
p16463
sg9
V7857145.xml
p16464
sa(dp16465
g3
VSTD-Maguire-1980
p16466
sg5
S'PMC1714830'
p16467
sg7
VCD005634 v. 7.2 Specialist breast care nurses for supportive care of women with breast cancer.rm5
p16468
sg9
V7192170.xml
p16469
sa(dp16470
g3
VSTD-McArdle-1996
p16471
sg5
S'PMC2350687'
p16472
sg7
g16468
sg9
V8608288.xml
p16473
sa(dp16474
g3
VSTD-Delvaux-2004
p16475
sg5
S'PMC2395320'
p16476
sg7
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p16477
sg9
V14710215.xml
p16478
sa(dp16479
g3
VSTD-Fox-1999
p16480
sg5
S'PMC1717884'
p16481
sg7
VCD008888 v. 2.0 Inhaled corticosteroids for subacute cough in children.rm5
p16482
sg9
V10086941.xml
p16483
sa(dp16484
g3
VSTD-Vic-1998
p16485
sg5
S'PMC1717599'
p16486
sg7
VCD002009 v. 13.0 Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.rm5
p16487
sg9
V9713009.xml
p16488
sa(dp16489
g3
VSTD-Calverley-2003
p16490
sg5
S'PMC1746483'
p16491
sg7
VCD002876 v. 8.0 Tiotropium for stable chronic obstructive pulmonary disease.rm5
p16492
sg9
V14514937.xml
p16493
sa(dp16494
g3
VSTD-Brusasco-2003
p16495
sg5
S'PMC1746668'
p16496
sg7
g16492
sg9
V12728159.xml
p16497
sa(dp16498
g3
VSTD-van-Noord-2000
p16499
sg5
S'PMC1745719'
p16500
sg7
g16492
sg9
V10722768.xml
p16501
sa(dp16502
g3
VSTD-Lindholm-2010
p16503
sg5
S'PMC3587763'
p16504
sg7
VCD008743 v. 2.8 Use of electronic health records to support smoking cessation.rm5
p16505
sg9
V21287886.xml
p16506
sa(dp16507
g3
VSTD-Koplan-2008
p16508
sg5
S'PMC2517966'
p16509
sg7
g16505
sg9
V18465176.xml
p16510
sa(dp16511
g3
VSTD-Linder-2009
p16512
sg5
S'PMC3005286'
p16513
sg7
g16505
sg9
V19398690.xml
p16514
sa(dp16515
g3
VSTD-Tehraninejad-2010
p16516
sg5
S'PMC3302709'
p16517
sg7
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p16518
sg9
V22427771.xml
p16519
sa(dp16520
g3
VSTD-Zeiger-2011
p16521
sg5
S'PMC3247621'
p16522
sg7
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p16523
sg9
V22111718.xml
p16524
sa(dp16525
g3
VSTD-Turpeinen-2008
p16526
sg5
S'PMC2532957'
p16527
sg7
g16523
sg9
V17634183.xml
p16528
sa(dp16529
g3
VSTD-Shukla-1966
p16530
sg5
S'PMC506219'
p16531
sg7
VCD001860 v. 9.6 Antibiotics for trachoma.rm5
p16532
sg9
V4952467.xml
p16533
sa(dp16534
g3
VSTD-Darougar-1980
p16535
sg5
S'PMC1043672'
p16536
sg7
g16532
sg9
V6992856.xml
p16537
sa(dp16538
g3
VSTD-Cochereau-2007
p16539
sg5
S'PMC1954762'
p16540
sg7
g16532
sg9
V17005549.xml
p16541
sa(dp16542
g3
VSTD-Wade-1992
p16543
sg5
S'PMC1881332'
p16544
sg7
VCD005952 v. 3.0 Therapy-based rehabilitation services for patients living at home more than one year after stroke.rm5
p16545
sg9
V1559090.xml
p16546
sa(dp16547
g3
VSTD-CREST-2010
p16548
sg5
S'PMC2932446'
p16549
sg7
VCD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
p16550
sg9
V20505173.xml
p16551
sa(dp16552
g3
VSTD-ICSS-2010
p16553
sg5
S'PMC2849002'
p16554
sg7
g16550
sg9
V20189239.xml
p16555
sa(dp16556
g3
VSTD-Spiro-1983
p16557
sg5
S'PMC459595'
p16558
sg7
VCD001316 v. 8.0 Steroids radiotherapy chemotherapy and stents for superior vena caval obstruction in carcinoma of .rm5
p16559
sg9
V6310812.xml
p16560
sa(dp16561
g3
VSTD-Stock-1995
p16562
sg5
S'PMC475086'
p16563
sg7
g16559
sg9
V8553270.xml
p16564
sa(dp16565
g3
VSTD-Watkinson-1993
p16566
sg5
S'PMC464777'
p16567
sg7
g16559
sg9
V7694384.xml
p16568
sa(dp16569
g3
VSTD-Lenssen-2008
p16570
sg5
S'PMC2386789'
p16571
sg7
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p16572
sg9
V18442423.xml
p16573
sa(dp16574
g3
VSTD-Lenssen-2003
p16575
sg5
S'PMC1403777'
p16576
sg7
g16572
sg9
V16504087.xml
p16577
sa(dp16578
g3
VSTD-Pacifico-1996
p16579
sg5
S'PMC163247'
p16580
sg7
VCD004872 v. 7.0 Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyng.rm5
p16581
sg9
V8849215.xml
p16582
sa(dp16583
g3
VSTD-Milatovic-1991
p16584
sg5
S'PMC2855147'
p16585
sg7
g16581
sg9
V20401325.xml
p16586
sa(dp16587
g3
VSTD-Ward-2005
p16588
sg5
S'PMC1747266'
p16589
sg7
VCD001941 v. 5.0 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and ches.rm5
p16590
sg9
V16299118.xml
p16591
sa(dp16592
g3
VSTD-Phimda-2007
p16593
sg5
S'PMC2043199'
p16594
sg7
VCD008264 v. 2.0 Antibiotics for leptospirosis.rm5
p16595
sg9
V17638700.xml
p16596
sa(dp16597
g3
VSTD-Li--2003
p16598
sg5
S'PMC3707322'
p16599
sg7
VCD006633 v. 5.0 Clozapine versus other atypical antipsychotics for schizophrenia.rm5
p16600
sg9
V23869281.xml
p16601
sa(dp16602
g3
VSTD-Sharma-1989
p16603
sg5
S'PMC1838188'
p16604
sg7
VCD004886 v. 3.9 Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated .rm5
p16605
sg9
V2513931.xml
p16606
sa(dp16607
g3
VSTD-Juster-2007
p16608
sg5
S'PMC2040364'
p16609
sg7
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p16610
sg9
V17901438.xml
p16611
sa(dp16612
g3
VSTD-Mulcahy-2005
p16613
sg5
S'PMC1748138'
p16614
sg7
g16610
sg9
V16319361.xml
p16615
sa(dp16616
g3
VSTD-Fern_x00e1_ndez-2009
p16617
sg5
S'PMC2621339'
p16618
sg7
g16610
sg9
V19165321.xml
p16619
sa(dp16620
g3
VSTD-Farrelly-2005
p16621
sg5
S'PMC1748080'
p16622
sg7
g16610
sg9
V16046685.xml
p16623
sa(dp16624
g3
VSTD-Eagan-2006
p16625
sg5
S'PMC2564667'
p16626
sg7
g16610
sg9
V16728756.xml
p16627
sa(dp16628
g3
VSTD-Hyland-2009
p16629
sg5
S'PMC2720733'
p16630
sg7
g16610
sg9
V19151105.xml
p16631
sa(dp16632
g3
VSTD-Fong-2006
p16633
sg5
S'PMC2593063'
p16634
sg7
g16610
sg9
V16754947.xml
p16635
sa(dp16636
g3
VSTD-Sargent-2004
p16637
sg5
S'PMC404491'
p16638
sg7
g16610
sg9
V15066887.xml
p16639
sa(dp16640
g3
VSTD-Gal_x00e1_n-2007
p16641
sg5
S'PMC2034550'
p16642
sg7
g16610
sg9
V17760974.xml
p16643
sa(dp16644
g3
VSTD-Allwright-2005
p16645
sg5
S'PMC1283274'
p16646
sg7
g16610
sg9
V16230313.xml
p16647
sa(dp16648
g3
VSTD-Fernando-2007
p16649
sg5
S'PMC2598530'
p16650
sg7
g16610
sg9
V17652238.xml
p16651
sa(dp16652
g3
VSTD-Gilpin-2002
p16653
sg5
S'PMC1447162'
p16654
sg7
g16610
sg9
V11988448.xml
p16655
sa(dp16656
g3
VSTD-Akhtar-2007
p16657
sg5
S'PMC1976539'
p16658
sg7
g16610
sg9
V17827487.xml
p16659
sa(dp16660
g3
VSTD-Abrams-2006
p16661
sg5
S'PMC1470494'
p16662
sg7
g16610
sg9
V16380571.xml
p16663
sa(dp16664
g3
VSTD-Haw-2007
p16665
sg5
S'PMC1976488'
p16666
sg7
g16610
sg9
V17827485.xml
p16667
sa(dp16668
g3
VSTD-McCusker-1995
p16669
sg5
S'PMC1615635'
p16670
sg7
VCD005338 v. 5.0 Therapeutic communities for substance related disorder.rm5
p16671
sg9
V7573630.xml
p16672
sa(dp16673
g3
VSTD-McCusker-1997a
p16674
sg5
S'PMC1381126'
p16675
sg7
g16671
sg9
V9357345.xml
p16676
sa(dp16677
g3
VSTD-Warner-2010
p16678
sg5
S'PMC2806180'
p16679
sg7
VCD003449 v. 11.0 Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.rm5
p16680
sg9
V19897857.xml
p16681
sa(dp16682
g3
VSTD-Weisberg-2009
p16683
sg5
S'PMC2710284'
p16684
sg7
g16680
sg9
V19369294.xml
p16685
sa(dp16686
g3
VSTD-Parker-1980
p16687
sg5
S'PMC3735938'
p16688
sg7
g16680
sg9
V23614904.xml
p16689
sa(dp16690
g3
VSTD-Sinha-1997
p16691
sg5
S'PMC1720717'
p16692
sg7
VCD003666 v. 6.1 Volume-targeted versus pressure-limited ventilation in the neonate.rm5
p16693
sg9
V9462190.xml
p16694
sa(dp16695
g3
VSTD-Ramenghi-1999
p16696
sg5
S'PMC1720910'
p16697
sg7
VCD001069 v. 7.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
p16698
sg9
V10325795.xml
p16699
sa(dp16700
g3
VSTD-Ramenghi-1996a
p16701
sg5
S'PMC2528545'
p16702
sg7
g16698
sg9
V8777660.xml
p16703
sa(dp16704
g3
VSTD-Ramenghi-1996b
p16705
sg5
S'PMC2528524'
p16706
sg7
g16698
sg9
V8777661.xml
p16707
sa(dp16708
g3
VSTD-Rushforth-1993
p16709
sg5
S'PMC1029529'
p16710
sg7
g16698
sg9
V8215552.xml
p16711
sa(dp16712
g3
VSTD-Alsaedi-2009
p16713
sg5
S'PMC2813645'
p16714
sg7
g16698
sg9
V19448377.xml
p16715
sa(dp16716
g3
VSTD-Boyle-2006
p16717
sg5
S'PMC2672697'
p16718
sg7
g16698
sg9
V16428355.xml
p16719
sa(dp16720
g3
VSTD-Carbajal-1999
p16721
sg5
S'PMC28282'
p16722
sg7
g16698
sg9
V10574854.xml
p16723
sa(dp16724
g3
VSTD-Ogawa-2005
p16725
sg5
S'PMC1721952'
p16726
sg7
g16698
sg9
V15871991.xml
p16727
sa(dp16728
g3
VSTD-Slater-2010
p16729
sg5
S'PMC2958259'
p16730
sg7
g16698
sg9
V20817247.xml
p16731
sa(dp16732
g3
VSTD-Acharya-2004
p16733
sg5
S'PMC1721636'
p16734
sg7
g16698
sg9
V14711847.xml
p16735
sa(dp16736
g3
VSTD-Taddio-2008
p16737
sg5
S'PMC2464480'
p16738
sg7
g16698
sg9
V18591525.xml
p16739
sa(dp16740
g3
VSTD-Haouari-1995
p16741
sg5
S'PMC2549876'
p16742
sg7
g16698
sg9
V7787595.xml
p16743
sa(dp16744
g3
VSTD-Saunders-1989
p16745
sg5
S'PMC1838287'
p16746
sg7
VCD009241 v. 2.0 Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.rm5
p16747
sg9
V2514824.xml
p16748
sa(dp16749
g3
VSTD-Tonnel-2008
p16750
sg5
S'PMC2629970'
p16751
sg7
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p16752
sg9
V18686739.xml
p16753
sa(dp16754
g3
VSTD-Bateman-2010b
p16755
sg5
S'PMC2921687'
p16756
sg7
g16752
sg9
V20714373.xml
p16757
sa(dp16758
g3
VSTD-Brusasco-2003
p16759
sg5
S'PMC1746668'
p16760
sg7
g16752
sg9
V12728159.xml
p16761
sa(dp16762
g3
VSTD-Chan-2007
p16763
sg5
S'PMC2677771'
p16764
sg7
g16752
sg9
V18060091.xml
p16765
sa(dp16766
g3
VSTD-Freeman-2007
p16767
sg5
S'PMC1913915'
p16768
sg7
g16752
sg9
V17605774.xml
p16769
sa(dp16770
g3
VSTD-Trooster-2011
p16771
sg5
S'PMC3078679'
p16772
sg7
g16752
sg9
V21503263.xml
p16773
sa(dp16774
g3
VSTD-Cooper-2010
p16775
sg5
S'PMC2981152'
p16776
sg7
g16752
sg9
V21103404.xml
p16777
sa(dp16778
g3
VSTD-Bauman-1991
p16779
sg5
S'PMC1405075'
p16780
sg7
VCD001006 v. 11.0 Mass media interventions for preventing smoking in young people.rm5
p16781
sg9
V2014859.xml
p16782
sa(dp16783
g3
VSTD-Flynn-2010
p16784
sg5
S'PMC2898197'
p16785
sg7
g16781
sg9
V20537841.xml
p16786
sa(dp16787
g3
VSTD-Poskitt-1987
p16788
sg5
S'PMC1245732'
p16789
sg7
VCD001737 v. 9.2 Skin grafting for venous leg ulcers.rm5
p16790
sg9
V3105681.xml
p16791
sa(dp16792
g3
VSTD-CATCHUP-2002
p16793
sg5
S'PMC1761064'
p16794
sg7
VCD004874 v. 10.0 Antibiotics for community-acquired pneumonia in children.rm5
p16795
sg9
V11827905.xml
p16796
sa(dp16797
g3
VSTD-Atkinson-2007
p16798
sg5
S'PMC2094276'
p16799
sg7
g16795
sg9
V17567657.xml
p16800
sa(dp16801
g3
VSTD-Keeley-1990
p16802
sg5
S'PMC2393134'
p16803
sg7
g16795
sg9
V2194687.xml
p16804
sa(dp16805
g3
VSTD-Asghar-2008
p16806
sg5
S'PMC2190277'
p16807
sg7
g16795
sg9
V18182412.xml
p16808
sa(dp16809
g3
VSTD-Roord-1996
p16810
sg5
S'PMC163618'
p16811
sg7
g16795
sg9
V9124837.xml
p16812
sa(dp16813
g3
VSTD-Hoffbrand-1988
p16814
sg5
S'PMC1033029'
p16815
sg7
VCD000094 v. 6.0 Gangliosides for acute ischaemic stroke.rm5
p16816
sg9
V3066849.xml
p16817
sa(dp16818
g3
VSTD-Rebello-2001
p16819
sg5
S'PMC30583'
p16820
sg7
VCD008054 v. 2.2 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.rm5
p16821
sg9
V11302900.xml
p16822
sa(dp16823
g3
VSTD-Guyot-2003
p16824
sg5
S'PMC222910'
p16825
sg7
g16821
sg9
V14511396.xml
p16826
sa(dp16827
g3
VSTD-Cattani-2009
p16828
sg5
S'PMC2786669'
p16829
sg7
g16821
sg9
V19828739.xml
p16830
sa(dp16831
g3
VSTD-Lytwyn-2000
p16832
sg5
S'PMC80165'
p16833
sg7
g16821
sg9
V11022584.xml
p16834
sa(dp16835
g3
VSTD-Choung-2008
p16836
sg5
S'PMC2671765'
p16837
sg7
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p16838
sg9
V19434268.xml
p16839
sa(dp16840
g3
VSTD-Leibovici-2001
p16841
sg5
S'PMC61047'
p16842
sg7
VCD000368 v. 12.0 Intercessory prayer for the alleviation of ill health.rm5
p16843
sg9
V11751349.xml
p16844
sa(dp16845
g3
VSTD-Staab-2006
p16846
sg5
S'PMC1444870'
p16847
sg7
VCD004054 v. 4.0 Psychological and educational interventions for atopic eczema in children.rm5
p16848
sg9
V16627509.xml
p16849
sa(dp16850
g3
VSTD-Kushner-2008
p16851
sg5
S'PMC2652083'
p16852
sg7
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p16853
sg9
V18809603.xml
p16854
sa(dp16855
g3
VSTD-Bertuzzi-2003
p16856
sg5
S'PMC2394317'
p16857
sg7
g16853
sg9
V14520438.xml
p16858
sa(dp16859
g3
VSTD-Mitchell-1994
p16860
sg5
S'PMC1029751'
p16861
sg7
g16853
sg9
V7907853.xml
p16862
sa(dp16863
g3
VSTD-Gara-2010
p16864
sg5
S'PMC2946754'
p16865
sg7
VCD006589 v. 5.5 Oral iron supplements for children in malaria-endemic areas.rm5
p16866
sg9
V20889877.xml
p16867
sa(dp16868
g3
VSTD-Zlotkin-2003
p16869
sg5
S'PMC2572396'
p16870
sg7
g16866
sg9
V12756979.xml
p16871
sa(dp16872
g3
VSTD-Aggarwal-2005
p16873
sg5
S'PMC1720080'
p16874
sg7
g16866
sg9
V15613506.xml
p16875
sa(dp16876
g3
VSTD-Johnson-2008
p16877
sg5
S'PMC2327253'
p16878
sg7
VCD008066 v. 4.0 Transtheoretical model for dietary and physical exercise modification in weight loss management for .rm5
p16879
sg9
V18055007.xml
p16880
sa(dp16881
g3
VSTD-Steptoe-2001
p16882
sg5
S'PMC1446539'
p16883
sg7
g16879
sg9
V11211636.xml
p16884
sa(dp16885
g3
VSTD-Lowe--1989
p16886
sg5
S'PMC3773236'
p16887
sg7
VCD001928 v. 6.0 Calcium antagonists for acute ischemic stroke.rm5
p16888
sg9
V23809206.xml
p16889
sa(dp16890
g3
VSTD-Roman-2010
p16891
sg5
S'PMC3103109'
p16892
sg7
VCD008643 v. 4.3 Red flags to screen for vertebral fracture in patients presenting with low-back pain.rm5
p16893
sg9
V21655423.xml
p16894
sa(dp16895
g3
VSTD-Gibson-1992
p16896
sg5
S'PMC1285823'
p16897
sg7
g16893
sg9
V1533126.xml
p16898
sa(dp16899
g3
VSTD-Leung-2006
p16900
sg5
S'PMC1804104'
p16901
sg7
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p16902
sg9
V17176279.xml
p16903
sa(dp16904
g3
VSTD-Katiyar-2006
p16905
sg5
S'PMC2856361'
p16906
sg7
VCD008250 v. 2.0 Breathing exercises for chronic obstructive pulmonary disease.rm5
p16907
sg9
V20418993.xml
p16908
sa(dp16909
g3
VSTD-Chauhan-1992
p16910
sg5
S'PMC1882360'
p16911
sg7
g16907
sg9
V1633520.xml
p16912
sa(dp16913
g3
VSTD-Donesky_x002d_Cuenco-2009
p16914
sg5
S'PMC3051406'
p16915
sg7
g16907
sg9
V19249998.xml
p16916
sa(dp16917
g3
VSTD-Saunders-1965
p16918
sg5
S'PMC1846091'
p16919
sg7
g16907
sg9
V14337735.xml
p16920
sa(dp16921
g3
VSTD-Zmora-2003
p16922
sg5
S'PMC1514315'
p16923
sg7
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p16924
sg9
V12616120.xml
p16925
sa(dp16926
g3
VSTD-Scabini-2010
p16927
sg5
S'PMC2873340'
p16928
sg7
g16924
sg9
V20433721.xml
p16929
sa(dp16930
g3
VSTD-Kirke-1992
p16931
sg5
S'PMC1793975'
p16932
sg7
VCD004073 v. 6.0 Vitamin supplementation for preventing miscarriage.rm5
p16933
sg9
V1489222.xml
p16934
sa(dp16935
g3
VSTD-Lefaucheur-2004
p16936
sg5
S'PMC1739005'
p16937
sg7
VCD008208 v. 4.0 Non-invasive brain stimulation techniques for chronic pain.rm5
p16938
sg9
V15026508.xml
p16939
sa(dp16940
g3
VSTD-Khedr-2005
p16941
sg5
S'PMC1739662'
p16942
sg7
g16938
sg9
V15897507.xml
p16943
sa(dp16944
g3
VSTD-Borckardt-2009
p16945
sg5
S'PMC2863136'
p16946
sg7
g16938
sg9
V19594842.xml
p16947
sa(dp16948
g3
VSTD-Jones-1982
p16949
sg5
S'PMC1627926'
p16950
sg7
VCD001072 v. 6.0 Continuous positive airway pressure versus theophylline for apnea in preterm infants.rm5
p16951
sg9
V6753769.xml
p16952
sa(dp16953
g3
VSTD-Aufenacker-2004
p16954
sg5
S'PMC1356511'
p16955
sg7
VCD003769 v. 9.0 Antibiotic prophylaxis for hernia repair..rm5
p16956
sg9
V15570201.xml
p16957
sa(dp16958
g3
VSTD-Yerdel-2001
p16959
sg5
S'PMC1421162'
p16960
sg7
g16956
sg9
V11141221.xml
p16961
sa(dp16962
g3
VSTD-Araki-2011
p16963
sg5
S'PMC3047641'
p16964
sg7
VCD008413 v. 2.0 Double-bundle versus single-bundle reconstruction for anterior cruciate ligament rupture in adults.rm5
p16965
sg9
V20734043.xml
p16966
sa(dp16967
g3
VSTD-Song-2009
p16968
sg5
S'PMC3740368'
p16969
sg7
g16965
sg9
V19509412.xml
p16970
sa(dp16971
g3
VSTD-Murray-2011
p16972
sg5
S'PMC3323493'
p16973
sg7
VCD008858 v. 2.0 Vaccines for preventing herpes zoster in older adults.rm5
p16974
sg9
V22048110.xml
p16975
sa(dp16976
g3
VSTD-Gilderman-2008
p16977
sg5
S'PMC2238040'
p16978
sg7
g16974
sg9
V18077611.xml
p16979
sa(dp16980
g3
VSTD-Baqui_x002d_CARE-INDIA-2008
p16981
sg5
S'PMC2649510'
p16982
sg7
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p16983
sg9
V18949217.xml
p16984
sa(dp16985
g3
VSTD-Syed-2006
p16986
sg5
S'PMC3001155'
p16987
sg7
g16983
sg9
V17591348.xml
p16988
sa(dp16989
g3
VSTD-Bhutta-2010
p16990
sg5
S'PMC3700035'
p16991
sg7
g16983
sg9
V23826502.xml
p16992
sa(dp16993
g3
VSTD-Bhutta-2008
p16994
sg5
S'PMC2647462'
p16995
sg7
g16983
sg9
V18568274.xml
p16996
sa(dp16997
g3
VSTD-Bari-2006
p16998
sg5
S'PMC3001156'
p16999
sg7
g16983
sg9
V17591349.xml
p17000
sa(dp17001
g3
VSTD-Leech-1987
p17002
sg5
S'PMC1492041'
p17003
sg7
VCD000422 v. 8.0 Vaccines for preventing pneumococcal infection in adults.rm5
p17004
sg9
V3545418.xml
p17005
sa(dp17006
g3
VSTD-Alfageme-2006
p17007
sg5
S'PMC2080738'
p17008
sg7
g17004
sg9
V16227328.xml
p17009
sa(dp17010
g3
VSTD-Maruyama-2010
p17011
sg5
S'PMC2834887'
p17012
sg7
g17004
sg9
V20211953.xml
p17013
sa(dp17014
g3
VSTD-Ferrari-2003-BRA
p17015
sg5
S'PMC2572425'
p17016
sg7
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p17017
sg9
V12764515.xml
p17018
sa(dp17019
g3
VSTD-Tweyongyere-2009-UGA
p17020
sg5
S'PMC2666740'
p17021
sg7
g17017
sg9
V19296834.xml
p17022
sa(dp17023
g3
VSTD-Omer-1978-SDN
p17024
sg5
S'PMC1606234'
p17025
sg7
g17017
sg9
V678831.xml
p17026
sa(dp17027
g3
VSTD-Olliaro-2011-TZA
p17028
sg5
S'PMC3114749'
p17029
sg7
g17017
sg9
V21695161.xml
p17030
sa(dp17031
g3
VSTD-Katz-1979b-BRA
p17032
sg5
S'PMC2395863'
p17033
sg7
g17017
sg9
V396054.xml
p17034
sa(dp17035
g3
VSTD-Olliaro-2011-MRT
p17036
sg5
S'PMC3114749'
p17037
sg7
g17017
sg9
V21695161.xml
p17038
sa(dp17039
g3
VSTD-Katz-1979a-BRA
p17040
sg5
S'PMC2395863'
p17041
sg7
g17017
sg9
V396054.xml
p17042
sa(dp17043
g3
VSTD-Olliaro-2011-BRA
p17044
sg5
S'PMC3114749'
p17045
sg7
g17017
sg9
V21695161.xml
p17046
sa(dp17047
g3
VSTD-Bergstrom-2009
p17048
sg5
S'PMC2759981'
p17049
sg7
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p17050
sg9
V19538406.xml
p17051
sa(dp17052
g3
VSTD-Lepantalo-1984
p17053
sg5
S'PMC1463567'
p17054
sg7
VCD003893 v. 8.0 Methyldopa for primary hypertension.rm5
p17055
sg9
V6378235.xml
p17056
sa(dp17057
g3
VSTD-Petrie-1976
p17058
sg5
S'PMC1687472'
p17059
sg7
g17055
sg9
V776350.xml
p17060
sa(dp17061
g3
VSTD-Fernandez-1980
p17062
sg5
S'PMC1704774'
p17063
sg7
g17055
sg9
V7020900.xml
p17064
sa(dp17065
g3
VSTD-Edwards-1999
p17066
sg5
S'PMC1745469'
p17067
sg7
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p17068
sg9
V10092691.xml
p17069
sa(dp17070
g3
VSTD-Fiocchi-1994
p17071
sg5
S'PMC2365600'
p17072
sg7
g17068
sg9
V18475604.xml
p17073
sa(dp17074
g3
VSTD-Muirhead-2006
p17075
sg5
S'PMC1828262'
p17076
sg7
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p17077
sg9
V16536959.xml
p17078
sa(dp17079
g3
VSTD-Kouyate-2008
p17080
sg5
S'PMC2287184'
p17081
sg7
g17077
sg9
V18364043.xml
p17082
sa(dp17083
g3
VSTD-Olds-2002
p17084
sg5
S'PMC1509014'
p17085
sg7
g17077
sg9
V10589314.xml
p17086
sa(dp17087
g3
VSTD-Graffy-2004
p17088
sg5
S'PMC313903'
p17089
sg7
g17077
sg9
V14703543.xml
p17090
sa(dp17091
g3
VSTD-Morisky-2001
p17092
sg5
S'PMC1497389'
p17093
sg7
g17077
sg9
V12196616.xml
p17094
sa(dp17095
g3
VSTD-Gadomski-2006
p17096
sg5
S'PMC1470549'
p17097
sg7
g17077
sg9
V16507741.xml
p17098
sa(dp17099
g3
VSTD-MacArthur-2009
p17100
sg5
S'PMC2636685'
p17101
sg7
g17077
sg9
V19181730.xml
p17102
sa(dp17103
g3
VSTD-Morrell-2000
p17104
sg5
S'PMC27472'
p17105
sg7
g17077
sg9
V10977833.xml
p17106
sa(dp17107
g3
VSTD-Schuler-2000
p17108
sg5
S'PMC3143381'
p17109
sg7
g17077
sg9
V10969426.xml
p17110
sa(dp17111
g3
VSTD-Bari-2006
p17112
sg5
S'PMC3001156'
p17113
sg7
g17077
sg9
V17591349.xml
p17114
sa(dp17115
g3
VSTD-Dennis-2009
p17116
sg5
S'PMC2628301'
p17117
sg7
g17077
sg9
V19147637.xml
p17118
sa(dp17119
g3
VSTD-Johnson-1993
p17120
sg5
S'PMC1677859'
p17121
sg7
g17077
sg9
V8518642.xml
p17122
sa(dp17123
g3
VSTD-Zaman-2008
p17124
sg5
S'PMC2740673'
p17125
sg7
g17077
sg9
V18686554.xml
p17126
sa(dp17127
g3
VSTD-Wang-2007
p17128
sg5
S'PMC2636406'
p17129
sg7
g17077
sg9
V18026625.xml
p17130
sa(dp17131
g3
VSTD-Colombo-1979
p17132
sg5
S'PMC1619135'
p17133
sg7
g17077
sg9
V434277.xml
p17134
sa(dp17135
g3
VSTD-Nottingham-2002
p17136
sg5
S'PMC1773232'
p17137
sg7
VCD001216 v. 8.0 Screening for colorectal cancer using the faecal occult blood test Hemoccult.rm5
p17138
sg9
V12010887.xml
p17139
sa(dp17140
g3
VSTD-Nottingham-1999
p17141
sg5
S'PMC1727686'
p17142
sg7
g17138
sg9
V10486370.xml
p17143
sa(dp17144
g3
VSTD-Funen-2002
p17145
sg5
S'PMC1773083'
p17146
sg7
g17138
sg9
V11772963.xml
p17147
sa(dp17148
g3
VSTD-Allen-2001
p17149
sg5
S'PMC1446631'
p17150
sg7
VCD002834 v. 7.0 Interventions targeted at women to encourage the uptake of cervical screening.rm5
p17151
sg9
V11291370.xml
p17152
sa(dp17153
g3
VSTD-Robson-1989
p17154
sg5
S'PMC1835698'
p17155
sg7
g17151
sg9
V2495053.xml
p17156
sa(dp17157
g3
VSTD-Adab-2003
p17158
sg5
S'PMC1732533'
p17159
sg7
g17151
sg9
V12883063.xml
p17160
sa(dp17161
g3
VSTD-Buehler-1997
p17162
sg5
S'PMC1227965'
p17163
sg7
g17151
sg9
V9294390.xml
p17164
sa(dp17165
g3
VSTD-McAvoy-1991
p17166
sg5
S'PMC1669184'
p17167
sg7
g17151
sg9
V1958248.xml
p17168
sa(dp17169
g3
VSTD-Taylor-2002
p17170
sg5
S'PMC1592333'
p17171
sg7
g17151
sg9
V11983755.xml
p17172
sa(dp17173
g3
VSTD-Lancaster-1992
p17174
sg5
S'PMC1059645'
p17175
sg7
g17151
sg9
V1479324.xml
p17176
sa(dp17177
g3
VSTD-Pierce-1989
p17178
sg5
S'PMC1837038'
p17179
sg7
g17151
sg9
V2504359.xml
p17180
sa(dp17181
g3
VSTD-Mock-2007
p17182
sg5
S'PMC1963308'
p17183
sg7
g17151
sg9
V17329652.xml
p17184
sa(dp17185
g3
VSTD-Wilson-1987
p17186
sg5
S'PMC1247036'
p17187
sg7
g17151
sg9
V3115368.xml
p17188
sa(dp17189
g3
VSTD-Aguado-95_x002d_Heart_x002f_GCV
p17190
sg5
S'PMC162800'
p17191
sg7
VCD005129 v. 8.0 Immunoglobulins vaccines or interferon for preventing cytomegalovirus disease in solid organ transp.rm5
p17192
sg9
V7492123.xml
p17193
sa(dp17194
g3
VSTD-Walsh-1997
p17195
sg5
S'PMC1380897'
p17196
sg7
VCD001055 v. 7.0 Interventions for promoting smoking cessation during pregnancy.rm5
p17197
sg9
V9240113.xml
p17198
sa(dp17199
g3
VSTD-Tappin-2005
p17200
sg5
S'PMC1184246'
p17201
sg7
g17197
sg9
V16096304.xml
p17202
sa(dp17203
g3
VSTD-Campbell-2006
p17204
sg5
S'PMC2563553'
p17205
sg7
g17197
sg9
V16565456.xml
p17206
sa(dp17207
g3
VSTD-Mayer-1990
p17208
sg5
S'PMC1404549'
p17209
sg7
g17197
sg9
V2293809.xml
p17210
sa(dp17211
g3
VSTD-McBride-1999
p17212
sg5
S'PMC1508743'
p17213
sg7
g17197
sg9
V10224982.xml
p17214
sa(dp17215
g3
VSTD-Bauman-1983
p17216
sg5
S'PMC1651063'
p17217
sg7
g17197
sg9
V6881407.xml
p17218
sa(dp17219
g3
VSTD-Cinciripini-2000
p17220
sg5
S'PMC1766306'
p17221
sg7
g17197
sg9
V10982910.xml
p17222
sa(dp17223
g3
VSTD-Donovan-1977
p17224
sg5
S'PMC478984'
p17225
sg7
g17197
sg9
V856371.xml
p17226
sa(dp17227
g3
VSTD-Donatelle-2000
p17228
sg5
S'PMC1766304'
p17229
sg7
g17197
sg9
V10982912.xml
p17230
sa(dp17231
g3
VSTD-Lawrence-2003
p17232
sg5
S'PMC1747729'
p17233
sg7
g17197
sg9
V12773727.xml
p17234
sa(dp17235
g3
VSTD-Strecher-2000
p17236
sg5
S'PMC1766311'
p17237
sg7
g17197
sg9
V10982916.xml
p17238
sa(dp17239
g3
VSTD-Kendrick-1995
p17240
sg5
S'PMC1615299'
p17241
sg7
g17197
sg9
V7856781.xml
p17242
sa(dp17243
g3
VSTD-Pollak-2007
p17244
sg5
S'PMC3602964'
p17245
sg7
g17197
sg9
V17888856.xml
p17246
sa(dp17247
g3
VSTD-Solomon-2000
p17248
sg5
S'PMC1766314'
p17249
sg7
g17197
sg9
V10982914.xml
p17250
sa(dp17251
g3
VSTD-Heil-2008
p17252
sg5
S'PMC2731575'
p17253
sg7
g17197
sg9
V18482424.xml
p17254
sa(dp17255
g3
VSTD-Windsor-1985
p17256
sg5
S'PMC1646449'
p17257
sg7
g17197
sg9
V4061709.xml
p17258
sa(dp17259
g3
VSTD-Ershoff-1989
p17260
sg5
S'PMC1349930'
p17261
sg7
g17197
sg9
V2913837.xml
p17262
sa(dp17263
g3
VSTD-Windsor-1993
p17264
sg5
S'PMC1694576'
p17265
sg7
g17197
sg9
V8427323.xml
p17266
sa(dp17267
g3
VSTD-Moore-2002
p17268
sg5
S'PMC138509'
p17269
sg7
g17197
sg9
V12480850.xml
p17270
sa(dp17271
g3
VSTD-Whalen-1997
p17272
sg5
S'PMC2860292'
p17273
sg7
VCD000171 v. 12.0 Treatment of latent tuberculosis infection in HIV infected persons.rm5
p17274
sg9
V17065029.xml
p17275
sa(dp17276
g3
VSTD-P_x002d_Layrargues-2001
p17277
sg5
S'PMC1760139'
p17278
sg7
VCD000553 v. 6.0 Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.rm5
p17279
sg9
V11171831.xml
p17280
sa(dp17281
g3
VSTD-Rikkers-1987
p17282
sg5
S'PMC1493196'
p17283
sg7
g17279
sg9
V3307653.xml
p17284
sa(dp17285
g3
VSTD-Spina-1990
p17286
sg5
S'PMC1357962'
p17287
sg7
g17279
sg9
V2405792.xml
p17288
sa(dp17289
g3
VSTD-Karatzas-2002
p17290
sg5
S'PMC153443'
p17291
sg7
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p17292
sg9
V12512504.xml
p17293
sa(dp17294
g3
VSTD-Tugrul-2002
p17295
sg5
S'PMC125317'
p17296
sg7
g17292
sg9
V12225613.xml
p17297
sa(dp17298
g3
VSTD-Barratt-1973
p17299
sg5
S'PMC1648329'
p17300
sg7
VCD002290 v. 11.0 Non-corticosteroid treatment for nephrotic syndrome in children.rm5
p17301
sg9
V4574639.xml
p17302
sa(dp17303
g3
VSTD-Barratt-1970
p17304
sg5
S'PMC1648329'
p17305
sg7
g17301
sg9
V4574639.xml
p17306
sa(dp17307
g3
VSTD-Barratt-1977
p17308
sg5
S'PMC1544692'
p17309
sg7
g17301
sg9
V879831.xml
p17310
sa(dp17311
g3
VSTD-Ueda-1990
p17312
sg5
S'PMC1792340'
p17313
sg7
g17301
sg9
V2248508.xml
p17314
sa(dp17315
g3
VSTD-McCleane-2000
p17316
sg5
S'PMC2015036'
p17317
sg7
VCD008943 v. 3.0 Combination pharmacotherapy for the treatment of neuropathic pain in adults.rm5
p17318
sg9
V10848721.xml
p17319
sa(dp17320
g3
VSTD-Khoromi-2007
p17321
sg5
S'PMC1974876'
p17322
sg7
g17318
sg9
V17182183.xml
p17323
sa(dp17324
g3
VSTD-Barton-2011
p17325
sg5
S'PMC3338170'
p17326
sg7
g17318
sg9
V20496177.xml
p17327
sa(dp17328
g3
VSTD-DIAS-2-2008
p17329
sg5
S'PMC2730486'
p17330
sg7
VCD000213 v. 7.0 Thrombolysis for acute ischaemic stroke.rm5
p17331
sg9
V19097942.xml
p17332
sa(dp17333
g3
VSTD-Unger-2004-_x0028_FLAVOR_x0029_
p17334
sg5
S'PMC1448241'
p17335
sg7
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p17336
sg9
V14759940.xml
p17337
sa(dp17338
g3
VSTD-Nutbeam-1993-_x0028_FSE_x0029_
p17339
sg5
S'PMC1676653'
p17340
sg7
g17336
sg9
V8435601.xml
p17341
sa(dp17342
g3
VSTD-Sun-2008-_x0028_Cognitive_x0029_
p17343
sg5
S'PMC2784033'
p17344
sg7
g17336
sg9
V18675294.xml
p17345
sa(dp17346
g3
VSTD-Crone-2003
p17347
sg5
S'PMC1732562'
p17348
sg7
g17336
sg9
V12933772.xml
p17349
sa(dp17350
g3
VSTD-Biglan-2000
p17351
sg5
S'PMC1748303'
p17352
sg7
g17336
sg9
V10691755.xml
p17353
sa(dp17354
g3
VSTD-Kellam-1998-_x0028_GBG_x0029_
p17355
sg5
S'PMC1508467'
p17356
sg7
g17336
sg9
V9772850.xml
p17357
sa(dp17358
g3
VSTD-Rohrbach-2010a
p17359
sg5
S'PMC2939247'
p17360
sg7
g17336
sg9
V20655946.xml
p17361
sa(dp17362
g3
VSTD-Hecht-2008
p17363
sg5
S'PMC2892822'
p17364
sg7
g17336
sg9
V19157042.xml
p17365
sa(dp17366
g3
VSTD-Campbell-2008
p17367
sg5
S'PMC2387195'
p17368
sg7
g17336
sg9
V18468543.xml
p17369
sa(dp17370
g3
VSTD-Johnson-2009
p17371
sg5
S'PMC2681204'
p17372
sg7
g17336
sg9
V19440519.xml
p17373
sa(dp17374
g3
VSTD-Aveyard-1999
p17375
sg5
S'PMC28247'
p17376
sg7
g17336
sg9
V10514156.xml
p17377
sa(dp17378
g3
VSTD-Schinke-1986c
p17379
sg5
S'PMC1839926'
p17380
sg7
g17336
sg9
V3957152.xml
p17381
sa(dp17382
g3
VSTD-Perry-1996
p17383
sg5
S'PMC1380436'
p17384
sg7
g17336
sg9
V8669519.xml
p17385
sa(dp17386
g3
VSTD-Cameron-1999
p17387
sg5
S'PMC1509003'
p17388
sg7
g17336
sg9
V10589310.xml
p17389
sa(dp17390
g3
VSTD-Ellickson-2003
p17391
sg5
S'PMC1448059'
p17392
sg7
g17336
sg9
V14600049.xml
p17393
sa(dp17394
g3
VSTD-Schinke-1986a
p17395
sg5
S'PMC1477741'
p17396
sg7
g17336
sg9
V3090603.xml
p17397
sa(dp17398
g3
VSTD-Schinke-1985a
p17399
sg5
S'PMC1646189'
p17400
sg7
g17336
sg9
V4003636.xml
p17401
sa(dp17402
g3
VSTD-Noland-1998
p17403
sg5
S'PMC1509045'
p17404
sg7
g17336
sg9
V9842390.xml
p17405
sa(dp17406
g3
VSTD-Spoth-2007
p17407
sg5
S'PMC2848497'
p17408
sg7
g17336
sg9
V17605536.xml
p17409
sa(dp17410
g3
VSTD-Perry-2009
p17411
sg5
S'PMC2667859'
p17412
sg7
g17336
sg9
V19299670.xml
p17413
sa(dp17414
g3
VSTD-Lal-1972
p17415
sg5
S'PMC1785512'
p17416
sg7
VCD002160 v. 11.0 Inhaled versus oral steroids for adults with chronic asthma.rm5
p17417
sg9
V4558306.xml
p17418
sa(dp17419
g3
VSTD-Jenkins-1988
p17420
sg5
S'PMC461253'
p17421
sg7
g17417
sg9
V3194866.xml
p17422
sa(dp17423
g3
VSTD-Bosman-1994
p17424
sg5
S'PMC474084'
p17425
sg7
g17417
sg9
V8153939.xml
p17426
sa(dp17427
g3
VSTD-Kok-2006
p17428
sg5
S'PMC1523437'
p17429
sg7
VCD006124 v. 4.1 Laparoscopic versus open nephrectomy for live kidney donors.rm5
p17430
sg9
V16847014.xml
p17431
sa(dp17432
g3
VSTD-Wolff-2004
p17433
sg5
S'PMC1356474'
p17434
sg7
VCD004930 v. 6.0 Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal sur.rm5
p17435
sg9
V15383800.xml
p17436
sa(dp17437
g3
VSTD-Luft-2004
p17438
sg5
S'PMC2930817'
p17439
sg7
VCD006432 v. 3.0 Simultaneous bilateral training for improving arm function after stroke.rm5
p17440
sg9
V15494583.xml
p17441
sa(dp17442
g3
VSTD-Oswalt-2007
p17443
sg5
S'PMC3639498'
p17444
sg7
VCD005038 v. 5.0 Massage for promoting mental and physical health in typically developing infants under the age of si.rm5
p17445
sg9
V23625101.xml
p17446
sa(dp17447
g3
VSTD-Edwards-1996
p17448
sg5
S'PMC2364515'
p17449
sg7
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p17450
sg9
V18476121.xml
p17451
sa(dp17452
g3
VSTD-Martin-1997
p17453
sg5
S'PMC2364533'
p17454
sg7
g17450
sg9
V18476128.xml
p17455
sa(dp17456
g3
VSTD-Rosenn-1995
p17457
sg5
S'PMC2364446'
p17458
sg7
g17450
sg9
V18476049.xml
p17459
sa(dp17460
g3
VSTD-Turrentine-1995
p17461
sg5
S'PMC2364394'
p17462
sg7
g17450
sg9
V18475393.xml
p17463
sa(dp17464
g3
VSTD-Khanna-2005
p17465
sg5
S'PMC1156915'
p17466
sg7
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p17467
sg9
V15946379.xml
p17468
sa(dp17469
g3
VSTD-Shah-1997
p17470
sg5
S'PMC1720690'
p17471
sg7
VCD001452 v. 10.0 Venepuncture versus heel lance for blood sampling in term neonates.rm5
p17472
sg9
V9377140.xml
p17473
sa(dp17474
g3
VSTD-Ogawa-2005
p17475
sg5
S'PMC1721952'
p17476
sg7
g17472
sg9
V15871991.xml
p17477
sa(dp17478
g3
VSTD-Korpan-1997
p17479
sg5
S'PMC1190648'
p17480
sg7
VCD006039 v. 6.0 Resection versus no intervention or other surgical interventions for colorectal cancer liver metasta.rm5
p17481
sg9
V9065296.xml
p17482
sa(dp17483
g3
VSTD-Boldt-1996
p17484
sg5
S'PMC484507'
p17485
sg7
VCD004126 v. 5.3 Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing su.rm5
p17486
sg9
V8868976.xml
p17487
sa(dp17488
g3
VSTD-Browning-1983a
p17489
sg5
S'PMC1549550'
p17490
sg7
VCD004618 v. 4.0 Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perfor.rm5
p17491
sg9
V6412934.xml
p17492
sa(dp17493
g3
VSTD-Hopewell-2004
p17494
sg5
S'PMC3646177'
p17495
sg7
VMR000010 v. 6.0 Grey literature in meta-analyses of randomized trials of health care interventions.rm5
p17496
sg9
V23645909.xml
p17497
sa(dp17498
g3
VSTD-Smithuis-2010-MMR
p17499
sg5
S'PMC2947715'
p17500
sg7
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p17501
sg9
V20832366.xml
p17502
sa(dp17503
g3
VSTD-Awab-2010-AFG
p17504
sg5
S'PMC2864284'
p17505
sg7
g17501
sg9
V20409302.xml
p17506
sa(dp17507
g3
VSTD-Krudsood-2007-THA
p17508
sg5
S'PMC2526312'
p17509
sg7
g17501
sg9
V17570973.xml
p17510
sa(dp17511
g3
VSTD-Hasugian-2007-IDN
p17512
sg5
S'PMC2532501'
p17513
sg7
g17501
sg9
V17366451.xml
p17514
sa(dp17515
g3
VSTD-Ratcliff-2007-IDN
p17516
sg5
S'PMC2532500'
p17517
sg7
g17501
sg9
V17336652.xml
p17518
sa(dp17519
g3
VSTD-Hutagalung-2005-THA
p17520
sg5
S'PMC1261533'
p17521
sg7
g17501
sg9
V16179089.xml
p17522
sa(dp17523
g3
VSTD-Poravuth-2010-ASIA
p17524
sg5
S'PMC3022577'
p17525
sg7
g17501
sg9
V21267072.xml
p17526
sa(dp17527
g3
VSTD-Bolliger-2000
p17528
sg5
S'PMC27447'
p17529
sg7
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p17530
sg9
V10926587.xml
p17531
sa(dp17532
g3
VSTD-Hanson-2008
p17533
sg5
S'PMC2441529'
p17534
sg7
g17530
sg9
V18242008.xml
p17535
sa(dp17536
g3
VSTD-Kralikova-2009
p17537
sg5
S'PMC2792228'
p17538
sg7
g17530
sg9
V19943947.xml
p17539
sa(dp17540
g3
VSTD-Sanyal-2008
p17541
sg5
S'PMC3730280'
p17542
sg7
VCD005162 v. 6.0 Terlipressin for hepatorenal syndrome.rm5
p17543
sg9
V18471513.xml
p17544
sa(dp17545
g3
VSTD-Leisti-1978
p17546
sg5
S'PMC1603701'
p17547
sg7
VCD001533 v. 12.0 Corticosteroid therapy for nephrotic syndrome in children.rm5
p17548
sg9
V346147.xml
p17549
sa(dp17550
g3
VSTD-Imbasciali-1985
p17551
sg5
S'PMC1417455'
p17552
sg7
g17548
sg9
V3933645.xml
p17553
sa(dp17554
g3
VSTD-WHO-1993-GP1pv
p17555
sg5
S'PMC1678631'
p17556
sg7
VCD002855 v. 8.0 Medical methods for first trimester abortion.rm5
p17557
sg9
V8400972.xml
p17558
sa(dp17559
g3
VSTD-Tee-2010
p17560
sg5
S'PMC2923764'
p17561
sg7
VCD008211 v. 3.0 Transparent Cap Colonoscopy versus Standard Colonoscopy to Improve Caecal Intubation.rm5
p17562
sg9
V20712051.xml
p17563
sa(dp17564
g3
VSTD-Collins-2004
p17565
sg5
S'PMC487729'
p17566
sg7
VCD005252 v. 3.0 Avoidance of bottles during the establishment of breast feeds in preterm infants.rm5
p17567
sg9
V15208209.xml
p17568
sa(dp17569
g3
VSTD-Hennrikus-2002
p17570
sg5
S'PMC1447056'
p17571
sg7
VCD004307 v. 10.0 Competitions and incentives for smoking cessation.rm5
p17572
sg9
V11818305.xml
p17573
sa(dp17574
g3
VSTD-Gomel-1993
p17575
sg5
S'PMC1694995'
p17576
sg7
g17572
sg9
V8362997.xml
p17577
sa(dp17578
g3
VSTD-Paxton-1980
p17579
sg5
S'PMC3633932'
p17580
sg7
g17572
sg9
V23626740.xml
p17581
sa(dp17582
g3
VSTD-Klesges-1986
p17583
sg5
S'PMC1646475'
p17584
sg7
g17572
sg9
V3946702.xml
p17585
sa(dp17586
g3
VSTD-Tevyaw-2009
p17587
sg5
S'PMC2688604'
p17588
sg7
g17572
sg9
V19443788.xml
p17589
sa(dp17590
g3
VSTD-Bayley-1976
p17591
sg5
S'PMC2158317'
p17592
sg7
VCD008922 v. 2.0 Muscle relaxants for pain management in rheumatoid arthritis.rm5
p17593
sg9
V787518.xml
p17594
sa(dp17595
g3
VSTD-Foley-2003
p17596
sg5
S'PMC1754378'
p17597
sg7
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p17598
sg9
V14644853.xml
p17599
sa(dp17600
g3
VSTD-Thomas-2002
p17601
sg5
S'PMC128377'
p17602
sg7
g17598
sg9
V12364304.xml
p17603
sa(dp17604
g3
VSTD-O_x0027_Reilly-1999
p17605
sg5
S'PMC1752761'
p17606
sg7
g17598
sg9
V10343535.xml
p17607
sa(dp17608
g3
VSTD-Thorstensson-2005
p17609
sg5
S'PMC1187893'
p17610
sg7
g17598
sg9
V15924620.xml
p17611
sa(dp17612
g3
VSTD-Bennell-2005
p17613
sg5
S'PMC1755542'
p17614
sg7
g17598
sg9
V15897310.xml
p17615
sa(dp17616
g3
VSTD-Hay-2006
p17617
sg5
S'PMC1635605'
p17618
sg7
g17598
sg9
V17056608.xml
p17619
sa(dp17620
g3
VSTD-Otto-2001-_x0028_unpublished_x0029_
p17621
sg5
S'PMC3607090'
p17622
sg7
VCD006018 v. 4.0 Adjuvant chemotherapy for invasive bladder cancer (individual patient data).rm5
p17623
sg9
V23533552.xml
p17624
sa(dp17625
g3
VSTD-Walker-2012
p17626
sg5
S'PMC2773219'
p17627
sg7
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p17628
sg9
V19805679.xml
p17629
sa(dp17630
g3
VSTD-Zorlu-2005
p17631
sg5
S'PMC3015649'
p17632
sg7
g17628
sg9
V16381364.xml
p17633
sa(dp17634
g3
VSTD-Misra-2007
p17635
sg5
S'PMC3476139'
p17636
sg7
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p17637
sg9
V17563841.xml
p17638
sa(dp17639
g3
VSTD-Misra-2004
p17640
sg5
S'PMC1743152'
p17641
sg7
g17637
sg9
V15579612.xml
p17642
sa(dp17643
g3
VSTD-Li-2006
p17644
sg5
S'PMC1764949'
p17645
sg7
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p17646
sg9
V17215967.xml
p17647
sa(dp17648
g3
VSTD-De-La-Rosa-2008
p17649
sg5
S'PMC2592751'
p17650
sg7
g17646
sg9
V18799004.xml
p17651
sa(dp17652
g3
VSTD-Chan-2008
p17653
sg5
S'PMC2671976'
p17654
sg7
g17646
sg9
V19142552.xml
p17655
sa(dp17656
g3
VSTD-Sharples-2002
p17657
sg5
S'PMC1746394'
p17658
sg7
VCD004359 v. 6.0 Nurse specialist care for bronchiectasis.rm5
p17659
sg9
V12149523.xml
p17660
sa(dp17661
g3
VSTD-Rahman-1998
p17662
sg5
S'PMC1722716'
p17663
sg7
VCD004241 v. 6.6 Medical interventions for fungal keratitis.rm5
p17664
sg9
V9828778.xml
p17665
sa(dp17666
g3
VSTD-Prajna-2003
p17667
sg5
S'PMC1920780'
p17668
sg7
g17664
sg9
V14507756.xml
p17669
sa(dp17670
g3
VSTD-Mohan-1988
p17671
sg5
S'PMC1041404'
p17672
sg7
g17664
sg9
V3281706.xml
p17673
sa(dp17674
g3
VSTD-Prajna-2010
p17675
sg5
S'PMC3774126'
p17676
sg7
g17664
sg9
V20547942.xml
p17677
sa(dp17678
g3
VSTD-Campieri-1997
p17679
sg5
S'PMC1891473'
p17680
sg7
VCD000296 v. 6.0 Budesonide for induction of remission in Crohn's disease.rm5
p17681
sg9
V9301500.xml
p17682
sa(dp17683
g3
VSTD-Rennie-1991
p17684
sg5
S'PMC1590349'
p17685
sg7
VCD003480 v. 5.0 Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in prete.rm5
p17686
sg9
V1996894.xml
p17687
sa(dp17688
g3
VSTD-Hoskins-2008
p17689
sg5
S'PMC3204266'
p17690
sg7
VCD006782 v. 4.0 Interventions for preventing hamstring injuries.rm5
p17691
sg9
V21967753.xml
p17692
sa(dp17693
g3
VSTD-Holcroft-1986a
p17694
sg5
S'PMC1251120'
p17695
sg7
VCD004477 v. 7.0 Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.rm5
p17696
sg9
V3516085.xml
p17697
sa(dp17698
g3
VSTD-Li-2008
p17699
sg5
S'PMC2597744'
p17700
sg7
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p17701
sg9
V19081791.xml
p17702
sa(dp17703
g3
VSTD-Liu-LY-2010
p17704
sg5
S'PMC3759346'
p17705
sg7
VCD005292 v. 5.2 Herbal preparations for uterine fibroids.rm5
p17706
sg9
V23813869.xml
p17707
sa(dp17708
g3
VSTD-Zhu-FH-2006
p17709
sg5
S'PMC2960419'
p17710
sg7
g17706
sg9
V21201460.xml
p17711
sa(dp17712
g3
VSTD-Chan-2007
p17713
sg5
S'PMC3757333'
p17714
sg7
VCD006577 v. 3.0 Music for stress and anxiety reduction in coronary heart disease patients.rm5
p17715
sg9
V23813962.xml
p17716
sa(dp17717
g3
VSTD-Wideroe-1974
p17718
sg5
S'PMC1611139'
p17719
sg7
VCD003225 v. 11.0 Propranolol for migraine prophylaxis.rm5
p17720
sg9
V4604977.xml
p17721
sa(dp17722
g3
VSTD-Goldbach_x002d_Mansky-2009
p17723
sg5
S'PMC2938780'
p17724
sg7
VCD002948 v. 5.0 Herbal therapy for treating rheumatoid arthritis.rm5
p17725
sg9
V19687490.xml
p17726
sa(dp17727
g3
VSTD-Pattrick-1989
p17728
sg5
S'PMC1003814'
p17729
sg7
g17725
sg9
V2673080.xml
p17730
sa(dp17731
g3
VSTD-Belch-1988
p17732
sg5
S'PMC1003460'
p17733
sg7
g17725
sg9
V2833184.xml
p17734
sa(dp17735
g3
VSTD-Mitchell-2009
p17736
sg5
S'PMC2864467'
p17737
sg7
VCD000262 v. 11.0 Antibiotics for treating bacterial vaginosis in pregnancy.rm5
p17738
sg9
V19951217.xml
p17739
sa(dp17740
g3
VSTD-Kiss-2004
p17741
sg5
S'PMC509340'
p17742
sg7
g17738
sg9
V15294856.xml
p17743
sa(dp17744
g3
VSTD-Wardle-2001
p17745
sg5
S'PMC1721189'
p17746
sg7
VCD000501 v. 10.0 Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthw.rm5
p17747
sg9
V11124916.xml
p17748
sa(dp17749
g3
VSTD-James-1983
p17750
sg5
S'PMC1438733'
p17751
sg7
VCD001206 v. 10.0 Pharmacotherapy for social anxiety disorder.rm5
p17752
sg9
V6834370.xml
p17753
sa(dp17754
g3
VSTD-Edan-1997
p17755
sg5
S'PMC486720'
p17756
sg7
VCD008933 v. 3.0 Immunomodulators and immunosuppressants for multiple sclerosis a network meta-analysis.rm5
p17757
sg9
V9048709.xml
p17758
sa(dp17759
g3
VSTD-Andersen-2004
p17760
sg5
S'PMC1763573'
p17761
sg7
g17757
sg9
V15090564.xml
p17762
sa(dp17763
g3
VSTD-Likosky-1991
p17764
sg5
S'PMC1014677'
p17765
sg7
g17757
sg9
V1783915.xml
p17766
sa(dp17767
g3
VSTD-ASSET_x002d_1
p17768
sg5
S'PMC2914575'
p17769
sg7
VCD004434 v. 8.2 Endothelin receptor antagonists for pulmonary arterial hypertension.rm5
p17770
sg9
V20175775.xml
p17771
sa(dp17772
g3
VSTD-Dammers-1999
p17773
sg5
S'PMC28242'
p17774
sg7
VCD001554 v. 8.0 Local corticosteroid injection for carpal tunnel syndrome.rm5
p17775
sg9
V10506042.xml
p17776
sa(dp17777
g3
VSTD-O_x0027_Gradaigh-2000
p17778
sg5
S'PMC1753030'
p17779
sg7
g17775
sg9
V11053073.xml
p17780
sa(dp17781
g3
VSTD-Wattchow-2006
p17782
sg5
S'PMC2361245'
p17783
sg7
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p17784
sg9
V16622437.xml
p17785
sa(dp17786
g3
VSTD-Upward-1988
p17787
sg5
S'PMC1386560'
p17788
sg7
VCD004185 v. 9.0 Fluoxetine versus other types of pharmacotherapy for depression.rm5
p17789
sg9
V3263876.xml
p17790
sa(dp17791
g3
VSTD-Lapierre-1997
p17792
sg5
S'PMC1188834'
p17793
sg7
g17789
sg9
V9074306.xml
p17794
sa(dp17795
g3
VSTD-Basu-2008a
p17796
sg5
S'PMC2701394'
p17797
sg7
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p17798
sg9
V18769904.xml
p17799
sa(dp17800
g3
VSTD-Russell_x002d_Jones-2009
p17801
sg5
S'PMC2744824'
p17802
sg7
g17798
sg9
V19688338.xml
p17803
sa(dp17804
g3
VSTD-Hundal-2000
p17805
sg5
S'PMC2995498'
p17806
sg7
g17798
sg9
V11118008.xml
p17807
sa(dp17808
g3
VSTD-Clarke-1977
p17809
sg5
S'PMC1632725'
p17810
sg7
g17798
sg9
V589351.xml
p17811
sa(dp17812
g3
VSTD-Lingvay-2007
p17813
sg5
S'PMC1994788'
p17814
sg7
g17798
sg9
V17493545.xml
p17815
sa(dp17816
g3
VSTD-Home-2007
p17817
sg5
S'PMC1974817'
p17818
sg7
g17798
sg9
V17403121.xml
p17819
sa(dp17820
g3
VSTD-Phillips-2009
p17821
sg5
S'PMC2739702'
p17822
sg7
g17798
sg9
V19622782.xml
p17823
sa(dp17824
g3
VSTD-Gupta-2009
p17825
sg5
S'PMC2748337'
p17826
sg7
g17798
sg9
V19267711.xml
p17827
sa(dp17828
g3
VSTD-Vahatalo-2007
p17829
sg5
S'PMC3379773'
p17830
sg7
g17798
sg9
V17846932.xml
p17831
sa(dp17832
g3
VSTD-Rains-1989
p17833
sg5
S'PMC1292002'
p17834
sg7
g17798
sg9
V2647992.xml
p17835
sa(dp17836
g3
VSTD-Zinman-2009
p17837
sg5
S'PMC2699702'
p17838
sg7
g17798
sg9
V19289857.xml
p17839
sa(dp17840
g3
VSTD-List-2009
p17841
sg5
S'PMC2660449'
p17842
sg7
g17798
sg9
V19114612.xml
p17843
sa(dp17844
g3
VSTD-Nauck-2009b
p17845
sg5
S'PMC2699710'
p17846
sg7
g17798
sg9
V19366970.xml
p17847
sa(dp17848
g3
VSTD-Nauck-2009a
p17849
sg5
S'PMC2606836'
p17850
sg7
g17798
sg9
V18931095.xml
p17851
sa(dp17852
g3
VSTD-McBain-1988
p17853
sg5
S'PMC1141646'
p17854
sg7
g17798
sg9
V3192752.xml
p17855
sa(dp17856
g3
VSTD-Peacock-1984
p17857
sg5
S'PMC1442249'
p17858
sg7
g17798
sg9
V6428619.xml
p17859
sa(dp17860
g3
VSTD-Lord-1983
p17861
sg5
S'PMC1547150'
p17862
sg7
g17798
sg9
V6403102.xml
p17863
sa(dp17864
g3
VSTD-Oldaeus-1997
p17865
sg5
S'PMC1717242'
p17866
sg7
VCD003664 v. 5.0 Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.rm5
p17867
sg9
V9279143.xml
p17868
sa(dp17869
g3
VSTD-Masia_x002d_Warner-2011
p17870
sg5
S'PMC3128648'
p17871
sg7
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p17872
sg9
V21681863.xml
p17873
sa(dp17874
g3
VSTD-McNally-Keehn-2012
p17875
sg5
S'PMC3537891'
p17876
sg7
g17872
sg9
V22588377.xml
p17877
sa(dp17878
g3
VSTD-Melfsen-2011
p17879
sg5
S'PMC3058082'
p17880
sg7
g17872
sg9
V21356037.xml
p17881
sa(dp17882
g3
VSTD-White-2012
p17883
sg5
S'PMC3494811'
p17884
sg7
g17872
sg9
V22735897.xml
p17885
sa(dp17886
g3
VSTD-Walkup-2008
p17887
sg5
S'PMC2702984'
p17888
sg7
g17872
sg9
V18974308.xml
p17889
sa(dp17890
g3
VSTD-Schnoll-2010b
p17891
sg5
S'PMC2834192'
p17892
sg7
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p17893
sg9
V20004065.xml
p17894
sa(dp17895
g3
VSTD-Schnoll-2010a
p17896
sg5
S'PMC3782858'
p17897
sg7
g17893
sg9
V20124230.xml
p17898
sa(dp17899
g3
VSTD-Hand-2002
p17900
sg5
S'PMC1746389'
p17901
sg7
g17893
sg9
V12149533.xml
p17902
sa(dp17903
g3
VSTD-Molyneux-2003
p17904
sg5
S'PMC1746718'
p17905
sg7
g17893
sg9
V12775857.xml
p17906
sa(dp17907
g3
VSTD-Pirie-1992
p17908
sg5
S'PMC1694323'
p17909
sg7
g17893
sg9
V1503165.xml
p17910
sa(dp17911
g3
VSTD-Blondal-1999
p17912
sg5
S'PMC27708'
p17913
sg7
g17893
sg9
V9924052.xml
p17914
sa(dp17915
g3
VSTD-Cooney-2009
p17916
sg5
S'PMC2753831'
p17917
sg7
g17893
sg9
V19549054.xml
p17918
sa(dp17919
g3
VSTD-Marshall-1985
p17920
sg5
S'PMC1415622'
p17921
sg7
g17893
sg9
V3922510.xml
p17922
sa(dp17923
g3
VSTD-T_x00f8_nnesen-2012
p17924
sg5
S'PMC3432241'
p17925
sg7
g17893
sg9
V22323576.xml
p17926
sa(dp17927
g3
VSTD-Ahluwalia-1998
p17928
sg5
S'PMC1496888'
p17929
sg7
g17893
sg9
V9462488.xml
p17930
sa(dp17931
g3
VSTD-Hughes-2010
p17932
sg5
S'PMC2930079'
p17933
sg7
g17893
sg9
V20537810.xml
p17934
sa(dp17935
g3
VSTD-Piper-2009
p17936
sg5
S'PMC2933113'
p17937
sg7
g17893
sg9
V19884613.xml
p17938
sa(dp17939
g3
VSTD-Oncken-2008
p17940
sg5
S'PMC2630492'
p17941
sg7
g17893
sg9
V18827129.xml
p17942
sa(dp17943
g3
VSTD-Gourlay-1995
p17944
sg5
S'PMC2550432'
p17945
sg7
g17893
sg9
V7640544.xml
p17946
sa(dp17947
g3
VSTD-Br-Thor-Society-1983
p17948
sg5
S'PMC1546807'
p17949
sg7
g17893
sg9
V6402162.xml
p17950
sa(dp17951
g3
VSTD-ICRF-1994
p17952
sg5
S'PMC2540289'
p17953
sg7
g17893
sg9
V8019282.xml
p17954
sa(dp17955
g3
VSTD-Bolliger-2000a
p17956
sg5
S'PMC27447'
p17957
sg7
g17893
sg9
V10926587.xml
p17958
sa(dp17959
g3
VSTD-Smith-2009
p17960
sg5
S'PMC2891174'
p17961
sg7
g17893
sg9
V20008701.xml
p17962
sa(dp17963
g3
VSTD-Clavel-1985
p17964
sg5
S'PMC1418170'
p17965
sg7
g17893
sg9
V3933739.xml
p17966
sa(dp17967
g3
VSTD-Gariti-2009
p17968
sg5
S'PMC2778325'
p17969
sg7
g17893
sg9
V19339135.xml
p17970
sa(dp17971
g3
VSTD-Jamrozik-1984
p17972
sg5
S'PMC1442980'
p17973
sg7
g17893
sg9
V6434084.xml
p17974
sa(dp17975
g3
VSTD-Rose-2010
p17976
sg5
S'PMC2896464'
p17977
sg7
g17893
sg9
V20379614.xml
p17978
sa(dp17979
g3
VSTD-Piper-2007
p17980
sg5
S'PMC3030120'
p17981
sg7
g17893
sg9
V17763111.xml
p17982
sa(dp17983
g3
VSTD-Pollak-2007
p17984
sg5
S'PMC3602964'
p17985
sg7
g17893
sg9
V17888856.xml
p17986
sa(dp17987
g3
VSTD-Russell-1983
p17988
sg5
S'PMC1549849'
p17989
sg7
g17893
sg9
V6416593.xml
p17990
sa(dp17991
g3
VSTD-Hays-1999
p17992
sg5
S'PMC1508975'
p17993
sg7
g17893
sg9
V10553392.xml
p17994
sa(dp17995
g3
VSTD-Rosenstock-2008
p17996
sg5
S'PMC2235909'
p17997
sg7
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p17998
sg9
V18204830.xml
p17999
sa(dp18000
g3
VSTD-Swinnen-2010a
p18001
sg5
S'PMC2875419'
p18002
sg7
g17998
sg9
V20200301.xml
p18003
sa(dp18004
g3
VSTD-Bradley-2002
p18005
sg5
S'PMC100764'
p18006
sg7
VCD007335 v. 3.0 Interventions to improve question formulation in professional practice and self-directed learning.rm5
p18007
sg9
V11999177.xml
p18008
sa(dp18009
g3
VSTD-Villanueva-2001
p18010
sg5
S'PMC59901'
p18011
sg7
g18007
sg9
V11716797.xml
p18012
sa(dp18013
g3
VSTD-SU.FOL.OM3-2010
p18014
sg5
S'PMC2993045'
p18015
sg7
VCD006612 v. 4.0 Homocysteine-lowering interventions for preventing cardiovascular events.rm5
p18016
sg9
V21115589.xml
p18017
sa(dp18018
g3
VSTD-WAFACS-2008
p18019
sg5
S'PMC2684623'
p18020
sg7
g18016
sg9
V18460663.xml
p18021
sa(dp18022
g3
VSTD-BVAIT-2009
p18023
sg5
S'PMC2701290'
p18024
sg7
g18016
sg9
V19118243.xml
p18025
sa(dp18026
g3
VSTD-Edan-1997
p18027
sg5
S'PMC486720'
p18028
sg7
VCD002127 v. 5.0 Mitoxantrone for multiple sclerosis.rm5
p18029
sg9
V9048709.xml
p18030
sa(dp18031
g3
VSTD-Westerbeek-2010
p18032
sg5
S'PMC2579424'
p18033
sg7
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p18034
sg9
V18947426.xml
p18035
sa(dp18036
g3
VSTD-Moro-2006
p18037
sg5
S'PMC2066015'
p18038
sg7
g18034
sg9
V16873437.xml
p18039
sa(dp18040
g3
VSTD-DuPont-1984
p18041
sg5
S'PMC284111'
p18042
sg7
VCD002242 v. 6.0 Antibiotic treatment for travellers' diarrhoea.rm5
p18043
sg9
V6385838.xml
p18044
sa(dp18045
g3
VSTD-Ericsson-1992
p18046
sg5
S'PMC245552'
p18047
sg7
g18043
sg9
V1482152.xml
p18048
sa(dp18049
g3
VSTD-Ericsson-1986
p18050
sg5
S'PMC180497'
p18051
sg7
g18043
sg9
V3524436.xml
p18052
sa(dp18053
g3
VSTD-DuPont-1992b
p18054
sg5
S'PMC189232'
p18055
sg7
g18043
sg9
V1590705.xml
p18056
sa(dp18057
g3
VSTD-Ertzeid-1999
p18058
sg5
S'PMC3455375'
p18059
sg7
VCD004378 v. 4.0 Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm .rm5
p18060
sg9
V10575581.xml
p18061
sa(dp18062
g3
VSTD-Griffin-1999
p18063
sg5
S'PMC1720946'
p18064
sg7
VCD005095 v. 5.0 Enteral iron supplementation in preterm and low birth weight infants.rm5
p18065
sg9
V10375362.xml
p18066
sa(dp18067
g3
VSTD-Coles-1954
p18068
sg5
S'PMC2011580'
p18069
sg7
g18065
sg9
V13149207.xml
p18070
sa(dp18071
g3
VSTD-Aggarwal-2005
p18072
sg5
S'PMC1720080'
p18073
sg7
g18065
sg9
V15613506.xml
p18074
sa(dp18075
g3
VSTD-Spitzyna-2007
p18076
sg5
S'PMC2651560'
p18077
sg7
VCD008388 v. 2.0 Interventions for visual field defects in patients with stroke.rm5
p18078
sg9
V17536049.xml
p18079
sa(dp18080
g3
VSTD-Evans-1974
p18081
sg5
S'PMC470171'
p18082
sg7
VCD005374 v. 3.0 Oral corticosteroids for stable chronic obstructive pulmonary disease.rm5
p18083
sg9
V4603999.xml
p18084
sa(dp18085
g3
VSTD-Mitchell-1986
p18086
sg5
S'PMC460405'
p18087
sg7
g18083
sg9
V3538487.xml
p18088
sa(dp18089
g3
VSTD-Weir-1993
p18090
sg5
S'PMC464423'
p18091
sg7
g18083
sg9
V8511727.xml
p18092
sa(dp18093
g3
VSTD-Weir-1990
p18094
sg5
S'PMC462320'
p18095
sg7
g18083
sg9
V2180105.xml
p18096
sa(dp18097
g3
VSTD-Wempe-1992
p18098
sg5
S'PMC463924'
p18099
sg7
g18083
sg9
V1412119.xml
p18100
sa(dp18101
g3
VSTD-Morris-2008
p18102
sg5
S'PMC2821221'
p18103
sg7
VCD007966 v. 2.19 Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.rm5
p18104
sg9
V18971491.xml
p18105
sa(dp18106
g3
VSTD-Jangaard-2007
p18107
sg5
S'PMC2532565'
p18108
sg7
g18104
sg9
V19043499.xml
p18109
sa(dp18110
g3
VSTD-Pontari-2010
p18111
sg5
S'PMC3767281'
p18112
sg7
VCD009063 v. 2.0 Pregabalin for chronic prostatitis.rm5
p18113
sg9
V20876412.xml
p18114
sa(dp18115
g3
VSTD-Tuck-1982
p18116
sg5
S'PMC1627664'
p18117
sg7
VCD000499 v. 6.0 Kinesthetic stimulation for treating apnea in preterm infants.rm5
p18118
sg9
V7092314.xml
p18119
sa(dp18120
g3
VSTD-Weber-2010
p18121
sg5
S'PMC2880820'
p18122
sg7
VCD009689 v. 2.0 Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment f.rm5
p18123
sg9
V20434603.xml
p18124
sa(dp18125
g3
VSTD-Hendricks-1999
p18126
sg5
S'PMC1634668'
p18127
sg7
VCD004517 v. 8.0 Music therapy for depression.rm5
p18128
sg9
V18746179.xml
p18129
sa(dp18130
g3
VSTD-Emet-2004
p18131
sg5
S'PMC522835'
p18132
sg7
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p18133
sg9
V15312215.xml
p18134
sa(dp18135
g3
VSTD-Charunwatthana-2009
p18136
sg5
S'PMC2731834'
p18137
sg7
g18133
sg9
V19114891.xml
p18138
sa(dp18139
g3
VSTD-Keays-1991
p18140
sg5
S'PMC1671790'
p18141
sg7
g18133
sg9
V1954453.xml
p18142
sa(dp18143
g3
VSTD-Lee-2009
p18144
sg5
S'PMC3189485'
p18145
sg7
g18133
sg9
V19524577.xml
p18146
sa(dp18147
g3
VSTD-Bianchi-Porro-1993
p18148
sg5
S'PMC1374304'
p18149
sg7
VCD003840 v. 10.0 Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.rm5
p18150
sg9
V8491391.xml
p18151
sa(dp18152
g3
VSTD-Hosking-1992
p18153
sg5
S'PMC1882868'
p18154
sg7
g18150
sg9
V1392995.xml
p18155
sa(dp18156
g3
VSTD-Lam-1997
p18157
sg5
S'PMC1027226'
p18158
sg7
g18150
sg9
V9274470.xml
p18159
sa(dp18160
g3
VSTD-Axon-1997
p18161
sg5
S'PMC2126021'
p18162
sg7
g18150
sg9
V9055715.xml
p18163
sa(dp18164
g3
VSTD-Bardhan-1997
p18165
sg5
S'PMC1891448'
p18166
sg7
g18150
sg9
V9301496.xml
p18167
sa(dp18168
g3
VSTD-Lesurtel-2005
p18169
sg5
S'PMC1409877'
p18170
sg7
VCD006880 v. 2.4 Techniques for liver parenchymal transection in liver resection.rm5
p18171
sg9
V16327491.xml
p18172
sa(dp18173
g3
VSTD-Stendell_x002d_Hollis-2010
p18174
sg5
S'PMC2966548'
p18175
sg7
VCD009934 v. 2.0 Green and black tea for the primary prevention of cardiovascular disease.rm5
p18176
sg9
V20807303.xml
p18177
sa(dp18178
g3
VSTD-Mukamal-2007
p18179
sg5
S'PMC2084262'
p18180
sg7
g18176
sg9
V17892999.xml
p18181
sa(dp18182
g3
VSTD-Shale-1987
p18183
sg5
S'PMC460599'
p18184
sg7
VCD001108 v. 9.0 Azoles for allergic bronchopulmonary aspergillosis associated with asthma.rm5
p18185
sg9
V3303424.xml
p18186
sa(dp18187
g3
VSTD-Tarshis-2001
p18188
sg5
S'PMC90654'
p18189
sg7
VCD004299 v. 3.0 Interventions for cellulitis and erysipelas.rm5
p18190
sg9
V11451697.xml
p18191
sa(dp18192
g3
VSTD-Weigelt-2005
p18193
sg5
S'PMC1140485'
p18194
sg7
g18190
sg9
V15917519.xml
p18195
sa(dp18196
g3
VSTD-Bernard-2002
p18197
sg5
S'PMC129632'
p18198
sg7
g18190
sg9
V12386036.xml
p18199
sa(dp18200
g3
VSTD-Leman-2005
p18201
sg5
S'PMC1726763'
p18202
sg7
g18190
sg9
V15843702.xml
p18203
sa(dp18204
g3
VSTD-_x0031_-Pirie-1992
p18205
sg5
S'PMC1694323'
p18206
sg7
VCD006219 v. 5.25 Interventions for preventing weight gain after smoking cessation.rm5
p18207
sg9
V1503165.xml
p18208
sa(dp18209
g3
VSTD-_x0031_-Hall-1992
p18210
sg5
S'PMC1694191'
p18211
sg7
g18207
sg9
V1585959.xml
p18212
sa(dp18213
g3
VSTD-_x0032_-NRT-Pirie-1992
p18214
sg5
S'PMC1694323'
p18215
sg7
g18207
sg9
V1503165.xml
p18216
sa(dp18217
g3
VSTD-_x0032_-VA-Aubin-2008
p18218
sg5
S'PMC2569194'
p18219
sg7
g18207
sg9
V18263663.xml
p18220
sa(dp18221
g3
VSTD-_x0031_-Levine-2010
p18222
sg5
S'PMC3113531'
p18223
sg7
g18207
sg9
V20308641.xml
p18224
sa(dp18225
g3
VSTD-_x0032_-NRT-Pack-2008
p18226
sg5
S'PMC3174063'
p18227
sg7
g18207
sg9
V18777992.xml
p18228
sa(dp18229
g3
VSTD-_x0032_-NRT-Blondal-1999
p18230
sg5
S'PMC27708'
p18231
sg7
g18207
sg9
V9924052.xml
p18232
sa(dp18233
g3
VSTD-_x0031_-Danielsson-1999
p18234
sg5
S'PMC28202'
p18235
sg7
g18207
sg9
V10454403.xml
p18236
sa(dp18237
g3
VSTD-_x0032_-AD-Piper-2007
p18238
sg5
S'PMC3030120'
p18239
sg7
g18207
sg9
V17763111.xml
p18240
sa(dp18241
g3
VSTD-_x0031_-Toll-2010
p18242
sg5
S'PMC3771701'
p18243
sg7
g18207
sg9
V20542391.xml
p18244
sa(dp18245
g3
VSTD-_x0032_-NRT-Gourlay-1995
p18246
sg5
S'PMC2550432'
p18247
sg7
g18207
sg9
V7640544.xml
p18248
sa(dp18249
g3
VSTD-Feltelius-1986
p18250
sg5
S'PMC1001898'
p18251
sg7
VCD004800 v. 6.0 Sulfasalazine for ankylosing spondylitis.rm5
p18252
sg9
V2872857.xml
p18253
sa(dp18254
g3
VSTD-Dougados-1986
p18255
sg5
S'PMC1341708'
p18256
sg7
g18252
sg9
V2876744.xml
p18257
sa(dp18258
g3
VSTD-Kuijper-2009
p18259
sg5
S'PMC2758937'
p18260
sg7
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p18261
sg9
V19812130.xml
p18262
sa(dp18263
g3
VSTD-Viljanen-2006
p18264
sg5
S'PMC188429'
p18265
sg7
g18261
sg9
V12946968.xml
p18266
sa(dp18267
g3
VSTD-Martel-2011
p18268
sg5
S'PMC3045999'
p18269
sg7
g18261
sg9
V21303529.xml
p18270
sa(dp18271
g3
VSTD-Kusalic-1993
p18272
sg5
S'PMC1188546'
p18273
sg7
VCD009138 v. 2.0 Amitriptyline versus placebo for major depressive disorder.rm5
p18274
sg9
V8297924.xml
p18275
sa(dp18276
g3
VSTD-Blashki-1971
p18277
sg5
S'PMC1795147'
p18278
sg7
g18274
sg9
V4923928.xml
p18279
sa(dp18280
g3
VSTD-Mynors_x002d_Wallis-1995
p18281
sg5
S'PMC2548821'
p18282
sg7
g18274
sg9
V7873952.xml
p18283
sa(dp18284
g3
VSTD-Str_x00f6_hlein-2009
p18285
sg5
S'PMC2644666'
p18286
sg7
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p18287
sg9
V19216794.xml
p18288
sa(dp18289
g3
VSTD-Gulley-2008
p18290
sg5
S'PMC2673097'
p18291
sg7
g18287
sg9
V18483372.xml
p18292
sa(dp18293
g3
VSTD-Odunsi-2007
p18294
sg5
S'PMC1937553'
p18295
sg7
g18287
sg9
V17652518.xml
p18296
sa(dp18297
g3
VSTD-Odunsi-2007a
p18298
sg5
S'PMC1937553'
p18299
sg7
g18287
sg9
V17652518.xml
p18300
sa(dp18301
g3
VSTD-Gajdos-1993
p18302
sg5
S'PMC489815'
p18303
sg7
VCD002828 v. 9.0 Corticosteroids for myasthenia gravis.rm5
p18304
sg9
V8229026.xml
p18305
sa(dp18306
g3
VSTD-Van-Noord-1999
p18307
sg5
S'PMC1745431'
p18308
sg7
VCD005533 v. 3.0 Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in ad.rm5
p18309
sg9
V10325895.xml
p18310
sa(dp18311
g3
VSTD-Heuck-2000
p18312
sg5
S'PMC1718508'
p18313
sg7
g18309
sg9
V10999872.xml
p18314
sa(dp18315
g3
VSTD-Brooten-2001
p18316
sg5
S'PMC3544939'
p18317
sg7
VCD000198 v. 12.0 Support during pregnancy for women at increased risk of low birthweight babies.rm5
p18318
sg9
V11519238.xml
p18319
sa(dp18320
g3
VSTD-Klerman-2001
p18321
sg5
S'PMC1446489'
p18322
sg7
g18318
sg9
V11189800.xml
p18323
sa(dp18324
g3
VSTD-Buchbinder-2004
p18325
sg5
S'PMC1754915'
p18326
sg7
VCD007005 v. 2.0 Arthrographic distension for adhesive capsulitis (frozen shoulder).rm5
p18327
sg9
V14962967.xml
p18328
sa(dp18329
g3
VSTD-Jacobs-1991
p18330
sg5
S'PMC1670184'
p18331
sg7
g18327
sg9
V1855018.xml
p18332
sa(dp18333
g3
VSTD-Manegold-2003
p18334
sg5
S'PMC2361263'
p18335
sg7
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p18336
sg9
V16641904.xml
p18337
sa(dp18338
g3
VSTD-Huskamp-2005
p18339
sg5
S'PMC1403292'
p18340
sg7
VCD007017 v. 4.2 Pharmaceutical policies effects of cap and co-payment on rational drug use.rm5
p18341
sg9
V15809411.xml
p18342
sa(dp18343
g3
VSTD-Kozyrskyj-2001
p18344
sg5
S'PMC81497'
p18345
sg7
g18341
sg9
V11599328.xml
p18346
sa(dp18347
g3
VSTD-Cromwell-1999
p18348
sg5
S'PMC1070338'
p18349
sg7
g18341
sg9
V10029499.xml
p18350
sa(dp18351
g3
VSTD-D_x0027_Ignazio-2005
p18352
sg5
S'PMC1251562'
p18353
sg7
VCD002109 v. 7.0 Antibiotics for community acquired pneumonia in adult outpatients.rm5
p18354
sg9
V16189077.xml
p18355
sa(dp18356
g3
VSTD-van-der-Kooi-2007
p18357
sg5
S'PMC2779375'
p18358
sg7
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p18359
sg9
V17361345.xml
p18360
sa(dp18361
g3
VSTD-Siu-1998
p18362
sg5
S'PMC1720837'
p18363
sg7
VCD000405 v. 10.0 Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants.rm5
p18364
sg9
V9828735.xml
p18365
sa(dp18366
g3
VSTD-Gaffey-1988
p18367
sg5
S'PMC175945'
p18368
sg7
VCD008231 v. 3.0 Intranasal ipratropium bromide for the common cold.rm5
p18369
sg9
V2855297.xml
p18370
sa(dp18371
g3
VSTD-Dale-1999
p18372
sg5
S'PMC28239'
p18373
sg7
VCD001733 v. 13.0 Pentoxifylline for treating venous leg ulcers.rm5
p18374
sg9
V10506039.xml
p18375
sa(dp18376
g3
VSTD-Colgan-1990
p18377
sg5
S'PMC1662706'
p18378
sg7
g18374
sg9
V2256974.xml
p18379
sa(dp18380
g3
VSTD-Yu-1993
p18381
sg5
S'PMC1380136'
p18382
sg7
VCD000096 v. 7.0 Glycerol for acute stroke.rm5
p18383
sg9
V2310658.xml
p18384
sa(dp18385
g3
VSTD-Schwinn-2010
p18386
sg5
S'PMC2822104'
p18387
sg7
VCD009287 v. 2.0 Media campaigns for the prevention of illicit drug use in young people.rm5
p18388
sg9
V19728091.xml
p18389
sa(dp18390
g3
VSTD-Fishbein-2002
p18391
sg5
S'PMC1447050'
p18392
sg7
g18388
sg9
V11818299.xml
p18393
sa(dp18394
g3
VSTD-Lee-2010
p18395
sg5
S'PMC2891541'
p18396
sg7
g18388
sg9
V20565152.xml
p18397
sa(dp18398
g3
VSTD-Slater-2011
p18399
sg5
S'PMC3042048'
p18400
sg7
g18388
sg9
V21271357.xml
p18401
sa(dp18402
g3
VSTD-Palmgreen-2001
p18403
sg5
S'PMC1446528'
p18404
sg7
g18388
sg9
V11211642.xml
p18405
sa(dp18406
g3
VSTD-Fang-2010
p18407
sg5
S'PMC2964276'
p18408
sg7
g18388
sg9
V20970090.xml
p18409
sa(dp18410
g3
VSTD-Carpenter-2011
p18411
sg5
S'PMC3076395'
p18412
sg7
g18388
sg9
V21421952.xml
p18413
sa(dp18414
g3
VSTD-Alijani-2004
p18415
sg5
S'PMC1356238'
p18416
sg7
VCD006574 v. 4.0 Abdominal lift for laparoscopic cholecystectomy.rm5
p18417
sg9
V15075657.xml
p18418
sa(dp18419
g3
VSTD-Hopkins-1985
p18420
sg5
S'PMC1001603'
p18421
sg7
VCD000212 v. 7.0 Interventions for treating psoriatic arthritis.rm5
p18422
sg9
V3883917.xml
p18423
sa(dp18424
g3
VSTD-McKendry-1993
p18425
sg5
S'PMC1005197'
p18426
sg7
g18422
sg9
V8250615.xml
p18427
sa(dp18428
g3
VSTD-Khoo-2007
p18429
sg5
S'PMC1876970'
p18430
sg7
VCD007635 v. 2.0 Fast track surgery versus conventional recovery strategies for colorectal surgery.rm5
p18431
sg9
V17522511.xml
p18432
sa(dp18433
g3
VSTD-Gregson-2007
p18434
sg5
S'PMC1831737'
p18435
sg7
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p18436
sg9
V17388666.xml
p18437
sa(dp18438
g3
VSTD-Dale-1995
p18439
sg5
S'PMC2550494'
p18440
sg7
VCD002097 v. 6.15 Primary care professionals providing non-urgent care in hospital emergency departments.rm5
p18441
sg9
V7640592.xml
p18442
sa(dp18443
g3
VSTD-Murphy-1996
p18444
sg5
S'PMC2350641'
p18445
sg7
g18441
sg9
V8620132.xml
p18446
sa(dp18447
g3
VSTD-Gibney-1999
p18448
sg5
S'PMC1313317'
p18449
sg7
g18441
sg9
V10622016.xml
p18450
sa(dp18451
g3
VSTD-Echeverry-2009
p18452
sg5
S'PMC2782968'
p18453
sg7
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p18454
sg9
V19729522.xml
p18455
sa(dp18456
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p18457
sg5
S'PMC1914073'
p18458
sg7
g18454
sg9
V17570858.xml
p18459
sa(dp18460
g3
VSTD-Piette-2011
p18461
sg5
S'PMC3117978'
p18462
sg7
g18454
sg9
V21478777.xml
p18463
sa(dp18464
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p18465
sg5
S'PMC165418'
p18466
sg7
g18454
sg9
V12747810.xml
p18467
sa(dp18468
g3
VSTD-Xue-2004
p18469
sg5
S'PMC3772925'
p18470
sg7
g18454
sg9
V24058553.xml
p18471
sa(dp18472
g3
VSTD-van-Bastelaar-2011
p18473
sg5
S'PMC3024341'
p18474
sg7
g18454
sg9
V21216855.xml
p18475
sa(dp18476
g3
VSTD-Adcock-1972
p18477
sg5
S'PMC1648034'
p18478
sg7
VCD004404 v. 9.0 Antibiotics for whooping cough (pertussis).rm5
p18479
sg9
V4336846.xml
p18480
sa(dp18481
g3
VSTD-Uhari-1996
p18482
sg5
S'PMC2352484'
p18483
sg7
VCD007095 v. 5.0 Xylitol for preventing acute otitis media in children up to 12 years of age.rm5
p18484
sg9
V8916749.xml
p18485
sa(dp18486
g3
VSTD-Dolan-2006
p18487
sg5
S'PMC3205443'
p18488
sg7
VCD001796 v. 8.0 Aerobic exercise interventions for adults living with HIVAIDS.rm5
p18489
sg9
V16772251.xml
p18490
sa(dp18491
g3
VSTD-Mutimura-2008a
p18492
sg5
S'PMC3167195'
p18493
sg7
g18489
sg9
V18320351.xml
p18494
sa(dp18495
g3
VSTD-Campbell-1991
p18496
sg5
S'PMC2448633'
p18497
sg7
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p18498
sg9
V1853495.xml
p18499
sa(dp18500
g3
VSTD-Bisgaard-2003
p18501
sg5
S'PMC1356141'
p18502
sg7
g18498
sg9
V14578725.xml
p18503
sa(dp18504
g3
VSTD-Dundee-1975
p18505
sg5
S'PMC1402493'
p18506
sg7
g18498
sg9
V1234491.xml
p18507
sa(dp18508
g3
VSTD-Waldmann-1985
p18509
sg5
S'PMC1463742'
p18510
sg7
g18498
sg9
V3885984.xml
p18511
sa(dp18512
g3
VSTD-Dabbous-1998
p18513
sg5
S'PMC3015295'
p18514
sg7
g18498
sg9
V9876753.xml
p18515
sa(dp18516
g3
VSTD-Joris-2003
p18517
sg5
S'PMC1343506'
p18518
sg7
g18498
sg9
V14633758.xml
p18519
sa(dp18520
g3
VSTD-Usmani-2003
p18521
sg5
S'PMC3451062'
p18522
sg7
g18498
sg9
V23119952.xml
p18523
sa(dp18524
g3
VSTD-Apfel-2004
p18525
sg5
S'PMC1307533'
p18526
sg7
g18498
sg9
V15190136.xml
p18527
sa(dp18528
g3
VSTD-Fujii-2001e
p18529
sg5
S'PMC1724019'
p18530
sg7
g18498
sg9
V11371485.xml
p18531
sa(dp18532
g3
VSTD-Brooten-1994
p18533
sg5
S'PMC3694422'
p18534
sg7
VCD002958 v. 6.0 Early postnatal discharge from hospital for healthy mothers and term infants.rm5
p18535
sg9
V7936522.xml
p18536
sa(dp18537
g3
VSTD-Provenzano-2009-HD
p18538
sg5
S'PMC2637590'
p18539
sg7
VCD007857 v. 3.4 Parenteral versus oral iron therapy for adults and children with chronic kidney disease.rm5
p18540
sg9
V19176796.xml
p18541
sa(dp18542
g3
VSTD-Spinowitz-2008-CKD
p18543
sg5
S'PMC2488268'
p18544
sg7
g18540
sg9
V18525001.xml
p18545
sa(dp18546
g3
VSTD-Fisher-2008
p18547
sg5
S'PMC2989816'
p18548
sg7
VCD007830 v. 2.0 Treadmill training for patients with Parkinson's disease.rm5
p18549
sg9
V18534554.xml
p18550
sa(dp18551
g3
VSTD-ThanMYA91
p18552
sg5
S'PMC3688502'
p18553
sg7
VCD000256 v. 10.0 Artemisinin derivatives for treating uncomplicated malaria.rm5
p18554
sg9
V23818874.xml
p18555
sa(dp18556
g3
VSTD-ThanMYA97
p18557
sg5
S'PMC3688502'
p18558
sg7
g18554
sg9
V23818874.xml
p18559
sa(dp18560
g3
VSTD-KarbwangTHI92b
p18561
sg5
S'PMC2486535'
p18562
sg7
g18554
sg9
V8205643.xml
p18563
sa(dp18564
g3
VSTD-KarbwangTHI92a
p18565
sg5
S'PMC2486514'
p18566
sg7
g18554
sg9
V8131255.xml
p18567
sa(dp18568
g3
VSTD-ThanMYA93b
p18569
sg5
S'PMC3688502'
p18570
sg7
g18554
sg9
V23818874.xml
p18571
sa(dp18572
g3
VSTD-ThanMYA93c
p18573
sg5
S'PMC3688502'
p18574
sg7
g18554
sg9
V23818874.xml
p18575
sa(dp18576
g3
VSTD-ThanMYA93a
p18577
sg5
S'PMC3688502'
p18578
sg7
g18554
sg9
V23818874.xml
p18579
sa(dp18580
g3
VSTD-ThanMYA96a
p18581
sg5
S'PMC3688502'
p18582
sg7
g18554
sg9
V23818874.xml
p18583
sa(dp18584
g3
VSTD-AlinTAZ94
p18585
sg5
S'PMC2042621'
p18586
sg7
g18554
sg9
V8799526.xml
p18587
sa(dp18588
g3
VSTD-ThanMYA94a
p18589
sg5
S'PMC3688502'
p18590
sg7
g18554
sg9
V23818874.xml
p18591
sa(dp18592
g3
VSTD-ThanMYA90_x002d_91
p18593
sg5
S'PMC3688502'
p18594
sg7
g18554
sg9
V23818874.xml
p18595
sa(dp18596
g3
VSTD-_x0030_13-Papanikolaou-2004
p18597
sg5
S'PMC524504'
p18598
sg7
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p18599
sg9
V15450119.xml
p18600
sa(dp18601
g3
VSTD-Finlay-1982
p18602
sg5
S'PMC1083128'
p18603
sg7
VCD004762 v. 9.0 Drug treatment for myotonia.rm5
p18604
sg9
V7045292.xml
p18605
sa(dp18606
g3
VSTD-Grant-1987
p18607
sg5
S'PMC1031492'
p18608
sg7
g18604
sg9
V3553433.xml
p18609
sa(dp18610
g3
VSTD-Schneider-2006
p18611
sg5
S'PMC1856122'
p18612
sg7
VCD005111 v. 5.0 Acupuncture for treatment of irritable bowel syndrome.rm5
p18613
sg9
V16150852.xml
p18614
sa(dp18615
g3
VSTD-Lembo-2009
p18616
sg5
S'PMC2694961'
p18617
sg7
g18613
sg9
V19455132.xml
p18618
sa(dp18619
g3
VSTD-Varshney-2011
p18620
sg5
S'PMC3060783'
p18621
sg7
VCD009014 v. 2.8 Allergen-specific oral immunotherapy for peanut allergy.rm5
p18622
sg9
V21377034.xml
p18623
sa(dp18624
g3
VSTD-FinHer
p18625
sg5
S'PMC2860103'
p18626
sg7
VCD004421 v. 8.0 Taxanes for adjuvant treatment of early breast cancer.rm5
p18627
sg9
V19819914.xml
p18628
sa(dp18629
g3
VSTD-Kueuk-2008
p18630
sg5
S'PMC2582075'
p18631
sg7
VCD000099 v. 7.0 Growth hormone for in vitro fertilization.rm5
p18632
sg9
V18392675.xml
p18633
sa(dp18634
g3
VSTD-Stephenson-2011
p18635
sg5
S'PMC3115412'
p18636
sg7
VCD006964 v. 5.0 Strategies for communicating contraceptive effectiveness.rm5
p18637
sg9
V21410332.xml
p18638
sa(dp18639
g3
VSTD-Vassar-1991
p18640
sg5
S'PMC1493198'
p18641
sg7
VCD000567 v. 15.0 Colloids versus crystalloids for fluid resuscitation in critically ill patients.rm5
p18642
sg9
V2443087.xml
p18643
sa(dp18644
g3
VSTD-Goodwin-1983
p18645
sg5
S'PMC1353023'
p18646
sg7
g18642
sg9
V6342554.xml
p18647
sa(dp18648
g3
VSTD-Shires-1983
p18649
sg5
S'PMC1353021'
p18650
sg7
g18642
sg9
V6847271.xml
p18651
sa(dp18652
g3
VSTD-Bulger-2011
p18653
sg5
S'PMC3232054'
p18654
sg7
g18642
sg9
V21178763.xml
p18655
sa(dp18656
g3
VSTD-Evans-1996
p18657
sg5
S'PMC1295671'
p18658
sg7
g18642
sg9
V8683491.xml
p18659
sa(dp18660
g3
VSTD-Dick-1995
p18661
sg5
S'PMC1511304'
p18662
sg7
VCD007786 v. 3.0 Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in ch.rm5
p18663
sg9
V7492164.xml
p18664
sa(dp18665
g3
VSTD-Swann-1979
p18666
sg5
S'PMC1597274'
p18667
sg7
g18663
sg9
V519355.xml
p18668
sa(dp18669
g3
VSTD-Dalzell-1986
p18670
sg5
S'PMC1777777'
p18671
sg7
g18663
sg9
V3013104.xml
p18672
sa(dp18673
g3
VSTD-Perneger-1998
p18674
sg5
S'PMC28595'
p18675
sg7
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p18676
sg9
V9651260.xml
p18677
sa(dp18678
g3
VSTD-CCBH-_x0028_A_x0029_-2002
p18679
sg5
S'PMC169643'
p18680
sg7
g18676
sg9
V12907482.xml
p18681
sa(dp18682
g3
VSTD-RIOTT-2010
p18683
sg5
S'PMC1613238'
p18684
sg7
g18676
sg9
V17002810.xml
p18685
sa(dp18686
g3
VSTD-Lincoln-2002
p18687
sg5
S'PMC1737698'
p18688
sg7
VCD009131 v. 2.0 Neuropsychological rehabilitation for multiple sclerosis.rm5
p18689
sg9
V11784832.xml
p18690
sa(dp18691
g3
VSTD-Brownlee-1993
p18692
sg5
S'PMC1029492'
p18693
sg7
VCD005256 v. 2.0 Early introduction of lipids to parenterally-fed preterm infants.rm5
p18694
sg9
V8215565.xml
p18695
sa(dp18696
g3
VSTD-McElhinney-2000
p18697
sg5
S'PMC2449154'
p18698
sg7
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p18699
sg9
V10881642.xml
p18700
sa(dp18701
g3
VSTD-Sacks-high-protein-2009
p18702
sg5
S'PMC2763382'
p18703
sg7
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p18704
sg9
V19246357.xml
p18705
sa(dp18706
g3
VSTD-Rose-1965
p18707
sg5
S'PMC2166702'
p18708
sg7
g18704
sg9
V14288105.xml
p18709
sa(dp18710
g3
VSTD-WHEL-2007
p18711
sg5
S'PMC2083253'
p18712
sg7
g18704
sg9
V17635889.xml
p18713
sa(dp18714
g3
VSTD-Sacks-low-protein-2009
p18715
sg5
S'PMC2763382'
p18716
sg7
g18704
sg9
V19246357.xml
p18717
sa(dp18718
g3
VSTD-Rivellese-1994
p18719
sg5
S'PMC2539301'
p18720
sg7
g18704
sg9
V8111257.xml
p18721
sa(dp18722
g3
VSTD-Strychar-2009
p18723
sg5
S'PMC2732152'
p18724
sg7
g18704
sg9
V19542011.xml
p18725
sa(dp18726
g3
VSTD-Carey-2006
p18727
sg5
S'PMC2442891'
p18728
sg7
VCD008063 v. 4.0 Motivational interviewing for substance abuse.rm5
p18729
sg9
V17032098.xml
p18730
sa(dp18731
g3
VSTD-Parsons-2009
p18732
sg5
S'PMC2666542'
p18733
sg7
g18729
sg9
V18077833.xml
p18734
sa(dp18735
g3
VSTD-Walters-2009
p18736
sg5
S'PMC2704891'
p18737
sg7
g18729
sg9
V19170454.xml
p18738
sa(dp18739
g3
VSTD-Schaus-2009
p18740
sg5
S'PMC2701092'
p18741
sg7
g18729
sg9
V19538921.xml
p18742
sa(dp18743
g3
VSTD-Bernstein-2009
p18744
sg5
S'PMC2910362'
p18745
sg7
g18729
sg9
V20053238.xml
p18746
sa(dp18747
g3
VSTD-Martin-2008
p18748
sg5
S'PMC2996851'
p18749
sg7
g18729
sg9
V17869051.xml
p18750
sa(dp18751
g3
VSTD-Walitzer-2008
p18752
sg5
S'PMC2802221'
p18753
sg7
g18729
sg9
V19207347.xml
p18754
sa(dp18755
g3
VSTD-Carroll-2006a
p18756
sg5
S'PMC2386852'
p18757
sg7
g18729
sg9
V16169159.xml
p18758
sa(dp18759
g3
VSTD-Carroll-2006b
p18760
sg5
S'PMC2148500'
p18761
sg7
g18729
sg9
V17032099.xml
p18762
sa(dp18763
g3
VSTD-Winhusen-2008
p18764
sg5
S'PMC2546520'
p18765
sg7
g18729
sg9
V18083322.xml
p18766
sa(dp18767
g3
VSTD-Carroll-2009
p18768
sg5
S'PMC2792592'
p18769
sg7
g18729
sg9
V19803579.xml
p18770
sa(dp18771
g3
VSTD-Ball-2007b
p18772
sg5
S'PMC2148493'
p18773
sg7
g18729
sg9
V17663610.xml
p18774
sa(dp18775
g3
VSTD-Morgenstern-2009
p18776
sg5
S'PMC2758623'
p18777
sg7
g18729
sg9
V19634958.xml
p18778
sa(dp18779
g3
VSTD-Stein-2010
p18780
sg5
S'PMC2858363'
p18781
sg7
g18729
sg9
V20402990.xml
p18782
sa(dp18783
g3
VSTD-Thush-2009
p18784
sg5
S'PMC3140345'
p18785
sg7
g18729
sg9
V19290699.xml
p18786
sa(dp18787
g3
VSTD-Borsari-2005
p18788
sg5
S'PMC2663045'
p18789
sg7
g18729
sg9
V16187809.xml
p18790
sa(dp18791
g3
VSTD-Walker-2006
p18792
sg5
S'PMC2587139'
p18793
sg7
g18729
sg9
V16822119.xml
p18794
sa(dp18795
g3
VSTD-UKATT-2005
p18796
sg5
S'PMC1200586'
p18797
sg7
g18729
sg9
V16150764.xml
p18798
sa(dp18799
g3
VSTD-Mastroleo-2010
p18800
sg5
S'PMC2937069'
p18801
sg7
g18729
sg9
V20673621.xml
p18802
sa(dp18803
g3
VSTD-Barnett-2007
p18804
sg5
S'PMC2000456'
p18805
sg7
g18729
sg9
V17707594.xml
p18806
sa(dp18807
g3
VSTD-Kadden-2007
p18808
sg5
S'PMC1903379'
p18809
sg7
g18729
sg9
V16996224.xml
p18810
sa(dp18811
g3
VSTD-Whipps-Cross-1998
p18812
sg5
S'PMC28600'
p18813
sg7
VCD001785 v. 10.0 Laparoscopic techniques versus open techniques for inguinal hernia repair.rm5
p18814
sg9
V9657784.xml
p18815
sa(dp18816
g3
VSTD-SCUR-1999
p18817
sg5
S'PMC1420865'
p18818
sg7
g18814
sg9
V10450737.xml
p18819
sa(dp18820
g3
VSTD-Oxford-1995
p18821
sg5
S'PMC2550988'
p18822
sg7
g18814
sg9
V7580639.xml
p18823
sa(dp18824
g3
VSTD-Jarvis-1980
p18825
sg5
S'PMC1714748'
p18826
sg7
VCD001308 v. 5.0 Bladder training for urinary incontinence in adults.rm5
p18827
sg9
V7002250.xml
p18828
sa(dp18829
g3
VSTD-Mynors_x002d_Wallis-1995
p18830
sg5
S'PMC2548821'
p18831
sg7
VCD007954 v. 1.2 Antidepressants versus placebo for depression in primary care.rm5
p18832
sg9
V7873952.xml
p18833
sa(dp18834
g3
VSTD-Blashki-_x0028_75mg_x0029_-1971
p18835
sg5
S'PMC1795147'
p18836
sg7
g18832
sg9
V4923928.xml
p18837
sa(dp18838
g3
VSTD-Blashki-_x0028_150-mg_x0029_-1971
p18839
sg5
S'PMC1795147'
p18840
sg7
g18832
sg9
V4923928.xml
p18841
sa(dp18842
g3
VSTD-Hollyman-1988
p18843
sg5
S'PMC1711591'
p18844
sg7
g18832
sg9
V3076905.xml
p18845
sa(dp18846
g3
VSTD-Philipp-1999
p18847
sg5
S'PMC28296'
p18848
sg7
g18832
sg9
V10591711.xml
p18849
sa(dp18850
g3
VSTD-Malt--1999
p18851
sg5
S'PMC34546'
p18852
sg7
g18832
sg9
V10221945.xml
p18853
sa(dp18854
g3
VSTD-Zafar-2008
p18855
sg5
S'PMC3734022'
p18856
sg7
VCD000947 v. 8.0 Continuous and interrupted suturing techniques for repair of episiotomy or second-degree tears.rm5
p18857
sg9
V24059980.xml
p18858
sa(dp18859
g3
VSTD-Barrowman-2003
p18860
sg5
S'PMC212708'
p18861
sg7
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p18862
sg9
V12877755.xml
p18863
sa(dp18864
g3
VSTD-Weller-1998
p18865
sg5
S'PMC3314787'
p18866
sg7
g18862
sg9
V22415239.xml
p18867
sa(dp18868
g3
VSTD-Ioannidis-2001
p18869
sg5
S'PMC14669'
p18870
sg7
g18862
sg9
V11158556.xml
p18871
sa(dp18872
g3
VSTD-Neuhaus-2009
p18873
sg5
S'PMC2634726'
p18874
sg7
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p18875
sg9
V19127261.xml
p18876
sa(dp18877
g3
VSTD-Kocher-2011
p18878
sg5
S'PMC3058272'
p18879
sg7
g18875
sg9
V21041710.xml
p18880
sa(dp18881
g3
VSTD-McKay-2008
p18882
sg5
S'PMC2630830'
p18883
sg7
VCD002295 v. 9.0 Exercise interventions for smoking cessation.rm5
p18884
sg9
V19017582.xml
p18885
sa(dp18886
g3
VSTD-Ciccolo-2011
p18887
sg5
S'PMC3150692'
p18888
sg7
g18884
sg9
V21504883.xml
p18889
sa(dp18890
g3
VSTD-Kinnunen-2008
p18891
sg5
S'PMC3695732'
p18892
sg7
g18884
sg9
V18418791.xml
p18893
sa(dp18894
g3
VSTD-Rubidge-1970
p18895
sg5
S'PMC2020286'
p18896
sg7
VCD006085 v. 4.0 Antiamoebic drugs for treating amoebic colitis.rm5
p18897
sg9
V4315969.xml
p18898
sa(dp18899
g3
VSTD-Shabat-2005
p18900
sg5
S'PMC3489231'
p18901
sg7
VCD005275 v. 7.0 Insoles for prevention and treatment of back pain.rm5
p18902
sg9
V15668775.xml
p18903
sa(dp18904
g3
VSTD-Thomas-1984
p18905
sg5
S'PMC1027683'
p18906
sg7
VCD005953 v. 3.0 Extracranial-intracranial arterial bypass surgery for occlusive carotid artery disease.rm5
p18907
sg9
V6707653.xml
p18908
sa(dp18909
g3
VSTD-Kerstjens-1994
p18910
sg5
S'PMC475051'
p18911
sg7
VCD003537 v. 4.0 Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary d.rm5
p18912
sg9
V8066559.xml
p18913
sa(dp18914
g3
VSTD-Tattersfield-2001
p18915
sg5
S'PMC1746016'
p18916
sg7
g18912
sg9
V11254817.xml
p18917
sa(dp18918
g3
VSTD-Corney-1997
p18919
sg5
S'PMC1313103'
p18920
sg7
VCD006731 v. 6.0 Pharmaceutical policies effects of financial incentives for prescribers.rm5
p18921
sg9
V9406488.xml
p18922
sa(dp18923
g3
VSTD-Harris-1996
p18924
sg5
S'PMC2353056'
p18925
sg7
g18921
sg9
V8978232.xml
p18926
sa(dp18927
g3
VSTD-Wilson-1999
p18928
sg5
S'PMC1313438'
p18929
sg7
g18921
sg9
V10562740.xml
p18930
sa(dp18931
g3
VSTD-Wilson-1995
p18932
sg5
S'PMC2551250'
p18933
sg7
g18921
sg9
V7496289.xml
p18934
sa(dp18935
g3
VSTD-Rafferty-1997
p18936
sg5
S'PMC2127119'
p18937
sg7
g18921
sg9
V9251548.xml
p18938
sa(dp18939
g3
VSTD-Kammerling-1996
p18940
sg5
S'PMC2351139'
p18941
sg7
g18921
sg9
V8646099.xml
p18942
sa(dp18943
g3
VSTD-Bradlow-1993
p18944
sg5
S'PMC1679320'
p18945
sg7
g18921
sg9
V8251847.xml
p18946
sa(dp18947
g3
VSTD-Kylmala-1997
p18948
sg5
S'PMC2228066'
p18949
sg7
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p18950
sg9
V9328156.xml
p18951
sa(dp18952
g3
VSTD-Mustafa-2002
p18953
sg5
S'PMC3366228'
p18954
sg7
VCD005455 v. 4.0 Choice of instruments for assisted vaginal delivery.rm5
p18955
sg9
V22685661.xml
p18956
sa(dp18957
g3
VSTD-Szigethy-2007
p18958
sg5
S'PMC2638168'
p18959
sg7
VCD006913 v. 5.0 Psychological interventions for treatment of inflammatory bowel disease.rm5
p18960
sg9
V18831071.xml
p18961
sa(dp18962
g3
VSTD-Kennedy-2004
p18963
sg5
S'PMC1774266'
p18964
sg7
g18960
sg9
V15479685.xml
p18965
sa(dp18966
g3
VSTD-Opiyo-2008
p18967
sg5
S'PMC2229665'
p18968
sg7
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p18969
sg9
V18270586.xml
p18970
sa(dp18971
g3
VSTD-Majumdar-2008
p18972
sg5
S'PMC2244663'
p18973
sg7
VCD000125 v. 12.8 Local opinion leaders effects on professional practice and health care outcomes.rm5
p18974
sg9
V18299546.xml
p18975
sa(dp18976
g3
VSTD-McAlister-2009
p18977
sg5
S'PMC2789127'
p18978
sg7
g18974
sg9
V19933787.xml
p18979
sa(dp18980
g3
VSTD-Sculier-2001
p18981
sg5
S'PMC2363948'
p18982
sg7
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p18983
sg9
V11720426.xml
p18984
sa(dp18985
g3
VSTD-Waites-2006
p18986
sg5
S'PMC1864807'
p18987
sg7
VCD004012 v. 7.0 Washout policies in long-term indwelling urinary catheterisation in adults.rm5
p18988
sg9
V16859225.xml
p18989
sa(dp18990
g3
VSTD-Callaghan-1985
p18991
sg5
S'PMC1028404'
p18992
sg7
VCD001769 v. 12.0 Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic.rm5
p18993
sg9
V3928820.xml
p18994
sa(dp18995
g3
VSTD-Turnbull-1985
p18996
sg5
S'PMC1418605'
p18997
sg7
g18993
sg9
V3919805.xml
p18998
sa(dp18999
g3
VSTD-Heller-1995
p19000
sg5
S'PMC1073267'
p19001
sg7
g18993
sg9
V7823066.xml
p19002
sa(dp19003
g3
VSTD-LEADER-2002
p19004
sg5
S'PMC133451'
p19005
sg7
VCD003697 v. 5.0 Statins and fibrates for preventing melanoma.rm5
p19006
sg9
V12433762.xml
p19007
sa(dp19008
g3
VSTD-WHO-1973
p19009
sg5
S'PMC2481013'
p19010
sg7
g19006
sg9
V4578364.xml
p19011
sa(dp19012
g3
VSTD-Attard-1992
p19013
sg5
S'PMC1883284'
p19014
sg7
VCD005660 v. 5.0 Analgesia in patients with acute abdominal pain.rm5
p19015
sg9
V1393034.xml
p19016
sa(dp19017
g3
VSTD-Patki-1990
p19018
sg5
S'PMC1663843'
p19019
sg7
VCD004805 v. 12.0 Combined calcium magnesium and potassium supplementation for the management of primary hypertension.rm5
p19020
sg9
V2207419.xml
p19021
sa(dp19022
g3
VSTD-Geleijnse-1994
p19023
sg5
S'PMC2540967'
p19024
sg7
g19020
sg9
V7920126.xml
p19025
sa(dp19026
g3
VSTD-Vedder-2007
p19027
sg5
S'PMC1913555'
p19028
sg7
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p19029
sg9
V17622343.xml
p19030
sa(dp19031
g3
VSTD-Frihagen-2007
p19032
sg5
S'PMC2137068'
p19033
sg7
VCD001708 v. 10.0 Internal fixation versus arthroplasty for intracapsular proximal femoral fractures in adults.rm5
p19034
sg9
V18056740.xml
p19035
sa(dp19036
g3
VSTD-Mouzopoulos-2008
p19037
sg5
S'PMC2323425'
p19038
sg7
g19034
sg9
V17431621.xml
p19039
sa(dp19040
g3
VSTD-Walker-1987
p19041
sg5
S'PMC1246354'
p19042
sg7
VCD006771 v. 3.4 Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.rm5
p19043
sg9
V3109574.xml
p19044
sa(dp19045
g3
VSTD-Madge-1997
p19046
sg5
S'PMC1758505'
p19047
sg7
VCD001290 v. 7.0 Interventions for educating children who are at risk of asthma-related emergency department attendan.rm5
p19048
sg9
V9093336.xml
p19049
sa(dp19050
g3
VSTD-Mitchell-1986
p19051
sg5
S'PMC1778203'
p19052
sg7
g19048
sg9
V3545094.xml
p19053
sa(dp19054
g3
VSTD-McNabb-1985
p19055
sg5
S'PMC1646372'
p19056
sg7
g19048
sg9
V4037168.xml
p19057
sa(dp19058
g3
VSTD-Charlton-1994
p19059
sg5
S'PMC1029785'
p19060
sg7
g19048
sg9
V8185365.xml
p19061
sa(dp19062
g3
VSTD-Wesseldine-1999
p19063
sg5
S'PMC1717832'
p19064
sg7
g19048
sg9
V10325723.xml
p19065
sa(dp19066
g3
VSTD-Garrett-1994
p19067
sg5
S'PMC475232'
p19068
sg7
g19048
sg9
V7974314.xml
p19069
sa(dp19070
g3
VSTD-Butz-2006
p19071
sg5
S'PMC2269706'
p19072
sg7
g19048
sg9
V16754825.xml
p19073
sa(dp19074
g3
VSTD-Stevens-2002
p19075
sg5
S'PMC1746177'
p19076
sg7
g19048
sg9
V11809988.xml
p19077
sa(dp19078
g3
VSTD-Westlake-2009
p19079
sg5
S'PMC2708184'
p19080
sg7
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p19081
sg9
V19523207.xml
p19082
sa(dp19083
g3
VSTD-Pritchard-1999
p19084
sg5
S'PMC1756872'
p19085
sg7
VCD000984 v. 10.0 Interventions to change the behaviour of health professionals and the organisation of care to promot.rm5
p19086
sg9
V10396539.xml
p19087
sa(dp19088
g3
VSTD-Moore-2003
p19089
sg5
S'PMC261745'
p19090
sg7
g19086
sg9
V14604931.xml
p19091
sa(dp19092
g3
VSTD-O_x0027_Donnell-2003
p19093
sg5
S'PMC214016'
p19094
sg7
VCD003442 v. 4.0 Compliance therapy for schizophrenia.rm5
p19095
sg9
V14551096.xml
p19096
sa(dp19097
g3
VSTD-Ruger-2008
p19098
sg5
S'PMC2775431'
p19099
sg7
VCD003999 v. 6.23 Relapse prevention interventions for smoking cessation.rm5
p19100
sg9
V17854434.xml
p19101
sa(dp19102
g3
VSTD-McBride-1999
p19103
sg5
S'PMC1508743'
p19104
sg7
g19100
sg9
V10224982.xml
p19105
sa(dp19106
g3
VSTD-Lando-1996
p19107
sg5
S'PMC1380734'
p19108
sg7
g19100
sg9
V9003138.xml
p19109
sa(dp19110
g3
VSTD-Van_x0027_t-Hof-2000
p19111
sg5
S'PMC1766291'
p19112
sg7
g19100
sg9
V10982911.xml
p19113
sa(dp19114
g3
VSTD-Hajek-2002
p19115
sg5
S'PMC64504'
p19116
sg7
g19100
sg9
V11786452.xml
p19117
sa(dp19118
g3
VSTD-Lindholm-1994
p19119
sg5
S'PMC3644018'
p19120
sg7
VCD001103 v. 9.0 Dressings for healing venous leg ulcers.rm5
p19121
sg9
V22941749.xml
p19122
sa(dp19123
g3
VSTD-Smith-1994
p19124
sg5
S'PMC3644009'
p19125
sg7
g19121
sg9
V23179315.xml
p19126
sa(dp19127
g3
VSTD-Grotewohl-1994
p19128
sg5
S'PMC3608232'
p19129
sg7
g19121
sg9
V23555325.xml
p19130
sa(dp19131
g3
VSTD-Ormiston-1988
p19132
sg5
S'PMC1416577'
p19133
sg7
g19121
sg9
V3926169.xml
p19134
sa(dp19135
g3
VSTD-Prendiville-1988
p19136
sg5
S'PMC1834913'
p19137
sg7
VCD007412 v. 4.0 Active versus expectant management for women in the third stage of labour.rm5
p19138
sg9
V3144366.xml
p19139
sa(dp19140
g3
VSTD-Kreisman-1981
p19141
sg5
S'PMC471515'
p19142
sg7
VCD003269 v. 7.0 Anticholinergic agents for chronic asthma in adults.rm5
p19143
sg9
V6458919.xml
p19144
sa(dp19145
g3
VSTD-van-Schayck-1995
p19146
sg5
S'PMC1239228'
p19147
sg7
g19143
sg9
V7619569.xml
p19148
sa(dp19149
g3
VSTD-Bellia-1988
p19150
sg5
S'PMC2428919'
p19151
sg7
g19143
sg9
V3074291.xml
p19152
sa(dp19153
g3
VSTD-Taylor-1986
p19154
sg5
S'PMC460313'
p19155
sg7
g19143
sg9
V2943050.xml
p19156
sa(dp19157
g3
VSTD-van-Schayck-1991a
p19158
sg5
S'PMC1671690'
p19159
sg7
g19143
sg9
V1837744.xml
p19160
sa(dp19161
g3
VSTD-van-Schayck-1991b
p19162
sg5
S'PMC463136'
p19163
sg7
g19143
sg9
V1829865.xml
p19164
sa(dp19165
g3
VSTD-Sherwood-1983
p19166
sg5
S'PMC1650873'
p19167
sg7
VCD006860 v. 3.0 Personal assistance for adults (19-64) with both physical and intellectual impairments.rm5
p19168
sg9
V6405641.xml
p19169
sa(dp19170
g3
VSTD-Carlson-2007
p19171
sg5
S'PMC1955332'
p19172
sg7
g19168
sg9
V17244293.xml
p19173
sa(dp19174
g3
VSTD-Rosenfeld-2008
p19175
sg5
S'PMC2631354'
p19176
sg7
VCD004157 v. 4.0 Treatment for cramps in amyotrophic lateral sclerosismotor neuron disease.rm5
p19177
sg9
V18608103.xml
p19178
sa(dp19179
g3
VSTD-Gerr-2005
p19180
sg5
S'PMC1741055'
p19181
sg7
VCD008570 v. 4.0 Ergonomic design and training for preventing work-related musculoskeletal disorders of the upper lim.rm5
p19182
sg9
V15961625.xml
p19183
sa(dp19184
g3
VSTD-Rempel-2006
p19185
sg5
S'PMC2092482'
p19186
sg7
g19182
sg9
V16621849.xml
p19187
sa(dp19188
g3
VSTD-Barennes-2006
p19189
sg5
S'PMC1458599'
p19190
sg7
VCD004009 v. 4.0 Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum m.rm5
p19191
sg9
V16675812.xml
p19192
sa(dp19193
g3
VSTD-Pussard-2004
p19194
sg5
S'PMC525409'
p19195
sg7
g19191
sg9
V15504872.xml
p19196
sa(dp19197
g3
VSTD-Barennes-1996a
p19198
sg5
S'PMC2042609'
p19199
sg7
g19191
sg9
V8735679.xml
p19200
sa(dp19201
g3
VSTD-Carlo-2010
p19202
sg5
S'PMC3565382'
p19203
sg7
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p19204
sg9
V20164485.xml
p19205
sa(dp19206
g3
VSTD-Gill-2011
p19207
sg5
S'PMC3032994'
p19208
sg7
g19204
sg9
V21292711.xml
p19209
sa(dp19210
g3
VSTD-Mertens-1992
p19211
sg5
S'PMC191603'
p19212
sg7
VCD001954 v. 12.0 Azithromycin for acute lower respiratory tract infections.rm5
p19213
sg9
V1324645.xml
p19214
sa(dp19215
g3
VSTD-Patten-2009
p19216
sg5
S'PMC2670370'
p19217
sg7
VCD002928 v. 7.0 Enhancing partner support to improve smoking cessation.rm5
p19218
sg9
V19357315.xml
p19219
sa(dp19220
g3
VSTD-Malott-1984
p19221
sg5
S'PMC1307970'
p19222
sg7
g19218
sg9
V6441794.xml
p19223
sa(dp19224
g3
VSTD-Arathoon-2002
p19225
sg5
S'PMC127070'
p19226
sg7
VCD003940 v. 6.0 Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV inf.rm5
p19227
sg9
V11796357.xml
p19228
sa(dp19229
g3
VSTD-Nittayananta-2008
p19230
sg5
S'PMC3253386'
p19231
sg7
g19227
sg9
V18627504.xml
p19232
sa(dp19233
g3
VSTD-Chavanet-1992
p19234
sg5
S'PMC1883525'
p19235
sg7
g19227
sg9
V1458072.xml
p19236
sa(dp19237
g3
VSTD-Bedford_x002d_Russell-2001
p19238
sg5
S'PMC1721238'
p19239
sg7
VCD003066 v. 5.0 G-CSF and GM-CSF for treating or preventing neonatal infections.rm5
p19240
sg9
V11320043.xml
p19241
sa(dp19242
g3
VSTD-Greenwood-1978
p19243
sg5
S'PMC1604678'
p19244
sg7
VCD001093 v. 7.3 Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.rm5
p19245
sg9
V417754.xml
p19246
sa(dp19247
g3
VSTD-Wahdan-1973
p19248
sg5
S'PMC2483073'
p19249
sg7
g19245
sg9
V4206451.xml
p19250
sa(dp19251
g3
VSTD-Erwa-1973
p19252
sg5
S'PMC2481142'
p19253
sg7
g19245
sg9
V4211056.xml
p19254
sa(dp19255
g3
VSTD-Wahdan-1977
p19256
sg5
S'PMC2366720'
p19257
sg7
g19245
sg9
V413639.xml
p19258
sa(dp19259
g3
VSTD-ASTEC_x002f_EN.5
p19260
sg5
S'PMC2646125'
p19261
sg7
VCD003916 v. 7.1 Adjuvant radiotherapy for stage I endometrial cancer.rm5
p19262
sg9
V19070891.xml
p19263
sa(dp19264
g3
VSTD-Rindone-2000
p19265
sg5
S'PMC1070762'
p19266
sg7
VCD002946 v. 8.0 Glucosamine therapy for treating osteoarthritis.rm5
p19267
sg9
V10693368.xml
p19268
sa(dp19269
g3
VSTD-Mehta-2007
p19270
sg5
S'PMC2131759'
p19271
sg7
g19267
sg9
V17974032.xml
p19272
sa(dp19273
g3
VSTD-Rovati-1997
p19274
sg5
S'PMC3400104'
p19275
sg7
g19267
sg9
V22850875.xml
p19276
sa(dp19277
g3
VSTD-McManus-1998
p19278
sg5
S'PMC28735'
p19279
sg7
VMR000026 v. 2.3 Checking reference lists to find additional studies for systematic reviews.rm5
p19280
sg9
V9836655.xml
p19281
sa(dp19282
g3
VSTD-McNally-2004
p19283
sg5
S'PMC2080777'
p19284
sg7
g19280
sg9
V15318916.xml
p19285
sa(dp19286
g3
VSTD-Ogilvie-2005
p19287
sg5
S'PMC1733146'
p19288
sg7
g19280
sg9
V16100321.xml
p19289
sa(dp19290
g3
VSTD-Greenhalgh-2005
p19291
sg5
S'PMC1283190'
p19292
sg7
g19280
sg9
V16230312.xml
p19293
sa(dp19294
g3
VSTD-Mann-1986
p19295
sg5
S'PMC1342106'
p19296
sg7
VCD006982 v. 3.0 Cycled light in the intensive care unit for preterm and low birth weight infants.rm5
p19297
sg9
V3096460.xml
p19298
sa(dp19299
g3
VSTD-Howden_x002d_Chapman-2007
p19300
sg5
S'PMC1808149'
p19301
sg7
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p19302
sg9
V17324975.xml
p19303
sa(dp19304
g3
VSTD-Kercsmar-2006
p19305
sg5
S'PMC1626393'
p19306
sg7
g19302
sg9
V17035145.xml
p19307
sa(dp19308
g3
VSTD-Baker-1991
p19309
sg5
S'PMC1368470'
p19310
sg7
VCD002104 v. 10.0 Written information about individual medicines for consumers.rm5
p19311
sg9
V1888619.xml
p19312
sa(dp19313
g3
VSTD-Gibbs-1989
p19314
sg5
S'PMC1379799'
p19315
sg7
g19311
sg9
V2569323.xml
p19316
sa(dp19317
g3
VSTD-Bergus-2002
p19318
sg5
S'PMC1495093'
p19319
sg7
g19311
sg9
V12213142.xml
p19320
sa(dp19321
g3
VSTD-Little-1998
p19322
sg5
S'PMC28594'
p19323
sg7
g19311
sg9
V9641933.xml
p19324
sa(dp19325
g3
VSTD-Knapp-2004
p19326
sg5
S'PMC1743828'
p19327
sg7
g19311
sg9
V15175486.xml
p19328
sa(dp19329
g3
VSTD-Peveler-1999
p19330
sg5
S'PMC28214'
p19331
sg7
g19311
sg9
V10473477.xml
p19332
sa(dp19333
g3
VSTD-Clark-1972
p19334
sg5
S'PMC1530384'
p19335
sg7
g19311
sg9
V5046455.xml
p19336
sa(dp19337
g3
VSTD-Bhardwaj-1994
p19338
sg5
S'PMC3590536'
p19339
sg7
VCD002006 v. 10.0 Position in the second stage of labour for women without epidural anaesthesia.rm5
p19340
sg9
V23492921.xml
p19341
sa(dp19342
g3
VSTD-Bradley-2002
p19343
sg5
S'PMC100764'
p19344
sg7
VCD006093 v. 5.0 Interventions for promoting information and communication technologies adoption in healthcare profes.rm5
p19345
sg9
V11999177.xml
p19346
sa(dp19347
g3
VSTD-Haynes-1991
p19348
sg5
S'PMC225582'
p19349
sg7
g19345
sg9
V1958910.xml
p19350
sa(dp19351
g3
VSTD-Cabell-2001
p19352
sg5
S'PMC1495306'
p19353
sg7
g19345
sg9
V11903763.xml
p19354
sa(dp19355
g3
VSTD-Haynes-2006
p19356
sg5
S'PMC1656957'
p19357
sg7
g19345
sg9
V16929034.xml
p19358
sa(dp19359
g3
VSTD-Katz-2003
p19360
sg5
S'PMC1494914'
p19361
sg7
g19345
sg9
V12950483.xml
p19362
sa(dp19363
g3
VSTD-Warburton-1987
p19364
sg5
S'PMC1386096'
p19365
sg7
VCD005044 v. 4.0 Quinine for muscle cramps.rm5
p19366
sg9
V3555580.xml
p19367
sa(dp19368
g3
VSTD-Woodfield-2005
p19369
sg5
S'PMC1463087'
p19370
sg7
g19366
sg9
V15808032.xml
p19371
sa(dp19372
g3
VSTD-Dunn-1993
p19373
sg5
S'PMC1372336'
p19374
sg7
g19366
sg9
V8323792.xml
p19375
sa(dp19376
g3
VSTD-Fung-1989
p19377
sg5
S'PMC1026949'
p19378
sg7
g19366
sg9
V2669346.xml
p19379
sa(dp19380
g3
VSTD-Glasgow-2000
p19381
sg5
S'PMC27300'
p19382
sg7
VCD003585 v. 5.0 Occupational therapy for patients with problems in activities of daily living after stroke.rm5
p19383
sg9
V10698876.xml
p19384
sa(dp19385
g3
VSTD-Arrieta-2003
p19386
sg5
S'PMC201139'
p19387
sg7
VCD001095 v. 14.0 Short-course antibiotics for acute otitis media.rm5
p19388
sg9
V14506028.xml
p19389
sa(dp19390
g3
VSTD-de-Saintongue-1982
p19391
sg5
S'PMC1497899'
p19392
sg7
g19388
sg9
V6802412.xml
p19393
sa(dp19394
g3
VSTD-Dagan-2000b
p19395
sg5
S'PMC89626'
p19396
sg7
g19388
sg9
V10602721.xml
p19397
sa(dp19398
g3
VSTD-Arthur-2007
p19399
sg5
S'PMC2598642'
p19400
sg7
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p19401
sg9
V17991688.xml
p19402
sa(dp19403
g3
VSTD-Cremin-2010
p19404
sg5
S'PMC2865634'
p19405
sg7
g19401
sg9
V19623481.xml
p19406
sa(dp19407
g3
VSTD-de-Lacey-1985-RA
p19408
sg5
S'PMC1416756'
p19409
sg7
VMR000002 v. 7.0 Technical editing of research reports in biomedical journals.rm5
p19410
sg9
V3931753.xml
p19411
sa(dp19412
g3
VSTD-Taddio-1994
p19413
sg5
S'PMC1336964'
p19414
sg7
g19410
sg9
V8174031.xml
p19415
sa(dp19416
g3
VSTD-Aronsky-2005-RA
p19417
sg5
S'PMC551554'
p19418
sg7
g19410
sg9
V15561784.xml
p19419
sa(dp19420
g3
VSTD-Eichorn-1987-RA
p19421
sg5
S'PMC1647239'
p19422
sg7
g19410
sg9
V3079520.xml
p19423
sa(dp19424
g3
VSTD-Harbourt-1995
p19425
sg5
S'PMC226026'
p19426
sg7
g19410
sg9
V7599584.xml
p19427
sa(dp19428
g3
VSTD-VargasOrigel-2001-RA
p19429
sg5
S'PMC1719006'
p19430
sg7
g19410
sg9
V11719341.xml
p19431
sa(dp19432
g3
VSTD-Darrow-2008
p19433
sg5
S'PMC2376895'
p19434
sg7
VCD009337 v. 2.0 Social marketing interventions to increase HIVSTI testing uptake among men who have sex with men an.rm5
p19435
sg9
V18172146.xml
p19436
sa(dp19437
g3
VSTD-Grant-2009
p19438
sg5
S'PMC2799061'
p19439
sg7
VCD003720 v. 5.0 Timing of breast surgery in premenopausal breast cancer patients.rm5
p19440
sg9
V19487378.xml
p19441
sa(dp19442
g3
VSTD-Swoboda-2010
p19443
sg5
S'PMC2924376'
p19444
sg7
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p19445
sg9
V20808854.xml
p19446
sa(dp19447
g3
VSTD-Schiff-2008
p19448
sg5
S'PMC2564802'
p19449
sg7
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p19450
sg9
V18055472.xml
p19451
sa(dp19452
g3
VSTD-Weinblatt-2007
p19453
sg5
S'PMC1798511'
p19454
sg7
g19450
sg9
V16935912.xml
p19455
sa(dp19456
g3
VSTD-Brett-1992
p19457
sg5
S'PMC1793633'
p19458
sg7
VCD002767 v. 12.0 Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.rm5
p19459
sg9
V1417051.xml
p19460
sa(dp19461
g3
VSTD-Elborn-2000
p19462
sg5
S'PMC1745744'
p19463
sg7
g19459
sg9
V10770814.xml
p19464
sa(dp19465
g3
VSTD-Xia-2002-_x0028_CPZ_x0029_
p19466
sg5
S'PMC3745831'
p19467
sg7
VCD000059 v. 12.0 Clozapine versus typical neuroleptic medication for schizophrenia.rm5
p19468
sg9
V23984190.xml
p19469
sa(dp19470
g3
VSTD-Grove-1996
p19471
sg5
S'PMC472490'
p19472
sg7
VCD001104 v. 7.0 Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.rm5
p19473
sg9
V8882074.xml
p19474
sa(dp19475
g3
VSTD-Ulrik-1995
p19476
sg5
S'PMC474647'
p19477
sg7
g19473
sg9
V7570409.xml
p19478
sa(dp19479
g3
VSTD-Combe-2006
p19480
sg5
S'PMC2689524'
p19481
sg7
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p19482
sg9
V18794178.xml
p19483
sa(dp19484
g3
VSTD-Gardner-1988
p19485
sg5
S'PMC1349736'
p19486
sg7
VCD000450 v. 6.0 Interventions for preventing and treating stress fractures and stress reactions of bone of the lower.rm5
p19487
sg9
V3056045.xml
p19488
sa(dp19489
g3
VSTD-Pinter-1999
p19490
sg5
S'PMC1736320'
p19491
sg7
VCD002261 v. 4.2 Pramipexole for levodopa-induced complications in Parkinson's disease.rm5
p19492
sg9
V10201413.xml
p19493
sa(dp19494
g3
VSTD-MacDougall-1990
p19495
sg5
S'PMC1664403'
p19496
sg7
VCD006387 v. 3.0 Interventions for the treatment of oral cavity and oropharyngeal cancer radiotherapy.rm5
p19497
sg9
V2125513.xml
p19498
sa(dp19499
g3
VSTD-Johnson-1989
p19500
sg5
S'PMC461792'
p19501
sg7
VCD003134 v. 5.0 Non-steroid agents for idiopathic pulmonary fibrosis.rm5
p19502
sg9
V2669218.xml
p19503
sa(dp19504
g3
VSTD-Premawardhena-1999
p19505
sg5
S'PMC27835'
p19506
sg7
VCD002153 v. 4.0 Interventions for preventing reactions to snake antivenom.rm5
p19507
sg9
V10205101.xml
p19508
sa(dp19509
g3
VSTD-Fan-1999
p19510
sg5
S'PMC27887'
p19511
sg7
g19507
sg9
V10346769.xml
p19512
sa(dp19513
g3
VSTD-Ietswaart-2011
p19514
sg5
S'PMC3097892'
p19515
sg7
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p19516
sg9
V21515905.xml
p19517
sa(dp19518
g3
VSTD-Yun-2010
p19519
sg5
S'PMC3309215'
p19520
sg7
g19516
sg9
V22506139.xml
p19521
sa(dp19522
g3
VSTD-Viljanen-2003
p19523
sg5
S'PMC188429'
p19524
sg7
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p19525
sg9
V12946968.xml
p19526
sa(dp19527
g3
VSTD-Hurley-2007
p19528
sg5
S'PMC2673355'
p19529
sg7
g19525
sg9
V17907147.xml
p19530
sa(dp19531
g3
VSTD-Nour-2006
p19532
sg5
S'PMC1525193'
p19533
sg7
g19525
sg9
V16734904.xml
p19534
sa(dp19535
g3
VSTD-Ersek-2004
p19536
sg5
S'PMC509247'
p19537
sg7
g19525
sg9
V15285783.xml
p19538
sa(dp19539
g3
VSTD-Smeets-2006
p19540
sg5
S'PMC1382224'
p19541
sg7
g19525
sg9
V16426449.xml
p19542
sa(dp19543
g3
VSTD-Latimer-1982
p19544
sg5
S'PMC1862216'
p19545
sg7
VCD002158 v. 6.0 Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agoni.rm5
p19546
sg9
V7139504.xml
p19547
sa(dp19548
g3
VSTD-Taggart-1995
p19549
sg5
S'PMC2550012'
p19550
sg7
g19546
sg9
V7795451.xml
p19551
sa(dp19552
g3
VSTD-Zainudin-1990
p19553
sg5
S'PMC462532'
p19554
sg7
g19546
sg9
V2392793.xml
p19555
sa(dp19556
g3
VSTD-Selroos-1994
p19557
sg5
S'PMC475329'
p19558
sg7
g19546
sg9
V7878558.xml
p19559
sa(dp19560
g3
VSTD-NCBRG-1981
p19561
sg5
S'PMC1627274'
p19562
sg7
VCD006943 v. 4.49 Interventions for covert bacteriuria in children.rm5
p19563
sg9
V7271298.xml
p19564
sa(dp19565
g3
VSTD-Van-Vliet-2005
p19566
sg5
S'PMC1739598'
p19567
sg7
VCD006073 v. 3.0 Repetitive task training for improving functional ability after stroke.rm5
p19568
sg9
V15774435.xml
p19569
sa(dp19570
g3
VSTD-Bland-1973
p19571
sg5
S'PMC1648558'
p19572
sg7
VCD001208 v. 12.2 Human albumin solution for resuscitation and volume expansion in critically ill patients.rm5
p19573
sg9
V4749684.xml
p19574
sa(dp19575
g3
VSTD-Goodwin-1983
p19576
sg5
S'PMC1353023'
p19577
sg7
g19573
sg9
V6342554.xml
p19578
sa(dp19579
g3
VSTD-So-1997
p19580
sg5
S'PMC1720603'
p19581
sg7
g19573
sg9
V9059186.xml
p19582
sa(dp19583
g3
VSTD-Browner-1994
p19584
sg5
S'PMC1022738'
p19585
sg7
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p19586
sg9
V7856157.xml
p19587
sa(dp19588
g3
VSTD-Moore-2003-b
p19589
sg5
S'PMC261745'
p19590
sg7
g19586
sg9
V14604931.xml
p19591
sa(dp19592
g3
VSTD-Moore-2003-a
p19593
sg5
S'PMC1314568'
p19594
sg7
g19586
sg9
V12879826.xml
p19595
sa(dp19596
g3
VSTD-Dolan1997
p19597
sg5
S'PMC1497157'
p19598
sg7
g19586
sg9
V9294786.xml
p19599
sa(dp19600
g3
VSTD-Forsetlund-2003
p19601
sg5
S'PMC153535'
p19602
sg7
g19586
sg9
V12694632.xml
p19603
sa(dp19604
g3
VSTD-Harmsen-2005
p19605
sg5
S'PMC1463156'
p19606
sg7
g19586
sg9
V15904552.xml
p19607
sa(dp19608
g3
VSTD-Dietrich-1992
p19609
sg5
S'PMC1881551'
p19610
sg7
g19586
sg9
V1571644.xml
p19611
sa(dp19612
g3
VSTD-Wilson-1992
p19613
sg5
S'PMC2145470'
p19614
sg7
g19586
sg9
V21221270.xml
p19615
sa(dp19616
g3
VSTD-Smeele-1999
p19617
sg5
S'PMC2483639'
p19618
sg7
g19586
sg9
V10557684.xml
p19619
sa(dp19620
g3
VSTD-Bekkering-2005
p19621
sg5
S'PMC1743983'
p19622
sg7
g19586
sg9
V15805455.xml
p19623
sa(dp19624
g3
VSTD-Flottorp-2002
p19625
sg5
S'PMC117890'
p19626
sg7
g19586
sg9
V12183309.xml
p19627
sa(dp19628
g3
VSTD-Schectman-2003
p19629
sg5
S'PMC1494929'
p19630
sg7
g19586
sg9
V14521638.xml
p19631
sa(dp19632
g3
VSTD-Westphal-1995
p19633
sg5
S'PMC2486792'
p19634
sg7
g19586
sg9
V7554017.xml
p19635
sa(dp19636
g3
VSTD-Worrall-1999
p19637
sg5
S'PMC1232647'
p19638
sg7
g19586
sg9
V10420862.xml
p19639
sa(dp19640
g3
VSTD-Morrison-2001
p19641
sg5
S'PMC31924'
p19642
sg7
g19586
sg9
V11375232.xml
p19643
sa(dp19644
g3
VSTD-Lewin-2005
p19645
sg5
S'PMC2626204'
p19646
sg7
g19586
sg9
V15868015.xml
p19647
sa(dp19648
g3
VSTD-Welschen-2004
p19649
sg5
S'PMC514206'
p19650
sg7
g19586
sg9
V15297305.xml
p19651
sa(dp19652
g3
VSTD-Kerse-1999
p19653
sg5
S'PMC28221'
p19654
sg7
g19586
sg9
V10480825.xml
p19655
sa(dp19656
g3
VSTD-Simons-2001
p19657
sg5
S'PMC1314123'
p19658
sg7
g19586
sg9
V11677701.xml
p19659
sa(dp19660
g3
VSTD-King-2002
p19661
sg5
S'PMC102328'
p19662
sg7
g19586
sg9
V11964340.xml
p19663
sa(dp19664
g3
VSTD-Garcia-2003
p19665
sg5
S'PMC2572366'
p19666
sg7
g19586
sg9
V14758407.xml
p19667
sa(dp19668
g3
VSTD-Verstappen-2004
p19669
sg5
S'PMC1466745'
p19670
sg7
g19586
sg9
V15576543.xml
p19671
sa(dp19672
g3
VSTD-Kiessling-2002
p19673
sg5
S'PMC129638'
p19674
sg7
g19586
sg9
V12386042.xml
p19675
sa(dp19676
g3
VSTD-Chappell-2008
p19677
sg5
S'PMC2840539'
p19678
sg7
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p19679
sg9
V20428412.xml
p19680
sa(dp19681
g3
VSTD-Baumslag-1970
p19682
sg5
S'PMC1700896'
p19683
sg7
VCD006896 v. 4.0 Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes.rm5
p19684
sg9
V5460838.xml
p19685
sa(dp19686
g3
VSTD-Trigg-1976
p19687
sg5
S'PMC2158056'
p19688
sg7
g19684
sg9
V1263177.xml
p19689
sa(dp19690
g3
VSTD-Chanarin-1968
p19691
sg5
S'PMC1986006'
p19692
sg7
g19684
sg9
V5648998.xml
p19693
sa(dp19694
g3
VSTD-Rae-1970
p19695
sg5
S'PMC476777'
p19696
sg7
g19684
sg9
V5476865.xml
p19697
sa(dp19698
g3
VSTD-Chanarin-1965
p19699
sg5
S'PMC2165857'
p19700
sg7
g19684
sg9
V14238675.xml
p19701
sa(dp19702
g3
VSTD-Weaver-1994
p19703
sg5
S'PMC1029705'
p19704
sg7
VCD001912 v. 12.0 Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.rm5
p19705
sg9
V8129449.xml
p19706
sa(dp19707
g3
VSTD-Chatfield-1991
p19708
sg5
S'PMC1590363'
p19709
sg7
g19705
sg9
V1996888.xml
p19710
sa(dp19711
g3
VSTD-Pfizer588
p19712
sg5
S'PMC2955947'
p19713
sg7
VCD002795 v. 8.0 Pharmacotherapy for post traumatic stress disorder (PTSD).rm5
p19714
sg9
V21407853.xml
p19715
sa(dp19716
g3
VSTD-Pfizer589
p19717
sg5
S'PMC2955947'
p19718
sg7
g19714
sg9
V21407853.xml
p19719
sa(dp19720
g3
VSTD-Gilchrist-1988
p19721
sg5
S'PMC1834849'
p19722
sg7
VCD007125 v. 3.0 Multidisciplinary rehabilitation for older people with hip fractures.rm5
p19723
sg9
V3143450.xml
p19724
sa(dp19725
g3
VSTD-Kennie-1988
p19726
sg5
S'PMC1834847'
p19727
sg7
g19723
sg9
V3143436.xml
p19728
sa(dp19729
g3
VSTD-Naglie-2002
p19730
sg5
S'PMC116636'
p19731
sg7
g19723
sg9
V12137074.xml
p19732
sa(dp19733
g3
VSTD-Rogahn-2000
p19734
sg5
S'PMC1721136'
p19735
sg7
VCD005253 v. 3.0 Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in pr.rm5
p19736
sg9
V10952698.xml
p19737
sa(dp19738
g3
VSTD-Hodges-1971
p19739
sg5
S'PMC472390'
p19740
sg7
VCD003270 v. 9.2 Azathioprine as an oral corticosteroid sparing agent for asthma.rm5
p19741
sg9
V4947381.xml
p19742
sa(dp19743
g3
VSTD-Hodges-1971a
p19744
sg5
S'PMC472390'
p19745
sg7
g19741
sg9
V4947381.xml
p19746
sa(dp19747
g3
VSTD-Schiffman-2007
p19748
sg5
S'PMC2278036'
p19749
sg7
VCD006385 v. 3.0 Arthroscopy for temporomandibular disorders.rm5
p19750
sg9
V17189464.xml
p19751
sa(dp19752
g3
VSTD-Agarwal-2004
p19753
sg5
S'PMC383371'
p19754
sg7
VCD005976 v. 9.2 Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in ch.rm5
p19755
sg9
V15070633.xml
p19756
sa(dp19757
g3
VSTD-Gordon-2005
p19758
sg5
S'PMC1449162'
p19759
sg7
VCD008194 v. 3.0 Outreach strategies for expanding health insurance coverage in children.rm5
p19760
sg9
V15671460.xml
p19761
sa(dp19762
g3
VSTD-Smithuis-2010
p19763
sg5
S'PMC2947715'
p19764
sg7
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p19765
sg9
V20832366.xml
p19766
sa(dp19767
g3
VSTD-Kolaczinski-2012
p19768
sg5
S'PMC3269419'
p19769
sg7
g19765
sg9
V22303437.xml
p19770
sa(dp19771
g3
VSTD-El_x002d_Sayed-2007
p19772
sg5
S'PMC2111052'
p19773
sg7
g19765
sg9
V18074034.xml
p19774
sa(dp19775
g3
VSTD-Ledermann-2006
p19776
sg5
S'PMC1665467'
p19777
sg7
g19765
sg9
V17105658.xml
p19778
sa(dp19779
g3
VSTD-Pukrittayakamee-2004
p19780
sg5
S'PMC375327'
p19781
sg7
g19765
sg9
V15047537.xml
p19782
sa(dp19783
g3
VSTD-Shekalaghe-2007
p19784
sg5
S'PMC1995753'
p19785
sg7
g19765
sg9
V17925871.xml
p19786
sa(dp19787
g3
VSTD-Smith-1991
p19788
sg5
S'PMC463022'
p19789
sg7
VCD006849 v. 3.0 Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.rm5
p19790
sg9
V1851339.xml
p19791
sa(dp19792
g3
VSTD-Norton-1996
p19793
sg5
S'PMC2349687'
p19794
sg7
VCD008096 v. 4.0 Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing distu.rm5
p19795
sg9
V8555849.xml
p19796
sa(dp19797
g3
VSTD-Park-1992
p19798
sg5
S'PMC1882203'
p19799
sg7
g19795
sg9
V1628013.xml
p19800
sa(dp19801
g3
VSTD-Mistiaen-2009
p19802
sg5
S'PMC2924330'
p19803
sg7
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p19804
sg9
V20687915.xml
p19805
sa(dp19806
g3
VSTD-Emslie-2007-Trial-1
p19807
sg5
S'PMC3268850'
p19808
sg7
VCD004851 v. 11.2 Newer generation antidepressants for depressive disorders in children and adolescents.rm5
p19809
sg9
V22155653.xml
p19810
sa(dp19811
g3
VSTD-Emslie-2007-Trial-2
p19812
sg5
S'PMC3268850'
p19813
sg7
g19809
sg9
V22155653.xml
p19814
sa(dp19815
g3
VSTD-Sorensen-work_x002b_family
p19816
sg5
S'PMC1508509'
p19817
sg7
VCD002128 v. 7.0 Dietary advice for reducing cardiovascular risk.rm5
p19818
sg9
V9987465.xml
p19819
sa(dp19820
g3
VSTD-ENCORE
p19821
sg5
S'PMC3633078'
p19822
sg7
g19818
sg9
V20101007.xml
p19823
sa(dp19824
g3
VSTD-Sorensen-worksite
p19825
sg5
S'PMC1508509'
p19826
sg7
g19818
sg9
V9987465.xml
p19827
sa(dp19828
g3
VSTD-Little--2004
p19829
sg5
S'PMC403849'
p19830
sg7
g19818
sg9
V15082472.xml
p19831
sa(dp19832
g3
VSTD-Havas-1998
p19833
sg5
S'PMC1508288'
p19834
sg7
g19818
sg9
V9702141.xml
p19835
sa(dp19836
g3
VSTD-Neil-dietitian1995
p19837
sg5
S'PMC2548942'
p19838
sg7
g19818
sg9
V7888933.xml
p19839
sa(dp19840
g3
VSTD-Neil-nurse-1995
p19841
sg5
S'PMC2548942'
p19842
sg7
g19818
sg9
V7888933.xml
p19843
sa(dp19844
g3
VSTD-Beresford-1997
p19845
sg5
S'PMC1380841'
p19846
sg7
g19818
sg9
V9146440.xml
p19847
sa(dp19848
g3
VSTD-Baron-men-1990
p19849
sg5
S'PMC1371239'
p19850
sg7
g19818
sg9
V2115348.xml
p19851
sa(dp19852
g3
VSTD-Baron-women-1990
p19853
sg5
S'PMC1371239'
p19854
sg7
g19818
sg9
V2115348.xml
p19855
sa(dp19856
g3
VSTD-PITCH-2012
p19857
sg5
S'PMC3420230'
p19858
sg7
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p19859
sg9
V22695903.xml
p19860
sa(dp19861
g3
VSTD-Fenster-1966
p19862
sg5
S'PMC1238286'
p19863
sg7
VCD003045 v. 8.0 Anabolic-androgenic steroids for alcoholic liver disease.rm5
p19864
sg9
V695564.xml
p19865
sa(dp19866
g3
VSTD-Campieri-1991b
p19867
sg5
S'PMC1378964'
p19868
sg7
VCD004115 v. 4.2 Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p19869
sg9
V1885075.xml
p19870
sa(dp19871
g3
VSTD-Palmer-1981
p19872
sg5
S'PMC1505556'
p19873
sg7
g19869
sg9
V6113021.xml
p19874
sa(dp19875
g3
VSTD-Powell_x002d_Tuck-1986
p19876
sg5
S'PMC1339576'
p19877
sg7
g19869
sg9
V3081188.xml
p19878
sa(dp19879
g3
VSTD-Lee-1996
p19880
sg5
S'PMC1383028'
p19881
sg7
g19869
sg9
V8801202.xml
p19882
sa(dp19883
g3
VSTD-CLOTS-2009
p19884
sg5
S'PMC2692021'
p19885
sg7
VCD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
p19886
sg9
V19477503.xml
p19887
sa(dp19888
g3
VSTD-Louie-2005
p19889
sg5
S'PMC3211537'
p19890
sg7
VCD002837 v. 10.0 Enteral versus parenteral nutrition for acute pancreatitis.rm5
p19891
sg9
V16149365.xml
p19892
sa(dp19893
g3
VSTD-Brown-2009
p19894
sg5
S'PMC2727938'
p19895
sg7
VCD007506 v. 6.0 Lifestyle changes in women with polycystic ovary syndrome.rm5
p19896
sg9
V19204602.xml
p19897
sa(dp19898
g3
VSTD-Hoeger-2008
p19899
sg5
S'PMC2582568'
p19900
sg7
g19896
sg9
V18728175.xml
p19901
sa(dp19902
g3
VSTD-PRoFESS-2008
p19903
sg5
S'PMC2714259'
p19904
sg7
VCD005449 v. 3.0 Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in typ.rm5
p19905
sg9
V18753638.xml
p19906
sa(dp19907
g3
VSTD-Huang-2005
p19908
sg5
S'PMC1357702'
p19909
sg7
VCD006745 v. 4.2 Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcino.rm5
p19910
sg9
V15973099.xml
p19911
sa(dp19912
g3
VSTD-Lin-2005
p19913
sg5
S'PMC1774888'
p19914
sg7
g19910
sg9
V16009687.xml
p19915
sa(dp19916
g3
VSTD-Harland-1999
p19917
sg5
S'PMC314213'
p19918
sg7
VCD003180 v. 8.0 Interventions for promoting physical activity.rm5
p19919
sg9
V10496829.xml
p19920
sa(dp19921
g3
VSTD-Stevens-1998
p19922
sg5
S'PMC1756094'
p19923
sg7
g19919
sg9
V9773174.xml
p19924
sa(dp19925
g3
VSTD-Reid-1979
p19926
sg5
S'PMC1618997'
p19927
sg7
g19919
sg9
V443500.xml
p19928
sa(dp19929
g3
VSTD-Stewart-2001
p19930
sg5
S'PMC1780022'
p19931
sg7
g19919
sg9
V11487597.xml
p19932
sa(dp19933
g3
VSTD-Lamb-2002
p19934
sg5
S'PMC1732126'
p19935
sg7
g19919
sg9
V11896130.xml
p19936
sa(dp19937
g3
VSTD-Smith-2000
p19938
sg5
S'PMC1724212'
p19939
sg7
g19919
sg9
V10953898.xml
p19940
sa(dp19941
g3
VSTD-Elley-2003
p19942
sg5
S'PMC153098'
p19943
sg7
g19919
sg9
V12689976.xml
p19944
sa(dp19945
g3
VSTD-Shortland-1998
p19946
sg5
S'PMC1720799'
p19947
sg7
VCD000950 v. 6.0 Carnitine supplementation of parenterally fed neonates.rm5
p19948
sg9
V9713029.xml
p19949
sa(dp19950
g3
VSTD-Mok-2007
p19951
sg5
S'PMC2656338'
p19952
sg7
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p19953
sg9
V19300631.xml
p19954
sa(dp19955
g3
VSTD-Baker-2006
p19956
sg5
S'PMC1730866'
p19957
sg7
VCD003300 v. 7.0 Graduated driver licensing for reducing motor vehicle crashes among young drivers.rm5
p19958
sg9
V12226120.xml
p19959
sa(dp19960
g3
VSTD-Strunk-2008
p19961
sg5
S'PMC2647106'
p19962
sg7
VCD004249 v. 9.0 Manipulation or Mobilisation for Neck Pain.rm5
p19963
sg9
V19674713.xml
p19964
sa(dp19965
g3
VSTD-Howe-1983
p19966
sg5
S'PMC1973006'
p19967
sg7
g19963
sg9
V6355460.xml
p19968
sa(dp19969
g3
VSTD-Krauss-2008
p19970
sg5
S'PMC2565124'
p19971
sg7
g19963
sg9
V19119394.xml
p19972
sa(dp19973
g3
VSTD-Hurwitz-2002
p19974
sg5
S'PMC1447299'
p19975
sg7
g19963
sg9
V12356613.xml
p19976
sa(dp19977
g3
VSTD-Wade-1997
p19978
sg5
S'PMC486856'
p19979
sg7
VCD004170 v. 9.12 Multi-disciplinary rehabilitation for acquired brain injury in adults of working age.rm5
p19980
sg9
V9153604.xml
p19981
sa(dp19982
g3
VSTD-Smith-1981
p19983
sg5
S'PMC1504295'
p19984
sg7
g19980
sg9
V6780105.xml
p19985
sa(dp19986
g3
VSTD-Wade-1998
p19987
sg5
S'PMC2170203'
p19988
sg7
g19980
sg9
V9703167.xml
p19989
sa(dp19990
g3
VSTD-Powell-2002
p19991
sg5
S'PMC1737759'
p19992
sg7
g19980
sg9
V11796769.xml
p19993
sa(dp19994
g3
VSTD-Carlini-2012
p19995
sg5
S'PMC3438078'
p19996
sg7
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p19997
sg9
V22768793.xml
p19998
sa(dp19999
g3
VSTD-McClure-2009
p20000
sg5
S'PMC2889910'
p20001
sg7
g19997
sg9
V19524389.xml
p20002
sa(dp20003
g3
VSTD-Hennrikus-2002
p20004
sg5
S'PMC1447056'
p20005
sg7
g19997
sg9
V11818305.xml
p20006
sa(dp20007
g3
VSTD-McClure-2006
p20008
sg5
S'PMC2018826'
p20009
sg7
g19997
sg9
V16954124.xml
p20010
sa(dp20011
g3
VSTD-Lung-Health-Study
p20012
sg5
S'PMC1615316'
p20013
sg7
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p20014
sg9
V7856782.xml
p20015
sa(dp20016
g3
VSTD-Cooney-2007
p20017
sg5
S'PMC2702144'
p20018
sg7
g20014
sg9
V18072840.xml
p20019
sa(dp20020
g3
VSTD-Binnie-2007
p20021
sg5
S'PMC1871574'
p20022
sg7
g20014
sg9
V17475005.xml
p20023
sa(dp20024
g3
VSTD-Wewers-2009
p20025
sg5
S'PMC2791896'
p20026
sg7
g20014
sg9
V19959695.xml
p20027
sa(dp20028
g3
VSTD-Rodriguez-2003
p20029
sg5
S'PMC1740534'
p20030
sg7
g20014
sg9
V12709522.xml
p20031
sa(dp20032
g3
VSTD-Hollis-2007
p20033
sg5
S'PMC2598511'
p20034
sg7
g20014
sg9
V18048633.xml
p20035
sa(dp20036
g3
VSTD-Schauffler-2001
p20037
sg5
S'PMC1747566'
p20038
sg7
g20014
sg9
V11387540.xml
p20039
sa(dp20040
g3
VSTD-Brandstein-2011
p20041
sg5
S'PMC3453521'
p20042
sg7
g20014
sg9
V22853197.xml
p20043
sa(dp20044
g3
VSTD-Molyneux-2003
p20045
sg5
S'PMC1746718'
p20046
sg7
g20014
sg9
V12775857.xml
p20047
sa(dp20048
g3
VSTD-Hall-2006
p20049
sg5
S'PMC1586139'
p20050
sg7
g20014
sg9
V17008577.xml
p20051
sa(dp20052
g3
VSTD-_x00c5_gren-2011
p20053
sg5
S'PMC3233272'
p20054
sg7
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p20055
sg9
V22066891.xml
p20056
sa(dp20057
g3
VSTD-Bennell-2010
p20058
sg5
S'PMC2830179'
p20059
sg7
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p20060
sg9
V20163739.xml
p20061
sa(dp20062
g3
VSTD-Stevens-2002
p20063
sg5
S'PMC3733520'
p20064
sg7
VCD007177 v. 3.0 Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee re.rm5
p20065
sg9
V23930227.xml
p20066
sa(dp20067
g3
VSTD-Morgan-2010
p20068
sg5
S'PMC3639680'
p20069
sg7
VCD003188 v. 15.3 Bisphosphonates in multiple myeloma a network meta-analysis.rm5
p20070
sg9
V21131037.xml
p20071
sa(dp20072
g3
VSTD-Ogilvie-2004
p20073
sg5
S'PMC1747869'
p20074
sg7
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p20075
sg9
V15175527.xml
p20076
sa(dp20077
g3
VSTD-Jepson-2010
p20078
sg5
S'PMC2944371'
p20079
sg7
g20075
sg9
V20825660.xml
p20080
sa(dp20081
g3
VSTD-Bambra-2010
p20082
sg5
S'PMC2921286'
p20083
sg7
g20075
sg9
V19692738.xml
p20084
sa(dp20085
g3
VSTD-Darmstadt-2009
p20086
sg5
S'PMC2679412'
p20087
sg7
g20075
sg9
V19426469.xml
p20088
sa(dp20089
g3
VSTD-Main-2008
p20090
sg5
S'PMC2412872'
p20091
sg7
g20075
sg9
V18505545.xml
p20092
sa(dp20093
g3
VSTD-Yakoob-2009
p20094
sg5
S'PMC2679409'
p20095
sg7
g20075
sg9
V19426466.xml
p20096
sa(dp20097
g3
VSTD-Menezes-2009
p20098
sg5
S'PMC2679410'
p20099
sg7
g20075
sg9
V19426467.xml
p20100
sa(dp20101
g3
VSTD-Haws-2009
p20102
sg5
S'PMC2679411'
p20103
sg7
g20075
sg9
V19426468.xml
p20104
sa(dp20105
g3
VSTD-Shea-2009
p20106
sg5
S'PMC3226237'
p20107
sg7
g20075
sg9
V19828063.xml
p20108
sa(dp20109
g3
VSTD-Bhutta-2009
p20110
sg5
S'PMC2679413'
p20111
sg7
g20075
sg9
V19426470.xml
p20112
sa(dp20113
g3
VSTD-Barros-2010
p20114
sg5
S'PMC2841444'
p20115
sg7
g20075
sg9
V20233384.xml
p20116
sa(dp20117
g3
VSTD-Lepore-_x0028_PE_x0029_-2003
p20118
sg5
S'PMC2593114'
p20119
sg7
VCD007569 v. 4.0 Interventions to enhance return-to-work for cancer patients.rm5
p20120
sg9
V14570527.xml
p20121
sa(dp20122
g3
VSTD-Lepore-_x0028_PE_x002b_discus_x0029_-2003
p20123
sg5
S'PMC2593114'
p20124
sg7
g20120
sg9
V14570527.xml
p20125
sa(dp20126
g3
VSTD-Kornblith-2009
p20127
sg5
S'PMC2773220'
p20128
sg7
g20120
sg9
V19805678.xml
p20129
sa(dp20130
g3
VSTD-Hollis-2007
p20131
sg5
S'PMC2598511'
p20132
sg7
VCD006936 v. 5.0 Motivational interviewing for smoking cessation.rm5
p20133
sg9
V18048633.xml
p20134
sa(dp20135
g3
VSTD-Soria-2006
p20136
sg5
S'PMC1920717'
p20137
sg7
g20133
sg9
V17007707.xml
p20138
sa(dp20139
g3
VSTD-Glasgow-2000
p20140
sg5
S'PMC1446229'
p20141
sg7
g20133
sg9
V10800431.xml
p20142
sa(dp20143
g3
VSTD-Nimmo-1979
p20144
sg5
S'PMC1597257'
p20145
sg7
VCD006332 v. 8.0 Mu-opioid antagonists for opioid-induced bowel dysfunction.rm5
p20146
sg9
V519357.xml
p20147
sa(dp20148
g3
VSTD-Wolff-2004
p20149
sg5
S'PMC1356474'
p20150
sg7
g20146
sg9
V15383800.xml
p20151
sa(dp20152
g3
VSTD-Collins-2008a
p20153
sg5
S'PMC2572211'
p20154
sg7
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p20155
sg9
V18952682.xml
p20156
sa(dp20157
g3
VSTD-Ballard-2007
p20158
sg5
S'PMC2556913'
p20159
sg7
VCD003531 v. 6.0 Pressure modification for improving usage of continuous positive airway pressure machines in adults .rm5
p20160
sg9
V18198804.xml
p20161
sa(dp20162
g3
VSTD-West-2006
p20163
sg5
S'PMC2080742'
p20164
sg7
g20160
sg9
V16254055.xml
p20165
sa(dp20166
g3
VSTD-Yeka-2007-UGA
p20167
sg5
S'PMC2405936'
p20168
sg7
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p20169
sg9
V18545692.xml
p20170
sa(dp20171
g3
VSTD-Adjei-2006-GHA
p20172
sg5
S'PMC2478668'
p20173
sg7
g20169
sg9
V18620577.xml
p20174
sa(dp20175
g3
VSTD-Van-den-Broek-2004-ZAR
p20176
sg5
S'PMC1697822'
p20177
sg7
g20169
sg9
V17125496.xml
p20178
sa(dp20179
g3
VSTD-Hasugian-2005-IDN
p20180
sg5
S'PMC2532501'
p20181
sg7
g20169
sg9
V17366451.xml
p20182
sa(dp20183
g3
VSTD-Yeka-2004-UGA
p20184
sg5
S'PMC1181876'
p20185
sg7
g20169
sg9
V16033307.xml
p20186
sa(dp20187
g3
VSTD-Faye-2003-SEN
p20188
sg5
S'PMC1919387'
p20189
sg7
g20169
sg9
V17570848.xml
p20190
sa(dp20191
g3
VSTD-Grande-2005-PER
p20192
sg5
S'PMC2040506'
p20193
sg7
g20169
sg9
V17971864.xml
p20194
sa(dp20195
g3
VSTD-Mukhtar-2005-SDN
p20196
sg5
S'PMC1940006'
p20197
sg7
g20169
sg9
V17631681.xml
p20198
sa(dp20199
g3
VSTD-Kobbe-2007-GHA
p20200
sg5
S'PMC2625364'
p20201
sg7
g20169
sg9
V19099594.xml
p20202
sa(dp20203
g3
VSTD-Kamya-2006-UGA
p20204
sg5
S'PMC1876597'
p20205
sg7
g20169
sg9
V17525792.xml
p20206
sa(dp20207
g3
VSTD-Mens-2007-KEN
p20208
sg5
S'PMC2600646'
p20209
sg7
g20169
sg9
V19017387.xml
p20210
sa(dp20211
g3
VSTD-Ratcliff-2005-IDN
p20212
sg5
S'PMC2532500'
p20213
sg7
g20169
sg9
V17336652.xml
p20214
sa(dp20215
g3
VSTD-Bonnet-2004-GIN
p20216
sg5
S'PMC1868032'
p20217
sg7
g20169
sg9
V17477865.xml
p20218
sa(dp20219
g3
VSTD-Bukirwa-2005-UGA
p20220
sg5
S'PMC1488893'
p20221
sg7
g20169
sg9
V16871329.xml
p20222
sa(dp20223
g3
VSTD-Hutagalung-2002-THA
p20224
sg5
S'PMC1261533'
p20225
sg7
g20169
sg9
V16179089.xml
p20226
sa(dp20227
g3
VSTD-Menard-2006-MDG
p20228
sg5
S'PMC1887535'
p20229
sg7
g20169
sg9
V17519010.xml
p20230
sa(dp20231
g3
VSTD-Owusu_x002d_Agyei-2006-GHA
p20232
sg5
S'PMC2430614'
p20233
sg7
g20169
sg9
V18575626.xml
p20234
sa(dp20235
g3
VSTD-Kayentao-2006-MLI
p20236
sg5
S'PMC2631542'
p20237
sg7
g20169
sg9
V19128455.xml
p20238
sa(dp20239
g3
VSTD-Fang-1995
p20240
sg5
S'PMC3487803'
p20241
sg7
VCD004921 v. 5.0 Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.rm5
p20242
sg9
V22937790.xml
p20243
sa(dp20244
g3
VSTD-Patte-2007
p20245
sg5
S'PMC1852229'
p20246
sg7
VCD005198 v. 8.7 Therapeutic interventions for Burkitt lymphoma in children.rm5
p20247
sg9
V17132719.xml
p20248
sa(dp20249
g3
VSTD-Magrath-1976
p20250
sg5
S'PMC1639074'
p20251
sg7
g20247
sg9
V766905.xml
p20252
sa(dp20253
g3
VSTD-Ziegler-1971
p20254
sg5
S'PMC1800463'
p20255
sg7
g20247
sg9
V5109411.xml
p20256
sa(dp20257
g3
VSTD-Candy-1995
p20258
sg5
S'PMC1382873'
p20259
sg7
VCD000067 v. 7.0 Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.rm5
p20260
sg9
V8549944.xml
p20261
sa(dp20262
g3
VSTD-Sangdee-2002-_x002a_
p20263
sg5
S'PMC102323'
p20264
sg7
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p20265
sg9
V11914160.xml
p20266
sa(dp20267
g3
VSTD-Vas-2004
p20268
sg5
S'PMC529365'
p20269
sg7
g20265
sg9
V15494348.xml
p20270
sa(dp20271
g3
VSTD-Foster-2007
p20272
sg5
S'PMC1962890'
p20273
sg7
g20265
sg9
V17699546.xml
p20274
sa(dp20275
g3
VSTD-Sangdee-2002-_x002a__x002a_
p20276
sg5
S'PMC102323'
p20277
sg7
g20265
sg9
V11914160.xml
p20278
sa(dp20279
g3
VSTD-Silverberg-1976
p20280
sg5
S'PMC1878979'
p20281
sg7
VCD004293 v. 6.0 Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.rm5
p20282
sg9
V793706.xml
p20283
sa(dp20284
g3
VSTD-Schapel-1993
p20285
sg5
S'PMC1014998'
p20286
sg7
VCD001909 v. 12.0 Lamotrigine add-on for drug-resistant partial epilepsy.rm5
p20287
sg9
V8505632.xml
p20288
sa(dp20289
g3
VSTD-Albers-2005
p20290
sg5
S'PMC1357063'
p20291
sg7
VCD005947 v. 5.0 Glutamine supplementation for young infants with severe gastrointestinal disease.rm5
p20292
sg9
V15798461.xml
p20293
sa(dp20294
g3
VSTD-SST-2004-Group-N
p20295
sg5
S'PMC1256024'
p20296
sg7
VCD006931 v. 3.0 Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration.rm5
p20297
sg9
V15522362.xml
p20298
sa(dp20299
g3
VSTD-SST-2004-Group-B
p20300
sg5
S'PMC1256022'
p20301
sg7
g20297
sg9
V15522364.xml
p20302
sa(dp20303
g3
VSTD-Bates-1978
p20304
sg5
S'PMC1608620'
p20305
sg7
VCD004192 v. 8.0 Dietary interventions for multiple sclerosis.rm5
p20306
sg9
V363236.xml
p20307
sa(dp20308
g3
VSTD-Bates-1977
p20309
sg5
S'PMC1631630'
p20310
sg7
g20306
sg9
V334337.xml
p20311
sa(dp20312
g3
VSTD-Bates-1989
p20313
sg5
S'PMC1032650'
p20314
sg7
g20306
sg9
V2540285.xml
p20315
sa(dp20316
g3
VSTD-Millar-1973
p20317
sg5
S'PMC1588925'
p20318
sg7
g20306
sg9
V4571680.xml
p20319
sa(dp20320
g3
VSTD-Shen-2004
p20321
sg5
S'PMC397380'
p20322
sg7
VCD009594 v. 3.0 The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.rm5
p20323
sg9
V15044693.xml
p20324
sa(dp20325
g3
VSTD-Powell-2010
p20326
sg5
S'PMC2981533'
p20327
sg7
g20323
sg9
V20705755.xml
p20328
sa(dp20329
g3
VSTD-OPUS_x002d_Scandinavia
p20330
sg5
S'PMC1215551'
p20331
sg7
VCD004718 v. 7.0 Early intervention for psychosis.rm5
p20332
sg9
V16141449.xml
p20333
sa(dp20334
g3
VSTD-Alam-1993
p20335
sg5
S'PMC489825'
p20336
sg7
VCD006921 v. 4.0 Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.rm5
p20337
sg9
V8229035.xml
p20338
sa(dp20339
g3
VSTD-Dyer-2008
p20340
sg5
S'PMC2596972'
p20341
sg7
VCD007967 v. 3.0 Acetylcholinesterase inhibitors for schizophrenia.rm5
p20342
sg9
V18325740.xml
p20343
sa(dp20344
g3
VSTD-Smith-1978
p20345
sg5
S'PMC1412084'
p20346
sg7
VCD000301 v. 7.0 Corticosteroids for maintenance of remission in Crohn's disease.rm5
p20347
sg9
V355071.xml
p20348
sa(dp20349
g3
VSTD-Durbin-1976
p20350
sg5
S'PMC1545933'
p20351
sg7
VCD002271 v. 5.0 Continuous distending pressure for respiratory distress in preterm infants.rm5
p20352
sg9
V782375.xml
p20353
sa(dp20354
g3
VSTD-Assadi-2003
p20355
sg5
S'PMC293465'
p20356
sg7
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p20357
sg9
V14624703.xml
p20358
sa(dp20359
g3
VSTD-Jorge-2010
p20360
sg5
S'PMC3718472'
p20361
sg7
VCD008391 v. 2.0 Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult non-progress.rm5
p20362
sg9
V20124118.xml
p20363
sa(dp20364
g3
VSTD-Check-1998
p20365
sg5
S'PMC3454856'
p20366
sg7
VCD004832 v. 7.2 Aspirin for in vitro fertilisation.rm5
p20367
sg9
V9866064.xml
p20368
sa(dp20369
g3
VSTD-Urman-2000
p20370
sg5
S'PMC3455451'
p20371
sg7
g20367
sg9
V11209540.xml
p20372
sa(dp20373
g3
VSTD-Duvan-2006
p20374
sg5
S'PMC3455434'
p20375
sg7
g20367
sg9
V16518579.xml
p20376
sa(dp20377
g3
VSTD-Jenkins-1997
p20378
sg5
S'PMC1891518'
p20379
sg7
VCD002233 v. 5.2 Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patien.rm5
p20380
sg9
V9391254.xml
p20381
sa(dp20382
g3
VSTD-Moylan-1988
p20383
sg5
S'PMC1493556'
p20384
sg7
VCD009228 v. 2.4 Helicopter emergency medical services for adults with major trauma.rm5
p20385
sg9
V3389935.xml
p20386
sa(dp20387
g3
VSTD-Mitchell-2007
p20388
sg5
S'PMC2384270'
p20389
sg7
g20385
sg9
V17550717.xml
p20390
sa(dp20391
g3
VSTD-Newgard-2010
p20392
sg5
S'PMC3008652'
p20393
sg7
g20385
sg9
V19783323.xml
p20394
sa(dp20395
g3
VSTD-Nicholl-1995
p20396
sg5
S'PMC2550277'
p20397
sg7
g20385
sg9
V7627033.xml
p20398
sa(dp20399
g3
VSTD-Palumbo-2010
p20400
sg5
S'PMC3021781'
p20401
sg7
VCD004772 v. 5.0 Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.rm5
p20402
sg9
V20942667.xml
p20403
sa(dp20404
g3
VSTD-Violari-2008
p20405
sg5
S'PMC2950021'
p20406
sg7
g20402
sg9
V19020325.xml
p20407
sa(dp20408
g3
VSTD-Cluett-2004
p20409
sg5
S'PMC338094'
p20410
sg7
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p20411
sg9
V14744822.xml
p20412
sa(dp20413
g3
VSTD-Nachum-2010
p20414
sg5
S'PMC2988803'
p20415
sg7
g20411
sg9
V21054896.xml
p20416
sa(dp20417
g3
VSTD-Li-1998a
p20418
sg5
S'PMC2305576'
p20419
sg7
VCD004614 v. 6.0 Unit-dose packaged drugs for treating malaria.rm5
p20420
sg9
V9763719.xml
p20421
sa(dp20422
g3
VSTD-Yeboah_x002d_Antwi-2001
p20423
sg5
S'PMC2566421'
p20424
sg7
g20420
sg9
V11417034.xml
p20425
sa(dp20426
g3
VSTD-Li-1998b
p20427
sg5
S'PMC2305576'
p20428
sg7
g20420
sg9
V9763719.xml
p20429
sa(dp20430
g3
VSTD-Glasgow-1984
p20431
sg5
S'PMC1443311'
p20432
sg7
VCD001451 v. 8.2 Routine ultrasound in late pregnancy (after 24 weeks' gestation).rm5
p20433
sg9
V6437476.xml
p20434
sa(dp20435
g3
VSTD-Peterborough-1987
p20436
sg5
S'PMC1246821'
p20437
sg7
g20433
sg9
V3113566.xml
p20438
sa(dp20439
g3
VSTD-ES-Barcelona
p20440
sg5
S'PMC1963295'
p20441
sg7
VCD004607 v. 10.0 Speed cameras for the prevention of road traffic injuries and deaths.rm5
p20442
sg9
V17666698.xml
p20443
sa(dp20444
g3
VSTD-GB-South-Wales
p20445
sg5
S'PMC1731028'
p20446
sg7
g20442
sg9
V14693888.xml
p20447
sa(dp20448
g3
VSTD-Arun-2008
p20449
sg5
S'PMC2772000'
p20450
sg7
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p20451
sg9
V19902034.xml
p20452
sa(dp20453
g3
VSTD-Zwarenstein-2007
p20454
sg5
S'PMC2200659'
p20455
sg7
g20451
sg9
V17892588.xml
p20456
sa(dp20457
g3
VSTD-Haworth-2001
p20458
sg5
S'PMC1746027'
p20459
sg7
VCD002010 v. 12.0 Bisphosphonates for osteoporosis in people with cystic fibrosis.rm5
p20460
sg9
V11254825.xml
p20461
sa(dp20462
g3
VSTD-Boyle-2005
p20463
sg5
S'PMC2718468'
p20464
sg7
g20460
sg9
V15860755.xml
p20465
sa(dp20466
g3
VSTD-Coskun-1998
p20467
sg5
S'PMC3454860'
p20468
sg7
VCD009391 v. 2.0 Brief co-incubation of sperm and oocytes for in vitro fertilization techniques.rm5
p20469
sg9
V9866069.xml
p20470
sa(dp20471
g3
VSTD-Lin-2000
p20472
sg5
S'PMC3455400'
p20473
sg7
g20469
sg9
V11042832.xml
p20474
sa(dp20475
g3
VSTD-Boone-2001
p20476
sg5
S'PMC3455812'
p20477
sg7
g20469
sg9
V11292990.xml
p20478
sa(dp20479
g3
VSTD-Sharieff-2006a
p20480
sg5
S'PMC2082848'
p20481
sg7
VCD008959 v. 3.5 Home fortification of foods with multiple micronutrient powders for health and nutrition in children.rm5
p20482
sg9
V16556612.xml
p20483
sa(dp20484
g3
VSTD-Straker-1966
p20485
sg5
S'PMC1935503'
p20486
sg7
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p20487
sg9
V5328359.xml
p20488
sa(dp20489
g3
VSTD-Edwards-1996
p20490
sg5
S'PMC2042690'
p20491
sg7
g20487
sg9
V8904622.xml
p20492
sa(dp20493
g3
VSTD-Feighner-1983
p20494
sg5
S'PMC1427892'
p20495
sg7
g20487
sg9
V6337610.xml
p20496
sa(dp20497
g3
VSTD-Upward-1988
p20498
sg5
S'PMC1386560'
p20499
sg7
g20487
sg9
V3263876.xml
p20500
sa(dp20501
g3
VSTD-Grof-1977
p20502
sg5
S'PMC1429109'
p20503
sg7
g20487
sg9
V334227.xml
p20504
sa(dp20505
g3
VSTD-Quadri-1980
p20506
sg5
S'PMC3013310'
p20507
sg7
g20487
sg9
V22058460.xml
p20508
sa(dp20509
g3
VSTD-Burton-1978
p20510
sg5
S'PMC1608325'
p20511
sg7
VCD002292 v. 10.0 Interventions for bullous pemphigoid.rm5
p20512
sg9
V363229.xml
p20513
sa(dp20514
g3
VSTD-Avril-1997
p20515
sg5
S'PMC2223779'
p20516
sg7
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p20517
sg9
V9218740.xml
p20518
sa(dp20519
g3
VSTD-Jolley-1990
p20520
sg5
S'PMC1663999'
p20521
sg7
VCD000307 v. 8.0 Depot fluphenazine decanoate and enanthate for schizophrenia.rm5
p20522
sg9
V2282421.xml
p20523
sa(dp20524
g3
VSTD-Marson-2007
p20525
sg5
S'PMC2080688'
p20526
sg7
VCD006453 v. 4.0 Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.rm5
p20527
sg9
V17382827.xml
p20528
sa(dp20529
g3
VSTD-Nafisi-2006
p20530
sg5
S'PMC1764008'
p20531
sg7
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p20532
sg9
V17176461.xml
p20533
sa(dp20534
g3
VSTD-Benenson-1968a
p20535
sg5
S'PMC2554479'
p20536
sg7
VCD000974 v. 14.1 Vaccines for preventing cholera killed whole cell or other subunit vaccines (injected).rm5
p20537
sg9
V5302328.xml
p20538
sa(dp20539
g3
VSTD-Saroso-1978i
p20540
sg5
S'PMC2395651'
p20541
sg7
g20537
sg9
V365388.xml
p20542
sa(dp20543
g3
VSTD-PCC-1968
p20544
sg5
S'PMC2554519'
p20545
sg7
g20537
sg9
V5303665.xml
p20546
sa(dp20547
g3
VSTD-PCC-1973b
p20548
sg5
S'PMC2480948'
p20549
sg7
g20537
sg9
V4603994.xml
p20550
sa(dp20551
g3
VSTD-PCC-1973a_x002d_i
p20552
sg5
S'PMC2481072'
p20553
sg7
g20537
sg9
V4596491.xml
p20554
sa(dp20555
g3
VSTD-das-Gupta-1965b_x002d_i
p20556
sg5
S'PMC2554277'
p20557
sg7
g20537
sg9
V5301381.xml
p20558
sa(dp20559
g3
VSTD-Pal-1980
p20560
sg5
S'PMC2395994'
p20561
sg7
g20537
sg9
V7028299.xml
p20562
sa(dp20563
g3
VSTD-das-Gupta-1965a
p20564
sg5
S'PMC2554277'
p20565
sg7
g20537
sg9
V5301381.xml
p20566
sa(dp20567
g3
VSTD-Benenson-1968b_x002d_i
p20568
sg5
S'PMC2554494'
p20569
sg7
g20537
sg9
V5302329.xml
p20570
sa(dp20571
g3
VSTD-Burgasov-1976
p20572
sg5
S'PMC2366434'
p20573
sg7
g20537
sg9
V798636.xml
p20574
sa(dp20575
g3
VSTD-McCormack-1969
p20576
sg5
S'PMC2554602'
p20577
sg7
g20537
sg9
V5306540.xml
p20578
sa(dp20579
g3
VSTD-Azurin-1965i
p20580
sg5
S'PMC2555245'
p20581
sg7
g20537
sg9
V5294176.xml
p20582
sa(dp20583
g3
VSTD-Herfarth-2006
p20584
sg5
S'PMC1856424'
p20585
sg7
VCD006873 v. 3.0 Interventions for prevention of post-operative recurrence of Crohn's disease.rm5
p20586
sg9
V16966711.xml
p20587
sa(dp20588
g3
VSTD-Marteau-2006
p20589
sg5
S'PMC1856210'
p20590
sg7
g20586
sg9
V16377775.xml
p20591
sa(dp20592
g3
VSTD-Colombel-2001
p20593
sg5
S'PMC1728363'
p20594
sg7
g20586
sg9
V11413109.xml
p20595
sa(dp20596
g3
VSTD-Prantera-2002
p20597
sg5
S'PMC1773351'
p20598
sg7
g20586
sg9
V12171964.xml
p20599
sa(dp20600
g3
VSTD-Pollock-1989
p20601
sg5
S'PMC2498915'
p20602
sg7
VCD001181 v. 5.0 Antimicrobial prophylaxis for colorectal surgery.rm5
p20603
sg9
V2523210.xml
p20604
sa(dp20605
g3
VSTD-Sauven-1986
p20606
sg5
S'PMC1290230'
p20607
sg7
g20603
sg9
V2939239.xml
p20608
sa(dp20609
g3
VSTD-Kaiser-1983
p20610
sg5
S'PMC1353198'
p20611
sg7
g20603
sg9
V6354113.xml
p20612
sa(dp20613
g3
VSTD-Schoetz-1990
p20614
sg5
S'PMC1358059'
p20615
sg7
g20603
sg9
V2100983.xml
p20616
sa(dp20617
g3
VSTD-Bates-1992
p20618
sg5
S'PMC2399526'
p20619
sg7
g20603
sg9
V1461853.xml
p20620
sa(dp20621
g3
VSTD-Becker-1991
p20622
sg5
S'PMC1358335'
p20623
sg7
g20603
sg9
V1847796.xml
p20624
sa(dp20625
g3
VSTD-Lewis-2002
p20626
sg5
S'PMC3686946'
p20627
sg7
g20603
sg9
V12067168.xml
p20628
sa(dp20629
g3
VSTD-Bergman-1987
p20630
sg5
S'PMC1492867'
p20631
sg7
g20603
sg9
V3541803.xml
p20632
sa(dp20633
g3
VSTD-Hoffmann-1981
p20634
sg5
S'PMC1345075'
p20635
sg7
g20603
sg9
V7011223.xml
p20636
sa(dp20637
g3
VSTD-Rowe_x002d_Jones-1990
p20638
sg5
S'PMC1661869'
p20639
sg7
g20603
sg9
V2105115.xml
p20640
sa(dp20641
g3
VSTD-Robinson-1988
p20642
sg5
S'PMC1779094'
p20643
sg7
VCD003424 v. 10.0 Drug therapies for reducing gastric acidity in people with cystic fibrosis.rm5
p20644
sg9
V3140739.xml
p20645
sa(dp20646
g3
VSTD-Durie-1980
p20647
sg5
S'PMC1419526'
p20648
sg7
g20644
sg9
V7429342.xml
p20649
sa(dp20650
g3
VSTD-Siani-1987
p20651
sg5
S'PMC1246609'
p20652
sg7
VCD004641 v. 10.0 Potassium supplementation for the management of primary hypertension in adults.rm5
p20653
sg9
V3300841.xml
p20654
sa(dp20655
g3
VSTD-Zehnder-2010
p20656
sg5
S'PMC2841102'
p20657
sg7
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p20658
sg9
V20181120.xml
p20659
sa(dp20660
g3
VSTD-Stice-c2008
p20661
sg5
S'PMC2553682'
p20662
sg7
g20658
sg9
V18665688.xml
p20663
sa(dp20664
g3
VSTD-Mason-2007
p20665
sg5
S'PMC2987740'
p20666
sg7
g20658
sg9
V19398279.xml
p20667
sa(dp20668
g3
VSTD-Stice-b2008
p20669
sg5
S'PMC2553682'
p20670
sg7
g20658
sg9
V18665688.xml
p20671
sa(dp20672
g3
VSTD-Stice-b2006
p20673
sg5
S'PMC2330269'
p20674
sg7
g20658
sg9
V17007812.xml
p20675
sa(dp20676
g3
VSTD-Stice-a2008
p20677
sg5
S'PMC2553682'
p20678
sg7
g20658
sg9
V18665688.xml
p20679
sa(dp20680
g3
VSTD-Barnet-2007
p20681
sg5
S'PMC1886481'
p20682
sg7
g20658
sg9
V17548850.xml
p20683
sa(dp20684
g3
VSTD-Bond-2004
p20685
sg5
S'PMC1732649'
p20686
sg7
g20658
sg9
V15547059.xml
p20687
sa(dp20688
g3
VSTD-Compas-2009
p20689
sg5
S'PMC2821830'
p20690
sg7
g20658
sg9
V19968378.xml
p20691
sa(dp20692
g3
VSTD-Stice-c2006
p20693
sg5
S'PMC2330269'
p20694
sg7
g20658
sg9
V17007812.xml
p20695
sa(dp20696
g3
VSTD-Stice-d2006
p20697
sg5
S'PMC2330269'
p20698
sg7
g20658
sg9
V17007812.xml
p20699
sa(dp20700
g3
VSTD-Stice-e2006
p20701
sg5
S'PMC2330269'
p20702
sg7
g20658
sg9
V17007812.xml
p20703
sa(dp20704
g3
VSTD-Stice-a2006
p20705
sg5
S'PMC2330269'
p20706
sg7
g20658
sg9
V17007812.xml
p20707
sa(dp20708
g3
VSTD-Garber-2009
p20709
sg5
S'PMC2737625'
p20710
sg7
g20658
sg9
V19491183.xml
p20711
sa(dp20712
g3
VSTD-Palermo-2009
p20713
sg5
S'PMC2760656'
p20714
sg7
g20658
sg9
V19695776.xml
p20715
sa(dp20716
g3
VSTD-TREC_x002d_Rio_x002d_II
p20717
sg5
S'PMC2043463'
p20718
sg7
VCD005146 v. 8.0 Haloperidol plus promethazine for psychosis-induced aggression.rm5
p20719
sg9
V17954515.xml
p20720
sa(dp20721
g3
VSTD-TREC_x002d_Rio_x002d_I
p20722
sg5
S'PMC200800'
p20723
sg7
g20719
sg9
V14512476.xml
p20724
sa(dp20725
g3
VSTD-TREC_x002d_Vellore_x002d_II
p20726
sg5
S'PMC2043469'
p20727
sg7
g20719
sg9
V17954514.xml
p20728
sa(dp20729
g3
VSTD-Wolfson-2007
p20730
sg5
S'PMC2752331'
p20731
sg7
VCD006812 v. 4.2 Adjuvant radiotherapy andor chemotherapy after surgery for uterine carcinosarcoma.rm5
p20732
sg9
V17822748.xml
p20733
sa(dp20734
g3
VSTD-Newell-1966
p20735
sg5
S'PMC2476295'
p20736
sg7
VCD002959 v. 9.0 Vaccines for women to prevent neonatal tetanus.rm5
p20737
sg9
V5338377.xml
p20738
sa(dp20739
g3
VSTD-Black-1980
p20740
sg5
S'PMC2396004'
p20741
sg7
g20737
sg9
V6971190.xml
p20742
sa(dp20743
g3
VSTD-UK-1989
p20744
sg5
S'PMC1837690'
p20745
sg7
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p20746
sg9
V2510845.xml
p20747
sa(dp20748
g3
VSTD-Nepal-2003
p20749
sg5
S'PMC151518'
p20750
sg7
g20746
sg9
V12637400.xml
p20751
sa(dp20752
g3
VSTD-Pakistan-2005
p20753
sg5
S'PMC1721853'
p20754
sg7
g20746
sg9
V15724045.xml
p20755
sa(dp20756
g3
VSTD-Ghana-2009
p20757
sg5
S'PMC2928084'
p20758
sg7
g20746
sg9
V19902797.xml
p20759
sa(dp20760
g3
VSTD-Bogden-1997
p20761
sg5
S'PMC1497081'
p20762
sg7
VCD000336 v. 7.0 Effect of outpatient pharmacists'non-dispensing roleson patient outcomes and prescribing patterns.rm5
p20763
sg9
V9100140.xml
p20764
sa(dp20765
g3
VSTD-Bond-2000
p20766
sg5
S'PMC1313673'
p20767
sg7
g20763
sg9
V10897509.xml
p20768
sa(dp20769
g3
VSTD-Barbanel-2003
p20770
sg5
S'PMC1746491'
p20771
sg7
g20763
sg9
V14514935.xml
p20772
sa(dp20773
g3
VSTD-Ilett-2000
p20774
sg5
S'PMC2014897'
p20775
sg7
g20763
sg9
V10671912.xml
p20776
sa(dp20777
g3
VSTD-Sadik-2005
p20778
sg5
S'PMC1884928'
p20779
sg7
g20763
sg9
V16042672.xml
p20780
sa(dp20781
g3
VSTD-Freemantle-2002
p20782
sg5
S'PMC1314269'
p20783
sg7
g20763
sg9
V11942445.xml
p20784
sa(dp20785
g3
VSTD-Nathanson-2005
p20786
sg5
S'PMC1357723'
p20787
sg7
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p20788
sg9
V16041208.xml
p20789
sa(dp20790
g3
VSTD-Kapoor-1996
p20791
sg5
S'PMC2443081'
p20792
sg7
g20788
sg9
V8725454.xml
p20793
sa(dp20794
g3
VSTD-Neoptolemos-1987
p20795
sg5
S'PMC1245519'
p20796
sg7
g20788
sg9
V3103731.xml
p20797
sa(dp20798
g3
VSTD-Stain-1991
p20799
sg5
S'PMC1358591'
p20800
sg7
g20788
sg9
V2039294.xml
p20801
sa(dp20802
g3
VSTD-Martins--2004
p20803
sg5
S'PMC3455614'
p20804
sg7
VCD006107 v. 4.0 Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women.rm5
p20805
sg9
V15704516.xml
p20806
sa(dp20807
g3
VSTD-Li-2005
p20808
sg5
S'PMC3455385'
p20809
sg7
g20805
sg9
V15807215.xml
p20810
sa(dp20811
g3
VSTD-Horemans-2003
p20812
sg5
S'PMC1757426'
p20813
sg7
VCD007818 v. 4.3 Treatment for postpolio syndrome.rm5
p20814
sg9
V14638885.xml
p20815
sa(dp20816
g3
VSTD-FEIG-2008
p20817
sg5
S'PMC2684336'
p20818
sg7
VCD008652 v. 2.0 Pharmacotherapy for hyperuricemia in hypertensive patients.rm5
p20819
sg9
V18728266.xml
p20820
sa(dp20821
g3
VSTD-Wynn-2007
p20822
sg5
S'PMC2716219'
p20823
sg7
VCD006626 v. 4.0 Risperidone versus other atypical antipsychotics for schizophrenia.rm5
p20824
sg9
V17662577.xml
p20825
sa(dp20826
g3
VSTD-Devanand-ADAD--2012
p20827
sg5
S'PMC3490406'
p20828
sg7
VCD007726 v. 3.0 Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symp.rm5
p20829
sg9
V23075176.xml
p20830
sa(dp20831
g3
VSTD-Devanand-2011
p20832
sg5
S'PMC3685500'
p20833
sg7
g20829
sg9
V21845596.xml
p20834
sa(dp20835
g3
VSTD-Davis-2008
p20836
sg5
S'PMC2408888'
p20837
sg7
VCD008081 v. 2.0 Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinop.rm5
p20838
sg9
V18316700.xml
p20839
sa(dp20840
g3
VSTD-Sadda-2006
p20841
sg5
S'PMC1779509'
p20842
sg7
g20838
sg9
V16647123.xml
p20843
sa(dp20844
g3
VSTD-Hee-1998
p20845
sg5
S'PMC2923575'
p20846
sg7
g20838
sg9
V9479300.xml
p20847
sa(dp20848
g3
VSTD-Meade-1990
p20849
sg5
S'PMC1663160'
p20850
sg7
VCD005427 v. 6.0 Combined chiropractic interventions for low-back pain.rm5
p20851
sg9
V2143092.xml
p20852
sa(dp20853
g3
VSTD-Gudavalli-2006
p20854
sg5
S'PMC3233943'
p20855
sg7
g20851
sg9
V16341712.xml
p20856
sa(dp20857
g3
VSTD-Br_x00f8_nfort-1989
p20858
sg5
S'PMC2841070'
p20859
sg7
g20851
sg9
V20184717.xml
p20860
sa(dp20861
g3
VSTD-Reacher-1990
p20862
sg5
S'PMC1042003'
p20863
sg7
VCD004008 v. 4.0 Interventions for trachoma trichiasis.rm5
p20864
sg9
V2178677.xml
p20865
sa(dp20866
g3
VSTD-Burton-2005
p20867
sg5
S'PMC1772881'
p20868
sg7
g20864
sg9
V16170117.xml
p20869
sa(dp20870
g3
VSTD-Nierop-1992
p20871
sg5
S'PMC463749'
p20872
sg7
VCD002985 v. 8.0 Gold as an oral corticosteroid sparing agent in stable asthma.rm5
p20873
sg9
V1609377.xml
p20874
sa(dp20875
g3
VSTD-Ward-1998
p20876
sg5
S'PMC1728578'
p20877
sg7
VCD004194 v. 7.0 Drugs and pacemakers for vasovagal carotid sinus and situational syncope.rm5
p20878
sg9
V9505918.xml
p20879
sa(dp20880
g3
VSTD-McIntosh-1997
p20881
sg5
S'PMC484800'
p20882
sg7
g20878
sg9
V9227301.xml
p20883
sa(dp20884
g3
VSTD-Biffi-1997
p20885
sg5
S'PMC484696'
p20886
sg7
g20878
sg9
V9093048.xml
p20887
sa(dp20888
g3
VSTD-Maclean-1990
p20889
sg5
S'PMC1380116'
p20890
sg7
VCD007185 v. 3.3 Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.rm5
p20891
sg9
V2183868.xml
p20892
sa(dp20893
g3
VSTD-Mulley-1978
p20894
sg5
S'PMC1607934'
p20895
sg7
VCD000064 v. 8.0 Corticosteroids for acute ischaemic stroke.rm5
p20896
sg9
V361156.xml
p20897
sa(dp20898
g3
VSTD-Norris-1986
p20899
sg5
S'PMC1338973'
p20900
sg7
g20896
sg9
V3080050.xml
p20901
sa(dp20902
g3
VSTD-Dowling-2007
p20903
sg5
S'PMC2387134'
p20904
sg7
VCD003946 v. 10.0 Light therapy for managing cognitive sleep functional behavioural or psychiatric disturbances in.rm5
p20905
sg9
V17596638.xml
p20906
sa(dp20907
g3
VSTD-Dowling-2005b
p20908
sg5
S'PMC2387133'
p20909
sg7
g20905
sg9
V16035127.xml
p20910
sa(dp20911
g3
VSTD-Dowling-2008
p20912
sg5
S'PMC2642966'
p20913
sg7
g20905
sg9
V18070004.xml
p20914
sa(dp20915
g3
VSTD-Rai-1997
p20916
sg5
S'PMC2125731'
p20917
sg7
VCD002859 v. 7.0 Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.rm5
p20918
sg9
V9022487.xml
p20919
sa(dp20920
g3
VSTD-Netley-1984
p20921
sg5
S'PMC1483635'
p20922
sg7
VCD002911 v. 6.0 Alarm interventions for nocturnal enuresis in children.rm5
p20923
sg9
V6478342.xml
p20924
sa(dp20925
g3
VSTD-McKendry-1975
p20926
sg5
S'PMC1956570'
p20927
sg7
g20923
sg9
V1192312.xml
p20928
sa(dp20929
g3
VSTD-Caceres-1982
p20930
sg5
S'PMC3443867'
p20931
sg7
g20923
sg9
V22974648.xml
p20932
sa(dp20933
g3
VSTD-Wille-1986
p20934
sg5
S'PMC1777552'
p20935
sg7
g20923
sg9
V3513716.xml
p20936
sa(dp20937
g3
VSTD-Alho-2007
p20938
sg5
S'PMC1865439'
p20939
sg7
VCD001802 v. 6.0 Tonsillectomy or adeno-tonsillectomy versus non-surgical treatment for chronicrecurrent acute tonsi.rm5
p20940
sg9
V17347187.xml
p20941
sa(dp20942
g3
VSTD-van-Staaij-2004
p20943
sg5
S'PMC517640'
p20944
sg7
g20940
sg9
V15361407.xml
p20945
sa(dp20946
g3
VSTD-Shyu-2006
p20947
sg5
S'PMC1405861'
p20948
sg7
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p20949
sg9
V16517764.xml
p20950
sa(dp20951
g3
VSTD-Yip-2011
p20952
sg5
S'PMC3221969'
p20953
sg7
g20949
sg9
V21269484.xml
p20954
sa(dp20955
g3
VSTD-Prasad-2011
p20956
sg5
S'PMC3191816'
p20957
sg7
g20949
sg9
V22007348.xml
p20958
sa(dp20959
g3
VSTD-Ehrenreich-2002
p20960
sg5
S'PMC2040012'
p20961
sg7
g20949
sg9
V12435860.xml
p20962
sa(dp20963
g3
VSTD-Matsumoto-2002
p20964
sg5
S'PMC2375187'
p20965
sg7
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p20966
sg9
V11870500.xml
p20967
sa(dp20968
g3
VSTD-Dodson_x005f_P-1989
p20969
sg5
S'PMC1835532'
p20970
sg7
VCD006763 v. 3.0 Altered dietary salt intake for preventing and treating diabetic kidney disease.rm5
p20971
sg9
V2493869.xml
p20972
sa(dp20973
g3
VSTD-Dodson_x005f_X-1989
p20974
sg5
S'PMC1835532'
p20975
sg7
g20971
sg9
V2493869.xml
p20976
sa(dp20977
g3
VSTD-MCG-2001
p20978
sg5
S'PMC2375253'
p20979
sg7
VCD003139 v. 10.0 High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional c.rm5
p20980
sg9
V11720455.xml
p20981
sa(dp20982
g3
VSTD-Gilles-2004
p20983
sg5
S'PMC2866634'
p20984
sg7
VCD002253 v. 7.0 Medical treatment for early fetal death (less than 24 weeks).rm5
p20985
sg9
V14981379.xml
p20986
sa(dp20987
g3
VSTD-Neiman-1985
p20988
sg5
S'PMC1028364'
p20989
sg7
VCD003057 v. 7.0 Hyperbaric oxygen therapy for multiple sclerosis.rm5
p20990
sg9
V3891920.xml
p20991
sa(dp20992
g3
VSTD-Wiles-1986
p20993
sg5
S'PMC1339347'
p20994
sg7
g20990
sg9
V3080173.xml
p20995
sa(dp20996
g3
VSTD-Barnes-1985
p20997
sg5
S'PMC1032548'
p20998
sg7
g20990
sg9
V3320274.xml
p20999
sa(dp21000
g3
VSTD-Barnes-1987
p21001
sg5
S'PMC1032548'
p21002
sg7
g20990
sg9
V3320274.xml
p21003
sa(dp21004
g3
VSTD-Cohen-1998
p21005
sg5
S'PMC3013499'
p21006
sg7
VCD001930 v. 8.4 Cognitive-behavioural interventions for children who have been sexually abused.rm5
p21007
sg9
V20814304.xml
p21008
sa(dp21009
g3
VSTD-Cohen-2004
p21010
sg5
S'PMC1201422'
p21011
sg7
g21007
sg9
V15187799.xml
p21012
sa(dp21013
g3
VSTD-Augustin-1976
p21014
sg5
S'PMC3647991'
p21015
sg7
VCD003120 v. 12.0 Ginkgo biloba for cognitive impairment and dementia.rm5
p21016
sg9
V23478315.xml
p21017
sa(dp21018
g3
VSTD-LOTUS-Trial-2008
p21019
sg5
S'PMC2565581'
p21020
sg7
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p21021
sg9
V18469091.xml
p21022
sa(dp21023
g3
VSTD-Keuter-1990
p21024
sg5
S'PMC1663772'
p21025
sg7
VCD004387 v. 6.0 Chlorproguanil-dapsone for treating uncomplicated malaria.rm5
p21026
sg9
V2207399.xml
p21027
sa(dp21028
g3
VSTD-Amukoye-1997
p21029
sg5
S'PMC164103'
p21030
sg7
g21026
sg9
V9333058.xml
p21031
sa(dp21032
g3
VSTD-Meyer-2003
p21033
sg5
S'PMC139934'
p21034
sg7
VCD001255 v. 14.0 Hip protectors for preventing hip fractures in older people.rm5
p21035
sg9
V12521969.xml
p21036
sa(dp21037
g3
VSTD-Cameron-2003
p21038
sg5
S'PMC1730958'
p21039
sg7
g21035
sg9
V12810740.xml
p21040
sa(dp21041
g3
VSTD-Gerotto-1999
p21042
sg5
S'PMC104248'
p21043
sg7
VCD005445 v. 6.4 Ribavirin plus interferon versus interferon for chronic hepatitis C.rm5
p21044
sg9
V10438811.xml
p21045
sa(dp21046
g3
VSTD-Khakoo-1998
p21047
sg5
S'PMC1873804'
p21048
sg7
g21044
sg9
V9862245.xml
p21049
sa(dp21050
g3
VSTD-Memmos-1981
p21051
sg5
S'PMC1505819'
p21052
sg7
VCD005633 v. 5.2 Vitamin D compounds for people with chronic kidney disease requiring dialysis.rm5
p21053
sg9
V6786673.xml
p21054
sa(dp21055
g3
VSTD-Johnson-1997
p21056
sg5
S'PMC1191122'
p21057
sg7
VCD008057 v. 3.0 Staples versus sutures for closing leg wounds after vein graft harvesting for coronary artery bypass.rm5
p21058
sg9
V9389394.xml
p21059
sa(dp21060
g3
VSTD-Angelini-1984
p21061
sg5
S'PMC459958'
p21062
sg7
g21058
sg9
V6096982.xml
p21063
sa(dp21064
g3
VSTD-Chick-1985
p21065
sg5
S'PMC1418284'
p21066
sg7
VCD005191 v. 8.0 Brief interventions for heavy alcohol users admitted to general hospital wards.rm5
p21067
sg9
V2858246.xml
p21068
sa(dp21069
g3
VSTD-Gentilello-1999
p21070
sg5
S'PMC1420896'
p21071
sg7
g21067
sg9
V10522717.xml
p21072
sa(dp21073
g3
VSTD-Cooke-2011
p21074
sg5
S'PMC3272376'
p21075
sg7
VCD008552 v. 2.0 Interventions for increasing fruit and vegetable consumption in children aged 5 years and under.rm5
p21076
sg9
V21191095.xml
p21077
sa(dp21078
g3
VSTD-Haire_x002d_Joshu-2008
p21079
sg5
S'PMC3607447'
p21080
sg7
g21076
sg9
V18486203.xml
p21081
sa(dp21082
g3
VSTD-Demark_x002d_Wahnefried-2006
p21083
sg5
S'PMC1532928'
p21084
sg7
VCD007730 v. 3.0 Multidimensional rehabilitation programmes for adult cancer survivors.rm5
p21085
sg9
V16849763.xml
p21086
sa(dp21087
g3
VSTD-Lepore-1999
p21088
sg5
S'PMC2593114'
p21089
sg7
g21085
sg9
V14570527.xml
p21090
sa(dp21091
g3
VSTD-Begley-2009
p21092
sg5
S'PMC3226589'
p21093
sg7
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p21094
sg9
V22035427.xml
p21095
sa(dp21096
g3
VSTD-Bernitz-2011
p21097
sg5
S'PMC3187863'
p21098
sg7
g21094
sg9
V21749629.xml
p21099
sa(dp21100
g3
VSTD-Klein-1984
p21101
sg5
S'PMC1440352'
p21102
sg7
g21094
sg9
V6388776.xml
p21103
sa(dp21104
g3
VSTD-Hundley-1994
p21105
sg5
S'PMC2541316'
p21106
sg7
g21094
sg9
V7819846.xml
p21107
sa(dp21108
g3
VSTD-So-1997
p21109
sg5
S'PMC1720603'
p21110
sg7
VCD002055 v. 7.4 Early volume expansion for prevention of morbidity and mortality in very preterm infants.rm5
p21111
sg9
V9059186.xml
p21112
sa(dp21113
g3
VSTD-Beverley-1985
p21114
sg5
S'PMC1777434'
p21115
sg7
g21111
sg9
V3899020.xml
p21116
sa(dp21117
g3
VSTD-Emery-1992
p21118
sg5
S'PMC1590455'
p21119
sg7
g21111
sg9
V1444555.xml
p21120
sa(dp21121
g3
VSTD-Jaeger-2001
p21122
sg5
S'PMC3634691'
p21123
sg7
VCD003229 v. 5.0 Phlebotonics for venous insufficiency.rm5
p21124
sg9
V23543784.xml
p21125
sa(dp21126
g3
VSTD-Ehsanullah-1988
p21127
sg5
S'PMC1834765'
p21128
sg7
VCD002296 v. 13.0 Prevention of NSAID-induced gastroduodenal ulcers.rm5
p21129
sg9
V3142593.xml
p21130
sa(dp21131
g3
VSTD-Melo-Gomes-1993
p21132
sg5
S'PMC1005220'
p21133
sg7
g21129
sg9
V8311540.xml
p21134
sa(dp21135
g3
VSTD-Chalton-1985
p21136
sg5
S'PMC1417153'
p21137
sg7
VCD006549 v. 3.0 Topical steroids for nasal polyps.rm5
p21138
sg9
V3929943.xml
p21139
sa(dp21140
g3
VSTD-Campbell-1982
p21141
sg5
S'PMC1308271'
p21142
sg7
VCD003466 v. 4.1 Speech and language therapy to improve the communication skills of children with cerebral palsy.rm5
p21143
sg9
V7118759.xml
p21144
sa(dp21145
g3
VSTD-Hurlbut-1982
p21146
sg5
S'PMC1308268'
p21147
sg7
g21143
sg9
V6181049.xml
p21148
sa(dp21149
g3
VSTD-Johnson-1993
p21150
sg5
S'PMC1677859'
p21151
sg7
VCD008131 v. 4.0 Home-based child development interventions for preschool children from socially disadvantaged famili.rm5
p21152
sg9
V8518642.xml
p21153
sa(dp21154
g3
VSTD-Turner-1987
p21155
sg5
S'PMC1247354'
p21156
sg7
VCD004775 v. 4.0 Mass media interventions for promoting HIV testing.rm5
p21157
sg9
V3117190.xml
p21158
sa(dp21159
g3
VSTD-Simpson-1998
p21160
sg5
S'PMC2665496'
p21161
sg7
g21157
sg9
V9472506.xml
p21162
sa(dp21163
g3
VSTD-Beck-1987
p21164
sg5
S'PMC1247040'
p21165
sg7
g21157
sg9
V3115372.xml
p21166
sa(dp21167
g3
VSTD-Amaro-2001
p21168
sg5
S'PMC1497375'
p21169
sg7
g21157
sg9
V12196620.xml
p21170
sa(dp21171
g3
VSTD-Tran-2004
p21172
sg5
S'PMC1356476'
p21173
sg7
VCD006053 v. 7.0 Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whip.rm5
p21174
sg9
V15492552.xml
p21175
sa(dp21176
g3
VSTD-Perrett-2007
p21177
sg5
S'PMC2423222'
p21178
sg7
VCD007281 v. 2.0 Interventions for cutaneous Bowen's disease.rm5
p21179
sg9
V17223873.xml
p21180
sa(dp21181
g3
VSTD-Taylor-1988
p21182
sg5
S'PMC1041529'
p21183
sg7
VCD002219 v. 13.0 Ivermectin for onchocercal eye disease (river blindness).rm5
p21184
sg9
V3046657.xml
p21185
sa(dp21186
g3
VSTD-Scalambrino-1989
p21187
sg5
S'PMC1852268'
p21188
sg7
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p21189
sg9
V12839630.xml
p21190
sa(dp21191
g3
VSTD-Chatwani-1997
p21192
sg5
S'PMC2364549'
p21193
sg7
g21189
sg9
V18476152.xml
p21194
sa(dp21195
g3
VSTD-Chatwani-1995
p21196
sg5
S'PMC2364413'
p21197
sg7
g21189
sg9
V18475417.xml
p21198
sa(dp21199
g3
VSTD-Blanco-1983
p21200
sg5
S'PMC185362'
p21201
sg7
g21189
sg9
V6360038.xml
p21202
sa(dp21203
g3
VSTD-Roy-2003
p21204
sg5
S'PMC1852268'
p21205
sg7
g21189
sg9
V12839630.xml
p21206
sa(dp21207
g3
VSTD-Knodel-1988
p21208
sg5
S'PMC172295'
p21209
sg7
g21189
sg9
V3415207.xml
p21210
sa(dp21211
g3
VSTD-Montgomery-2004
p21212
sg5
S'PMC1719807'
p21213
sg7
VCD002206 v. 9.2 Media-based behavioural treatments for behavioural problems in children.rm5
p21214
sg9
V14736626.xml
p21215
sa(dp21216
g3
VSTD-Forster-1996
p21217
sg5
S'PMC2351368'
p21218
sg7
VCD003689 v. 5.2 Interventions for preventing depression after stroke.rm5
p21219
sg9
V8664717.xml
p21220
sa(dp21221
g3
VSTD-Palomaki-1999
p21222
sg5
S'PMC1736281'
p21223
sg7
g21219
sg9
V10201422.xml
p21224
sa(dp21225
g3
VSTD-Fairbank-2005
p21226
sg5
S'PMC558090'
p21227
sg7
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p21228
sg9
V15911537.xml
p21229
sa(dp21230
g3
VSTD-van-der-Roer-2008
p21231
sg5
S'PMC2527421'
p21232
sg7
g21228
sg9
V18663487.xml
p21233
sa(dp21234
g3
VSTD-Strong-1998
p21235
sg5
S'PMC3617092'
p21236
sg7
g21228
sg9
V23537369.xml
p21237
sa(dp21238
g3
VSTD-Smeets-2006
p21239
sg5
S'PMC1382224'
p21240
sg7
g21228
sg9
V16426449.xml
p21241
sa(dp21242
g3
VSTD-Heller-1995
p21243
sg5
S'PMC1073267'
p21244
sg7
VCD002217 v. 10.0 Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-c.rm5
p21245
sg9
V7823066.xml
p21246
sa(dp21247
g3
VSTD-John-1984
p21248
sg5
S'PMC1441216'
p21249
sg7
VCD003427 v. 12.0 Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.rm5
p21250
sg9
V6426646.xml
p21251
sa(dp21252
g3
VSTD-Fujimoto-2002
p21253
sg5
S'PMC3455835'
p21254
sg7
VCD009154 v. 5.0 Luteal phase support for assisted reproduction cycles.rm5
p21255
sg9
V12503886.xml
p21256
sa(dp21257
g3
VSTD-Hovell-2000
p21258
sg5
S'PMC27449'
p21259
sg7
VCD001746 v. 6.0 Family and carer smoking control programmes for reducing children's exposure to environmental tobacc.rm5
p21260
sg9
V10926589.xml
p21261
sa(dp21262
g3
VSTD-Conway-2004
p21263
sg5
S'PMC1747828'
p21264
sg7
g21260
sg9
V14985605.xml
p21265
sa(dp21266
g3
VSTD-Irvine-1999
p21267
sg5
S'PMC27890'
p21268
sg7
g21260
sg9
V10346773.xml
p21269
sa(dp21270
g3
VSTD-Krieger-2005
p21271
sg5
S'PMC1449237'
p21272
sg7
g21260
sg9
V15798126.xml
p21273
sa(dp21274
g3
VSTD-Wiggins-2005
p21275
sg5
S'PMC1733057'
p21276
sg7
g21260
sg9
V15767382.xml
p21277
sa(dp21278
g3
VSTD-Muir-2012
p21279
sg5
S'PMC3703932'
p21280
sg7
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p21281
sg9
V22000272.xml
p21282
sa(dp21283
g3
VSTD-Gray-2011
p21284
sg5
S'PMC3299012'
p21285
sg7
g21281
sg9
V22094303.xml
p21286
sa(dp21287
g3
VSTD-I_x002d_SIGHT
p21288
sg5
S'PMC3593648'
p21289
sg7
g21281
sg9
V22688429.xml
p21290
sa(dp21291
g3
VSTD-Nakakura-2012
p21292
sg5
S'PMC3299559'
p21293
sg7
g21281
sg9
V22419858.xml
p21294
sa(dp21295
g3
VSTD-Sippel-1999
p21296
sg5
S'PMC1496767'
p21297
sg7
VCD004705 v. 7.2 Biomedical risk assessment as an aid for smoking cessation.rm5
p21298
sg9
V10571715.xml
p21299
sa(dp21300
g3
VSTD-Jamrozik-1984
p21301
sg5
S'PMC1441184'
p21302
sg7
g21298
sg9
V6426618.xml
p21303
sa(dp21304
g3
VSTD-Parkes-2008
p21305
sg5
S'PMC2267989'
p21306
sg7
g21298
sg9
V18326503.xml
p21307
sa(dp21308
g3
VSTD-McClure-2009
p21309
sg5
S'PMC2889910'
p21310
sg7
g21298
sg9
V19524389.xml
p21311
sa(dp21312
g3
VSTD-Sanders-1989
p21313
sg5
S'PMC1711904'
p21314
sg7
g21298
sg9
V2556540.xml
p21315
sa(dp21316
g3
VSTD-Mcleod-2001
p21317
sg5
S'PMC1421263'
p21318
sg7
VCD001217 v. 8.2 Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.rm5
p21319
sg9
V11224634.xml
p21320
sa(dp21321
g3
VSTD-Yelnik-2007
p21322
sg5
S'PMC2117719'
p21323
sg7
VCD008271 v. 4.0 Botulinum toxin for shoulder pain.rm5
p21324
sg9
V17088333.xml
p21325
sa(dp21326
g3
VSTD-Mires-2001
p21327
sg5
S'PMC32308'
p21328
sg7
VCD005122 v. 10.0 Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for ass.rm5
p21329
sg9
V11408301.xml
p21330
sa(dp21331
g3
VSTD-Mitchell-2008
p21332
sg5
S'PMC3767723'
p21333
sg7
g21329
sg9
V24019284.xml
p21334
sa(dp21335
g3
VSTD-John-1984
p21336
sg5
S'PMC1441216'
p21337
sg7
VCD003885 v. 9.2 Pneumococcal vaccines for sickle cell disease.rm5
p21338
sg9
V6426646.xml
p21339
sa(dp21340
g3
VSTD-UK_x002d_PDRG-_x0028_RR_x0029_-1998
p21341
sg5
S'PMC28519'
p21342
sg7
VCD004898 v. 5.0 Monoamine oxidase B inhibitors for early Parkinson's disease.rm5
p21343
sg9
V9583926.xml
p21344
sa(dp21345
g3
VSTD-Heimler-1992
p21346
sg5
S'PMC1793668'
p21347
sg7
VCD004951 v. 4.2 Body positioning for spontaneously breathing preterm infants with apnoea.rm5
p21348
sg9
V1575555.xml
p21349
sa(dp21350
g3
VSTD-Tack-2005
p21351
sg5
S'PMC1774790'
p21352
sg7
VCD003960 v. 7.0 Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.rm5
p21353
sg9
V16020489.xml
p21354
sa(dp21355
g3
VSTD-Kellow-2003
p21356
sg5
S'PMC1773630'
p21357
sg7
g21353
sg9
V12692051.xml
p21358
sa(dp21359
g3
VSTD-Thomson-2007
p21360
sg5
S'PMC2464985'
p21361
sg7
VCD008600 v. 2.2 Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrilla.rm5
p21362
sg9
V17545350.xml
p21363
sa(dp21364
g3
VSTD-McAlister-2005
p21365
sg5
S'PMC1188186'
p21366
sg7
g21362
sg9
V16129870.xml
p21367
sa(dp21368
g3
VSTD-Wang-2008
p21369
sg5
S'PMC2693759'
p21370
sg7
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p21371
sg9
V18330955.xml
p21372
sa(dp21373
g3
VSTD-Promrat-2010
p21374
sg5
S'PMC2799538'
p21375
sg7
g21371
sg9
V19827166.xml
p21376
sa(dp21377
g3
VSTD-Lazo-2010
p21378
sg5
S'PMC2945152'
p21379
sg7
g21371
sg9
V20664019.xml
p21380
sa(dp21381
g3
VSTD-Seideman-1993
p21382
sg5
S'PMC1005122'
p21383
sg7
VCD008872 v. 2.0 Safety of non-steroidal anti-inflammatory drugs including aspirin and paracetamol (acetaminophen) i.rm5
p21384
sg9
V8215627.xml
p21385
sa(dp21386
g3
VSTD-Fallis-2001
p21387
sg5
S'PMC3695182'
p21388
sg7
VCD004510 v. 4.2 Telephone follow-up initiated by a hospital-based health professional for postdischarge problems i.rm5
p21389
sg9
V11220797.xml
p21390
sa(dp21391
g3
VSTD-Phillips-2001
p21392
sg5
S'PMC1913671'
p21393
sg7
g21389
sg9
V11889278.xml
p21394
sa(dp21395
g3
VSTD-Empire-1995
p21396
sg5
S'PMC1006832'
p21397
sg7
VCD001158 v. 6.0 Moderate-term low-dose corticosteroids for rheumatoid arthritis.rm5
p21398
sg9
V13275875.xml
p21399
sa(dp21400
g3
VSTD-Coppin-2005
p21401
sg5
S'PMC1463088'
p21402
sg7
VCD008496 v. 2.0 Non-drug therapies for lower limb muscle cramps.rm5
p21403
sg9
V15808033.xml
p21404
sa(dp21405
g3
VSTD-Moorfields-1982
p21406
sg5
S'PMC1039921'
p21407
sg7
VCD004763 v. 4.0 Laser photocoagulation for neovascular age-related macular degeneration.rm5
p21408
sg9
V6184070.xml
p21409
sa(dp21410
g3
VSTD-Harms-2008
p21411
sg5
S'PMC2373885'
p21412
sg7
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p21413
sg9
V18478129.xml
p21414
sa(dp21415
g3
VSTD-Flynn-1978
p21416
sg5
S'PMC1607519'
p21417
sg7
VCD003934 v. 3.0 Maternal positions and mobility during first stage labour.rm5
p21418
sg9
V698606.xml
p21419
sa(dp21420
g3
VSTD-Schooler-1997
p21421
sg5
S'PMC3330401'
p21422
sg7
VCD000088 v. 14.0 Family intervention for schizophrenia.rm5
p21423
sg9
V22700264.xml
p21424
sa(dp21425
g3
VSTD-Sandri-2004
p21426
sg5
S'PMC1721765'
p21427
sg7
VCD001243 v. 7.0 Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in ve.rm5
p21428
sg9
V15321956.xml
p21429
sa(dp21430
g3
VSTD-Carlson-2007
p21431
sg5
S'PMC1955332'
p21432
sg7
VCD006856 v. 2.5 Personal assistance for adults (19-64) with physical impairments.rm5
p21433
sg9
V17244293.xml
p21434
sa(dp21435
g3
VSTD-Mowat-1980
p21436
sg5
S'PMC1000462'
p21437
sg7
VCD003114 v. 7.0 Occupational therapy for rheumatoid arthritis.rm5
p21438
sg9
V7377854.xml
p21439
sa(dp21440
g3
VSTD-Begley-2008
p21441
sg5
S'PMC2443289'
p21442
sg7
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p21443
sg9
V18628946.xml
p21444
sa(dp21445
g3
VSTD-McDaid-2010
p21446
sg5
S'PMC3010905'
p21447
sg7
g21443
sg9
V20595141.xml
p21448
sa(dp21449
g3
VSTD-Mor-2007-_x0028_HIV_x002d_pos_x0029_
p21450
sg5
S'PMC1955830'
p21451
sg7
g21443
sg9
V17848992.xml
p21452
sa(dp21453
g3
VSTD-Templeton-2009-_x0028_CS_x0029_
p21454
sg5
S'PMC2784211'
p21455
sg7
g21443
sg9
V19911990.xml
p21456
sa(dp21457
g3
VSTD-Mor-2007
p21458
sg5
S'PMC1955830'
p21459
sg7
g21443
sg9
V17848992.xml
p21460
sa(dp21461
g3
VSTD-Mor-2007-_x0028_HIV_x002d_neg_x0029_
p21462
sg5
S'PMC1955830'
p21463
sg7
g21443
sg9
V17848992.xml
p21464
sa(dp21465
g3
VSTD-Lane-2011
p21466
sg5
S'PMC2888758'
p21467
sg7
g21443
sg9
V19662523.xml
p21468
sa(dp21469
g3
VSTD-Templeton-2009-_x0028_P_x0029_
p21470
sg5
S'PMC2784211'
p21471
sg7
g21443
sg9
V19911990.xml
p21472
sa(dp21473
g3
VSTD-Skripak-2008
p21474
sg5
S'PMC3764488'
p21475
sg7
VCD009542 v. 2.5 Oral immunotherapy for milk allergy.rm5
p21476
sg9
V18951617.xml
p21477
sa(dp21478
g3
VSTD-Koes-1992
p21479
sg5
S'PMC1881307'
p21480
sg7
VCD000319 v. 14.0 Medicinal and injection therapies for mechanical neck disorders.rm5
p21481
sg9
V1532760.xml
p21482
sa(dp21483
g3
VSTD-Ventriculomegaly--90
p21484
sg5
S'PMC1590164'
p21485
sg7
VCD000216 v. 7.0 Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage.rm5
p21486
sg9
V2407200.xml
p21487
sa(dp21488
g3
VSTD-David-1982
p21489
sg5
S'PMC491629'
p21490
sg7
VCD000425 v. 8.0 Speech and language therapy for aphasia following stroke.rm5
p21491
sg9
V6184453.xml
p21492
sa(dp21493
g3
VSTD-Meikle-1979
p21494
sg5
S'PMC1596055'
p21495
sg7
g21491
sg9
V466329.xml
p21496
sa(dp21497
g3
VSTD-Hall-2001-_x0028_Study-2_x0029_
p21498
sg5
S'PMC98234'
p21499
sg7
VCD009029 v. 2.2 Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.rm5
p21500
sg9
V11292698.xml
p21501
sa(dp21502
g3
VSTD-Hall-2001-_x0028_Study-3_x0029_
p21503
sg5
S'PMC98234'
p21504
sg7
g21500
sg9
V11292698.xml
p21505
sa(dp21506
g3
VSTD-Cohen-2000-_x0028_Study-2_x0029_
p21507
sg5
S'PMC98356'
p21508
sg7
g21500
sg9
V10899847.xml
p21509
sa(dp21510
g3
VSTD-Jertborn-2001
p21511
sg5
S'PMC96073'
p21512
sg7
g21500
sg9
V11238232.xml
p21513
sa(dp21514
g3
VSTD-Hall-2001-_x0028_Study-1_x0029_
p21515
sg5
S'PMC98234'
p21516
sg7
g21500
sg9
V11292698.xml
p21517
sa(dp21518
g3
VSTD-Cohen-2000-_x0028_Study-1_x0029_
p21519
sg5
S'PMC98356'
p21520
sg7
g21500
sg9
V10899847.xml
p21521
sa(dp21522
g3
VSTD-Swift-1994
p21523
sg5
S'PMC1374591'
p21524
sg7
VCD000299 v. 4.0 Anti-tuberculous therapy for maintenance of remission in Crohn's disease.rm5
p21525
sg9
V8150348.xml
p21526
sa(dp21527
g3
VSTD-Shaffer-1984
p21528
sg5
S'PMC1432256'
p21529
sg7
g21525
sg9
V6363219.xml
p21530
sa(dp21531
g3
VSTD-Anwar-1986
p21532
sg5
S'PMC1777581'
p21533
sg7
VCD001691 v. 5.0 Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants.rm5
p21534
sg9
V3513720.xml
p21535
sa(dp21536
g3
VSTD-Rosenfeld-2008
p21537
sg5
S'PMC2631354'
p21538
sg7
VCD005225 v. 6.2 Creatine for amyotrophic lateral sclerosismotor neuron disease.rm5
p21539
sg9
V18608103.xml
p21540
sa(dp21541
g3
VSTD-Forney-2001
p21542
sg5
S'PMC88255'
p21543
sg7
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p21544
sg9
V11474008.xml
p21545
sa(dp21546
g3
VSTD-Forney-2003
p21547
sg5
S'PMC156472'
p21548
sg7
g21544
sg9
V12791849.xml
p21549
sa(dp21550
g3
VSTD-Abeku-2008a
p21551
sg5
S'PMC2571107'
p21552
sg7
g21544
sg9
V18834523.xml
p21553
sa(dp21554
g3
VSTD-Abeku-2008b
p21555
sg5
S'PMC2571107'
p21556
sg7
g21544
sg9
V18834523.xml
p21557
sa(dp21558
g3
VSTD-Bell-2001b
p21559
sg5
S'PMC2566678'
p21560
sg7
g21544
sg9
V11693975.xml
p21561
sa(dp21562
g3
VSTD-Bell-2001a
p21563
sg5
S'PMC2566678'
p21564
sg7
g21544
sg9
V11693975.xml
p21565
sa(dp21566
g3
VSTD-Kyabayinze-2008
p21567
sg5
S'PMC2584069'
p21568
sg7
g21544
sg9
V18959777.xml
p21569
sa(dp21570
g3
VSTD-Msellem-2009
p21571
sg5
S'PMC2667629'
p21572
sg7
g21544
sg9
V19399156.xml
p21573
sa(dp21574
g3
VSTD-Tjitra-1999
p21575
sg5
S'PMC85241'
p21576
sg7
g21544
sg9
V10405377.xml
p21577
sa(dp21578
g3
VSTD-Bharti-2008
p21579
sg5
S'PMC2478667'
p21580
sg7
g21544
sg9
V18620560.xml
p21581
sa(dp21582
g3
VSTD-Retting-Oxnard-2002
p21583
sg5
S'PMC1447335'
p21584
sg7
VCD003862 v. 8.0 Red-light cameras for the prevention of road traffic crashes.rm5
p21585
sg9
V12406815.xml
p21586
sa(dp21587
g3
VSTD-Muller-2001
p21588
sg5
S'PMC33513'
p21589
sg7
VCD006639 v. 6.0 Zinc supplements for preventing otitis media.rm5
p21590
sg9
V11431296.xml
p21591
sa(dp21592
g3
VSTD-Bhandari-2002
p21593
sg5
S'PMC115208'
p21594
sg7
g21590
sg9
V12052800.xml
p21595
sa(dp21596
g3
VSTD-Zhang-2004
p21597
sg5
S'PMC3522714'
p21598
sg7
VCD007028 v. 3.2 Mailuoning for acute ischaemic stroke.rm5
p21599
sg9
V23272146.xml
p21600
sa(dp21601
g3
VSTD-Kolko-1989
p21602
sg5
S'PMC3057358'
p21603
sg7
VCD004380 v. 4.0 School-based education programmes for the prevention of child sexual abuse.rm5
p21604
sg9
V20495474.xml
p21605
sa(dp21606
g3
VSTD-Poche-1988
p21607
sg5
S'PMC1286121'
p21608
sg7
g21604
sg9
V3198545.xml
p21609
sa(dp21610
g3
VSTD-GRASP-2009
p21611
sg5
S'PMC2790382'
p21612
sg7
VCD005346 v. 8.0 Insulin for glycaemic control in acute ischaemic stroke.rm5
p21613
sg9
V19834016.xml
p21614
sa(dp21615
g3
VSTD-Arezzo-2008
p21616
sg5
S'PMC2565674'
p21617
sg7
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p21618
sg9
V18796160.xml
p21619
sa(dp21620
g3
VSTD-Hillman-2005
p21621
sg5
S'PMC1237155'
p21622
sg7
VCD008685 v. 2.2 Optimal loading dose of warfarin for the initiation of oral anticoagulation.rm5
p21623
sg9
V16160068.xml
p21624
sa(dp21625
g3
VSTD-Ward-2002
p21626
sg5
S'PMC117136'
p21627
sg7
VCD002912 v. 13.3 Open retropubic colposuspension for urinary incontinence in women.rm5
p21628
sg9
V12114234.xml
p21629
sa(dp21630
g3
VSTD-Bakitas-2009
p21631
sg5
S'PMC3657724'
p21632
sg7
VCD007760 v. 3.0 Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illne.rm5
p21633
sg9
V19690306.xml
p21634
sa(dp21635
g3
VSTD-Zimmer-1985
p21636
sg5
S'PMC1645992'
p21637
sg7
g21633
sg9
V3966617.xml
p21638
sa(dp21639
g3
VSTD-McWhinney-1994
p21640
sg5
S'PMC2541867'
p21641
sg7
g21633
sg9
V7532501.xml
p21642
sa(dp21643
g3
VSTD-Hughes-1992
p21644
sg5
S'PMC1069857'
p21645
sg7
g21633
sg9
V1737710.xml
p21646
sa(dp21647
g3
VSTD-Grande-1999
p21648
sg5
S'PMC28293'
p21649
sg7
g21633
sg9
V10582932.xml
p21650
sa(dp21651
g3
VSTD-Altan_x002d_Yaycioglu-2005
p21652
sg5
S'PMC1884849'
p21653
sg7
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p21654
sg9
V15842558.xml
p21655
sa(dp21656
g3
VSTD-Choo-2008
p21657
sg5
S'PMC2680337'
p21658
sg7
g21654
sg9
V19143854.xml
p21659
sa(dp21660
g3
VSTD-L-_x002d_-LEAD-1-Marre-2009
p21661
sg5
S'PMC2871176'
p21662
sg7
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p21663
sg9
V19317822.xml
p21664
sa(dp21665
g3
VSTD-Lixi-_x002d_-Ratner-2010
p21666
sg5
S'PMC3068287'
p21667
sg7
g21663
sg9
V20722676.xml
p21668
sa(dp21669
g3
VSTD-T-_x002d_-Nauck-2009
p21670
sg5
S'PMC2699710'
p21671
sg7
g21663
sg9
V19366970.xml
p21672
sa(dp21673
g3
VSTD-A-_x002d_-Rosenstock-2009
p21674
sg5
S'PMC2752910'
p21675
sg7
g21663
sg9
V19592625.xml
p21676
sa(dp21677
g3
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p21678
sg5
S'PMC2606836'
p21679
sg7
g21663
sg9
V18931095.xml
p21680
sa(dp21681
g3
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p21682
sg5
S'PMC2744824'
p21683
sg7
g21663
sg9
V19688338.xml
p21684
sa(dp21685
g3
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p21686
sg5
S'PMC2699702'
p21687
sg7
g21663
sg9
V19289857.xml
p21688
sa(dp21689
g3
VSTD-T_x002d_-Ratner-2010
p21690
sg5
S'PMC2948428'
p21691
sg7
g21663
sg9
V20536952.xml
p21692
sa(dp21693
g3
VSTD-Cornelius-1996
p21694
sg5
S'PMC1342770'
p21695
sg7
VCD006581 v. 4.0 Adjusting the pH of lidocaine for reducing pain on injection.rm5
p21696
sg9
V8894861.xml
p21697
sa(dp21698
g3
VSTD-Younis-2004
p21699
sg5
S'PMC1964174'
p21700
sg7
g21696
sg9
V15140310.xml
p21701
sa(dp21702
g3
VSTD-Moayyedi-1995
p21703
sg5
S'PMC474895'
p21704
sg7
VCD003900 v. 7.0 Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chron.rm5
p21705
sg9
V7570433.xml
p21706
sa(dp21707
g3
VSTD-Nakintu-2001
p21708
sg5
S'PMC2141556'
p21709
sg7
VCD004901 v. 5.0 Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for wome.rm5
p21710
sg9
V12789117.xml
p21711
sa(dp21712
g3
VSTD-Bateman-2006
p21713
sg5
S'PMC1386666'
p21714
sg7
VCD002308 v. 8.18 Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.rm5
p21715
sg9
V16433920.xml
p21716
sa(dp21717
g3
VSTD-UKPDS_x002d_39_x002d_1998
p21718
sg5
S'PMC28660'
p21719
sg7
VCD002003 v. 12.0 Beta-blockers for hypertension.rm5
p21720
sg9
V9732338.xml
p21721
sa(dp21722
g3
VSTD-Coope-1986
p21723
sg5
S'PMC1245188'
p21724
sg7
g21720
sg9
V3109557.xml
p21725
sa(dp21726
g3
VSTD-MRC-1985
p21727
sg5
S'PMC1416260'
p21728
sg7
g21720
sg9
V2861880.xml
p21729
sa(dp21730
g3
VSTD-Feste-2000
p21731
sg5
S'PMC3015351'
p21732
sg7
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p21733
sg9
V10772522.xml
p21734
sa(dp21735
g3
VSTD-Venkatesh-2007
p21736
sg5
S'PMC3015718'
p21737
sg7
g21733
sg9
V17761080.xml
p21738
sa(dp21739
g3
VSTD-Carapeti-1999
p21740
sg5
S'PMC1727506'
p21741
sg7
VCD003431 v. 9.2 Non surgical therapy for anal fissure.rm5
p21742
sg9
V10205213.xml
p21743
sa(dp21744
g3
VSTD-Jensen-1987
p21745
sg5
S'PMC1290813'
p21746
sg7
g21742
sg9
V3039130.xml
p21747
sa(dp21748
g3
VSTD-Jensen-1986
p21749
sg5
S'PMC1340178'
p21750
sg7
g21742
sg9
V3011180.xml
p21751
sa(dp21752
g3
VSTD-Scholefield-2003
p21753
sg5
S'PMC1774963'
p21754
sg7
g21742
sg9
V12524411.xml
p21755
sa(dp21756
g3
VSTD-Kenny-2001
p21757
sg5
S'PMC1718983'
p21758
sg7
g21742
sg9
V11668104.xml
p21759
sa(dp21760
g3
VSTD-Patterson-2003
p21761
sg5
S'PMC1884398'
p21762
sg7
VCD003822 v. 7.0 Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.rm5
p21763
sg9
V14651725.xml
p21764
sa(dp21765
g3
VSTD-Kinlock-2007
p21766
sg5
S'PMC2423344'
p21767
sg7
VCD002209 v. 11.0 Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.rm5
p21768
sg9
V17628351.xml
p21769
sa(dp21770
g3
VSTD-Gruber-2008
p21771
sg5
S'PMC2821580'
p21772
sg7
g21768
sg9
V18243585.xml
p21773
sa(dp21774
g3
VSTD-Yancovitz-1991
p21775
sg5
S'PMC1405649'
p21776
sg7
g21768
sg9
V1659236.xml
p21777
sa(dp21778
g3
VSTD-Bonnema-1998
p21779
sg5
S'PMC28526'
p21780
sg7
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p21781
sg9
V9554895.xml
p21782
sa(dp21783
g3
VSTD-Addington_x002d_Hall-1992
p21784
sg5
S'PMC1883850'
p21785
sg7
g21781
sg9
V1483075.xml
p21786
sa(dp21787
g3
VSTD-McWhinney-1994
p21788
sg5
S'PMC2541867'
p21789
sg7
g21781
sg9
V7532501.xml
p21790
sa(dp21791
g3
VSTD-Moore-2002
p21792
sg5
S'PMC133453'
p21793
sg7
g21781
sg9
V12433764.xml
p21794
sa(dp21795
g3
VSTD-Grunfeld-1996
p21796
sg5
S'PMC1313497'
p21797
sg7
g21781
sg9
V10756611.xml
p21798
sa(dp21799
g3
VSTD-Wells-2004
p21800
sg5
S'PMC2364768'
p21801
sg7
g21781
sg9
V15238983.xml
p21802
sa(dp21803
g3
VSTD-Hughes-1992
p21804
sg5
S'PMC1069857'
p21805
sg7
g21781
sg9
V1737710.xml
p21806
sa(dp21807
g3
VSTD-Williams-2001
p21808
sg5
S'PMC1743428'
p21809
sg7
g21781
sg9
V11533423.xml
p21810
sa(dp21811
g3
VSTD-King-2009
p21812
sg5
S'PMC2634705'
p21813
sg7
g21781
sg9
V19107130.xml
p21814
sa(dp21815
g3
VSTD-McArdle-1996
p21816
sg5
S'PMC2350687'
p21817
sg7
g21781
sg9
V8608288.xml
p21818
sa(dp21819
g3
VSTD-Drury-2000
p21820
sg5
S'PMC1313626'
p21821
sg7
g21781
sg9
V10750206.xml
p21822
sa(dp21823
g3
VSTD-Wattchow-2006
p21824
sg5
S'PMC2361245'
p21825
sg7
g21781
sg9
V16622437.xml
p21826
sa(dp21827
g3
VSTD-Hanks-2002
p21828
sg5
S'PMC2364271'
p21829
sg7
g21781
sg9
V12232756.xml
p21830
sa(dp21831
g3
VSTD-Guttman-1997
p21832
sg5
S'PMC3756563'
p21833
sg7
VCD002259 v. 4.3 Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
p21834
sg9
V23810193.xml
p21835
sa(dp21836
g3
VSTD-Poon-2007
p21837
sg5
S'PMC1959348'
p21838
sg7
VCD008914 v. 3.0 Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy.rm5
p21839
sg9
V17717446.xml
p21840
sa(dp21841
g3
VSTD-Morisky-2001
p21842
sg5
S'PMC1497389'
p21843
sg7
VCD006591 v. 3.0 Patient education and counselling for promoting adherence to treatment for tuberculosis.rm5
p21844
sg9
V12196616.xml
p21845
sa(dp21846
g3
VSTD-Van-Horn-1991
p21847
sg5
S'PMC1404954'
p21848
sg7
VCD005051 v. 3.0 Wholegrain cereals for coronary heart disease.rm5
p21849
sg9
V1846723.xml
p21850
sa(dp21851
g3
VSTD-Hochreiter-2009
p21852
sg5
S'PMC2717450'
p21853
sg7
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p21854
sg9
V19493352.xml
p21855
sa(dp21856
g3
VSTD-Zhu-2002
p21857
sg5
S'PMC3756114'
p21858
sg7
VCD002755 v. 6.0 Intravenous magnesium for acute myocardial infarction.rm5
p21859
sg9
V23611177.xml
p21860
sa(dp21861
g3
VSTD-Woods-1992
p21862
sg5
S'PMC483633'
p21863
sg7
g21859
sg9
V8130021.xml
p21864
sa(dp21865
g3
VSTD-Appleby-1997
p21866
sg5
S'PMC2126383'
p21867
sg7
VCD006116 v. 4.0 Psychosocial and psychological interventions for treating postpartum depression.rm5
p21868
sg9
V9099116.xml
p21869
sa(dp21870
g3
VSTD-Holden-1989
p21871
sg5
S'PMC1835559'
p21872
sg7
g21868
sg9
V2493868.xml
p21873
sa(dp21874
g3
VSTD-Brown-2001
p21875
sg5
S'PMC2375236'
p21876
sg7
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p21877
sg9
V11720460.xml
p21878
sa(dp21879
g3
VSTD-Hornberger-1997
p21880
sg5
S'PMC1497170'
p21881
sg7
g21877
sg9
V9346455.xml
p21882
sa(dp21883
g3
VSTD-Brown-1999
p21884
sg5
S'PMC2363012'
p21885
sg7
g21877
sg9
V10390003.xml
p21886
sa(dp21887
g3
VSTD-Little-2004
p21888
sg5
S'PMC344265'
p21889
sg7
g21877
sg9
V14966078.xml
p21890
sa(dp21891
g3
VSTD-Finney-1990
p21892
sg5
S'PMC1286226'
p21893
sg7
g21877
sg9
V2373656.xml
p21894
sa(dp21895
g3
VSTD-Middleton-2006
p21896
sg5
S'PMC1471934'
p21897
sg7
g21877
sg9
V16707508.xml
p21898
sa(dp21899
g3
VSTD-Patra-1982
p21900
sg5
S'PMC1628063'
p21901
sg7
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p21902
sg9
V6758706.xml
p21903
sa(dp21904
g3
VSTD-Alam-1992
p21905
sg5
S'PMC1374078'
p21906
sg7
g21902
sg9
V1582603.xml
p21907
sa(dp21908
g3
VSTD-El_x002d_Mougi-1996
p21909
sg5
S'PMC2486870'
p21910
sg7
g21902
sg9
V9002327.xml
p21911
sa(dp21912
g3
VSTD-Islam-1994
p21913
sg5
S'PMC1029905'
p21914
sg7
g21902
sg9
V8067787.xml
p21915
sa(dp21916
g3
VSTD-Alam-1987
p21917
sg5
S'PMC1778371'
p21918
sg7
g21902
sg9
V3300569.xml
p21919
sa(dp21920
g3
VSTD-Ramakrishna-2008
p21921
sg5
S'PMC2217593'
p21922
sg7
g21902
sg9
V18270575.xml
p21923
sa(dp21924
g3
VSTD-Molla-1985
p21925
sg5
S'PMC2536376'
p21926
sg7
g21902
sg9
V3910298.xml
p21927
sa(dp21928
g3
VSTD-Miskelly-1988
p21929
sg5
S'PMC1778829'
p21930
sg7
VCD003741 v. 7.0 Soy formula for prevention of allergy and food intolerance in infants.rm5
p21931
sg9
V3365008.xml
p21932
sa(dp21933
g3
VSTD-Mahmud-2001
p21934
sg5
S'PMC1728458'
p21935
sg7
VCD003715 v. 7.0 Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.rm5
p21936
sg9
V11559654.xml
p21937
sa(dp21938
g3
VSTD-Jones-1995
p21939
sg5
S'PMC474903'
p21940
sg7
VCD004107 v. 4.0 Options for self-management education for adults with asthma.rm5
p21941
sg9
V7570436.xml
p21942
sa(dp21943
g3
VSTD-Charlton-1990
p21944
sg5
S'PMC1664498'
p21945
sg7
g21941
sg9
V2148702.xml
p21946
sa(dp21947
g3
VSTD-Lahdensuo-1996
p21948
sg5
S'PMC2350456'
p21949
sg7
g21941
sg9
V8605463.xml
p21950
sa(dp21951
g3
VSTD-Grampian-1994
p21952
sg5
S'PMC2539575'
p21953
sg7
g21941
sg9
V8148679.xml
p21954
sa(dp21955
g3
VSTD-Matsumoto-1999
p21956
sg5
S'PMC1745437'
p21957
sg7
VCD009607 v. 2.2 Swimming training for asthma in children and adolescents aged 18 years and under.rm5
p21958
sg9
V10325893.xml
p21959
sa(dp21960
g3
VSTD-Malcolm-2002
p21961
sg5
S'PMC1495040'
p21962
sg7
VCD005063 v. 8.3 Benzodiazepines for alcohol withdrawal.rm5
p21963
sg9
V12047731.xml
p21964
sa(dp21965
g3
VSTD-Yardley-1998
p21966
sg5
S'PMC1410046'
p21967
sg7
VCD005397 v. 5.0 Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.rm5
p21968
sg9
V9667087.xml
p21969
sa(dp21970
g3
VSTD-Christophersen-2002
p21971
sg5
S'PMC1874309'
p21972
sg7
VCD003328 v. 7.0 Interventions for paracetamol (acetaminophen) overdose.rm5
p21973
sg9
V11874395.xml
p21974
sa(dp21975
g3
VSTD-Keays-1991
p21976
sg5
S'PMC1671790'
p21977
sg7
g21973
sg9
V1954453.xml
p21978
sa(dp21979
g3
VSTD-Gazzard-1974a
p21980
sg5
S'PMC1402556'
p21981
sg7
g21973
sg9
V22454960.xml
p21982
sa(dp21983
g3
VSTD-Underhill-1990
p21984
sg5
S'PMC1285692'
p21985
sg7
g21973
sg9
V1983801.xml
p21986
sa(dp21987
g3
VSTD-Prescott-1979
p21988
sg5
S'PMC1597048'
p21989
sg7
g21973
sg9
V519312.xml
p21990
sa(dp21991
g3
VSTD-Gazzard-1975
p21992
sg5
S'PMC1411015'
p21993
sg7
g21973
sg9
V1102398.xml
p21994
sa(dp21995
g3
VSTD-Gazzard-1974
p21996
sg5
S'PMC1412898'
p21997
sg7
g21973
sg9
V4820642.xml
p21998
sa(dp21999
g3
VSTD-Smith-1978
p22000
sg5
S'PMC1602895'
p22001
sg7
g21973
sg9
V623980.xml
p22002
sa(dp22003
g3
VSTD-O_x0027_Grady-1991
p22004
sg5
S'PMC1670505'
p22005
sg7
g21973
sg9
V1884059.xml
p22006
sa(dp22007
g3
VSTD-Mutimer-1994
p22008
sg5
S'PMC1374884'
p22009
sg7
g21973
sg9
V8020810.xml
p22010
sa(dp22011
g3
VSTD-Hughes-1977
p22012
sg5
S'PMC1632345'
p22013
sg7
g21973
sg9
V338110.xml
p22014
sa(dp22015
g3
VSTD-Yeates-2000
p22016
sg5
S'PMC2014891'
p22017
sg7
g21973
sg9
V10606832.xml
p22018
sa(dp22019
g3
VSTD-Susanna-2003
p22020
sg5
S'PMC1771784'
p22021
sg7
VCD004918 v. 4.0 Aqueous shunts for glaucoma.rm5
p22022
sg9
V12881343.xml
p22023
sa(dp22024
g3
VSTD-Jones-1981
p22025
sg5
S'PMC1627404'
p22026
sg7
VCD000373 v. 7.2 Kinesthetic stimulation for preventing apnea in preterm infants.rm5
p22027
sg9
V7030228.xml
p22028
sa(dp22029
g3
VSTD-McDonald-1993
p22030
sg5
S'PMC1679299'
p22031
sg7
VCD000201 v. 6.0 Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.rm5
p22032
sg9
V8251842.xml
p22033
sa(dp22034
g3
VSTD-JUPITER-trial
p22035
sg5
S'PMC2710995'
p22036
sg7
VCD008203 v. 2.0 Statins for primary prevention of venous thromboembolism.rm5
p22037
sg9
V19329822.xml
p22038
sa(dp22039
g3
VSTD-Holt-2005
p22040
sg5
S'PMC1747282'
p22041
sg7
VCD009046 v. 2.5 Interventions for smoking cessation in Indigenous populations.rm5
p22042
sg9
V15681499.xml
p22043
sa(dp22044
g3
VSTD-Stewart-2007
p22045
sg5
S'PMC3163239'
p22046
sg7
VCD009805 v. 2.0 Hormonal and intrauterine methods for contraception for women aged 25 years and younger.rm5
p22047
sg9
V18082856.xml
p22048
sa(dp22049
g3
VSTD-Roberts-2001
p22050
sg5
S'PMC2015028'
p22051
sg7
VCD009095 v. 3.0 Interventions to optimise prescribing for older people in care homes.rm5
p22052
sg9
V11298072.xml
p22053
sa(dp22054
g3
VSTD-Juvenile-2009
p22055
sg5
S'PMC2945155'
p22056
sg7
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p22057
sg9
V20696865.xml
p22058
sa(dp22059
g3
VSTD-Raccah-2009
p22060
sg5
S'PMC2782985'
p22061
sg7
g22057
sg9
V19767384.xml
p22062
sa(dp22063
g3
VSTD-Battelino-2011
p22064
sg5
S'PMC3064030'
p22065
sg7
g22057
sg9
V21335621.xml
p22066
sa(dp22067
g3
VSTD-Black-1990
p22068
sg5
S'PMC1663097'
p22069
sg7
VCD001801 v. 8.0 Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.rm5
p22070
sg9
V2196954.xml
p22071
sa(dp22072
g3
VSTD-Edwards-1984
p22073
sg5
S'PMC1046385'
p22074
sg7
VCD004785 v. 9.0 Antibiotics for preventing meningococcal infections.rm5
p22075
sg9
V6440658.xml
p22076
sa(dp22077
g3
VSTD-Dworzack-1988
p22078
sg5
S'PMC175963'
p22079
sg7
g22075
sg9
V3252755.xml
p22080
sa(dp22081
g3
VSTD-Renkonen-1987
p22082
sg5
S'PMC284224'
p22083
sg7
g22075
sg9
V3113331.xml
p22084
sa(dp22085
g3
VSTD-Pugsley-1984
p22086
sg5
S'PMC185560'
p22087
sg7
g22075
sg9
V6732217.xml
p22088
sa(dp22089
g3
VSTD-Reynolds-1981
p22090
sg5
S'PMC1505182'
p22091
sg7
VCD001539 v. 6.0 Recordings or summaries of consultations for people with cancer.rm5
p22092
sg9
V6784861.xml
p22093
sa(dp22094
g3
VSTD-Lorenz-1998
p22095
sg5
S'PMC1191593'
p22096
sg7
VCD003770 v. 6.0 Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer .rm5
p22097
sg9
V9860474.xml
p22098
sa(dp22099
g3
VSTD-Luckner-2006
p22100
sg5
S'PMC1550871'
p22101
sg7
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p22102
sg9
V16542484.xml
p22103
sa(dp22104
g3
VSTD-Morelli-2008b
p22105
sg5
S'PMC2646303'
p22106
sg7
g22102
sg9
V19017409.xml
p22107
sa(dp22108
g3
VSTD-Seguin-2006
p22109
sg5
S'PMC1550826'
p22110
sg7
g22102
sg9
V16507156.xml
p22111
sa(dp22112
g3
VSTD-Morelli-2009
p22113
sg5
S'PMC2750187'
p22114
sg7
g22102
sg9
V19664253.xml
p22115
sa(dp22116
g3
VSTD-Fraser-1993
p22117
sg5
S'PMC1968186'
p22118
sg7
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p22119
sg9
V8431375.xml
p22120
sa(dp22121
g3
VSTD-Brambilla-1976
p22122
sg5
S'PMC1639498'
p22123
sg7
g22119
sg9
V1260337.xml
p22124
sa(dp22125
g3
VSTD-Harper_x002d_Wynne-1999
p22126
sg5
S'PMC2362871'
p22127
sg7
g22119
sg9
V10496359.xml
p22128
sa(dp22129
g3
VSTD-Akova-1993
p22130
sg5
S'PMC188077'
p22131
sg7
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p22132
sg9
V8239591.xml
p22133
sa(dp22134
g3
VSTD-Karabay-2004
p22135
sg5
S'PMC459220'
p22136
sg7
g22132
sg9
V15214959.xml
p22137
sa(dp22138
g3
VSTD-McDevitt-1970
p22139
sg5
S'PMC1009044'
p22140
sg7
g22132
sg9
V4907514.xml
p22141
sa(dp22142
g3
VSTD-Colmenero-1994
p22143
sg5
S'PMC188288'
p22144
sg7
g22132
sg9
V7695265.xml
p22145
sa(dp22146
g3
VSTD-Crone-2003
p22147
sg5
S'PMC1732562'
p22148
sg7
VCD008645 v. 2.0 Incentives for preventing smoking in children and adolescents.rm5
p22149
sg9
V12933772.xml
p22150
sa(dp22151
g3
VSTD-Koopmans-2006
p22152
sg5
S'PMC2104614'
p22153
sg7
VCD006922 v. 4.0 Regular treatment with salmeterol and inhaled steroids for chronic asthma serious adverse events.rm5
p22154
sg9
V16449264.xml
p22155
sa(dp22156
g3
VSTD-Lumley-2006
p22157
sg5
S'PMC1479326'
p22158
sg7
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p22159
sg9
V16483383.xml
p22160
sa(dp22161
g3
VSTD-Small-2000
p22162
sg5
S'PMC27510'
p22163
sg7
g22159
sg9
V11053173.xml
p22164
sa(dp22165
g3
VSTD-Feinberg-2008
p22166
sg5
S'PMC3178882'
p22167
sg7
g22159
sg9
V18410212.xml
p22168
sa(dp22169
g3
VSTD-Ickovics-2011
p22170
sg5
S'PMC3311036'
p22171
sg7
g22159
sg9
V21318932.xml
p22172
sa(dp22173
g3
VSTD-Morrell-2000
p22174
sg5
S'PMC27472'
p22175
sg7
g22159
sg9
V10977833.xml
p22176
sa(dp22177
g3
VSTD-Dennis-2009
p22178
sg5
S'PMC2628301'
p22179
sg7
g22159
sg9
V19147637.xml
p22180
sa(dp22181
g3
VSTD-Pang-2005
p22182
sg5
S'PMC3226792'
p22183
sg7
VCD006075 v. 3.0 Overground physical therapy gait training for chronic stroke patients with mobility deficits.rm5
p22184
sg9
V16181164.xml
p22185
sa(dp22186
g3
VSTD-Wade-1992
p22187
sg5
S'PMC1881332'
p22188
sg7
g22184
sg9
V1559090.xml
p22189
sa(dp22190
g3
VSTD-King-1994
p22191
sg5
S'PMC3250832'
p22192
sg7
VCD004405 v. 7.0 Corticosteroids for acute bacterial meningitis.rm5
p22193
sg9
V22346503.xml
p22194
sa(dp22195
g3
VSTD-Qazi-1996
p22196
sg5
S'PMC1511808'
p22197
sg7
g22193
sg9
V9014599.xml
p22198
sa(dp22199
g3
VSTD-Oncken-2008
p22200
sg5
S'PMC2630492'
p22201
sg7
VCD010078 v. 1.0 Pharmacological interventions for promoting smoking cessation during pregnancy.rm5
p22202
sg9
V18827129.xml
p22203
sa(dp22204
g3
VSTD-Pollak-2007
p22205
sg5
S'PMC3602964'
p22206
sg7
g22202
sg9
V17888856.xml
p22207
sa(dp22208
g3
VSTD-Canada-1980b
p22209
sg5
S'PMC1336544'
p22210
sg7
VCD001877 v. 12.0 Screening for breast cancer with mammography.rm5
p22211
sg9
V1423088.xml
p22212
sa(dp22213
g3
VSTD-Canada-1980
p22214
sg5
S'PMC1226907'
p22215
sg7
g22211
sg9
V9012720.xml
p22216
sa(dp22217
g3
VSTD-UK-age-trial-1991
p22218
sg5
S'PMC2978129'
p22219
sg7
g22211
sg9
V20837718.xml
p22220
sa(dp22221
g3
VSTD-Edinburgh-1978
p22222
sg5
S'PMC1052787'
p22223
sg7
g22211
sg9
V2592888.xml
p22224
sa(dp22225
g3
VSTD-Levy-2003
p22226
sg5
S'PMC1719589'
p22227
sg7
VCD003495 v. 5.2 Intravenous secretin for autism spectrum disorders (ASD).rm5
p22228
sg9
V12876177.xml
p22229
sa(dp22230
g3
VSTD-Milligan-1987
p22231
sg5
S'PMC1031960'
p22232
sg7
VCD001331 v. 5.0 Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.rm5
p22233
sg9
V3295122.xml
p22234
sa(dp22235
g3
VSTD-Martin-1994-Liver
p22236
sg5
S'PMC2958671'
p22237
sg7
VCD003774 v. 13.0 Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.rm5
p22238
sg9
V7940710.xml
p22239
sa(dp22240
g3
VSTD-Young-2007
p22241
sg5
S'PMC2219885'
p22242
sg7
VCD008451 v. 2.4 The effect of financial incentives on the quality of health care provided by primary care physicians.rm5
p22243
sg9
V17443360.xml
p22244
sa(dp22245
g3
VSTD-Twardella-2007
p22246
sg5
S'PMC2598437'
p22247
sg7
g22243
sg9
V17297068.xml
p22248
sa(dp22249
g3
VSTD-Curley-2005
p22250
sg5
S'PMC1237036'
p22251
sg7
VCD003645 v. 10.0 Positioning for acute respiratory distress in hospitalised infants and children.rm5
p22252
sg9
V16014597.xml
p22253
sa(dp22254
g3
VSTD-Levene-1990
p22255
sg5
S'PMC1792134'
p22256
sg7
g22252
sg9
V2357093.xml
p22257
sa(dp22258
g3
VSTD-Gilbert-2008
p22259
sg5
S'PMC2292251'
p22260
sg7
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p22261
sg9
V18431475.xml
p22262
sa(dp22263
g3
VSTD-Cornman-2008
p22264
sg5
S'PMC2813056'
p22265
sg7
g22261
sg9
V18645518.xml
p22266
sa(dp22267
g3
VSTD-Pitt-1985
p22268
sg5
S'PMC1250755'
p22269
sg7
VCD005444 v. 6.4 Pre-operative biliary drainage for obstructive jaundice.rm5
p22270
sg9
V2986562.xml
p22271
sa(dp22272
g3
VSTD-Brandon-1985
p22273
sg5
S'PMC1444141'
p22274
sg7
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p22275
sg9
V6418300.xml
p22276
sa(dp22277
g3
VSTD-Girish-2003
p22278
sg5
S'PMC2951534'
p22279
sg7
g22275
sg9
V21206808.xml
p22280
sa(dp22281
g3
VSTD-Agarwal-1985
p22282
sg5
S'PMC3011123'
p22283
sg7
g22275
sg9
V21927109.xml
p22284
sa(dp22285
g3
VSTD-Bagadia-1981
p22286
sg5
S'PMC3012902'
p22287
sg7
g22275
sg9
V22058556.xml
p22288
sa(dp22289
g3
VSTD-Janakiramiah-1981
p22290
sg5
S'PMC3012948'
p22291
sg7
g22275
sg9
V22058544.xml
p22292
sa(dp22293
g3
VSTD-Grant-2010
p22294
sg5
S'PMC3079639'
p22295
sg7
VCD007189 v. 4.9 Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.rm5
p22296
sg9
V21091279.xml
p22297
sa(dp22298
g3
VSTD-Peterson-2007
p22299
sg5
S'PMC1876601'
p22300
sg7
g22296
sg9
V17525796.xml
p22301
sa(dp22302
g3
VSTD-Van-Damme-2012
p22303
sg5
S'PMC3687217'
p22304
sg7
g22296
sg9
V22784040.xml
p22305
sa(dp22306
g3
VSTD-Baeten-2012
p22307
sg5
S'PMC3770474'
p22308
sg7
g22296
sg9
V22784037.xml
p22309
sa(dp22310
g3
VSTD-Brazil-2000a
p22311
sg5
S'PMC3611911'
p22312
sg7
VCD002252 v. 8.0 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.rm5
p22313
sg9
V23560009.xml
p22314
sa(dp22315
g3
VSTD-Australia-1985
p22316
sg5
S'PMC1418204'
p22317
sg7
g22313
sg9
V3929874.xml
p22318
sa(dp22319
g3
VSTD-UK-1990
p22320
sg5
S'PMC1663720'
p22321
sg7
g22313
sg9
V2242456.xml
p22322
sa(dp22323
g3
VSTD-UK-1983a
p22324
sg5
S'PMC1548251'
p22325
sg7
g22313
sg9
V6407638.xml
p22326
sa(dp22327
g3
VSTD-Jordan-2003
p22328
sg5
S'PMC1241771'
p22329
sg7
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p22330
sg9
V14644671.xml
p22331
sa(dp22332
g3
VSTD-Farrell-1998
p22333
sg5
S'PMC1509060'
p22334
sg7
g22330
sg9
V9842383.xml
p22335
sa(dp22336
g3
VSTD-Campbell-2011
p22337
sg5
S'PMC3072906'
p22338
sg7
g22330
sg9
V21563715.xml
p22339
sa(dp22340
g3
VSTD-OCTAVE-1991
p22341
sg5
S'PMC1590232'
p22342
sg7
VCD000456 v. 7.0 Synchronized mechanical ventilation for respiratory support in newborn infants.rm5
p22343
sg9
V1863121.xml
p22344
sa(dp22345
g3
VSTD-Dimitriou-1995b
p22346
sg5
S'PMC2528429'
p22347
sg7
g22343
sg9
V7796236.xml
p22348
sa(dp22349
g3
VSTD-Beresford-2000
p22350
sg5
S'PMC1721039'
p22351
sg7
g22343
sg9
V10634835.xml
p22352
sa(dp22353
g3
VSTD-Baumer-2000
p22354
sg5
S'PMC1721044'
p22355
sg7
g22343
sg9
V10634832.xml
p22356
sa(dp22357
g3
VSTD-Dimitriou-1995a
p22358
sg5
S'PMC2528429'
p22359
sg7
g22343
sg9
V7796236.xml
p22360
sa(dp22361
g3
VSTD-Blazar-2006
p22362
sg5
S'PMC1895527'
p22363
sg7
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p22364
sg9
V16835378.xml
p22365
sa(dp22366
g3
VSTD-Symonds-1996
p22367
sg5
S'PMC2074575'
p22368
sg7
g22364
sg9
V8688343.xml
p22369
sa(dp22370
g3
VSTD-Stokman-2003
p22371
sg5
S'PMC2376383'
p22372
sg7
g22364
sg9
V12671696.xml
p22373
sa(dp22374
g3
VSTD-Jebb-1994
p22375
sg5
S'PMC2033386'
p22376
sg7
g22364
sg9
V7917930.xml
p22377
sa(dp22378
g3
VSTD-Bubley-1989
p22379
sg5
S'PMC284246'
p22380
sg7
g22364
sg9
V2669626.xml
p22381
sa(dp22382
g3
VSTD-Mills-1988
p22383
sg5
S'PMC2246575'
p22384
sg7
g22364
sg9
V3390377.xml
p22385
sa(dp22386
g3
VSTD-Hartmann-2001
p22387
sg5
S'PMC2363753'
p22388
sg7
g22364
sg9
V11161394.xml
p22389
sa(dp22390
g3
VSTD-Arad-1981
p22391
sg5
S'PMC1627396'
p22392
sg7
VCD001057 v. 6.0 Topical umbilical cord care at birth.rm5
p22393
sg9
V7030227.xml
p22394
sa(dp22395
g3
VSTD-Korpan-1997
p22396
sg5
S'PMC1190648'
p22397
sg7
VCD009058 v. 2.0 Cryotherapy for liver metastases.rm5
p22398
sg9
V9065296.xml
p22399
sa(dp22400
g3
VSTD-Sherwood-1987
p22401
sg5
S'PMC1041116'
p22402
sg7
VCD003919 v. 3.0 Laser trabeculoplasty for open angle glaucoma.rm5
p22403
sg9
V3828273.xml
p22404
sa(dp22405
g3
VSTD-Damji-1999
p22406
sg5
S'PMC1723059'
p22407
sg7
g22403
sg9
V10340983.xml
p22408
sa(dp22409
g3
VSTD-Croft-1986
p22410
sg5
S'PMC1960639'
p22411
sg7
VCD008274 v. 2.2 Long-term effects of weight-reducing diets in hypertensive patients.rm5
p22412
sg9
V3440987.xml
p22413
sa(dp22414
g3
VSTD-Khaodhiar-2007
p22415
sg5
S'PMC3207039'
p22416
sg7
VCD001395 v. 6.0 Phytoestrogens for vasomotor menopausal symptoms.rm5
p22417
sg9
V18257146.xml
p22418
sa(dp22419
g3
VSTD-Kavatha-2003
p22420
sg5
S'PMC149311'
p22421
sg7
VCD007182 v. 5.0 Antimicrobial agents for treating uncomplicated urinary tract infection in women.rm5
p22422
sg9
V12604518.xml
p22423
sa(dp22424
g3
VSTD-Hooton-1989
p22425
sg5
S'PMC172645'
p22426
sg7
g22422
sg9
V2802557.xml
p22427
sa(dp22428
g3
VSTD-Boyko-1990
p22429
sg5
S'PMC171664'
p22430
sg7
g22422
sg9
V2188590.xml
p22431
sa(dp22432
g3
VSTD-Goldstein-1985
p22433
sg5
S'PMC176290'
p22434
sg7
g22422
sg9
V3158277.xml
p22435
sa(dp22436
g3
VSTD-Ten-Centre-1987
p22437
sg5
S'PMC1590200'
p22438
sg7
VCD001079 v. 5.0 Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm inf.rm5
p22439
sg9
V2201266.xml
p22440
sa(dp22441
g3
VSTD-McGavin-1977
p22442
sg5
S'PMC470605'
p22443
sg7
VCD003793 v. 7.0 Pulmonary rehabilitation for chronic obstructive pulmonary disease.rm5
p22444
sg9
V882944.xml
p22445
sa(dp22446
g3
VSTD-Simpson-1992
p22447
sg5
S'PMC463573'
p22448
sg7
g22444
sg9
V1549826.xml
p22449
sa(dp22450
g3
VSTD-Cockcroft-1981
p22451
sg5
S'PMC471476'
p22452
sg7
g22444
sg9
V7025334.xml
p22453
sa(dp22454
g3
VSTD-Cornelius-2009
p22455
sg5
S'PMC2720419'
p22456
sg7
VCD008324 v. 3.0 Psychological therapies versus antidepressant medication alone and in combination for depression in.rm5
p22457
sg9
V19321268.xml
p22458
sa(dp22459
g3
VSTD-TASA-2009
p22460
sg5
S'PMC2891930'
p22461
sg7
g22457
sg9
V19730274.xml
p22462
sa(dp22463
g3
VSTD-ADAPT-2007
p22464
sg5
S'PMC1925185'
p22465
sg7
g22457
sg9
V17556431.xml
p22466
sa(dp22467
g3
VSTD-Fitzmaurice-2002
p22468
sg5
S'PMC1769803'
p22469
sg7
VCD003839 v. 7.8 Self-monitoring and self-management of oral anticoagulation.rm5
p22470
sg9
V12401823.xml
p22471
sa(dp22472
g3
VSTD-Fitzmaurice-2005
p22473
sg5
S'PMC1283185'
p22474
sg7
g22470
sg9
V16216821.xml
p22475
sa(dp22476
g3
VSTD-START-A-2008
p22477
sg5
S'PMC2323709'
p22478
sg7
VCD003860 v. 8.4 Fraction size in radiation treatment for breast conservation in early breast cancer.rm5
p22479
sg9
V18356109.xml
p22480
sa(dp22481
g3
VSTD-Newton-1978
p22482
sg5
S'PMC1608821'
p22483
sg7
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p22484
sg9
V365289.xml
p22485
sa(dp22486
g3
VSTD-Vargas-2005
p22487
sg5
S'PMC1269449'
p22488
sg7
g22484
sg9
V16137351.xml
p22489
sa(dp22490
g3
VSTD-Aukland-1982
p22491
sg5
S'PMC497768'
p22492
sg7
VCD001272 v. 7.0 Antiplatelet agents for intermittent claudication.rm5
p22493
sg9
V7047575.xml
p22494
sa(dp22495
g3
VSTD-Bourjeily_x002d_Habr-2002
p22496
sg5
S'PMC1758803'
p22497
sg7
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p22498
sg9
V12454299.xml
p22499
sa(dp22500
g3
VSTD-Neder-2002
p22501
sg5
S'PMC1746295'
p22502
sg7
g22498
sg9
V11923552.xml
p22503
sa(dp22504
g3
VSTD-N_x00e1_polis-2011
p22505
sg5
S'PMC3071998'
p22506
sg7
g22498
sg9
V21552662.xml
p22507
sa(dp22508
g3
VSTD-Murphy-1993
p22509
sg5
S'PMC1293006'
p22510
sg7
VCD001825 v. 6.0 Closed suction surgical wound drainage after orthopaedic surgery.rm5
p22511
sg9
V8371245.xml
p22512
sa(dp22513
g3
VSTD-Rowe-2009
p22514
sg5
S'PMC2667861'
p22515
sg7
VCD006413 v. 3.0 Managerial supervision to improve primary health care in low- and middle-income countries.rm5
p22516
sg9
V19299681.xml
p22517
sa(dp22518
g3
VSTD-White-1983
p22519
sg5
S'PMC1548305'
p22520
sg7
VCD003005 v. 6.0 Caudal epidural block versus other methods of postoperative pain relief for circumcision in boys.rm5
p22521
sg9
V6407642.xml
p22522
sa(dp22523
g3
VSTD-Nilsson-2009
p22524
sg5
S'PMC2760502'
p22525
sg7
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p22526
sg9
V19781053.xml
p22527
sa(dp22528
g3
VSTD-Franke-2008
p22529
sg5
S'PMC2269030'
p22530
sg7
g22526
sg9
V17206496.xml
p22531
sa(dp22532
g3
VSTD-Hedstrom-1994
p22533
sg5
S'PMC3619593'
p22534
sg7
g22526
sg9
V9728313.xml
p22535
sa(dp22536
g3
VSTD-Grilo-2005b
p22537
sg5
S'PMC3327763'
p22538
sg7
VCD004191 v. 9.0 Self-help and guided self-help for eating disorders.rm5
p22539
sg9
V22449893.xml
p22540
sa(dp22541
g3
VSTD-Durand-2003
p22542
sg5
S'PMC1314596'
p22543
sg7
g22539
sg9
V12830564.xml
p22544
sa(dp22545
g3
VSTD-Stone-1979
p22546
sg5
S'PMC1344502'
p22547
sg7
VCD002247 v. 13.0 Primary repair for penetrating colon injuries.rm5
p22548
sg9
V384941.xml
p22549
sa(dp22550
g3
VSTD-Chappius-1991
p22551
sg5
S'PMC1358480'
p22552
sg7
g22548
sg9
V2025069.xml
p22553
sa(dp22554
g3
VSTD-QALS-Study-Group-2009
p22555
sg5
S'PMC2854625'
p22556
sg7
VCD002829 v. 8.0 Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease.rm5
p22557
sg9
V19743457.xml
p22558
sa(dp22559
g3
VSTD-Millet-1982
p22560
sg5
S'PMC181819'
p22561
sg7
VCD001169 v. 14.0 Amantadine and rimantadine for influenza A in adults.rm5
p22562
sg9
V7044294.xml
p22563
sa(dp22564
g3
VSTD-Schapira-1971
p22565
sg5
S'PMC2156417'
p22566
sg7
g22562
sg9
V4947223.xml
p22567
sa(dp22568
g3
VSTD-Hayden-1981
p22569
sg5
S'PMC181399'
p22570
sg7
g22562
sg9
V7347558.xml
p22571
sa(dp22572
g3
VSTD-Nafta-1970
p22573
sg5
S'PMC2427540'
p22574
sg7
g22562
sg9
V5310209.xml
p22575
sa(dp22576
g3
VSTD-Hayden-1986
p22577
sg5
S'PMC176405'
p22578
sg7
g22562
sg9
V3521480.xml
p22579
sa(dp22580
g3
VSTD-Brady-1990
p22581
sg5
S'PMC171896'
p22582
sg7
g22562
sg9
V2285274.xml
p22583
sa(dp22584
g3
VSTD-Smorodintsev-1970
p22585
sg5
S'PMC2427564'
p22586
sg7
g22562
sg9
V5312248.xml
p22587
sa(dp22588
g3
VSTD-Oker_x002d_Blom-1970
p22589
sg5
S'PMC1701794'
p22590
sg7
g22562
sg9
V4919024.xml
p22591
sa(dp22592
g3
VSTD-Younkin-1983
p22593
sg5
S'PMC184704'
p22594
sg7
g22562
sg9
V6859836.xml
p22595
sa(dp22596
g3
VSTD-Hornick-1969d
p22597
sg5
S'PMC2427751'
p22598
sg7
g22562
sg9
V4908341.xml
p22599
sa(dp22600
g3
VSTD-Hornick-1969c
p22601
sg5
S'PMC2427751'
p22602
sg7
g22562
sg9
V4908341.xml
p22603
sa(dp22604
g3
VSTD-Hornick-1969b
p22605
sg5
S'PMC2427751'
p22606
sg7
g22562
sg9
V4908341.xml
p22607
sa(dp22608
g3
VSTD-Hornick-1969a
p22609
sg5
S'PMC2427751'
p22610
sg7
g22562
sg9
V4908341.xml
p22611
sa(dp22612
g3
VSTD-Ferrer-2005
p22613
sg5
S'PMC3666262'
p22614
sg7
VCD006911 v. 6.0 Music interventions for improving psychological and physical outcomes in cancer patients.rm5
p22615
sg9
V23741635.xml
p22616
sa(dp22617
g3
VSTD-Belanger-2009
p22618
sg5
S'PMC2661342'
p22619
sg7
VCD007986 v. 4.0 Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children a.rm5
p22620
sg9
V19436468.xml
p22621
sa(dp22622
g3
VSTD-Koldsland-1993
p22623
sg5
S'PMC464703'
p22624
sg7
VCD002916 v. 9.0 Pleurodesis for malignant pleural effusions.rm5
p22625
sg9
V7692617.xml
p22626
sa(dp22627
g3
VSTD-Lo-1998
p22628
sg5
S'PMC1191296'
p22629
sg7
VCD005440 v. 9.0 Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis.rm5
p22630
sg9
V9563529.xml
p22631
sa(dp22632
g3
VSTD-PEDIG-2006
p22633
sg5
S'PMC1609192'
p22634
sg7
VCD006461 v. 5.0 Interventions for strabismic amblyopia.rm5
p22635
sg9
V16751033.xml
p22636
sa(dp22637
g3
VSTD-PEDIG-2008
p22638
sg5
S'PMC2615691'
p22639
sg7
g22635
sg9
V18789533.xml
p22640
sa(dp22641
g3
VSTD-Laurence-1981
p22642
sg5
S'PMC1505459'
p22643
sg7
VCD007950 v. 2.0 Effects and safety of periconceptional folate supplementation for preventing birth defects.rm5
p22644
sg9
V6786536.xml
p22645
sa(dp22646
g3
VSTD-Kirke-1992
p22647
sg5
S'PMC1793975'
p22648
sg7
g22644
sg9
V1489222.xml
p22649
sa(dp22650
g3
VSTD-Wahl-2008
p22651
sg5
S'PMC2573879'
p22652
sg7
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p22653
sg9
V18831749.xml
p22654
sa(dp22655
g3
VSTD-Liu-2000
p22656
sg5
S'PMC1447620'
p22657
sg7
VCD006061 v. 3.0 Whole grain foods for the prevention of type 2 diabetes mellitus.rm5
p22658
sg9
V10983198.xml
p22659
sa(dp22660
g3
VSTD-Petrowsky-2006
p22661
sg5
S'PMC1856627'
p22662
sg7
VCD007632 v. 1.2 Methods of vascular occlusion for elective liver resections.rm5
p22663
sg9
V17122617.xml
p22664
sa(dp22665
g3
VSTD-Figueras-2005
p22666
sg5
S'PMC1357061'
p22667
sg7
g22663
sg9
V15798459.xml
p22668
sa(dp22669
g3
VSTD-Belghiti-1996
p22670
sg5
S'PMC1235336'
p22671
sg7
g22663
sg9
V8757378.xml
p22672
sa(dp22673
g3
VSTD-Belghiti-1999
p22674
sg5
S'PMC1191702'
p22675
sg7
g22663
sg9
V10077049.xml
p22676
sa(dp22677
g3
VSTD-Mansour-2011
p22678
sg5
S'PMC3233274'
p22679
sg7
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p22680
sg9
V21995590.xml
p22681
sa(dp22682
g3
VSTD-Griffith-2009
p22683
sg5
S'PMC2761503'
p22684
sg7
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p22685
sg9
V19637345.xml
p22686
sa(dp22687
g3
VSTD-Hwang-2008
p22688
sg5
S'PMC2615347'
p22689
sg7
g22685
sg9
V18581595.xml
p22690
sa(dp22691
g3
VSTD-Mustian-2009
p22692
sg5
S'PMC3034389'
p22693
sg7
g22685
sg9
V19831159.xml
p22694
sa(dp22695
g3
VSTD-Hacker-2011
p22696
sg5
S'PMC3085978'
p22697
sg7
g22685
sg9
V21116175.xml
p22698
sa(dp22699
g3
VSTD-Vadiraja-2009b
p22700
sg5
S'PMC2933732'
p22701
sg7
g22685
sg9
V20842268.xml
p22702
sa(dp22703
g3
VSTD-Mutrie-2007
p22704
sg5
S'PMC1819494'
p22705
sg7
g22685
sg9
V17307761.xml
p22706
sa(dp22707
g3
VSTD-Adamsen-2009
p22708
sg5
S'PMC2762035'
p22709
sg7
g22685
sg9
V19826172.xml
p22710
sa(dp22711
g3
VSTD-Oh-2010
p22712
sg5
S'PMC2826100'
p22713
sg7
g22685
sg9
V19880433.xml
p22714
sa(dp22715
g3
VSTD-Moudgil-2000
p22716
sg5
S'PMC1745690'
p22717
sg7
VCD006580 v. 4.0 Culture-specific programs for children and adults from minority groups who have asthma.rm5
p22718
sg9
V10679534.xml
p22719
sa(dp22720
g3
VSTD-Canino-2008
p22721
sg5
S'PMC3136215'
p22722
sg7
g22718
sg9
V18061648.xml
p22723
sa(dp22724
g3
VSTD-Rapp-2006
p22725
sg5
S'PMC1986793'
p22726
sg7
VCD006265 v. 6.0 Case management for persons with substance use disorders.rm5
p22727
sg9
V16616167.xml
p22728
sa(dp22729
g3
VSTD-Morgenstern-2006
p22730
sg5
S'PMC1751803'
p22731
sg7
g22727
sg9
V17018819.xml
p22732
sa(dp22733
g3
VSTD-Liu-2006
p22734
sg5
S'PMC3454905'
p22735
sg7
VCD003854 v. 7.0 Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples.rm5
p22736
sg9
V16496208.xml
p22737
sa(dp22738
g3
VSTD-Voerman-2007
p22739
sg5
S'PMC1915628'
p22740
sg7
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p22741
sg9
V17260162.xml
p22742
sa(dp22743
g3
VSTD-Barratt-1992
p22744
sg5
S'PMC1793542'
p22745
sg7
VCD004110 v. 6.0 Speech and language therapy interventions for children with primary speech and language delay or dis.rm5
p22746
sg9
V1739321.xml
p22747
sa(dp22748
g3
VSTD-Glogowska_x002c_-2000
p22749
sg5
S'PMC27499'
p22750
sg7
g22746
sg9
V11030677.xml
p22751
sa(dp22752
g3
VSTD-P_x00e4_rssinen-1989
p22753
sg5
S'PMC1041798'
p22754
sg7
VCD004916 v. 5.4 Interventions to slow progression of myopia in children.rm5
p22755
sg9
V2667638.xml
p22756
sa(dp22757
g3
VSTD-Schwartz-1981
p22758
sg5
S'PMC3703778'
p22759
sg7
g22755
sg9
V22986450.xml
p22760
sa(dp22761
g3
VSTD-Hwang-2008
p22762
sg5
S'PMC2615347'
p22763
sg7
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p22764
sg9
V18581595.xml
p22765
sa(dp22766
g3
VSTD-Pan-XS-2010
p22767
sg5
S'PMC2553588'
p22768
sg7
VCD003711 v. 7.5 Herbal medicines for viral myocarditis.rm5
p22769
sg9
V18723572.xml
p22770
sa(dp22771
g3
VSTD-Champault-1984
p22772
sg5
S'PMC1463641'
p22773
sg7
VCD001423 v. 12.0 Serenoa repens for benign prostatic hyperplasia.rm5
p22774
sg9
V6207850.xml
p22775
sa(dp22776
g3
VSTD-Barry-2011
p22777
sg5
S'PMC3326341'
p22778
sg7
g22774
sg9
V21954478.xml
p22779
sa(dp22780
g3
VSTD-Sabine-1983
p22781
sg5
S'PMC1427898'
p22782
sg7
VCD003391 v. 7.0 Antidepressants versus placebo for people with bulimia nervosa.rm5
p22783
sg9
V6337607.xml
p22784
sa(dp22785
g3
VSTD-Carey-2005
p22786
sg5
S'PMC547907'
p22787
sg7
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p22788
sg9
V15667657.xml
p22789
sa(dp22790
g3
VSTD-Macsai-2008
p22791
sg5
S'PMC2646454'
p22792
sg7
VCD005556 v. 3.3 Interventions for chronic blepharitis.rm5
p22793
sg9
V19277245.xml
p22794
sa(dp22795
g3
VSTD-Seal-1995
p22796
sg5
S'PMC505018'
p22797
sg7
g22793
sg9
V7880791.xml
p22798
sa(dp22799
g3
VSTD-Hyndiuk-1990
p22800
sg5
S'PMC171652'
p22801
sg7
g22793
sg9
V2344168.xml
p22802
sa(dp22803
g3
VSTD-More-1968
p22804
sg5
S'PMC506604'
p22805
sg7
g22793
sg9
V4872706.xml
p22806
sa(dp22807
g3
VSTD-Mandelbrot-2002
p22808
sg5
S'PMC1744488'
p22809
sg7
VCD003651 v. 7.0 Vaginal disinfection for preventing mother-to-child transmission of HIV infection.rm5
p22810
sg9
V12181464.xml
p22811
sa(dp22812
g3
VSTD-Pearson-2004
p22813
sg5
S'PMC1875562'
p22814
sg7
VCD007982 v. 3.0 Email for the provision of information on disease prevention and health promotion.rm5
p22815
sg9
V6224550.xml
p22816
sa(dp22817
g3
VSTD-Mermelstein-2006
p22818
sg5
S'PMC2373262'
p22819
sg7
VCD007078 v. 6.0 Internet-based interventions for smoking cessation.rm5
p22820
sg9
V17491173.xml
p22821
sa(dp22822
g3
VSTD-Munoz-2006-Study-3
p22823
sg5
S'PMC150356'
p22824
sg7
g22820
sg9
V12509354.xml
p22825
sa(dp22826
g3
VSTD-Strecher-2008
p22827
sg5
S'PMC2697448'
p22828
sg7
g22820
sg9
V18407003.xml
p22829
sa(dp22830
g3
VSTD-Rabius-2008
p22831
sg5
S'PMC2630842'
p22832
sg7
g22820
sg9
V19033146.xml
p22833
sa(dp22834
g3
VSTD-Swartz-2006
p22835
sg5
S'PMC2563640'
p22836
sg7
g22820
sg9
V16436397.xml
p22837
sa(dp22838
g3
VSTD-Stoddard-2008
p22839
sg5
S'PMC2630832'
p22840
sg7
g22820
sg9
V19097974.xml
p22841
sa(dp22842
g3
VSTD-Etter-2005
p22843
sg5
S'PMC1550632'
p22844
sg7
g22820
sg9
V15829474.xml
p22845
sa(dp22846
g3
VSTD-Munoz-2009
p22847
sg5
S'PMC2725004'
p22848
sg7
g22820
sg9
V19640833.xml
p22849
sa(dp22850
g3
VSTD-McKay-2008
p22851
sg5
S'PMC2630830'
p22852
sg7
g22820
sg9
V19017582.xml
p22853
sa(dp22854
g3
VSTD-Brendryen-2008a
p22855
sg5
S'PMC2630841'
p22856
sg7
g22820
sg9
V19087949.xml
p22857
sa(dp22858
g3
VSTD-Ding-1999
p22859
sg5
S'PMC3608539'
p22860
sg7
VCD008305 v. 3.3 Chinese herbal medicines for hypercholesterolemia.rm5
p22861
sg9
V23555827.xml
p22862
sa(dp22863
g3
VSTD-Meyer-2003
p22864
sg5
S'PMC1756013'
p22865
sg7
VCD004863 v. 6.0 Early erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight in.rm5
p22866
sg9
V12496225.xml
p22867
sa(dp22868
g3
VSTD-Carnielli-1998
p22869
sg5
S'PMC1720813'
p22870
sg7
g22866
sg9
V9797624.xml
p22871
sa(dp22872
g3
VSTD-Pullar-1983
p22873
sg5
S'PMC1549364'
p22874
sg7
VCD000958 v. 7.0 Sulfasalazine for treating rheumatoid arthritis.rm5
p22875
sg9
V6138117.xml
p22876
sa(dp22877
g3
VSTD-Danis-1992
p22878
sg5
S'PMC1004800'
p22879
sg7
g22875
sg9
V1358037.xml
p22880
sa(dp22881
g3
VSTD-Wilding-1996
p22882
sg5
S'PMC472646'
p22883
sg7
VCD001285 v. 6.0 Inhaled short acting beta2-agonist use in chronic asthma regular versus as needed treatment.rm5
p22884
sg9
V8977598.xml
p22885
sa(dp22886
g3
VSTD-Taylor-1998
p22887
sg5
S'PMC1745306'
p22888
sg7
g22884
sg9
V10319056.xml
p22889
sa(dp22890
g3
VSTD-Hancox--1999a
p22891
sg5
S'PMC1745487'
p22892
sg7
g22884
sg9
V10335000.xml
p22893
sa(dp22894
g3
VSTD-Chavasse-2000
p22895
sg5
S'PMC1718341'
p22896
sg7
g22884
sg9
V10799426.xml
p22897
sa(dp22898
g3
VSTD-Hancox-1999b
p22899
sg5
S'PMC1745487'
p22900
sg7
g22884
sg9
V10335000.xml
p22901
sa(dp22902
g3
VSTD-Phimda-2007
p22903
sg5
S'PMC2043199'
p22904
sg7
VCD002150 v. 6.0 Antibiotics for treating scrub typhus.rm5
p22905
sg9
V17638700.xml
p22906
sa(dp22907
g3
VSTD-Kim-2007
p22908
sg5
S'PMC1891405'
p22909
sg7
g22905
sg9
V17404000.xml
p22910
sa(dp22911
g3
VSTD-Nickel-1996
p22912
sg5
S'PMC1335066'
p22913
sg7
VCD006015 v. 7.0 Finasteride for benign prostatic hyperplasia.rm5
p22914
sg9
V8911291.xml
p22915
sa(dp22916
g3
VSTD-Thompson-1990
p22917
sg5
S'PMC1405121'
p22918
sg7
VCD001855 v. 11.0 Helmets for preventing head and facial injuries in bicyclists.rm5
p22919
sg9
V2240332.xml
p22920
sa(dp22921
g3
VSTD-Thomas-1994
p22922
sg5
S'PMC2542522'
p22923
sg7
g22919
sg9
V8312768.xml
p22924
sa(dp22925
g3
VSTD-Maimaris-1994
p22926
sg5
S'PMC2540472'
p22927
sg7
g22919
sg9
V8019309.xml
p22928
sa(dp22929
g3
VSTD-Magann-_x0028_M_x0029_-1993b
p22930
sg5
S'PMC2364670'
p22931
sg7
VCD000085 v. 5.0 Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section.rm5
p22932
sg9
V18476211.xml
p22933
sa(dp22934
g3
VSTD-Magann-_x0028_S_x0029_-1993b
p22935
sg5
S'PMC2364670'
p22936
sg7
g22932
sg9
V18476211.xml
p22937
sa(dp22938
g3
VSTD-Earley-2009
p22939
sg5
S'PMC2703581'
p22940
sg7
VCD007834 v. 2.0 Iron for restless legs syndrome.rm5
p22941
sg9
V18280205.xml
p22942
sa(dp22943
g3
VSTD-Nandi-2003
p22944
sg5
S'PMC1746761'
p22945
sg7
VCD006429 v. 3.0 Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.rm5
p22946
sg9
V12885981.xml
p22947
sa(dp22948
g3
VSTD-Leach-1992
p22949
sg5
S'PMC464043'
p22950
sg7
g22946
sg9
V1481177.xml
p22951
sa(dp22952
g3
VSTD-Garrod-1999
p22953
sg5
S'PMC1745430'
p22954
sg7
g22946
sg9
V10325901.xml
p22955
sa(dp22956
g3
VSTD-Davidson-1988
p22957
sg5
S'PMC461601'
p22958
sg7
g22946
sg9
V3238640.xml
p22959
sa(dp22960
g3
VSTD-McKeon-1988a
p22961
sg5
S'PMC461095'
p22962
sg7
g22946
sg9
V3353874.xml
p22963
sa(dp22964
g3
VSTD-Killen-2000
p22965
sg5
S'PMC1745798'
p22966
sg7
g22946
sg9
V10856311.xml
p22967
sa(dp22968
g3
VSTD-Torre-et-al-1998
p22969
sg5
S'PMC105601'
p22970
sg7
VCD005420 v. 5.0 Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor set.rm5
p22971
sg9
V9624473.xml
p22972
sa(dp22973
g3
VSTD-HEP-1986
p22974
sg5
S'PMC1341855'
p22975
sg7
VCD000028 v. 14.0 Pharmacotherapy for hypertension in the elderly.rm5
p22976
sg9
V3094811.xml
p22977
sa(dp22978
g3
VSTD-MRCOA-1992
p22979
sg5
S'PMC1995577'
p22980
sg7
g22976
sg9
V1445513.xml
p22981
sa(dp22982
g3
VSTD-Sprackling-1981
p22983
sg5
S'PMC1507336'
p22984
sg7
g22976
sg9
V6794796.xml
p22985
sa(dp22986
g3
VSTD-Carter-1970
p22987
sg5
S'PMC3327043'
p22988
sg7
g22976
sg9
V22530180.xml
p22989
sa(dp22990
g3
VSTD-Zainudin-1994
p22991
sg5
S'PMC1021158'
p22992
sg7
VCD002742 v. 7.4 Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthma.rm5
p22993
sg9
V8202885.xml
p22994
sa(dp22995
g3
VSTD-Cardozo-1986
p22996
sg5
S'PMC1341914'
p22997
sg7
VCD003101 v. 6.0 Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.rm5
p22998
sg9
V3094775.xml
p22999
sa(dp23000
g3
VSTD-Harrison-1984
p23001
sg5
S'PMC1442189'
p23002
sg7
VCD000081 v. 8.2 Episiotomy for vaginal birth.rm5
p23003
sg9
V6428627.xml
p23004
sa(dp23005
g3
VSTD-Dodd-2010a
p23006
sg5
S'PMC2891044'
p23007
sg7
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p23008
sg9
V20467301.xml
p23009
sa(dp23010
g3
VSTD-Hwang-2008
p23011
sg5
S'PMC2615347'
p23012
sg7
g23008
sg9
V18581595.xml
p23013
sa(dp23014
g3
VSTD-Mustian-2009
p23015
sg5
S'PMC3034389'
p23016
sg7
g23008
sg9
V19831159.xml
p23017
sa(dp23018
g3
VSTD-Dodd-2010b
p23019
sg5
S'PMC2891044'
p23020
sg7
g23008
sg9
V20467301.xml
p23021
sa(dp23022
g3
VSTD-Mutrie-2007
p23023
sg5
S'PMC1819494'
p23024
sg7
g23008
sg9
V17307761.xml
p23025
sa(dp23026
g3
VSTD-Adamsen-2009
p23027
sg5
S'PMC2762035'
p23028
sg7
g23008
sg9
V19826172.xml
p23029
sa(dp23030
g3
VSTD-Oh-2010
p23031
sg5
S'PMC2826100'
p23032
sg7
g23008
sg9
V19880433.xml
p23033
sa(dp23034
g3
VSTD-Wardrope-1985
p23035
sg5
S'PMC1285259'
p23036
sg7
VCD003320 v. 10.0 Anaesthesia for treating distal radial fracture in adults.rm5
p23037
sg9
V3893460.xml
p23038
sa(dp23039
g3
VSTD-Cobb-1985
p23040
sg5
S'PMC1418745'
p23041
sg7
g23037
sg9
V3935242.xml
p23042
sa(dp23043
g3
VSTD-McGlone-1988
p23044
sg5
S'PMC1285492'
p23045
sg7
g23037
sg9
V3408537.xml
p23046
sa(dp23047
g3
VSTD-Kendall-1997
p23048
sg5
S'PMC1342971'
p23049
sg7
g23037
sg9
V9413772.xml
p23050
sa(dp23051
g3
VSTD-London-1996
p23052
sg5
S'PMC1342769'
p23053
sg7
g23037
sg9
V8894860.xml
p23054
sa(dp23055
g3
VSTD-Lepere-2000
p23056
sg5
S'PMC3015374'
p23057
sg7
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p23058
sg9
V10917122.xml
p23059
sa(dp23060
g3
VSTD-Paradise-2005
p23061
sg5
S'PMC1201478'
p23062
sg7
VCD004163 v. 5.0 Identification of children in the first four years of life for early treatment for otitis media with.rm5
p23063
sg9
V16093466.xml
p23064
sa(dp23065
g3
VSTD-McHugh-1988
p23066
sg5
S'PMC1003442'
p23067
sg7
VCD000953 v. 7.0 Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.rm5
p23068
sg9
V2449871.xml
p23069
sa(dp23070
g3
VSTD-Belch-1995
p23071
sg5
S'PMC1005556'
p23072
sg7
g23068
sg9
V7538285.xml
p23073
sa(dp23074
g3
VSTD-North-London-Study
p23075
sg5
S'PMC1629689'
p23076
sg7
VCD001991 v. 10.0 Screening for lung cancer.rm5
p23077
sg9
V5345935.xml
p23078
sa(dp23079
g3
VSTD-Clarke-1993
p23080
sg5
S'PMC1029426'
p23081
sg7
VCD002873 v. 6.0 Short acting beta2-agonists for recurrent wheeze in children under two years of age.rm5
p23082
sg9
V8024294.xml
p23083
sa(dp23084
g3
VSTD-Prendiville-1987a
p23085
sg5
S'PMC460631'
p23086
sg7
g23082
sg9
V2829374.xml
p23087
sa(dp23088
g3
VSTD-Chavasse-1999a
p23089
sg5
S'PMC1718341'
p23090
sg7
g23082
sg9
V10799426.xml
p23091
sa(dp23092
g3
VSTD-Dougados-1999
p23093
sg5
S'PMC1752864'
p23094
sg7
VCD008495 v. 1.2 Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying.rm5
p23095
sg9
V10364900.xml
p23096
sa(dp23097
g3
VSTD-Capell-2007
p23098
sg5
S'PMC1798490'
p23099
sg7
g23095
sg9
V16926184.xml
p23100
sa(dp23101
g3
VSTD-Augensen-1987
p23102
sg5
S'PMC1246355'
p23103
sg7
VCD004945 v. 7.0 Induction of labour for improving birth outcomes for women at or beyond term.rm5
p23104
sg9
V3109575.xml
p23105
sa(dp23106
g3
VSTD-Machiels-1990a
p23107
sg5
S'PMC296531'
p23108
sg7
VCD001186 v. 6.0 Injection allergen immunotherapy for asthma.rm5
p23109
sg9
V2318962.xml
p23110
sa(dp23111
g3
VSTD-Varney-1991
p23112
sg5
S'PMC1668945'
p23113
sg7
g23109
sg9
V1998791.xml
p23114
sa(dp23115
g3
VSTD-Gaddie-1976
p23116
sg5
S'PMC1689452'
p23117
sg7
g23109
sg9
V990806.xml
p23118
sa(dp23119
g3
VSTD-Hill-1982
p23120
sg5
S'PMC1495893'
p23121
sg7
g23109
sg9
V6800440.xml
p23122
sa(dp23123
g3
VSTD-Klaus-1986
p23124
sg5
S'PMC1341377'
p23125
sg7
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p23126
sg9
V3092934.xml
p23127
sa(dp23128
g3
VSTD-Bruggemann-2007
p23129
sg5
S'PMC1936417'
p23130
sg7
g23126
sg9
V17612408.xml
p23131
sa(dp23132
g3
VSTD-Cascinu-1995
p23133
sg5
S'PMC2033463'
p23134
sg7
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p23135
sg9
V7819058.xml
p23136
sa(dp23137
g3
VSTD-Scheithauer-1993
p23138
sg5
S'PMC1677246'
p23139
sg7
g23135
sg9
V7683942.xml
p23140
sa(dp23141
g3
VSTD-Koivunen-2004
p23142
sg5
S'PMC351838'
p23143
sg7
VCD008282 v. 2.0 Adenoidectomy for recurrent or chronic nasal symptoms in children.rm5
p23144
sg9
V14769785.xml
p23145
sa(dp23146
g3
VSTD-Hollingworth-1983
p23147
sg5
S'PMC1549498'
p23148
sg7
VCD004016 v. 6.0 Corticosteroid injections for shoulder pain.rm5
p23149
sg9
V6416401.xml
p23150
sa(dp23151
g3
VSTD-van-der-Windt-1998
p23152
sg5
S'PMC28713'
p23153
sg7
g23149
sg9
V9804720.xml
p23154
sa(dp23155
g3
VSTD-Jacobs-1991
p23156
sg5
S'PMC1670184'
p23157
sg7
g23149
sg9
V1855018.xml
p23158
sa(dp23159
g3
VSTD-Dacre-1989
p23160
sg5
S'PMC1003749'
p23161
sg7
g23149
sg9
V2712613.xml
p23162
sa(dp23163
g3
VSTD-Winters-1997
p23164
sg5
S'PMC2126546'
p23165
sg7
g23149
sg9
V9158469.xml
p23166
sa(dp23167
g3
VSTD-Plafki-2000
p23168
sg5
S'PMC3619854'
p23169
sg7
g23149
sg9
V10774861.xml
p23170
sa(dp23171
g3
VSTD-Richardson-1975
p23172
sg5
S'PMC1864199'
p23173
sg7
g23149
sg9
V53845.xml
p23174
sa(dp23175
g3
VSTD-Bulgen-1984
p23176
sg5
S'PMC1001344'
p23177
sg7
g23149
sg9
V6742895.xml
p23178
sa(dp23179
g3
VSTD-Kikuchi-2006
p23180
sg5
S'PMC2360636'
p23181
sg7
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p23182
sg9
V16804523.xml
p23183
sa(dp23184
g3
VSTD-Hoshiyama-2002
p23185
sg5
S'PMC2364221'
p23186
sg7
g23182
sg9
V12177800.xml
p23187
sa(dp23188
g3
VSTD-Suzuki-2004
p23189
sg5
S'PMC2409667'
p23190
sg7
g23182
sg9
V15054454.xml
p23191
sa(dp23192
g3
VSTD-Inoue-2008
p23193
sg5
S'PMC2574755'
p23194
sg7
g23182
sg9
V18669903.xml
p23195
sa(dp23196
g3
VSTD-Key-1999
p23197
sg5
S'PMC2374337'
p23198
sg7
g23182
sg9
V10584890.xml
p23199
sa(dp23200
g3
VSTD-Li-2008
p23201
sg5
S'PMC2567088'
p23202
sg7
g23182
sg9
V18766189.xml
p23203
sa(dp23204
g3
VSTD-Chao-2008
p23205
sg5
S'PMC2483341'
p23206
sg7
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p23207
sg9
V18317253.xml
p23208
sa(dp23209
g3
VSTD-Wright-2008
p23210
sg5
S'PMC2440307'
p23211
sg7
g23207
sg9
V18261131.xml
p23212
sa(dp23213
g3
VSTD-Zar-2007
p23214
sg5
S'PMC2083341'
p23215
sg7
VCD005536 v. 5.0 Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in childr.rm5
p23216
sg9
V16905564.xml
p23217
sa(dp23218
g3
VSTD-Lub_x002d_Int-9
p23219
sg5
S'PMC3704336'
p23220
sg7
VCD001244 v. 4.0 Excitatory amino acid antagonists for acute stroke.rm5
p23221
sg9
V23709702.xml
p23222
sa(dp23223
g3
VSTD-Sipatrigine-137_x002d_101
p23224
sg5
S'PMC2042617'
p23225
sg7
g23221
sg9
V8799514.xml
p23226
sa(dp23227
g3
VSTD-Eaton-1999
p23228
sg5
S'PMC1508977'
p23229
sg7
VCD008366 v. 3.0 Community wide interventions for increasing physical activity.rm5
p23230
sg9
V10553400.xml
p23231
sa(dp23232
g3
VSTD-Sarrafzadegan-2009
p23233
sg5
S'PMC2649597'
p23234
sg7
g23230
sg9
V19197403.xml
p23235
sa(dp23236
g3
VSTD-O_x0027_Loughlin-1999
p23237
sg5
S'PMC1509008'
p23238
sg7
g23230
sg9
V10589309.xml
p23239
sa(dp23240
g3
VSTD-Evans-1981
p23241
sg5
S'PMC1505984'
p23242
sg7
VCD002885 v. 5.4 Oral xanthines as maintenance treatment for asthma in children.rm5
p23243
sg9
V6788244.xml
p23244
sa(dp23245
g3
VSTD-Glass-1981
p23246
sg5
S'PMC1627266'
p23247
sg7
g23243
sg9
V6791596.xml
p23248
sa(dp23249
g3
VSTD-Conway-1986
p23250
sg5
S'PMC1777982'
p23251
sg7
g23243
sg9
V3535686.xml
p23252
sa(dp23253
g3
VSTD-Edmunds-1980
p23254
sg5
S'PMC1714307'
p23255
sg7
g23243
sg9
V6775752.xml
p23256
sa(dp23257
g3
VSTD-Wilson-1982
p23258
sg5
S'PMC474269'
p23259
sg7
g23243
sg9
V7785004.xml
p23260
sa(dp23261
g3
VSTD-Issenman-1993
p23262
sg5
S'PMC2379847'
p23263
sg7
VCD004390 v. 5.0 Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.rm5
p23264
sg9
V8219860.xml
p23265
sa(dp23266
g3
VSTD-Mackenzie-1991
p23267
sg5
S'PMC1670684'
p23268
sg7
g23264
sg9
V1789830.xml
p23269
sa(dp23270
g3
VSTD-Sharifi-1985
p23271
sg5
S'PMC1777458'
p23272
sg7
g23264
sg9
V3901934.xml
p23273
sa(dp23274
g3
VSTD-Byrne-2003
p23275
sg5
S'PMC1719590'
p23276
sg7
VCD007639 v. 5.0 Nebuliser systems for drug delivery in cystic fibrosis.rm5
p23277
sg9
V12876172.xml
p23278
sa(dp23279
g3
VSTD-Thomas-1991
p23280
sg5
S'PMC463390'
p23281
sg7
g23277
sg9
V1750018.xml
p23282
sa(dp23283
g3
VSTD-Newman-1988
p23284
sg5
S'PMC461220'
p23285
sg7
g23277
sg9
V3406919.xml
p23286
sa(dp23287
g3
VSTD-Mazzella-2001
p23288
sg5
S'PMC1721298'
p23289
sg7
VCD002977 v. 6.0 Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP).rm5
p23290
sg9
V11517199.xml
p23291
sa(dp23292
g3
VSTD-Baharvand-2010
p23293
sg5
S'PMC3232086'
p23294
sg7
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p23295
sg9
V22615593.xml
p23296
sa(dp23297
g3
VSTD-Osman-2010
p23298
sg5
S'PMC2922723'
p23299
sg7
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p23300
sg9
V19703826.xml
p23301
sa(dp23302
g3
VSTD-Schwartz-2008
p23303
sg5
S'PMC2517895'
p23304
sg7
VCD005497 v. 7.0 Advance provision of emergency contraception for pregnancy prevention.rm5
p23305
sg9
V18398664.xml
p23306
sa(dp23307
g3
VSTD-Kumar-2009
p23308
sg5
S'PMC2672933'
p23309
sg7
VCD005481 v. 4.4 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.rm5
p23310
sg9
V19358725.xml
p23311
sa(dp23312
g3
VSTD-Shapiro-2010
p23313
sg5
S'PMC2999916'
p23314
sg7
g23310
sg9
V20554983.xml
p23315
sa.